Citrus Sinensis ID: 003274
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S972 | 847 | Receptor-like serine/thre | yes | no | 0.950 | 0.936 | 0.435 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.950 | 0.951 | 0.419 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.960 | 0.942 | 0.430 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.949 | 0.939 | 0.425 | 1e-178 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.950 | 0.938 | 0.423 | 1e-178 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.966 | 0.949 | 0.414 | 1e-178 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.959 | 0.933 | 0.407 | 1e-167 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.960 | 0.951 | 0.402 | 1e-166 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.949 | 0.940 | 0.390 | 1e-166 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.949 | 0.928 | 0.410 | 1e-165 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 642 bits (1657), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/850 (43%), Positives = 521/850 (61%), Gaps = 57/850 (6%)
Query: 17 FSMKAS--LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTV 73
FS+ AS A +++T +S + + S SQ FELGFF+P S YLGIW++ +P T
Sbjct: 23 FSVYASNFSATESLTISS----NKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTY 78
Query: 74 VWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNPVA-QLRDDGNLV 131
VWVANRD P+S N L IS+N NLV+ Q++ +WSTN++ DV++PVA +L D GN V
Sbjct: 79 VWVANRDNPLSSSNGTLKISDN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFV 137
Query: 132 IRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSG-LERLLSSWQSAEDPSPGRYTY 190
+RD S ++ +LWQSFD P+DTLL DMK+GWD KSG R+L SW++ +DPS G ++
Sbjct: 138 LRD-SKNNKPSGFLWQSFDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFST 196
Query: 191 GLDIHVLPKMCTFNGSVKFTCSGQWDGTGF--VSALSYTNFIYKQFMTENKDEFVYWYEA 248
L P+ +N SG W G F V + ++I F TEN + VY Y
Sbjct: 197 KLRTSGFPEFYIYNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSF-TENNQQVVYSYRV 255
Query: 249 YNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVP----DQY--CGKYGYCGANTICSL 302
L L+ +G + R W E + W +L+ P D Y CG YGYC ANT
Sbjct: 256 NKTNIYSILSLSSTGLLQRLTWMEAAQSWKQLWYSPKDLCDNYKECGNYGYCDANT---- 311
Query: 303 DQTPMCECLEGFKLKSQVNQTR--PIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQ 360
+P+C C++GF+ ++ R + C R C F +L ++ PD S+++
Sbjct: 312 --SPICNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDK 369
Query: 361 SMNLEQCAAECLKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNFT--GQSVYLQV 417
+ L++C CLK C C A+AN+++ G SGC++W G L D IRN+ GQ +Y++V
Sbjct: 370 GIGLKECEERCLKGCNCTAFANTDIRNGGSGCVIWSGGLFD----IRNYAKGGQDLYVRV 425
Query: 418 PTSESGNKKLLWILVV---LVLPLVLLPSFYIFCRRRRKCKEKETENTET-----NQDLL 469
+ +K++ ++ + + ++LL SF IF +RK K T T +QD L
Sbjct: 426 AAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSL 485
Query: 470 AFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPV 529
++ + T++ ++K LPL ++A AT NFS KLG+GGFG V
Sbjct: 486 MNELVKASRSYTSK--------ENKTDYLELPLMEWKALAMATNNFSTDNKLGQGGFGIV 537
Query: 530 YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589
YKG L +G+E+AVKRLS S QG EF NE+ LIA+LQH NLVR+LGCCV++GEK+LI E
Sbjct: 538 YKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYE 597
Query: 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649
Y+ N SLD +LFD + L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLD
Sbjct: 598 YLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLD 657
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
K+M PKISDFG+AR+FG +E + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE
Sbjct: 658 KNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLE 717
Query: 710 TLSSRKNTGVYNTD-SFNLLGHAWDLWKHERVHELMDPV---ILQDEIPLPMLMRYVNVA 765
+S ++N G YN++ NLLG W WK + E++DP+ L E P ++R + +
Sbjct: 718 IISGKRNKGFYNSNRDLNLLGFVWRHWKEGKELEIVDPINIDALSSEFPTHEILRCIQIG 777
Query: 766 LLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGK-NVKNSSYSTSGTSEICSVN 824
LLCVQE A DRP MS V+ M+ +E +P PK+ F G+ +++ S S++ + C+VN
Sbjct: 778 LLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCVGRSSLEVDSSSSTQRDDECTVN 837
Query: 825 DVTVSLVSPR 834
VT+S++ R
Sbjct: 838 QVTLSVIDAR 847
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 638 bits (1646), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/836 (41%), Positives = 505/836 (60%), Gaps = 43/836 (5%)
Query: 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD-TVVWVANRDR 81
++ DT+ +RDGE + S+ +RF GFFS G S+ RY+GIW+ ++ T+VWVANRD
Sbjct: 17 ISVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDH 76
Query: 82 PISGRNAVLTISNNGNLVLLSQTNGT--IWSTNVSSDVKNP--VAQLRDDGNLVIRDNSS 137
PI+ + ++ SN GNL + + N T IWSTNVS + P VA L D GNLV+ D
Sbjct: 77 PINDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFD--- 133
Query: 138 DSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVL 197
T S+ W+SFDHP+DT L M+LG+ K GL+R L+SW+S DP G ++
Sbjct: 134 PVTGRSF-WESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGF 192
Query: 198 PKMCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQFMTENKDEFVYWYEAYNRPSIMT 256
P++ + G + G W G + +I+ N+DE + Y + I
Sbjct: 193 PQLILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITR 252
Query: 257 LKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSL--DQTPMCECLEGF 314
+N +G + R W +W++ +SVP + C Y +CG N C +T C CL GF
Sbjct: 253 TMVNETGTMHRFTWIARDKRWNDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPGF 312
Query: 315 KLKSQ----VNQTRPIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAE 370
+ K + + ++ +S C+ F KL +K PD + S++ ++ L++C
Sbjct: 313 EPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQR 372
Query: 371 CLKNCTCKAYANS--NVTEGS-GCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSE------ 421
CLKNC+C AYA++ G+ GCL W+G +LD+R + +GQ Y++V E
Sbjct: 373 CLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLN--SGQDFYIRVDKEELARWNR 430
Query: 422 ---SGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGIT 478
SG +++L IL+ L+ ++LL + +FC R + K ++ N + FD
Sbjct: 431 NGLSGKRRVLLILISLIAAVMLL-TVILFCVVRERRKSNRHRSSSANFAPVPFD------ 483
Query: 479 TRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQ 538
F E +DK ++ LPLF L ++ AAT NFS Q KLG GGFGPVYKG L N
Sbjct: 484 -----FDESFRFEQDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRM 538
Query: 539 EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDV 598
E+AVKRLS SGQG++EFKNE+ LI++LQHRNLVRILGCCVE EK+L+ EY+PNKSLD
Sbjct: 539 EIAVKRLSRNSGQGMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDY 598
Query: 599 YLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658
++F ++ LDW R+ I++GIA+G+LYLHQ SRLRIIHRDLKASN+LLD +M PKISD
Sbjct: 599 FIFHEEQRAELDWPKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISD 658
Query: 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTG 718
FG+AR+FGG++++G T R+VGT+GYM+PEYA++G FSIKSDV+SFG+LMLE ++ +KN+
Sbjct: 659 FGMARIFGGNQMEGCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSA 718
Query: 719 VYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT 778
++ +S NL+GH WDLW++ E++D ++ Q+ +M+ + + LLCVQENA+DR
Sbjct: 719 -FHEESSNLVGHIWDLWENGEATEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVD 777
Query: 779 MSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
MS VV M+ + NLP PK F + + + SVNDVT S + R
Sbjct: 778 MSSVVIMLGHNATNLPNPKHPAFTSARRRGGENGACLKGQTGISVNDVTFSDIQGR 833
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 635 bits (1637), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 360/837 (43%), Positives = 508/837 (60%), Gaps = 36/837 (4%)
Query: 22 SLAADTMTTAS--FIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD-TVVWVAN 78
S++A+T++ + I + S FELGFF PG YLGIW++ + T VWVAN
Sbjct: 26 SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVAN 85
Query: 79 RDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVS-SDVKNP-VAQLRDDGNLVIRDNS 136
RD P+S L IS++ NLV+L Q++ +WSTN++ DV++P VA+L D+GN V+RD S
Sbjct: 86 RDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRD-S 143
Query: 137 SDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHV 196
+S + LWQSFD P+DTLL +MKLGWD K+G R + SW+S +DPS G +++ L+
Sbjct: 144 KNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEG 203
Query: 197 LPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKDEFVYWYEAYNRPSIM 255
P++ +N + SG W+G F F Y F T +K+E Y +
Sbjct: 204 FPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYS 263
Query: 256 TLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFK 315
L ++ SG + R W E + W++ + P C +Y CG C + +P+C C++GFK
Sbjct: 264 RLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSNTSPVCNCIKGFK 323
Query: 316 LKS-QVNQTRPIK--CERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECL 372
++ QV R C R C G F +L +K PD S+++ + +++C +CL
Sbjct: 324 PRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKCL 383
Query: 373 KNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESGNKKLLW 429
++C C A+AN+++ GSGC+ W G+L D IRN+ GQ +Y+++ ++ +K+
Sbjct: 384 RDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRLAATDLEDKRNRS 439
Query: 430 ILVV---LVLPLVLLPSFYIFCRRRRKCKEK-ETENTETNQDLLAFDINMG---ITTRTN 482
++ + + ++LL SF IF +RK K E + L + D+ M I++R +
Sbjct: 440 AKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEVVISSRRH 499
Query: 483 EFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAV 542
E N D D LPL VA AT NFS KLG+GGFG VYKG+L +GQE+AV
Sbjct: 500 ISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMAV 553
Query: 543 KRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602
KRLS S QG EFKNE+ LIA LQH NLVR+L CCV+ GEK+LI EY+ N SLD +LFD
Sbjct: 554 KRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLFD 613
Query: 603 PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
+ L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK M PKISDFG+A
Sbjct: 614 KSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGMA 673
Query: 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT 722
R+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +SS++N G YN+
Sbjct: 674 RIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYNS 733
Query: 723 D-SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPM--LMRYVNVALLCVQENAADRPTM 779
D NLLG W WK + E++DP+I ++R + + LLCVQE A DRPTM
Sbjct: 734 DRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLLCVQERAEDRPTM 793
Query: 780 SDVVSMISNEHLNLPFPKKLTFV--KGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
S V+ M+ +E +P PK + + +SS S E +VN +TVS++ R
Sbjct: 794 SLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQITVSVLDAR 850
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 626 bits (1614), Expect = e-178, Method: Compositional matrix adjust.
Identities = 354/831 (42%), Positives = 506/831 (60%), Gaps = 39/831 (4%)
Query: 24 AADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTVVWVANRDRP 82
A +++T +S + + S SQ FELGFF+P S YLGIW++ +P T VWVANRD P
Sbjct: 32 ATESLTISS----NKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNP 87
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNPVA-QLRDDGNLVIRDNSSDST 140
+S N L IS N NLV+ Q++ +WSTN++ DV++PVA +L D+GN ++RD+++
Sbjct: 88 LSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNN--- 143
Query: 141 AESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKM 200
LWQSFD P+DTLL +MKLGWD K+G R+L SW++ +DPS G ++ L+ P+
Sbjct: 144 --RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEF 201
Query: 201 CTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKDEFVYWYEAYNRPSIMTLKL 259
+ SG W+G F S Y + T +K+E Y Y L L
Sbjct: 202 YICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYL 261
Query: 260 NPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFK-LKS 318
N +G + R W E + W +L+ P C Y CG C + P C C++GFK +
Sbjct: 262 NSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLPNCYCIKGFKPVNE 321
Query: 319 QVNQTR--PIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCT 376
Q R C R C F +L +K PD +++ + L+ C CL++C
Sbjct: 322 QAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCN 381
Query: 377 CKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESGNKKLLWILVV 433
C A+AN+++ G SGC++W ++LD +RN+ GQ +Y+++ +E +K++ ++
Sbjct: 382 CTAFANADIRNGGSGCVIWTREILD----MRNYAKGGQDLYVRLAAAELEDKRIKNEKII 437
Query: 434 ---LVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFD--INMGITTRTNEFGEVN 488
+ + ++LL SF IF +RK K T T + + D IN + +R +
Sbjct: 438 GSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSK-- 495
Query: 489 GDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ 548
+ K + LPL L ++A AT NFS KLG+GGFG VYKGRL +G+E+AVKRLS
Sbjct: 496 ---EKKSEYLELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKM 552
Query: 549 SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL 608
S QG EF NE+ LIA+LQH NLVR+LGCCV++GEK+LI EY+ N SLD +LFD +
Sbjct: 553 SSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSN 612
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLDK+M PKISDFG+AR+FG +
Sbjct: 613 LNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGRE 672
Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD-SFNL 727
E + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S ++N G YN++ NL
Sbjct: 673 ETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNL 732
Query: 728 LGHAWDLWKHERVHELMDPV---ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784
LG W WK E++DP+ L + P ++R + + LLCVQE A DRP MS V+
Sbjct: 733 LGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGLLCVQERAEDRPVMSSVMV 792
Query: 785 MISNEHLNLPFPKKLTFVKGKN-VKNSSYSTSGTSEICSVNDVTVSLVSPR 834
M+ +E +P PK+ F G++ ++ S S++ + C+VN +T+S++ R
Sbjct: 793 MLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDECTVNQITLSVIDAR 843
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 625 bits (1611), Expect = e-178, Method: Compositional matrix adjust.
Identities = 355/839 (42%), Positives = 517/839 (61%), Gaps = 46/839 (5%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD-TVVWVANRDRPIS 84
+T+ + ++DG+ + S +RF GFFS G SK RY+GIW+ +V + T+VWVANRD PI+
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 85 GRNAVLTISNNGNLVLLSQTNGT--IWSTNVSSDVKNP--VAQLRDDGNLVIRDNSSDST 140
+ ++ S GNL + + NGT IWST+V ++ P VA+L D GNLV+ D T
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLD---PVT 139
Query: 141 AESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKM 200
+S+ W+SF+HP++TLL MK G+ +SG++R+++SW+S DP G TY ++ P+M
Sbjct: 140 GKSF-WESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFPQM 198
Query: 201 CTFNGSVKFTCSGQWDGTGFVSALSYTN-FIYKQFMTENKDEFVYWYEAYNRPSIMTLKL 259
+ G + +G W G + TN FI+ N DE Y + + L
Sbjct: 199 MMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRMVL 258
Query: 260 NPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPM--CECLEGFKLK 317
N +G + R W+ KW +S P+ C Y +CG N C T C CL G++ K
Sbjct: 259 NETGTLQRFRWNGRDKKWIGFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLPGYEPK 318
Query: 318 SQVN---QTRPIKCERSHSSECTRGTQ-FKKLDNVKAPDFINVSLNQSMNLEQCAAECLK 373
+ + + C R + G + F KL VK P+ V+++ ++ L++C CLK
Sbjct: 319 TPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECEQRCLK 378
Query: 374 NCTCKAYANS---NVTEGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSE--------- 421
NC+C AYA++ + GCL W+G++LD+R + +GQ YL+V SE
Sbjct: 379 NCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLS--SGQDFYLRVDKSELARWNGNGA 436
Query: 422 SGNKKLLWILVVLV-LPLVLLPSFYIFCRRRR-KCKEKETENTETNQDLLAFDINMGITT 479
SG K+L+ IL+ L+ + ++LL SF+ + R+RR + + ++ +FD+
Sbjct: 437 SGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDSFIL 496
Query: 480 RTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQE 539
E DK + LPLF L+++A AT NF+ Q KLG GGFGPVYKG L NG E
Sbjct: 497 EELE---------DKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGME 547
Query: 540 VAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVY 599
+AVKRLS SGQG++EFKNE+ LI++LQHRNLVRILGCCVE EK+L+ EY+PNKSLD +
Sbjct: 548 IAVKRLSKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYF 607
Query: 600 LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659
+F ++ LDW R+ II+GI +G+LYLHQ SRLRIIHRDLKASNVLLD +M PKI+DF
Sbjct: 608 IFHEEQRAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADF 667
Query: 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGV 719
GLAR+FGG++++G+T R+VGTYGYMSPEYA+DG FSIKSDV+SFG+L+LE ++ ++N+
Sbjct: 668 GLARIFGGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF 727
Query: 720 YNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTM 779
Y +S NL+ H WD W++ E++D ++ ++ +M+ +++ LLCVQEN++DRP M
Sbjct: 728 YE-ESLNLVKHIWDRWENGEAIEIIDKLMGEETYDEGEVMKCLHIGLLCVQENSSDRPDM 786
Query: 780 SDVVSMISNEHLNLPFPKKLTFVKG--KNVKNSSYSTSGTSEICS--VNDVTVSLVSPR 834
S VV M+ + ++LP PK F G +N K S + S S +NDVT++ V R
Sbjct: 787 SSVVFMLGHNAIDLPSPKHPAFTAGRRRNTKTGGSSDNWPSGETSSTINDVTLTDVQGR 845
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1610), Expect = e-178, Method: Compositional matrix adjust.
Identities = 353/852 (41%), Positives = 532/852 (62%), Gaps = 46/852 (5%)
Query: 13 LIFLFSMKASLAADTMTTASFIRDG---EKLTSSSQRFELGFFSPGKSKSRYLGIWFRRV 69
++ F ++S+AA+T+ +RDG + L S + FELGFFSPG S R+LGIW+ +
Sbjct: 14 FLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIWYGNI 73
Query: 70 PD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDV---KNPVAQLR 125
D VVWVANR PIS ++ VL ISN+GNLVLL N T+WS+N+ S N V +
Sbjct: 74 EDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVSIH 133
Query: 126 DDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSP 185
D GN V+ + +D +W+SF+HP+DT L M++ + ++G SW+S DPSP
Sbjct: 134 DTGNFVLSETDTDRP----IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189
Query: 186 GRYTYGLDIHVLPKMCTFNGS-VKFTCSGQWDG---TGFVSALSYTNFIYKQFMTENKDE 241
G Y+ G+D P++ + G+ + SGQW+ TG + TN++Y ++ DE
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPDE 249
Query: 242 F--VYWYEAYNRPSIM-TLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANT 298
VY+ + PS++ K+ +G W+E KW + S PD C +Y CG
Sbjct: 250 TGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKFG 309
Query: 299 ICSLDQT-PMCECLEGFKLKSQVNQTR------PIKCERSHSSECTRGTQFKKLDNVKAP 351
IC + + +C C+ G++ S N +R P+KCER+ S +F L +VK P
Sbjct: 310 ICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKCERNIS---VGEDEFLTLKSVKLP 366
Query: 352 DFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT-- 409
DF + + ++ E C CL+NC+C AY+ + G GC++W DL+D ++ F
Sbjct: 367 DF-EIPEHNLVDPEDCRERCLRNCSCNAYS---LVGGIGCMIWNQDLVD----LQQFEAG 418
Query: 410 GQSVYLQVPTSESGN--KKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQD 467
G S+++++ SE G K + ++V +++ ++L+ F + R ++ K+ N D
Sbjct: 419 GSSLHIRLADSEVGENRKTKIAVIVAVLVGVILIGIFALLLWRFKRKKDVSGAYCGKNTD 478
Query: 468 --LLAFDINMGITTRTNEFGEVNGDGKDKGKD-SWLPLFSLASVAAATENFSMQCKLGEG 524
++ D+ T + G V+ + K + S LP+FSL ++A AT +F + +LG G
Sbjct: 479 TSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENELGRG 538
Query: 525 GFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584
GFGPVYKG L +G+E+AVKRLS +SGQG+ EFKNE++LIA+LQHRNLVR+LGCC E EK
Sbjct: 539 GFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEK 598
Query: 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKAS 644
+L+ EYMPNKSLD +LFD K+ L+DW+ R II+GIA+GLLYLH+ SRLRIIHRDLK S
Sbjct: 599 MLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVS 658
Query: 645 NVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFG 704
NVLLD +MNPKISDFG+AR+FGG++ + NT R+VGTYGYMSPEYA++GLFS+KSDV+SFG
Sbjct: 659 NVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFG 718
Query: 705 ILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNV 764
+L+LE +S ++NT + +++ +L+G+AW L+ H R EL+DP I + +R ++V
Sbjct: 719 VLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTHGRSEELVDPKI-RVTCSKREALRCIHV 777
Query: 765 ALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKG-KNVKNSSYSTSGTSE-ICS 822
A+LCVQ++AA+RP M+ V+ M+ ++ L P++ TF +N + +++ + + I S
Sbjct: 778 AMLCVQDSAAERPNMASVLLMLESDTATLAAPRQPTFTSTRRNSIDVNFALDSSQQYIVS 837
Query: 823 VNDVTVSLVSPR 834
N++T ++V R
Sbjct: 838 SNEITSTVVLGR 849
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 588 bits (1517), Expect = e-167, Method: Compositional matrix adjust.
Identities = 355/871 (40%), Positives = 508/871 (58%), Gaps = 71/871 (8%)
Query: 7 FGIFCSLIFLFSMKASLAADTMTTAS--FIRDGEKLTSSSQRFELGFFSPGKSKSR-YLG 63
F + ++ L S+ +T+++ I + L S FE+GFF ++ SR YLG
Sbjct: 15 FLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWYLG 71
Query: 64 IWFRRVPD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVS-SDVKNPV 121
+W+++V D T VWVANRD P+S L IS N NLVLL +N +W TN++ + ++PV
Sbjct: 72 MWYKKVSDRTYVWVANRDNPLSNAIGTLKISGN-NLVLLDHSNKPVWWTNLTRGNERSPV 130
Query: 122 -AQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSA 180
A+L +GN V+RD SS++ A YLWQSFD+P+DTLL +MKLG++ K+GL R L+SW+S+
Sbjct: 131 VAELLANGNFVMRD-SSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSWRSS 189
Query: 181 EDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFV-----SALSYT--NFIYKQ 233
+DPS G ++Y L+ LP+ + SG W+G F LSY NFI
Sbjct: 190 DDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFI--- 246
Query: 234 FMTENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVP-DQYCGKYG 292
EN +E Y + N L L G+ R W + W+ +S P D C Y
Sbjct: 247 ---ENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRFWSSPVDPQCDTYI 303
Query: 293 YCGANTICSLDQTPMCECLEGFKLKSQVNQTRPI---KCERSHSSECTRGTQFKKLDNVK 349
CG C ++ +P+C C++GF ++ + + C R C+ G F ++ +K
Sbjct: 304 MCGPYAYCDVNTSPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMK 362
Query: 350 APDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNF 408
P+ ++++S+ +++C C+ +C C A+AN+++ G SGC++W L D IRN+
Sbjct: 363 LPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLED----IRNY 418
Query: 409 T-----GQSVYLQVPTSESGNKK----LLWILVVLVLPLVLLPSFYIFCRRRRKCKEKET 459
GQ +Y+++ ++ K+ + L V V L+LL F ++ R++++ K
Sbjct: 419 ATDAIDGQDLYVRLAAADIAKKRNASGKIISLTVGVSVLLLLIMFCLWKRKQKRAKASAI 478
Query: 460 E--NTETNQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSM 517
NT+ NQ+L +N + + EF G+ K ++ LPL + +V ATENFS
Sbjct: 479 SIANTQRNQNL---PMNEMVLSSKREFS-----GEYKFEELELPLIEMETVVKATENFSS 530
Query: 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGC 577
KLG+GGFG VYKGRL +G+E+AVKRLS S QG EF NE+ LIA LQH NLV++LGC
Sbjct: 531 CNKLGQGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGC 590
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
C+E EK+LI EY+ N SLD YLF ++ L+W R I G+A+GLLYLHQ SR RII
Sbjct: 591 CIEGDEKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRII 650
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
HRDLK SN+LLDK+M PKISDFG+AR+F DE + NT ++VGTYGYMSPEYA+ G+FS K
Sbjct: 651 HRDLKVSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEK 710
Query: 698 SDVFSFGILMLETLSSRKNTGVYNTDSFN-LLGHAWDLWKHERVHELMDPVIL-----QD 751
SDVFSFG+++LE +S +KN G YN D N LL + W WK R E++DPVI+ Q
Sbjct: 711 SDVFSFGVIVLEIVSGKKNRGFYNLDYENDLLSYVWSRWKEGRALEIVDPVIVDSLSSQP 770
Query: 752 EIPLPM-LMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNS 810
I P +++ + + LLCVQE A RP MS VV M +E +P PK G V+ S
Sbjct: 771 SIFQPQEVLKCIQIGLLCVQELAEHRPAMSSVVWMFGSEATEIPQPKP----PGYCVRRS 826
Query: 811 SYSTSGTS-------EICSVNDVTVSLVSPR 834
Y +S E +VN T S++ R
Sbjct: 827 PYELDPSSSWQCDENESWTVNQYTCSVIDAR 857
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 587 bits (1513), Expect = e-166, Method: Compositional matrix adjust.
Identities = 342/849 (40%), Positives = 498/849 (58%), Gaps = 48/849 (5%)
Query: 13 LIF--LFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRV- 69
LIF L S + +++ T IR+G+ L S + FELGFF+P S RY+GIW++ +
Sbjct: 15 LIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVGIWYKNIE 74
Query: 70 PDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGN 129
P TVVWVANR++P+ L I+++GNLV+++ N TIWSTNV + N VA L G+
Sbjct: 75 PQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNNTVAVLFKTGD 134
Query: 130 LVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYT 189
LV+ SDS + W+SF++P+DT L M++ + G R W+S DPSPG+Y+
Sbjct: 135 LVL---CSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPSPGKYS 191
Query: 190 YGLDIHVLPKMCTFNGSVKFTCSGQWDG---TGFVSALSYTNFIY--KQFMTENKDEFVY 244
G+D ++ + G + SG W+ TG L +TN+IY K ++D VY
Sbjct: 192 MGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDMLRFTNYIYGFKLSSPPDRDGSVY 251
Query: 245 W-YEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
+ Y A + + + P G + W+++ W+ L P C KY CG ++C
Sbjct: 252 FTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRCGNYSVCDDS 311
Query: 304 Q---TPMCECLEGFKLKSQ-----------VNQTRPIKCERSHSSECTRGTQFKKLDNVK 349
+ + C C++GF+ Q + P+ C +S + G F L +K
Sbjct: 312 KEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLVAGQEDG--FTVLKGIK 369
Query: 350 APDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT 409
PDF +V L+ N E C C ++C+CKAYA + G GC++W DL+D R
Sbjct: 370 VPDFGSVVLHN--NSETCKDVCARDCSCKAYA---LVVGIGCMIWTRDLIDMEHFERG-- 422
Query: 410 GQSVYLQVPTSESGNKK---LLWILVVLVLPLVLLP-SFYIFCRRRRKCKEKETENTETN 465
G S+ +++ S+ G K LWI+V V+ LL +I + ++ K +
Sbjct: 423 GNSINIRLAGSKLGGGKENSTLWIIVFSVIGAFLLGLCIWILWKFKKSLKAFLWKK---- 478
Query: 466 QDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGG 525
+D+ DI ++ + GD D LP+FS SVA+AT +F+ + KLG+GG
Sbjct: 479 KDITVSDIIENRDYSSSPIKVLVGDQVDTPD---LPIFSFDSVASATGDFAEENKLGQGG 535
Query: 526 FGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585
FG VYKG G+E+AVKRLS +S QGL+EFKNE++LIA+LQHRNLVR+LGCC+E EK+
Sbjct: 536 FGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKM 595
Query: 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645
L+ EYMPNKSLD +LFD K+ LDW R +I GIA+GLLYLH+ SRL+IIHRDLKASN
Sbjct: 596 LLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASN 655
Query: 646 VLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
+LLD +MNPKISDFG+AR+F + NT R+VGTYGYM+PEYA++G+FS KSDV+SFG+
Sbjct: 656 ILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGV 715
Query: 706 LMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVA 765
L+LE +S RKN TD +L+G+AW LW + E++DP++ +D + MR ++V
Sbjct: 716 LILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGKTKEMIDPIV-KDTRDVTEAMRCIHVG 774
Query: 766 LLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVND 825
+LC Q++ RP M V+ M+ ++ LP P++ TF N + + G ++ SVND
Sbjct: 775 MLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQPTFHSFLNSGDIELNFDG-HDVASVND 833
Query: 826 VTVSLVSPR 834
VT + + R
Sbjct: 834 VTFTTIVGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 584 bits (1506), Expect = e-166, Method: Compositional matrix adjust.
Identities = 330/845 (39%), Positives = 493/845 (58%), Gaps = 53/845 (6%)
Query: 18 SMKASLAADTMTTASFIRDGEK--LTSSSQRFELGFFSPGKSKSR--YLGIWFRRVP-DT 72
S + D +T +S I+D E L S F GFF+P S +R Y+GIW+ ++P T
Sbjct: 23 SRRLCFGEDRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQT 82
Query: 73 VVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVA---QLRDDGN 129
VVWVAN+D PI+ + V++I +GNL + N +WSTNVS V P A QL D GN
Sbjct: 83 VVWVANKDSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVA-PNATWVQLMDSGN 141
Query: 130 LVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYT 189
L+++DN ++ LW+SF HP D+ + M LG D ++G L+SW S +DPS G YT
Sbjct: 142 LMLQDNRNNG---EILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYT 198
Query: 190 YGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQFMTENKDEFVYWYEAY 249
G+ P++ + +V SG W+G F+ + + ++ N D +Y
Sbjct: 199 AGIAPFTFPELLIWKNNVPTWRSGPWNGQVFIGLPNMDSLLFLDGFNLNSDNQGTISMSY 258
Query: 250 NRPSIM-TLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMC 308
S M L+P G + ++ W + W P C YG CG C + P C
Sbjct: 259 ANDSFMYHFNLDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPC 318
Query: 309 ECLEGFKLKSQVN-----------QTRPIKCER----SHSSECTRGTQFKKLDNVKAPDF 353
+C++GF K+ + P++CER S+ + F KL +K P
Sbjct: 319 KCVKGFVPKNNTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVP-- 376
Query: 354 INVSLNQSMNLEQ-CAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFTGQS 412
+S +S EQ C CL NC+C AYA G GC++W GDL+D +++F G
Sbjct: 377 --ISAERSEASEQVCPKVCLDNCSCTAYA---YDRGIGCMLWSGDLVD----MQSFLGSG 427
Query: 413 V--YLQVPTSESGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLA 470
+ +++V SE L +++ + V+L + RK K++ + + +L+
Sbjct: 428 IDLFIRVAHSELKTHSNLAVMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELM- 486
Query: 471 FDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVY 530
R N ++ K LPLF +A +T++FS++ KLG+GGFGPVY
Sbjct: 487 -------FKRMEALTSDNESASNQIKLKELPLFEFQVLATSTDSFSLRNKLGQGGFGPVY 539
Query: 531 KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590
KG+L GQE+AVKRLS +SGQGL+E NE+++I++LQHRNLV++LGCC+E E++L+ EY
Sbjct: 540 KGKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEY 599
Query: 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650
MP KSLD YLFDP+K+++LDW+ R I++GI +GLLYLH+ SRL+IIHRDLKASN+LLD+
Sbjct: 600 MPKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDE 659
Query: 651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
++NPKISDFGLAR+F +E + NT+R+VGTYGYMSPEYA++G FS KSDVFS G++ LE
Sbjct: 660 NLNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSLGVIFLEI 719
Query: 711 LSSRKNTGVYNTD-SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCV 769
+S R+N+ + + + NLL +AW LW L DP + D+ + + V++ LLCV
Sbjct: 720 ISGRRNSSSHKEENNLNLLAYAWKLWNDGEAASLADPAVF-DKCFEKEIEKCVHIGLLCV 778
Query: 770 QENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVS 829
QE A DRP +S+V+ M++ E+++L PK+ F+ + + S+ +S+ S+NDV+++
Sbjct: 779 QEVANDRPNVSNVIWMLTTENMSLADPKQPAFIVRRGASEAE-SSDQSSQKVSINDVSLT 837
Query: 830 LVSPR 834
V+ R
Sbjct: 838 AVTGR 842
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 583 bits (1503), Expect = e-165, Method: Compositional matrix adjust.
Identities = 347/846 (41%), Positives = 504/846 (59%), Gaps = 54/846 (6%)
Query: 22 SLAADTM--TTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD-TVVWVAN 78
S++ +T+ T + I + + S FELGFF S YLGIW++++ T VWVAN
Sbjct: 29 SISVNTLSATESLTISSNKTIVSPGGVFELGFFRI-LGDSWYLGIWYKKISQRTYVWVAN 87
Query: 79 RDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPV-AQLRDDGNLVIRDNSS 137
RD P+S +L ISN NLV+L ++ +WSTN++ V++ V A+L D+GN V+R +
Sbjct: 88 RDTPLSNPIGILKISN-ANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKI 146
Query: 138 DSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVL 197
+ + E +LWQSFD P+DTLL MKLG D K GL R ++SW+S+ DPS G + + L+ L
Sbjct: 147 NESDE-FLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGL 205
Query: 198 PKMCTFNGSVKFTCSGQWDG---TGFVSALSYTNFIYKQFMTENKDEFVYWYEAYNRPSI 254
P+ F ++ SG WDG +G + + + IY TEN++E Y + + S
Sbjct: 206 PEFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYN--FTENREEVAYTFRVTDHNSY 263
Query: 255 MTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGF 314
L +N G + +W+ +W+ + +P C YG CG C + +P C C++GF
Sbjct: 264 SRLTINTVGRLEGFMWEPTQQEWNMFWFMPKDTCDLYGICGPYAYCDMSTSPTCNCIKGF 323
Query: 315 K-LKSQVNQTRPI--KCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAEC 371
+ L Q + + +C R C +F +L N+K P +++ + L++C +C
Sbjct: 324 QPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEKC 382
Query: 372 LKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESGNKK-- 426
+C C AYANS++ G SGC++W G+ R IRN+ GQ +++++ +E G ++
Sbjct: 383 KTHCNCTAYANSDIRNGGSGCIIWIGEF----RDIRNYAADGQDLFVRLAAAEFGERRTI 438
Query: 427 -LLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGITTRTNEFG 485
I +++ + L+L+ SF I+C ++K K A +G R E
Sbjct: 439 RGKIIGLIIGISLMLVLSFIIYCFWKKKQKRAR-----------ATAAPIGYRDRIQELI 487
Query: 486 EVNGDGKDKGK-------DSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQ 538
NG G+ D LPL +V ATENFS LG GGFG VYKGRL +GQ
Sbjct: 488 ITNGVVMSSGRRLLGEEEDLELPLTEFETVVMATENFSDSNILGRGGFGIVYKGRLLDGQ 547
Query: 539 EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDV 598
E+AVKRLS S QG EFKNE+ LIA LQH NLVR+L CC+ EKILI EY+ N SLD
Sbjct: 548 EIAVKRLSEMSSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDS 607
Query: 599 YLFDPIKK-RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657
+LF+ + L+W+ R II GIA+GLLYLHQ SR +IIHRDLKASNVLLDK+M PKIS
Sbjct: 608 HLFETTQSSNKLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKIS 667
Query: 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNT 717
DFG+AR+F DE + NT+++VGTYGYMSPEYA++G+FS+KSDVFSFG+L+LE +S ++N
Sbjct: 668 DFGMARIFERDETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNR 727
Query: 718 GVYNT-DSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPM-----LMRYVNVALLCVQE 771
G +N+ NLLG+ W+ WK + E++D +I+ + + ++R + + LLCVQE
Sbjct: 728 GFHNSGQDNNLLGYTWENWKEGKGLEIVDSIIVDSSSSMSLFQPHEVLRCIQIGLLCVQE 787
Query: 772 NAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGK---NVKNSSYSTSGTSEICSVNDVTV 828
A DRP MS VV M+ +E +P PK+ + G+ + +SS ST SE +VN +TV
Sbjct: 788 RAEDRPKMSSVVLMLGSEKGEIPQPKRPGYCVGRSSLDTADSSSSTKRDSESLTVNQITV 847
Query: 829 SLVSPR 834
S+++ R
Sbjct: 848 SVINAR 853
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | ||||||
| 359493711 | 1081 | PREDICTED: G-type lectin S-receptor-like | 0.926 | 0.715 | 0.473 | 0.0 | |
| 224115098 | 802 | predicted protein [Populus trichocarpa] | 0.948 | 0.986 | 0.466 | 0.0 | |
| 224124250 | 820 | predicted protein [Populus trichocarpa] | 0.930 | 0.946 | 0.465 | 0.0 | |
| 356545297 | 824 | PREDICTED: G-type lectin S-receptor-like | 0.956 | 0.968 | 0.473 | 0.0 | |
| 224126243 | 836 | predicted protein [Populus trichocarpa] | 0.948 | 0.946 | 0.470 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.955 | 0.959 | 0.458 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.946 | 0.971 | 0.455 | 0.0 | |
| 359493713 | 1988 | PREDICTED: uncharacterized protein LOC10 | 0.926 | 0.388 | 0.479 | 0.0 | |
| 356514895 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.961 | 0.976 | 0.464 | 0.0 | |
| 356514897 | 821 | PREDICTED: G-type lectin S-receptor-like | 0.949 | 0.964 | 0.469 | 0.0 |
| >gi|359493711|ref|XP_002281022.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 730 bits (1885), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/823 (47%), Positives = 512/823 (62%), Gaps = 50/823 (6%)
Query: 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPIS 84
AD++ I D E L SS Q FELGFFSPG SK+RYLGIW++ P T VWVANR+ PI+
Sbjct: 296 ADSIRMDQSISDSETLVSSGQSFELGFFSPGSSKNRYLGIWYKNTPQTAVWVANRNNPIA 355
Query: 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESY 144
VLTI NNG LVLL+Q+ IWS N+S +NPVAQL + GNLV+RD S++ T++SY
Sbjct: 356 DSYGVLTIINNGALVLLNQSKSVIWSPNLSRVPENPVAQLLETGNLVLRDGSNE-TSKSY 414
Query: 145 LWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFN 204
+WQSFD PSDT+L MK+GW+ K+GL+R L+SW+S++DPS G ++YG DI+VLP +
Sbjct: 415 IWQSFDDPSDTMLPGMKVGWNLKTGLQRKLTSWKSSDDPSLGDFSYGFDINVLPYLVLGV 474
Query: 205 GSVKFTCSGQWDGTGFVSALSYTNFIYKQFMTENKDEFVYWYEAYNRPSIMTLKLNPSGF 264
GS K SG W+G F N +YK N DE YE+ N I L LN SGF
Sbjct: 475 GSSKIVRSGPWNGLEFNGVYVLDNSVYKAVFVANNDEVYALYESNNNKIISRLTLNHSGF 534
Query: 265 VTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFKLKSQVNQ-- 322
+ R + + S+ WDEL+S+P + C YG+CGAN IC + + +CECL GF KSQ
Sbjct: 535 LQRLLLKKGSSVWDELYSIPSELCENYGHCGANGICRIGKLQICECLTGFTPKSQEEWDM 594
Query: 323 -TRPIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYA 381
C R +C F K+ VK PD I+ + ++L +C CL NC+C AYA
Sbjct: 595 FNTSSGCTRRMPLDCQIEEGFVKVTGVKLPDLIDFHVIMGVSLRECKVSCLNNCSCTAYA 654
Query: 382 NSNVTEGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSESG------NKKLLWILVVLV 435
+N GCLMW GDL+D R + +Y+++ TSE G KKL+ ILV+
Sbjct: 655 YTNPNGSGGCLMWSGDLIDIRELTSEKHAEDIYIRMHTSELGLNTNQKKKKLVIILVIST 714
Query: 436 LPLVL---LPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGITTRTNEFGEVNGDGK 492
+L L ++ F ++R ++E++ + N +L FD
Sbjct: 715 FSGILTLGLSFWFRFWKKRTMGTDQESK--KENLELPLFD-------------------- 752
Query: 493 DKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG 552
L ++A AT NFS K+G GGFG VYKG L G VAVKRLS S QG
Sbjct: 753 ------------LPTIATATNNFSNTNKIGAGGFGSVYKGNLPEGVAVAVKRLSKNSAQG 800
Query: 553 LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWE 612
++EFKNE +LIA+LQH+NLVR+LGCC++ E+IL+ EYMPNKSLD ++FD ++ LL W+
Sbjct: 801 VQEFKNEAVLIAKLQHKNLVRLLGCCIQGEERILLYEYMPNKSLDYFIFDQNRRALLAWD 860
Query: 613 ARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672
R I+ GIA+GLLYLHQ SR +IIHRDLK SN+LLD ++NPKISDFGLAR+FG +E++
Sbjct: 861 KRCEIVMGIARGLLYLHQDSRFQIIHRDLKTSNILLDDNLNPKISDFGLARIFGENEMET 920
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD-SFNLLGHA 731
TKRIVGTYGYMSPEY +DG FSIK DVFSFG+L+LE +S KN G + D NLLGHA
Sbjct: 921 RTKRIVGTYGYMSPEYVIDGHFSIKLDVFSFGVLLLEIVSGEKNRGFSHPDHHHNLLGHA 980
Query: 732 WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791
W LW+ R ELMD L+D ++R + V LLCVQ ADRP MS V+ M+ NE
Sbjct: 981 WLLWEQNRALELMD-ACLEDSCVASQVLRCIQVGLLCVQNLPADRPAMSSVIFMLGNEGA 1039
Query: 792 NLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
LP PK F ++ ++ + SG E+ S N VT+S++ R
Sbjct: 1040 TLPQPKHPGFFTERSSVDTD-TMSGKIELHSENAVTISMLKGR 1081
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224115098|ref|XP_002316939.1| predicted protein [Populus trichocarpa] gi|222860004|gb|EEE97551.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 717 bits (1852), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 394/845 (46%), Positives = 520/845 (61%), Gaps = 54/845 (6%)
Query: 1 MAILPCFGIFCSLIFLFSMK-ASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKS 59
M LP F IF S +F+ S+ S +AD +T ++DG+ L S SQ FELGFFSPG SK
Sbjct: 1 MESLPFF-IFFSTLFIQSLHFLSFSADIITPDLPVKDGQTLISVSQSFELGFFSPGTSKY 59
Query: 60 RYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKN 119
RY+GIW+++ P+TVVWVANR+ P++ VLTI N GNLVLL Q IWS+N SS +
Sbjct: 60 RYVGIWYKKSPETVVWVANRNNPLTDHFGVLTIDNRGNLVLLDQIKNIIWSSNSSSIIAG 119
Query: 120 PVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQS 179
PVAQL D GNLV+RDN S ESY WQSFD PSDTLL MKLGW+ K+G ER L +W+S
Sbjct: 120 PVAQLLDSGNLVVRDNGSSRNTESYRWQSFDQPSDTLLPGMKLGWNLKTGQERYLITWRS 179
Query: 180 AEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQFMTENK 239
DPSPG +TY LDIH LP++ GSVK SG W+G F N +++ + N+
Sbjct: 180 ISDPSPGDFTYRLDIHGLPQLFIVVGSVKKVRSGPWNGIFFGGTPKVHNSVFEPILVRNE 239
Query: 240 DEFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTI 299
DE Y Y N L LN SG V R + ++ W ++SVP C YG CGAN I
Sbjct: 240 DEIYYTYRLLNNSVCSRLTLNQSGAVERLVMYGQNSGWTTIYSVPVDTCENYGQCGANGI 299
Query: 300 CSLDQTPMCECLEGFKLKSQ-----VNQTRPIKCERSHSSECTRGTQFKKLDNVKAPDFI 354
C +P+CECL+GFK + N KCE + +C G F KL VK PD +
Sbjct: 300 CRTRTSPICECLKGFKSIPEEELDIQNFYGSRKCETRLTLDCQSGEGFLKLPGVKLPDLL 359
Query: 355 NVSLNQSMNLEQCAAECLKNCTCKAYANSNVT---EGSGCLMWYGDLLDSRRPIRNFTGQ 411
LN+SMNL++C AEC KNC+C A+A +N++ +GSGCLMW+G+L+D R + GQ
Sbjct: 360 EFRLNESMNLKECEAECFKNCSCSAFATTNLSGGGDGSGCLMWFGNLIDIREQSGSTIGQ 419
Query: 412 SVYLQVPTSESGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAF 471
++++VP SE R K K+ T + A
Sbjct: 420 DIHIRVPASE--------------------------LEMARSSKRKKMLKTALVASMSAL 453
Query: 472 DINMGITTRTNEFGEVNGDGKDKGKDSW-LPLFSLASVAAATENFSMQCKLGEGGFGPVY 530
+GI G D+ K+ PLF L ++A AT NF+ +G GGFG VY
Sbjct: 454 ---LGIFV----------SGMDRRKEGMEAPLFDLDTIATATNNFAPDSIIGAGGFGSVY 500
Query: 531 KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590
KG+L GQE+AVK+LS SGQG++EF+NE++LIA+LQHRNLV +LG C+ + E++LI EY
Sbjct: 501 KGKLLTGQEIAVKKLSMNSGQGVEEFRNEVVLIAKLQHRNLVGLLGSCIHREERMLIYEY 560
Query: 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650
MPNKSLD ++FD + LL W+ R II GIA+GLLYLHQ S+L+I+HRDLK SNVLLD
Sbjct: 561 MPNKSLDYFIFDHERSALLGWKERFVIILGIARGLLYLHQDSKLQIVHRDLKPSNVLLDS 620
Query: 651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
++ PKISDFGLAR+ G D + T+R++GTYGYM+PEYA+DG FS+KSDVFS G+L+LE
Sbjct: 621 NLIPKISDFGLARISGDDGKETKTRRVIGTYGYMAPEYAIDGKFSVKSDVFSLGVLLLEI 680
Query: 711 LSSRKNTGVYNTD-SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCV 769
+S +KN G + D +LLGHAW +W R EL+D L+D L+R + V LLCV
Sbjct: 681 ISGKKNRGFVHPDHHHHLLGHAWLMWNEGRASELID-TGLEDTSGKSQLLRCIQVGLLCV 739
Query: 770 QENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVS 829
Q+ DRP MS VV M++NE LP PK+ F + + S +TS + S N+ ++
Sbjct: 740 QKLPEDRPVMSTVVFMLANEGAVLPQPKQPGFFIERG--SVSEATSRNEDSYSTNEANIT 797
Query: 830 LVSPR 834
++ R
Sbjct: 798 ILEAR 802
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124250|ref|XP_002319283.1| predicted protein [Populus trichocarpa] gi|222857659|gb|EEE95206.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 716 bits (1848), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/832 (46%), Positives = 525/832 (63%), Gaps = 56/832 (6%)
Query: 24 AADTMTTASFIRDG--EKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTVVWVANRD 80
A+T+T + IRDG L S FELGFFSPG S++RY+GIW++ +P TVVWVANR+
Sbjct: 24 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 83
Query: 81 RPISGRNAVLTISNNGNLVLLSQTNGTI-WSTNVSSDVKNPVAQLRDDGNLVIRDNSSDS 139
PI+ + L + N GN VL+S N T+ WS+N ++ + +L+D GNLV+RD D+
Sbjct: 84 NPINDSSGFLMLDNTGNFVLVSNNNSTVVWSSNSKKAAQSAMGELQDSGNLVLRDEKDDN 143
Query: 140 TAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPK 199
+ YLWQSFD+PSDTLL MKLGWD + GL+R LS+W+S +DPS G +T+G + P+
Sbjct: 144 SG-IYLWQSFDYPSDTLLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 202
Query: 200 MCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQFMTENKDEFVYWYEAYNRPSIMTLK 258
+ + GS K+ SG W+G GF L+ N ++ ++ +E Y Y N+ I +
Sbjct: 203 LVMWKGSKKYYRSGPWNGIGFSGGLALRINPVFYFDFVDDGEEVYYTYNLKNKSLITRIV 262
Query: 259 LNPSG-FVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFKLK 317
+N + F R W+E + W +VP YC Y CGA C + Q+P+C+CLE F +
Sbjct: 263 MNQTTYFRQRYTWNEINQTWVLYATVPRDYCDTYNLCGAYGNCIMSQSPVCQCLEKFTPR 322
Query: 318 SQVNQTR---PIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKN 374
S + C R+ +C +G F K +K PD N +N++MNL++C ++CL+N
Sbjct: 323 SPESWNSMDWSKGCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSKCLQN 382
Query: 375 CTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESGNKKLLWI-- 430
C+C AY +N+ E SGC +W+GDL+D IR F+ GQ +Y+++ SES K I
Sbjct: 383 CSCMAYTATNIKERSGCAVWFGDLID----IRQFSAAGQEIYIRLNASESRAKAASKIKM 438
Query: 431 -----LVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGITTRTNEFG 485
L + V +LL ++YIF R+ + EN
Sbjct: 439 TVGSALSIFVACGILLVAYYIFKRKAKHIGGNREEN------------------------ 474
Query: 486 EVNGDGKDKG--KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVK 543
D D G +D LPLF ++A AT FS KLGEGGFGPVYKG L +GQE+A K
Sbjct: 475 ----DQIDSGPKEDLELPLFQFTTIAKATNGFSFNNKLGEGGFGPVYKGTLEDGQEIAAK 530
Query: 544 RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP 603
LS SGQGL EFKNE++LI +LQHRNLV++LGCC++ EKIL+ EYMPNKSLD ++FD
Sbjct: 531 TLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNKSLDSFIFDQ 590
Query: 604 IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
+ +LLDW R II GIA+GLLYLHQ SRLRI+HRDLKASNVLLDKDMNPKISDFGLAR
Sbjct: 591 TRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKISDFGLAR 650
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD 723
MFGGD+ +GNT R+VGTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S +K+ G + D
Sbjct: 651 MFGGDQTEGNTTRVVGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKSRGFCHPD 710
Query: 724 -SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDV 782
S +L+GHAW LWK + L++ + ++MR +N++LLCVQ++ DRP+M+ V
Sbjct: 711 HSLSLIGHAWRLWKDGKPLGLIEAFPGESCNLSEVIMRCINISLLCVQQHPDDRPSMATV 770
Query: 783 VSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
V M+ E+ LP PK+ F KG S S+S +E+ S N++T SL+ PR
Sbjct: 771 VWMLGGEN-TLPQPKEPGFFKGSGPFRPS-SSSKNTELFSNNEITSSLLYPR 820
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545297|ref|XP_003541080.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 708 bits (1827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/860 (47%), Positives = 535/860 (62%), Gaps = 62/860 (7%)
Query: 1 MAILPCFGIFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGK-SKS 59
MA+L F + LIF FS K + A DT+ + D L S+ FELGFF PG S +
Sbjct: 1 MAMLTIFLLVSKLIFFFS-KFAAATDTINQFESLEDNTTLVSNDGTFELGFFIPGSTSPN 59
Query: 60 RYLGIWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVK 118
RYLGIW++ +P TVVWVANR+ PI ++ L I+ G+LVLL+Q IWS N ++
Sbjct: 60 RYLGIWYKNIPIRTVVWVANRETPIKDNSSKLNITPEGSLVLLNQNKTVIWSANPTTKGV 119
Query: 119 NPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQ 178
VAQL D GNLV+RD D+ E+YLWQSFD+P+DT L MKLGWD K GL +L++W+
Sbjct: 120 VVVAQLLDSGNLVLRD-EKDTNPENYLWQSFDNPTDTFLPGMKLGWDLKKGLNTVLTAWK 178
Query: 179 SAEDPSPGRYTYGLDIHV---LPKMCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQF 234
+ +DPSPG +T DI + P+ + G+ K+ SG WDGT F S +N I
Sbjct: 179 NWDDPSPGDFT---DITLRTNYPEEVMWKGTTKYWRSGPWDGTKFSGNPSVPSNAIVNYT 235
Query: 235 MTENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQI-WDENSNKWDELFSVPDQYCGKYGY 293
+ NKDEF Y ++ I + +N S +V +++ W+ +S W +P C Y
Sbjct: 236 IVSNKDEFYATYSMTDKSIISRIVMNQSLYVRQRLTWNTDSQTWRVSSELPGDLCDHYNT 295
Query: 294 CGANTICSLDQTPMCECLEGFKLKSQVNQTR---PIKCERSHSSECTRGTQ--FKKLDNV 348
CGA IC Q P+C+CL+GFK KS N + C + + C + F K NV
Sbjct: 296 CGAFGICVAGQAPVCKCLDGFKPKSPRNWNQMNWNQGCVHNQTWSCREKNKDGFTKFSNV 355
Query: 349 KAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRN 407
KAPD +N SM L +C +C +NC+C AYANSN+ EGSGC +W GDLLD R +
Sbjct: 356 KAPDTERSWVNASMTLGECRVKCWENCSCMAYANSNIRGEGSGCAIWIGDLLDIR--LMP 413
Query: 408 FTGQSVYLQVPTSESG----------NKKLLWILVVL--VLPLVLLPSFYIFCRRRRKCK 455
GQ +Y+++ SE+ NKK++ I + V+ ++L+ +I+ R K K
Sbjct: 414 NAGQDLYIRLAVSETAQQSHDQKDNSNKKVVVIASTISSVIAMILI-FIFIYWSYRNKNK 472
Query: 456 EKETENTETNQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENF 515
E I GI ++NE + +D LPLF L +A AT++F
Sbjct: 473 E----------------IITGIEGKSNE---------SQQEDFELPLFDLVLIAQATDHF 507
Query: 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
S KLGEGGFGPVYKG L +GQEVAVKRLS S QGLKEFKNE+ML AELQHRNLV++L
Sbjct: 508 SDHKKLGEGGFGPVYKGTLPDGQEVAVKRLSQTSRQGLKEFKNEVMLCAELQHRNLVKVL 567
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
GCC + EK+LI EYM NKSLDV+LFD + +LLDW R II GIA+GLLYLHQ SRLR
Sbjct: 568 GCCFQDDEKLLIYEYMSNKSLDVFLFDSSRSKLLDWPKRFCIINGIARGLLYLHQDSRLR 627
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
IIHRDLKASNVLLD +MNPKISDFGLARM GGD+++G T RIVGTYGYM+PEYA DGLFS
Sbjct: 628 IIHRDLKASNVLLDNEMNPKISDFGLARMCGGDQIEGETSRIVGTYGYMAPEYAFDGLFS 687
Query: 696 IKSDVFSFGILMLETLSSRKNTGV-YNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIP 754
IKSDVFSFG+L+LE +S +KN+ + Y D NL+GHAW LWK + +D L+D
Sbjct: 688 IKSDVFSFGVLLLEIVSGKKNSRLFYPNDYNNLIGHAWRLWKEGNPMQFIDSS-LEDSCI 746
Query: 755 LPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYST 814
L +R +++ LLCVQ + DRP M+ VV ++SNE+ LP PK +++ K++ S+
Sbjct: 747 LYEALRCIHIGLLCVQHHPNDRPNMASVVVLLSNENA-LPLPKDPSYL-SKDISTERESS 804
Query: 815 SGTSEICSVNDVTVSLVSPR 834
S S+NDVT+S++S R
Sbjct: 805 SENFTSVSINDVTISMLSDR 824
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224126243|ref|XP_002319790.1| predicted protein [Populus trichocarpa] gi|222858166|gb|EEE95713.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 708 bits (1827), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/839 (47%), Positives = 536/839 (63%), Gaps = 48/839 (5%)
Query: 24 AADTMTTASFIRDG--EKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVP-DTVVWVANRD 80
A+T+T + IRDG L S FELGFFSPG S++RY+GIW++ +P TVVWVANR+
Sbjct: 18 TANTLTLSQSIRDGGTRTLVSKDGSFELGFFSPGSSRNRYVGIWYKNIPVRTVVWVANRN 77
Query: 81 RPISGRNAVLTISNNGNLVLLSQTNGTI-WSTNVSSDVKNPVAQLRDDGNLVIRDNSSDS 139
PI+ + L + N GNLVL+S N T+ WS+N ++ + +L D GNLV+RD D
Sbjct: 78 NPINDSSGFLMLDNTGNLVLVSNNNSTVVWSSNSKKAAQSAMGELLDSGNLVLRD-EKDV 136
Query: 140 TAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPK 199
+ SYLWQSFD+PSDT+L MKLGWD + GL+R LS+W+S +DPS G +T+G + P+
Sbjct: 137 NSGSYLWQSFDYPSDTMLPGMKLGWDLRIGLDRRLSAWKSPDDPSSGDFTWGTQLQSNPE 196
Query: 200 MCTFNGSVKFTCSGQWDGTGFV--SALSYTNFIYKQFMTENKDEFVYWYEAYNRPSIMTL 257
+ + GS K+ SG W+G GF +AL Y F+ +N +E Y Y N+ I L
Sbjct: 197 LVIWKGSEKYFRSGPWNGIGFSGEAALRINPVFYFDFV-DNGEEVYYTYNLKNKSLITRL 255
Query: 258 KLN-PSGFV-TRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFK 315
+N +GF+ R W+E S W+ VP YC Y CGA C + Q+P+CECLE F
Sbjct: 256 VMNQTTGFLRQRYTWNEISQTWELYAYVPRDYCDNYNLCGAYGNCIISQSPVCECLEKFT 315
Query: 316 LKS-----QVNQTRPIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAE 370
KS +N ++ C R+ +C +G F K +K PD N +N++MNL++C ++
Sbjct: 316 PKSPESWNSMNWSQ--GCVRNKPLDCQKGDGFVKYVGLKLPDATNSWVNKTMNLKECRSK 373
Query: 371 CLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT--GQSVYLQVPTSESG----- 423
CL+NC+C AY +++ E SGC +W+GDL+D IR F GQ +Y+++ SES
Sbjct: 374 CLQNCSCMAYTATDIKERSGCAIWFGDLID----IRQFPDGGQEIYIRMNASESSECLSL 429
Query: 424 -NKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAF----DINMGIT 478
++ L + V +LL ++YIF K TE + + L D + ++
Sbjct: 430 IKMEMGIALSIFVACGMLLVAYYIF---------KRTEKLKAHYSFLLVYHVCDSHSLLS 480
Query: 479 TRTNEFGEVNGDGKDKG--KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFN 536
+T E N D D G +D LPLF ++A AT FS+ K+GEGGFGPVYKG L +
Sbjct: 481 EKTGGNREEN-DQIDSGPMEDMELPLFQFTTIAKATNGFSLNNKIGEGGFGPVYKGTLED 539
Query: 537 GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596
GQE+AVK LS SGQGL EFKNE++LI +LQHRNLV++LGCC++ EKIL+ EYMPN+SL
Sbjct: 540 GQEIAVKTLSRSSGQGLNEFKNEVILITKLQHRNLVKLLGCCIQGEEKILVYEYMPNRSL 599
Query: 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656
D ++FD + +LLDW R II GIA+GLLYLHQ SRLRI+HRDLKASNVLLDKDMNPKI
Sbjct: 600 DSFIFDQTRGKLLDWSKRFSIICGIARGLLYLHQDSRLRIVHRDLKASNVLLDKDMNPKI 659
Query: 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN 716
SDFGLARM GGD+ +GNT R++GTYGYM+PEYA DGLFS+KSDVFSFGILMLE +S +K+
Sbjct: 660 SDFGLARMVGGDQTEGNTTRVIGTYGYMAPEYATDGLFSVKSDVFSFGILMLEIISGKKS 719
Query: 717 TGVYNTD-SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAAD 775
G Y+ D S +L HAW LWK + +L++ + ++MR +N++LLCVQ + D
Sbjct: 720 RGFYHPDRSLSLTAHAWRLWKDGKPLDLIEAFPGESRNLSEVIMRCINISLLCVQHHPDD 779
Query: 776 RPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
RP+M+ VV M+ E+ LP P + F KG S S+S E+ S N+ T SL+ PR
Sbjct: 780 RPSMATVVWMLGGEN-TLPQPNEPGFFKGSGPFGPSSSSSNI-ELYSNNEFTASLLYPR 836
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 705 bits (1819), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/840 (45%), Positives = 532/840 (63%), Gaps = 43/840 (5%)
Query: 12 SLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD 71
S++F S+ S A +++ + DG+ L SS FELGFFSPG S++RY+GIW++++
Sbjct: 18 SIVFFLSI-PSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYMGIWYKKISS 76
Query: 72 -TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNL 130
TVVWVANR+ P++ + +L ++GNL ++ TNGTIWS+N+S NPVAQL D GNL
Sbjct: 77 FTVVWVANRNTPLNDSSGMLKFVDHGNLAFINSTNGTIWSSNISRAAINPVAQLLDTGNL 136
Query: 131 VIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTY 190
V+R +D+ E++LWQSFD+P D+ L MK G F +GL R L+SW+S DPS G+YT
Sbjct: 137 VVR-AENDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSPSDPSTGKYTN 195
Query: 191 GLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVYWYEAY 249
LD + LP+ GSV SG W+G F ++ N IY N++E Y Y+
Sbjct: 196 KLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQEEIYYKYQIA 255
Query: 250 NRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCE 309
N + + L+P G + R W + + W + C ++ CGA+ +C+++ +P C+
Sbjct: 256 NSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLTANMDNCDRFALCGAHGVCNINNSPACD 315
Query: 310 CLEGFKLKSQVNQTRP---IKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQ 366
CL+ F+ KS T C R +C+ G F K +K PD N+++NLE+
Sbjct: 316 CLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPDTRKSWYNKTINLEE 375
Query: 367 CAAECLKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNFTGQSVYLQV-------P 418
C CLKNC+C AYAN +V +G SGC++W+GDL+D R+ N GQ +Y+++ P
Sbjct: 376 CEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQ--YNENGQDIYIRIAASVIDKP 433
Query: 419 TSESGNKKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETE---NTETNQDLLAFDINM 475
G K++ I++ + L L + +F R RK K+++ N TN +
Sbjct: 434 VKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREGNVVTNPE-------- 485
Query: 476 GITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLF 535
RT E + +D LPLF LA++ AT FS+ KLG+GGFGPVYKG L
Sbjct: 486 --QDRTKE---------SRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQ 534
Query: 536 NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595
+GQE+AVKRLS +S QG+ EF+NE++ IA+LQHRNLV++LGCC+E E++LI EYMPNKS
Sbjct: 535 DGQEIAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKS 594
Query: 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655
LD ++FD + LLDW R II GIA+GLLYLHQ SRLRIIHRDLKASN+LLD +MNPK
Sbjct: 595 LDSFIFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPK 654
Query: 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRK 715
ISDFG+AR FGGDE NT RIVGTYGYMSPEYA+DGLFS+KSDVFSFG+L+LE +S RK
Sbjct: 655 ISDFGMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRK 714
Query: 716 NTGVYNTD-SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAA 774
N G + + NLLGHAW L K R +L+D I+ D + ++R + VALLCVQ++
Sbjct: 715 NRGFRHAEHKLNLLGHAWMLHKEGRPLDLIDESIV-DTCIISEVLRSIEVALLCVQKSPE 773
Query: 775 DRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
DRP MS VV M+S++ + LP PK+ F +++ N S ST EI SVN++T +L+ R
Sbjct: 774 DRPKMSIVVLMLSSD-IVLPQPKEPGFFTERDLSNDSSSTI-KHEISSVNELTSTLLEAR 831
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 384/843 (45%), Positives = 514/843 (60%), Gaps = 54/843 (6%)
Query: 9 IFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRR 68
IF +F +K S A D M T +RDGE L S+ FELGFF+P S SRYLG+W+++
Sbjct: 7 IFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWYKK 66
Query: 69 VPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDG 128
P TVVWVANR PIS + L +++ G LVLL+ TN +WS+N S+ V+NPVAQL D G
Sbjct: 67 SPQTVVWVANRGIPISNKFGTLNVTSQGILVLLNGTNNIVWSSNTSTTVQNPVAQLLDSG 126
Query: 129 NLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRY 188
NLV+RD +D+ A+++LWQSFD+P DTLL MKLG + +GL LSSW+ E+P+PG++
Sbjct: 127 NLVVRD-GNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPAPGQF 185
Query: 189 TYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVYWYE 247
T G+D+ P++ + G W+G F + IY N++E + +E
Sbjct: 186 TLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVYFKFE 245
Query: 248 AYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPM 307
N L + PSG V W +N W + C Y CGAN C + +P+
Sbjct: 246 LQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFATAVVDRCENYALCGANARCDSNSSPV 305
Query: 308 CECLEGFKLKSQV---NQTRPIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNL 364
C+CL+GF KS +Q C R +CT F+ VK PD + + S +L
Sbjct: 306 CDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSSWYDDSFSL 365
Query: 365 EQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSESG 423
+C C++NC+C AYAN + GSGCL W+GDL+D+RR GQ +Y+++ S+SG
Sbjct: 366 VECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEG--GQDIYIRLAASQSG 423
Query: 424 ------NKKLLWILVV---LVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDIN 474
KK V+ ++L +L +FC RRRK ++
Sbjct: 424 VTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRK------------------ 465
Query: 475 MGITTRTNEFGEVNGDGKDKGKDSW-LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR 533
NG+ +D+ ++ LP+ L ++ AT+NFS KLGEGGFG VYKG
Sbjct: 466 -------------NGNFEDRKEEEMELPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGE 512
Query: 534 LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593
L GQE+AVKRLS SGQGL EFKNE++LIA+LQHRNLV++LGCC+ + EK+LI EYMPN
Sbjct: 513 LIEGQEIAVKRLSKSSGQGLNEFKNEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPN 572
Query: 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653
+SLD ++FDP +++ LDW R II GIA+GLLYLHQ SRLRIIHRD+KASN+LLD ++N
Sbjct: 573 RSLDSFIFDPTRRKFLDWSKRTHIIDGIARGLLYLHQDSRLRIIHRDIKASNILLDNELN 632
Query: 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS 713
PKISDFGLARMFGGD+ + NTKR+VGTYGYMSPEYALDG FS+KSDVFSFG+L+LE +S
Sbjct: 633 PKISDFGLARMFGGDQTEANTKRVVGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIVSG 692
Query: 714 RKNTGVYNTD--SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQE 771
+KN G + D NLLGHAW LW + EL+D P L R ++VALLCVQ+
Sbjct: 693 KKNRGFCHPDYNQKNLLGHAWMLWFNGIPLELIDECFADSCTPSEAL-RCIHVALLCVQQ 751
Query: 772 NAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVSLV 831
DRP MS VV M+ +E+ LP PK+ F G N ++S + S N+VTV+L+
Sbjct: 752 RPEDRPNMSSVVLMLGSEN-PLPQPKQPGFFMGSNPPEKD-TSSNKHQSHSANEVTVTLL 809
Query: 832 SPR 834
R
Sbjct: 810 QAR 812
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493713|ref|XP_002281009.2| PREDICTED: uncharacterized protein LOC100265866 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 701 bits (1809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 389/811 (47%), Positives = 530/811 (65%), Gaps = 38/811 (4%)
Query: 17 FSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPD-TVVW 75
FS+ A DT+ + +R + + S+ FELGFFSPG S S ++GIW++++ + TVVW
Sbjct: 293 FSISVDAAPDTIFSGQMLRQTDTIISAGGNFELGFFSPGNSPSYFVGIWYKKISEQTVVW 352
Query: 76 VANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDN 135
VANRD I+G + LTI+++GNLV+L T N+S +N A L D GNL++R+
Sbjct: 353 VANRDYTITGSSPSLTINDDGNLVILD-GRVTYMVANISLG-QNVSATLLDSGNLILRNG 410
Query: 136 SSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIH 195
+S+ LWQSFD+PS+ L MK+G++ K+G +SW++AEDP G + +D
Sbjct: 411 NSN-----ILWQSFDYPSNHFLPGMKIGYNRKTGEVWSFTSWKNAEDPGLGPVSLKMDPE 465
Query: 196 VLPKMCTFNGSVKFTCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVYWYEAYNRPSI 254
+ +N + ++ SG W+G F S ++I+ E+ E + Y Y+ I
Sbjct: 466 THQFVIMWNSQMVWS-SGVWNGHAFSSVPEMRLDYIFNYSYFEDMSEAYFTYSLYDNSII 524
Query: 255 MTLKLNPSGFVTRQIWDENSNKWDELFSVPDQY-CGKYGYCGANTICSLDQTPMCECLEG 313
L ++ SG + + W + S W+ +S P + C Y YCG+ + C+ TP+C+CL G
Sbjct: 525 SRLLIDVSGNIKQLTWLDRSG-WNLFWSQPQNFECDYYSYCGSFSSCNNQTTPICQCLYG 583
Query: 314 FKLKS----QVNQTRPIKCERSHSSEC-------TRGTQFKKLDNVKAPDFINVSLNQSM 362
F+ S +NQ R C R S +C + +F K+ NVK P + QS
Sbjct: 584 FRPNSAGDWMMNQFRD-GCVRKTSLQCDDLTSVNSEKDKFLKMANVKFPQSPQILETQS- 641
Query: 363 NLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRR-PIRNFTGQSVYLQVPTSE 421
+E C CL C+C AYA++ CLMW LL+ ++ ++ G+++YL++ SE
Sbjct: 642 -IETCKMTCLNKCSCNAYAHN-----GSCLMWDQILLNLQQLSKKDPDGRTLYLKLAASE 695
Query: 422 SGN----KKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGI 477
N K W++ ++V+ +++L C R+ K + ++ E T+QD+L ++ MG
Sbjct: 696 LQNSRESKMPRWVIGMVVVAVLVLLLASYICYRQMK-RVQDREEMTTSQDILLYEFGMGS 754
Query: 478 TTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNG 537
NE E N GKDK KD+WLPLFS ASV+AATE+FS + KLG+GGFGPVYKG LFNG
Sbjct: 755 KATENELNEGNRVGKDKNKDAWLPLFSFASVSAATEHFSTENKLGQGGFGPVYKGELFNG 814
Query: 538 QEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLD 597
QE+AVKRLS SGQGL+E KNE +L+AELQHRNLVR+LGCC+EQGEKILI EYMPNKSLD
Sbjct: 815 QEIAVKRLSRSSGQGLEELKNETVLLAELQHRNLVRLLGCCIEQGEKILIYEYMPNKSLD 874
Query: 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657
+LFDP K+ LDW R+ II+GIAQGLLYLH+YSRLRIIHRDLKASN+LLD DMNPKIS
Sbjct: 875 SFLFDPNKRGQLDWAKRVSIIEGIAQGLLYLHEYSRLRIIHRDLKASNILLDNDMNPKIS 934
Query: 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNT 717
DFG+ARMFGG+E NT RIVGTYGYMSPEYAL+GLFS KSDVFSFG+LMLE LS +KNT
Sbjct: 935 DFGMARMFGGNESYANTNRIVGTYGYMSPEYALEGLFSTKSDVFSFGVLMLEILSGKKNT 994
Query: 718 GVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP 777
G YN+D+ NL+G+AW+LWK + LMDP +L+ + ML+RY+NV LLCV+E AADRP
Sbjct: 995 GFYNSDTLNLIGYAWELWKSDMAINLMDP-MLEGQSSQYMLLRYINVGLLCVEEIAADRP 1053
Query: 778 TMSDVVSMISNEHLNLPFPKKLTFVKGKNVK 808
T+S+VVSM++NE LP PK F +++
Sbjct: 1054 TLSEVVSMLTNELAVLPSPKHPAFSTASSLQ 1084
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514895|ref|XP_003526137.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1802), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 396/853 (46%), Positives = 527/853 (61%), Gaps = 51/853 (5%)
Query: 1 MAILPCFGIFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGK-SKS 59
MA L + LIF FS A D + + D L S+ FELGFF+PG S +
Sbjct: 1 MAFLVIVILVSKLIF-FSSNFLAATDMINQFQSLEDNTTLVSNDGTFELGFFTPGSTSPN 59
Query: 60 RYLGIWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGT-IWSTNVSSDV 117
RYLGIW++ +P TVVWVANRD PI ++ L+I+ GN +LL+Q N T IWSTN ++
Sbjct: 60 RYLGIWYKNIPIRTVVWVANRDNPIKDNSSKLSINTAGNFILLNQNNNTVIWSTNTTTKA 119
Query: 118 KNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSW 177
VAQL D GNLV+RD D+ E+Y WQSFD+PSDT L MK GWD K GL R+L++W
Sbjct: 120 SLVVAQLLDSGNLVLRD-EKDNNPENYSWQSFDYPSDTFLPGMKAGWDLKKGLNRVLTAW 178
Query: 178 QSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQFMT 236
++ +DPS G +T P+ + G+ ++ SG WDG F + S TN I +
Sbjct: 179 KNWDDPSSGDFTANSSRTNFPEEVMWKGTSEYYRSGPWDGRKFSGSPSVPTNSIVNYSVV 238
Query: 237 ENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQI-WDENSNKWDELFSVPDQYCGKYGYCG 295
NKDEF Y ++ I + +N + +V +++ W+E+S W +P C Y CG
Sbjct: 239 SNKDEFYATYSMIDKSLISRVVVNQTLYVRQRLTWNEDSQTWRVSSELPGDLCDNYSTCG 298
Query: 296 ANTICSLDQTPMCECLEGFKLKSQVNQTR---PIKCERSHSSECTRGTQ--FKKLDNVKA 350
A IC Q P+C CL+GFK KS N T+ C + + C + FKK N+KA
Sbjct: 299 AFGICVAGQAPVCNCLDGFKPKSTRNWTQMNWNQGCVHNQTWSCMEKNKDGFKKFSNLKA 358
Query: 351 PDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFT 409
PD +N SM L++C +C +NC+C AYAN ++ EGSGC +W+GDLLD R I N
Sbjct: 359 PDTERSWVNASMTLDECKNKCRENCSCTAYANFDMRGEGSGCAIWFGDLLDIRL-IPN-A 416
Query: 410 GQSVYLQVPTSESGNKKLLWILVVLVLPLV------LLPSFYIFCRRRRKCKEKETENTE 463
GQ +Y+++ SE+ K VV++ +V LL +I+ + KE
Sbjct: 417 GQDLYIRLAVSETDEKDDSKKKVVVIASIVSSVVATLLIFIFIYWSNAKNIKE------- 469
Query: 464 TNQDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGE 523
I +GI + NE + +D LPLF L S+A AT++FS KLGE
Sbjct: 470 ---------IILGIEVKNNE---------SQQEDFELPLFDLVSIAQATDHFSDHNKLGE 511
Query: 524 GGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583
GGFGPVYKG L +G EVAVKRLS SGQGLKEFKNE+ML A+LQHRNLV++LGCC+++ E
Sbjct: 512 GGFGPVYKGTLPDGLEVAVKRLSQTSGQGLKEFKNEVMLCAKLQHRNLVKVLGCCIQENE 571
Query: 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643
K+LI EYM NKSLDV+LFD + +LLDW R II IA+GLLYLHQ SRLRIIHRDLKA
Sbjct: 572 KLLIYEYMANKSLDVFLFDSDRSKLLDWPKRFYIINRIARGLLYLHQDSRLRIIHRDLKA 631
Query: 644 SNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703
SNVLLD +MNPKISDFGLARM GGD+++G T+R+VGTYGYM+PEYA DGLFSIKSDVFSF
Sbjct: 632 SNVLLDNEMNPKISDFGLARMCGGDQIEGKTRRVVGTYGYMAPEYAFDGLFSIKSDVFSF 691
Query: 704 GILMLETLSSRKNTGVYNTDSF--NLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRY 761
G+L+LE +S +KN ++ + + NL+GHAW LW E + L+D L +R
Sbjct: 692 GVLLLEIVSGKKNNRLFYPNDYNNNLIGHAWSLWNEGNPMEFI-ATSLEDSCILYEALRC 750
Query: 762 VNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEIC 821
+++ LLCVQ + DRP M+ VV ++SNE+ LP PK ++ ++ S+S
Sbjct: 751 IHIGLLCVQHHPNDRPNMASVVVLLSNENA-LPLPKYPRYLI-TDISTERESSSEKFTSY 808
Query: 822 SVNDVTVSLVSPR 834
S+NDVT+S++S R
Sbjct: 809 SINDVTISMLSDR 821
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356514897|ref|XP_003526138.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 698 bits (1801), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/848 (46%), Positives = 525/848 (61%), Gaps = 56/848 (6%)
Query: 9 IFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKS-RYLGIWFR 67
I S + LF K S A DT+T + D L S FELGFF+P S S RYLGIW++
Sbjct: 8 ILVSKLLLFFPKFSAATDTITQFEPLEDNTTLVSKGGTFELGFFTPASSSSNRYLGIWYK 67
Query: 68 RVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNG-TIWSTNVSSDVKNPVAQLR 125
+P TVVWVANRD PI + L I+ GNLVLL+ N IWSTN ++ VAQL
Sbjct: 68 SIPIRTVVWVANRDNPIKDNSTELAITTEGNLVLLNPNNNIVIWSTNTTTKASVVVAQLL 127
Query: 126 DDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSP 185
D GNLV+RD D+ E+YLWQSFD+PSDT L MK GWD K GL R+L++W++ +DPS
Sbjct: 128 DSGNLVLRD-EKDTDPENYLWQSFDYPSDTFLPGMKAGWDLKKGLNRVLTAWKNWDDPSS 186
Query: 186 GRYTYGLDIHV-LPKMCTFNGSVKFTCSGQWDGTGFVSALSY-TNFIYKQFMTENKDEFV 243
G + + +H P+ G+ K+ SG WDGT F S +N I + N DEF
Sbjct: 187 GDFR-DIALHTNYPEEVMLKGTTKYWRSGPWDGTKFSGNPSVPSNAIVNYTVVSNNDEFY 245
Query: 244 YWYEAYNRPSIMTLKLNPSGFVTRQI-WDENSNKWDELFSVPDQYCGKYGYCGANTICSL 302
Y ++ I + +N + +V +++ W+ +S W +P C +Y CGA IC L
Sbjct: 246 AMYSMTDKSVISRIIMNQTLYVRQRLTWNTDSQMWRVSSELPGDLCDRYNTCGAFGICDL 305
Query: 303 DQTPMCECLEGFKLKSQVNQTR---PIKCERSHSSECTRGTQ--FKKLDNVKAPDFINVS 357
+ P+C+CL+GFK KS N T+ C + + C + FKK NVKAPD
Sbjct: 306 SEAPVCKCLDGFKPKSPRNWTQMNWNQGCVHNQTWSCREKNKDGFKKFSNVKAPDTERSW 365
Query: 358 LNQSMNLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFTGQSVYLQ 416
+N SM LE+C +C +NC+C AYANS++ EGSGC +W+GDLLD R + + GQ +Y++
Sbjct: 366 VNASMTLEECKHKCTENCSCMAYANSDIRGEGSGCAIWFGDLLDIR--LMSNAGQDLYIR 423
Query: 417 VPTSESGN---------KKLLWILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQD 467
+ SE+ + KK + ++ + ++ + +IF R K E E T+
Sbjct: 424 LAMSETAHQDQDEKDSSKKKVVVIASSISSVIAMLLIFIFIYWRYTNKNNEIEGTKN--- 480
Query: 468 LLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFG 527
+ + +D LPLF LASVA AT NFS KLGEGGFG
Sbjct: 481 ------------------------QSQQEDFELPLFDLASVAHATSNFSNDKKLGEGGFG 516
Query: 528 PVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587
PVYKG L NGQEVAVKRLS S QGLKEFKNE+ML AELQHRNLV++LGCC++ EK+LI
Sbjct: 517 PVYKGTLPNGQEVAVKRLSQTSRQGLKEFKNEVMLCAELQHRNLVKVLGCCIQDDEKLLI 576
Query: 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647
EYM NKSLDV+LFD + +LLDW R II GIA+GLLYLHQ SRLRIIHRDLKASNVL
Sbjct: 577 YEYMANKSLDVFLFDSSQSKLLDWPMRFGIINGIARGLLYLHQDSRLRIIHRDLKASNVL 636
Query: 648 LDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
LD +MNPKISDFGLARM GGD+++G T R+VGTYGYM+PEYA DG+FSIKSDVFSFG+L+
Sbjct: 637 LDNEMNPKISDFGLARMCGGDQIEGETSRVVGTYGYMAPEYAFDGIFSIKSDVFSFGVLL 696
Query: 708 LETLSSRKNTGV-YNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVAL 766
LE +S +KN+ + Y D NL+GHAW LWK + +D L+D L +R +++ L
Sbjct: 697 LEIVSGKKNSRLFYPNDYNNLIGHAWMLWKEGNPMQFID-TSLEDSCILYEALRCIHIGL 755
Query: 767 LCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDV 826
LCVQ + DRP M+ VV ++SNE+ LP PK +++ ++ S+ S+NDV
Sbjct: 756 LCVQHHPNDRPNMASVVVLLSNENA-LPLPKDPSYL-SNDISTERESSFKNFTSFSINDV 813
Query: 827 TVSLVSPR 834
T+S++S +
Sbjct: 814 TMSMMSAK 821
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 834 | ||||||
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.400 | 0.394 | 0.563 | 2.8e-174 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.438 | 0.467 | 0.537 | 4.1e-173 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.973 | 0.955 | 0.421 | 2.8e-169 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.972 | 0.962 | 0.421 | 7.4e-169 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.402 | 0.395 | 0.548 | 2.8e-165 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.408 | 0.418 | 0.537 | 1.1e-163 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.399 | 0.395 | 0.537 | 5.5e-156 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.966 | 0.971 | 0.392 | 2.6e-150 | |
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.393 | 0.407 | 0.517 | 1.2e-149 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.410 | 0.403 | 0.541 | 2.3e-146 |
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 969 (346.2 bits), Expect = 2.8e-174, Sum P(2) = 2.8e-174
Identities = 192/341 (56%), Positives = 247/341 (72%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE 559
LPL ++A AT NFS KLG+GGFG VYKG L +G+E+AVKRLS S QG EF NE
Sbjct: 508 LPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNE 567
Query: 560 MMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ 619
+ LIA+LQH NLVR+LGCCV++GEK+LI EY+ N SLD +LFD + L+W+ R II
Sbjct: 568 VRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIIN 627
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
GIA+GLLYLHQ SR RIIHRDLKASNVLLDK+M PKISDFG+AR+FG +E + NT+R+VG
Sbjct: 628 GIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVG 687
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD-SFNLLGHAWDLWKHE 738
TYGYMSPEYA+DG+FS+KSDVFSFG+L+LE +S ++N G YN++ NLLG W WK
Sbjct: 688 TYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFVWRHWKEG 747
Query: 739 RVHELMDPV---ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPF 795
+ E++DP+ L E P ++R + + LLCVQE A DRP MS V+ M+ +E +P
Sbjct: 748 KELEIVDPINIDALSSEFPTHEILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQ 807
Query: 796 PKKLTFVKGKNVK--NSSYSTSGTSEICSVNDVTVSLVSPR 834
PK+ F G++ +SS ST E C+VN VT+S++ R
Sbjct: 808 PKRPGFCVGRSSLEVDSSSSTQRDDE-CTVNQVTLSVIDAR 847
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 954 (340.9 bits), Expect = 4.1e-173, Sum P(2) = 4.1e-173
Identities = 199/370 (53%), Positives = 259/370 (70%)
Query: 466 QDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGG 525
QDL + I T E V+ K + +D LP L +V+ AT FS KLG+GG
Sbjct: 417 QDLYVRLASSEIETLQRESSRVSSR-KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGG 475
Query: 526 FGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585
FGPVYKG L GQEVAVKRLS S QG++EFKNE+ LIA+LQHRNLV+ILG CV++ E++
Sbjct: 476 FGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERM 535
Query: 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645
LI EY PNKSLD ++FD ++R LDW R+ II+GIA+G+LYLH+ SRLRIIHRDLKASN
Sbjct: 536 LIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASN 595
Query: 646 VLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
VLLD DMN KISDFGLAR GGDE + NT R+VGTYGYMSPEY +DG FS+KSDVFSFG+
Sbjct: 596 VLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGV 655
Query: 706 LMLETLSSRKNTGVYNTD-SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNV 764
L+LE +S R+N G N + NLLGHAW + ++ +E++D + + + ++R +++
Sbjct: 656 LVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKAYEIIDEAVNESCTDISEVLRVIHI 715
Query: 765 ALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVN 824
LLCVQ++ DRP MS VV M+S+E L L P++ F +N+ S + S EI S N
Sbjct: 716 GLLCVQQDPKDRPNMSVVVLMLSSEMLLLD-PRQPGFFNERNLLFSD-TVSINLEIPSNN 773
Query: 825 DVTVSLVSPR 834
T+S++ PR
Sbjct: 774 FQTMSVIDPR 783
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1646 (584.5 bits), Expect = 2.8e-169, P = 2.8e-169
Identities = 358/849 (42%), Positives = 500/849 (58%)
Query: 10 FCSLIFLFSMKASLAADTMTTASF--IRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFR 67
F L+ LF S++A+T++ + I + S FELGFF PG YLGIW++
Sbjct: 15 FFFLLILFPAY-SISANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYK 73
Query: 68 RVPD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNP-VAQL 124
+ T VWVANRD P+S L IS++ NLV+L Q++ +WSTN++ DV++P VA+L
Sbjct: 74 AISKRTYVWVANRDTPLSSSIGTLKISDS-NLVVLDQSDTPVWSTNLTGGDVRSPLVAEL 132
Query: 125 RDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPS 184
D+GN V+RD S +S + LWQSFD P+DTLL +MKLGWD K+G R + SW+S +DPS
Sbjct: 133 LDNGNFVLRD-SKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 185 PGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKDEFV 243
G +++ L+ P++ +N + SG W+G F F Y F T +K+E
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 244 YWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLD 303
Y + L ++ SG + R W E + W++ + P C +Y CG C +
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSN 311
Query: 304 QTPMCECLEGFKLKS-QVNQTRPIK--CERSHSSECTRGTQFKKLDNVKAPDFINVSLNQ 360
+P+C C++GFK ++ QV R C R C G F +L +K PD S+++
Sbjct: 312 TSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDR 371
Query: 361 SMNLEQCAAECLKNCTCKAYANSNVT-EGSGCLMWYGDLLDSRRPIRNFT--GQSVYLQV 417
+ +++C +CL++C C A+AN+++ GSGC+ W G+L D IRN+ GQ +Y+++
Sbjct: 372 GIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFD----IRNYAKGGQDLYVRL 427
Query: 418 PTSE---SGNKKXXXXXXXXXXXXXXXPSFYIFXXXXXXXXXXXXXXX-XXXQDLLAFDI 473
++ N+ SF IF L + D+
Sbjct: 428 AATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDL 487
Query: 474 NMG---ITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVY 530
M I++R + E N D D LPL VA AT NFS KLG+GGFG VY
Sbjct: 488 LMNEVVISSRRHISRENNTD------DLELPLMEFEEVAMATNNFSNANKLGQGGFGIVY 541
Query: 531 KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590
KG+L +GQE+AVKRLS S QG EFKNE+ LIA LQH NLVR+L CCV+ GEK+LI EY
Sbjct: 542 KGKLLDGQEMAVKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEY 601
Query: 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650
+ N SLD +LFD + L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASN+LLDK
Sbjct: 602 LENLSLDSHLFDKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDK 661
Query: 651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
M PKISDFG+AR+FG DE + NT+++VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE
Sbjct: 662 YMTPKISDFGMARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 721
Query: 711 LSSRKNTGVYNTD-SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPM--LMRYVNVALL 767
+SS++N G YN+D NLLG W WK + E++DP+I ++R + + LL
Sbjct: 722 ISSKRNKGFYNSDRDLNLLGCVWRNWKEGKGLEIIDPIITDSSSTFRQHEILRCIQIGLL 781
Query: 768 CVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNV--KNSSYSTSGTSEICSVND 825
CVQE A DRPTMS V+ M+ +E +P PK + +++ +SS S E +VN
Sbjct: 782 CVQERAEDRPTMSLVILMLGSESTTIPQPKAPGYCLERSLLDTDSSSSKQRDDESWTVNQ 841
Query: 826 VTVSLVSPR 834
+TVS++ R
Sbjct: 842 ITVSVLDAR 850
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1642 (583.1 bits), Expect = 7.4e-169, P = 7.4e-169
Identities = 358/850 (42%), Positives = 504/850 (59%)
Query: 7 FGIFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWF 66
F IF LI + S + T + I + + S SQ FELGFF+P S YLGIW+
Sbjct: 11 FFIFLILILFLAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWY 70
Query: 67 RRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSS-DVKNPVA-Q 123
+ +P T VWVANRD P+S N L IS N NLV+ Q++ +WSTN++ DV++PVA +
Sbjct: 71 KIIPIRTYVWVANRDNPLSSSNGTLKISGN-NLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 124 LRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDP 183
L D+GN ++RD+++ LWQSFD P+DTLL +MKLGWD K+G R+L SW++ +DP
Sbjct: 130 LLDNGNFLLRDSNN-----RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDP 184
Query: 184 SPGRYTYGLDIHVLPK--MCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQF-MTENKD 240
S G ++ L+ P+ +C+ S+ + SG W+G F S Y + T +K+
Sbjct: 185 SSGEFSTKLETSEFPEFYICS-KESILYR-SGPWNGMRFSSVPGTIQVDYMVYNFTASKE 242
Query: 241 EFVYWYEAYNRPSIMT-LKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTI 299
E Y Y N+ ++ + L LN +G + R W E + W +L+ P C Y CG
Sbjct: 243 EVTYSYRI-NKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGY 301
Query: 300 CSLDQTPMCECLEGFK-LKSQVNQTRP--IKCERSHSSECTRGTQFKKLDNVKAPDFINV 356
C + P C C++GFK + Q R C R C F +L +K PD
Sbjct: 302 CDSNSLPNCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTAT 361
Query: 357 SLNQSMNLEQCAAECLKNCTCKAYANSNVTEG-SGCLMWYGDLLDSRRPIRNFTGQSVYL 415
+++ + L+ C CL++C C A+AN+++ G SGC++W ++LD R + GQ +Y+
Sbjct: 362 IVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKG--GQDLYV 419
Query: 416 QVPTSESGNKKXXXXXXXXXXXXXXXP---SFYIFXXXXXXXXXXXXXXXXXXQDLLAFD 472
++ +E +K+ SF IF + + D
Sbjct: 420 RLAAAELEDKRIKNEKIIGSSIGVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQD 479
Query: 473 --INMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVY 530
IN + +R G + + K + + LPL L ++A AT NFS KLG+GGFG VY
Sbjct: 480 SLINDVVVSRR---GYTSKEKKSEYLE--LPLLELEALATATNNFSNDNKLGQGGFGIVY 534
Query: 531 KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590
KGRL +G+E+AVKRLS S QG EF NE+ LIA+LQH NLVR+LGCCV++GEK+LI EY
Sbjct: 535 KGRLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEY 594
Query: 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650
+ N SLD +LFD + L+W+ R II GIA+GLLYLHQ SR RIIHRDLKASNVLLDK
Sbjct: 595 LENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLKASNVLLDK 654
Query: 651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
+M PKISDFG+AR+FG +E + NT+R+VGTYGYMSPEYA+DG+FS+KSDVFSFG+L+LE
Sbjct: 655 NMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEI 714
Query: 711 LSSRKNTGVYNTD-SFNLLGHAWDLWKHERVHELMDPV---ILQDEIPLPMLMRYVNVAL 766
+S ++N G YN++ NLLG W WK E++DP+ L + P ++R + + L
Sbjct: 715 ISGKRNKGFYNSNRDLNLLGFVWRHWKEGNELEIVDPINIDSLSSKFPTHEILRCIQIGL 774
Query: 767 LCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNV--KNSSYSTSGTSEICSVN 824
LCVQE A DRP MS V+ M+ +E +P PK+ F G++ +SS ST E C+VN
Sbjct: 775 LCVQERAEDRPVMSSVMVMLGSETTAIPQPKRPGFCIGRSPLEADSSSSTQRDDE-CTVN 833
Query: 825 DVTVSLVSPR 834
+T+S++ R
Sbjct: 834 QITLSVIDAR 843
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 964 (344.4 bits), Expect = 2.8e-165, Sum P(2) = 2.8e-165
Identities = 186/339 (54%), Positives = 261/339 (76%)
Query: 498 SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFK 557
S LP+FSL ++A AT +F + +LG GGFGPVYKG L +G+E+AVKRLS +SGQG+ EFK
Sbjct: 512 SELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFK 571
Query: 558 NEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI 617
NE++LIA+LQHRNLVR+LGCC E EK+L+ EYMPNKSLD +LFD K+ L+DW+ R I
Sbjct: 572 NEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSI 631
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677
I+GIA+GLLYLH+ SRLRIIHRDLK SNVLLD +MNPKISDFG+AR+FGG++ + NT R+
Sbjct: 632 IEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRV 691
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737
VGTYGYMSPEYA++GLFS+KSDV+SFG+L+LE +S ++NT + +++ +L+G+AW L+ H
Sbjct: 692 VGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSLIGYAWYLYTH 751
Query: 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPK 797
R EL+DP I + +R ++VA+LCVQ++AA+RP M+ V+ M+ ++ L P+
Sbjct: 752 GRSEELVDPKI-RVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPR 810
Query: 798 KLTFVKGK-NVKNSSYSTSGTSE-ICSVNDVTVSLVSPR 834
+ TF + N + +++ + + I S N++T ++V R
Sbjct: 811 QPTFTSTRRNSIDVNFALDSSQQYIVSSNEITSTVVLGR 849
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 956 (341.6 bits), Expect = 1.1e-163, Sum P(2) = 1.1e-163
Identities = 188/350 (53%), Positives = 255/350 (72%)
Query: 489 GDGKDKG---KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRL 545
G+ KG +D LP+F +++ AT++FS LG GGFGPVYKG+L +GQE+AVKRL
Sbjct: 471 GENFRKGIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRL 530
Query: 546 SSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK 605
S+ SGQG++EFKNE+ LIA+LQHRNLVR+LGCC++ E +LI EYMPNKSLD ++FD +
Sbjct: 531 SANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERR 590
Query: 606 KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
LDW+ R+ II G+A+G+LYLHQ SRLRIIHRDLKA NVLLD DMNPKISDFGLA+ F
Sbjct: 591 STELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSF 650
Query: 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD-S 724
GGD+ + +T R+VGTYGYM PEYA+DG FS+KSDVFSFG+L+LE ++ + N G + D
Sbjct: 651 GGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHD 710
Query: 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784
NLLGH W +W +R E+ + L++ +P ++R ++VALLCVQ+ DRPTM+ VV
Sbjct: 711 LNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALLCVQQKPEDRPTMASVVL 770
Query: 785 MISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
M ++ +LP P + F +NV + S S S S+ N+V+++++ R
Sbjct: 771 MFGSDS-SLPHPTQPGFFTNRNVPDISSSLSLRSQ----NEVSITMLQGR 815
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 5.5e-156, Sum P(2) = 5.5e-156
Identities = 180/335 (53%), Positives = 244/335 (72%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE 559
LP+FS SVA+AT +F+ + KLG+GGFG VYKG G+E+AVKRLS +S QGL+EFKNE
Sbjct: 510 LPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNE 569
Query: 560 MMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ 619
++LIA+LQHRNLVR+LGCC+E EK+L+ EYMPNKSLD +LFD K+ LDW R +I
Sbjct: 570 ILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIG 629
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
GIA+GLLYLH+ SRL+IIHRDLKASN+LLD +MNPKISDFG+AR+F + NT R+VG
Sbjct: 630 GIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVG 689
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER 739
TYGYM+PEYA++G+FS KSDV+SFG+L+LE +S RKN TD +L+G+AW LW +
Sbjct: 690 TYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHGSLIGYAWHLWSQGK 749
Query: 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKL 799
E++DP++ +D + MR ++V +LC Q++ RP M V+ M+ ++ LP P++
Sbjct: 750 TKEMIDPIV-KDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQP 808
Query: 800 TFVKGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
TF N + + G ++ SVNDVT + + R
Sbjct: 809 TFHSFLNSGDIELNFDG-HDVASVNDVTFTTIVGR 842
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1467 (521.5 bits), Expect = 2.6e-150, P = 2.6e-150
Identities = 334/851 (39%), Positives = 486/851 (57%)
Query: 6 CFGIFCSLIFLFSMKASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIW 65
C I + FS++ LA D +T +S RD E + S+ F GFFSP S RY GIW
Sbjct: 3 CLLILLLTLICFSLRLCLATDVITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIW 62
Query: 66 FRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVK-NPV-A 122
F +P TVVWVAN + PI+ + +++IS GNLV++ WSTNV V N A
Sbjct: 63 FNNIPVQTVVWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYA 122
Query: 123 QLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAED 182
+L + GNLV+ ++ T + LW+SF+HP + L M L D K+G L SW+S D
Sbjct: 123 RLLNTGNLVLLGTTN--TGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFD 180
Query: 183 PSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSA--LSYT-NFIYKQFMTENK 239
PSPGRY+ GL P++ + + SG W+G F+ + Y N ++N+
Sbjct: 181 PSPGRYSAGLIPLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNR 240
Query: 240 DEFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYCGKYGYCGANTI 299
Y A N + L+ G V ++ W+ +W VP C Y CG
Sbjct: 241 GSVSMSY-AGNT-LLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFAS 298
Query: 300 CSLD--QTPMCECLEGFKLKSQV-----NQTR------PIKCERSHSSECTRGTQ-FKKL 345
C + TP C C+ GFK +S N T+ P++CE +++ +R + F ++
Sbjct: 299 CRFNPGSTPPCMCIRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRV 358
Query: 346 DNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPI 405
+K P N N + C CLKNC+C AY+ G GCL+W G+L+D +
Sbjct: 359 QKMKVPH--NPQ-RSGANEQDCPESCLKNCSCTAYS---FDRGIGCLLWSGNLMD----M 408
Query: 406 RNFTGQSVYLQVPTSESGNKKXXXXXXXXXXXXXXXPSFYIFXXXXXXXXXXXXXXXXXX 465
+ F+G V + ++S KK ++F
Sbjct: 409 QEFSGTGVVFYIRLADSEFKKRTNRSIVITVTLLVGA--FLFAGTVVLALWKIAKHREKN 466
Query: 466 QDLLAFDINMGITTRTNEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGG 525
++ + M + +N+ G + + + K K+ LPLF +A AT NFS+ KLG+GG
Sbjct: 467 RNTRLLNERMEALS-SNDVGAILVN-QYKLKE--LPLFEFQVLAVATNNFSITNKLGQGG 522
Query: 526 FGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585
FG VYKGRL G ++AVKRLS SGQG++EF NE+++I++LQHRNLVR+LG C+E E++
Sbjct: 523 FGAVYKGRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERM 582
Query: 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645
L+ E+MP LD YLFDP+K+RLLDW+ R II GI +GL+YLH+ SRL+IIHRDLKASN
Sbjct: 583 LVYEFMPENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASN 642
Query: 646 VLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
+LLD+++NPKISDFGLAR+F G+E + +T R+VGTYGYM+PEYA+ GLFS KSDVFS G+
Sbjct: 643 ILLDENLNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGV 702
Query: 706 LMLETLSSRKNTGVYNT-DSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNV 764
++LE +S R+N+ YN + NL +AW LW L+DPVI ++ + R V+V
Sbjct: 703 ILLEIVSGRRNSSFYNDGQNPNLSAYAWKLWNTGEDIALVDPVIFEECFENE-IRRCVHV 761
Query: 765 ALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEI-CSV 823
LLCVQ++A DRP+++ V+ M+S+E+ NLP PK+ F+ + S +SG S+ S+
Sbjct: 762 GLLCVQDHANDRPSVATVIWMLSSENSNLPEPKQPAFIPRRGT--SEVESSGQSDPRASI 819
Query: 824 NDVTVSLVSPR 834
N+V+++ ++ R
Sbjct: 820 NNVSLTKITGR 830
|
|
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 866 (309.9 bits), Expect = 1.2e-149, Sum P(2) = 1.2e-149
Identities = 174/336 (51%), Positives = 237/336 (70%)
Query: 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE 559
L F + ++ AT NFS+ KLG+GGFG VYKG+L +G+E+AVKRLSS SGQG +EF NE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 560 MMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ 619
++LI++LQHRNLVR+LGCC+E+ EK+LI E+M NKSLD +LFD K+ +DW R IIQ
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
GIA+GLLYLH SRLR+IHRDLK SN+LLD+ MNPKISDFGLARM+ G E Q NT+R+VG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGV-YNTDSFNLLGHAWDLWKHE 738
T GYMSPEYA G+FS KSD++SFG+LMLE +S K + Y + L+ +AW+ W
Sbjct: 656 TLGYMSPEYAWTGMFSEKSDIYSFGVLMLEIISGEKISRFSYGVEGKTLIAYAWESWSEY 715
Query: 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKK 798
R +L+D + PL + R + + LLCVQ ADRP ++++M++ +LP PK+
Sbjct: 716 RGIDLLDQDLADSCHPLEV-GRCIQIGLLCVQHQPADRPNTLELLAMLTTTS-DLPSPKQ 773
Query: 799 LTFVKGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
TF ++ S ++++ +VN +T S++ R
Sbjct: 774 PTFAF-----HTRDDESLSNDLITVNGMTQSVILGR 804
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 981 (350.4 bits), Expect = 2.3e-146, Sum P(2) = 2.3e-146
Identities = 188/347 (54%), Positives = 258/347 (74%)
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS 549
D + GK L ++SL + AT NFS KLGEGGFGPVY G L G+EVAVKRL S
Sbjct: 505 DDVEDGKSHELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNS 564
Query: 550 GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLL 609
GQGL+EFKNE++LIA+LQHRNLVR+LGCC+ + EKIL+ EYMPNKSLD +LF+P K+RLL
Sbjct: 565 GQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLL 624
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
DW+ R II+GIA+GLLYLH+ SRLR++HRDLKASN+LLD DM PKISDFG+ARMFGGD+
Sbjct: 625 DWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQ 684
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVY-NTDSFNLL 728
Q NT R+VGT+GYMSPEYA++G+FS+KSDV+ FG+L+LE ++ ++ + + DS N+
Sbjct: 685 NQFNTNRVVGTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIA 744
Query: 729 GHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
G+AW W + EL+DPVI + + ++R +++ALLCVQ++A +RP + V+ M+SN
Sbjct: 745 GYAWRQWNEDNAAELIDPVI-RASCSVRQVLRCIHIALLCVQDHADERPDIPTVILMLSN 803
Query: 789 EHLNLPFPKKLTFV-KGKNVKNSSYSTSGTSEICSVNDVTVSLVSPR 834
+ +LP P+ T + +G+ +++S S S S+ VT++ + R
Sbjct: 804 DSSSLPNPRPPTLMLRGREIESSKSSEKDRSH--SIGTVTMTQLHGR 848
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S972 | SD16_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4352 | 0.9508 | 0.9362 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00027534001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (814 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 834 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-55 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-41 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-38 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 6e-38 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 8e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-34 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-33 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-32 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-31 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-31 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-30 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-30 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-30 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-28 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-28 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-28 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-27 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-27 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-27 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-27 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-27 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-27 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 5e-26 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-25 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 5e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-25 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-24 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-23 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-23 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-23 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-23 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-23 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-22 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-22 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-22 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-22 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-22 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-22 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 6e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-20 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-20 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 9e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 9e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 4e-19 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 4e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 7e-19 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 8e-19 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-18 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-18 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-17 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 1e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-17 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-15 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-15 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-15 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-15 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-14 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 5e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-13 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-13 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-11 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-10 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 3e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| COG1718 | 268 | COG1718, RIO1, Serine/threonine protein kinase inv | 0.003 | |
| pfam11883 | 48 | pfam11883, DUF3403, Domain of unknown function (DU | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 90/283 (31%), Positives = 137/283 (48%), Gaps = 38/283 (13%)
Query: 516 SMQCKLGEGGFGPVYKGRLFNG-----QEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHR 569
++ KLGEG FG VYKG L EVAVK L S Q ++EF E ++ +L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V++LG C E+ ++++EYMP L YL + + L + IA+G+ YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE 120
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSPEY 688
IHRDL A N L+ +++ KISDFGL+R ++ D + ++ +M+PE
Sbjct: 121 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPES 175
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-WDLWKHERVHELMDPV 747
+G F+ KSDV+SFG+L+ E + LG + + V E
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT---------------LGEEPYPGMSNAEVLEY---- 216
Query: 748 ILQD----EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
L+ P + L C E+ DRPT S++V ++
Sbjct: 217 -LKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 92/284 (32%), Positives = 137/284 (48%), Gaps = 41/284 (14%)
Query: 516 SMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHR 569
++ KLGEG FG VYKG+L EVAVK L S Q ++EF E ++ +L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V++LG C E+ +++EYM L YL K L + IA+G+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE 119
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPE 687
IHRDL A N L+ +++ KISDFGL+R D+ + K + +M+PE
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI---RWMAPE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-WDLWKHERVHELMDP 746
+G F+ KSDV+SFG+L+ E + LG + +E V E
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLEY--- 215
Query: 747 VILQD----EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
L++ P ++ L C E+ DRPT S++V ++
Sbjct: 216 --LKNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 1e-54
Identities = 99/281 (35%), Positives = 142/281 (50%), Gaps = 35/281 (12%)
Query: 520 KLGEGGFGPVYKGRLFNGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRI 574
KLGEG FG VYKG+L EVAVK L S + K+F E ++ +L H N+VR+
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLYL 628
LG C E+ L+LEYM L YL F +K L + + IA+G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYGYMSPE 687
+ +HRDL A N L+ +D+ KISDFGL+R ++ D + T + +M+PE
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAPE 177
Query: 688 YALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
DG+F+ KSDV+SFG+L+ E TL + G+ N + L + + L
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---------RKGYRLPK 228
Query: 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
P DE+ Y + L C Q + DRPT S++V +
Sbjct: 229 PEYCPDEL-------Y-ELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 6e-53
Identities = 93/292 (31%), Positives = 136/292 (46%), Gaps = 54/292 (18%)
Query: 515 FSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQH 568
+ KLGEG FG VYKG L +VAVK L + + +EF E ++ +L H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
N+VR+LG C + ++ EYMP L +L L + +++ IA+G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE---LQGNTKRIVGTYGYMS 685
+HRDL A N L+ +++ KISDFGL+R D+ +G K + +M+
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMA 172
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-WDLWKHERVHELM 744
PE DG F+ KSDV+SFG+L+ E + LG + +E V EL
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT---------------LGEQPYPGMSNEEVLEL- 216
Query: 745 DPVILQDEIPLP----------MLMRYVNVALLCVQENAADRPTMSDVVSMI 786
L+D LP LM L C + DRPT S++V +
Sbjct: 217 ----LEDGYRLPRPENCPDELYELM------LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 2e-51
Identities = 74/193 (38%), Positives = 109/193 (56%), Gaps = 11/193 (5%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
LGEGGFG VY R G++VA+K + + L E E+ ++ +L H N+V++ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
++ L++EY SL L + K L + +RI+ I +GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK--LSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 639 RDLKASNVLLDKD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSI 696
RDLK N+LLD D K++DFGL+++ D+ T IVGT YM+PE L G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSE 173
Query: 697 KSDVFSFGILMLE 709
KSD++S G+++ E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-47
Identities = 70/199 (35%), Positives = 104/199 (52%), Gaps = 12/199 (6%)
Query: 520 KLGEGGFGPVYKGRLFN-GQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLG G FG VYK + G+ VAVK L S+ + + + E+ ++ L H N+VR++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
++ L++EY L YL + L + +I I +GL YLH I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNGI 119
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS 695
IHRDLK N+LLD++ KI+DFGLA+ + VGT YM+PE L G +
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKS--SSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 696 IKSDVFSFGILMLETLSSR 714
K DV+S G+++ E L+ +
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 3e-46
Identities = 67/197 (34%), Positives = 104/197 (52%), Gaps = 11/197 (5%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLV 572
+ + KLGEG FG VY R G+ VA+K + + + +E E+ ++ +L+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R+ ++ + L++EY L L + RL + EAR ++ I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK--RGRLSEDEAR-FYLRQILSALEYLHS-- 115
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
I+HRDLK N+LLD+D + K++DFGLAR E VGT YM+PE L
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171
Query: 693 LFSIKSDVFSFGILMLE 709
+ D++S G+++ E
Sbjct: 172 GYGKAVDIWSLGVILYE 188
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 78/287 (27%), Positives = 126/287 (43%), Gaps = 43/287 (14%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG G FG VY G+ +AVK LS S + L+ + E+ +++ LQH N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 576 GCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQGLLYLHQY 631
G ++ + L LEY+ SL +KK +L + R Q I +GL YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLS----SLLKKFGKLPEPVIRKYTRQ-ILEGLAYLH-- 118
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
I+HRD+K +N+L+D D K++DFG A+ G E T + GT +M+PE
Sbjct: 119 -SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
+ +D++S G ++E + + W + + +
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK---------------PPW--SELGNPMAALYKIGSSG 220
Query: 752 EIP-LP--MLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPF 795
E P +P + + C++ + RPT ++E L PF
Sbjct: 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPT--------ADELLQHPF 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 83/286 (29%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 520 KLGEGGFGPVYKGRLFN-----GQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRNLVR 573
+LGEG FG V R G++VAVK L+ S Q +F+ E+ ++ L H N+V+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 574 ILGCCVEQGEKI--LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
G C + G + LI+EY+P+ SL YL + ++ + + I +G+ YL
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS- 127
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYA 689
R IHRDL A N+L++ + KISDFGLA++ D + Y +PE
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP-VI 748
FS SDV+SFG+ + E + + + ++G A R+ EL+
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER 244
Query: 749 LQDEIPLP----MLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790
L P LM+ LC + DRP+ +D++ ++
Sbjct: 245 LPRPPSCPDEVYDLMK------LCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 50/119 (42%), Positives = 68/119 (57%), Gaps = 6/119 (5%)
Query: 34 IRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTIS 93
+ G+ L SS FELGFF Y I ++ TVVWVANRD P SG + LT+
Sbjct: 4 LSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNP-SGSSCTLTLQ 62
Query: 94 NNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHP 152
++GNLV+ + +WS+N + N V L DDGNLV+ D+ ++LWQSFD+P
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 54/115 (46%), Positives = 68/115 (59%), Gaps = 6/115 (5%)
Query: 70 PDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGN 129
TVVWVANR P++ + L + ++GNLVL +WS+N S VA L+DDGN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 130 LVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPS 184
LV+ DNS LWQSFDHP+DTLL K G + G R L+SW+S DPS
Sbjct: 61 LVLYDNSG-----KVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 15/206 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRN 570
N+ + +G G FG VYKG L G VA+K++S + + LK E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V+ +G +ILEY N SL + F P + L+ + + QGL YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV-----AVYVYQVLQGLAYL 115
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H+ +IHRD+KA+N+L KD K++DFG+A + +VGT +M+PE
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEV 170
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSR 714
S SD++S G ++E L+
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 63/192 (32%), Positives = 106/192 (55%), Gaps = 11/192 (5%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+G+GGFG VYK R G+EVA+K + +S + ++ NE+ ++ + +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLLYLHQYSRLRII 637
+++ E +++E+ SL L + L E++I + + + +GL YLH II
Sbjct: 67 LKKDELWIVMEFCSGGSLK-DLLKSTNQTLT--ESQIAYVCKELLKGLEYLHSN---GII 120
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
HRD+KA+N+LL D K+ DFGL+ +VGT +M+PE + K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 698 SDVFSFGILMLE 709
+D++S GI +E
Sbjct: 178 ADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 71/200 (35%), Positives = 112/200 (56%), Gaps = 6/200 (3%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E F+++ KLG G FG V++G N VA+K L S ++F+ E+ + L+H++L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ C +I E M SL +L P + ++L + I + +A+G+ YL +
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ- 123
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
IHRDL A N+L+ +D+ K++DFGLAR+ D + K+I Y + +PE A G
Sbjct: 124 --NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHG 179
Query: 693 LFSIKSDVFSFGILMLETLS 712
FS KSDV+SFGIL+ E +
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 74/201 (36%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG G FG V+ G +VAVK L + + F E ++ +L+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLV 64
Query: 573 RILGCCVEQGEKILIL-EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
++ C + E I I+ EYM SL +L K+L + + IA+G+ YL
Sbjct: 65 QLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLVDMAAQIAEGMAYLE-- 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
IHRDL A N+L+ +++ KI+DFGLAR+ DE +G I T +PE
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEA 175
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
A G F+IKSDV+SFGIL+ E
Sbjct: 176 ANYGRFTIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-34
Identities = 49/120 (40%), Positives = 68/120 (56%), Gaps = 7/120 (5%)
Query: 32 SFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLT 91
+ + G+ L S + FELGFF+ Y I ++ TVVWVANRD P+S + LT
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSSSRTVVWVANRDNPVSD-SCTLT 59
Query: 92 ISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151
+ ++GNLVL +WS+N + N V L DDGNLVI D+ + +LWQSFD+
Sbjct: 60 LQSDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYDSDGN-----FLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 81/296 (27%), Positives = 129/296 (43%), Gaps = 45/296 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRN 570
+ LG+G G VYK R G+ A+K++ + K+ E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLH 629
+V+ G ++GE ++LEYM SL D +KK E + I + I +GL YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLA----DLLKKVGKIPEPVLAYIARQILKGLDYLH 116
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ IIHRD+K SN+L++ KI+DFG++++ + VGT YMSPE
Sbjct: 117 T--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERI 172
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
+S +D++S G+ +LE G + F G + ELM I
Sbjct: 173 QGESYSYAADIWSLGLTLLECA-----LGKF---PFLPPGQP-SFF------ELMQ-AIC 216
Query: 750 QDEIPL-------PMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKK 798
P P +++ C+Q++ RP+ + E L PF KK
Sbjct: 217 DGPPPSLPAEEFSPEFRDFIS---ACLQKDPKKRPS--------AAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 5e-32
Identities = 81/312 (25%), Positives = 133/312 (42%), Gaps = 21/312 (6%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH-R 569
++ + KLGEG FG VY R + + VA+K L+ + + ++ F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V++ ++G L++EY+ SL+ L +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMN-PKISDFGLARMFGGD----ELQGNTKRIVGTYGYM 684
IIHRD+K N+LLD+D K+ DFGLA++ + VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 685 SPEYALDGLF---SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741
+PE L S SD++S GI + E L+ + + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTP 233
Query: 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTF 801
L L P + ++ + ++ +R + S +S HL L
Sbjct: 234 SL--ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDL 291
Query: 802 VKGKNVKNSSYS 813
+K + S
Sbjct: 292 LKPDDSAPLRLS 303
|
Length = 384 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 73/213 (34%), Positives = 112/213 (52%), Gaps = 25/213 (11%)
Query: 521 LGEGGFGPVYKGRLF--NGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVR 573
LGEG FG VYKG L N + VA+K L + + +EF+ E L+++LQH N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLF-------------DPIKKRLLDWEARIRIIQG 620
+LG C ++ ++ EY+ + L +L D K LD + I
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGNTKRIVG 679
IA G+ YL S +HRDL A N L+ + + KISDFGL+R ++ D + +K ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M PE L G F+ +SD++SFG+++ E S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 63/194 (32%), Positives = 103/194 (53%), Gaps = 15/194 (7%)
Query: 520 KLGEGGFGPVYKG-RLFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
K+GEG G VYK G+EVA+K RL Q+ + + NE++++ + +H N+V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLLYLHQYSRLR 635
+ E +++EYM SL + R+ E +I + + + QGL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSL-TDIITQNFVRMN--EPQIAYVCREVLQGLEYLHS---QN 136
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
+IHRD+K+ N+LL KD + K++DFG A + + +VGT +M+PE +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT--KEKSKRNSVVGTPYWMAPEVIKRKDYG 194
Query: 696 IKSDVFSFGILMLE 709
K D++S GI+ +E
Sbjct: 195 PKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 84/276 (30%), Positives = 138/276 (50%), Gaps = 31/276 (11%)
Query: 521 LGEGGFGPVYKGRL-FNGQE---VAVKRLSSQSGQGLK-EFKNEMMLIAELQHRNLVRIL 575
+G G FG V +GRL G++ VA+K L + S + +F E ++ + H N++R+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 576 GCCVEQGEKILIL-EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
G V + ++I+ EYM N SLD +L + K + +++GIA G+ YL S +
Sbjct: 72 GV-VTKSRPVMIITEYMENGSLDKFLRENDGK--FTVGQLVGMLRGIASGMKYL---SEM 125
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK--RIVGTYGYMSPEYALDG 692
+HRDL A N+L++ ++ K+SDFGL+R E TK +I + +PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKI--PIRWTAPEAIAYR 183
Query: 693 LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752
F+ SDV+SFGI+M E +S Y + WD+ + + + D L
Sbjct: 184 KFTSASDVWSFGIVMWEVMS-------YGERPY------WDMSNQDVIKAVEDGYRLPPP 230
Query: 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ P + + L C Q++ +RPT S +VS +
Sbjct: 231 MDCPSALY--QLMLDCWQKDRNERPTFSQIVSTLDK 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-30
Identities = 72/286 (25%), Positives = 135/286 (47%), Gaps = 53/286 (18%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
++G+G FG VY R +G+ +K LS+ S + ++ NE+ ++ +L H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKR-----------LLDWEARIRIIQGIAQGL 625
E+G+ +++EY L IKK+ +LDW +Q + L
Sbjct: 67 SFEEKGKLCIVMEYADGGDLS----QKIKKQKKEGKPFPEEQILDW-----FVQ-LCLAL 116
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
YLH SR +I+HRD+K N+ L + K+ DFG++++ T +VGT Y+S
Sbjct: 117 KYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLS 171
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
PE + ++ KSD++S G ++ E + L H ++ E + EL
Sbjct: 172 PELCQNKPYNYKSDIWSLGCVLYELCT---------------LKHPFE---GENLLELAL 213
Query: 746 PVILQDEIPLPMLMRY----VNVALLCVQENAADRPTMSDVVSMIS 787
++ P+P +Y N+ +Q++ +RP+++ ++
Sbjct: 214 KILKGQYPPIP--SQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 81/280 (28%), Positives = 138/280 (49%), Gaps = 41/280 (14%)
Query: 521 LGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG VYKG VA+K L ++ + KE +E ++A + H ++VR+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPI----KKRLLDWEARIRIIQGIAQGLLYLH 629
LG C+ ++ LI + MP L Y+ + + LL+W +I A+G+ YL
Sbjct: 75 LGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ R++HRDL A NVL+ + KI+DFGLA++ DE + + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 690 LDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747
L +++ KSDV+S+G+ + E T ++ G+ + +LL E+ L P
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL---------EKGERLPQPP 234
Query: 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
I I + M++ + C +A RPT ++++ S
Sbjct: 235 IC--TIDVYMVL------VKCWMIDAESRPTFKELINEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 77/210 (36%), Positives = 110/210 (52%), Gaps = 22/210 (10%)
Query: 521 LGEGGFGPVYKGRLFN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLV 572
LG G FG VY+G + VAVK L + Q KEF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR----LLDWEARIRIIQGIAQGLLYL 628
++LG C+ + +I+E M L YL D +R LL + + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 629 HQYSRLRIIHRDLKASNVLL-----DKDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYG 682
Q + IHRDL A N L+ D D KI DFGLAR ++ D + + ++
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR- 178
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE LDG F+ +SDV+SFG+LM E L+
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 29/214 (13%)
Query: 521 LGEGGFGPVYKGRLFNGQE------VAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVR 573
LGEG FG V+ G ++ + VAVK L + ++ F+ E L+ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRL---------LDWEARIRIIQGIA 622
G C E I++ EYM + L+ +L P L L ++I IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT-- 680
G++YL + +HRDL N L+ D+ KI DFG++R D + R+ G
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185
Query: 681 --YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M PE + F+ +SDV+SFG+++ E +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 63/202 (31%), Positives = 111/202 (54%), Gaps = 15/202 (7%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRN 570
+F + K+G+G FG V+K R + + A+K+ LS + + +E +E ++A+L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLD---WEARIRIIQGIAQGLLY 627
++R +++G+ +++EY N L L + L + W I+I+ G+A +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA----H 116
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH +I+HRD+K+ N+ LD N KI D G+A++ + NT IVGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 688 YALDGLFSIKSDVFSFGILMLE 709
D ++ KSDV++ G+++ E
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 72/197 (36%), Positives = 100/197 (50%), Gaps = 14/197 (7%)
Query: 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
+ KLG G FG V++G N VAVK L + K+F E ++ +L+H L+++
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYA 68
Query: 577 CCVEQGEKILIL-EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
C E I I+ E M SL YL R L I + +A G+ YL +
Sbjct: 69 VCT-LEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQN--- 123
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDG 692
IHRDL A NVL+ ++ K++DFGLAR+ D + G + +PE AL
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYN 179
Query: 693 LFSIKSDVFSFGILMLE 709
FSIKSDV+SFGIL+ E
Sbjct: 180 RFSIKSDVWSFGILLTE 196
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
E F + KLGEG +G VYK GQ VA+K + + L+E E+ ++ + +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYI 60
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK--KRLLDWEARIRII-QGIAQGLLYL 628
V+ G + + +++EY S+ D +K + L E I I +GL YL
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVS----DIMKITNKTLT-EEEIAAILYQTLKGLEYL 115
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H + IHRD+KA N+LL+++ K++DFG++ + NT ++GT +M+PE
Sbjct: 116 HS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEV 170
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+ ++ K+D++S GI +E
Sbjct: 171 IQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 68/197 (34%), Positives = 103/197 (52%), Gaps = 21/197 (10%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580
+G+G FG V G + GQ+VAVK L S + F E ++ L+H NLV++LG ++
Sbjct: 14 IGKGEFGDVMLG-DYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 581 QGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
++ EYM SL YL + R ++ ++ + +G+ YL + +
Sbjct: 72 GNPLYIVTEYMAKGSLVDYL----RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYALDGLFS 695
HRDL A NVL+ +D+ K+SDFGLA+ + QG G + +PE + FS
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQD---SGKLPVKWTAPEALREKKFS 177
Query: 696 IKSDVFSFGILMLETLS 712
KSDV+SFGIL+ E S
Sbjct: 178 TKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 82/293 (27%), Positives = 135/293 (46%), Gaps = 38/293 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGLK-EFKNEMMLIAE 565
E ++ +LG+G FG VY+G VA+K ++ + + EF NE ++ E
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLF----DPIKKRLLDWEARIRIIQ-- 619
++VR+LG ++++E M L YL + L + IQ
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA 125
Query: 620 -GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGNTKRI 677
IA G+ YL + +HRDL A N ++ +D+ KI DFG+ R ++ D + K +
Sbjct: 126 AEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLW 735
+ +M+PE DG+F+ KSDV+SFG+++ E TL+ + G+ N + + L
Sbjct: 183 LPVR-WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD 241
Query: 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
E P L + LMR +C Q N RPT ++VS + +
Sbjct: 242 LPENC-----PDKLLE------LMR------MCWQYNPKMRPTFLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-28
Identities = 92/276 (33%), Positives = 129/276 (46%), Gaps = 42/276 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E + KLG G FG V+ G +VA+K L S + F E L+ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQGLLY 627
R L V Q +I EYM N SL +L P +L+D A+I A+G+ +
Sbjct: 65 R-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQI------AEGMAF 117
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYM 684
+ R IHRDL+A+N+L+ + + KI+DFGLAR+ +E +G I T
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWT---- 170
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742
+PE G F+IKSDV+SFGIL+ E T G+ N + L ER +
Sbjct: 171 APEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---------ERGYR 221
Query: 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT 778
+ P D P + LC +E +RPT
Sbjct: 222 MPRP----DNCP----EELYELMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 87/285 (30%), Positives = 127/285 (44%), Gaps = 50/285 (17%)
Query: 521 LGEGGFGPVYKG--RLFNGQE--VAVKRLS-SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG G FG V KG + +G+E VAVK L G KEF E ++A+L H +VR++
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFD----PIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
G C + +L++E P L YL P+ L + ++ A G+ YL
Sbjct: 63 GVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSD-LKELAHQV------AMGMAYLES- 113
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM--FGGDELQGNT--KRIVGTYGYMSPE 687
+HRDL A NVLL KISDFG++R G D + T + + Y +PE
Sbjct: 114 --KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APE 168
Query: 688 YALDGLFSIKSDVFSFGILMLETLS--SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
G FS KSDV+S+G+ + E S ++ + + +L E L
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML---------ESGERLPR 219
Query: 746 PVILQDEIPLPM--LMRYVNVALLCVQENAADRPTMSDVVSMISN 788
P +E P + +M L C + DRPT S++ S
Sbjct: 220 P----EECPQEIYSIM------LSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 79/205 (38%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 517 MQCKLGEGGFGPV--YKGRLFN---GQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRN 570
LGEG FG V Y N G+ VAVK L + GQ +K E+ ++ L H N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 571 LVRILGCCVEQGEKI--LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V+ GCC EQG K LI+EY+P SL YL K L+ + Q I +G+ YL
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYL 123
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYMSPE 687
H IHRDL A NVLLD D KI DFGLA+ G E + + + E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+ FS SDV+SFG+ + E L+
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 22/202 (10%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
K+G+G FG VYKG L EVAVK S LK F E ++ + H N+V+++G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGI------AQGLLYLHQYS 632
V++ +++E +P SL +L + R+ + + + A G+ YL +
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKK--------KNRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD--ELQGNTKRIVGTYGYMSPEYAL 690
IHRDL A N L+ ++ KISDFG++R G + K+I + +PE
Sbjct: 114 ---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALN 168
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
G ++ +SDV+S+GIL+ ET S
Sbjct: 169 YGRYTSESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 79/276 (28%), Positives = 134/276 (48%), Gaps = 38/276 (13%)
Query: 516 SMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+M+ KLG G +G VY+G VAVK L + ++EF E ++ E++H NLV++
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQL 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
LG C + +I E+M +L YL + ++ ++ + + I+ + YL + +
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN-- 124
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPEYALDG 692
IHRDL A N L+ ++ K++DFGL+R+ GD K + + +PE
Sbjct: 125 -FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPESLAYN 180
Query: 693 LFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWKHE----RVHELMDP 746
FSIKSDV++FG+L+ E T G+ + + LL + + + E +V+ELM
Sbjct: 181 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELM-- 238
Query: 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDV 782
C Q N +DRP+ +++
Sbjct: 239 -------------------RACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 76/288 (26%), Positives = 122/288 (42%), Gaps = 45/288 (15%)
Query: 521 LGEGGFGPVYKGRLFNGQE------VAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVR 573
LG G FG V+ + +E V VK L + EF+ E+ + +L H+N+VR
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLY 627
+LG C E +ILEY L +L + +K L + ++ + IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L S R +HRDL A N L+ K+S L++ E ++ +++PE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAPE 188
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRK--NTGVYNTDSFNLLGHAWDLWKH-----ERV 740
+ FS KSDV+SFG+LM E + + G+ + + N L R+
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRL 248
Query: 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
++LM C N DRP+ S++VS +
Sbjct: 249 YKLM---------------------TRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-27
Identities = 82/291 (28%), Positives = 139/291 (47%), Gaps = 49/291 (16%)
Query: 521 LGEGGFGPVYKGRL----FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LGEG FG V +G+L + +VAVK +L + ++EF +E + + H N++++
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 575 LGCCVEQGEK------ILILEYMPNKSLDVYLFDPIKKRL------LDWEARIRIIQGIA 622
+G C E ++IL +M + L +L RL L + ++ + IA
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDEL-QGNTKRIVGT 680
G+ YL S IHRDL A N +L +DM ++DFGL++ ++ GD QG ++
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM--P 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNT---GVYNTDSFNLLGHAWDLWKH 737
+++ E D +++ KSDV++FG+ M E +R T GV N + ++ L H
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIA-TRGQTPYPGVENHEIYDYLRHG------ 231
Query: 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ L P DE+ M C + + DRPT + + ++ N
Sbjct: 232 ---NRLKQPEDCLDELYDLMYS--------CWRADPKDRPTFTKLREVLEN 271
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 7e-27
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 31/215 (14%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAELQH 568
+ ++GEG +G VYK R G+ VA+K++ ++ KE E+ L+ +L+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENE---KEGFPITAIREIKLLQKLRH 57
Query: 569 RNLVRILGCCVE--QGEKILILEYMPN------KSLDVYLFDPIKKRLLDWEARIRIIQG 620
N+VR+ +G ++ EYM + S +V + K + +
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM---------KQ 108
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +GL YLH I+HRD+K SN+L++ D K++DFGLAR + T R++ T
Sbjct: 109 LLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164
Query: 681 YGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSR 714
Y PE L + + D++S G ++ E +
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 90/285 (31%), Positives = 140/285 (49%), Gaps = 39/285 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ + KLG G FG V+ G N +VAVK L + ++ F E L+ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLV 64
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDP-----IKKRLLDWEARIRIIQGIAQGLLY 627
R+ ++ +I EYM SL +L + +L+D+ A+I A+G+ Y
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI------AEGMAY 118
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMS 685
+ R IHRDL+A+NVL+ + + KI+DFGLAR+ +E T R + + +
Sbjct: 119 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTA 172
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRK--NTGVYNTDSFNLLGHAWDLWKHERVHEL 743
PE G F+IKSDV+SFGIL+ E ++ K G+ N+D + L + + + E
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENC--- 229
Query: 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
P L D + C +E A +RPT + S++ +
Sbjct: 230 --PDELYD------------IMKTCWKEKAEERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (271), Expect = 3e-26
Identities = 67/203 (33%), Positives = 97/203 (47%), Gaps = 26/203 (12%)
Query: 521 LGEGGFGPVYK------GRLFNGQEVAVKRLSSQSGQGLKEF---KNEMMLIAELQHRNL 571
LG+G FG V G+L+ A+K L + KE E +++ + H +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 572 VRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLH 629
V+ L + EK+ L+LEY P LF + K E R R I L YLH
Sbjct: 56 VK-LHYAFQTEEKLYLVLEYAPGG----ELFSHLSKEGRFSEERARFYAAEIVLALEYLH 110
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
L II+RDLK N+LLD D + K++DFGLA+ + + NT GT Y++PE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVL 165
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
L + D +S G+L+ E L+
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 20/197 (10%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMM---LIAELQHRNLVRIL 575
+LG G G V K G+ +AVK + + K + ++ + +V
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 576 GCCVEQGEKILILEYMPNKSLDVYL---FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
G G+ + +EYM SLD L I +R+L +I + +GL YLH
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLH--E 118
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+ +IIHRD+K SN+L++ K+ DFG++ G + K VGT YM+PE
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTFVGTSSYMAPERIQGN 174
Query: 693 LFSIKSDVFSFGILMLE 709
+S+KSD++S G+ ++E
Sbjct: 175 DYSVKSDIWSLGLSLIE 191
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 54/293 (18%)
Query: 521 LGEGGFGPVYKGR---LFNGQE---VAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVR 573
+G+G FG V++ R L + VAVK L + S +F+ E L+AE H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFD-------------------PIKKRLLDWEAR 614
+LG C L+ EYM L+ +L + L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGN 673
+ I + +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R ++ D + +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD 733
+ +M PE ++ +SDV+++G+++ E S Y + + H
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFS-------YGMQPYYGMAH--- 238
Query: 734 LWKHERVHELMDPVILQ--DEIPLPM--LMRYVNVALLCVQENAADRPTMSDV 782
E ++ + D +L D PL + LMR LC + +DRP+ + +
Sbjct: 239 ---EEVIYYVRDGNVLSCPDNCPLELYNLMR------LCWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 79/294 (26%), Positives = 127/294 (43%), Gaps = 43/294 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+ ++ LGEG FG V K VAVK L + + L + +EM ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD-----PIKKRLLDWEARIRIIQ 619
+ +H+N++ +LG C ++G +++EY + +L +L + Q
Sbjct: 72 IGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQ 131
Query: 620 --------GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
+A+G+ +L + IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLG 729
T +M+PE D +++ +SDV+SFG+L+ E TL G+ + F LL
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK 248
Query: 730 HAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783
+ + P E L LMR C E + RPT +V
Sbjct: 249 EG---------YRMEKPQNCTQE--LYHLMRD------CWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 62/199 (31%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
++G G FG V+ G ++VA+K + + ++F E ++ +L H LV++ G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639
E+ L+ E+M + L YL ++ E + + + +G+ YL + +IHR
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 640 DLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLFSI 696
DL A N L+ ++ K+SDFG+ R D+ +T GT + SPE +S
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKYSS 180
Query: 697 KSDVFSFGILMLETLSSRK 715
KSDV+SFG+LM E S K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 66/200 (33%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAELQHRNLVRILG 576
K+GEG +G VYK R G+ VA+K++ + E+ L+ EL H N++++L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLLYLHQYSRLR 635
+G+ L+ E+M D+Y ++R L E+ I+ + + QGL + H +
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLP-ESLIKSYLYQLLQGLAFCHSH---G 118
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-DGLF 694
I+HRDLK N+L++ + K++DFGLAR FG V T Y +PE L D +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSP--VRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 695 SIKSDVFSFGILMLETLSSR 714
S D++S G + E LS R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 82/299 (27%), Positives = 138/299 (46%), Gaps = 50/299 (16%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG--RLFNG----QEVAVKRL-SSQSGQGLKEFKNEMMLI 563
++ ++ LG G FG VY+G R +G +VAVK L S S Q +F E +++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD----PIKKRLLDWEARIRIIQ 619
++ H+N+VR++G E+ + ++LE M L +L + P + L + + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLAR-MFGGDELQGNTK 675
+A+G YL + IHRD+ A N LL KI+DFG+AR ++ + +
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735
++ +M PE LDG+F+ K+DV+SFG+L+ E S LG+
Sbjct: 181 AML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS---------------LGYMPYPG 224
Query: 736 KHERVHELMDPVIL------QDEIPLPM--LMRYVNVALLCVQENAADRPTMSDVVSMI 786
+ + E+M+ V P P+ +M C Q DRP + ++ I
Sbjct: 225 RTNQ--EVMEFVTGGGRLDPPKGCPGPVYRIMTD------CWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 5e-25
Identities = 28/65 (43%), Positives = 43/65 (66%)
Query: 336 CTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWY 395
C G F +L N+K PD +++S+ L++C CL NC+C AYA +++ GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWT 60
Query: 396 GDLLD 400
G+L+D
Sbjct: 61 GELVD 65
|
Length = 66 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 22/212 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGL-KEFKNEMMLIAELQHRN 570
E +LGEG G V K RL N + A+K +++ L K+ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 571 LVRILGCCVE--QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI------RIIQGIA 622
+V+ G ++ + +EY SLD I K++ RI +I + +
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLD-----SIYKKVKKRGGRIGEKVLGKIAESVL 115
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
+GL YLH +IIHRD+K SN+LL + K+ DFG++ G+ + GT
Sbjct: 116 KGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTFTGTSF 168
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
YM+PE +SI SDV+S G+ +LE +R
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 74/216 (34%), Positives = 112/216 (51%), Gaps = 29/216 (13%)
Query: 520 KLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLV 572
+LGE FG VYKG LF Q VA+K L ++ L+E FK+E M+ + LQH N+V
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLF-------------DPIKKRLLDWEARIRIIQ 619
+LG ++ +I Y + L +L D K L+ + I+
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--ELQGNTKR 676
IA G+ +L S ++H+DL NVL+ +N KISD GL R ++ D +L GN+
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +MSPE + G FSI SD++S+G+++ E S
Sbjct: 189 PI---RWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 79/270 (29%), Positives = 120/270 (44%), Gaps = 30/270 (11%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580
LG G FG V+ G+ +VA+K + + +F E ++ +L H NLV++ G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRD 640
Q ++ EYM N L YL + +K L E + + + + + YL IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 641 LKASNVLLDKDMNPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPEYALDGLFSIKS 698
L A N L+ +D K+SDFGLAR D+ TK V + PE FS KS
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV---KWAPPEVFDYSRFSSKS 182
Query: 699 DVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPML 758
DV+SFG+LM E S K ++ + + E+++ V + P L
Sbjct: 183 DVWSFGVLMWEVFSEGKM--------------PYERFSNS---EVVESVSAGYRLYRPKL 225
Query: 759 --MRYVNVALLCVQENAADRPTMSDVVSMI 786
+ C E DRP ++S +
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 82/285 (28%), Positives = 139/285 (48%), Gaps = 52/285 (18%)
Query: 521 LGEGGFGPVYKG--RLFNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAELQHRNLVRIL 575
+G G FG V++G ++ +EVAV + + G K+ F +E ++ + H N++R+
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
G + ++I EYM N +LD YL F + + +++GIA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ--------LVGMLRGIAAGMKYL- 123
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------Y 683
S + +HRDL A N+L++ ++ K+SDFGL+R+ L+ + + T G +
Sbjct: 124 --SDMNYVHRDLAARNILVNSNLECKVSDFGLSRV-----LEDDPEGTYTTSGGKIPIRW 176
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743
+PE F+ SDV+SFGI+M E +S + + WD+ HE + +
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS-------FGERPY------WDMSNHEVMKAI 223
Query: 744 MDPVILQDEIPLPM--LMRYVNVALLCVQENAADRPTMSDVVSMI 786
D L P PM + L C Q++ A RP D+V+++
Sbjct: 224 NDGFRL----PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 67/222 (30%), Positives = 103/222 (46%), Gaps = 35/222 (15%)
Query: 520 KLGEGGFGPVYKGRLFNGQE-----------------VAVKRL-SSQSGQGLKEFKNEMM 561
KLGEG FG V+ Q+ VAVK L S ++F E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL--------FDPIKKRLLDWEA 613
+++ L N+ R+LG C +I+EYM N L+ +L + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--EL 670
+ + IA G+ YL L +HRDL N L+ K+ KI+DFG++R ++ D +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
QG R +M+ E L G F+ KSDV++FG+ + E L+
Sbjct: 189 QG---RAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 77/274 (28%), Positives = 123/274 (44%), Gaps = 37/274 (13%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
LG+G +G VY R L +A+K + + + ++ E+ L + L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 580 EQGEKILILEYMPNKSLDVYL---FDPIKKRLLDWEARIRII-QGIAQGLLYLHQYSRLR 635
E G + +E +P SL L + P+K D E I + I +GL YLH +
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLK----DNEQTIIFYTKQILEGLKYLHD---NQ 128
Query: 636 IIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL- 693
I+HRD+K NVL++ KISDFG ++ G + T+ GT YM+PE G
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDKGPR 186
Query: 694 -FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL--- 749
+ +D++S G ++E + + F LG M V +
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKP--------PFIELGEP---------QAAMFKVGMFKI 229
Query: 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783
EIP + N L C + + R + D++
Sbjct: 230 HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 65/207 (31%), Positives = 108/207 (52%), Gaps = 18/207 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+++ + +G G VY L N ++VA+KR+ + + E + E+ +++ H N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL----LDWEARI-RIIQGIAQGL 625
+V+ V E L++ Y+ SL D +K LD EA I +++ + +GL
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSL----LDIMKSSYPRGGLD-EAIIATVLKEVLKGL 115
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGY 683
YLH + IHRD+KA N+LL +D + KI+DFG++ GGD + K VGT +
Sbjct: 116 EYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCW 172
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLE 709
M+PE + K+D++SFGI +E
Sbjct: 173 MAPEVMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 77/269 (28%), Positives = 128/269 (47%), Gaps = 37/269 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQ------EVAVKRLSSQSGQG-LKEFKNEMMLIAEL 566
N + LGEG FG V K F + VAVK L + L++ +E L+ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK--------------------- 605
H +++++ G C + G +LI+EY SL +L + K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 606 KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
+R L I I++G+ YL + ++++HRDL A NVL+ + KISDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 666 GGDE--LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYN 721
++ ++ + RI +M+ E D +++ +SDV+SFG+L+ E TL G+
Sbjct: 178 YEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 722 TDSFNLLGHAWDLWKHERVHELMDPVILQ 750
FNLL + + + E E M ++L
Sbjct: 236 ERLFNLLKTGYRMERPENCSEEMYNLMLT 264
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 70/213 (32%), Positives = 110/213 (51%), Gaps = 30/213 (14%)
Query: 521 LGEGGFGPVYKG-RLFNGQEVAVKR--LSSQSGQG-------LKEFKNEMMLIAELQHRN 570
+G G FG VY G +G+ +AVK+ L S S L E+ L+ ELQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 571 LVRILGCCVEQGEKILILEYMPNKS----LDVYLFDPIKKRLLDWEARIR-IIQGIAQGL 625
+V+ LG ++ + LEY+P S L+ Y E +R ++ I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--------ETLVRNFVRQILKGL 119
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG--NTKR--IVGTY 681
YLH +R IIHRD+K +N+L+D KISDFG+++ + L N R + G+
Sbjct: 120 NYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
+M+PE ++ K+D++S G L++E L+ +
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 97/318 (30%), Positives = 143/318 (44%), Gaps = 56/318 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE--------VAVKRLSSQ-SGQGLKEFKNEMMLI 563
+ + LGEG FG V + + + VAVK L + + L + +EM L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FDPIK--KRLL 609
+ +H+N++ +LG C ++G +I+EY +L +L FD K + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
++ + +A+G+ YL SR R IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 132 SFKDLVSCAYQVARGMEYLE--SR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDID 188
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNL 727
T +M+PE D +++ +SDV+SFGILM E TL G+ + F L
Sbjct: 189 YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL 248
Query: 728 L--GHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785
L GH D HEL MLMR C RPT +V
Sbjct: 249 LREGHRMDK-PSNCTHELY------------MLMRE------CWHAVPTQRPTFKQLVEA 289
Query: 786 -------ISNEHLNLPFP 796
+S E+L+L P
Sbjct: 290 LDKVLAAVSEEYLDLSMP 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 72/205 (35%), Positives = 109/205 (53%), Gaps = 13/205 (6%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
E+ + KLG G FG V+ G +VAVK L + + F E ++ +L+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDK 62
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
LV++ E+ I + EYM SL +L D + R L + + +A G+ Y+
Sbjct: 63 LVQLYAVVSEEPIYI-VTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE- 119
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPE 687
R+ IHRDL+++N+L+ + KI+DFGLAR+ +E QG I T +PE
Sbjct: 120 --RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
AL G F+IKSDV+SFGIL+ E ++
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 69/204 (33%), Positives = 107/204 (52%), Gaps = 22/204 (10%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRL-SSQSGQGLKEFKN---EMMLIAELQHRNLVRI 574
KLGEG +G VYK R G+ VA+K++ +G+ E+ L+ EL+H N+V++
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIP--STALREISLLKELKHPNIVKL 63
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARI--RIIQGIAQGLLYLHQY 631
L K+ L+ EY + L YL KR + I+ + +GL Y H +
Sbjct: 64 LDVIH-TERKLYLVFEYC-DMDLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL- 690
RI+HRDLK N+L+++D K++DFGLAR F G L+ T +V T Y +PE L
Sbjct: 118 ---RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TLWYRAPEILLG 172
Query: 691 DGLFSIKSDVFSFGILMLETLSSR 714
+S D++S G + E ++ +
Sbjct: 173 SKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN-----EMMLIAELQ 567
+ KLGEG + VYK R G+ VA+K++ + K+ N E+ L+ EL+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLL 626
H N++ +L + L+ E+M L+ + D K ++ A I+ + +GL
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKD---KSIVLTPADIKSYMLMTLRGLE 116
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YLH I+HRDLK +N+L+ D K++DFGLAR FG + + V T Y +P
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ--VVTRWYRAP 171
Query: 687 EYALDGLFSIKS-----DVFSFGILMLETL 711
E LF + D++S G + E L
Sbjct: 172 EL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 69/213 (32%), Positives = 108/213 (50%), Gaps = 30/213 (14%)
Query: 521 LGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG+G FG V R G+ VAVK+L + + L++F+ E+ ++ LQH N+V+
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 576 GCCVEQGEK--ILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLY 627
G C G + L++EY+P SL YL D K L + I +G+ Y
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ--------ICKGMEY 123
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYM 684
L R +HRDL N+L++ + KI DFGL ++ D+ + R G + Y
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY- 178
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLS-SRKN 716
+PE + FS+ SDV+SFG+++ E + S K+
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 83/283 (29%), Positives = 116/283 (40%), Gaps = 43/283 (15%)
Query: 520 KLGEGGFGPVYKG-------RLFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNL 571
KLG+G FG V +G ++ VAVK L S + +F E ++ L H NL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIP---VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQGLL 626
+R+ G V +++ E P SL L L D+ +Q IA G+
Sbjct: 59 IRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA-----VQ-IANGMR 111
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYM 684
YL R IHRDL A N+LL D KI DFGL R D V + +
Sbjct: 112 YLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PFAWC 167
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
+PE FS SDV+ FG+ + E + Y + + L + L K ++ E +
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT-------YGEEPWAGLSGSQILKKIDKEGERL 220
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
E P NV L C N ADRPT + + +
Sbjct: 221 -------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 81/300 (27%), Positives = 137/300 (45%), Gaps = 44/300 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG-----QEVAVKRLSSQSGQ-GLKEFKNEMMLIAEL 566
+ ++ L EG FG ++ G L + +EV VK + + + + E L+ L
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKS-LDVYLFDPIKKRLLDWEARIRI-------- 617
H+N++ IL C+E GE +L N L ++L RL + +
Sbjct: 66 SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC---RLGEANNPQALSTQQLVHM 122
Query: 618 -IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDE--LQGN 673
IQ IA G+ YLH + +IH+D+ A N ++D+++ KI+D L+R +F D L N
Sbjct: 123 AIQ-IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD 733
R V +M+ E ++ +S SDV+SFG+L+ E L + T D F + + D
Sbjct: 179 ENRPV---KWMALESLVNKEYSSASDVWSFGVLLWE-LMTLGQTPYVEIDPFEMAAYLKD 234
Query: 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793
++ L P+ DE+ V C + +RP+ S +V +++ H L
Sbjct: 235 GYR------LAQPINCPDEL--------FAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 45/285 (15%)
Query: 521 LGEGGFGPVYKG-RLFNGQEVAVKRLS----SQSGQG-LKEFKNEMMLIAELQHRNLVRI 574
LG G FG VY+G L +G AVK +S Q+GQ +K+ + E+ L+++LQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRI-IQGIAQGLLYLHQY 631
LG E+ + LE +P SL L + E IR+ + I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFP------EPVIRLYTRQILLGLEYLH-- 119
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
R +HRD+K +N+L+D + K++DFG+A+ K G+ +M+PE
Sbjct: 120 DR-NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 692 -GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750
G + + +D++S G +LE + + + ++K R EL P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--------VFKIGRSKEL--P---- 221
Query: 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPF 795
IP + + L C+Q + + RPT + E L PF
Sbjct: 222 -PIPDHLSDEAKDFILKCLQRDPSLRPTAA--------ELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 4e-23
Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 17/203 (8%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKR-----LSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+G FG VY + G+E+AVK+ S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQYS 632
GC + + +EYMP S+ D +K L + R Q I +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVK----DQLKAYGALTETVTRKYTRQ-ILEGVEYLH--- 121
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV-GTYGYMSPEYALD 691
I+HRD+K +N+L D N K+ DFG ++ G + V GT +MSPE
Sbjct: 122 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181
Query: 692 GLFSIKSDVFSFGILMLETLSSR 714
+ K+DV+S G ++E L+ +
Sbjct: 182 EGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 4e-23
Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 509 AAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH 568
A + + +G+G FG V G + G +VAVK + + + + F E ++ +L+H
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIKNDATA--QAFLAEASVMTQLRH 58
Query: 569 RNLVRILGCCVEQ-GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
NLV++LG VE+ G ++ EYM SL YL + +L + ++ + + + Y
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEY 117
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L + +HRDL A NVL+ +D K+SDFGL + Q K V + +PE
Sbjct: 118 LEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPE 169
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+ FS KSDV+SFGIL+ E S
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 63/211 (29%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL-------SSQSGQGLKEFKNEMMLI 563
NF ++ K+G+G F VYK L +G+ VA+K++ + LKE L+
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEID----LL 56
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK-----KRLLDWEARIRII 618
+L H N+++ L +E E ++LE L IK KRL+ +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRM----IKHFKKQKRLIPERTIWKYF 112
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ L ++H RI+HRD+K +NV + K+ D GL R F ++ V
Sbjct: 113 VQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--V 167
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GT YMSPE + ++ KSD++S G L+ E
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 7e-23
Identities = 71/203 (34%), Positives = 108/203 (53%), Gaps = 18/203 (8%)
Query: 521 LGEGGFGPV----YKGRLFN-GQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRI 574
LGEG FG V Y N G++VAVK L +SG + + K E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 575 LGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL--HQ 630
G C E G LI+E++P+ SL YL P K ++ + +++ I +G+ YL Q
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT-YGYMSPEYA 689
Y +HRDL A NVL++ + KI DFGL + D+ K + + + +PE
Sbjct: 130 Y-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 690 LDGLFSIKSDVFSFGILMLETLS 712
+ F I SDV+SFG+ + E L+
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 7e-23
Identities = 67/193 (34%), Positives = 104/193 (53%), Gaps = 13/193 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
+GEG FG V +G + GQ+VAVK + + F E ++ +L H+NLVR+LG +
Sbjct: 13 IIGEGEFGAVLQGE-YTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639
G I ++E M +L V + L+ ++ +A+G+ YL +++HR
Sbjct: 70 HNGLYI-VMELMSKGNL-VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124
Query: 640 DLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSD 699
DL A N+L+ +D K+SDFGLAR+ G N+K V + +PE FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPV---KWTAPEALKHKKFSSKSD 179
Query: 700 VFSFGILMLETLS 712
V+S+G+L+ E S
Sbjct: 180 VWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 8e-23
Identities = 72/281 (25%), Positives = 132/281 (46%), Gaps = 44/281 (15%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAELQHRNLVR 573
LG G F Y+ R + G +AVK+++ S+ + ++ + E+ L+A L H +++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+LG E L +E+M S+ L + K+ ++ I + + +GL YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN 122
Query: 632 SRLRIIHRDLKASNVLLDKD-MNPKISDFGLA-----RMFGGDELQGNTKRIVGTYGYMS 685
+IIHRD+K +N+L+D +I+DFG A + G E QG +++GT +M+
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQG---QLLGTIAFMA 176
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
PE + DV+S G +++E +++ W+ KH L+
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKP---------------PWNAEKHSNHLALIF 221
Query: 746 PVILQDEIP-LPMLMR--YVNVALLCVQENAADRPTMSDVV 783
+ P +P + +V L C++ DRP +++
Sbjct: 222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 8e-23
Identities = 74/206 (35%), Positives = 113/206 (54%), Gaps = 25/206 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ +L+H LV
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 64
Query: 573 RILGCCVEQGEKILIL-EYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQGLL 626
++ E E I I+ EYM SL +L + K +L+D A+I A G+
Sbjct: 65 QLYAVVSE--EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI------ASGMA 116
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGY 683
Y+ R+ +HRDL+A+N+L+ +++ K++DFGLAR+ +E QG I T
Sbjct: 117 YVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT--- 170
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLE 709
+PE AL G F+IKSDV+SFGIL+ E
Sbjct: 171 -APEAALYGRFTIKSDVWSFGILLTE 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 60/207 (28%), Positives = 113/207 (54%), Gaps = 19/207 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ + + +LG+G FG VYK + G A K + +S + L++F E+ +++E +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLH 629
+V + + + +++E+ +LD + +++ L E +IR + + + + L +LH
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLT--EPQIRYVCRQMLEALNFLH 120
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPE 687
+ ++IHRDLKA N+LL D + K++DFG++ LQ KR +GT +M+PE
Sbjct: 121 SH---KVIHRDLKAGNILLTLDGDVKLADFGVSAK-NKSTLQ---KRDTFIGTPYWMAPE 173
Query: 688 YAL-----DGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 174 VVACETFKDNPYDYKADIWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 81/272 (29%), Positives = 124/272 (45%), Gaps = 32/272 (11%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
+LG G FG V G+ +VA+K + S EF E ++ +L H LV++ G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL--HQYSRLRII 637
+Q ++ EYM N L YL + K+ + + + + +G+ YL Q+ I
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESKQF-----I 122
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT---YGYMSPEYALDGLF 694
HRDL A N L+D K+SDFGL+R DE + VG+ + PE L F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178
Query: 695 SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIP 754
S KSDV++FG+LM E S K + ++ + K + L P + +++
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGKM-------PYERFNNSETVEKVSQGLRLYRPHLASEKVY 231
Query: 755 LPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
M C E A +RPT ++S I
Sbjct: 232 AIMYS--------CWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 72/202 (35%), Positives = 109/202 (53%), Gaps = 16/202 (7%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
K+GEG +G VYKGR GQ VA+K RL S+ E+ L+ ELQH N+V +
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 577 CCVEQGEKILILEYMPNKSLDV--YLFDPIKK-RLLDWEARIRIIQGIAQGLLYLHQYSR 633
+++ LI E++ S+D+ YL D + K + +D E + I QG+L+ H
Sbjct: 67 VLMQESRLYLIFEFL---SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCH---S 119
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG- 692
R++HRDLK N+L+D K++DFGLAR F G ++ T +V T Y +PE L
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEVLLGSP 177
Query: 693 LFSIKSDVFSFGILMLETLSSR 714
+S D++S G + E + +
Sbjct: 178 RYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 42/270 (15%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG VY R + + VA+K++S QS + ++ E+ + +L+H N +
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
GC + + L++EY + D+ + KK L + E I G QGL YLH + R
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDI--LEVHKKPLQEVEIAA-ICHGALQGLAYLHSHER-- 136
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
IHRD+KA N+LL + K++DFG A + N+ VGT +M+PE L +G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVILAMDEG 189
Query: 693 LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752
+ K DV+S GI +E L+ RK ++N ++ + L H I Q++
Sbjct: 190 QYDGKVDVWSLGITCIE-LAERKPP-LFNMNAMSALYH-----------------IAQND 230
Query: 753 IP-LPML---MRYVNVALLCVQENAADRPT 778
P L + N C+Q+ DRP+
Sbjct: 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 71/202 (35%), Positives = 112/202 (55%), Gaps = 20/202 (9%)
Query: 521 LGEGGFGPVYKGRLFNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG VYKG E VA+K L+ +G + EF +E +++A + H +LVR+
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLF---DPIKKRLL-DWEARIRIIQGIAQGLLYLHQ 630
LG C+ + L+ + MP+ L Y+ D I +LL +W +I A+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
R++HRDL A NVL+ + KI+DFGLAR+ GDE + N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
F+ +SDV+S+G+ + E ++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 82/287 (28%), Positives = 138/287 (48%), Gaps = 44/287 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLV 64
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFD------PIKKRLLDWEARIRIIQGIAQGLL 626
+ L V + +I E+M SL +L P+ K L+D+ A+I A+G+
Sbjct: 65 K-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK-LIDFSAQI------AEGMA 116
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYM 684
++ Q + IHRDL+A+N+L+ + KI+DFGLAR+ +E T R + +
Sbjct: 117 FIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWT 170
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWKHERV-H 741
+PE G F+IKSDV+SFGIL++E ++ + G+ N + L + + + E
Sbjct: 171 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPE 230
Query: 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
EL + + + C + +RPT + S++ +
Sbjct: 231 ELYN------------------IMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 70/205 (34%), Positives = 111/205 (54%), Gaps = 23/205 (11%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFK-NEMMLIAELQHRNLVRIL 575
K+GEG +G VYK R G+ VA+K RL ++ +G+ E+ L+ EL H N+VR+L
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLL 64
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG----IAQGLLYLHQ 630
V K+ L+ E++ + L Y+ D LD +I+ + QG+ Y H
Sbjct: 65 DV-VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLD----PPLIKSYLYQLLQGIAYCHS 117
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ R++HRDLK N+L+D++ K++DFGLAR F G ++ T +V T Y +PE L
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 172
Query: 691 DG-LFSIKSDVFSFGILMLETLSSR 714
+S D++S G + E ++ R
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 25/214 (11%)
Query: 520 KLGEGGFGPVYKGRLF-----NGQEVAVKRLSS-QSGQGLKEFKNEMMLIAELQHRNLVR 573
+LGE FG +YKG L+ + Q VA+K L + Q EF+ E L+AEL H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLF--------------DPIKKRLLDWEARIRIIQ 619
+LG ++ ++ EY+ L +L D K LD + I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGNTKRIV 678
IA G+ YL + +H+DL A N+L+ + ++ KISD GL+R ++ D + K ++
Sbjct: 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M PE + G FS SD++SFG+++ E S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 4e-22
Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 46/283 (16%)
Query: 521 LGEGGFGPVYKGRL-FNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G FG V +GRL G+ VA+K L S + + ++F +E ++ + H N++ +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
G + ++I E+M N +LD +L F I+ + +++GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ--------LVGMLRGIAAGMKYL- 122
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG---TYGYMSP 686
S + +HRDL A N+L++ ++ K+SDFGL+R D +G + +P
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 687 EYALDGLFSIKSDVFSFGILMLETLS--SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
E F+ SDV+S+GI+M E +S R + N D N + + R+ M
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY------RLPPPM 234
Query: 745 D-PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
D P L LM L C Q++ RP +VS +
Sbjct: 235 DCPTALH------QLM------LDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 6e-22
Identities = 71/230 (30%), Positives = 128/230 (55%), Gaps = 31/230 (13%)
Query: 521 LGEGGFGPVYKGRLFNGQ---EVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LGEG FG V +G+L +VAVK +++ + +++F +E + + E H N++R++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 576 GCCVEQGEK------ILILEYMPNKSLDVYLFDPIKKRLLDW------EARIRIIQGIAQ 623
G C++ E ++IL +M + L +L + RL D + ++ + IA
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFL---LYSRLGDCPQYLPTQMLVKFMTDIAS 123
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDEL-QGNTKRIVGTY 681
G+ YL S IHRDL A N +L+++MN ++DFGL+ +++ GD QG ++
Sbjct: 124 GMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PV 178
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNT---GVYNTDSFNLL 728
+++ E D +++ KSDV+SFG+ M E +++R T GV N++ ++ L
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWE-IATRGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 64/218 (29%), Positives = 94/218 (43%), Gaps = 45/218 (20%)
Query: 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFK-----NE---MMLIAELQHRNL 571
+GEG F V + +E A+K L + Q +KE K E + + H +
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLN--GHPGI 64
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR-LLDWEARIRIIQGIAQ---GLLY 627
+++ ++ +LEY PN L I+K LD E R A+ L Y
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGEL----LQYIRKYGSLD-EKCTRFY--AAEILLALEY 117
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL-------------QGNT 674
LH IIHRDLK N+LLDKDM+ KI+DFG A++ + Q
Sbjct: 118 LHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 675 KRI-----VGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
R VGT Y+SPE + SD+++ G ++
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 77/283 (27%), Positives = 135/283 (47%), Gaps = 48/283 (16%)
Query: 521 LGEGGFGPVYKGRL-FNGQE---VAVKRLSS-QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G FG V GRL G+ VA+K L + + + ++F +E ++ + H N++ +
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ------GIAQGLLYLH 629
G + +++ EYM N SLD +L +K + + +IQ GIA G+ YL
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL----RKH----DGQFTVIQLVGMLRGIASGMKYL- 122
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------Y 683
S + +HRDL A N+L++ ++ K+SDFGL+R+ D T R G +
Sbjct: 123 --SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIRW 175
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743
+PE F+ SDV+S+GI+M E +S Y + W++ + + +
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMS-------YGERPY------WEMSNQDVIKAI 222
Query: 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
+ L + P + + L C Q++ +RP +VS++
Sbjct: 223 EEGYRLPAPMDCPAALH--QLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 9e-22
Identities = 63/205 (30%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 514 NFSMQCKLGEGGFGPVYK-GRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRN 570
+F + KLG+G +G VYK RL + Q A+K L S S + ++ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 571 LVR-----ILGCCVEQGEKILILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQG 624
++ + G + +++EY P L + K ++L+ + RI + +G
Sbjct: 61 IISYKEAFLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L LH+ +I+HRDLK++N+LL + KI D G++++ + K +GT YM
Sbjct: 116 LQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTPHYM 168
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
+PE +S KSD++S G L+ E
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 52/178 (29%), Positives = 95/178 (53%), Gaps = 24/178 (13%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG------LKEFKNEMMLIAELQHRNLV 572
++GEG G V+K + G+ VA+K+++ + +G L+E K + QH +V
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLH 629
++L +L++EYMP+ L + ++ L + + + ++ + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVK-SYMRMLLKGVAYMH 116
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
I+HRDLK +N+L+ D KI+DFGLAR+F +E + + + V T Y +PE
Sbjct: 117 A---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 61/208 (29%), Positives = 100/208 (48%), Gaps = 30/208 (14%)
Query: 520 KLGEGGFGPVYK------GRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV- 572
+G+G FG V K G++ +E+ ++ + Q L +E+ ++ EL+H N+V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV---SEVNILRELKHPNIVR 63
Query: 573 ---RILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQ 623
RI+ + + +++EY L I+K + ++ E RI+ +
Sbjct: 64 YYDRII---DRSNQTLYIVMEYCEGGDLAQL----IQKCKKERKYIEEEFIWRILTQLLL 116
Query: 624 GLLYLH--QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
L H ++HRDLK +N+ LD + N K+ DFGLA++ G D K VGT
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SSFAKTYVGTP 174
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLE 709
YMSPE + KSD++S G L+ E
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 69/222 (31%), Positives = 108/222 (48%), Gaps = 27/222 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFN---GQE---VAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
N ++ +LGEG FG V+ +N Q+ VAVK L S K+F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEAR----------IRI 617
H ++V+ G CVE I++ EYM + L+ +L +L E + I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677
Q IA G++YL + +HRDL N L+ +++ KI DFG++R D + R+
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRV 178
Query: 678 VG----TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRK 715
G +M PE + F+ +SDV+S G+++ E + K
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGK 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 18/211 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGLKE-FKNEMMLIAE 565
N S LG G FG V + + +VAVK L + +E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
L H N+V +LG C G ++I EY L +L ++ L E + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKG 153
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE---LQGNTKRIVGTY 681
+ +L + IHRDL A NVLL KI DFGLAR D ++GN + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 72/204 (35%), Positives = 111/204 (54%), Gaps = 15/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNL 571
E+ + KLG+G FG V+ G +VA+K L + G + E F E ++ +L+H L
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKL 63
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V + E+ I + E+M SL +L + K L + + IA G+ Y+
Sbjct: 64 VPLYAVVSEEPIYI-VTEFMGKGSLLDFLKEGDGKYL-KLPQLVDMAAQIADGMAYIE-- 119
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGYMSPEY 688
R+ IHRDL+A+N+L+ ++ KI+DFGLAR+ +E QG I + +PE
Sbjct: 120 -RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPI----KWTAPEA 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
AL G F+IKSDV+SFGIL+ E ++
Sbjct: 175 ALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 54/200 (27%), Positives = 102/200 (51%), Gaps = 17/200 (8%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRNLV 572
F++ +G+G FG VYK Q VA+K + ++ +++ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ G ++ + +I+EY S D +K LD I++ + GL YLH+
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR---IVGTYGYMSPEYA 689
IHRD+KA+N+LL ++ + K++DFG++ +L + VGT +M+PE
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEVI 170
Query: 690 LDGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 171 KQSGYDEKADIWSLGITAIE 190
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 84/275 (30%), Positives = 134/275 (48%), Gaps = 43/275 (15%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG VY R + N + VA+K++S QS + ++ E+ + +L+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
GC + + L++EY + D L + KK L + E + G QGL YLH ++
Sbjct: 82 GCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGALQGLAYLHSHN--- 135
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
+IHRD+KA N+LL + K+ DFG A + VGT +M+PE L +G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEG 189
Query: 693 LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752
+ K DV+S GI +E L+ RK ++N ++ + L H I Q+E
Sbjct: 190 QYDGKVDVWSLGITCIE-LAERKPP-LFNMNAMSALYH-----------------IAQNE 230
Query: 753 IPLPMLMRYV----NVALLCVQENAADRPTMSDVV 783
P + N C+Q+ DRPT S+V+
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPT-SEVL 264
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 65/194 (33%), Positives = 102/194 (52%), Gaps = 9/194 (4%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAELQHRNLVRILGCCV 579
LG+G FG V+KG L + VAVK Q LK +F +E ++ + H N+V+++G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639
++ +++E +P +L KK L + ++ A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 640 DLKASNVLLDKDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
DL A N L+ ++ KISDFG++R G K+I + +PE G +S +S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--PIKWTAPEALNYGRYSSES 175
Query: 699 DVFSFGILMLETLS 712
DV+S+GIL+ ET S
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 75/271 (27%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 521 LGEGGFGPVYK-GRLFNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAELQHRNLVRILGCC 578
LG G G V K + G +A K + + + K+ E+ ++ E + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 579 VEQGEKILILEYMPNKSLD-VY-LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ + + +E+M SLD +Y PI +L +I + +GL YL Y+ RI
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRI 125
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSI 696
+HRD+K SN+L++ K+ DFG++ G+ + VGT YMSPE G +++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 697 KSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--WDLWKHERVHELMDPVILQDEIP 754
KSDV+S GI ++E + N D DL + V E P + + P
Sbjct: 182 KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL-QQIVQE-PPPRLPSSDFP 239
Query: 755 LPMLMRYVNVALLCVQENAADRPTMSDVVSM 785
L +V+ C+ ++ +RPT + +M
Sbjct: 240 -EDLRDFVD---ACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 4e-21
Identities = 73/276 (26%), Positives = 124/276 (44%), Gaps = 38/276 (13%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
+LG G FG V+ G+ +VA+K ++ + ++F E ++ +L H LV++ G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHR 639
+Q ++ E+M N L YL ++ L + + + Q + +G+ YL + S IHR
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 640 DLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMSPEYALDGL 693
DL A N L+ K+SDFG+ R DE + G + PE
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-------TSSSGAKFPVKWSPPEVFNFSK 177
Query: 694 FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753
+S KSDV+SFG+LM E + K ++ + +E+++ + +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMP-----------------FEKKSNYEVVEMISRGFRL 220
Query: 754 PLPML--MRYVNVALLCVQENAADRPTMSDVVSMIS 787
P L M V C E RPT ++++ I+
Sbjct: 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 5e-21
Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 21/217 (9%)
Query: 517 MQCKLGEGGFGPVYKGR---LFNGQE---VAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
++ +LGEG FG V+ L Q+ VAVK L S ++F+ E L+ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRL----------LDWEARIRII 618
+VR G C E +++ EYM + L+ +L P K L L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
IA G++YL + L +HRDL N L+ + + KI DFG++R + R +
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRK 715
+M PE L F+ +SD++SFG+++ E + K
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGK 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 59/202 (29%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KRL + G+ + + +++ E +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKIL---EKVSSRFIVS 57
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYS 632
L E + + L++ M L ++++ + + EAR I GL +LHQ
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLKYHIYN-VGEPGFP-EARAIFYAAQIICGLEHLHQ-- 113
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
RI++RDLK NVLLD N +ISD GLA G K GT GYM+PE
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGE 169
Query: 693 LFSIKSDVFSFGILMLETLSSR 714
++ D F+ G + E ++ R
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 7e-21
Identities = 83/283 (29%), Positives = 133/283 (46%), Gaps = 42/283 (14%)
Query: 515 FSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLS---SQSGQGLKEFKNEMMLIAELQHRN 570
F+ ++G G FG VY R EV A+K++S QS + ++ E+ + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+ GC + + L++EY + D L + KK L + E I G QGL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHS 143
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
++ +IHRD+KA N+LL + K++DFG A + VGT +M+PE L
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTPYWMAPEVIL 194
Query: 691 ---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747
+G + K DV+S GI +E L+ RK ++N ++ + L H
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIE-LAERKPP-LFNMNAMSALYH----------------- 235
Query: 748 ILQDEIPLPMLMRYV----NVALLCVQENAADRPTMSDVVSMI 786
I Q+E P + N C+Q+ DRPT +++ +
Sbjct: 236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 8e-21
Identities = 66/219 (30%), Positives = 105/219 (47%), Gaps = 30/219 (13%)
Query: 520 KLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR 573
+LGEG FG V+ +N VAVK L + K+F+ E L+ LQH ++V+
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEAR-----------IRIIQG 620
G C + I++ EYM + L+ +L P L+D + R + I
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG- 679
IA G++YL + +HRDL N L+ ++ KI DFG++R D + R+ G
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184
Query: 680 ---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRK 715
+M PE + F+ +SDV+SFG+++ E + K
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 60/208 (28%), Positives = 109/208 (52%), Gaps = 25/208 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
E++ + ++G G +G VYK R + G+ VA+K + + G + + E+ ++ E +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 572 VRILGCCVEQGEKILILEYMPNKSL-DVY--LFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
V G + + + +++EY SL D+Y P+ + + + R + +GL YL
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETL-----KGLAYL 117
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT--KR--IVGTYGYM 684
H+ IHRD+K +N+LL +D + K++DFG++ T KR +GT +M
Sbjct: 118 HE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQL------TATIAKRKSFIGTPYWM 168
Query: 685 SPEYA---LDGLFSIKSDVFSFGILMLE 709
+PE A G + K D+++ GI +E
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 84/307 (27%), Positives = 143/307 (46%), Gaps = 54/307 (17%)
Query: 520 KLGEGGFGPVYKGRLFNGQE-----------------VAVKRLSSQSGQGLK-EFKNEMM 561
KLGEG FG V+ + N Q+ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL--------------FDPIKKR 607
+++ L+ N++R+LG CV++ +I EYM N L+ +L P
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 608 LL--DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-M 664
L + + + + IA G+ YL S L +HRDL N L+ +++ KI+DFG++R +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 665 FGGD--ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT 722
+ GD +QG R V +M+ E L G F+ SDV++FG+ + E L K
Sbjct: 189 YAGDYYRIQG---RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245
Query: 723 DSFNLLGHAWDLWKHE--RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMS 780
++ +A + ++ + +V+ P Q L LM L C + +RP+ S
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPPCPQ---GLYELM------LQCWSRDCRERPSFS 296
Query: 781 DVVSMIS 787
D+ + ++
Sbjct: 297 DIHAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 79/276 (28%), Positives = 131/276 (47%), Gaps = 39/276 (14%)
Query: 520 KLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQG--LKEFKNEMMLIAELQHRNLVRILG 576
K+G G FG VY L G+ +AVK + Q +KE +EM ++ L+H NLV+ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI--IQGIAQGLLYLHQYSRL 634
V + + + +EY +L+ L R+LD E IR+ +Q + +GL YLH +
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEH---GRILD-EHVIRVYTLQ-LLEGLAYLHSH--- 118
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFG------GDELQGNTKRIVGTYGYMSPEY 688
I+HRD+K +N+ LD + K+ DFG A G+E+Q + GT YM+PE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS----LAGTPAYMAPEV 174
Query: 689 ALDGLFSIK---SDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
G +D++S G ++LE + ++ ++ L + + + H V
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR--------PWSELDNEFQIMFH--VGAGHK 224
Query: 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSD 781
P I P +++ C++ + RPT S+
Sbjct: 225 PPIPDSLQLSPEGKDFLD---RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 59/198 (29%), Positives = 113/198 (57%), Gaps = 17/198 (8%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
+LG+G FG VYK + G A K + ++S + L+++ E+ ++A H +V++LG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
G+ +++E+ P ++D + + + + L + + ++ I + + + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLE-LDRGLTEPQIQV-ICRQMLEALQYLHS---MKIIH 133
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEYAL-----D 691
RDLKA NVLL D + K++DFG++ ++ +R +GT +M+PE + D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 692 GLFSIKSDVFSFGILMLE 709
+ K+D++S GI ++E
Sbjct: 190 TPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-20
Identities = 87/301 (28%), Positives = 139/301 (46%), Gaps = 52/301 (17%)
Query: 521 LGEGGFGPVY--------KGRLFNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAEL-QHRN 570
LGEG FG V K + +VAVK L S + + L + +EM ++ + +H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FDP--IKKRLLDWEARIRI 617
++ +LG C + G +I+EY +L YL ++P + + L ++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677
+A+G+ YL + + IHRDL A NVL+ +D KI+DFGLAR + T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLW 735
+M+PE D +++ +SDV+SFG+L+ E TL GV + F LL
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG---- 258
Query: 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV-------SMISN 788
H + P +E L M+MR C + RPT +V ++ SN
Sbjct: 259 -----HRMDKPSNCTNE--LYMMMRD------CWHAVPSQRPTFKQLVEDLDRILALTSN 305
Query: 789 E 789
+
Sbjct: 306 Q 306
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 81/293 (27%), Positives = 135/293 (46%), Gaps = 44/293 (15%)
Query: 520 KLGEGGFGPVY----KGRL-FNGQE------------VAVKRLSSQSGQGLK-EFKNEMM 561
KLGEG FG V+ +G F ++ VAVK L + + + +F E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLF------DPIK--KRLLDWEA 613
+++ L+ N++R+L C+ +I EYM N L+ +L K + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--EL 670
I + IA G+ YL S L +HRDL N L+ K+ KI+DFG++R ++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH 730
QG R V +MS E L G F+ SDV++FG+ + E L+ K ++ +
Sbjct: 189 QG---RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN 245
Query: 731 AWDLWKHE-RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDV 782
+ ++ + R L P + D + L C + NA +RP+ ++
Sbjct: 246 TGEFFRDQGRQVYLPKPALCPDS--------LYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 3e-20
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 26/205 (12%)
Query: 521 LGEGGFGPVYKGRLFNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG V+KG + VA+K + +SG Q +E + M+ + L H +VR+
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYL------FDPIKKRLLDWEARIRIIQGIAQGLLY 627
LG C G + L+ + P SL ++ DP +RLL+W +I A+G+ Y
Sbjct: 75 LGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDP--QRLLNWCVQI------AKGMYY 124
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L ++ R++HR+L A N+LL D +I+DFG+A + D+ + +M+ E
Sbjct: 125 LEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
L G ++ +SDV+S+G+ + E +S
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 37/217 (17%)
Query: 521 LGEGGFGPVYKG-RLFNGQEVAVK----------RLSSQSGQGLKEFKNEMMLIAELQHR 569
+G+G +G VY + G+ +AVK R S+ +K ++E+ + +L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 570 NLVRILGCCVEQGEKIL--ILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIA 622
N+V+ LG E E+ L LEY+P S+ L F+ R + +
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--------TEQVL 118
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN--TKRIVGT 680
+GL YLH I+HRDLKA N+L+D D KISDFG+++ D++ N + G+
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK--SDDIYDNDQNMSMQGS 173
Query: 681 YGYMSPEY-ALDGL-FSIKSDVFSFGILMLETLSSRK 715
+M+PE +S K D++S G ++LE + R+
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 68/274 (24%), Positives = 127/274 (46%), Gaps = 37/274 (13%)
Query: 521 LGEGGFGP--VYKGRLFNGQ----EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+G FG +Y+ + EV + RLS + ++ NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQY 631
++ ++ +EY +L +D I K +L + E + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL----YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
I+HRD+K N+ L K K+ DFG++++ G + T +VGT YMSPE
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQG 175
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
++ KSD+++ G ++ E L+ ++ D+ N L + + PV+
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKR-----TFDATNPLNLVVKIVQGNYT-----PVVSVY 225
Query: 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785
L L+ +Q++ RPT +V+
Sbjct: 226 SSELISLVHS------LLQQDPEKRPTADEVLDQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 90/301 (29%), Positives = 142/301 (47%), Gaps = 54/301 (17%)
Query: 511 ATENFSMQCKLGEGGFGPVY----KGRLFNGQE--VAVKRLS-SQSGQGLKEFKNEMMLI 563
A E +M +LG+G FG VY KG + + E VA+K ++ + S + EF NE ++
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 564 AELQHRNLVRILGCCVEQGEKIL-ILEYMPNKSLDVYLFD--------------PIKKRL 608
E ++VR+LG V QG+ L I+E M L YL +KK
Sbjct: 64 KEFNCHHVVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM- 121
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGG 667
I++ IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R ++
Sbjct: 122 ------IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172
Query: 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSF 725
D + K ++ +MSPE DG+F+ SDV+SFG+++ E TL+ + G+ N
Sbjct: 173 DYYRKGGKGLLPVR-WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
Query: 726 NLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785
+ L K + ++ L LMR +C Q N RP+ +++S
Sbjct: 232 RFVMEGGLLDKPDNCPDM-----------LFELMR------MCWQYNPKMRPSFLEIISS 274
Query: 786 I 786
I
Sbjct: 275 I 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 5e-20
Identities = 80/259 (30%), Positives = 124/259 (47%), Gaps = 26/259 (10%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRN 570
NF KLGEG + VYKGR G+ VA+K L ++ G + E+ L+ EL+H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHEN 59
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+VR+ + + +L+ EYM +K L Y+ + LD + +G+ + H+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYA 689
R++HRDLK N+L++K K++DFGLAR FG + NT V T Y +P+
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFG---IPVNTFSNEVVTLWYRAPDVL 172
Query: 690 LDG-LFSIKSDVFSFGILMLETLSSRK-NTGVYNTDS----FNLLG----HAW----DLW 735
L +S D++S G +M E ++ R G N D F ++G W L
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLP 232
Query: 736 KHERVHELMDPVILQDEIP 754
+++ P LQ P
Sbjct: 233 EYKPTFPRYPPQDLQQLFP 251
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 6e-20
Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 11/205 (5%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRN 570
NF K+GEG +G VYK R G+ VA+K RL +++ E+ L+ EL H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V++L + + L+ E++ ++ L ++ D + + + QGL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ R++HRDLK N+L++ + K++DFGLAR F G ++ T +V T Y +PE L
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILL 173
Query: 691 DG-LFSIKSDVFSFGILMLETLSSR 714
+S D++S G + E ++ R
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 7e-20
Identities = 69/236 (29%), Positives = 120/236 (50%), Gaps = 30/236 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQH 568
F++ LG+G FG V + +L + Q+VAVK L + S ++EF E + E H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 569 RNLVRILGCCVEQGEK------ILILEYMPNKSLDVYLF------DPIKKRLLDWEARIR 616
N+++++G + K ++IL +M + L +L +P L + +R
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVR 117
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDEL-QGNT 674
+ IA G+ YL S IHRDL A N +L+++M ++DFGL++ ++ GD QG
Sbjct: 118 FMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLL 728
++ +++ E D +++ SDV++FG+ M E T GV N++ +N L
Sbjct: 175 SKL--PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 9e-20
Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+G FG VY GR ++V S ++ + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLLYLHQY 631
GC ++ EK L +EYMP S+ D +K E+ R + I +G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYMSPEYAL 690
I+HRD+K +N+L D N K+ DFG ++ + G R + GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 691 DGLFSIKSDVFSFGILMLETLSSR 714
+ K+DV+S G ++E L+ +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 67/202 (33%), Positives = 105/202 (51%), Gaps = 19/202 (9%)
Query: 520 KLGEGGFGPVYKG--RLFNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAELQHR----NLV 572
+LG G FG V KG ++ Q +VA+K L +++ K ++EMM AE+ H+ +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE---KSVRDEMMREAEIMHQLDNPYIV 58
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R++G C E +L++E L+ +L KK + + ++ ++ G+ YL +
Sbjct: 59 RMIGVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYMSPEYAL 690
+HRDL A NVLL KISDFGL++ G D+ R G + + +PE
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECIN 171
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
FS +SDV+S+GI M E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGC- 577
+GEG +G VYK R GQ VA+K + +E K E ++ + H N+ G
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72
Query: 578 -----CVEQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIR------IIQGIAQGL 625
+ L++E S+ D+ K L R++ I++ +GL
Sbjct: 73 IKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
YLH+ ++IHRD+K N+LL K+ K+ DFG++ + NT +GT +M+
Sbjct: 127 AYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT--FIGTPYWMA 181
Query: 686 PE-----YALDGLFSIKSDVFSFGILMLE 709
PE D + +SDV+S GI +E
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 83/308 (26%), Positives = 146/308 (47%), Gaps = 47/308 (15%)
Query: 511 ATENFSMQCKLGEGGFGPVYKG---RLFNGQ---EVAVKRLS-SQSGQGLKEFKNEMMLI 563
+ E ++ +LG+G FG VY+G + G+ VAVK ++ S S + EF NE ++
Sbjct: 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 63
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLF-------DPIKKRLLDWEARIR 616
++VR+LG + ++++E M + L YL + + + I+
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGNTK 675
+ IA G+ YL+ + +HRDL A N ++ D KI DFG+ R ++ D + K
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTD--SFNLLGHA 731
++ M+PE DG+F+ SD++SFG+++ E +L+ + G+ N F + G
Sbjct: 181 GLLPVRW-MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY 239
Query: 732 WDLWKH--ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789
D + ERV +LM +C Q N RPT ++V+++ +
Sbjct: 240 LDQPDNCPERVTDLMR---------------------MCWQFNPKMRPTFLEIVNLL-KD 277
Query: 790 HLNLPFPK 797
L+ FP+
Sbjct: 278 DLHPSFPE 285
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 40/218 (18%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAELQ---- 567
+ + +LG+G FG VY R G+ VA+K++ K+F + E M + E++
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRK 53
Query: 568 ---HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIR-IIQG 620
H N+V++ E E + EYM + L+ +K R E+ IR II
Sbjct: 54 LNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFS-ESVIRSIIYQ 107
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN---TKRI 677
I QGL ++H + HRDLK N+L+ KI+DFGLAR E++ T
Sbjct: 108 ILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTD-Y 158
Query: 678 VGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSR 714
V T Y +PE L +S D+++ G +M E + R
Sbjct: 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 69/221 (31%), Positives = 110/221 (49%), Gaps = 34/221 (15%)
Query: 520 KLGEGGFGPVY----KGRL---------FNGQE--VAVKRLSSQSGQGLK-EFKNEMMLI 563
KLGEG FG V+ +G F+GQ VAVK L + + + +F E+ ++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD-PIKKRL--------LDWEAR 614
+ L++ N++R+LG CV +I EYM N L+ +L I+ +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--ELQ 671
+ + IA G+ YL + L +HRDL N L+ KI+DFG++R ++ GD +Q
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQ 188
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
G R V +M+ E L G F+ SDV++FG+ + E +
Sbjct: 189 G---RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 82/288 (28%), Positives = 130/288 (45%), Gaps = 45/288 (15%)
Query: 521 LGEGGFGPVY--------KGRLFNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAEL-QHRN 570
LGEG FG V K + VAVK L + + L + +EM ++ + +H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FD--PIKKRLLDWEARIRI 617
++ +LG C + G +I+EY +L YL +D + + ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677
+A+G+ YL + + IHRDL A NVL+ ++ KI+DFGLAR + T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLW 735
+M+PE D +++ +SDV+SFG+LM E TL G+ + F LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG---- 255
Query: 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783
H + P +E L M+MR C + RPT +V
Sbjct: 256 -----HRMDKPANCTNE--LYMMMRD------CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 71/218 (32%), Positives = 113/218 (51%), Gaps = 21/218 (9%)
Query: 520 KLGEGGFGPVYKGRLFNGQE-VAVKRLS---SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG VY + E VAVK++S Q+ + ++ E+ + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
GC +++ L++EY + D L + KK L + E I G QGL YLH ++
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-ITHGALQGLAYLHSHN--- 141
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DG 692
+IHRD+KA N+LL + K++DFG A VGT +M+PE L +G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSA------SKSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 693 LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH 730
+ K DV+S GI +E L+ RK ++N ++ + L H
Sbjct: 196 QYDGKVDVWSLGITCIE-LAERK-PPLFNMNAMSALYH 231
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-19
Identities = 86/281 (30%), Positives = 139/281 (49%), Gaps = 40/281 (14%)
Query: 521 LGEGGFGPVYKGRLF--NGQEV--AVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRIL 575
+G+G FG VY G L +GQ++ AVK L+ + + +++F E +++ + H N++ +L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 576 GCCV-EQGEKILILEYMPNKSLDVYLF------DPIKKRLLDWEARIRIIQGIAQGLLYL 628
G C+ +G +++L YM K D+ F +P K L+ + ++ A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYM--KHGDLRNFIRSETHNPTVKDLIGFGLQV------AKGMEYL 114
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG--NTKRIVGTYGYMSP 686
+ +HRDL A N +LD+ K++DFGLAR E N +M+
Sbjct: 115 ASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746
E F+ KSDV+SFG+L+ E L +R + DSF++ + L + R L+ P
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWE-LMTRGAPPYPDVDSFDITVY---LLQGRR---LLQP 224
Query: 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
D PL +M L C RPT S++VS I
Sbjct: 225 EYCPD--PLYEVM------LSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-19
Identities = 37/112 (33%), Positives = 52/112 (46%), Gaps = 9/112 (8%)
Query: 212 SGQWDGTGF-----VSALSYTNFIYKQFMTENKDEFVYWYEAYNRPSIMTLKLNPSGFVT 266
SG W+G F + LSY + + TEN +E Y Y N L L+ G +
Sbjct: 3 SGPWNGIRFSGIPEMQKLSYYVYNF----TENNEEVYYTYRMTNNSIYSRLTLSSEGSLE 58
Query: 267 RQIWDENSNKWDELFSVPDQYCGKYGYCGANTICSLDQTPMCECLEGFKLKS 318
R W NS W+ +S P C YG CG C ++ +P C C++GF K+
Sbjct: 59 RFTWIPNSQDWNLFWSAPKDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 89/309 (28%), Positives = 140/309 (45%), Gaps = 53/309 (17%)
Query: 521 LGEGGFGPVY--------KGRLFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRN 570
LGEG FG V K + VAVK L + + L + +EM ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FDPIK--KRLLDWEARIRI 617
++ +LG C + G +++EY +L YL FD K + L ++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677
+A+G+ YL + + IHRDL A NVL+ +D KI+DFGLAR + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLW 735
+M+PE D +++ +SDV+SFG+L+ E TL G+ + F LL
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG---- 252
Query: 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV-------SMIS- 787
H + P E L M+MR C + RPT +V ++ S
Sbjct: 253 -----HRMDKPANCTHE--LYMIMRE------CWHAVPSQRPTFKQLVEDLDRVLTVTST 299
Query: 788 NEHLNLPFP 796
+E+L+L P
Sbjct: 300 DEYLDLSVP 308
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 7e-19
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 45/200 (22%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSG---QGLKEFKNEMMLI 563
++ + KLGEG FG VYK R + G+ VA+K++ + + G L+E K ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIK----IL 61
Query: 564 AELQHRNLVRILGCCVEQGEKI--------LILEYM----------PNKSLDVYLFDPIK 605
+L+H N+V ++ VE+ +K ++ YM P+ L
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYM 121
Query: 606 KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665
+LL+ G+ YLH+ I+HRD+KA+N+L+D KI+DFGLAR +
Sbjct: 122 LQLLE-------------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPY 165
Query: 666 GGDELQGNTKRIVGTYGYMS 685
G GT Y +
Sbjct: 166 DGPPPNPKGGGGGGTRKYTN 185
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 7e-19
Identities = 61/200 (30%), Positives = 111/200 (55%), Gaps = 13/200 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAELQHRN 570
E F+ ++G+G FG VYKG +EV A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKS-LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
+ R G ++ + +I+EY+ S LD+ P+++ + I++ I +GL YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
R IHRD+KA+NVLL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 119 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVI 173
Query: 690 LDGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 174 KQSAYDFKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 7e-19
Identities = 82/279 (29%), Positives = 138/279 (49%), Gaps = 39/279 (13%)
Query: 521 LGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG VYKG E VA+K L + S + KE +E ++A + + ++ R+
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLF---DPIKKR-LLDWEARIRIIQGIAQGLLYLHQ 630
LG C+ + LI + MP L Y+ D I + LL+W +Q IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW-----CVQ-IAKGMNYLEE 127
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
R++HRDL A NVL+ + KI+DFGLA++ G DE + + + +M+ E L
Sbjct: 128 R---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESIL 184
Query: 691 DGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748
+++ +SDV+S+G+ + E T S+ G+ ++ ++L E+ L P I
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------EKGERLPQPPI 235
Query: 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
++ + M+ C +A RP +++ S
Sbjct: 236 CTIDVYMIMVK--------CWMIDADSRPKFRELIIEFS 266
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 8e-19
Identities = 65/211 (30%), Positives = 115/211 (54%), Gaps = 14/211 (6%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQGLKEFK-NE 559
L ++ SV + ++ K+G+G G VY + GQEVA+K+++ Q Q KE NE
Sbjct: 8 LRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINE 66
Query: 560 MMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR-II 618
++++ E +H N+V L + E +++EY+ SL D + + +D E +I +
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD-EGQIAAVC 121
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +V
Sbjct: 122 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MV 176
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GT +M+PE + K D++S GI+ +E
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGL---KEFKN---EMMLIAELQHRNLVRI 574
LG+G +G VY G GQ +AVK++ + L KE++ E+ L+ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
LG C++ + +E++P S+ L F P+ + + + + I G+ YLH
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF-----CKYTKQILDGVAYLHNNC 122
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV----GTYGYMSPEY 688
++HRD+K +NV+L + K+ DFG AR L G ++ GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+ + KSD++S G + E
Sbjct: 180 INESGYGRKSDIWSIGCTVFE 200
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.1 bits (215), Expect = 1e-18
Identities = 62/212 (29%), Positives = 116/212 (54%), Gaps = 12/212 (5%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM 560
L ++ S+ + ++ K+G+G G V+ + GQEVA+K+++ Q + NE+
Sbjct: 8 LRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEI 67
Query: 561 MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQ 619
+++ EL++ N+V L + E +++EY+ SL D + + +D EA+I + +
Sbjct: 68 LVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMD-EAQIAAVCR 122
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
Q L +LH ++IHRD+K+ NVLL D + K++DFG ++ + +T +VG
Sbjct: 123 ECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVG 177
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
T +M+PE + K D++S GI+ +E +
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAELQHR 569
+F + +G+G FG V + + +++ A+K ++ Q ++ NE ++ EL H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 570 NLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLLY 627
LV L + E + L+++ + L +L +K E +++ I I L Y
Sbjct: 61 FLVN-LWYSFQDEENMYLVVDLLLGGDLRYHL---SQKVKFS-EEQVKFWICEIVLALEY 115
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH IIHRD+K N+LLD+ + I+DF +A D T GT GYM+PE
Sbjct: 116 LHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPE 169
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRK 715
+S+ D +S G+ E L ++
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 18/205 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQHR 569
NF ++ K+G G F VY+ L + + VA+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLD-VYLFDPIKKRLLD----WEARIRIIQGIAQG 624
N+++ L +E E ++LE L + + +KRL+ W+ +++ +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H +SR R++HRD+K +NV + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE + ++ KSD++S G L+ E
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 2e-18
Identities = 60/211 (28%), Positives = 111/211 (52%), Gaps = 10/211 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQGLKEFKNEM 560
L S+ SV + ++ K+G+G G VY + GQEVA+K+++ Q + NE+
Sbjct: 8 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67
Query: 561 MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG 620
+++ E ++ N+V L + E +++EY+ SL D + + +D + +
Sbjct: 68 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 123
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT
Sbjct: 124 CLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+M+PE + K D++S GI+ +E +
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 25/215 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAELQ 567
N+ + LG+G FG VY G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 568 HRNLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWEARI-----RIIQG 620
H +V+ GC + E+ L +E+MP S IK +L + A + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGS--------IKDQLKSYGALTENVTRKYTRQ 114
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN-TKRIVG 679
I +G+ YLH I+HRD+K +N+L D N K+ DFG ++ L G K + G
Sbjct: 115 ILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
T +MSPE + K+D++S G ++E L+ +
Sbjct: 172 TPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAELQHRNLVRILGC 577
+G G FG V+ R Q++ + + E +NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLHQYSRL 634
+E ++++EY P +L Y I+KR LLD + I+ Q LL LH
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEY----IQKRCNSLLDEDT---ILHFFVQILLALHHVHTK 120
Query: 635 RIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
I+HRDLK N+LLDK M KI DFG++++ + +VGT Y+SPE
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KSKAYTVVGTPCYISPELCEGKP 177
Query: 694 FSIKSDVFSFGILMLETLSSRK 715
++ KSD+++ G ++ E S ++
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-18
Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 26/207 (12%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAELQHRNLVRILG 576
K+GEG +G VYK R + +A+K++ Q +G+ E+ L+ E+QH N+VR+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRL---LDWEARIRIIQG----IAQGLLYLH 629
+ L+ EY+ LD +KK + D+ R+I+ I +G+ Y H
Sbjct: 69 VVHSEKRLYLVFEYL---DLD------LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
+ R++HRDLK N+L+D+ N K++DFGLAR F G ++ T +V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF-GIPVRTFTHEVV-TLWYRAPEI 174
Query: 689 ALDGL-FSIKSDVFSFGILMLETLSSR 714
L +S D++S G + E ++ +
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 3e-18
Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 10/211 (4%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM 560
L S+ SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 561 MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG 620
+++ E ++ N+V L + E +++EY+ SL D + + +D + +
Sbjct: 69 LVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRE 124
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
Q L +LH ++IHRD+K+ N+LL D + K++DFG + Q +VGT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGT 179
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
+M+PE + K D++S GI+ +E +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 7e-18
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQS--GQGLKE-FKNEMMLIAELQHRNLVRILG 576
LG GGFG V ++ + A+K + + G +E +E ++ E H +V++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKR-LLD-WEARIRIIQGIAQGLLYLHQYSRL 634
++ +++EY L + ++ R L D + AR I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLH---NR 112
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
II+RDLK N+LLD + K+ DFG A+ + T GT Y++PE L+ +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGY 169
Query: 695 SIKSDVFSFGILMLETLSSR 714
D +S GIL+ E L+ R
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 65/222 (29%), Positives = 113/222 (50%), Gaps = 34/222 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNG---QEVAVKRLSSQSGQG-LKEFKNEMMLIAEL-QH 568
+ Q +GEG FG V K R+ + A+KR+ + + ++F E+ ++ +L H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-------- 620
N++ +LG C +G L +EY P+ +L +L K R+L+ + I
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR---KSRVLETDPAFAIANSTASTLSSQ 124
Query: 621 --------IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672
+A+G+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R G E+
Sbjct: 125 QLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY- 177
Query: 673 NTKRIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
K+ +G +M+ E +++ SDV+S+G+L+ E +S
Sbjct: 178 -VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 56/198 (28%), Positives = 107/198 (54%), Gaps = 21/198 (10%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQH---RNLVRIL 575
+G G +G VY+G+ + G+ VA+K ++ + + + + E+ L+++L+ N+ +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 576 GCCVEQGEKILILEYMPNKSLDVYL-FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
G ++ +I+EY S+ + PI ++ + II+ + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-----IIREVLVALKYIHKVG-- 121
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI--VGTYGYMSPEYALDG 692
+IHRD+KA+N+L+ N K+ DFG+A + Q ++KR VGT +M+PE +G
Sbjct: 122 -VIHRDIKAANILVTNTGNVKLCDFGVAALLN----QNSSKRSTFVGTPYWMAPEVITEG 176
Query: 693 -LFSIKSDVFSFGILMLE 709
+ K+D++S GI + E
Sbjct: 177 KYYDTKADIWSLGITIYE 194
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 43/292 (14%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAELQHR 569
NF ++ K+G G F VY+ L +G VA+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLD-----WEARIRIIQGIAQG 624
N+++ +E E ++LE L + K++ L W+ +++ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H +SR R++HRD+K +NV + K+ D GL R F ++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
SPE + ++ KSD++S G L+ E + + + D NL + L
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL-------------YSLC 217
Query: 745 DPVILQDEIPLPM------LMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790
+ D PLP L + VN +C+ + RP ++ V + H
Sbjct: 218 KKIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-17
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 11/94 (11%)
Query: 325 PIKCERSHSSECTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSN 384
P+ C S++ F KL +VK PD + +++LE+C CL NC+C AYA +N
Sbjct: 2 PLNCGGDGSTD-----GFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN 54
Query: 385 VTEGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVP 418
GCL+W G L + R + G ++YL++
Sbjct: 55 G--SGGCLLWNGLLNNLRSL--SSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 17/212 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAEL 566
N+ + LG G FG VY G+E+AVK++ S ++ + + + E+ L+ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 567 QHRNLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKR-LLDWEARIRIIQGIAQ 623
+H +V+ GC + EK L +EYMP S+ D +K L R + I Q
Sbjct: 62 RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQ 117
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN-TKRIVGTYG 682
G+ YLH I+HRD+K +N+L D N K+ DFG ++ + G K + GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
+MSPE + K+DV+S ++E L+ +
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAELQHRNLVRILGC 577
++G G FG V+ GRL + VAVK LK +F E ++ + H N+VR++G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
C ++ +++E + +L + L + I++++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR--LKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
HRDL A N L+ + KISDFG++R G G K+I + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 696 IKSDVFSFGILMLETLS 712
+SDV+SFGIL+ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 56/191 (29%), Positives = 101/191 (52%), Gaps = 10/191 (5%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+GEG G V R +G++VAVK + + Q + NE++++ + QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ E +++E++ +L D + + L+ E + + + Q L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ ++LL D K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 699 DVFSFGILMLE 709
D++S GI+++E
Sbjct: 199 DIWSLGIMVIE 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 18/203 (8%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+L+ +++ KRL + +G + E ++A++ R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR--KGYEGAMVEKRILAKVHSRFIVS- 57
Query: 575 LGCCVE-QGEKILILEYMPNKSL--DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
L + + + L++ M L +Y D + A Q I GL +LHQ
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-IISGLEHLHQR 116
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
RII+RDLK NVLLD D N +ISD GLA + Q TK GT G+M+PE
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQG 171
Query: 692 GLFSIKSDVFSFGILMLETLSSR 714
+ D F+ G+ + E +++R
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 64/220 (29%), Positives = 112/220 (50%), Gaps = 28/220 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAEL-Q 567
E+ + +GEG FG V + + A+K L + + ++F E+ ++ +L
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKR------LLDWEAR 614
H N++ +LG C +G + +EY P +L +L DP + L +
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
++ +A G+ YL S + IHRDL A NVL+ +++ KI+DFGL+R G+E+
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY--V 173
Query: 675 KRIVGTYG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
K+ +G +M+ E +++ KSDV+SFG+L+ E +S
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 81/279 (29%), Positives = 132/279 (47%), Gaps = 39/279 (13%)
Query: 521 LGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG G FG VYKG E VA+K L + S + KE +E ++A + + R+
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLF---DPIKKR-LLDWEARIRIIQGIAQGLLYLHQ 630
LG C+ + L+ + MP L Y+ D I + LL+W +I A+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLEE 127
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+R++HRDL A NVL+ + KI+DFGLAR+ DE + + +M+ E L
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 691 DGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748
F+ +SDV+S+G+ + E T ++ G+ + +LL E+ L P I
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL---------EKGERLPQPPI 235
Query: 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
++ + M+ C ++ RP ++V S
Sbjct: 236 CTIDVYMIMVK--------CWMIDSECRPRFRELVDEFS 266
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 65/206 (31%), Positives = 110/206 (53%), Gaps = 20/206 (9%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFK-NEMMLIAELQ---HRNLVRI 574
+GEG +G VYK R L G+ VA+K++ S +G+ E+ L+ +L+ H N+VR+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 575 LGCC-VEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
L C + ++ L+ E++ ++ L YL K L E +++ + +G+ +LH
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLRGVDFLH 124
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ RI+HRDLK N+L+ D KI+DFGLAR++ + +V T Y +PE
Sbjct: 125 SH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS---FEMALTSVVVTLWYRAPEVL 178
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRK 715
L ++ D++S G + E L R+
Sbjct: 179 LQSSYATPVDMWSVGCIFAE-LFRRR 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 23/204 (11%)
Query: 520 KLGEGGFGPVYKG--RLFNGQE-VAVKRLSSQSGQGLKEFKNEMM----LIAELQHRNLV 572
+LG G FG V KG ++ ++ VAVK L + + K+E++ ++ +L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R++G C E +L++E L+ +L K + + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEY 688
+HRDL A NVLL KISDFGL++ G DE + + K V Y +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY---APEC 169
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
FS KSDV+SFG+LM E S
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 4e-17
Identities = 80/282 (28%), Positives = 133/282 (47%), Gaps = 43/282 (15%)
Query: 521 LGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMM----LIAELQHRNLVRIL 575
+G G FG V K G +AVKR+ S + KE K +M ++ +V+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFY 69
Query: 576 GCCVEQGEKILILEYMPNKSLD-----VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
G +G+ + +E M + SLD VY + K ++ E +I + L YL +
Sbjct: 70 GALFREGDCWICMELM-DISLDKFYKYVYE---VLKSVIPEEILGKIAVATVKALNYLKE 125
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK-RIVGTYGYMSPE-- 687
L+IIHRD+K SN+LLD++ N K+ DFG++ G + K R G YM+PE
Sbjct: 126 --ELKIIHRDVKPSNILLDRNGNIKLCDFGIS----GQLVDSIAKTRDAGCRPYMAPERI 179
Query: 688 --YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM- 744
A DG + ++SDV+S GI + E TG + +N + +++ +++
Sbjct: 180 DPSARDG-YDVRSDVWSLGITLYEV-----ATGKFPYPKWNSV--------FDQLTQVVK 225
Query: 745 -DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785
DP IL + +VN LC+ ++ + RP +++
Sbjct: 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
K+GEG G V + G++VAVK++ + Q + NE++++ + QH N+
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V + + E +++E++ +L D + ++ E + + + L +LH
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+IHRD+K+ ++LL D K+SDFG + + K +VGT +M+PE
Sbjct: 135 ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISR 189
Query: 692 GLFSIKSDVFSFGILMLE 709
+ + D++S GI+++E
Sbjct: 190 LPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGC 577
+G G +G V G++VA+K+LS QS K E+ L+ + H N++ +L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 578 CVEQGEKILILEYMPNKSL----DVYLFDP---------IK-KRLLDWEARIRIIQGIAQ 623
+ P SL DVYL +K ++L D + + Q I +
Sbjct: 83 ------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQ-ILR 129
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL Y+H IIHRDLK SN+ +++D KI DFGLAR DE+ G V T Y
Sbjct: 130 GLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWY 181
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSSR 714
+PE L+ + ++ D++S G +M E L+ +
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 20/207 (9%)
Query: 520 KLGEGGFGPVYKGR-LFNGQE-VAVKRL---SSQSGQGLKEFKNEMML--IAELQHRNLV 572
++GEG +G V+K R L NG VA+KR+ + + G L + +L + +H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 573 RILGCCV-----EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
R+ C + + L+ E++ ++ L YL D + + + E ++ + +GL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH + R++HRDLK N+L+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSR 714
L ++ D++S G + E +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 60/203 (29%), Positives = 111/203 (54%), Gaps = 27/203 (13%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
+LG+G FG VYK + G A K + ++S + L+++ E+ ++A H N+V++L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLHQYSRLRII 637
+ +++E+ ++D + + +++ L E +IR++ + + L YLH+ +II
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLE-LERPLT--EPQIRVVCKQTLEALNYLHEN---KII 125
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI------VGTYGYMSPEYAL- 690
HRDLKA N+L D + K++DFG++ NT+ I +GT +M+PE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS--------AKNTRTIQRRDSFIGTPYWMAPEVVMC 177
Query: 691 ----DGLFSIKSDVFSFGILMLE 709
D + K+DV+S GI ++E
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 7e-17
Identities = 61/201 (30%), Positives = 98/201 (48%), Gaps = 18/201 (8%)
Query: 521 LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAELQHRNLVRILGCCV 579
+G G +G VYKGR ++A ++ +G +E K E+ ML HRN+ G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 580 EQG------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
++ + L++E+ S+ L K L E I + I +GL +LHQ+
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 130
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL--- 690
++IHRD+K NVLL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 131 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIACDE 187
Query: 691 --DGLFSIKSDVFSFGILMLE 709
D + KSD++S GI +E
Sbjct: 188 NPDATYDFKSDLWSLGITAIE 208
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 57/210 (27%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAELQHR 569
+ + +GEG +G V K R G+ VA+K+ S+ + +K+ E+ ++ +L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V + +G L+ EY+ L++ P L +A I + Q + Y H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCH 117
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR----IVGTYGYMS 685
IIHRD+K N+L+ + K+ DFG AR L+ V T Y +
Sbjct: 118 ---SHNIIHRDIKPENILVSESGVLKLCDFGFAR-----ALRARPASPLTDYVATRWYRA 169
Query: 686 PEYAL-DGLFSIKSDVFSFGILMLETLSSR 714
PE + D + DV++ G +M E L
Sbjct: 170 PELLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 32/214 (14%)
Query: 521 LGEGGFGPVYK------GRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVR 573
+GEG FG V K G + +K +S+ ++F E+ ++ +L H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIIN 60
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKR------LLDWEARIRIIQG 620
+LG C +G L +EY P+ +L +L DP L + +
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+A+G+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R G E+ K+ +G
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--VKKTMGR 172
Query: 681 YG--YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+ E +++ SDV+S+G+L+ E +S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 55/203 (27%), Positives = 107/203 (52%), Gaps = 16/203 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
E+F + ++G G +G VYK R N G+ A+K + + G+ + E++++ + +H N+
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 572 VRILGCCVEQGEKILILEYMPNKSL-DVY-LFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
V G + + + + +E+ SL D+Y + P+ + + + +R + QGL YLH
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH 123
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ +HRD+K +N+LL + + K++DFG++ K +GT +M+PE A
Sbjct: 124 SKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 690 L---DGLFSIKSDVFSFGILMLE 709
G ++ D+++ GI +E
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 61/208 (29%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 524 GGFGPVYKGRLFN-GQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRILGCCV 579
G +G V+ + + G A+K + + + E ++++ Q +V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF- 62
Query: 580 EQGEKILIL--EYMPNKSLDVYLFDPIKKRLLD-------WEARIRIIQGIAQGLLYLHQ 630
QG+K L L EY+P L LL+ ARI I + I L YLH
Sbjct: 63 -QGKKNLYLVMEYLPGGDL---------ASLLENVGSLDEDVARIYIAE-IVLALEYLHS 111
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLA------RMFGGDELQGNTKRIVGTYGYM 684
IIHRDLK N+L+D + + K++DFGL+ R ++ + KRIVGT Y+
Sbjct: 112 NG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLS 712
+PE L S D +S G ++ E L
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 58/199 (29%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAELQHRN 570
E F+ K+G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+ + G ++ + +I+EY+ S D ++ LD I++ I +GL YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSA----LDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ IHRD+KA+NVLL + K++DFG+A +++ N VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIK 174
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 57/203 (28%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
++ + ++G G +G VYK R L G+ AVK + + G + E+ ++ E +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 572 VRILGCCVEQGEKILILEYMPNKSL-DVY-LFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
V G + + + + +EY SL D+Y + P+ + + + R + QGL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
++ HRD+K +N+LL + + K++DFG+A K +GT +M+PE A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITAT--IAKRKSFIGTPYWMAPEVA 178
Query: 690 L---DGLFSIKSDVFSFGILMLE 709
+G ++ D+++ GI +E
Sbjct: 179 AVEKNGGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 63/201 (31%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQH-RNLVRIL 575
+LG G +G V K R + G +AVKR+ + + Q K ++ + V
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLLYLHQYSRL 634
G +G+ + +E M + SLD + K L E + +I I + L YLH S+L
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKL 123
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALDGL 693
+IHRD+K SNVL++++ K+ DFG++ G + K I G YM+PE ++
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDAGCKPYMAPE-RINPE 178
Query: 694 -----FSIKSDVFSFGILMLE 709
+ +KSDV+S GI M+E
Sbjct: 179 LNQKGYDVKSDVWSLGITMIE 199
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-16
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 45/210 (21%)
Query: 520 KLGEGGFGPVYK------GRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
++G G G VYK GRL+ E V+R + E+ ++ ++
Sbjct: 81 RIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----------QICREIEILRDVN 130
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H N+V+ GE ++LE+M SL+ + D + + + I G+ Y
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAY 183
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH R I+HRD+K SN+L++ N KI+DFG++R+ N+ VGT YMSPE
Sbjct: 184 LH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPE 238
Query: 688 Y--------ALDGLFSIKSDVFSFGILMLE 709
A DG D++S G+ +LE
Sbjct: 239 RINTDLNHGAYDGY---AGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 60/231 (25%), Positives = 104/231 (45%), Gaps = 50/231 (21%)
Query: 515 FSMQCKLGEGGFGPVYKGRLFN---GQEVAVKRL--SSQSGQGLKEFK-NEMMLIAELQH 568
+ ++ +G G +G VYK + N G+E A+K+ + G+ + E+ L+ EL+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 569 RNLVRILGCCVEQGEKI--LILEYMPN----------KSLDVYLFDPIKKRLLDWEARIR 616
N+V ++ +E +K L+ +Y + ++ V + + K LL W+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-WQ---- 116
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP----KISDFGLARMF------- 665
I G+ YLH ++HRDLK +N+L+ + KI D GLAR+F
Sbjct: 117 ----ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 666 -GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSR 714
D +V T Y +PE L K+ D+++ G + E L+
Sbjct: 170 ADLD-------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 4e-16
Identities = 75/285 (26%), Positives = 124/285 (43%), Gaps = 52/285 (18%)
Query: 521 LGEGGFGPVYKG--RLFNGQE--VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG G FG + +G +L + +E VA+ L + S + + F E + + + H N+VR+
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDP----IKKRLLDWEARIRIIQGIAQGLLYLHQY 631
G +++ EYM N +LD +L + +L+ ++ G+A G+ YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS------ 685
S + +H+ L A VL++ D+ KIS F + + Y MS
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFR----------RLQEDKSEAIYTTMSGKSPVL 173
Query: 686 ---PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742
PE FS SDV+SFGI+M E +S Y + WD+ + +
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMS-------YGERPY------WDMSGQDVIKA 220
Query: 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
+ D L P L+ + L C Q+ +RP S + S++S
Sbjct: 221 VEDGFRLPAPRNCPNLLH--QLMLDCWQKERGERPRFSQIHSILS 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 14/211 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQ----EVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRI 574
+GEG FG VY+G + + VAVK + + ++E F E ++ + H ++V++
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+G E I ++E P L YL + K LD + I ++ L YL
Sbjct: 73 IGVITENPVWI-VMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES---K 126
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
R +HRD+ A NVL+ K+ DFGL+R + +K + +M+PE F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKWMAPESINFRRF 185
Query: 695 SIKSDVFSFGILMLETLSSRKN--TGVYNTD 723
+ SDV+ FG+ M E L GV N D
Sbjct: 186 TSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 56/199 (28%), Positives = 107/199 (53%), Gaps = 11/199 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQG-LKEFKNEMMLIAELQHRN 570
E F+ ++G+G FG V+KG Q+V A+K + + + +++ + E+ ++++
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+ + G ++ + +I+EY+ S D ++ D +++ I +GL YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ IHRD+KA+NVLL + + K++DFG+A +++ NT VGT +M+PE
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174
Query: 691 DGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 175 QSAYDSKADIWSLGITAIE 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 68/214 (31%), Positives = 113/214 (52%), Gaps = 26/214 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSG---QGLKEFKNEMMLIAE 565
+ + ++ EG +G VY+ R G+ VA+K+L + G L+E N ++ +
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREI-NILL---K 60
Query: 566 LQHRNLVRILGCCVEQG-EKI-LILEYMPN--KSLDVYLFDPIKKRLLDWEARIRIIQGI 621
LQH N+V + V +KI +++EY+ + KSL + +K+ L E + ++Q +
Sbjct: 61 LQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL----METMKQPFLQSEVKCLMLQ-L 115
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
G+ +LH I+HRDLK SN+LL+ KI DFGLAR + G L+ T+ +V T
Sbjct: 116 LSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYTQLVV-TL 170
Query: 682 GYMSPEYALD-GLFSIKSDVFSFGILMLETLSSR 714
Y +PE L +S D++S G + E L+ +
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 8e-16
Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 46/217 (21%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKR-LSSQSGQG-----LKEFKNEMMLIAELQHRNLV 572
K+G+G FG V+K R Q VA+K+ L +G L+E K ++ L+H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIK----ILQLLKHENVV 74
Query: 573 RILGCCVEQGEK--------ILILEY--------MPNKSLDVYLFDPIKKRLLDWEARIR 616
++ C + L+ E+ + NK++ L + IKK
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE-IKK---------- 123
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG---GDELQGN 673
+++ + GL Y+H R +I+HRD+KA+N+L+ KD K++DFGLAR F +
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 674 TKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLE 709
T R+V T Y PE L + + D++ G +M E
Sbjct: 181 TNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 8e-16
Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 33/209 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL-----SSQSGQGLKEFKNEMMLIAEL 566
+ + KLG+G +G V+K + VA+K++ ++ Q + F+ E+M + EL
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQ--RTFR-EIMFLQEL 63
Query: 567 -QHRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
H N+V++L + +K L+ EYM + L I+ +L+ + I+ + +
Sbjct: 64 GDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRYIMYQLLK 118
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI-----V 678
L Y+H S +IHRDLK SN+LL+ D K++DFGLAR EL+ N + V
Sbjct: 119 ALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSL--SELEENPENPVLTDYV 173
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILM 707
T Y +PE L S ++ G+ M
Sbjct: 174 ATRWYRAPEILL------GSTRYTKGVDM 196
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 49/150 (32%), Positives = 82/150 (54%), Gaps = 9/150 (6%)
Query: 520 KLGEGGFGPVYKGRLFNGQE-VAVKRLSSQS-GQGLKEFK-NEMMLIAELQHRNLVRILG 576
K+GEG +G V+K + E VA+KR+ +G+ E+ L+ EL+H+N+VR+
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ L+ EY ++ L Y FD + + + Q + +GL + H + +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDIDPEIVKSFMFQ-LLKGLAFCHSH---NV 120
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+HRDLK N+L++K+ K++DFGLAR FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KRL +SG+ + + E I E + +
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKE---ILEKVNSPFIVN 57
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
L E + L++ M L ++++ + +R L+ E I I G+L+LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+ I++RD+K NVLLD N ++SD GLA + G + T+R GT GYM+PE +
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQR-AGTNGYMAPEILKEE 169
Query: 693 LFSIKSDVFSFGILMLETLSSR 714
+S D F+ G + E ++ R
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 31/211 (14%)
Query: 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN---------------- 558
+ +Q +LG+G FG VY VK + + + LK K
Sbjct: 2 YILQQRLGKGSFGTVY----------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ 51
Query: 559 EMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
E L+++L H +V+ +E+ +I EY + LD L + K + ++
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEE--LKHTGKTLSENQVC 109
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ Q LL +H + RI+HRDLKA N+ L ++ KI DFG++R+ G T
Sbjct: 110 EWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FT 166
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GT YMSPE + KSD++S G ++ E
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 59/207 (28%), Positives = 103/207 (49%), Gaps = 24/207 (11%)
Query: 514 NFSMQCKLGEGGFGPVY--KGRLFNGQEVAVK-RLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ + K+GEG FG +Y K + + V + L+ + + K E++L+A+++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-------DVYLFDPIKKRLLDWEARIRIIQGIAQ 623
+V E G +++EY L LF + ++L W +Q I+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQILSW-----FVQ-ISL 112
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
GL ++H +I+HRD+K+ N+ L K+ M K+ DFG+AR T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGTPY 167
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLE 709
Y+SPE + ++ K+D++S G ++ E
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 81/286 (28%), Positives = 136/286 (47%), Gaps = 42/286 (14%)
Query: 521 LGEGGFGPVYKGRLFNGQE--VAVKRLSSQS---GQGLKE-------FKNEMMLIAE-LQ 567
LG G FG VYK R N + +A+K ++ + G+ +E +E+ +I E L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW-EARI-RIIQGIAQGL 625
H N+VR +E ++++ + L F+ +K++ + E RI I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLG-EHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
YLH+ R I+HRDL +N++L +D I+DFGLA+ + +VGT Y
Sbjct: 127 RYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSC 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
PE + + K+DV++FG ++ + + Y+T N+L A + E V+E
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTL--QPPFYST---NMLSLATKIV--EAVYE--- 231
Query: 746 PVILQDEIPLPMLMRYVNVALL---CVQENAADRPTMSDVVSMISN 788
PLP M +V + C+ +A RP + V +MIS+
Sbjct: 232 --------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQ-GLK-EFKNEMMLIAELQ---HRNLVR 573
++G G +G VYK R +G VA+K + Q+ + GL E+ L+ L+ H N+VR
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 574 ILGCC----VEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++ C ++ K+ L+ E++ ++ L YL D + L E +++ +GL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H I+HRDLK N+L+ K++DFGLAR++ Q +V T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
L ++ D++S G + E
Sbjct: 179 LLQSTYATPVDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 64/206 (31%), Positives = 109/206 (52%), Gaps = 30/206 (14%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++GEG +G VY+ R +G+ VA+K++ + + G + + E+ L+ L+H N+V +
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELK 72
Query: 576 GCCV-EQGEKI-LILEYMPNKSLDVYLFDPIKKRLLD------WEARIR-IIQGIAQGLL 626
V + + I L++EY D+ LLD E++++ ++ + +GL
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ---DL-------ASLLDNMPTPFSESQVKCLMLQLLRGLQ 122
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YLH+ IIHRDLK SN+LL KI+DFGLAR + G + T ++V T Y +P
Sbjct: 123 YLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAP 177
Query: 687 EYALDGLFSIKS-DVFSFGILMLETL 711
E L + D+++ G ++ E L
Sbjct: 178 ELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 62/217 (28%), Positives = 113/217 (52%), Gaps = 27/217 (12%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAELQHRN 570
F + ++GEG +G VYK R G+ VA+K++ + + G + + E+ ++ +L HRN
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRN 67
Query: 571 LVRILGCCV----------EQGEKILILEYMPNKSLDVYLFDPIKKRLLDW-EARIR-II 618
+V + ++G L+ EYM D L ++ L+ + E I+ +
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFM 122
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ + +GL Y H+ + L HRD+K SN+LL+ K++DFGLAR++ +E + T +++
Sbjct: 123 KQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179
Query: 679 GTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSR 714
T Y PE L + + DV+S G ++ E + +
Sbjct: 180 -TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 4e-15
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 31/238 (13%)
Query: 486 EVNGDGKDKGKD-----SWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEV 540
E + D D +P A A+ +++ L G G V+ GQ
Sbjct: 34 EYSDDDSASESDDDDDDGLIPTKQKAREVVASLGYTVIKTLTPGSEGRVFVATK-PGQPD 92
Query: 541 AVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL 600
V Q G L E ML+ + H +++R+ V ++L P+ S D+Y
Sbjct: 93 PVVLKIGQKGTTLIE----AMLLQNVNHPSVIRMKDTLVSGAITCMVL---PHYSSDLYT 145
Query: 601 FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660
+ + R L + + I + I +GL YLH RIIHRD+K N+ ++ I D G
Sbjct: 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLG 202
Query: 661 LAR------MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
A+ F G + GT +PE ++ K+D++S GI++ E L+
Sbjct: 203 AAQFPVVAPAFLG---------LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 5e-15
Identities = 60/196 (30%), Positives = 92/196 (46%), Gaps = 16/196 (8%)
Query: 521 LGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAELQHRNLVRILGCC 578
LG G G VYK L + +AVK + L K+ +E+ ++ + ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ + E+M SLDVY I + +L RI + +GL YL L+I+H
Sbjct: 69 FVENRISICTEFMDGGSLDVY--RKIPEHVLG-----RIAVAVVKGLTYLWS---LKILH 118
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K SN+L++ K+ DFG++ + K VGT YM+PE + I S
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHS 174
Query: 699 DVFSFGILMLETLSSR 714
DV+S GI +E R
Sbjct: 175 DVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 65/197 (32%), Positives = 95/197 (48%), Gaps = 19/197 (9%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQHRNLVRILG 576
LG G FG V R + A+K LS LK+ NE ++ ++H LV + G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ L++EY+P L F ++K R + AR Q + L YLH L
Sbjct: 69 SFQDDSNLYLVMEYVPGGEL----FSHLRKSGRFPEPVARFYAAQ-VVLALEYLHS---L 120
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
I++RDLK N+LLD D KI+DFG A+ ++G T + GT Y++PE L +
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGY 175
Query: 695 SIKSDVFSFGILMLETL 711
D ++ GIL+ E L
Sbjct: 176 GKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 65/249 (26%), Positives = 104/249 (41%), Gaps = 38/249 (15%)
Query: 515 FSMQCKLGEGGFGPVYKGRLFNGQE-VAVKRLSSQSGQGLKEFK---NEMMLIAELQHRN 570
F + ++G+GG+G V+ + + E VA+KR+ L E + E ++ +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLL-DWEARIRIIQGIAQGLLYLH 629
LV++L + L +EY+P L +L + AR + + + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL---NNLGVLSEDHARFYMAEMFE-AVDALH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
L IHRDLK N L+D + K++DFGL++ G +VG+ YM+PE
Sbjct: 119 ---ELGYIHRDLKPENFLIDASGHIKLTDFGLSK--GIVTY---ANSVVGSPDYMAPEVL 170
Query: 690 LDGLFSIKSDVFSFGILMLETL--------SSRKNT-------------GVYNTDSFNLL 728
+ D +S G ++ E L S+ T VY+ FNL
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230
Query: 729 GHAWDLWKH 737
AWDL
Sbjct: 231 DEAWDLITK 239
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 59/232 (25%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG------------------LKEFKNEMM 561
LGEG +G V K G+ VA+K++ L+E K
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK---- 72
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR----- 616
++ E++H N++ ++ VE L+++ M K+++D +IR
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM----------ASDLKKVVD--RKIRLTESQ 120
Query: 617 ---IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673
I+ I GL LH++ +HRDL +N+ ++ KI+DFGLAR +G
Sbjct: 121 VKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDT 177
Query: 674 TKRI------------VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLS 712
+ V T Y +PE + + D++S G + E L+
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAELQ-HRNLVRI 574
K+GEG F V K + G+ A+K + + + L++ N E+ + L H N++R+
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 575 LGCCVEQ--GEKILILEYMPNKSLDVYLFDPIK--KRLLDWEARIR-IIQGIAQGLLYLH 629
+ ++ G L+ E M D+ L++ IK KR L E R++ + + + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLDHMH 117
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
R I HRD+K N+L+ D K++DFG R G T+ I T Y +PE
Sbjct: 118 ---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI-STRWYRAPECL 170
Query: 690 L-DGLFSIKSDVFSFGILMLETLS 712
L DG + K D+++ G + E LS
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 61/204 (29%), Positives = 90/204 (44%), Gaps = 18/204 (8%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVA---VKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG V G G A VK L +S + F E+ EL H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI--RIIQGIAQGLLYLHQYSR 633
G C+E +L+LE+ P L YL + + R+ +A GLL+LHQ
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYA--- 689
IH DL N L D++ KI D+GLA + D V +++PE
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIR 177
Query: 690 ----LDGLFSIKSDVFSFGILMLE 709
L + KS+++S G+ M E
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 69/214 (32%), Positives = 103/214 (48%), Gaps = 43/214 (20%)
Query: 521 LGEGGFGPV---YKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G +G V + + G VAVK+LS QS K E+ L+ ++H N++ +L
Sbjct: 25 VGSGAYGSVCAAFDTK--TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 576 GCCVEQGEKILILEYMPNKSL----DVYLFDPIK----------KRLLDWEARIRIIQGI 621
+ P +SL DVYL + ++L D + I Q I
Sbjct: 83 DV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-I 129
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+GL Y+H IIHRDLK SN+ +++D KI DFGLAR DE+ G V T
Sbjct: 130 LRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATR 181
Query: 682 GYMSPEYALDGL-FSIKSDVFSFGILMLETLSSR 714
Y +PE L+ + ++ D++S G +M E L+ R
Sbjct: 182 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 54/149 (36%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 520 KLGEGGFGPVYKGRLFNG---QEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
++G G FG V G + +G +V VK L S S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI--RIIQGIAQGLLYLHQYSR 633
G C E +L++E+ P L YL K L+ + R+ IA GLL+LH+ +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA 662
IH DL N LL D+ KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-14
Identities = 87/364 (23%), Positives = 144/364 (39%), Gaps = 65/364 (17%)
Query: 430 ILVVLVLPLVLLPSFYIFCRRRRKCKEKETENTETNQDLLAFDINMGITTRTNEFGEVNG 489
L ++ L L+ ++F R R + K EN + +L FD
Sbjct: 635 TLGAFLV-LALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD----------------- 676
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCK----LGEGGFGPVYKGRLF-NGQEVAVKR 544
S S + + K + G G YKG+ NG + VK
Sbjct: 677 --------------SKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKE 722
Query: 545 LSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI 604
++ + E + + +LQH N+V+++G C + LI EY+ K+L L
Sbjct: 723 INDVNSIPSSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL---- 774
Query: 605 KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
R L WE R +I GIA+ L +LH ++ +L +++D P + L +
Sbjct: 775 --RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGL 831
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD- 723
D I + Y++PE + KSD++ FG++++E L TG D
Sbjct: 832 LCTD----TKCFI--SSAYVAPETRETKDITEKSDIYGFGLILIELL-----TGKSPADA 880
Query: 724 SFNLLGH--AWDLWKHERVHELM--DPVILQD-EIPLPMLMRYVNVALLCVQENAADRPT 778
F + G W + + H M DP I D + ++ +N+AL C + RP
Sbjct: 881 EFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC 940
Query: 779 MSDV 782
+DV
Sbjct: 941 ANDV 944
|
Length = 968 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 54/209 (25%), Positives = 103/209 (49%), Gaps = 35/209 (16%)
Query: 520 KLGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR 573
K+GEG FG G+ + +E+ + ++S + + E + E+ +++ ++H N+V+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNIVQ 63
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---------LLDWEARIRIIQGIAQG 624
E G ++++Y L + I + +LDW +Q I
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDW-----FVQ-ICLA 113
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGY 683
L ++H +I+HRD+K+ N+ L KD K+ DFG+AR+ EL + +GT Y
Sbjct: 114 LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL---ARTCIGTPYY 167
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLS 712
+SPE + ++ KSD+++ G ++ E +
Sbjct: 168 LSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 22/202 (10%)
Query: 521 LGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQGLK-----EFKNEMMLIAELQHRNL 571
LG+G FG V+ R GQ A+K L + LK K E ++AE+ H +
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHPFI 60
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLLYLHQ 630
V++ +G+ LIL+++ L F + K ++ E ++ + +A L +LH
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALALDHLH- 115
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
L II+RDLK N+LLD++ + K++DFGL++ E + GT YM+PE
Sbjct: 116 --SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPEVVN 171
Query: 691 DGLFSIKSDVFSFGILMLETLS 712
+ +D +SFG+LM E L+
Sbjct: 172 RRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 24/204 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAELQHRNLVRILGCC 578
+G G +G VYKGR + GQ A+K + + +E K E+ ML HRN+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 579 VEQG------EKILILEYMPNKSLDVYLFDPIKKRLL--DWEARIRIIQGIAQGLLYLHQ 630
+++ + L++E+ S+ L K L DW A I + I +GL +LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSV-TDLVKNTKGNALKEDWIAYI--CREILRGLAHLHA 139
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ ++IHRD+K NVLL ++ K+ DFG++ D G +GT +M+PE
Sbjct: 140 H---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIGTPYWMAPEVIA 194
Query: 691 -----DGLFSIKSDVFSFGILMLE 709
D + +SD++S GI +E
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 4e-14
Identities = 51/172 (29%), Positives = 78/172 (45%), Gaps = 45/172 (26%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAELQHRN 570
+G G +G V G++VA+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-DVYLFDP---------IK-KRLLDWEARIR--I 617
++ +L IL + DVY+ IK + L + I+ +
Sbjct: 61 IIGLL----------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLT-DDHIQYFL 109
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
Q I +GL YLH +IHRDLK SN+L++ + + KI DFGLAR DE
Sbjct: 110 YQ-ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-14
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVKR-LSSQSGQGLKEFK-NEMMLIAELQHRNLVRIL 575
K+GEG +G V+K R GQ VA+K+ + S+ +K+ E+ ++ +L+H NLV ++
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI 66
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
+ + L+ EY + L+ +P R + +II Q + + H+++
Sbjct: 67 EVFRRKRKLHLVFEYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN--- 120
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-DGLF 694
IHRD+K N+L+ K K+ DFG AR+ G + V T Y +PE + D +
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDYTDYVATRWYRAPELLVGDTQY 178
Query: 695 SIKSDVFSFGILMLETLSS 713
DV++ G + E L+
Sbjct: 179 GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
++ +G G FG V+ R + A+K ++ LK+ NE ++ E+ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIAQ 623
++R+ +Q +++EY+P L YL F E I
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE--------IVC 112
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
L YLH I++RDLK N+LLDK+ + K++DFG A+ +L+ T + GT Y
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEY 164
Query: 684 MSPEYALDGLFSIKS-------DVFSFGILMLETLS 712
++PE I+S D ++ GIL+ E L
Sbjct: 165 LAPE-------VIQSKGHNKAVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 51/193 (26%), Positives = 97/193 (50%), Gaps = 10/193 (5%)
Query: 520 KLGEGGFGPV-YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+GEG G V G++VAVK++ + Q + NE++++ + H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ E +++E++ +L D + ++ E + + + L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ ++LL D K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 699 DVFSFGILMLETL 711
D++S GI+++E +
Sbjct: 200 DIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/191 (27%), Positives = 97/191 (50%), Gaps = 10/191 (5%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+GEG G V + +G+ VAVK++ + Q + NE++++ + QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ E +++E++ +L D + ++ E + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ ++LL D K+SDFG E+ K +VGT +M+PE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV-SKEVP-RRKSLVGTPYWMAPELISRLPYGPEV 197
Query: 699 DVFSFGILMLE 709
D++S GI+++E
Sbjct: 198 DIWSLGIMVIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGL--KEFKNEMMLIAELQHRN 570
++F +LG G G V K + + ++L + + E+ ++ E
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V G GE + +E+M SLD L + KR+ + E ++ + +GL YL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPE-EILGKVSIAVLRGLAYLRE 121
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ +I+HRD+K SN+L++ K+ DFG++ G + VGT YMSPE
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQ 175
Query: 691 DGLFSIKSDVFSFGILMLETLSSR 714
+S++SD++S G+ ++E R
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 43/214 (20%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMML-------------IAEL 566
LG+G FG V L E+ AVK L K +++L + L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVL-----------KKDVILQDDDVECTMTEKRVLAL 51
Query: 567 QHRN--LVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IA 622
++ L + L C + +++ ++EY+ L +F + D E R R I
Sbjct: 52 AGKHPFLTQ-LHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFD-EPRARFYAAEIV 106
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGT 680
GL +LH+ II+RDLK NVLLD + + KI+DFG+ + + GG T GT
Sbjct: 107 LGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV----TTSTFCGT 159
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
Y++PE + D ++ G+L+ E L+ +
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 89/338 (26%), Positives = 137/338 (40%), Gaps = 90/338 (26%)
Query: 521 LGEGGFGPVYKGRLFNGQE------VAVKRLSSQSGQGLKEFKNEM----MLIAELQHRN 570
LG G FG V + F ++ VAVK L + G E+K M +LI H N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHHLN 72
Query: 571 LVRILGCCVEQGEKIL-ILEYMPNKSLDVYL------FDP---------------IKKRL 608
+V +LG C + G ++ I+EY +L YL F P KK+
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 609 LD--------------WEARIRIIQGIAQG-------------LLYLHQYSR-------L 634
LD + + ++ +G + Y Q +R
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR 192
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDG 692
+ IHRDL A N+LL ++ KI DFGLAR D ++ R+ +M+PE D
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDK 250
Query: 693 LFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750
+++ +SDV+SFG+L+ E +L + GV + F + + + P
Sbjct: 251 VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--------CRRLKEGTRMRAPEYAT 302
Query: 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
EI ML C N DRPT S++V ++ +
Sbjct: 303 PEIYSIMLD--------CWHNNPEDRPTFSELVEILGD 332
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 31/218 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAEL 566
+ +GEG +G V G +VA+K++S Q L+E K ++
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRF 60
Query: 567 QHRNLVRILGC----CVEQGEKI-LILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQG 620
+H N++ IL E + ++ E M D+Y IK + L + + + Q
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET---DLYKL--IKTQHLSNDHIQYFLYQ- 114
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI--- 677
I +GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR+ D +T +
Sbjct: 115 ILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLTEY 169
Query: 678 VGTYGYMSPEYALDGLFSIKS-DVFSFGILMLETLSSR 714
V T Y +PE L+ K+ D++S G ++ E LS+R
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 52/201 (25%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ + + KR+ + G+ + NE ++ ++ + +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ L+L M L ++++ + + E + I GL LH+ +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLHREN-- 122
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
++RDLK N+LLD + +ISD GLA ++ G+ ++G VGT GYM+PE +
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR----VGTVGYMAPEVLNNQR 177
Query: 694 FSIKSDVFSFGILMLETLSSR 714
+++ D + G L+ E + +
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 60/187 (32%), Positives = 89/187 (47%), Gaps = 32/187 (17%)
Query: 537 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594
GQ VA+K+LS Q+ K E++L+ + H+N++ +L + P K
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV------------FTPQK 88
Query: 595 SL----DVY----LFDP----IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642
SL DVY L D + + LD E ++ + G+ +LH IIHRDLK
Sbjct: 89 SLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLK 145
Query: 643 ASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFS 702
SN+++ D KI DFGLAR G + T +V Y Y +PE L + D++S
Sbjct: 146 PSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWS 202
Query: 703 FGILMLE 709
G +M E
Sbjct: 203 VGCIMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KR+ + G+ + NE ++ ++ R +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ L+L M L +++ + + + + I GL LHQ
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLHQE--- 121
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
RI++RDLK N+LLD + +ISD GLA + G ++G VGT GYM+PE +
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVVKNER 177
Query: 694 FSIKSDVFSFGILMLETLSSR 714
++ D ++ G L+ E ++ +
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 521 LGEGGFGPV---YKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G +G V Y RL Q+VAVK+LS QS + E+ L+ ++H N++ +L
Sbjct: 23 VGSGAYGSVCSAYDTRL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 576 -----GCCVEQGEKILILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLH 629
+E ++ Y+ + L + +K ++L D + I Q + +GL Y+H
Sbjct: 81 DVFTPATSIENFNEV----YLVTNLMGADLNNIVKCQKLSDEHVQFLIYQ-LLRGLKYIH 135
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
IIHRDLK SNV +++D +I DFGLAR DE+ G V T Y +PE
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ-ADDEMTG----YVATRWYRAPEIM 187
Query: 690 LDGL-FSIKSDVFSFGILMLETLSSR 714
L+ + ++ D++S G +M E L +
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 21/145 (14%)
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI------RIIQGIAQGLLYLH 629
G GE + +E+M SLD L K+ RI +I + +GL YL
Sbjct: 66 GAFYSDGEISICMEHMDGGSLDQVL-----KKA----GRIPENILGKISIAVLRGLTYLR 116
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ + +I+HRD+K SN+L++ K+ DFG++ G + VGT YMSPE
Sbjct: 117 E--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERL 170
Query: 690 LDGLFSIKSDVFSFGILMLETLSSR 714
++++SD++S G+ ++E R
Sbjct: 171 QGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-12
Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 29/187 (15%)
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
LD + +R +AQG+ +L + IHRD+ A NVLL KI DFGLAR D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 669 E---LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN---TGVYNT 722
++GN + V +M+PE D +++++SDV+S+GIL+ E S K+ + N+
Sbjct: 266 SNYVVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322
Query: 723 DSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDV 782
+ ++ +R +++ P EI M M C +RPT S +
Sbjct: 323 KFYKMV---------KRGYQMSRPDFAPPEIYSIMKM--------CWNLEPTERPTFSQI 365
Query: 783 VSMISNE 789
+I +
Sbjct: 366 SQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQ------GLKEFKNEMMLIAELQHRNLV 572
K+GEG +G VYK R G+ VA+K+ + + L+E ML +E + +V
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQML-SESIY--IV 64
Query: 573 RILGCCVEQGEK-------ILILEYMPN---KSLDVYLFDPIKKRLLDWEARIRIIQGIA 622
R+L VE E+ L+ EY+ + K +D P R L + + +
Sbjct: 65 RLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGP--GRPLPAKTIKSFMYQLL 120
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKRIVGTY 681
+G+ + H++ ++HRDLK N+L+DK KI+D GL R F ++ T IV T
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TL 175
Query: 682 GYMSPEYALDGL-FSIKSDVFSFGILMLETLSSRKN 716
Y +PE L +S D++S G + E SRK
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEM--SRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-12
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRLSS----QSGQGLKEFKNEMMLIAE 565
NF + LG G +G V+ R G + A+K L Q + + + E ++
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 566 LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
++ + L + K+ LIL+Y+ L +L+ ++ + E R+ I + I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAE-IVLA 117
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L +LHQ L II+RD+K N+LLD + + ++DFGL++ F +E + GT YM
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYM 173
Query: 685 SPEYAL--DGLFSIKSDVFSFGILMLETLS 712
+PE G D +S G+L E L+
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 75/256 (29%), Positives = 115/256 (44%), Gaps = 40/256 (15%)
Query: 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LG+G FG V RL +G+ AVK L Q + +L H L + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ-L 61
Query: 576 GCCVEQGEKIL-ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYSR 633
CC + +++ ++E++ L +F K R D EAR R I L++LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFD-EARARFYAAEITSALMFLHDKG- 116
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEYALD 691
II+RDLK NVLLD + + K++DFG+ + +F G T GT Y++PE +
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK----TTSTFCGTPDYIAPEILQE 170
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
L+ D ++ G+L+ E L GHA ++ E +L + IL D
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLC----------------GHA--PFEAENEDDLFE-AILND 211
Query: 752 EIPLPMLMRYVNVALL 767
E+ P + V +L
Sbjct: 212 EVVYPTWLSQDAVDIL 227
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 36/94 (38%), Positives = 54/94 (57%), Gaps = 9/94 (9%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
IA GL +LH II+RDLK NV+LD + + KI+DFG+ + +FGG T+
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK----TTRTFC 162
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
GT Y++PE + D ++FG+L+ E L+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 18/210 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAE 565
NF + LG G +G V+ R +G + A+K L Q + + + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 566 LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
++ + L + K+ LIL+Y+ L +L ++R + E +I + I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGE-IVLA 117
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L +LH +L II+RD+K N+LLD + + ++DFGL++ F DE++ GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 685 SPEYAL--DGLFSIKSDVFSFGILMLETLS 712
+P+ DG D +S G+LM E L+
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 31/203 (15%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KR+ + G+ + NE ++ ++ R +V +
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKRLLDWEARIRIIQGIAQGLLY 627
+ L+L M L ++ FD ++R + + A I GL
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD--EERAVFYAAEITC------GLED 117
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSP 686
LH R RI++RDLK N+LLD + +ISD GLA + G+ ++G VGT GYM+P
Sbjct: 118 LH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGR----VGTVGYMAP 170
Query: 687 EYALDGLFSIKSDVFSFGILMLE 709
E + ++ D + G L+ E
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYE 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 57/199 (28%), Positives = 100/199 (50%), Gaps = 19/199 (9%)
Query: 521 LGEGGFGPV------YKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
LG+GGFG V G+++ +++ KR+ + G+ + NE ++ ++ R +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVS- 64
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
L E + + L+L M L ++++ + D + I + GL L R
Sbjct: 65 LAYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---R 120
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
RI++RDLK N+LLD + +ISD GLA ++ G+ ++G VGT GYM+PE +
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR----VGTVGYMAPEVINNE 176
Query: 693 LFSIKSDVFSFGILMLETL 711
++ D + G L+ E +
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 14/150 (9%)
Query: 519 CKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
KLGEG + VYKGR GQ VA+K RL + G + E L+ +L+H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIV-TL 68
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLLYLHQYSR 633
+ + + L+ EY+ + L Y+ D L R+ + Q + +GL Y HQ
Sbjct: 69 HDIIHTKKTLTLVFEYL-DTDLKQYMDD--CGGGLSMHNVRLFLFQ-LLRGLAYCHQR-- 122
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
R++HRDLK N+L+ + K++DFGLAR
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-12
Identities = 57/205 (27%), Positives = 101/205 (49%), Gaps = 14/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKR-LSSQSGQGLKEFK-NEMMLIAELQHR 569
E + +GEG +G V K + GQ VA+K+ L S+ + +K+ E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
NLV ++ + L+ E++ + LD P LD + + I +G+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCH 117
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF-GGDELQGNTKRIVGTYGYMSPEY 688
++ IIHRD+K N+L+ + K+ DFG AR E+ + V T Y +PE
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD---YVATRWYRAPEL 171
Query: 689 AL-DGLFSIKSDVFSFGILMLETLS 712
+ D + D+++ G L+ E L+
Sbjct: 172 LVGDTKYGRAVDIWAVGCLVTEMLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFK-NEMMLIAELQHR----NL 571
+LG+G +G VYK G +A+K RL L E K N++++ ++ H+ +
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSPYI 61
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V G +G + +EYM SLD + + + RI + +GL +L +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE- 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--- 688
IIHRD+K +NVL++ + K+ DFG++ G+ + K +G YM+PE
Sbjct: 121 -EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS----GNLVASLAKTNIGCQSYMAPERIKS 175
Query: 689 ---ALDGLFSIKSDVFSFGILMLE 709
+ ++++SDV+S G+ +LE
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILE 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-12
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 42/224 (18%)
Query: 505 LASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN----- 558
+V T + +G G FG V R GQ VA+K++ +K F
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAK 54
Query: 559 ----EMMLIAELQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEA 613
E+ L+ L+H N++ + + E I + E + + P++K+ + +
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-- 112
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-----MFGGD 668
+ I +GL Y+H ++HRDLK SN+L++++ + KI DFGLAR M G
Sbjct: 113 ---FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG-- 164
Query: 669 ELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETL 711
V T Y +PE L + ++ D++S G + E L
Sbjct: 165 --------YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLGEG + VYKGR VA+K RL + G + E+ L+ +L+H N+V +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ L+ EY+ +K L YL D + ++ + Q + +GL Y H R ++
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYL-DDCGNSINMHNVKLFLFQ-LLRGLNYCH---RRKV 125
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGL-F 694
+HRDLK N+L+++ K++DFGLAR + T V T Y P+ L +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182
Query: 695 SIKSDVFSFGILMLETLSSR 714
S + D++ G + E + R
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 19/221 (8%)
Query: 502 LFSLASVAAATENFSMQCKLGEGGFGPVYK-GRLFNGQEVAVKRLSSQSGQGLKEFKNEM 560
+ L S+ T+ + + +G+G +G VYK +G AVK L S +E + E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 561 MLIAEL-QHRNLVRILGCCVEQ-----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEAR 614
++ L H N+V+ G + G+ L+LE S+ + + EA
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 615 IR-IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673
I I+ G GL +LH RIIHRD+K +N+LL + K+ DFG++ L+ N
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 674 TKRIVGTYGYMSPEY-----ALDGLFSIKSDVFSFGILMLE 709
T VGT +M+PE D + + DV+S GI +E
Sbjct: 187 TS--VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIE 225
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHR 569
E ++ ++G G +G V G++VA+K+LS QS K E+ L+ +QH
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 570 NLVRILGCCVEQG------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
N++ +L + L++ YM I L + ++ +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD------LQKIMGHPLSEDKVQYLVYQMLC 128
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T Y
Sbjct: 129 GLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-HADAEMTG----YVVTRWY 180
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLETLSSR 714
+PE L+ + ++ D++S G +M E L+ +
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 60/224 (26%), Positives = 99/224 (44%), Gaps = 37/224 (16%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGL--KEFKNEMMLIAELQHRNLVRIL 575
+G+GG G VY + VA+K++ S L K F E + A+L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 576 GCCVEQGEKILILEYMPN------KSL--DVYLFDPIKKRLLDWE---ARIRIIQGIAQG 624
C G+ + MP KSL V+ + + K L + A + I I
Sbjct: 69 SIC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE-----LQGNTK---- 675
+ Y+H S+ ++HRDLK N+LL I D+G A +E + + +
Sbjct: 126 IEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 676 -------RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+IVGT YM+PE L S +D+++ G+++ + L+
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLGEG + V+KGR VA+K RL + G + E+ L+ +L+H N+V +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
L+ EY+ +K L Y+ D + +I + Q I +GL Y H R ++
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYM-DDCGNIMSMHNVKIFLYQ-ILRGLAYCH---RRKV 125
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYAL-DGLF 694
+HRDLK N+L+++ K++DFGLAR + T V T Y P+ L +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182
Query: 695 SIKSDVFSFGILMLETLSSR 714
S + D++ G + E S R
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYK-GRLFNGQEVAVKRLSSQSGQGLK-EFKNEMMLIAELQHRN 570
++F +LG G G V+K +G +A K + + ++ + E+ ++ E
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDP--IKKRLLDWEARIRIIQGIAQGLLYL 628
+V G GE + +E+M SLD L I +++L ++ I + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---GKVSI--AVIKGLTYL 119
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
+ + +I+HRD+K SN+L++ K+ DFG++ G + VGT YMSPE
Sbjct: 120 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPER 173
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSR 714
+S++SD++S G+ ++E R
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 510 AATENFSMQCKLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSGQGLKEFK--NEMMLIAEL 566
AAT +++ KLGEG + VYKG NGQ VA+K +S ++ +G+ F E L+ L
Sbjct: 3 AATSYLNLE-KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGL 60
Query: 567 QHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+H N+V +L + E + + EYM + L Y+ L + R+ + Q + +GL
Sbjct: 61 KHANIV-LLHDIIHTKETLTFVFEYM-HTDLAQYMIQH-PGGLHPYNVRLFMFQ-LLRGL 116
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
Y+H I+HRDLK N+L+ K++DFGLAR Q + +V T Y
Sbjct: 117 AYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVV-TLWYRP 171
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETL 711
P+ L +S D++ G + +E L
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 36/206 (17%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVR---- 573
+G+G +G V R +G++ +K+L+ + S + K + E L+++L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 574 ----------ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
++G C E G+ L+ K L + ++++W +Q IA
Sbjct: 68 WEGEDGLLYIVMGFC-EGGDLYHKLKEQKGKLL-------PENQVVEW-----FVQ-IAM 113
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
L YLH+ I+HRDLK NV L + K+ D G+AR+ +T ++GT Y
Sbjct: 114 ALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYY 168
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLE 709
MSPE + ++ KSDV++ G + E
Sbjct: 169 MSPELFSNKPYNYKSDVWALGCCVYE 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 38/93 (40%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
I GL +LH+ II+RDLK NVLLDKD + KI+DFG+ + M G +G
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG----EGKASTFC 157
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT Y++PE ++ D +SFG+L+ E L
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 66/283 (23%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMM--LIAELQHR--NLVRIL 575
+G G G VYK R G +AVK++ + +E K +M + H +V+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 576 GCCVEQGEKILILEYMPN--KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
G + + + +E M L + PI + +L ++ I + L YL + +
Sbjct: 81 GYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG-----KMTVAIVKALHYLKE--K 133
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPEYALD- 691
+IHRD+K SN+LLD N K+ DFG++ R+ + + T R G YM+PE +D
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT-RSAGCAAYMAPE-RIDP 188
Query: 692 ----GLFSIKSDVFSFGILMLETLSSRKNTGVY-----NTDSFNLLGHAWDLWKHERVHE 742
+ I++DV+S GI ++E TG + T+ F +L
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELA-----TGQFPYKNCKTE-FEVL-------------- 228
Query: 743 LMDPVILQDEIPL--------PMLMRYVNVALLCVQENAADRP 777
ILQ+E P P +V+ LC+ ++ RP
Sbjct: 229 ---TKILQEEPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP 265
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 3e-11
Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 20/189 (10%)
Query: 537 GQEVAVKRLSSQSGQGLKE---FKNEMMLIAELQHRNLVRIL--GCCVEQGEKILILEYM 591
G EVA+K L + + + + F+ E L A L H N+V +L G G + EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL--- 648
P ++L L L R++ + L H I+HRDLK N+++
Sbjct: 62 PGRTLREVL---AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115
Query: 649 DKDMNPKISDFGLARMFGG----DELQGN-TKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703
+ K+ DFG+ + G D T ++GT Y +PE + SD++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 704 GILMLETLS 712
G++ LE L+
Sbjct: 176 GLIFLECLT 184
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 43/214 (20%)
Query: 521 LGEGGFGPV---YKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G +G V R G +VA+K+L QS K E+ L+ ++H N++ +L
Sbjct: 23 VGSGAYGTVCSALDRR--TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 576 GCCVEQGEKILILEYMPNKSLD----VYLFDP---------IKKRLLDWEARIR-IIQGI 621
+ P+ SLD YL P +K L E RI+ ++ +
Sbjct: 81 DV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS-EDRIQFLVYQM 127
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G V T
Sbjct: 128 LKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ-TDSEMTG----YVVTR 179
Query: 682 GYMSPEYALDGL-FSIKSDVFSFGILMLETLSSR 714
Y +PE L+ + ++ D++S G +M E L+ +
Sbjct: 180 WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 62/223 (27%), Positives = 104/223 (46%), Gaps = 27/223 (12%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSS----QSGQGLKEFKNEMMLIAE 565
NF + LG G +G V+ R G + A+K L Q + ++ + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 566 LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQ 623
++ + L + K+ LIL+Y+ + +L+ +R E +R G I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIIL 116
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
L +LH +L I++RD+K N+LLD + + ++DFGL++ F +E + T GT Y
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEY 172
Query: 684 MSPEYALDGLFSIKS-DVFSFGILMLE--------TLSSRKNT 717
M+PE K+ D +S GIL+ E TL +NT
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 60/243 (24%), Positives = 111/243 (45%), Gaps = 31/243 (12%)
Query: 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAELQHRNLVRILGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ EL+H N++ +
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY-----LHQ 630
+ ++ L+ +Y + + F K + +++ +G+ + LLY +H
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 123
Query: 631 YSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMS 685
++HRDLK +N+L+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 686 PEYALDGLFSIKS-DVFSFGILMLETLSSR----------KNTGVYNTDS----FNLLGH 730
PE L K+ D+++ G + E L+S K + Y+ D FN++G
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243
Query: 731 AWD 733
D
Sbjct: 244 PAD 246
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 20/181 (11%)
Query: 537 GQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------EKILIL 588
G VAVK+LS Q+ K E++L+ + H+N++ +L Q + L++
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648
E M V + LD E ++ + G+ +LH IIHRDLK SN+++
Sbjct: 106 ELMDANLCQVIHME------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708
D KI DFGLAR + + T +V Y Y +PE L + D++S G +M
Sbjct: 157 KSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 709 E 709
E
Sbjct: 214 E 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+G GGFG VY G+++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+ +K+ IL+ M L +L F + R E II G+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE----IILGLE------ 111
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H ++R +++RDLK +N+LLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 689 ALDGL-FSIKSDVFSFGILMLETL 711
G+ + +D FS G ++ + L
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 67/268 (25%), Positives = 120/268 (44%), Gaps = 28/268 (10%)
Query: 521 LGEGGFG-PVYKGRLFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
+GEG FG + + + Q+ A+K + +S +++ + E +L+A+++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
G +++EY L IK + I+Q Q L + R++H
Sbjct: 68 EADGHLYIVMEYCDGGDL----MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLH 123
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKS 698
RD+K+ N+ L ++ K+ DFG AR+ T VGT Y+ PE + ++ KS
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPYNNKS 181
Query: 699 DVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPML 758
D++S G ++ E L + K+ N+ WK+ L+ V PLP
Sbjct: 182 DIWSLGCILYE-LCTLKHPFQANS------------WKN-----LILKVCQGSYKPLPSH 223
Query: 759 MRYVNVALL--CVQENAADRPTMSDVVS 784
Y +L+ + N RP+ + ++S
Sbjct: 224 YSYELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 37/96 (38%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I +GL YLH I+HRD+K N+L++ + KI DFGLAR+ DE + T+ +V
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 681 YGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSR 714
Y Y +PE L G ++ D++S G + E L R
Sbjct: 169 Y-YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 45/136 (33%), Positives = 63/136 (46%), Gaps = 24/136 (17%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I L YLH +++RD+K N++LDKD + KI+DFGL + D K GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGT 158
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740
Y++PE D + D + G++M E + R YN D HER+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD-------------HERL 203
Query: 741 HELMDPVILQDEIPLP 756
EL IL +EI P
Sbjct: 204 FEL----ILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 39/107 (36%), Positives = 59/107 (55%), Gaps = 9/107 (8%)
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
LD E + +A+G+ +L + IHRDL A N+LL KI DFGLAR D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 669 E---LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
++GN + V +M+PE + +++ +SDV+S+GIL+ E S
Sbjct: 268 SNYVVKGNARLPV---KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 49/147 (33%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLGEG + V+KGR VA+K RL + G + E+ L+ L+H N+V +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ L+ EY+ + L YL D + +I + Q + +GL Y H + +I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKIFMFQ-LLRGLSYCH---KRKI 124
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLAR 663
+HRDLK N+L+++ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 28/204 (13%)
Query: 521 LGEGGFGPVY------KGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+G GGFG VY G+++ + + KR+ + G+ L + M+ + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+ +K+ IL+ M L +L F + R E II G+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE----IILGLE------ 111
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H ++R +++RDLK +N+LLD+ + +ISD GLA F + + VGT+GYM+PE
Sbjct: 112 HMHNRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEV 166
Query: 689 ALDGL-FSIKSDVFSFGILMLETL 711
G + +D FS G ++ + L
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 54/192 (28%), Positives = 91/192 (47%), Gaps = 10/192 (5%)
Query: 521 LGEGGFGPVYKGRLFNGQE-VAVKRLS-SQSGQGLKEFK-NEMMLIAELQHRNLVRILGC 577
+GEG +G V K R +E VA+K+ S+ + +KE E+ ++ L+ N+V +
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
+G+ L+ EY+ L+ L + + + + R I Q I +H + I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLIKA----IHWCHKNDIV 122
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK 697
HRD+K N+L+ + K+ DFG AR + N V T Y SPE L +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 698 SDVFSFGILMLE 709
D++S G ++ E
Sbjct: 182 VDMWSVGCILGE 193
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 46/136 (33%), Positives = 65/136 (47%), Gaps = 23/136 (16%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I L YLH S +++RDLK N++LDKD + KI+DFGL + G + K GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTFCGT 159
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740
Y++PE D + D + G++M E + R YN D HE++
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD-------------HEKL 204
Query: 741 HELMDPVILQDEIPLP 756
EL IL +EI P
Sbjct: 205 FEL----ILMEEIRFP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 45/136 (33%), Positives = 63/136 (46%), Gaps = 24/136 (17%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I L YLH +++RDLK N++LDKD + KI+DFGL + G K GT
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGT 158
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740
Y++PE D + D + G++M E + R YN D HE++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQD-------------HEKL 203
Query: 741 HELMDPVILQDEIPLP 756
EL IL +EI P
Sbjct: 204 FEL----ILMEEIRFP 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 56/185 (30%), Positives = 89/185 (48%), Gaps = 20/185 (10%)
Query: 538 QEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------EKILILE 589
+ VA+K+LS Q+ K E++L+ + H+N++ +L Q + L++E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649
M D L I+ L D E ++ + G+ +LH IIHRDLK SN+++
Sbjct: 103 LM-----DANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 650 KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
D KI DFGLAR G + T +V Y Y +PE L + D++S G +M E
Sbjct: 154 SDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 710 TLSSR 714
+ +
Sbjct: 211 MVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 38/94 (40%), Positives = 58/94 (61%), Gaps = 7/94 (7%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIV 678
+A+G+ +L SR + IHRDL A N+LL ++ KI DFGLAR D ++ R+
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL- 243
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D +++I+SDV+SFG+L+ E S
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
KLGEG + VYKG+ NG+ VA+K RL + G + E L+ L+H N+V +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHD 70
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ L+ EY+ + L Y+ D L ++ + Q + +GL Y+HQ I
Sbjct: 71 IIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVKLFLFQ-LLRGLSYIHQRY---I 124
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLAR 663
+HRDLK N+L+ K++DFGLAR
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 27/196 (13%)
Query: 537 GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI--------------LGCCVEQG 582
+ VAVK++ Q +K E+ +I L H N+V++ +G E
Sbjct: 30 DKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELN 89
Query: 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLLYLHQYSRLRIIHRDL 641
++ EYM + L + +++ L E AR+ + Q + +GL Y+H + ++HRDL
Sbjct: 90 SVYIVQEYM-----ETDLANVLEQGPLSEEHARLFMYQ-LLRGLKYIHSAN---VLHRDL 140
Query: 642 KASNVLLD-KDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMSPEYALDGLFSIKS- 698
K +NV ++ +D+ KI DFGLAR+ +G + T Y SP L K+
Sbjct: 141 KPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAI 200
Query: 699 DVFSFGILMLETLSSR 714
D+++ G + E L+ +
Sbjct: 201 DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 52/209 (24%), Positives = 99/209 (47%), Gaps = 17/209 (8%)
Query: 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFK-NEMMLIAELQHRNLVRILGC 577
CK+G G +G VYK + +G++ L G G+ E+ L+ EL+H N++ +
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 578 CVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY-----LHQ 630
+ ++ L+ +Y + + F K + +++ + + + LLY +H
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIHY 123
Query: 631 YSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGD-ELQGNTKRIVGTYGYMS 685
++HRDLK +N+L+ + KI+D G AR+F + + +V T+ Y +
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 686 PEYALDGLFSIKS-DVFSFGILMLETLSS 713
PE L K+ D+++ G + E L+S
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 26/205 (12%)
Query: 521 LGEGGFGPVYKGRLFNGQE----VAVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLV 572
LG+GG+G V++ R G + A+K L ++ + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLH 629
++ G+ LILEY+ L ++L +R ++ A + + I+ L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSE-ISLALEHLH 117
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN--TKRIVGTYGYMSPE 687
Q II+RDLK N+LLD + K++DFGL + + + T GT YM+PE
Sbjct: 118 Q---QGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVTHTFCGTIEYMAPE 170
Query: 688 YALDGLFSIKSDVFSFGILMLETLS 712
+ D +S G LM + L+
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 27/173 (15%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIV 678
+A+G+ +L SR + IHRDL A N+LL ++ KI DFGLAR D ++ + R+
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL- 238
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWK 736
+M+PE D +++ +SDV+SFG+L+ E +L + GV + F
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF----------- 286
Query: 737 HERVHELMDPVILQ-DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
L D ++ E P + R + L C Q + +RPT S +V ++ +
Sbjct: 287 ---CQRLKDGTRMRAPENATPEIYR---IMLACWQGDPKERPTFSALVEILGD 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 24/167 (14%)
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
Q LL +H +IHRD+K++N+LL + K+ DFG ++M+ + GT
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742
Y++PE +S K+D+FS G+L+ E L+ ++ + E + E
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP------------------FDGENMEE 252
Query: 743 LMDPVILQDEIPLPML----MRYVNVALLCVQENAADRPTMSDVVSM 785
+M + PLP M+ + ALL RP+ S +++M
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKR--RPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 60/197 (30%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 521 LGEGGFGPVY-KGRLFNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAELQHRNLVRIL 575
+G+G FG V R +G AVK L ++ KE + M +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG-L 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ EK+ +L+Y+ L +L ++ L+ AR + +A + YLH L
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAE-VASAIGYLHS---L 115
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
II+RDLK N+LLD + ++DFGL + G E + T GT Y++PE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GVEPEETTSTFCGTPEYLAPEVLRKEPY 173
Query: 695 SIKSDVFSFGILMLETL 711
D + G ++ E L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 36/89 (40%), Positives = 53/89 (59%), Gaps = 11/89 (12%)
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
G+ LHQ IIHRD+K N+L+D+ + K++DFGL+R G E K+ VGT Y
Sbjct: 109 GVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLE----NKKFVGTPDY 159
Query: 684 MSPEYALDGLFSIK-SDVFSFGILMLETL 711
++PE + G+ K SD +S G ++ E L
Sbjct: 160 LAPE-TILGVGDDKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 7e-10
Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 516 SMQCKLGE----GGFGPVYKGRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHR 569
+ +G+ + K + VAVK+ L S S + LK + E++ +LQH
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHP 59
Query: 570 NLVRILGCCVEQGEKILILEYMPNKS----LDVYLFDPIKKRLLDWEARIR-IIQGIAQG 624
N++ + + E ++ M S L + + + E I I++ +
Sbjct: 60 NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP------ELAIAFILKDVLNA 113
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQ----GNTKRIVG 679
L Y+H IHR +KAS++LL D +S + M + Q K V
Sbjct: 114 LDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 680 TYGYMSPEYALDGL--FSIKSDVFSFGI 705
++SPE L ++ KSD++S GI
Sbjct: 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGI 198
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 8e-10
Identities = 68/241 (28%), Positives = 104/241 (43%), Gaps = 33/241 (13%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAELQHRNLVRILG 576
LG+G FG V R +G+ A+K L + E + E ++ +H L +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYSRLR 635
+ ++EY+ L F ++R+ E R R I L YLH +
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL---FFHLSRERVFS-EDRTRFYGAEIVSALDYLHSG---K 115
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
I++RDLK N++LDKD + KI+DFGL + G K GT Y++PE D +
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKE--GITDAATMKTFCGTPEYLAPEVLEDNDYG 173
Query: 696 IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPL 755
D + G++M E + R YN D HE++ EL IL ++I
Sbjct: 174 RAVDWWGLGVVMYEMMCGR--LPFYNQD-------------HEKLFEL----ILMEDIKF 214
Query: 756 P 756
P
Sbjct: 215 P 215
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 45/226 (19%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G G FG V+ R + +V A+K L + Q + E ++A+ +V++
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIA-HVRAERDILADADSPWIVKLY 67
Query: 576 GCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLLYLHQYS 632
Q E+ L ++EYMP L L I+K + E AR I A+ +L L
Sbjct: 68 --YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEETARFYI----AELVLALDSVH 118
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLA--------RMFGGDELQGNTKR-------- 676
+L IHRD+K N+L+D D + K++DFGL R + ++ R
Sbjct: 119 KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRR 178
Query: 677 -----------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
VGT Y++PE + ++ D +S G+++ E L
Sbjct: 179 DHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 8e-10
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 55/224 (24%)
Query: 520 KLGEGGFGPVYKG-RLFNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLV 572
+G G +G V +G++VA+K++ + L+E K ++ +H N++
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67
Query: 573 RILGCCVEQGEKILILEYMPNKSL--DVYL-FDPIKKRLLDWEARIRIIQG--------- 620
I IL P + DVY+ D ++ L II
Sbjct: 68 AIR--------DIL----RPPGADFKDVYVVMDLMESDLH------HIIHSDQPLTEEHI 109
Query: 621 ------IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQG 672
+ +GL Y+H + +IHRDLK SN+L+++D +I DFG+AR E +
Sbjct: 110 RYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
Query: 673 NTKRIVGTYGYMSPE--YALDGLFSIKSDVFSFGILMLETLSSR 714
V T Y +PE +L ++ D++S G + E L R
Sbjct: 167 FMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILG 576
LG+G FG V L EV A+K L + E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 577 CCVEQGEKIL-ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYSRL 634
CC + +++ ++EY+ L +F + R D E R R + L++LH++
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRHG-- 116
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+I+RDLK N+LLD + + K++DFG+ + + G T GT Y++PE +
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV----TTTTFCGTPDYIAPEILQEL 171
Query: 693 LFSIKSDVFSFGILMLETLS 712
+ D ++ G+LM E ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMA 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 58/188 (30%), Positives = 89/188 (47%), Gaps = 32/188 (17%)
Query: 538 QEVAVKRLSS--QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595
+ VA+K+LS Q+ K E++L+ + H+N++ +L + P KS
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV------------FTPQKS 97
Query: 596 L----DVY----LFDP----IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643
L DVY L D + + LD E ++ + G+ +LH IIHRDLK
Sbjct: 98 LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKP 154
Query: 644 SNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703
SN+++ D KI DFGLAR G + T +V Y Y +PE L + D++S
Sbjct: 155 SNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPEVILGMGYKENVDIWSV 211
Query: 704 GILMLETL 711
G +M E +
Sbjct: 212 GCIMGEMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVA---VKRLSSQSGQGLKEFKNEMMLIAE----LQHRNLV 572
++G G FG V ++ VA VK L + + KE +NE + + LQH N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKE-QNEFLQQGDPYRILQHPNIL 58
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG----IAQGLLYL 628
+ LG CVE +L+ EY L YL R +++ ++Q IA G+ ++
Sbjct: 59 QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHR---RNSQLLLLQRMACEIAAGVTHM 115
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGYMSPE 687
H + +H DL N L D+ K+ D+G+ + D ++ + V +++PE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPE 171
Query: 688 YAL---DGLFSIK----SDVFSFGILMLE 709
GL + + S+V++ G+ + E
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 36/93 (38%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
I GL +LH I++RDLK N+LLD D + KI+DFG+ + M G T
Sbjct: 105 IICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG----DAKTCTFC 157
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT Y++PE L ++ D +SFG+L+ E L
Sbjct: 158 GTPDYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 61/202 (30%), Positives = 98/202 (48%), Gaps = 19/202 (9%)
Query: 521 LGEGGFGPVYK-GRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCC 578
+G+G +G V+K NG + AVK L +E + E ++ L H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 579 ----VEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLLYLHQYS 632
V+ G+++ L+LE S+ + +K+ E I I+ GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY---- 688
+ IHRD+K +N+LL + K+ DFG++ L+ NT VGT +M+PE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAPEVIACE 199
Query: 689 -ALDGLFSIKSDVFSFGILMLE 709
LD + + DV+S GI +E
Sbjct: 200 QQLDSTYDARCDVWSLGITAIE 221
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 15/173 (8%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAELQHRNLVRIL 575
+G+G FG V + +G+ AVK L ++ KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG-L 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ +K+ +L+Y+ L +L ++ + AR + IA L YLH L
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHL--QRERSFPEPRARFYAAE-IASALGYLHS---L 115
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
II+RDLK N+LLD + ++DFGL + G E T GT Y++PE
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKE--GIEHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 22/194 (11%)
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H LV + C + ++EY+ L +F ++R L E I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMS 685
LH+ II+RDLK NVLLD + + K++D+G+ + + GD T GT Y++
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD----TTSTFCGTPNYIA 164
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
PE + D ++ G+LM E ++ R F+++G + + + + +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSSDN--PDQNTEDYLF 214
Query: 746 PVILQDEIPLPMLM 759
VIL+ +I +P +
Sbjct: 215 QVILEKQIRIPRSL 228
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQ--EVAVKRLSSQSGQGLKEFK---NEMMLIAELQ 567
E+F+ LG G FG V N VA+KR K+ +E ++ +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H V + G ++ L+LE++ +L +R + + AQ +L
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL-----RRNKRFPNDVGCFYA-AQIVLI 143
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L I++RDLK N+LLDKD K++DFG A++ + T + GT Y++PE
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPE 198
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
L+ +D ++ GI + E L
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 31/146 (21%), Positives = 58/146 (39%), Gaps = 13/146 (8%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCC 578
L G VY ++ +K S+ +E + ++ + + V ++L
Sbjct: 5 LLKGGLTNRVYLLGT-KDEDYVLKINPSREKGADREREVAILQLLA-RKGLPVPKVLASG 62
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
G L++E++ ++LD + E + I + +A+ L LHQ L + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCH 112
Query: 639 RDLKASNVLLDKDMNPKISDFGLARM 664
DL N+L+D I D+ A
Sbjct: 113 GDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 5e-09
Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 28/204 (13%)
Query: 521 LGEGGFGPV----YKGRLFNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAELQHRN 570
LG G FG V YK G+ A+K L + + L K +H
Sbjct: 7 LGRGHFGKVLLAEYKK---TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLH 629
LV + C + ++EY L ++ I + E R + GL YLH
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMH----IHTDVFS-EPRAVFYAACVVLGLQYLH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPE 687
+ +I++RDLK N+LLD + KI+DFGL + M GD T GT +++PE
Sbjct: 119 EN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR----TSTFCGTPEFLAPE 171
Query: 688 YALDGLFSIKSDVFSFGILMLETL 711
+ ++ D + G+L+ E L
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 7e-09
Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
I GL +LH II+RDLK NV+LD+D + KI+DFG+ + +FG
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG----DNRASTFC 157
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT Y++PE ++ D +SFG+L+ E L
Sbjct: 158 GTPDYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+A+G+ +L + +HRDL A NVLL + KI DFGLAR D +
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE D L++ SDV+S+GIL+ E S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 514 NFSMQCKLGEGGFGPV----YKGRLFNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAEL 566
+F M LG G FG V +KG G+ A+K L + +K+ ++ E ++ EL
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQG 624
H +V ++ ++ +LE++ L F ++K R + A+ + +
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYHAE-LVLA 130
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
YLH II+RDLK N+LLD + K++DFG A+ ++ T + GT Y+
Sbjct: 131 FEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYL 182
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE D ++ G+L+ E +
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 35/94 (37%), Positives = 53/94 (56%), Gaps = 5/94 (5%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
IA GL +LH II+RDLK NV+LD + + KI+DFG+ + D + TK GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGT 164
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
Y++PE + D ++FG+L+ E L+ +
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 71/278 (25%), Positives = 116/278 (41%), Gaps = 56/278 (20%)
Query: 541 AVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE---YMPNKSLD 597
A R + Q +NE++ + L H N+++I E+IL E YM + D
Sbjct: 202 AGSRAAIQ-------LENEILALGRLNHENILKI--------EEILRSEANTYMITQKYD 246
Query: 598 VYLFDPIKKRLLDWEARI------RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD 651
L+ + DW+ R I++ + + Y+H ++IHRD+K N+ L+ D
Sbjct: 247 FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303
Query: 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLET 710
+ DFG A F E + VGT SPE A DG I +D++S G+++L+
Sbjct: 304 GKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDM 361
Query: 711 LSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV-ILQDEIPLP--MLMRYVNVALL 767
LS + +++ +++D + + +E P P L Y++ A
Sbjct: 362 LS--HDFCPIGDGGGK---------PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSA-- 408
Query: 768 CVQENAADRPTMSDVVSMISNEHL----NLPFPKKLTF 801
D S V +I N L P K LTF
Sbjct: 409 -----EIDHAGHS-VPPLIRNLGLPADFEYPLVKMLTF 440
|
Length = 501 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 44/146 (30%), Positives = 69/146 (47%), Gaps = 12/146 (8%)
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
LV + C L++EY+ L +F ++R L E I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYMSPEY 688
II+RDLK NVLLD D + K++D+G+ + + GD T GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD----TTSTFCGTPNYIAPEI 167
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSR 714
+ D ++ G+LM E ++ R
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 66/223 (29%), Positives = 103/223 (46%), Gaps = 48/223 (21%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAE------ 565
E+F + +G G FG V R + ++V A+K LS K EM+ ++
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS----------KFEMIKRSDSAFFWE 92
Query: 566 ----LQHRN---LVRILGCCVEQGEKIL--ILEYMPNKSLDVYL---FDPIKKRLLDWEA 613
+ H N +V++ Q +K L ++EYMP L V L +D +K W A
Sbjct: 93 ERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEK----W-A 144
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQG 672
R + + L +H IHRD+K N+LLDK + K++DFG +M ++
Sbjct: 145 RFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC 200
Query: 673 NTKRIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETL 711
+T VGT Y+SPE DG + + D +S G+ + E L
Sbjct: 201 DTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 34/96 (35%), Positives = 54/96 (56%), Gaps = 9/96 (9%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIV 678
I+ GL +LH R II+RDLK NV+LD + + KI+DFG+ + M G T+
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFC 162
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
GT Y++PE + D +++G+L+ E L+ +
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 32/211 (15%)
Query: 521 LGEGGFGPVYKG--------RLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
LG+G F ++KG + EV +K L + F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQ 630
G CV E I++ EY+ SLD YL KK L++ ++ + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISWKLEVAKQLAWALHFLED 118
Query: 631 YSRLRIIHRDLKASNVLL-----DKDMNP---KISDFGLARMFGGDELQGNTKRIVGTYG 682
+ H ++ A NVLL K NP K+SD G++ E+ +RI
Sbjct: 119 KG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL--LERI----P 169
Query: 683 YMSPEYALDGL-FSIKSDVFSFGILMLETLS 712
++ PE + S+ +D +SFG + E S
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 521 LGEGGFGPVYKGRLFN---------GQEVAVKR-LSSQSGQGLKEFKNEMMLIAELQHRN 570
LG+G F +YKG L GQEV+V + + F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
LV++ G CV E I++ EY+ LDV+L L W ++ + + +A L YL
Sbjct: 63 LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 631 YSRLRIIHRDLKASNVLLDKDMNP-------KISDFGLARMFGG-DELQGNTKRIVGTYG 682
+++H ++ N+L+ + K+SD G+ +E +RI
Sbjct: 120 ---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERV---ERI----P 169
Query: 683 YMSPEYALDGLFSIKS--DVFSFGILMLE 709
+++PE +G S+ D +SFG +LE
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 37/94 (39%), Positives = 49/94 (52%), Gaps = 6/94 (6%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIV 678
I GL Y+H + ++HRDLK N+L++ D KI DFGLAR F E G V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 679 GTYGYMSPEYALDGLFSIKS-DVFSFGILMLETL 711
T Y +PE L K+ DV+S G ++ E L
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 57/197 (28%), Positives = 89/197 (45%), Gaps = 15/197 (7%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAELQHRNLVRIL 575
+G+G FG V R ++ AVK L ++ KE K+ M +L+ ++H LV +
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGLLYLHQYSRL 634
+ +L+Y+ L F +++ E R R IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASALGYLHS---L 115
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF 694
I++RDLK N+LLD + ++DFGL + E G T GT Y++PE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 695 SIKSDVFSFGILMLETL 711
D + G ++ E L
Sbjct: 174 DRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 40/211 (18%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMMLIAELQHRN 570
+G G +G V + ++VA+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIA-------NAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 571 LVRILGC----CVEQGEKILIL-EYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQ 623
++ I E + I+ E M D L I+ + L D + + Q + +
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQ-LLR 119
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL Y+H + ++HRDLK SN+LL+ + + KI DFGLAR E V T Y
Sbjct: 120 GLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART--TSEKGDFMTEYVVTRWY 174
Query: 684 MSPEYAL---DGLFSIKSDVFSFGILMLETL 711
+PE L + +I DV+S G + E L
Sbjct: 175 RAPELLLNCSEYTTAI--DVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 44/150 (29%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLL 626
H LV + C + ++E++ L +F ++R L E AR + I+ L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALN 110
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
+LH+ II+RDLK NVLLD + + K++D+G+ + + GD T GT Y+
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD----TTSTFCGTPNYI 163
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSR 714
+PE + D ++ G+LM E ++ R
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 52/229 (22%), Positives = 99/229 (43%), Gaps = 22/229 (9%)
Query: 557 KNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIR 616
++E+ +A H +V+ + +LI+EY L+ + +K+ L E +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676
++ Q +L L + +++HRDLK++N+ L K+ DFG ++ +
Sbjct: 173 LL--FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736
GT Y++PE +S K+D++S G+++ E L+ + +K
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP------------------FK 272
Query: 737 HERVHELMDPVILQDEIPLPMLMRYVNVALL--CVQENAADRPTMSDVV 783
E+M V+ P P + ALL + +N A RPT ++
Sbjct: 273 GPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 521 LGEGGFGPVY-KGRLFNGQEVAVKRLSSQSGQGLKEFKNEM----MLIAELQHRNLVRIL 575
+G+G FG V R +G+ AVK L + KE K+ M +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG-L 61
Query: 576 GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLLYLHQYSR 633
+ EK+ +L+++ L F ++R E R R IA L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFP-EPRARFYAAEIASALGYLHS--- 114
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
+ I++RDLK N+LLD + ++DFGL + G T GT Y++PE
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKE--GIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 694 FSIKSDVFSFGILMLETL 711
+ D + G ++ E L
Sbjct: 173 YDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 34/97 (35%), Positives = 55/97 (56%), Gaps = 8/97 (8%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG-LARMFGGDELQGNTKRIVG 679
+A+ +L + +L +HRD+K NVLLDK+ + +++DFG R+ +Q N VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA--VG 165
Query: 680 TYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETL 711
T Y+SPE A++ G + + D +S G+ M E L
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 36/207 (17%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAELQH----RN-LVRI 574
+G+G FG VY+ R + + + A+K LS K E++ E+ H RN LVR
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS----------KKEIVAKKEVAHTIGERNILVRT 50
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLF-DPIKKRLLDW---------EARIRI-IQGIAQ 623
L +++ I+ L++ D+YL D + L W E R + I +
Sbjct: 51 L---LDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
L +LH+Y I++RDLK N+LLD + + DFGL++ D NT GT Y
Sbjct: 108 ALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEY 162
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLE 709
++PE LD ++ D +S G+L+ E
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 39/220 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAEL----Q 567
++F + +G G FG V ++ + + + A+K L+ K EM+ AE +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILN----------KWEMLKRAETACFRE 50
Query: 568 HRNLVRILGCCV----------EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI 617
RN V + G C ++ L+++Y L + L + RL + AR I
Sbjct: 51 ERN-VLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYI 108
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG-LARMFGGDELQGNTKR 676
A+ +L +H +L +HRD+K NVLLD + + +++DFG +M +Q +
Sbjct: 109 ----AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA- 163
Query: 677 IVGTYGYMSPEY--ALD---GLFSIKSDVFSFGILMLETL 711
VGT Y+SPE A++ G + + D +S G+ M E L
Sbjct: 164 -VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-07
Identities = 21/61 (34%), Positives = 35/61 (57%), Gaps = 4/61 (6%)
Query: 338 RGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLK-NCTCKAYANSNVTEGSGCLMWYG 396
F +L N K P F + ++ +LE+CA++CL NC+C+++ +N T GCL+W
Sbjct: 2 SDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTYNNGT--KGCLLWSE 58
Query: 397 D 397
Sbjct: 59 S 59
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 53/272 (19%), Positives = 118/272 (43%), Gaps = 43/272 (15%)
Query: 529 VYKGRLFNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK- 584
+YKG FN +EV ++ + +NE+ + + N+++I G ++ +
Sbjct: 36 IYKGI-FNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 585 ---ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL 641
LILEY L L K++ L ++ ++ + +GL L++Y+ +++L
Sbjct: 95 PRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNL 149
Query: 642 KASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS---IKS 698
+ + L+ ++ KI GL ++ L + V Y S + D +FS IK
Sbjct: 150 TSVSFLVTENYKLKIICHGLEKI-----LSSPPFKNVNFMVYFSYKMLND-IFSEYTIKD 203
Query: 699 DVFSFGILMLETLSSR---KNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPL 755
D++S G+++ E + + +N + ++L+ + L+ +
Sbjct: 204 DIYSLGVVLWEIFTGKIPFENLTT--KEIYDLI--------------INKNNSLKLPLDC 247
Query: 756 PMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
P+ ++ + A C ++ RP + +++ +S
Sbjct: 248 PLEIKCIVEA--CTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 3/92 (3%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+A G+ +L + +HRDL A NVL+ + KI DFGLAR D +
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+M+PE + L++ SDV+SFGIL+ E +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-07
Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 9/168 (5%)
Query: 548 QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR 607
++ G K E+ ++ + HR ++ ++ K + MP D++ +
Sbjct: 125 KAVTGGKTPGREIDILKTISHRAIINLIHA---YRWKSTVCMVMPKYKCDLFTYVDRSGP 181
Query: 608 LLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667
L E I I + + + L YLH IIHRD+K N+ LD+ N + DFG A
Sbjct: 182 L-PLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237
Query: 668 DELQGNTKRIVGTYGYMSPEY-ALDGLFSIKSDVFSFGILMLETLSSR 714
GT SPE ALD + K+D++S G+++ E
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKN 284
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 26/212 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE----FKNEMMLIAELQH 568
E++ + +G G FG V R + Q+V +L S+ + F E ++A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 569 RNLVRILGCCVEQGEKIL--ILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQG 624
+V++ C Q +K L ++EYMP L + +D +K + A +
Sbjct: 103 PWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV--------- 151
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA-RMFGGDELQGNTKRIVGTYGY 683
+L L + +IHRD+K N+LLDK + K++DFG +M ++ +T VGT Y
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA--VGTPDY 209
Query: 684 MSPEY----ALDGLFSIKSDVFSFGILMLETL 711
+SPE DG + + D +S G+ + E L
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 2/92 (2%)
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
A+ L L + +I+RDLK N+LLD + + DFGL ++ D+ + NT GT
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGT 156
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
Y++PE L ++ D ++ G+L+ E L+
Sbjct: 157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-07
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 48/245 (19%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIA-----ELQHRNLVRI 574
K+G G FG V+ + QE + + S +GLKE + ++I EL+H+N+VR
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 575 LGCCVEQGEKIL--ILEYMPNKSLD------VYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+ + + + L ++E+ L +F I++ A + I + + L
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE-----HAIVDITRQLLHALA 132
Query: 627 YLHQY----SRLRIIHRDLKASNVLLD-------------KDMN----PKISDFGLARMF 665
Y H + R++HRDLK N+ L ++N KI DFGL++
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI 192
Query: 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSI--KSDVFSFGILMLETLSSRKNTGVYNTD 723
G ++ VGT Y SPE L S KSD+++ G ++ E S + T + +
Sbjct: 193 G---IESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK--TPFHKAN 247
Query: 724 SFNLL 728
+F+ L
Sbjct: 248 NFSQL 252
|
Length = 1021 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 37/138 (26%), Positives = 70/138 (50%), Gaps = 18/138 (13%)
Query: 586 LILEYMPNKSLDVYL---FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642
L++EY P L L D + + + +A+ +L +H ++ +HRD+K
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--------LAELVLAIHSVHQMGYVHRDIK 129
Query: 643 ASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY--ALDG----LFSI 696
NVL+D+ + K++DFG A +++ N+K VGT Y++PE ++G + +
Sbjct: 130 PENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGV 188
Query: 697 KSDVFSFGILMLETLSSR 714
+ D +S G++ E + R
Sbjct: 189 ECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 2e-06
Identities = 37/123 (30%), Positives = 60/123 (48%), Gaps = 17/123 (13%)
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK-RLLDWEARIR-IIQGIAQGL 625
+ N +++ +LI++Y+ D LFD +KK L EA ++ II+ + + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLS-EAEVKKIIRQLVEAL 122
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
LH++ IIH D+K NVL D+ + + D+GL ++ G GT Y
Sbjct: 123 NDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYF 173
Query: 685 SPE 687
SPE
Sbjct: 174 SPE 176
|
Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 60/238 (25%)
Query: 521 LGEGGFGPVYKGRLF----NGQEVAVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLV 572
+G G FG V RL G A+K+L + Q + + E ++AE + +V
Sbjct: 9 IGRGAFGEV---RLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVV 64
Query: 573 RILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLL-DWEARIRIIQGIAQGLLYLH 629
++ Q E LI+EY+P + L +KK + E R I A+ +L +
Sbjct: 65 KLY--YSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYI----AETILAID 115
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGL------------ARMFGGD--------- 668
+L IHRD+K N+LLD + K+SDFGL R+
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 669 -------ELQGNTKR--------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
KR VGT Y++PE L ++ + D +S G++M E L
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 559 EMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
E ++ + H +++++ G LIL P D+Y + K+ + + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLIL---PRYKTDLYCYLAAKRNIAICDI-LAIE 188
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
+ + + + YLH+ RIIHRD+KA N+ ++ + + DFG A F D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GT +PE + D++S GI++ E
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFE 275
|
Length = 391 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 40/216 (18%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS------SQSGQGLKEFKNEMMLIAELQHRNLVR 573
+G+G +G V G++VA+K+++ S + + L+E K L+ L+H ++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIK----LLRLLRHPDIVE 63
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYL-FDPIKKRL---------LDWEARIRIIQGIAQ 623
I K ++L + D+Y+ F+ ++ L L E + + +
Sbjct: 64 I---------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDELQGNTKRIVGTYG 682
L Y+H + + HRDLK N+L + D KI DFGLAR F V T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 683 YMSPEYALDGLFSIKS----DVFSFGILMLETLSSR 714
Y +PE L G F K D++S G + E L+ +
Sbjct: 172 YRAPE--LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 7e-06
Identities = 32/100 (32%), Positives = 52/100 (52%), Gaps = 16/100 (16%)
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM---------FGG----DELQ 671
L YLH Y I+HRDLK N+L+ + K++DFGL+++ + G D +
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
K++ GT Y++PE L + D ++ GI++ E L
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 52/209 (24%), Positives = 100/209 (47%), Gaps = 17/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
E+F + +G G FG V +L N +V A+K L+ E F+ E ++ +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+ + + ++ L+++Y L + L + RL + AR + A+ ++ +
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDL-LTLLSKFEDRLPEDMARFYL----AEMVIAI 115
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFG-LARMFGGDELQGNTKRIVGTYGYMSPE 687
+L +HRD+K N+L+D + + +++DFG ++ +Q + VGT Y+SPE
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA--VGTPDYISPE 173
Query: 688 Y--ALD---GLFSIKSDVFSFGILMLETL 711
A++ G + + D +S G+ M E L
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGI 621
L++++ H +L + G CV E I++ E++ + LDV L + + W +I + Q +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDK-----DMNP--KISDFGLARMFGGDELQGNT 674
A L YL + ++H ++ A N+LL + +P K+SD G++ F +
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS--FTALSREERV 181
Query: 675 KRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
+RI +++PE G S +D +SFG +LE
Sbjct: 182 ERI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 42/171 (24%), Positives = 66/171 (38%), Gaps = 51/171 (29%)
Query: 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645
LI+E++P L L IK E R +A+ +L + +L IHRD+K N
Sbjct: 78 LIMEFLPGGDLMTML---IKYDTFS-EDVTRFY--MAECVLAIEAVHKLGFIHRDIKPDN 131
Query: 646 VLLDKDMNPKISDFGLA-------------RMFGGDELQ-GNTKR--------------- 676
+L+D+ + K+SDFGL+ ++ G + R
Sbjct: 132 ILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSK 191
Query: 677 ----------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
VGT Y++PE L + + D +S G +M E L
Sbjct: 192 DQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-05
Identities = 54/217 (24%), Positives = 103/217 (47%), Gaps = 51/217 (23%)
Query: 521 LGEGGFGPVYKGRLFNGQE-VAVKRLSSQSGQGLKEFKN-EMMLIAELQHRNLVRILGC- 577
+G G FG VY+ + E VA+K++ ++KN E++++ L H N++ +
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYY 128
Query: 578 ---CVEQGEKIL----ILEYMP-------------NKSLDVYLFDPIKKRLLDWEARIRI 617
C ++ EK + ++E++P N +L ++L +L ++
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLV-----KLYSYQ----- 178
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLAR-MFGGDELQGNTK 675
+ + L Y+H S+ I HRDLK N+L+D + + K+ DFG A+ + G Q +
Sbjct: 179 ---LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG---QRSVS 229
Query: 676 RIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETL 711
I + Y +PE L ++ D++S G ++ E +
Sbjct: 230 YICSRF-YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 586 LILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643
+++EYMP L + +D +K W AR A+ +L L + IHRD+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK----W-ARFYT----AEVVLALDAIHSMGFIHRDVKP 170
Query: 644 SNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY----ALDGLFSIKSD 699
N+LLDK + K++DFG + + VGT Y+SPE DG + + D
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229
Query: 700 VFSFGILMLETL 711
+S G+ + E L
Sbjct: 230 WWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 29/83 (34%), Positives = 48/83 (57%), Gaps = 14/83 (16%)
Query: 586 LILEYMPN---KSL-DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL 641
L++EY+ KSL +Y + D E ++ I +A L YLH++ IIHRDL
Sbjct: 81 LVMEYLIGGDVKSLLHIYGY-------FDEEMAVKYISEVALALDYLHRHG---IIHRDL 130
Query: 642 KASNVLLDKDMNPKISDFGLARM 664
K N+L+ + + K++DFGL+++
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 49/239 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVA-------VKRLSSQSGQGLKEFKNEMMLIAE 565
E+F +G G FG V RL ++ +++ + + + E ++ E
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+V++ ++ LI+E++P + L +KK L E I A+ +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYI---AETV 111
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE---------------- 669
L + +L IHRD+K N+LLD + K+SDFGL
Sbjct: 112 LAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 670 -LQG-NTKR---------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
Q N+KR VGT Y++PE + ++ D +S G++M E L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 3e-04
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 39/159 (24%)
Query: 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645
LI+E++P + L +KK L EA I + +HQ L IHRD+K N
Sbjct: 78 LIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDN 131
Query: 646 VLLDKDMNPKISDFGLARMFGGDE-----------------LQG-NTKR----------- 676
+LLD + K+SDFGL Q N+KR
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 677 ----IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
VGT Y++PE + ++ D +S G++M E L
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 42/223 (18%)
Query: 517 MQCKLGEG--GFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+Q ++G G VY R G V V+ L + + + LK +NE++L +H N+
Sbjct: 2 LQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI 61
Query: 572 VRILGCCVEQGEKILILEYM----PNKSLDVYLFDPIKKRLLDWEARIR-IIQGIAQGLL 626
+ +I +M N L Y + + EA I I+ G +GL
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS------EALIGNILFGALRGLN 115
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL-----QGNTKRIVGTY 681
YLHQ IHR++KAS++L IS GL + G L G ++V +
Sbjct: 116 YLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164
Query: 682 --------GYMSPEYALDGL--FSIKSDVFSFGILMLETLSSR 714
++SPE L +++KSD++S GI E + R
Sbjct: 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 12/150 (8%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILG 576
+G G FG V R + + A+K L K E ++AE + +V++
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWE-ARIRIIQGIAQGLLYLHQYSRLR 635
++ +++Y+P + L I+ + + + AR I + + + +H ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLL---IRLGIFEEDLARFYIAE-LTCAIESVH---KMG 121
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMF 665
IHRD+K N+L+D+D + K++DFGL F
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 54/246 (21%), Positives = 95/246 (38%), Gaps = 67/246 (27%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILG 576
LG G FG V R + + + A+K L + + K E ++AE + +VR+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG------IAQGLLYLHQ 630
++ +++Y+P + L R+ I IA+ +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLI------------RMGIFPEDLARFYIAELTCAVES 116
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG------------------------ 666
++ IHRD+K N+L+D+D + K++DFGL F
Sbjct: 117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNE 176
Query: 667 ---------GDELQGNTKR------------IVGTYGYMSPEYALDGLFSIKSDVFSFGI 705
GD L+ +R +VGT Y++PE L ++ D +S G+
Sbjct: 177 WGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236
Query: 706 LMLETL 711
++ E L
Sbjct: 237 ILYEML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 54/242 (22%), Positives = 96/242 (39%), Gaps = 59/242 (24%)
Query: 521 LGEGGFGPVYKGRLFNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILG 576
LG G FG V + + A+K L + + + K E ++AE + +V++
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68
Query: 577 CCVEQGEKILILEYMPNKSLDVYL--FDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
++ +++Y+P + L + + L AR I A+ L + ++
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYI----AELTLAIESVHKM 120
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFG---------------------------- 666
IHRD+K N+L+D D + K++DFGL F
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 667 -----GDELQGNTKR------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
GD L+ +R +VGT Y++PE L ++ D +S G+++ E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 710 TL 711
L
Sbjct: 241 ML 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 28/78 (35%), Positives = 43/78 (55%), Gaps = 8/78 (10%)
Query: 521 LGEGGFGPVYKGRLFN-GQE-----VAVKRLSSQSGQGLKE-FKNEMMLIAEL-QHRNLV 572
LG G FG V + F G+E VAVK L + + +E +E+ +++ L QH+N+V
Sbjct: 46 LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105
Query: 573 RILGCCVEQGEKILILEY 590
+LG C G ++I EY
Sbjct: 106 NLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 14/157 (8%)
Query: 558 NEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI 617
+E L+ L H ++ +L V G L+L P D+Y + + R L
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLVL---PKYRSDLYTYLGARLRPLGLAQ---- 261
Query: 618 IQGIAQGLL----YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673
+ +A+ LL Y+H IIHRD+K NVL++ + + DFG A G
Sbjct: 262 VTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318
Query: 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLET 710
I GT +PE ++ D++S G+++ E
Sbjct: 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 36/156 (23%), Positives = 61/156 (39%), Gaps = 28/156 (17%)
Query: 529 VYKGRLFNGQEVAVK--RLSSQSGQGLKE-------FKNE----MMLI---AELQHRNLV 572
VY +G+ VAVK R S+ + ++ F+N L+ A + RNL
Sbjct: 64 VYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLK 123
Query: 573 RILGCCVEQGEKI------LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
R V E I L++E++ + L + L + E + + + + +
Sbjct: 124 RAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAE---GLYEDVVEYMR 180
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
L Y ++H DL N+L+ P I D A
Sbjct: 181 RL--YKEAGLVHGDLSEYNILVHDG-EPYIIDVSQA 213
|
Length = 268 |
| >gnl|CDD|221289 pfam11883, DUF3403, Domain of unknown function (DUF3403) | Back alignment and domain information |
|---|
Score = 36.1 bits (84), Expect = 0.003
Identities = 15/43 (34%), Positives = 24/43 (55%), Gaps = 1/43 (2%)
Query: 793 LPFPKKLTFVKGKNVKNSSYSTSG-TSEICSVNDVTVSLVSPR 834
+P PK+ F G++ + S+S E +VN VTVS++ R
Sbjct: 6 IPQPKQPGFCVGRSPYETDSSSSTQRDESWTVNQVTVSVIDAR 48
|
This domain is functionally uncharacterized. This domain is found in eukaryotes. This presumed domain is about 50 amino acids in length. This domain is found associated with pfam00069, pfam08276, pfam00954, pfam01453. Length = 48 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.98 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.77 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.7 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.33 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.17 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.09 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.69 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.65 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.45 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.41 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.4 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.29 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.26 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.19 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.16 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.15 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.07 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.07 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.01 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.97 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.96 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.73 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.71 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.68 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.57 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.5 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.45 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.29 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.25 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.12 | |
| PF11883 | 48 | DUF3403: Domain of unknown function (DUF3403); Int | 97.05 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.05 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.03 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.83 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.77 | |
| PLN02236 | 344 | choline kinase | 96.69 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.52 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.36 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.03 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.91 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.71 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.62 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-53 Score=460.03 Aligned_cols=288 Identities=44% Similarity=0.733 Sum_probs=254.6
Q ss_pred CcCcccHHHHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEE
Q 003274 499 WLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578 (834)
Q Consensus 499 ~l~~~~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 578 (834)
....|++.++..||++|...+.||+|+||.||+|.+.+|+.||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999998765543156699999999999999999999999
Q ss_pred EeCC-eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 579 VEQG-EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 579 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
.+.+ +++||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...++|+||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875444 89999999999999999999999988899999999999999999999999
Q ss_pred ccccceecCCCCccCCceee-eccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCC-CCccccccchhhhh
Q 003274 658 DFGLARMFGGDELQGNTKRI-VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN-TDSFNLLGHAWDLW 735 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~-~~~~~~~~~~~~~~ 735 (834)
|||+|+...... ...... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+... .....+..|++..+
T Consensus 220 DFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 220 DFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred CccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999997654311 111112 79999999999999999999999999999999999999887654 34455788888888
Q ss_pred cccccccccccccccCCCCH-HHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 736 KHERVHELMDPVILQDEIPL-PMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+..+++|+.+.....+. .+...+..++.+|++.+|++||+|.||+++|+.+
T Consensus 298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 88899999999986455554 6888899999999999999999999999999665
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=398.02 Aligned_cols=262 Identities=33% Similarity=0.515 Sum_probs=215.0
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcc--cHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-eEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAELQHRNLVRILGCCVEQG-EKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E 589 (834)
+++.+.+.||+|+||+||+|.......||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 344555679999999999999765555999999765322 2568999999999999999999999999988 7999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-CeeecccccceecCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~ 668 (834)
||++|+|..+++.. ....+++..+++++.|||+||.|||++++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999999754 56789999999999999999999999874 99999999999999997 9999999999886543
Q ss_pred CccCCceeeeccCcccCceeec--CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYAL--DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~--~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
. ...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||..... . +. +... +...
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-~~---~~~v-----~~~~--- 262 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-QV---ASAV-----VVGG--- 262 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-HH---HHHH-----HhcC---
Confidence 2 2233368999999999999 56999999999999999999999999875443 1 00 0000 0111
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 794 (834)
.+...+......+..++.+||+.||++||++.+++.+|+.+.....
T Consensus 263 --~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 263 --LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred --CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1233344467788999999999999999999999999987754443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=396.82 Aligned_cols=255 Identities=33% Similarity=0.500 Sum_probs=216.1
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+.+...+.||+|.||.|+.|+++....||+|.++.. ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 455667899999999999999988889999999765 3455789999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
.|+|.++|.. ..+..+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+.+.++.+..
T Consensus 285 ~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 285 KGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 9999999965 35677999999999999999999999998 9999999999999999999999999999766555433
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.. ...-+..|.|||.+..+.++.|||||||||+||||+| |+.|++.....+ +.+.++... +-
T Consensus 361 ~~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---------------v~~~le~Gy-Rl 423 (468)
T KOG0197|consen 361 SE-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---------------VLELLERGY-RL 423 (468)
T ss_pred cC-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---------------HHHHHhccC-cC
Confidence 22 2344789999999999999999999999999999999 666765433211 222222222 22
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..|..++.++++||..||+.+|++|||+..+...|+.+
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 34556788999999999999999999999999999876
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-46 Score=416.85 Aligned_cols=259 Identities=31% Similarity=0.469 Sum_probs=221.1
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
+.+....+.||+|+||.||+|+.. +.+.||||.++..... ..++|++|+++++.++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 456677889999999999999843 3567999999887665 678999999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhccccc-------c----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC
Q 003274 585 ILILEYMPNKSLDVYLFDPI-------K----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 653 (834)
+||+|||.+|+|.+||.... . ..+|+..+.+.||.|||.||.||-++. +|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999995321 1 234889999999999999999999887 999999999999999999
Q ss_pred eeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchh
Q 003274 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 732 (834)
|||+||||++.+...++......-.-+.+|||||.|..++||++||||||||+||||++ |+.|+.....++
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-------- 713 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-------- 713 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--------
Confidence 99999999999988887766555566889999999999999999999999999999998 777766544332
Q ss_pred hhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 733 DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.+.+..... -..|..++.++++||..||+.+|++||+++||-..|+..
T Consensus 714 -------VIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~ 762 (774)
T KOG1026|consen 714 -------VIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW 762 (774)
T ss_pred -------HHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence 2222222221 245666788999999999999999999999999999876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=365.19 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=207.2
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-eEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-EKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~Ey 590 (834)
+++..+.||+|..|+|||++++ .++.+|+|.+... .+...+++.+|++++++.+||+||.++|.|...+ +..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4455679999999999999975 5778999999544 3445678999999999999999999999999999 59999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|++|+|+.++. ..+.+++..+.+|+.+|++||.|||+.. +||||||||+||||+..|++||+|||.+..+.+.
T Consensus 160 MDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999984 3366899999999999999999999632 4999999999999999999999999999987654
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc-
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL- 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 749 (834)
....++||..|||||.+.+..|+.++||||||+.|+|+..|+.|+........ ...++++....
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-------------~~~~Ll~~Iv~~ 297 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-------------DIFELLCAIVDE 297 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-------------CHHHHHHHHhcC
Confidence 23447899999999999999999999999999999999999999865421111 11222222221
Q ss_pred -cCCCCH-HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 -QDEIPL-PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 -~~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....|. ....++..++..||+.||.+||++.|+++
T Consensus 298 ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 298 PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 122333 36789999999999999999999999976
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=385.38 Aligned_cols=246 Identities=28% Similarity=0.424 Sum_probs=214.4
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
..|...+.||+|||+.+|+++. ..|+.||+|++.+. .....+...+|+++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999996 88999999999763 4556778999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|+|.+++|.+++. +++.+.+.++..+++||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999883 5678999999999999999999999998 999999999999999999999999999998755
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
... ...++|||.|.|||++....++..+||||+||+||-||.|++||+...-. +..+...
T Consensus 172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk------------------ety~~Ik 231 (592)
T KOG0575|consen 172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK------------------ETYNKIK 231 (592)
T ss_pred ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH------------------HHHHHHH
Confidence 433 33479999999999999999999999999999999999999999753211 1111111
Q ss_pred -ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 -LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.....|.....+..+||.++|+.||.+|||+++|+.
T Consensus 232 ~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 232 LNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred hcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 022345567788899999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=363.20 Aligned_cols=201 Identities=30% Similarity=0.549 Sum_probs=180.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.+|.+.+.||+|+||+||+|++. .+..||||.+... ..+..+.+..|+.+|+.++|||||++++++..++..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 67888889999999999999964 5789999998765 55566778999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC------CCeeecccccce
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD------MNPKISDFGLAR 663 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~------~~~kl~DFGla~ 663 (834)
||.+|+|..|++ +.+.+++.....+++|||.||++||+++ ||||||||+||||+.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~---~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIR---RRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999994 4557999999999999999999999998 9999999999999865 458999999999
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCC
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT 722 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~ 722 (834)
.+..... ....+|++-|||||++..++|+.|+|+||+|++|||+++|+.||.....
T Consensus 164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9875443 2347999999999999999999999999999999999999999985443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=361.05 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=200.8
Q ss_pred hcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcc-------cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQ-------GLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
.+.|.+.+.||+|+||.|-+|. ...|+.||||++++..-. ......+|+++|++|+|||||++++++.....
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3678888999999999999997 467999999999764211 12235689999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC---CCeeecccc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFG 660 (834)
.||||||+++|.|.+++- ..+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 251 ~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred eEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 999999999999998883 4456777777889999999999999998 9999999999999765 789999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCC---CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
+|+..+... .+..++||+.|.|||++.+.. +..++|+||+||+||-+|+|.+||.....+.. ..+.+..
T Consensus 325 lAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~eQI~~ 396 (475)
T KOG0615|consen 325 LAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKEQILK 396 (475)
T ss_pred hhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHHHHhc
Confidence 999876433 344579999999999998664 33588999999999999999999975433220 0000001
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
++.. . ....-....++..++|.+||..||++||++.|+++
T Consensus 397 G~y~--f-----~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYA--F-----GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Cccc--c-----cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 1100 0 01112234678899999999999999999999964
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=386.32 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=220.3
Q ss_pred cCcccccccccCCcEeEEEEEecC----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
....++++||.|.||.|++|+++- ...||||.|+... +++...|+.|+.||.++.||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 356778999999999999998642 3479999998764 55678899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
.|||+||+|+.||+. +.+.+.+.++..++++||.||+||-+.+ +|||||.++|||++.+..+|++||||+|.+.+
T Consensus 709 TEyMENGsLDsFLR~--~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhh--cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999954 4466999999999999999999999888 99999999999999999999999999998866
Q ss_pred CCccCCc-eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 668 DELQGNT-KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 668 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
+.....+ ..-.-+.+|.|||.|...++|.++|||||||+|||.++ |.+|+-....+ ++...+.
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---------------dVIkaIe 848 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------------DVIKAIE 848 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---------------HHHHHHH
Confidence 5422222 11233689999999999999999999999999999887 77775432221 1222222
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPK 797 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~ 797 (834)
..+ +-..|.+++..|++||+.||+.|-.+||.+.+|+..|++++.+..+-+
T Consensus 849 ~gy-RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk 899 (996)
T KOG0196|consen 849 QGY-RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLK 899 (996)
T ss_pred hcc-CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhc
Confidence 222 345677889999999999999999999999999999999876555444
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=348.82 Aligned_cols=255 Identities=26% Similarity=0.422 Sum_probs=208.3
Q ss_pred cCcccccccccCCcEeEEEEE-ecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEE-EEEeCCe-EEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILG-CCVEQGE-KILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~-~~~~~~~-~~lV 587 (834)
.+|.+.++||+|.||+|||+. +.+|..+|.|.++-. ..+..+.+..|+.+|++|+|||||++++ .+.++.+ .+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 568889999999999999997 678999999988643 3445677899999999999999999998 5556555 8999
Q ss_pred EEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 588 LEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSR-LRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~-~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
||||..|+|..++.... .++.+++..+++++.|+++||.++|++-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986533 35678999999999999999999998432 23899999999999999999999999999998
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....... ...+|||.||+||.+.+..|+.|+||||+||++|||+.-++||...+ +.. +..
T Consensus 179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~-------------L~~ 238 (375)
T KOG0591|consen 179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLS-------------LCK 238 (375)
T ss_pred cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHH-------------HHH
Confidence 7654333 34789999999999999999999999999999999999999987531 111 000
Q ss_pred cccccCC---CC-HHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 746 PVILQDE---IP-LPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 746 ~~~~~~~---~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.+.+.+ .| ...+..+.++|..|+..||+.||+...++..+..
T Consensus 239 -KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 239 -KIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -HHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 011122 22 4557899999999999999999996555555443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=356.69 Aligned_cols=240 Identities=25% Similarity=0.360 Sum_probs=203.7
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
-++|++.++||+|+||.||.++. +.++.+|+|++++.. ....+..++|..+|.+++||.||+++..|++.+++|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 47899999999999999999985 457899999997652 34567889999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+||+.||.|..+| .+.+.+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999998 45667899999999999999999999998 99999999999999999999999999996543
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. ..+..++||+.|||||++.+..|+..+|.||||+++|||++|.+||...+.. ++.+..
T Consensus 178 ~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------------------~~~~~I 237 (357)
T KOG0598|consen 178 DG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------------------KMYDKI 237 (357)
T ss_pred CC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------------------HHHHHH
Confidence 32 2344589999999999999999999999999999999999999998743321 111111
Q ss_pred ccc--CCCCHHHHhHHHHHHHhccccCCCCCC
Q 003274 748 ILQ--DEIPLPMLMRYVNVALLCVQENAADRP 777 (834)
Q Consensus 748 ~~~--~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
... ...+.....+..+++...|..||++|.
T Consensus 238 ~~~k~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 238 LKGKLPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred hcCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 111 123333567889999999999999995
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=395.04 Aligned_cols=260 Identities=30% Similarity=0.500 Sum_probs=217.6
Q ss_pred hcCcccccccccCCcEeEEEEEecC--cc----EEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN--GQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~--~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++.+..+.||+|+||.||+|...+ +. .||||.+++. +.+...+|.+|..+|++++|||||+++|+|.+.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566778899999999999998533 33 4899999775 456678899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 585 ILILEYMPNKSLDVYLFDPIK----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
++++|||++|+|..||.+.+. ...+...+++.++.|||+|+.|||+++ +|||||.++|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999975422 456899999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
||+.+...++........-+..|||||.+..+.++.|+|||||||+||||+| |..|+......+. .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~----------- 914 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--L----------- 914 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--H-----------
Confidence 9998877776655554455679999999999999999999999999999999 6677664332110 0
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
...+... +-..|..++..+++||..||+.+|++||++..+++.+..+.
T Consensus 915 -~~~~~gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~ 962 (1025)
T KOG1095|consen 915 -LDVLEGG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAIS 962 (1025)
T ss_pred -HHHHhCC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhh
Confidence 0011111 22456678889999999999999999999999999888764
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=360.83 Aligned_cols=267 Identities=25% Similarity=0.426 Sum_probs=218.8
Q ss_pred HHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCccc-HHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
..+..+.+.++||+|.||.|..+....+.+||||+++...... ..+|.+|+++|.+++|||||+|+|+|..++.+++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3456778889999999999999999888999999998875444 488999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|||++|+|..|+...... .+.-+..++|+.|||.||+||.+.+ +|||||.++|+|++.++++||+|||+++.+...
T Consensus 615 EYmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 999999999999543222 2455667789999999999999987 999999999999999999999999999988777
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc--CCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
++.....+.+-+.+|||||.+..++++.++|||+||++|||+++ ..+|++...++. .++..-...........
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vven~~~~~~~~~~~~~--- 765 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VVENAGEFFRDQGRQVV--- 765 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HHHhhhhhcCCCCccee---
Confidence 77666666778899999999999999999999999999999876 456766443322 12211112211111111
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...|.-++..++++|.+||..+.++||+++++...|.+.
T Consensus 766 ----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112334567889999999999999999999999988764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=331.73 Aligned_cols=263 Identities=22% Similarity=0.349 Sum_probs=204.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcc--cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
+.|+...++|+|+||+|||++.+ .|+.||||++....+. -.+-.++|+++|++++|+|+|.|+.+|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 56777889999999999999965 5899999999765432 23457899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||+..-|+++- .....++.+.+.+++.|+++|+.|+|+++ |+||||||+||||+.++.+||||||.|+.+...
T Consensus 82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 99998887664 34456889999999999999999999998 999999999999999999999999999988632
Q ss_pred ccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCC-Ccccccc--------chhhhhcccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNT-DSFNLLG--------HAWDLWKHER 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~-~~~~~~~--------~~~~~~~~~~ 739 (834)
....+..+.|..|.|||.+.+ .+|...+||||+||++.||++|.+.+....+ +....+. ...+++....
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 122334678999999999987 7899999999999999999999998875443 2211111 1111111111
Q ss_pred -ccccccc-----ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 -VHELMDP-----VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 -~~~~~~~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+.-| .-+...++ ....-+.+++..||+.||.+|++-++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1111111 11111111 12347889999999999999999999875
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.54 Aligned_cols=270 Identities=28% Similarity=0.387 Sum_probs=212.2
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhc--CCCceeeEEEEEEeCC----eEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL--QHRNLVRILGCCVEQG----EKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~~----~~~l 586 (834)
+...+.++||+|.||.||||.+.+ +.||||++.. +..+.|.+|-++.... +|+||++++++-.... +..|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 445667899999999999999864 9999999964 4556788888888765 8999999999987666 8899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY------SRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~------~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
|+||.+.|+|.++| +...++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999998 667899999999999999999999964 35789999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCC-CC-----ccccchhhHHHHHHHhcCCCCCCCCCCCccccccc--hh
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS-----IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH--AW 732 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-----~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~--~~ 732 (834)
+|..+...........-+||.+|||||++.+.. +. .+.||||+|.|||||++..........+++++... ..
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 999987666555555578999999999997653 22 57999999999999999876654322233322111 00
Q ss_pred -----hhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 733 -----DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 733 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
......-+.+..+|.+.........+..+++.+..||+.||+.|.|+.-|-+++.++.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 0111111222333333223333456788999999999999999999999999998773
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=351.37 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=210.3
Q ss_pred HhcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 585 (834)
...+|.+.+.||+|+|++|++++ ...++++|||++.+. .+...+-...|-.+|.+| .||.|++|+..|.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34789999999999999999998 456899999998654 233345567789999999 8999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+|+||+++|+|.++|. +.+.+++.....++.+|+.||.|||+.| ||||||||+|||||+|+++||.|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999994 4577999999999999999999999998 999999999999999999999999999988
Q ss_pred CCCCcc---------CCc--eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 666 GGDELQ---------GNT--KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 666 ~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
...... ... ..++||..|.+||++.++..+..+|+|+|||+||+|+.|.+||...++-. .
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl--i------- 295 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL--I------- 295 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--H-------
Confidence 543221 112 45899999999999999999999999999999999999999997543211 0
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..++++- .-.++....+.+.+|+.+.|..||++|++..+|-+
T Consensus 296 -----FqkI~~l---~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 296 -----FQKIQAL---DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred -----HHHHHHh---cccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1111111 22344455578899999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=355.33 Aligned_cols=267 Identities=28% Similarity=0.428 Sum_probs=211.8
Q ss_pred HHHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
.+..+.-+.+.+.+.||+|.||+||+|++. ..||||+++.. .++..+.|++|+..+++-+|.||+-+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 344445567778899999999999999865 36999999765 34567899999999999999999999999999877
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.+|..+|++.+|..+|+.. +..++....+.|++|||+||.|||.++ |||||||+.||||.+++.|||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999754 356888999999999999999999998 9999999999999999999999999987
Q ss_pred ecCCCCccCCceeeeccCcccCceeecC---CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
.-..-.-........|...|||||+++. .+|++++||||||+++|||++|..|+.. ...+. ++.. -++-
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dq-Iifm------VGrG 608 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQ-IIFM------VGRG 608 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhh-eEEE------eccc
Confidence 5422111112222357789999999974 4799999999999999999999999872 22221 1111 1111
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLN 792 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
.-..|.. .....+..++.+|+..||..++++||.+.+|+.+|+++...
T Consensus 609 ~l~pd~s----~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 609 YLMPDLS----KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccCccch----hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111111 22334567889999999999999999999999999877443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=357.59 Aligned_cols=262 Identities=27% Similarity=0.397 Sum_probs=205.0
Q ss_pred HhcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 582 (834)
..++|.+.++||+|+||.||+|.. ..++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 457899999999999999999973 235689999987543 23346789999999999 8999999999987654
Q ss_pred -eEEEEEEecCCCCcchhcccccc--------------------------------------------------------
Q 003274 583 -EKILILEYMPNKSLDVYLFDPIK-------------------------------------------------------- 605 (834)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------------------------- 605 (834)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999988853211
Q ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCc
Q 003274 606 ---KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682 (834)
Q Consensus 606 ---~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (834)
...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 134788899999999999999999987 99999999999999999999999999987643322222223356788
Q ss_pred ccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHH
Q 003274 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRY 761 (834)
Q Consensus 683 y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 761 (834)
|+|||++.+..++.++|||||||+||||++ |..||........ + ........ ....+......+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~----~~~~~~~~----------~~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-F----CQRLKDGT----------RMRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-H----HHHHhcCC----------CCCCCCCCCHHH
Confidence 999999999999999999999999999997 8988864332110 0 00000000 001122345678
Q ss_pred HHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 762 VNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 762 ~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.+++.+||+.||++||++.|++++|+++.
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.63 Aligned_cols=287 Identities=26% Similarity=0.414 Sum_probs=216.8
Q ss_pred CCCCCCCcCcccHHHHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhh--cCCCc
Q 003274 493 DKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAE--LQHRN 570 (834)
Q Consensus 493 ~~~~~~~l~~~~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~n 570 (834)
.++..+.+|.+-...+. .+..+.+.||+|.||.|++|++ .|+.||||++....+ +.+.+|.++.+. |+|+|
T Consensus 194 tSGSGSGlplLVQRTia---rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHEN 266 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIA---RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHEN 266 (513)
T ss_pred cCCCCCCchhHhHHhhh---heeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccch
Confidence 33444566665444433 6788999999999999999985 589999999976543 456677777775 59999
Q ss_pred eeeEEEEEEeCC----eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHH-----hcCCCCeEecCC
Q 003274 571 LVRILGCCVEQG----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH-----QYSRLRIIHRDL 641 (834)
Q Consensus 571 iv~l~~~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-----~~~~~~ivH~Dl 641 (834)
|+.+++.-..+. .++||.+|.++|||.+|| ....++.+..++++..+|.||+||| .++++.|+||||
T Consensus 267 ILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl 342 (513)
T KOG2052|consen 267 ILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL 342 (513)
T ss_pred hhhhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence 999999877654 689999999999999998 4578999999999999999999999 468899999999
Q ss_pred CCCCEEeccCCCeeecccccceecCCC--CccCCceeeeccCcccCceeecCCC----CC--ccccchhhHHHHHHHhcC
Q 003274 642 KASNVLLDKDMNPKISDFGLARMFGGD--ELQGNTKRIVGTYGYMSPEYALDGL----FS--IKSDVFSFGILMLETLSS 713 (834)
Q Consensus 642 k~~NILl~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~t--~~sDVwSlGvll~elltG 713 (834)
|++|||+..++.+.|+|+|||...... .........+||.+|||||++.... +. ..+||||||.++||+...
T Consensus 343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR 422 (513)
T KOG2052|consen 343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR 422 (513)
T ss_pred ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999887544 2233344568999999999986542 22 569999999999998763
Q ss_pred CCCCC---CCCCCccccccchh--hhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 714 RKNTG---VYNTDSFNLLGHAW--DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 714 ~~p~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
...-+ .+..+.++++.... ...+..-..+.++|.+.......+.+..+.++|+.||..||..|-|+-.+-+.|.+
T Consensus 423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~ 502 (513)
T KOG2052|consen 423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAK 502 (513)
T ss_pred hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHH
Confidence 32111 01111111111111 11111122344455554555667788999999999999999999999999999987
Q ss_pred cc
Q 003274 789 EH 790 (834)
Q Consensus 789 ~~ 790 (834)
+.
T Consensus 503 l~ 504 (513)
T KOG2052|consen 503 LS 504 (513)
T ss_pred Hh
Confidence 73
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=340.33 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=202.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--eEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG--EKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~E 589 (834)
.++...+.||+|+||.||++... +|...|||.+........+.+.+|+++|.+++|||||+++|...... ..++.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45667789999999999999854 48999999987653333677899999999999999999999855554 6899999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeecccccceecCC-
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGG- 667 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~- 667 (834)
|+++|+|.+++.... ..+++..+.++..||++||+|||+++ |+||||||+||||+. ++.+||+|||+++....
T Consensus 97 y~~~GsL~~~~~~~g--~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYG--GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999984322 26999999999999999999999998 999999999999999 79999999999987764
Q ss_pred CCccCCceeeeccCcccCceeecCCC-CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
...........||+.|||||++.++. ...++|||||||++.||+||++|+... .+. ....... ...
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~---~~~~~~i---------g~~ 238 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEE---AEALLLI---------GRE 238 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cch---HHHHHHH---------hcc
Confidence 12222344578999999999999643 346999999999999999999998643 000 0000000 000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ...++.....+..+++.+|++.+|++|||+.++++.
T Consensus 239 ~~-~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 239 DS-LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CC-CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 00 124455567789999999999999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.06 Aligned_cols=263 Identities=31% Similarity=0.437 Sum_probs=209.6
Q ss_pred HhcCcccccccccCCcEeEEEEEecC--c---cEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN--G---QEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~--~---~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 582 (834)
..++..+.++||+|+||.||+|++.. + ..||||..+.. ......+|.+|+++|++++|||||+++|++....
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34666777999999999999998543 2 23899998752 3567789999999999999999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
.+++|||+|.+|+|+++|... ...++..++++++.++|+||+|||+++ ++||||.++|+|++.++.+||+||||+
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999532 236999999999999999999999998 999999999999999999999999998
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+.-. .+........-+..|+|||.+....|+.++|||||||++||+++ |..|+....... ...
T Consensus 310 ~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~-------- 373 (474)
T KOG0194|consen 310 RAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKA-------- 373 (474)
T ss_pred cCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHH--------
Confidence 7643 11111111235789999999999999999999999999999998 677765332110 000
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCC
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPF 795 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~ 795 (834)
.++.... .-..+...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus 374 kI~~~~~-r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 374 KIVKNGY-RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred HHHhcCc-cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 0001011 1223334567888899999999999999999999999887655443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=340.76 Aligned_cols=266 Identities=25% Similarity=0.357 Sum_probs=205.0
Q ss_pred hcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 586 (834)
.+.|+..++||+|.||.|||++ +..|+.||+|++.... +.......+|+.+|++|+||||++|.+...+. +.+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4678888999999999999998 5679999999987654 44556678999999999999999999999887 68999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+|||++ +|.-++. ...-.++..++..++.|++.||.|+|+.+ |+|||||.+|||||.+|.+||+|||||+++.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999987 5555552 22346889999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-c----cccc-hhhhhcccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-N----LLGH-AWDLWKHER 739 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~----~~~~-~~~~~~~~~ 739 (834)
.......+. .+-|..|.|||++.+. .|+.++|+||.||||.||+.|++.+....+-++ + +.+. ....|...+
T Consensus 270 ~~~~~~~T~-rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 270 PSGSAPYTS-RVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred CCCCccccc-ceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 665444443 4669999999999875 699999999999999999999999876543211 1 1110 011111001
Q ss_pred c--ccccccccc-cC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 V--HELMDPVIL-QD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~--~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+ ...+.+... .. +.-.......++|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 011111100 00 001123457789999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=314.17 Aligned_cols=279 Identities=27% Similarity=0.352 Sum_probs=211.3
Q ss_pred cCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcc--cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|...++||+|.||.||+|+ ...|+.||||+++..... -.....+|++.|+.++|+||+.+++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 457778899999999999998 467999999998765322 23467899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||+. +|...+.+ +...+...++..++.++.+|++|||++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 9965 78877754 4567899999999999999999999988 9999999999999999999999999999987654
Q ss_pred ccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcccccc--chhhhhcc---cccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG--HAWDLWKH---ERVHEL 743 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~--~~~~~~~~---~~~~~~ 743 (834)
..... .+-|..|.|||.+.+. .|+..+|+||.||++.||+-|.+.|....+ ..++.. .+.-.... ..+.++
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD-idQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD-IDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch-HHHHHHHHHHcCCCCcccCcccccc
Confidence 33222 2678999999998765 699999999999999999998887765432 222111 00000000 012222
Q ss_pred cccccccC-------CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCcccc
Q 003274 744 MDPVILQD-------EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFV 802 (834)
Q Consensus 744 ~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~~~~~ 802 (834)
.|....+. ..-......+.+++..|+..||.+|+++.|++++= -...+|.|-.+..+
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~--yf~~~P~pt~~~~l 296 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP--YFKSLPLPTPPSKL 296 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcch--hhhcCCCCCChhhC
Confidence 22211110 01112345679999999999999999999998752 12345665554444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.32 Aligned_cols=241 Identities=27% Similarity=0.442 Sum_probs=202.0
Q ss_pred ccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 003274 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
...+-||+|+.|.||.|++. ++.||||+++.-. ..+++-|++|+||||+.+.|+|....-++||||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 34568999999999999975 6899999986432 357788999999999999999999999999999999999
Q ss_pred cchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCce
Q 003274 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 675 (834)
|...|. .+..+.......+..+||.||.|||.+. |||||||+-||||..+..+||+|||-++..... ....
T Consensus 199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 999983 5567888999999999999999999986 999999999999999999999999999886543 2233
Q ss_pred eeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCH
Q 003274 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPL 755 (834)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (834)
.+.||..|||||+|.+.+.++|+|||||||||||||||..|+...+... + .|- +....+.-..|.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--I---IwG----------VGsNsL~LpvPs 334 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--I---IWG----------VGSNSLHLPVPS 334 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe--e---EEe----------ccCCcccccCcc
Confidence 4789999999999999999999999999999999999999975322110 0 000 111122334566
Q ss_pred HHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 756 PMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.++.-+.-|+++||+..|.+||++++++..|+=
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 677888999999999999999999999998853
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=342.62 Aligned_cols=264 Identities=27% Similarity=0.467 Sum_probs=203.0
Q ss_pred cCcccccccccCCcEeEEEEEecC-----------------ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRI 574 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 574 (834)
++|.+.++||+|+||.||++...+ +..||+|.+.... ......|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578888999999999999997432 3469999987643 3345679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCcchhccccc----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 003274 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPI----------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638 (834)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 638 (834)
++++.+.+..++||||+++|+|.+++.... ....+++..+++++.||++||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999998874321 1134788899999999999999999987 999
Q ss_pred cCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcC--CCC
Q 003274 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS--RKN 716 (834)
Q Consensus 639 ~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG--~~p 716 (834)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999876443322222334567899999999999999999999999999999974 445
Q ss_pred CCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 717 TGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
+...... ............... .. ....+......+.+++.+||+.+|++||++.+|.+.|++
T Consensus 242 ~~~~~~~--~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDE--QVIENAGEFFRDQGR-QV------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHH--HHHHHHHHHhhhccc-cc------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5433211 111111111110000 00 001122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.74 Aligned_cols=262 Identities=24% Similarity=0.374 Sum_probs=209.1
Q ss_pred hcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||.|..++||+|+ ...+..||||++... .....+.+++|+..|..++||||++++..|..+..+++||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4789999999999999999998 566799999999754 33446889999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||.+|++.+++..... ..+++..+..|++++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+....
T Consensus 105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 9999999999865433 34889999999999999999999998 9999999999999999999999999987664432
Q ss_pred ccC--CceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 670 LQG--NTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 670 ~~~--~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
... ....+.||+.|||||++.. ..|+.|+||||||++..||.+|..||..++.-..-+. .+... +....
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-----tLqn~-pp~~~- 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-----TLQND-PPTLL- 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-----HhcCC-CCCcc-
Confidence 111 1145689999999999654 3699999999999999999999999986553221111 11110 00000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
-.....+........+.+++..||+.||++|||+.++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 001111122233458899999999999999999999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=340.86 Aligned_cols=264 Identities=26% Similarity=0.363 Sum_probs=206.7
Q ss_pred HhcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHH--HHHHHHHHhhcC-CCceeeEEEEEEeCC-eEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE--FKNEMMLIAELQ-HRNLVRILGCCVEQG-EKI 585 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l~-H~niv~l~~~~~~~~-~~~ 585 (834)
..++|.+.++||.|.||.||+|+ ...+..||||+++..-.. +++ -++|+..|++|+ |||||+|.+++.+.. .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45789999999999999999998 566889999999765332 333 367999999998 999999999999988 999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+|||||+. +|.+++.+. .+.++++.+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+||.+
T Consensus 87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999965 777777543 778999999999999999999999998 999999999999999999999999999988
Q ss_pred CCCCccCCceeeeccCcccCceeec-CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc--cc---c-chhhhhccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN--LL---G-HAWDLWKHE 738 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~--~~---~-~~~~~~~~~ 738 (834)
.... ..+..+.|..|+|||++. .+.|+.+.|+||+||+++||.+-++.|...++-++. +. + ..++.+..+
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 6543 334467899999999975 668999999999999999999999988765432110 11 0 111111111
Q ss_pred -cccccccccc-------ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 739 -RVHELMDPVI-------LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 739 -~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.+...+.-.+ +..-.+ ....++.+++.+|+..||.+|||+.|.++.
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111111 011112 256789999999999999999999999873
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.43 Aligned_cols=284 Identities=21% Similarity=0.311 Sum_probs=226.1
Q ss_pred HHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 584 (834)
..-++|.+.++||+|+||+|+.+.++ +++.+|||.+++. ..+..+..+.|.+++... +||.++.|+.++...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34589999999999999999999865 4778999999876 356678889999999888 599999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+.+|++..+ .....+++.++..++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999995443 35578999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
--... ..+..++||+.|||||++.+..|+.++|.|||||+|||||.|..||...++++ +.
T Consensus 518 ~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------------------~F 577 (694)
T KOG0694|consen 518 GMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------------------VF 577 (694)
T ss_pred cCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------------------HH
Confidence 53222 34566899999999999999999999999999999999999999997544332 11
Q ss_pred ccccc-cCCCCHHHHhHHHHHHHhccccCCCCCCCH----HHHHH---HHhccc------CCCCCCCCccccccccccCC
Q 003274 745 DPVIL-QDEIPLPMLMRYVNVALLCVQENAADRPTM----SDVVS---MISNEH------LNLPFPKKLTFVKGKNVKNS 810 (834)
Q Consensus 745 ~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~---~L~~~~------~~l~~p~~~~~~~~~~~~~~ 810 (834)
|..+. ...+|...+.+...++.++|..+|++|.-+ .+.++ ++++|. .+++.|=.|.......++|.
T Consensus 578 dsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snF 657 (694)
T KOG0694|consen 578 DSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNF 657 (694)
T ss_pred HHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhccc
Confidence 11111 123566677899999999999999999876 33332 222221 45555555665555666655
Q ss_pred CCCCCCCCcc
Q 003274 811 SYSTSGTSEI 820 (834)
Q Consensus 811 ~~~~~~~~~~ 820 (834)
...-..+.|.
T Consensus 658 d~eFt~e~p~ 667 (694)
T KOG0694|consen 658 DEEFTSEKPA 667 (694)
T ss_pred chhhhcCCCc
Confidence 4443333333
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=344.81 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=209.2
Q ss_pred cCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
..|...++||+|+-|.||.++ ...++.||||++........+-+.+|+.+|+..+|+|||.++..+..+++++.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 456667899999999999997 5568899999998776666677899999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+.+ ....+++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 999998877 4456899999999999999999999998 99999999999999999999999999998765543
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....+||+.|||||+.....|++|+||||||++++||+-|.+||-. +... ...+. +.+..-..-
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln--E~Pl---rAlyL---------Ia~ng~P~l 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN--ENPL---RALYL---------IATNGTPKL 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC--CChH---HHHHH---------HhhcCCCCc
Confidence 33447899999999999999999999999999999999999999742 1100 00000 011111112
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+......+.+++.+||+.|+++||++.|+|+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 334456778999999999999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=343.97 Aligned_cols=245 Identities=29% Similarity=0.436 Sum_probs=209.6
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.+.||+|+||.||||+. .+.+.||+|.+.+. .++..+.+.+|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 6788889999999999999984 45788999998764 34567789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+.+ +|..+|. ....++++.+..|+.++..||.|||+.. |+|||+||+||||+.++.+|++|||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9988 9999883 4567999999999999999999999987 9999999999999999999999999999876533
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
...+.+.|||.|||||...+++|+..+|.||+||+|||+.+|++||-... +.+++.....
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------------------i~~Lv~~I~~ 214 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------------------ITQLVKSILK 214 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------------------HHHHHHHHhc
Confidence 34456789999999999999999999999999999999999999985211 1122222111
Q ss_pred -cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 -QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 -~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++...|+.||.+|.+-.+++.
T Consensus 215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 11344567789999999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.27 Aligned_cols=236 Identities=27% Similarity=0.377 Sum_probs=203.3
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|+..+.||.|+||.|..++.+ +|.-+|+|++++.. .++.+...+|..+|+.+.||+++++++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 67888999999999999999865 47789999997653 345667888999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|.|.++| ++.+.+++..+..++.+|+.||+|||+.+ |++|||||+|||||.+|.+||.|||.|+.+...
T Consensus 124 eyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999998 45677999999999999999999999998 999999999999999999999999999987543
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
+-.++|||.|+|||++....+..++|.|||||++|||+.|.+||.....-. . .+ .++..
T Consensus 198 -----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~--i----Y~--------KI~~~-- 256 (355)
T KOG0616|consen 198 -----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ--I----YE--------KILEG-- 256 (355)
T ss_pred -----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH--H----HH--------HHHhC--
Confidence 456899999999999999999999999999999999999999987543310 0 00 11111
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCC
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADR 776 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 776 (834)
+-.+|......+.+|+...|+.|-.+|
T Consensus 257 -~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 -KVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 224566667788999999999999998
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=336.86 Aligned_cols=244 Identities=19% Similarity=0.340 Sum_probs=198.3
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCccc---HHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEEEEEEec
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKILILEYM 591 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~ 591 (834)
..||+|++|.||+|+. +|+.||||+++...... .+.|.+|+.++.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999986 68899999997653332 5678899999999999999999999877 34678999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++|+|.+++.. ...+++...++++.+++.||+|||+. + ++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999843 35688999999999999999999984 5 7899999999999999999999999998654322
Q ss_pred cCCceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....... +... ..... .
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--~~~~---i~~~~-----~---- 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--IYDL---IINKN-----N---- 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--HHHH---HHhcC-----C----
Confidence 12357889999999976 689999999999999999999999987433211 1000 00000 0
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 240 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 240 -SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred -CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1112223456889999999999999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=350.64 Aligned_cols=260 Identities=28% Similarity=0.393 Sum_probs=204.3
Q ss_pred hcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
.++|.+.++||+|+||.||+++. ..+..||||+++... ....+.+.+|++++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 46788999999999999999963 235689999997543 23456788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccc----------------------------------------------------------
Q 003274 584 KILILEYMPNKSLDVYLFDPIK---------------------------------------------------------- 605 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 605 (834)
.++||||+++|+|..++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999988853210
Q ss_pred --------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 606 --------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 606 --------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124788999999999999999999987 999999999999999999999999999876543322
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.......++..|+|||++.+..++.++|||||||++|||++ |..|+.....+.. + ........ .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~----~~~~~~~~----------~ 335 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-F----YKMIKEGY----------R 335 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-H----HHHHHhCc----------c
Confidence 22222345678999999999999999999999999999998 7777754322110 0 01111100 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+.....++.+++.+||+.||++||++.||+++|++.
T Consensus 336 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 336 MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 011112345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=342.71 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=204.9
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC----Cc-ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ----SG-QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGE 583 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~ 583 (834)
....|.+.+.||+|+||.|+.|+. ..++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 346889999999999999999974 46799999977553 11 23456778999999998 9999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeecccccc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLA 662 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla 662 (834)
.++||||+.+|+|.+++. +.+.+.+.++.++++|++.|++|+|+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~---~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIV---NKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHH---HcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 999999999999999984 3567888999999999999999999998 9999999999999999 99999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCC-CC-ccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FS-IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
...... .......+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+...... +. ..
T Consensus 169 ~~~~~~--~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--l~----~k------ 234 (370)
T KOG0583|consen 169 AISPGE--DGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--LY----RK------ 234 (370)
T ss_pred cccCCC--CCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--HH----HH------
Confidence 987411 12334469999999999999877 76 88999999999999999999997522111 00 00
Q ss_pred ccccccccccCCCCHHH-HhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMDPVILQDEIPLPM-LMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+... .-.++... ..++..++.+||..||.+|+++.++++
T Consensus 235 ---i~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 235 ---IRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred ---HhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 0000 11223333 678899999999999999999999983
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=348.96 Aligned_cols=260 Identities=29% Similarity=0.426 Sum_probs=204.1
Q ss_pred hcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
.++|.+.++||+|+||.||+++. .++..||||+++... ....+.+.+|+++++.+ +|+||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 46788999999999999999873 234579999997543 23356788999999999 89999999999999999
Q ss_pred EEEEEEecCCCCcchhccccc-----------------------------------------------------------
Q 003274 584 KILILEYMPNKSLDVYLFDPI----------------------------------------------------------- 604 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 604 (834)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999998874321
Q ss_pred --------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCcee
Q 003274 605 --------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 605 --------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1124788899999999999999999987 99999999999999999999999999987643322111122
Q ss_pred eeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCH
Q 003274 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPL 755 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (834)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ . ..... ... ....+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~----~~~~~---------~~~-~~~~~~ 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-F----YKMVK---------RGY-QMSRPD 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-H----HHHHH---------ccc-CccCCC
Confidence 335678999999999999999999999999999997 9998864322110 0 00000 000 011111
Q ss_pred HHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 756 PMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.++.+++.+||+.||++||++.+|+++|+++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=353.14 Aligned_cols=269 Identities=24% Similarity=0.318 Sum_probs=215.6
Q ss_pred HHhcCcccccccccCCcEeEEEEEecCc-cEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEE-EEEeC-----
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLFNG-QEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILG-CCVEQ----- 581 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~-~~~~~----- 581 (834)
...-++++.++|.+|||+.||.+....+ .++|+|++-...+...+.+++|+++|++|+ |+|||.+++ .....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3456788999999999999999997665 999999998888889999999999999996 999999999 33221
Q ss_pred -CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 582 -GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
-+.+|+||||.+|.|-+++......+ |.+.++++|+.++++|+++||... ++|||||||-+||||+.+++.||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 36789999999999999986544444 999999999999999999999985 789999999999999999999999999
Q ss_pred cceecCCCCcc-CCc------eeeeccCcccCceee---cCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc
Q 003274 661 LARMFGGDELQ-GNT------KRIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH 730 (834)
Q Consensus 661 la~~~~~~~~~-~~~------~~~~gt~~y~aPE~~---~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 730 (834)
.+.-.-..... ... -....|+-|+|||.+ .+..+++|+|||+|||+||-|+....||+....
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------- 263 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------- 263 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------
Confidence 98653222110 000 012468999999987 578999999999999999999999999985422
Q ss_pred hhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc-CCCCCCCCc
Q 003274 731 AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH-LNLPFPKKL 799 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~-~~l~~p~~~ 799 (834)
..+++-.+ .-.........|.+||..||++||++||++-+|++.+-++. ...|.+..+
T Consensus 264 ----------laIlng~Y-~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 264 ----------LAILNGNY-SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ----------eeEEeccc-cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 11222222 11112356789999999999999999999999999887663 344444444
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=331.09 Aligned_cols=250 Identities=34% Similarity=0.547 Sum_probs=194.4
Q ss_pred cccccccCCcEeEEEEEec-----CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 517 MQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+.+.||.|.||.||+|++. .+..|+||.++... ....+.|.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999876 36789999996543 33478899999999999999999999999988889999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.++|... ....+++..+.+|+.||++||+|||+.+ ++|+||+++|||++.++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999998543 3457899999999999999999999987 99999999999999999999999999988733322
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
............|+|||.+....++.++||||||+++|||++ |+.|+..... .++.. .. .. ..
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~--~~~~~---~~-~~--------~~-- 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN--EEIIE---KL-KQ--------GQ-- 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH--HHHHH---HH-HT--------TE--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccc---cc-cc--------cc--
Confidence 222222456789999999999999999999999999999999 6777653321 11100 00 00 00
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
....+......+.+++..||+.+|++||++.++++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122333456789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=329.50 Aligned_cols=257 Identities=30% Similarity=0.495 Sum_probs=206.9
Q ss_pred cCcccccccccCCcEeEEEEEecC------ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|.... .+.+|+|.+.... ......|.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468888999999999999997533 2579999986543 234567899999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC
Q 003274 586 LILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~ 652 (834)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999998853211 145888999999999999999999987 99999999999999999
Q ss_pred CeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccch
Q 003274 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHA 731 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~ 731 (834)
.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||....... +.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--~~--- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--VI--- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH---
Confidence 999999999987654433333333456889999999999999999999999999999998 988875432211 00
Q ss_pred hhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 732 WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
+.+.... ....+...+.++.+++.+||+.||.+||++.||++.|++
T Consensus 237 ----------~~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 ----------EMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 0010000 111233456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=333.26 Aligned_cols=263 Identities=26% Similarity=0.394 Sum_probs=217.2
Q ss_pred HHHHHHHhcCcccccccccCCcEeEEEEEec---Ccc--EEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEE
Q 003274 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLF---NGQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCC 578 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~---~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~ 578 (834)
....+..++.....++||+|.||.||+|... .|. .||||..+.+ .....+.|+.|..+|++++|||||+|+|+|
T Consensus 381 ~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 381 VRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 3344556677788899999999999999732 233 6899999874 345678899999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecc
Q 003274 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658 (834)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 658 (834)
.+. ..++|||.++-|.|.++|. .++..++......++.||+.+|+|||+.. +|||||..+|||+....-+||+|
T Consensus 461 ~e~-P~WivmEL~~~GELr~yLq--~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 461 VEQ-PMWIVMELAPLGELREYLQ--QNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred ecc-ceeEEEecccchhHHHHHH--hccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecc
Confidence 875 7899999999999999994 35667899999999999999999999987 99999999999999999999999
Q ss_pred cccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcc
Q 003274 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
||+++.+..+.+.... ...-+..|||||.+.-..++.++|||.|||.+|||++ |.+||..-...+
T Consensus 535 FGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD------------- 600 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD------------- 600 (974)
T ss_pred cchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------------
Confidence 9999999877665544 3455789999999999999999999999999999887 888886533221
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
+.-.+... .+-..|..++..|+.++.+||..+|.+||.+.|+...|+.+.
T Consensus 601 --VI~~iEnG-eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~ 650 (974)
T KOG4257|consen 601 --VIGHIENG-ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL 650 (974)
T ss_pred --eEEEecCC-CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence 11111111 122456667889999999999999999999999988776654
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=378.96 Aligned_cols=260 Identities=24% Similarity=0.430 Sum_probs=207.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
..+...++||+|+||.||+|+. .++..||||++...... ...|++++++++|||||+++++|.+....++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999986 57899999998654322 235688999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+++. .++|..+.+++.|+|+||+|||.....+|+||||||+||+++.++..++. ||........
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--- 835 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--- 835 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---
Confidence 9999999983 37899999999999999999997655679999999999999999988875 6655433211
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
....+|+.|+|||++.+..++.++|||||||++|||++|+.|++...........+.............+++.+...
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 912 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence 12367899999999999999999999999999999999999985433323333334333333333344455544221
Q ss_pred -CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 752 -EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 752 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.....++.+++.+||+.+|++||+|.||++.|+++
T Consensus 913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~ 951 (968)
T PLN00113 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951 (968)
T ss_pred CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence 23445677889999999999999999999999999876
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=331.99 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=203.7
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
..++|++..+||+|+||.||.++. ..|..+|+|++++.. ..+.+..+.|-.+|....+|.||+|+..|.+...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 458999999999999999999984 558899999998753 3456778999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||++||++-.+| .+...|++..+..++.+++-|+..||+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999998 56788999999999999999999999998 9999999999999999999999999985431
Q ss_pred C----------------------CCccC-----C------------------ceeeeccCcccCceeecCCCCCccccch
Q 003274 667 G----------------------DELQG-----N------------------TKRIVGTYGYMSPEYALDGLFSIKSDVF 701 (834)
Q Consensus 667 ~----------------------~~~~~-----~------------------~~~~~gt~~y~aPE~~~~~~~t~~sDVw 701 (834)
. .+... . ....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 00010 0 0125799999999999999999999999
Q ss_pred hhHHHHHHHhcCCCCCCCCCCCcc--ccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC-
Q 003274 702 SFGILMLETLSSRKNTGVYNTDSF--NLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT- 778 (834)
Q Consensus 702 SlGvll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt- 778 (834)
|||||+||||.|.+||......+. .++-|.. .+ ......+...+..+||.+||. ||++|.-
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~---------~l------~fP~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE---------TL------KFPEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh---------hc------cCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999976543321 1111100 00 111112233688899999998 9999975
Q ss_pred --HHHHH
Q 003274 779 --MSDVV 783 (834)
Q Consensus 779 --~~evl 783 (834)
+.||-
T Consensus 437 ~G~~EIK 443 (550)
T KOG0605|consen 437 KGAEEIK 443 (550)
T ss_pred ccHHHHh
Confidence 55554
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=337.18 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=214.8
Q ss_pred HHHhcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 509 AAATENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 509 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+..+.++...++||-|.||.||.|.++. .-.||||.|+.. ....++|+.|+.+|+.++|||+|+|+|+|......|||
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 4445677888999999999999998754 568999999764 45678999999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
.|||..|+|.++|.+. ++..++.-.++.++.||+.||.||..++ +|||||.++|+|+.++..+||+||||++++..
T Consensus 342 TEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred EecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 9999999999999653 3445677788899999999999999888 99999999999999999999999999999977
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
+.+..... ..-++.|.|||-+....++.|+|||+|||+||||.| |-.|+...+ ...+..++..
T Consensus 418 DTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid---------------lSqVY~LLEk 481 (1157)
T KOG4278|consen 418 DTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID---------------LSQVYGLLEK 481 (1157)
T ss_pred CceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc---------------HHHHHHHHhc
Confidence 65543221 223678999999999999999999999999999998 445543221 1112233333
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.+ +-+.+..++..+++||+.||+.+|.+||++.|+-+.++.+.
T Consensus 482 gy-RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 482 GY-RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred cc-cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 22 22345567789999999999999999999999999887764
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=326.41 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=203.8
Q ss_pred hcCcccccccccCCcEeEEEEEec----CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 357888999999999999999753 35689999987653 2334678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRK--HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999998843 2346899999999999999999999987 9999999999999999999999999876543
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... ......++..|+|||.+.+..++.++|||||||++||+++ |+.|+....... ... ..... .
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~----~~~~~-----~- 225 (266)
T cd05064 159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIK----AVEDG-----F- 225 (266)
T ss_pred ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH----HHHCC-----C-
Confidence 22111 1112345678999999999999999999999999999875 998876432211 000 00000 0
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ----RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0112233456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=323.21 Aligned_cols=252 Identities=22% Similarity=0.353 Sum_probs=199.4
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc--------------ccHHHHHHHHHHHhhcCCCceeeEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--------------QGLKEFKNEMMLIAELQHRNLVRIL 575 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~H~niv~l~ 575 (834)
.-++|++.+.||+|.||.|-+++. .+++.||||++.+... ...+...+|+.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 347899999999999999999984 5688999999865321 1246789999999999999999999
Q ss_pred EEEEeC--CeEEEEEEecCCCCcchhcccccccCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC
Q 003274 576 GCCVEQ--GEKILILEYMPNKSLDVYLFDPIKKRL-LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (834)
Q Consensus 576 ~~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~ 652 (834)
.+..+. +..|||+|||..|.+...- ...+ +...++.+++.++..||.|||.++ ||||||||.|+||+++|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 998764 5889999999999886543 2333 899999999999999999999998 99999999999999999
Q ss_pred CeeecccccceecCCCC---ccCCceeeeccCcccCceeecCCC----CCccccchhhHHHHHHHhcCCCCCCCCCCCcc
Q 003274 653 NPKISDFGLARMFGGDE---LQGNTKRIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSRKNTGVYNTDSF 725 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwSlGvll~elltG~~p~~~~~~~~~ 725 (834)
++||+|||.+....... .........|||.|+|||.+.++. .+.+.||||+||+||-|+.|+.||-.... .
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--~ 325 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--L 325 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--H
Confidence 99999999998763221 112233468999999999987632 45889999999999999999999853111 0
Q ss_pred ccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 726 NLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. . ...++...+.- ....+..+++.+||+++|..||++|.+..+|..
T Consensus 326 ~-------l-----~~KIvn~pL~f-P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 326 E-------L-----FDKIVNDPLEF-PENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred H-------H-----HHHHhcCcccC-CCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 0 0 11222222211 112245678999999999999999999999854
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=327.45 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=206.6
Q ss_pred hcCcccccccccCCcEeEEEEEecC------ccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|+||.||+|+..+ ++.+|||.++..... ..+.+.+|++++.+++|+||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998533 478999998765443 457899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccc-----------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC
Q 003274 585 ILILEYMPNKSLDVYLFDP-----------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~-----------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 653 (834)
++||||+++++|.+++... .....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 9999999999999998532 12345788999999999999999999987 999999999999999999
Q ss_pred eeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchh
Q 003274 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..|+....... ..
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~---- 234 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VI---- 234 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH----
Confidence 99999999987644332222223346788999999999999999999999999999998 998875432211 00
Q ss_pred hhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 733 DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
....... ....+......+.+++.+||+.||++||++.||++.|+
T Consensus 235 ~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQGR----------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0000000 01112234567899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=342.19 Aligned_cols=261 Identities=27% Similarity=0.394 Sum_probs=205.7
Q ss_pred HhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 582 (834)
..++|.+.++||+|+||.||+|+.. .+..||||++..... ...+.+.+|++++.++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4578999999999999999999742 134799999975432 33467899999999995 999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccccc---------------------------------------------------------
Q 003274 583 EKILILEYMPNKSLDVYLFDPIK--------------------------------------------------------- 605 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (834)
..+|||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999988753210
Q ss_pred ------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec
Q 003274 606 ------------------------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (834)
Q Consensus 606 ------------------------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~ 649 (834)
...+++..+++++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 124778889999999999999999987 99999999999999
Q ss_pred cCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccc
Q 003274 650 KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~ 728 (834)
.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+.. +
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~- 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-F- 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-H-
Confidence 999999999999987644332222223456788999999999999999999999999999997 8888754321110 0
Q ss_pred cchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 729 GHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....... . ....+......+.+++.+||+.+|++||++.+|+++|+++
T Consensus 350 ---~~~~~~~-----~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 ---YNKIKSG-----Y-----RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred ---HHHHhcC-----C-----CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0000000 0 0111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=335.58 Aligned_cols=246 Identities=25% Similarity=0.361 Sum_probs=207.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.-|.+.+.||+|+-|.|-.|++ ..|+..|||++.+.. ......+.+|+.+|+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3467788999999999999985 569999999997652 233456788999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|.|.+++ ..++.+++.++++++.||+.|+.|+|..+ |+||||||+|+|||...++||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999998 56788999999999999999999999988 999999999999999999999999999875443
Q ss_pred CccCCceeeeccCcccCceeecCCCCC-ccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. ....-+|.+.|.|||++.+.+|. .++||||.|||||.||+|+.||+..+.. .+ ...+..+
T Consensus 166 k---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir--~L----LlKV~~G--------- 227 (786)
T KOG0588|consen 166 K---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR--VL----LLKVQRG--------- 227 (786)
T ss_pred c---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH--HH----HHHHHcC---------
Confidence 3 23335899999999999999885 8999999999999999999999832211 11 1111111
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.-+.|.....+..+|+.+|+..||+.|.|+.||++
T Consensus 228 --~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 228 --VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred --cccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 12345556778899999999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=304.02 Aligned_cols=265 Identities=21% Similarity=0.240 Sum_probs=212.6
Q ss_pred HHhcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----e
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----E 583 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~ 583 (834)
.+.++|.+.+.||+|||+-||.++ +.+++.+|+|++...+.++.+..++|++..++++|||+++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 455789999999999999999998 6678899999998877778889999999999999999999998876543 5
Q ss_pred EEEEEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 584 KILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
.||+++|...|+|.+.+.... ++..+++.+.++|+.+|++||.+||+.. ++++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 899999999999998885433 4457999999999999999999999986 47999999999999999999999999998
Q ss_pred eecCCCCcc-------CCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchh
Q 003274 663 RMFGGDELQ-------GNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAW 732 (834)
Q Consensus 663 ~~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 732 (834)
....-.... .......-|..|.|||.+. +...++++|||||||+||+|+.|..||+..-..
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------- 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------- 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence 765321100 0011124588999999985 567899999999999999999999998742221
Q ss_pred hhhcccccc-cccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 733 DLWKHERVH-ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 733 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.+. .+....+ ........++.+.+++.+|++.||.+||++.+++..++.+
T Consensus 248 ----GgSlaLAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 ----GGSLALAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----CCeEEEeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 11111 1122122 1111222678899999999999999999999999998765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=320.07 Aligned_cols=245 Identities=23% Similarity=0.395 Sum_probs=208.3
Q ss_pred cCcccccccccCCcEeEEEEE-ecCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
-+|++.+.||+|.||.|-+++ ...|+.||||.+++. .+++.-.+++|+++|..|+||||+.++.+|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 467888999999999999997 478999999998765 4556677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||..+|.|.+++ ...+.|++.++..++.||..|+.|+|.+. ++|||||.+|||||.++++||+||||+..+...
T Consensus 133 EYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 999999999998 35677999999999999999999999887 999999999999999999999999999887654
Q ss_pred CccCCceeeeccCcccCceeecCCCCC-ccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .+.++|.+-|.+||++.+.+|. +.+|-|||||+||.|+.|..||+..+... ++..
T Consensus 207 kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~------------------lvrQ- 264 (668)
T KOG0611|consen 207 KF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR------------------LVRQ- 264 (668)
T ss_pred cH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH------------------HHHH-
Confidence 32 3447999999999999999985 88999999999999999999998544211 1111
Q ss_pred cccCC-CCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 748 ILQDE-IPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 748 ~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+..+. ...+.+....-||++||..||++|.|+.+|...
T Consensus 265 Is~GaYrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 265 ISRGAYREPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hhcccccCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11111 122234566789999999999999999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=329.41 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=209.9
Q ss_pred cCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46788899999999999999742 345789999876655556789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC
Q 003274 587 ILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 653 (834)
||||+++++|.+++.... ....+++..+++++.||+.||+|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999985321 1235889999999999999999999988 999999999999999999
Q ss_pred eeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchh
Q 003274 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~----~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--V----I 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----H
Confidence 99999999987644332222233456788999999999999999999999999999998 888875433211 0 0
Q ss_pred hhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 003274 733 DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLN 792 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
......... ..+...+..+.+++.+||+.+|++||++.+|+++|+++...
T Consensus 236 ~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGRVL----------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCCCC----------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111111100 11222346789999999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=321.13 Aligned_cols=256 Identities=30% Similarity=0.435 Sum_probs=206.8
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..++|++.+.||+|++|.||+|...+++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788999999999999999998778899999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.... ...+++..+.+++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999985432 346899999999999999999999987 99999999999999999999999999988753321
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.. ......+..|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ..... ..
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~----~~~~~---------~~- 221 (261)
T cd05068 159 EA-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VL----QQVDQ---------GY- 221 (261)
T ss_pred cc-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH----HHHHc---------CC-
Confidence 11 111223468999999999999999999999999999999 888875432110 00 00000 00
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
....+......+.+++.+||+.+|++||++.++++.|++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 001122345678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.11 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=200.1
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
|...+.||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66778999999999999985 568999999986432 22345678999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe
Confidence 9999998877432 2346889999999999999999999987 99999999999999999999999999987543221
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.....||..|+|||++.+..++.++|||||||+||||++|+.||......... ..... .+... .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~--~~~~~--------~~~~~---~ 221 (285)
T cd05631 158 ---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR--EEVDR--------RVKED---Q 221 (285)
T ss_pred ---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH--HHHHH--------Hhhcc---c
Confidence 12346899999999999999999999999999999999999998754321100 00000 00000 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
...+......+.+|+.+||+.||++||+ +.++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1223334567889999999999999997 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=321.91 Aligned_cols=255 Identities=30% Similarity=0.435 Sum_probs=206.9
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|...+++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36789999999999999999998888899999986532 34578999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999988542 3346888999999999999999999987 999999999999999999999999999876543221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....++..|+|||++....++.++||||||+++|||++ |+.|+....... .. ...... ...
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~----~~~~~~-----~~~---- 223 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VM----SALQRG-----YRM---- 223 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HH----HHHHcC-----CCC----
Confidence 1 122345678999999999999999999999999999998 888875432111 00 000000 000
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.........+.+++.+||+.+|++||++.++.+.|++
T Consensus 224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111234578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=332.44 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=203.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.+.||+|+||.||+++.. .+..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 378999999999999999999864 57889999987542 3345679999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++. ....+++..+..++.|++.||+|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 158 (331)
T cd06649 84 HMDGGSLDQVLK---EAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (331)
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence 999999999884 3346889999999999999999999853 49999999999999999999999999987654321
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-cccchh-h----hhc----c--
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-LLGHAW-D----LWK----H-- 737 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~-~----~~~----~-- 737 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||......... ...... . ... .
T Consensus 159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence 22346899999999999999999999999999999999999998643221100 000000 0 000 0
Q ss_pred ----------------cccccccccccc---cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ----------------ERVHELMDPVIL---QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ----------------~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....++.+.... ..........++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~ 300 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN 300 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000 00001123467899999999999999999999976
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=320.26 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=202.2
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|+||.||+++..++..+|+|.+... ....+.+.+|+.++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 467888999999999999999888889999988643 3345678999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999887532 235889999999999999999999987 9999999999999999999999999998754332221
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... +.... . .... ..
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~---i-~~~~--~~-------- 220 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEM---I-SRGF--RL-------- 220 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHH---H-HCCC--CC--------
Confidence 112235678999999998899999999999999999999 88887533211 11100 0 0000 00
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..+......+.+++.+||+.+|++||++.++++.|
T Consensus 221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11122345789999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.60 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=203.8
Q ss_pred HhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
.+++|++.+.||+|+||.||+|... .+..+|+|.+.... .....++.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4578999999999999999998743 35679999986432 2344578999999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeee
Q 003274 584 KILILEYMPNKSLDVYLFDPIK-------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 656 (834)
.++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999998853221 234678889999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhh
Q 003274 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+....... .. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--~~----~~~ 234 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--VL----RFV 234 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----HHH
Confidence 99999986644332222222345788999999999999999999999999999999 677765332111 00 000
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..... ...+......+.+++.+||+.+|++||++.|+++.|++
T Consensus 235 ~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 235 MEGGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HcCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00000 01122334578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=322.88 Aligned_cols=257 Identities=30% Similarity=0.469 Sum_probs=211.6
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
...+|++.++||+|+||.||+|+..+++.+|+|.+..........+..|+.+++.++|+||+++++++......++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44678899999999999999999878999999999876655667899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+.+++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999998643 3456899999999999999999999987 99999999999999999999999999987643322
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
... ...++..|+|||.+.+..++.++||||||++++||++ |+.|+....... ... ... ...
T Consensus 160 ~~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~----~~~---------~~~- 221 (261)
T cd05148 160 LSS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYD----QIT---------AGY- 221 (261)
T ss_pred ccc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH----HHH---------hCC-
Confidence 211 2345778999999999999999999999999999998 788875432111 000 000 000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1112234456789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=335.72 Aligned_cols=244 Identities=23% Similarity=0.284 Sum_probs=200.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67889999999999999999864 57899999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999998884 3456888999999999999999999988 999999999999999999999999999876432
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .. ....... .
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~----~~~i~~~--------~- 231 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RI----YEKILAG--------R- 231 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HH----HHHHhcC--------C-
Confidence 2 2357899999999999999999999999999999999999998532211 00 0000000 0
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
...+.....++.+++.+||+.||++||+ +.+++.
T Consensus 232 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 --LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0112223457889999999999999997 677764
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.35 Aligned_cols=241 Identities=26% Similarity=0.346 Sum_probs=194.4
Q ss_pred cccccCCcEeEEEEEe----cCccEEEEEEcccC----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 519 CKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++||+|+||.||+++. ..++.+|+|.++.. .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5899999999999974 35789999998643 223345678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++. ....+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999988873 3456788889999999999999999988 99999999999999999999999999876432221
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......||+.|+|||++.+..++.++|||||||+||||++|+.||....... . ...+....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--~------------~~~~~~~~--- 216 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--T------------IDKILKGK--- 216 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--H------------HHHHHcCC---
Confidence 2233578999999999999999999999999999999999999986432111 0 00001000
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
...+......+.+++.+||+.+|++|| ++.++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 112223456788999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=326.26 Aligned_cols=248 Identities=24% Similarity=0.359 Sum_probs=205.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..|+..+.||+|.||.||||.. ..++.||+|++.... ....+...+|+.++..++|+||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4566678999999999999984 457889999997653 44567889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|.+|++.+.|. ....+++....-|+.++..|+.|||.++ .+|||||+.|||+.++|.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL~---~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLK---SGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhc---cCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999998883 3445588888889999999999999998 99999999999999999999999999988766554
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.. ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+.....-. +.-++-... .
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr---------------vlflIpk~~-P 228 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR---------------VLFLIPKSA-P 228 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce---------------EEEeccCCC-C
Confidence 43 45799999999999998899999999999999999999999976433211 111110000 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++..||+.||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1112244567899999999999999999999986
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=334.10 Aligned_cols=241 Identities=24% Similarity=0.305 Sum_probs=196.3
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+++. .+|+.+|+|+++... ......+..|+.++.+++||||+++++++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 468899999987532 234456788999999999999999999999999999999999999
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCc
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 674 (834)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 9988874 3457899999999999999999999988 9999999999999999999999999987532211 122
Q ss_pred eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 003274 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIP 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.....+. +. ...... ....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~----~~~~~~-----------~~~~p 215 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF----ELILME-----------EIRFP 215 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HH----HHHHcC-----------CCCCC
Confidence 34579999999999999999999999999999999999999985422111 00 000000 11223
Q ss_pred HHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 755 LPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
.....++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 33456789999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=326.49 Aligned_cols=260 Identities=27% Similarity=0.449 Sum_probs=208.3
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++||||+++++++......+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 367889999999999999999742 24568999987666556678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhccccc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCee
Q 003274 586 LILEYMPNKSLDVYLFDPI----------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 655 (834)
+||||+++++|.+++.... +...+++..+++++.|++.||+|||+.+ ++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999998885321 2235899999999999999999999987 99999999999999999999
Q ss_pred ecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhh
Q 003274 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....... . ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~----~~~ 234 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--V----IEC 234 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHH
Confidence 999999986644332222223345778999999999999999999999999999998 888875432211 0 001
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....... ..+......+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 235 i~~~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 235 ITQGRVL----------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HHcCCcC----------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111100 011123457899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=335.53 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=203.3
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+..|++++..++||||+++++++......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999865 58899999986542 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999883 3456889999999999999999999988 99999999999999999999999999986543
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
......||+.|+|||++.+..++.++|||||||+||||++|+.||........ .. .... ....+....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~----~i~~--~~~~~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WE----NLKY--WKETLQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HH----HHHh--ccccccCCC
Confidence 22335789999999999999999999999999999999999999864332110 00 0000 000000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........++.+++.+||..+|++||++.++++.
T Consensus 222 -~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 -YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=331.69 Aligned_cols=244 Identities=24% Similarity=0.289 Sum_probs=199.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888999999999999999864 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999998884 3456889999999999999999999988 999999999999999999999999999865432
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. ... ...
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~----~~i--------~~~-- 213 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IY----EKI--------LAG-- 213 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHH--------HhC--
Confidence 223568999999999999999999999999999999999999986432111 00 000 000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
....+......+.+++.+||+.||.+||+ +.++++
T Consensus 214 -~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 214 -KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 01122233557889999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=324.32 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=203.3
Q ss_pred cCcccccccccCCcEeEEEEEe-----cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|++.++||+|+||.||+|+. ..++.+|+|.+.... ......+.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999974 245789999997533 3344678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhccccc--------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC
Q 003274 587 ILEYMPNKSLDVYLFDPI--------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~ 652 (834)
||||+++++|.+++.... ....+++...+.++.|+++||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999874221 1235788999999999999999999987 99999999999999999
Q ss_pred CeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccch
Q 003274 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHA 731 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~ 731 (834)
.+||+|||+++...............++..|+|||++.+..++.++||||||++||||++ |..|+...... .+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~-- 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIE-- 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHH--
Confidence 999999999987644332222233345778999999998899999999999999999998 88887532211 0000
Q ss_pred hhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 732 WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
....... ...+.....++.+++.+||+.+|++||++.++++.|..
T Consensus 238 --~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 --MVRKRQL----------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred --HHHcCCc----------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0000000 01122234678899999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=333.55 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=199.9
Q ss_pred cCcccccccccCCcEeEEEEEecC--ccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN--GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
++|.+.+.||+|+||.||+|+... +..||+|++... .....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 678999999999999999997543 368999998643 223456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999884 3456889999999999999999999988 99999999999999999999999999987543
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ... +....
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~----~~~--------i~~~~ 244 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--I----YQK--------ILEGI 244 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--H----HHH--------HhcCC
Confidence 2 223578999999999999999999999999999999999999986432110 0 000 00000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
...+......+.+++.+||+.+|++|+ ++.++++
T Consensus 245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 112223345678999999999999995 8888876
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.35 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=201.9
Q ss_pred cCcccccccccCCcEeEEEEEec-Ccc----EEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.+|++.+.||+|+||.||+|+.. +++ .||+|.++... ....+++..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 56889999999999999999853 333 48999987543 34457789999999999999999999999865 5789
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+||+++|+|.+++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999998853 2345889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... + .......
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--I----SSILEKG------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHhCC-------
Confidence 4332211222234678999999999999999999999999999998 888876432111 0 0000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
. ....+......+.+++.+||+.+|++||++.+++..|..+.
T Consensus 228 --~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 228 --E-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred --C-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 00111223457889999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.84 Aligned_cols=238 Identities=21% Similarity=0.282 Sum_probs=192.2
Q ss_pred cccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||.||+++.. +++.||+|++... .......+..|+.++.+++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999864 5789999998643 233456788999999999999999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCcee
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQ---REGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 98884 3456899999999999999999999987 9999999999999999999999999998643222 12234
Q ss_pred eeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH
Q 003274 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (834)
..||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ... ++.. ....+..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~---~~~---------~~~~---~~~~~~~ 215 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--M---YRK---------ILQE---PLRFPDG 215 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--H---HHH---------HHcC---CCCCCCc
Confidence 579999999999999999999999999999999999999986422110 0 000 0000 0112233
Q ss_pred HHhHHHHHHHhccccCCCCCCCH---HHHH
Q 003274 757 MLMRYVNVALLCVQENAADRPTM---SDVV 783 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~---~evl 783 (834)
....+.+++.+||+.||++||++ .|++
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 45678899999999999999864 5554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=322.92 Aligned_cols=267 Identities=31% Similarity=0.400 Sum_probs=203.6
Q ss_pred cccccccccCCcEeEEEEE-----ecCccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 003274 515 FSMQCKLGEGGFGPVYKGR-----LFNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~-----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 586 (834)
|.+.+.||+|+||+||+++ ..+++.||+|.+..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 3778899999999998764 23577899999875432 3456788999999999999999999998764 35789
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~----~~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLP----KHKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHH----HcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 999999999999883 235899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccC-CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+........................+.++
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 432111 1112245667999999998999999999999999999999999876443222111111111111111111111
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... ....+.....++.+++.+||+.+|++||++++++++|+++
T Consensus 239 ~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 239 RGM-RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 111 1112333457899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=348.26 Aligned_cols=252 Identities=18% Similarity=0.253 Sum_probs=204.1
Q ss_pred CcccccccccCCcEeEEEEEec-C-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-N-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.|.+.+.||+|+||.||++... + ++.||+|.+..........+..|+.+++.++||||+++++++...+..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 4888999999999999999743 3 6788999876555555567888999999999999999999999999999999999
Q ss_pred CCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 592 PNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++|+|..++.... ....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999998875432 3456889999999999999999999987 99999999999999999999999999987654332
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
........||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... ..++... .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~------------~~~~~~~--~ 288 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIM------------QQVLYGK--Y 288 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHH------------HHHHhCC--C
Confidence 22334467999999999999999999999999999999999999998532211 000 0000000 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+......+.+++.+||+.+|++||++.+++.
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0112234467899999999999999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=319.71 Aligned_cols=256 Identities=29% Similarity=0.459 Sum_probs=204.9
Q ss_pred cCcccccccccCCcEeEEEEEecC----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|+... ...||||.+.... ......|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 678899999999999999998642 3579999987543 33456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ....+++..+.+++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999998843 2346899999999999999999999987 99999999999999999999999999988752
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
...........++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .. .......
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~----~~~~~~~------- 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VI----KAVEDGY------- 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HH----HHHHcCC-------
Confidence 221111222345678999999999999999999999999999998 888875322111 00 0000000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.+|++||++.||++.|+++
T Consensus 226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.98 Aligned_cols=248 Identities=26% Similarity=0.363 Sum_probs=207.9
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
-++|++.+.||+|.||.||.|+. .++-.||+|++.+.. .+...++++|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 37899999999999999999985 456789999986542 33456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+||.+.|.|...|.+. ....+++.....++.|+|.|+.|+|..+ ++||||||+|+|++.++.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999888532 4456888899999999999999999987 9999999999999999999999999987643
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.......+||..|.+||...+..++..+|+|++|++.||++.|.+||+....++. ...+. -.
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI~---k~------ 237 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRIR---KV------ 237 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHHH---Hc------
Confidence 2334457999999999999999999999999999999999999999985432211 11110 01
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.-.+|........++|.+|+..+|.+|.+..|++.
T Consensus 238 --~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 238 --DLKFPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred --cccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 11234455678899999999999999999999865
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=319.73 Aligned_cols=255 Identities=28% Similarity=0.446 Sum_probs=205.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|.+.++||+|+||.||+|... .++.+|+|.+... ....+++.+|++++.+++|+||+++++++......++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999854 5889999998653 334567899999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988432 2346899999999999999999999987 999999999999999999999999999876543221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.....+. . ..... ... .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----~~~~~---------~~~-~ 223 (263)
T cd05052 161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YELLE---------KGY-R 223 (263)
T ss_pred c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHH---------CCC-C
Confidence 1 111234678999999999999999999999999999998 888875322111 0 01110 000 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+...+.++.+++.+||+.+|++||++.+++++|+++
T Consensus 224 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 224 MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 112223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.65 Aligned_cols=265 Identities=21% Similarity=0.285 Sum_probs=201.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.+.||+|+||.||+++.. +++.+|+|++.... ....+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999865 57889999986542 3345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++++.+..+.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999987765542 2346889999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcccc-ccch--------hhhh-cccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNL-LGHA--------WDLW-KHER 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~--------~~~~-~~~~ 739 (834)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||.......... .... ...+ ....
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1 12223568999999999999999999999999999999999999987533211000 0000 0000 0000
Q ss_pred ccccccccccc-----CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 VHELMDPVILQ-----DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......+.... ..........+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0001123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.44 Aligned_cols=257 Identities=30% Similarity=0.447 Sum_probs=203.4
Q ss_pred cCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
.+|.+.++||+|+||.||+|+.. .++.||+|+++..... ..+.+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 35677889999999999999853 2578999999755332 3466889999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC
Q 003274 586 LILEYMPNKSLDVYLFDP-------------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~ 652 (834)
+++||+.+++|..++... .....+++..+.+++.|+++||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 999999999999887421 11245888999999999999999999987 99999999999999999
Q ss_pred CeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccch
Q 003274 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHA 731 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~ 731 (834)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....... .
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~---- 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--V---- 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--H----
Confidence 999999999987644332222233456789999999998999999999999999999998 777765322110 0
Q ss_pred hhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 732 WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..... +.. ....+......+.+++.+||+.+|++||++.+|+..|++
T Consensus 236 ~~~i~--------~~~--~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIR--------NRQ--VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHH--------cCC--cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 00000 000 011233455678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.12 Aligned_cols=241 Identities=23% Similarity=0.311 Sum_probs=195.2
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+++. .+|+.||+|.+... .......+..|++++.+++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999985 46889999998653 2234556788999999999999999999999999999999999999
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCc
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 674 (834)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 9988773 3456899999999999999999999987 9999999999999999999999999987543222 112
Q ss_pred eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 003274 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIP 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||+||||++|+.||........ . .. +... ....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--~----~~--------~~~~---~~~~p 215 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--F----EL--------ILME---EIRFP 215 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--H----HH--------HhcC---CCCCC
Confidence 235689999999999999999999999999999999999999864322110 0 00 0000 01122
Q ss_pred HHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 755 LPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
.....++.+++.+||+.||++|| ++.++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 33456788999999999999998 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=325.57 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=207.3
Q ss_pred HhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 582 (834)
..++|++.+.||+|+||.||++... ....+|+|.+... ......++.+|++++.++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 4467888999999999999999753 2367999998754 233456788999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec
Q 003274 583 EKILILEYMPNKSLDVYLFDP-------------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~ 649 (834)
..+++|||+++|+|..++... .....+++..+++++.|++.||+|||+.+ |+||||||+|||++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999988532 22456889999999999999999999987 99999999999999
Q ss_pred cCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccc
Q 003274 650 KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~ 728 (834)
.++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|||++ |..|+....... .
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~- 243 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--L- 243 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--H-
Confidence 999999999999987654333222222345678999999999999999999999999999997 888865322111 0
Q ss_pred cchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 729 GHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... +.... ....+......+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 244 ---~~~---------~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 ---FKL---------LKEGY-RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ---HHH---------HHcCC-cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 000 00000 1112233456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.13 Aligned_cols=260 Identities=30% Similarity=0.442 Sum_probs=203.1
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC-C
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ-G 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 582 (834)
.++|.+.++||+|+||.||+|... .++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 367899999999999999999632 24789999987543 22345678899999999 899999999988754 5
Q ss_pred eEEEEEEecCCCCcchhcccccc---------------------------------------------------------
Q 003274 583 EKILILEYMPNKSLDVYLFDPIK--------------------------------------------------------- 605 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (834)
..+++|||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999988743211
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCccc
Q 003274 606 -KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684 (834)
Q Consensus 606 -~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 684 (834)
...+++..+.+++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136889999999999999999999987 9999999999999999999999999998764433222223345677899
Q ss_pred CceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHH
Q 003274 685 SPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVN 763 (834)
Q Consensus 685 aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 763 (834)
|||++.+..++.++|||||||+||||++ |..|+......+. +. ...... . ....+.....++.+
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~----~~~~~~-----~-----~~~~~~~~~~~~~~ 307 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FC----RRLKEG-----T-----RMRAPEYATPEIYS 307 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HH----HHHhcc-----C-----CCCCCccCCHHHHH
Confidence 9999999999999999999999999998 8888754221110 00 000000 0 01112233467899
Q ss_pred HHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 764 VALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 764 li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
++.+||+.+|++||++.|+++.|+++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=318.57 Aligned_cols=256 Identities=26% Similarity=0.452 Sum_probs=202.4
Q ss_pred cccccccccCCcEeEEEEEecC----ccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-----
Q 003274 515 FSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE----- 583 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----- 583 (834)
|.+.+.||+|+||.||+|+... +..+|+|+++... ....+.+..|++.++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4667899999999999998642 3679999987542 3345678999999999999999999999876554
Q ss_pred -EEEEEEecCCCCcchhccccc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccc
Q 003274 584 -KILILEYMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (834)
Q Consensus 584 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 659 (834)
.++++||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2346889999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccc
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHE 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .. ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~----~~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IY----DYLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcC
Confidence 99987654433222222345678999999999999999999999999999999 778775322111 10 000000
Q ss_pred ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ....+.....++.+++.+||+.||++||++.|+++.|+++
T Consensus 232 ~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 N----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 1112333456889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=320.81 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=200.6
Q ss_pred cCcccccccccCCcEeEEEEEec-Ccc----EEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|.+.+.||+|+||.||+|+.. +++ ++++|.+..... ....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 56788899999999999999853 344 578888764432 23467888888999999999999999875 456789
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999853 2346899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . .........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~~~----- 229 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--V----PDLLEKGER----- 229 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H----HHHHHCCCc-----
Confidence 4332222333457789999999999999999999999999999998 888875432111 0 011111000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
...+......+.+++.+||..+|++||++.|+++.|..+.
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 -----LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0011112356788999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.36 Aligned_cols=252 Identities=29% Similarity=0.455 Sum_probs=202.7
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|.+.+.||+|+||.||+++..++..+|+|.+.... ...+.+.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4678889999999999999987777789999986533 345679999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999988432 236899999999999999999999987 9999999999999999999999999998764432211
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... .. ... . ..
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~---~~-~~~-----~-----~~ 220 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVE---KV-SQG-----L-----RL 220 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHH---HH-hcC-----C-----CC
Confidence 111235678999999998899999999999999999998 888875433211 000 00 000 0 00
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
..+......+.+++.+||+.+|++||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 111223568899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=330.39 Aligned_cols=241 Identities=24% Similarity=0.302 Sum_probs=195.9
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+++. .+++.+|+|++... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 46889999998653 2334567888999999999999999999999999999999999999
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCc
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 674 (834)
+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 9988773 3456899999999999999999999987 9999999999999999999999999987543221 122
Q ss_pred eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCC
Q 003274 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIP 754 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 754 (834)
....||+.|+|||++.+..++.++|||||||+||||++|+.||....... .. ... ... ....+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~~----~~~--------~~~---~~~~p 215 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF----ELI--------LME---DIKFP 215 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--HH----HHh--------ccC---CccCC
Confidence 33579999999999999999999999999999999999999986432111 00 000 000 11223
Q ss_pred HHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 755 LPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 755 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
.....++.+++.+||+.||++|| ++.|+++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 33456788999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=315.23 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=196.5
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
+.||+|+||.||+|+. .+++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4799999999999986 468899999876543 33456799999999999999999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCcee
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 998842 2345889999999999999999999987 99999999999999999999999999876543221111111
Q ss_pred eeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCH
Q 003274 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPL 755 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (834)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+....... . ... +.... ....+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~----~~~---------~~~~~-~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--T----REA---------IEQGV-RLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--H----HHH---------HHcCC-CCCCcc
Confidence 223567999999999999999999999999999998 777775322110 0 000 00000 111222
Q ss_pred HHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 756 PMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.....+.+++.+||+.+|++||++.+++++|.
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 33567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=331.71 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=193.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|...++||+|+||.||+++.. +++.||||++..... ...+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999854 689999999865432 3356789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.... ...+..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999985432 3456778899999999999999987 99999999999999999999999999987643221
Q ss_pred cCCceeeeccCcccCceeecC-----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
......||..|+|||++.. ...+.++|||||||+||||++|+.||........... .... ..
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~---------~~ 290 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL--MCAI---------CM 290 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH--HHHH---------hc
Confidence 1223578999999998853 2345789999999999999999999873222111000 0000 00
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .....+.....++.+++.+||+.||++||++.|+++
T Consensus 291 ~--~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 291 S--QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred c--CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011122234567899999999999999999999976
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=347.77 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=205.0
Q ss_pred HHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG---- 582 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 582 (834)
...++|.+.++||+|+||+||+++. .+++.||||++... .......+.+|+.++..++|+||++++..+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3457999999999999999999984 56899999998654 2344567889999999999999999988775432
Q ss_pred ----eEEEEEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 583 ----EKILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 583 ----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 3679999999999999885432 3456899999999999999999999987 9999999999999999999999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
|||+++.+.............||+.|+|||++.+..++.++|||||||+||||++|+.||....... ... .
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~~----~--- 256 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VMH----K--- 256 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----H---
Confidence 9999987654332333344679999999999999999999999999999999999999986422110 000 0
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+... ....+.....++.+++.+||+.+|++||++.++++
T Consensus 257 -----~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 257 -----TLAGR--YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred -----HhcCC--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 00000 01122334567899999999999999999999976
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=322.45 Aligned_cols=261 Identities=25% Similarity=0.394 Sum_probs=207.5
Q ss_pred HhcCcccccccccCCcEeEEEEEecC-----ccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGE 583 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 583 (834)
..++|.+.++||+|+||.||+|...+ +..|++|++... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999998655 688999998754 23345678999999999999999999998876 467
Q ss_pred EEEEEEecCCCCcchhccccccc-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKK-----RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 658 (834)
.++++||+++++|..++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998543222 56899999999999999999999987 99999999999999999999999
Q ss_pred cccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcc
Q 003274 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... ..+.. ....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~----~~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAA----YLKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHH----HHHc
Confidence 999987644332222222345778999999999999999999999999999999 8988754321 11110 0000
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
. . ....+.....++.+++.+||+.+|++||++.++++.|+++.
T Consensus 235 ~-----~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 G-----Y-----RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred C-----C-----CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 0 00111123457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=316.88 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=207.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+|+. .+++.+|||.+... .......+.+|++++++++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5788999999999999999985 46889999987542 2233456889999999999999999999999999999999
Q ss_pred EecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|..++.... ....++...+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999988874322 2345788999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.|+.....+...+.. . +.....
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~----~-----~~~~~~-- 225 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQ----K-----IEQCDY-- 225 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHH----H-----HhcCCC--
Confidence 321 112246788999999999888999999999999999999999997532221111110 0 000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 --~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 --PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1111223456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=327.79 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=201.3
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||.||+++.. .+..+|+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999865 57789999886542 3344678999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++. ....+++..+..++.++++||+|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 999999999884 3346889999999999999999999753 39999999999999999999999999987653221
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcccc-ccchh--hhhcc---cc----
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNL-LGHAW--DLWKH---ER---- 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~-~~~~~--~~~~~---~~---- 739 (834)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+.......... ..... ..... ..
T Consensus 159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence 223468999999999999999999999999999999999999986433211100 00000 00000 00
Q ss_pred ----------------cccccccccccC--CC-CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 ----------------VHELMDPVILQD--EI-PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ----------------~~~~~~~~~~~~--~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+.+...... .. ......++.+++.+||+.||++||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000000000000 00 0012457889999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=322.54 Aligned_cols=264 Identities=23% Similarity=0.302 Sum_probs=197.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++||||+++++++......++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57888999999999999999854 57899999986543 23345678999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 88777632 2345788999999999999999999987 99999999999999999999999999986543221
Q ss_pred cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-cccc-----chhhhhcc----cc
Q 003274 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLG-----HAWDLWKH----ER 739 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~-----~~~~~~~~----~~ 739 (834)
......+++.|+|||++.+ ..++.++|||||||++|||++|++||........ .... .....+.. ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1223467899999998865 5689999999999999999999999864332111 0000 00000000 00
Q ss_pred cccccccccccC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 VHELMDPVILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......+..... ........++.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000111100000 001112457789999999999999999999964
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=322.30 Aligned_cols=257 Identities=29% Similarity=0.469 Sum_probs=203.3
Q ss_pred CcccccccccCCcEeEEEEEec------CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
+|.+.+.||+|+||.||+|+.. ....+++|.+..... ...+.+..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677899999999999999742 235789998865432 345678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhccccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 003274 587 ILEYMPNKSLDVYLFDPI---------------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N 645 (834)
++||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999998874321 1235789999999999999999999887 9999999999
Q ss_pred EEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCc
Q 003274 646 VLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDS 724 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~ 724 (834)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |..|+.....+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999986543322222222345778999999998999999999999999999998 888875432111
Q ss_pred cccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+ +... .... ....+.....++.+++.+||+.+|++||++.|+++.|+++
T Consensus 238 --~----~~~~---------~~~~-~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 --L----FNLL---------KTGY-RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred --H----HHHH---------hCCC-CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 0 1111 1100 1111223346788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=320.37 Aligned_cols=271 Identities=25% Similarity=0.421 Sum_probs=203.4
Q ss_pred cCcccccccccCCcEeEEEEEe-----cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 585 (834)
++|.+.+.||+|+||.||++.. .+++.||+|++........+.+.+|++++.+++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788889999999999999974 35789999999876666677899999999999999999999987543 4678
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999998843 2345899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccC-CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhh-hhcccccccc
Q 003274 666 GGDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD-LWKHERVHEL 743 (834)
Q Consensus 666 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 743 (834)
....... ......++..|+|||++.+..++.++||||||++++||++|..+................. ........+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4332111 1111223456999999999999999999999999999999876643222110000000000 0000000011
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ....+.....++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNG-RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCC-cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11100 0111223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=302.69 Aligned_cols=282 Identities=24% Similarity=0.315 Sum_probs=209.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcc--cHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 587 (834)
++|...+.|++|.||.||+|+. .+++.||+|+++-..+. -.-..++|+.+|.+++|||||.+..+.... +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 5688889999999999999985 45789999999755322 122358899999999999999999888754 478999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||||++ +|...+.. ....+...++.-+..|+++|++|||... |+|||||++|+|++..|.+||+|||+|+.++.
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999987 67777732 2357888999999999999999999987 99999999999999999999999999999875
Q ss_pred CCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCC-Cccc----cccch-hhhhccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNT-DSFN----LLGHA-WDLWKHERV 740 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~-~~~~----~~~~~-~~~~~~~~~ 740 (834)
.. ...+..+-|..|.|||.+.+. .|+++.|+||+|||+.||+++++.|....+ ++.+ +++.. ...|..-..
T Consensus 230 p~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 230 PL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred Cc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 42 234456779999999998865 699999999999999999999998875443 2211 11110 011110000
Q ss_pred ccccc--------cccccCCCCHH-HHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCcccccc
Q 003274 741 HELMD--------PVILQDEIPLP-MLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKG 804 (834)
Q Consensus 741 ~~~~~--------~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~~~~~~~ 804 (834)
...+. ...+...++.. ..+.-.+|+...|..||.+|.|+.|.++. +--.+.|.|..|..+.+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMFPT 378 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhcCC
Confidence 00000 00011122222 34677889999999999999999999863 22245566665555543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=324.90 Aligned_cols=265 Identities=25% Similarity=0.296 Sum_probs=196.6
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.++||+|+||.||+|+.. +++.+|||++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 378999999999999999999864 688999999875432 233467889999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+. ++|.+++.. ....++++.+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 567666532 3356888999999999999999999988 9999999999999999999999999997643222
Q ss_pred ccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchh-------hhhcccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAW-------DLWKHERVH 741 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~ 741 (834)
.......+++.|+|||++.+ ..++.++|||||||++|||++|+.||.........+..... ..+......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 11223467899999999865 46889999999999999999999998754321111100000 000000000
Q ss_pred cccccccc----cCC-----CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 ELMDPVIL----QDE-----IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 ~~~~~~~~----~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+... ... ........+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000000 000 00012346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=319.94 Aligned_cols=258 Identities=28% Similarity=0.430 Sum_probs=203.4
Q ss_pred HhcCcccccccccCCcEeEEEEEecC------ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
++++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......|..|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35778999999999999999998643 5688999886543 3334568999999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC---Ceee
Q 003274 584 KILILEYMPNKSLDVYLFDPIK----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKI 656 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl 656 (834)
.++||||+++++|.+++..... ...+++..+++++.||++||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999998854321 235899999999999999999999987 99999999999998754 5999
Q ss_pred cccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhh
Q 003274 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+|||+++.+..............+..|+|||++.+..++.++|||||||++|||++ |..||.....+. +.. .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~----~- 233 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VME----F- 233 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHH----H-
Confidence 99999987643332222222234568999999999999999999999999999997 888876432211 000 0
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
+.... ....+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 234 --------~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 --------VTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------HHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 00000 11122334567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=317.72 Aligned_cols=256 Identities=26% Similarity=0.456 Sum_probs=198.4
Q ss_pred cccccccccCCcEeEEEEEecCc-c--EEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------Ce
Q 003274 515 FSMQCKLGEGGFGPVYKGRLFNG-Q--EVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------GE 583 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~~~-~--~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 583 (834)
|.+.++||+|+||.||+|+.... + .+|+|.++.. .....+.+..|++++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 34678999999999999986543 2 6899988653 234467789999999999999999999988542 24
Q ss_pred EEEEEEecCCCCcchhccccc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 584 KILILEYMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
.+++|||+++|+|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999988874221 2345889999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+++.+.............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+ ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~----~~~~~~~~ 231 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EI----YDYLRQGN 231 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHHcCC
Confidence 9987654332222222345778999999999999999999999999999999 77787532211 11 01111110
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ...+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 R----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011223445789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=320.14 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=204.6
Q ss_pred cCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|...++||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788899999999999999632 356899999877666667789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCe
Q 003274 587 ILEYMPNKSLDVYLFDPIK------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
+|||+++++|.+++..... ...+++..++.++.|++.|++|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999998853211 135789999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhh
Q 003274 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |.+|+........ . .
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~----~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--I----E 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--H----H
Confidence 9999999986644332222222345788999999999999999999999999999998 8888753221110 0 0
Q ss_pred hhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
...... ....+......+.+++.+||+.||++||++.||++.|+
T Consensus 236 ~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000000 01112233457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=321.75 Aligned_cols=264 Identities=24% Similarity=0.406 Sum_probs=200.9
Q ss_pred cCcccccccccCCcEeEEEEEecC---------------ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN---------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILG 576 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~ 576 (834)
++|.+.++||+|+||.||+++... ...||+|.++... ....+.|.+|++++.+++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578899999999999999987432 2358999987542 334567999999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCcchhccccc---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 003274 577 CCVEQGEKILILEYMPNKSLDVYLFDPI---------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (834)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NIL 647 (834)
++......++||||+++++|.+++.... ....+++..+++++.|+++||+|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999884321 1124688999999999999999999987 999999999999
Q ss_pred eccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcC--CCCCCCCCCCcc
Q 003274 648 LDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS--RKNTGVYNTDSF 725 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG--~~p~~~~~~~~~ 725 (834)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||++++||+++ ..|+......
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~-- 239 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE-- 239 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH--
Confidence 999999999999999875433322222233457789999999999999999999999999999984 4455432211
Q ss_pred ccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 726 NLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
............... .. ....+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 240 ~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 240 QVIENTGEFFRNQGR-QI------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHHHHHHhhhhccc-cc------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 111111110000000 00 001112234688999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=334.32 Aligned_cols=261 Identities=27% Similarity=0.397 Sum_probs=204.8
Q ss_pred HhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~ 582 (834)
..++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+..|++++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3467888899999999999999853 34689999997543 233457899999999997 999999999999999
Q ss_pred eEEEEEEecCCCCcchhccccc----------------------------------------------------------
Q 003274 583 EKILILEYMPNKSLDVYLFDPI---------------------------------------------------------- 604 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---------------------------------------------------------- 604 (834)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999885321
Q ss_pred -------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 003274 605 -------------------------------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (834)
Q Consensus 605 -------------------------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NIL 647 (834)
....+++..+++++.|+++||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1124677888999999999999999887 999999999999
Q ss_pred eccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccc
Q 003274 648 LDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFN 726 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~ 726 (834)
+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999987543222111222356789999999999999999999999999999998 8888754322110
Q ss_pred cccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 727 LLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.......+ . ....+.....++.+++.+||+.+|++||+++||++.|+++
T Consensus 351 ----~~~~~~~~-----~-----~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 ----FYNAIKRG-----Y-----RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ----HHHHHHcC-----C-----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 00000000 0 0111223456889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=319.89 Aligned_cols=264 Identities=26% Similarity=0.422 Sum_probs=205.1
Q ss_pred hcCcccccccccCCcEeEEEEEecC-----------------ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceee
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN-----------------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVR 573 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~ 573 (834)
..+|.+.++||+|+||.||+++..+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678899999999999999987532 2458999987553 334667899999999999999999
Q ss_pred EEEEEEeCCeEEEEEEecCCCCcchhccccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 003274 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPI--------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (834)
Q Consensus 574 l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N 645 (834)
+++++......+++|||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999885432 1236899999999999999999999987 9999999999
Q ss_pred EEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc--CCCCCCCCCCC
Q 003274 646 VLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SRKNTGVYNTD 723 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt--G~~p~~~~~~~ 723 (834)
|+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999987654433333333456789999999998899999999999999999998 5566543221
Q ss_pred ccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 724 SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.................. ....+...+.++.+++.+||+.+|++||++.||++.|+
T Consensus 240 -~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 -QQVIENAGHFFRDDGRQI-------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred -HHHHHHHHhccccccccc-------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111100000 00112223468999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=336.70 Aligned_cols=255 Identities=28% Similarity=0.399 Sum_probs=209.4
Q ss_pred ccccccccCCcEeEEEEEe-cCc----cEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 516 SMQCKLGEGGFGPVYKGRL-FNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~-~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
...++||+|+||+||||.+ ..| -+||+|++... ..+.-+++++|+-+|.+|+|||+++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3457999999999999974 333 37899998665 3445688999999999999999999999998876 889999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||+.|.|.+|++. .+..+..+..+.|..|||+||.|||.+. ++||||.++||||.+-..+||.|||+++....+.
T Consensus 778 ~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 9999999999854 5567889999999999999999999886 9999999999999999999999999999987665
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.........-.+.|||-|.+....|+.++|||||||++||++| |.+|++..+.++ +.+++....
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e---------------I~dlle~ge 917 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE---------------IPDLLEKGE 917 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH---------------hhHHHhccc
Confidence 4444444455789999999999999999999999999999998 777766443221 111111111
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLN 792 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
+-..|.....+++.++.+||..|+..||+++++...+.+...+
T Consensus 918 -RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 -RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred -cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1234555678999999999999999999999999887766443
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.95 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=210.9
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-EEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE-KILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-~~lV~ 588 (834)
++|...++||+|+||.++..+++ +++.+++|.+... .....+....|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 67888999999999999998754 4678999987643 33344567899999999999999999999999998 99999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
+|++||+|.+.+... ++..++++.+.+++.|++.|+.|||++. |+|||||+.|||++.+..|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999998653 3567899999999999999999999776 999999999999999999999999999998765
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.. ......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+.... +.+++...
T Consensus 160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L--------------i~ki~~~~- 222 (426)
T KOG0589|consen 160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL--------------ILKINRGL- 222 (426)
T ss_pred hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH--------------HHHHhhcc-
Confidence 52 23346899999999999999999999999999999999999999875443221 01111111
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
-...+.....++..++..|++.+|+.||++.+++.+
T Consensus 223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 123455567799999999999999999999999874
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.91 Aligned_cols=251 Identities=29% Similarity=0.422 Sum_probs=201.4
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.+|++.+.||+|+||.||+++...+..+|+|.+.... ...+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 4577889999999999999987777789999986432 234578899999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999988532 336899999999999999999999988 9999999999999999999999999998764332211
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. . . ...... .
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~---~-~-----~~~~~~-----~ 220 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VV---E-S-----VSAGYR-----L 220 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HH---H-H-----HHcCCc-----C
Confidence 111223568999999999999999999999999999999 788876432211 00 0 0 000000 1
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..+...+.++.+++.+||..+|++||++.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11223456889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=325.92 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=193.1
Q ss_pred cccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHH---hhcCCCceeeEEEEEEeCCeEEEE
Q 003274 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLI---AELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
|.+.++||+|+||.||+++.. +++.||||+++... ....+.+..|++++ .+++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999854 58899999986432 23345566776655 456799999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988763 346899999999999999999999987 99999999999999999999999999875422
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. . .+...
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~~----~--------~i~~~- 216 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--VF----D--------SIVND- 216 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--HH----H--------HHHhC-
Confidence 21 12234578999999999999999999999999999999999999986432211 00 0 00000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
....+......+.+++.+||+.||++|| ++.++++
T Consensus 217 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 --EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 0112223456788999999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=332.56 Aligned_cols=252 Identities=21% Similarity=0.308 Sum_probs=195.6
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.|.+.++||+|+||+||+|+. .+++.+|||++.... ....+.+..|++++.+++||||+++++++.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999985 457899999986532 2345678999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++. +...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999998884 3346888999999999999999999987 9999999999999999999999999986432100
Q ss_pred c---------------------------------------------cCCceeeeccCcccCceeecCCCCCccccchhhH
Q 003274 670 L---------------------------------------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (834)
Q Consensus 670 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlG 704 (834)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001234699999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHh--ccccCCCCCCCHHHH
Q 003274 705 ILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALL--CVQENAADRPTMSDV 782 (834)
Q Consensus 705 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~ev 782 (834)
|++|||++|+.||.......... ....... .+ ..........++.+++.+ |+..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~-----~i~~~~~-------~~-~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQL-----KVINWEN-------TL-HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHH-----HHHcccc-------cc-CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 99999999999986533211100 0000000 00 001111234567778877 556677779999999
Q ss_pred HH
Q 003274 783 VS 784 (834)
Q Consensus 783 l~ 784 (834)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.89 Aligned_cols=253 Identities=30% Similarity=0.476 Sum_probs=202.9
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|.+.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 57888999999999999999988888999999875433 3567999999999999999999999875 456899999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ....+++..+..++.+++.||+|||+.+ |+||||||+||++++++.+||+|||++..+.......
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999988542 2345889999999999999999999987 9999999999999999999999999998765432211
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+...... .... .. .... ..
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~----~~---------~~~~-~~ 222 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLE----QV---------ERGY-RM 222 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHH----HH---------HcCC-CC
Confidence 111235678999999998999999999999999999999 78887532211 0000 00 0000 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..+......+.+++.+||+.+|++|||+.++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=320.68 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=204.0
Q ss_pred HhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
..++|++.++||+|+||.||+|... .+..||+|.+.... ......+.+|+.++++++||||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999643 24589999886443 2234568889999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeee
Q 003274 584 KILILEYMPNKSLDVYLFDPIK-------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 656 (834)
.++||||+++|+|.+++..... ...+.+..+.+++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999853211 234567888999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhh
Q 003274 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..|+.....+. .. ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~----~~- 233 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VL----KF- 233 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HH-
Confidence 99999987644332222222345778999999999999999999999999999998 677765322111 00 00
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.+... ...+......+.+++.+||+.+|++||++.++++.|++.
T Consensus 234 -------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 234 -------VMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -------HHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 000000 011222346899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=331.22 Aligned_cols=259 Identities=18% Similarity=0.215 Sum_probs=194.4
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.++||+|+||.||++.. ..++.||+|.... +.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999985 4578999997532 3568899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+. ++|..++. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 85 67777763 3346889999999999999999999987 9999999999999999999999999997543211
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCC-Cc----cccccchhhhhc---------
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT-DS----FNLLGHAWDLWK--------- 736 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~-~~----~~~~~~~~~~~~--------- 736 (834)
........||+.|+|||++.+..++.++|||||||+||||++|+.|+-.... +. ............
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~ 316 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID 316 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence 1122235799999999999999999999999999999999999977532211 00 000000000000
Q ss_pred c-ccccccc----c-cccccC-CC----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 H-ERVHELM----D-PVILQD-EI----PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~-~~~~~~~----~-~~~~~~-~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ....+.. . ...... .. ......++.+++.+||+.||++|||+.|+++
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 0000000 0 000000 00 0123457889999999999999999999985
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.60 Aligned_cols=240 Identities=25% Similarity=0.329 Sum_probs=190.5
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+|+.. .++.||+|.++... ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999864 47889999986532 23345566677777655 899999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQ---SSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 99988874 3346889999999999999999999987 9999999999999999999999999998653322 22
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ..... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--~~~----~i~~~-----------~~~~ 215 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--LFD----SILND-----------RPHF 215 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHcC-----------CCCC
Confidence 234578999999999999999999999999999999999999986432211 000 00000 1112
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHH-HHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMS-DVV 783 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 783 (834)
+.....++.+++.+||+.+|++||++. +++
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 223456778999999999999999876 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=318.09 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=205.8
Q ss_pred hcCcccccccccCCcEeEEEEEecC------ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|+||.||+|.... +..+|+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678899999999999999997532 3689999986543 23456788999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhccccc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 585 ILILEYMPNKSLDVYLFDPI-------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
++||||+++++|..++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999885422 1234788999999999999999999887 9999999999999999999999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhc
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... .. ....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~----~~~~ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VL----KFVI 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HH----HHHh
Confidence 9999987654433222333456789999999998899999999999999999998 888875322211 00 0110
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
... ....+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 ~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 01122233568899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=323.73 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=204.5
Q ss_pred hcCcccccccccCCcEeEEEEEec--------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 581 (834)
.++|.+.+.||+|+||.||+++.. ....+|+|.+.... .....++..|+.++.++ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 367999999999999999999742 23579999997542 33456788999999999 799999999999999
Q ss_pred CeEEEEEEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 582 GEKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
+..++||||+++|+|.+++.... ....+++..+++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999985432 1235889999999999999999999987 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCcccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..|+.....+. +
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~--~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--H
Confidence 9999999999999986643222222222234578999999999999999999999999999998 777775322110 0
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ...... . ....+.....++.+++.+||+.+|++||++.+|++.|+++
T Consensus 252 ~----~~~~~~---------~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 252 F----KLLKEG---------H-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred H----HHHHcC---------C-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 0 000000 0 0112223456888999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.51 Aligned_cols=260 Identities=27% Similarity=0.443 Sum_probs=206.2
Q ss_pred HhcCcccccccccCCcEeEEEEEec--------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE 580 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 580 (834)
..++|.+.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3477888999999999999999631 24579999986542 34457789999999999 89999999999999
Q ss_pred CCeEEEEEEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NIL 647 (834)
....++||||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 999999999999999999985421 1235788999999999999999999987 999999999999
Q ss_pred eccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccc
Q 003274 648 LDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFN 726 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~ 726 (834)
++.++.+||+|||+++.+.............+++.|+|||++.+..++.++||||||+++|||++ |..|+.......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 99999999999999987754333222223345678999999999999999999999999999998 677764322111
Q ss_pred cccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 727 LLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+ ........ ....+......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 248 ~----~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 248 L----FKLLKEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred H----HHHHHcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 0 00111000 0011223456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.43 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=208.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57889999999999999999865 7899999988642 2233567899999999999999999999999999999999
Q ss_pred EecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|..++.... ....+++..+..++.++++||+|||+.+ |+|+||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999998875422 2456889999999999999999999987 99999999999999999999999999886543
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+............ .+...
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~ 223 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-------------KIEKC 223 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh-------------hhhcC
Confidence 3211 22346888999999999999999999999999999999999997533221111100 00000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.............+.+++.+||..+|++||++.+|+++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 001111113456789999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.32 Aligned_cols=260 Identities=23% Similarity=0.393 Sum_probs=208.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++. .+++.+|||.+.... ....+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4678889999999999999984 578999999876432 234467889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|.+++... .....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999987532 23456899999999999999999999987 99999999999999999999999999887643
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.... .....++..|+|||.+.+..++.++||||||+++|||++|..|+.....+...... .......+
T Consensus 159 ~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~~~- 226 (267)
T cd08229 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK---------KIEQCDYP- 226 (267)
T ss_pred CCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh---------hhhcCCCC-
Confidence 3211 12346889999999999999999999999999999999999997533221111100 00000001
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
...+......+.+++.+||+.+|++||||.+|++++++++
T Consensus 227 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 227 ---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred ---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1112234568899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.52 Aligned_cols=264 Identities=22% Similarity=0.310 Sum_probs=194.3
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 585 (834)
+|++.++||+|+||.||+|+. .+++.||||++... .......+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 478889999999999999985 46889999998643 2234457889999999999999999999886432 479
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+. ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 67877763 3346899999999999999999999988 999999999999999999999999999865
Q ss_pred CCCCc-cCCceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-cccc--------chhh
Q 003274 666 GGDEL-QGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLG--------HAWD 733 (834)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~--------~~~~ 733 (834)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||........ .... ....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 33221 111233568999999999876 6789999999999999999999999864332100 0000 0000
Q ss_pred hhcccccccccccccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 734 LWKHERVHELMDPVILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+......+.+.........+ ......+.+++.+||+.||++||++.|+++
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000000000000000 012356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.79 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=203.5
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|.+.++||+|+||.||+|+..++..||+|++.... ...+.+.+|++++.+++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 35689999999999999999987777789999997532 345678999999999999999999998754 5689999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.++.+......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 999999998532 2345789999999999999999999987 999999999999999999999999999876543321
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....++..|+|||+..+..++.++||||||+++|||++ |..|+....... .. ...... . .
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~----~~~~~~-----~-----~ 221 (262)
T cd05071 159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL----DQVERG-----Y-----R 221 (262)
T ss_pred c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HH----HHHhcC-----C-----C
Confidence 1 112346778999999999999999999999999999999 777775332111 00 000000 0 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+...+..+.+++.+|++.+|++||++.+++++|++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 111233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.01 Aligned_cols=251 Identities=23% Similarity=0.299 Sum_probs=197.6
Q ss_pred CcccccccccCCcEeEEEEEe----cCccEEEEEEcccC----CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQ----SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 584 (834)
+|++.++||+|+||.||+++. ..++.+|+|++... .....+.+..|+.++.++ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999874 35789999998642 223345688899999999 599999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999998884 3456899999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
....... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||......... ...... .. .
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~-----~~-~ 225 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRR-----IL-K 225 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHH-----Hh-c
Confidence 5433221 22235799999999999865 4789999999999999999999998643221110 000000 00 0
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
.+ ...+......+.+++.+||+.||++|| ++.++++
T Consensus 226 ~~-----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 CD-----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC-----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01 112223456788999999999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.20 Aligned_cols=252 Identities=29% Similarity=0.366 Sum_probs=208.0
Q ss_pred cCcccccccccCCcEeEEEEEec--Ccc--EEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF--NGQ--EVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+++...++||+|.||+|++|.+. +|+ .||||.++..... ....|++|+.+|.+|+|+|+++|+|+..+ ...+||
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 45566789999999999999854 344 6899999876544 67889999999999999999999999987 788999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||.++.|+|.+.|++ ..+..+....+..++.|||.||.||.++. +|||||.++|+||-....+||+||||.+.++.
T Consensus 189 ~ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999977 56677889999999999999999999987 99999999999999999999999999998875
Q ss_pred CCc-cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcC-CCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 668 DEL-QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-RKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 668 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
++. ........-...|.|||.+....++.++|||+|||+||||+++ ..|+-... ...+.+.+|
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~---------------g~qIL~~iD 329 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR---------------GIQILKNID 329 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC---------------HHHHHHhcc
Confidence 542 3233333457789999999999999999999999999999984 45543221 111223333
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ..-.-+..+.++++++++.||..+|.+||++..+.+.
T Consensus 330 ~~-erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 AG-ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred cc-ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 21 1234466788999999999999999999999999743
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.10 Aligned_cols=259 Identities=28% Similarity=0.435 Sum_probs=204.7
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
.++|.+.++||+|+||.||+++.. .+..+|||.++... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 367899999999999999999742 34579999987543 23456789999999999 79999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++|+|.+++... ....+++..+..++.+++.||+|||+++ |+|+||||+|||++.++.+||+|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999988532 2234899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
...............++..|+|||.+.+..++.++|||||||++|||++ |..|+........ + ...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~----~~~-------- 256 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-F----YKL-------- 256 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-H----HHH--------
Confidence 6643321111222345778999999999999999999999999999998 8888754322110 0 000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ....+.....++.+++.+||+.+|++||++.|+++.|++.
T Consensus 257 -~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 -IKEGY-RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -HHcCC-cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00000 0011122346789999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=312.07 Aligned_cols=247 Identities=29% Similarity=0.409 Sum_probs=195.9
Q ss_pred ccccCCcEeEEEEEe---cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 520 KLGEGGFGPVYKGRL---FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+||+|+||.||+|.. .+++.+|+|+++... ....+++..|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999964 357889999986543 234567899999999999999999999875 45778999999999
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC-C
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG-N 673 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 673 (834)
+|.+++. ....+++..+.+++.|++.||+|||+.+ |+||||||.||+++.++.+||+|||+++.+....... .
T Consensus 81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999884 3346889999999999999999999987 9999999999999999999999999998765433211 1
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.....++..|+|||.+....++.++||||||+++|||++ |+.||....... .. ....... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~----~~i~~~~----------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VT----QMIESGE----------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHCCC----------CCC
Confidence 112234678999999988899999999999999999998 888886432111 10 0111000 111
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.....++.+++.+||+.||++||++.+|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2233456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=327.55 Aligned_cols=241 Identities=23% Similarity=0.296 Sum_probs=194.5
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+++. .+++.+|+|.+... .......+..|++++..++||||+++++++......++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 46889999998653 2234566788999999999999999999999999999999999999
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
+|..++. ....+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 9988773 34568999999999999999999997 56 9999999999999999999999999987643221 11
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||.....+.. . ...... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--~----~~i~~~-----------~~~~ 215 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--F----ELILME-----------EIRF 215 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--H----HHHhcC-----------CCCC
Confidence 2235699999999999999999999999999999999999999864322110 0 000000 0112
Q ss_pred CHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
+.....++.+++.+||+.||++|+ ++.++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 223456788999999999999996 8999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=318.14 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=193.4
Q ss_pred cCcccccccccCCcEeEEEEEe--cCccEEEEEEcccCC--cccHHHHHHHHHHHhhc---CCCceeeEEEEEEe-----
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL--FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL---QHRNLVRILGCCVE----- 580 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~----- 580 (834)
++|.+.+.||+|+||.||+++. .+++.||+|+++... ......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688889999999999999985 246789999886532 22234566787777766 69999999999863
Q ss_pred CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
....++||||+. ++|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346899999997 5888877432 2345889999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc----
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK---- 736 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---- 736 (834)
+++..... .......||+.|+|||.+.+..++.++|||||||++|||++|++||....... ..........
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence 99876433 12233568999999999999999999999999999999999999987543211 0000000000
Q ss_pred ccccc--cccccccc-cCC-----CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HERVH--ELMDPVIL-QDE-----IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~--~~~~~~~~-~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ......+. ... ........+.+++.+||+.||++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 00000000 000 01123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=331.85 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=202.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+++.. +++.||||++.... ......+..|++++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999864 68899999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999998843 357899999999999999999999987 999999999999999999999999999876433
Q ss_pred C---------------------------ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCC
Q 003274 669 E---------------------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN 721 (834)
Q Consensus 669 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~ 721 (834)
. .........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223568999999999999999999999999999999999999986533
Q ss_pred CCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC-HHHHHHH
Q 003274 722 TDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT-MSDVVSM 785 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~ 785 (834)
.... ...... .. ..+ ..........++.+++.+|+. +|.+||+ +.++++.
T Consensus 235 ~~~~-----~~~i~~------~~-~~~-~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET-----YNKIIN------WK-ESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH-----HHHHhc------cC-Ccc-cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2110 000000 00 000 000011135678899999997 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.27 Aligned_cols=242 Identities=23% Similarity=0.331 Sum_probs=191.2
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+++.. +++.+|+|+++.. .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999854 5789999998753 223445678899888877 899999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 99988773 3456899999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc---ccccchhhhhccccccccccccccc
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF---NLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ............ . .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~--------~---~ 221 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--------K---Q 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc--------C---C
Confidence 2335789999999999999999999999999999999999999864221110 000011111000 0 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTM 779 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
...+......+.+++.+||+.||++||+.
T Consensus 222 ~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 12333445678899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=319.89 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=200.8
Q ss_pred cCcccccccccCCcEeEEEEEecC-cc--EEEEEEcccC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 587 (834)
++|++.++||+|+||.||+|...+ +. .+++|.++.. .....+.+..|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578889999999999999998643 32 4788888743 233456789999999999 799999999999999999999
Q ss_pred EEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCe
Q 003274 588 LEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
+||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999885321 1235889999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhh
Q 003274 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||....... .. .
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~----~ 229 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LY----E 229 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----H
Confidence 999999986432110 1111223567999999999999999999999999999997 988875432211 00 0
Q ss_pred hhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.. .... ....+......+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 230 ~~---------~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 230 KL---------PQGY-RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HH---------hcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 00 0000 11122234467889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=321.71 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=195.3
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+++.. +++.||+|+++.. .....+.+..|..++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999854 5789999999753 223456688899999998 799999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 99988773 3456899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCc---cccccchhhhhccccccccccccccc
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS---FNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........... ... .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--------~~~---~ 221 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI--------LEK---Q 221 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH--------HcC---C
Confidence 233578999999999999999999999999999999999999986432211 00001111111 000 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCC------HHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPT------MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~ 784 (834)
...+.....++.+++.+||+.||++||+ +.++++
T Consensus 222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1123334567899999999999999997 567754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.59 Aligned_cols=271 Identities=27% Similarity=0.413 Sum_probs=202.5
Q ss_pred cCcccccccccCCcEeEEEEEe-----cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 584 (834)
+.|.+.++||+|+||.||+++. ..+..||+|.++... ....+.+.+|++++++++||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4467889999999999999973 357789999987543 33456799999999999999999999998875 568
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999998843 2335899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433211 111234567789999999988999999999999999999998765322111000000000000000000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEGK-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcCc-cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 1111223456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.53 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=201.5
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCcc----EEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.++||+|+||+||+|+. .+++ +||+|.++... ....+++.+|+.++..++|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 36788889999999999999984 3444 48999986543 33456788999999999999999999999754 578
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+++||+++|+|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999998853 2346899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... +. .......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~----~~~~~~~----- 228 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IP----DLLEKGE----- 228 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HH----HHHHCCC-----
Confidence 53322111112234678999999999999999999999999999998 888875322111 00 0000000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.||++||++.++++.|+++
T Consensus 229 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~ 268 (279)
T cd05109 229 -----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM 268 (279)
T ss_pred -----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 0111223456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.70 Aligned_cols=240 Identities=23% Similarity=0.317 Sum_probs=191.3
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+++.. +++.||+|.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999864 57899999986532 23445667788888765 899999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQ---DKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 99988873 3356889999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ...... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~----~~~~~~-----------~~~~ 215 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LF----ESIRVD-----------TPHY 215 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH----HHHHhC-----------CCCC
Confidence 234578999999999999999999999999999999999999986432211 00 000000 0111
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHH-HHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMS-DVV 783 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 783 (834)
+.....++.+++.+||+.||++||++. +++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 222445788999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.79 Aligned_cols=254 Identities=23% Similarity=0.362 Sum_probs=201.7
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.+.||+|+||.||+|+. .+++.+|+|++........+.+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 5788999999999999999985 568899999987655555667889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.....
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 9999998874 3356889999999999999999999987 99999999999999999999999999987643221
Q ss_pred CCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
......|+..|+|||.+. ...++.++|||||||++|||++|+.|+......... ... ... ...+..
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~~~-----~~~----~~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLM-----SKS----NFQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-eee-----ecC----CCCCCC
Confidence 122346889999999884 455789999999999999999999987532211100 000 000 000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..........+.+++.+||+.+|++||++.++++.|
T Consensus 231 --~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 --LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred --CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 001112346889999999999999999999998643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=332.09 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=198.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||.||+++.. .++.||||++.... ......+.+|+.++..++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47889999999999999999864 58899999986532 234456888999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999884 3456899999999999999999999988 999999999999999999999999998765321
Q ss_pred CccC------------------------------------CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc
Q 003274 669 ELQG------------------------------------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (834)
Q Consensus 669 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt 712 (834)
.... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0012368999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC---HHHHHH
Q 003274 713 SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT---MSDVVS 784 (834)
Q Consensus 713 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 784 (834)
|+.||....... .. ....... ..+ ...........+.+++.+|+. +|.+|++ +.|+++
T Consensus 235 G~~Pf~~~~~~~--~~---~~i~~~~-------~~~-~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQE--TY---RKIINWK-------ETL-QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHH--HH---HHHHcCC-------Ccc-CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999986432211 00 0000000 000 000111234577889999996 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=317.06 Aligned_cols=264 Identities=26% Similarity=0.426 Sum_probs=201.8
Q ss_pred cCcccccccccCCcEeEEEEEec-----------------CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-----------------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRI 574 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l 574 (834)
++|++.++||+|+||.||+++.. +...+|+|.+.... ....+.+.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 57899999999999999998532 23468999987543 3345679999999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCcchhccccc--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 003274 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPI--------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNV 646 (834)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NI 646 (834)
++++......++||||+++++|.+++.... ....+++..+.+++.|++.||+|||+.+ ++|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999885421 1234778899999999999999999987 99999999999
Q ss_pred EeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc--CCCCCCCCCCCc
Q 003274 647 LLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS--SRKNTGVYNTDS 724 (834)
Q Consensus 647 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt--G~~p~~~~~~~~ 724 (834)
|++.++.+||+|||+++.+.............++..|+|||....+.++.++|||||||++|||++ |..|+.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999987644332222222344678999999888899999999999999999998 556664332211
Q ss_pred cccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.............. .. ....+......+.+++.+||+.||++||++.+|++.|++
T Consensus 242 --~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 --VIENTGEFFRDQGR-QV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHhhccc-cc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11111111100000 00 001122234688999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=324.73 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=193.7
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+|+.. .++.+|+|++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 47999999999999864 4789999998653 233455678899998876 799999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|...+. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~ 152 (321)
T cd05591 81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T 152 (321)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence 99988873 3456889999999999999999999987 99999999999999999999999999876432221 2
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .. ... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~----~i--------~~~---~~~~ 215 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFE----SI--------LHD---DVLY 215 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHH----HH--------HcC---CCCC
Confidence 233568999999999999999999999999999999999999986433211 000 00 000 0011
Q ss_pred CHHHHhHHHHHHHhccccCCCCCC-------CHHHHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRP-------TMSDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~ 784 (834)
+.....++.+++.+||+.||++|| ++.++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 222346788999999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=324.28 Aligned_cols=241 Identities=24% Similarity=0.321 Sum_probs=193.5
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~ 588 (834)
+|++.+.||+|+||.||+|+.. .++.||||++... .....+.+..|.+++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999854 4678999998653 23345678889999999976 46888999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999988873 3446889999999999999999999987 999999999999999999999999998753221
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... . +...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~----~--------i~~~-- 216 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LFQ----S--------IMEH-- 216 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH----H--------HHcC--
Confidence 1 12334579999999999999999999999999999999999999986432111 000 0 0000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTM 779 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
....+.....++.+++.+||+.||.+|++.
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111222345678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.56 Aligned_cols=266 Identities=23% Similarity=0.335 Sum_probs=202.4
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcc--cCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-----CCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-----QGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-----~~~ 583 (834)
...|...+.||+|+||.|..+.. .+|+.||||++. -......++..+|+++|+.++|+||+.+.+.+.- -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 34566578999999999999984 568999999987 3345566788999999999999999999998865 347
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.|+|+|+| ..+|...+. ....+.......++.|+++||+|+|+.+ ++||||||.|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 567777762 3344899999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCCccCCceeeeccCcccCceeec-CCCCCccccchhhHHHHHHHhcCCCCCCCCCC-Cccccccch--------hh
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSRKNTGVYNT-DSFNLLGHA--------WD 733 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGvll~elltG~~p~~~~~~-~~~~~~~~~--------~~ 733 (834)
...........+..+.|..|.|||++. ...|+.+.||||.||+|.||++|++.|.+.+. ++..++... ..
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ 253 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence 886543333445567899999999975 56899999999999999999999998875443 111111110 11
Q ss_pred hhcccccccccccccccCCCCH-----HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 734 LWKHERVHELMDPVILQDEIPL-----PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.....+.........+. .......+|+.+||..||.+|+|++|.++
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111111111111110111111 23457889999999999999999999976
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=303.40 Aligned_cols=268 Identities=25% Similarity=0.303 Sum_probs=199.4
Q ss_pred hcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCc-eeeEEEEEEeCC-----
Q 003274 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRN-LVRILGCCVEQG----- 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~----- 582 (834)
...|...++||+|+||+||+|+ ..+|+.||+|++....+ .......+|+.++++++|+| ||+|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3556667889999999999998 45689999999876533 23455689999999999999 999999999877
Q ss_pred -eEEEEEEecCCCCcchhccccccc-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 583 -EKILILEYMPNKSLDVYLFDPIKK-RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
..++||||++. +|..++...... ..++...+..++.||++||+|||+++ |+||||||+||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 78899999854 787777443221 45677889999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-----cccc-hhh
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-----LLGH-AWD 733 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-----~~~~-~~~ 733 (834)
+|+...-.. ......++|..|.|||++.+. .|+...||||+||++.||+++++-|....+..+. +.+. ...
T Consensus 166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEK 243 (323)
T ss_pred hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCcc
Confidence 999654222 113345789999999999877 7999999999999999999999888765441110 0100 001
Q ss_pred hhcccccccccccccccCCCCHHH-------HhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 734 LWKHERVHELMDPVILQDEIPLPM-------LMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.|.......-.+........+... .....+++.+||+.+|.+|.++..+++.
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111010111111000001111 1477899999999999999999999875
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.02 Aligned_cols=271 Identities=28% Similarity=0.415 Sum_probs=205.9
Q ss_pred cCcccccccccCCcEeEEEEEec-----CccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~ 584 (834)
++|.+.+.||+|+||.||+++.. .+..+|||.+...... ..+.|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46777889999999999999853 3678999999765443 46789999999999999999999999887 5578
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999998532 235899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+........................+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 7532211 111122445679999999988999999999999999999999988654322111100000000000011111
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ....+.....++.+++.+||+.+|++||++.||+++|+++
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKEGE-RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHcCC-cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11111 1111223346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.09 Aligned_cols=254 Identities=31% Similarity=0.451 Sum_probs=204.4
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|.+.++||+|+||.||+|...+++.+|+|.+.... ...+.+.+|+.++++++|+||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46788899999999999999998889999999987543 34567899999999999999999999864 55789999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999987532 3346889999999999999999999987 999999999999999999999999999876533221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....++..|+|||++....++.++||||||+++|||++ |+.|+....... ... ... ... .
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~---------~~~-~ 221 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQ----NLE---------RGY-R 221 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHH----HHH---------cCC-C
Confidence 1 112345678999999999999999999999999999998 898886432111 000 000 000 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
...+.....++.+++.+||+.+|++||++.++++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11122234579999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=312.20 Aligned_cols=254 Identities=28% Similarity=0.391 Sum_probs=193.1
Q ss_pred cccccCCcEeEEEEEecC---ccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 519 CKLGEGGFGPVYKGRLFN---GQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.||+|+||.||+|+..+ +..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998543 45799999875432 33457889999999999999999999999999999999999999
Q ss_pred Ccchhccccc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 595 SLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 595 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999985432 2234677788899999999999999987 9999999999999999999999999997654433222
Q ss_pred CceeeeccCcccCceeecCC-------CCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 673 NTKRIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~-------~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
......++..|+|||++.+. .++.++||||||+++|||++ |+.|+........ ... ..........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTY----TVREQQLKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHH----HhhcccCCCC
Confidence 22334578899999998642 35789999999999999996 9989864332211 000 0000001111
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
++ .........+.+++..|+ .+|++||++.||+..|.
T Consensus 232 ~~-----~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KP-----RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CC-----ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11 112223456788999999 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.07 Aligned_cols=240 Identities=21% Similarity=0.274 Sum_probs=188.7
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHH-HHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+++. .+|+.+|+|++.... ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4799999999999985 468899999986531 223345555655 46778999999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 152 (325)
T cd05604 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT 152 (325)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence 99988773 3456899999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. .. ++.... ..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~----~~--------~~~~~~---~~ 215 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MY----DN--------ILHKPL---VL 215 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--HH----HH--------HHcCCc---cC
Confidence 234578999999999999999999999999999999999999986432111 00 00 000000 11
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHHHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
+......+.+++.+||+.+|++||++.+.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 122345778999999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=311.10 Aligned_cols=239 Identities=21% Similarity=0.326 Sum_probs=188.7
Q ss_pred cccccCCcEeEEEEEecC-------------ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 519 CKLGEGGFGPVYKGRLFN-------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
+.||+|+||.||+|+... ...+++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 469999999999997432 2258999987655555667899999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC-------eeecc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-------PKISD 658 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~-------~kl~D 658 (834)
+||||+++++|+.++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888742 2346899999999999999999999987 999999999999987664 89999
Q ss_pred cccceecCCCCccCCceeeeccCcccCceeec-CCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhc
Q 003274 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
||++...... ....++..|+|||.+. +..++.++|||||||++|||++ |..|+........ ....
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~- 222 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK------ERFY- 222 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH------HHHH-
Confidence 9998764322 1235788999999887 5678999999999999999984 7776543221110 0000
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
... .....+...++.+++.+||+.||++||++.++++.|
T Consensus 223 --------~~~---~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 --------EGQ---CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --------hcC---ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 011112345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=312.40 Aligned_cols=257 Identities=28% Similarity=0.469 Sum_probs=203.7
Q ss_pred hcCcccccccccCCcEeEEEEEecC-c---cEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN-G---QEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|+..+.||+|+||.||+|+... + ..+|+|.+.... ....+.+..|++++.+++|+||+++++++...+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3577888999999999999998642 3 379999986542 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|..++.. ....+++..+..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999998843 2356899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCCccCCc-eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 667 GDELQGNT-KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 667 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
........ .....+..|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ......
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--~~----~~i~~~------ 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--VM----KAINDG------ 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH----HHHhcC------
Confidence 33221111 11223567999999998899999999999999999997 999875332111 00 000000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ....+......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ---~-~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ---F-RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---C-CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 1111223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=307.50 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=198.4
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcc
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
++||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 47999999999999988889999999876543 23456889999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceee
Q 003274 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 677 (834)
+++.. ....+++..+..++.+++.+|.|||+.+ ++|+||||+||+++.++.+||+|||++......... .....
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~ 154 (250)
T cd05085 81 SFLRK--KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK 154 (250)
T ss_pred HHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence 98743 2345789999999999999999999987 999999999999999999999999999765432221 11122
Q ss_pred eccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH
Q 003274 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (834)
.++..|+|||++....++.++||||||+++|||++ |..|+....... .. ...... . ....+..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~----~~~~~~-----~-----~~~~~~~ 218 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AR----EQVEKG-----Y-----RMSCPQK 218 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HH----HHHHcC-----C-----CCCCCCC
Confidence 34678999999999999999999999999999998 888875332111 00 000000 0 1112223
Q ss_pred HHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 757 MLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
....+.+++.+||+.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 4568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.08 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=203.5
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999853 46789999987543 23456789999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhccccc-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 003274 585 ILILEYMPNKSLDVYLFDPI-------------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N 645 (834)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999985321 1234788899999999999999999987 9999999999
Q ss_pred EEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCc
Q 003274 646 VLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDS 724 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~ 724 (834)
|+++.++.+||+|||+++.+..............+..|+|||.+.+..++.++|||||||++|||++ |..|+.......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999986644332222222334678999999999999999999999999999997 777764322110
Q ss_pred cccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.. ........ ...+.....++.+++.+||+.+|++||++.|+++.|++
T Consensus 241 --~~----~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 --VI----YYVRDGNV----------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HH----HHHhcCCC----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 00 00111100 01122234678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=321.32 Aligned_cols=241 Identities=24% Similarity=0.302 Sum_probs=194.3
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+++.. +++.+|||++... .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999864 4789999998753 233456678899999888 799999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 99988773 3346899999999999999999999987 9999999999999999999999999987532221 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..... . ....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~~----~~i~~--------~---~~~~ 215 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--LF----QSILE--------D---EVRY 215 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--HH----HHHHc--------C---CCCC
Confidence 233578999999999999999999999999999999999999986432111 00 00000 0 0112
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTM-----SDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 784 (834)
+......+.+++.+||+.||++||++ .++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 22345678999999999999999999 88765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=320.47 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=204.8
Q ss_pred hcCcccccccccCCcEeEEEEEec--------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 581 (834)
.++|.+.++||+|+||.||+++.. ....+|+|.++... ......+..|++++.++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 367888999999999999999742 24578999987542 34456789999999999 699999999999999
Q ss_pred CeEEEEEEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 582 GEKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
+..++||||+++|+|..++.... ....+++..+.+++.|++.||+|||+.+ ++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999985421 1245889999999999999999999987 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCcccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+....... +
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--L 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--H
Confidence 9999999999999987654322222222234568999999999999999999999999999999 777775322111 0
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
. ....... ....+.....++.+++.+||+.+|++||++.++++.|.++.
T Consensus 246 ~----~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 246 F----KLLREGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred H----HHHHcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 0 0000000 01112233457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.56 Aligned_cols=241 Identities=24% Similarity=0.328 Sum_probs=193.6
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 588 (834)
+|.+.++||+|+||.||+++.. +++.+|+|.+.... ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999854 46799999987532 23345567788888877 6899999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999988873 3356889999999999999999999987 999999999999999999999999999764322
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. .. +...
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~----~~--------i~~~-- 216 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LF----QS--------IMEH-- 216 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HH----HH--------HHhC--
Confidence 2 12233578999999999999999999999999999999999999986432211 10 00 0000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTM 779 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
....+.....++.+++.+||+.+|++|++.
T Consensus 217 -~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111233345678999999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.61 Aligned_cols=251 Identities=24% Similarity=0.314 Sum_probs=199.9
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.|++.++||+|+||.||++.. .+++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 367788999999999999985 468899999986532 2223457889999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|..++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887532 2346899999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||........ .. .....+...
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~---------~~~~~~~~~-- 220 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--RE---------EVERRVKED-- 220 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HH---------HHHHHhhhc--
Confidence 1 1234689999999999999999999999999999999999999864322110 00 000000000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
....+......+.+++.+||+.||++|| ++.++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1112233456789999999999999999 7778754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.75 Aligned_cols=201 Identities=26% Similarity=0.352 Sum_probs=173.8
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||+||+++.. .++.+|+|++.... ......+..|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999854 58899999986532 233456888999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. +...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999884 3457899999999999999999999987 999999999999999999999999998765321
Q ss_pred Ccc---------------------------------CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCC
Q 003274 669 ELQ---------------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRK 715 (834)
Q Consensus 669 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~ 715 (834)
... .......||+.|+|||++.+..++.++|||||||+||||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123479999999999999999999999999999999999999
Q ss_pred CCCC
Q 003274 716 NTGV 719 (834)
Q Consensus 716 p~~~ 719 (834)
||..
T Consensus 235 Pf~~ 238 (363)
T cd05628 235 PFCS 238 (363)
T ss_pred CCCC
Confidence 9864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=309.20 Aligned_cols=251 Identities=29% Similarity=0.428 Sum_probs=204.8
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|.+.+.||+|+||.||++.. .++.||+|.+..... ..+++.+|+.++.+++|+||+++++++......++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 36788899999999999999985 478999999976543 5678999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999988432 2236899999999999999999999987 99999999999999999999999999987632221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
....+..|+|||.+....++.++||||||+++|||++ |+.|+....... +.. .... .. .
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~----~~~~---------~~-~ 217 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVP----HVEK---------GY-R 217 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH----HHhc---------CC-C
Confidence 2234678999999998899999999999999999997 888875432111 100 0000 00 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+...+..+.+++.+||..+|++||++.|++++|+++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 111223356889999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=314.60 Aligned_cols=246 Identities=24% Similarity=0.323 Sum_probs=195.1
Q ss_pred cccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||+||++.. .+++.+|+|.+.... ....+.+..|++++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999985 468899999986532 22345678899999999999999999999999999999999999999
Q ss_pred chhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCce
Q 003274 597 DVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 597 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 675 (834)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88774322 3456899999999999999999999987 99999999999999999999999999987644322 122
Q ss_pred eeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCH
Q 003274 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPL 755 (834)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (834)
...||+.|+|||++.+..++.++||||||+++|||++|+.||......... . .. ........ ...+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~-----~~----~~~~~~~~---~~~~~ 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-K-----EL----KQRILNDS---VTYPD 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-H-----HH----HHhhcccC---CCCcc
Confidence 357899999999999999999999999999999999999998643221100 0 00 00011110 11223
Q ss_pred HHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 756 PMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
.....+.+++.+||+.||++|| ++.++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 3456788999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=323.48 Aligned_cols=236 Identities=25% Similarity=0.349 Sum_probs=190.6
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+++.. +++.||||++... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999864 5789999998643 233456678888888877 699999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 99988874 3456899999999999999999999987 9999999999999999999999999987643221 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ...... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~----~~i~~~-----------~~~~ 215 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LF----EAILND-----------EVVY 215 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HH----HHHhcC-----------CCCC
Confidence 233578999999999999999999999999999999999999986433211 00 000000 0011
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTM 779 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
+.....++.+++.+||+.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 22245678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.62 Aligned_cols=260 Identities=28% Similarity=0.414 Sum_probs=200.5
Q ss_pred hcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC-C
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ-G 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~-~ 582 (834)
.++|.+.++||+|+||.||+|.. ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 36789999999999999999963 346789999997543 23346788999999999 789999999988654 4
Q ss_pred eEEEEEEecCCCCcchhcccccc---------------------------------------------------------
Q 003274 583 EKILILEYMPNKSLDVYLFDPIK--------------------------------------------------------- 605 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 605 (834)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999988753210
Q ss_pred -------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeee
Q 003274 606 -------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678 (834)
Q Consensus 606 -------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 678 (834)
...+++..+.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124688889999999999999999987 9999999999999999999999999998754332211222234
Q ss_pred ccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHH
Q 003274 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPM 757 (834)
Q Consensus 679 gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 757 (834)
++..|+|||.+.+..++.++||||||+++|||++ |..|+........ + ........ ....+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~----~~~~~~~~----------~~~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F----CRRLKEGT----------RMRAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-H----HHHHhccC----------CCCCCCCC
Confidence 5678999999999999999999999999999997 8888753221110 0 00000000 00111122
Q ss_pred HhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 758 LMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 758 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..++.+++..||+.+|++||++.|+++.|+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 35789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.68 Aligned_cols=253 Identities=23% Similarity=0.291 Sum_probs=196.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+++. .+++.||||++... .....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4788899999999999999974 46889999998643 2234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLI---KYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999998884 3456888999999999999999999988 999999999999999999999999999643211
Q ss_pred Cc------------cC---------------------------------CceeeeccCcccCceeecCCCCCccccchhh
Q 003274 669 EL------------QG---------------------------------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSF 703 (834)
Q Consensus 669 ~~------------~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSl 703 (834)
.. .. ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 00 00 0012469999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCC---CCHH
Q 003274 704 GILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADR---PTMS 780 (834)
Q Consensus 704 Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~ 780 (834)
||+||||++|+.||....... ... ....... .+ .-........++.+++.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~--~~~---~i~~~~~-------~~-~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE--TYR---KIINWRE-------TL-YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH--HHH---HHHccCC-------cc-CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999986432211 000 0000000 00 000011234577899999997 67765 5999
Q ss_pred HHHHH
Q 003274 781 DVVSM 785 (834)
Q Consensus 781 evl~~ 785 (834)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=312.24 Aligned_cols=249 Identities=26% Similarity=0.378 Sum_probs=197.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+|+. .+++.+|+|.+... .....+++.+|++++.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4677889999999999999984 56889999998654 233456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9999996542 4678888999999999999999987 9999999999999999999999999998654322
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcccccc-chhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG-HAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 749 (834)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||............ ......... ..+.
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 219 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPV-- 219 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCC--
Confidence 22347899999999999999999999999999999999999998653322111100 000000000 0000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........++.+++.+||+.+|++||++.|+++
T Consensus 220 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 --LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred --CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 011123457889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.57 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=199.4
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
..++|.+.++||+|+||.||+++.. +++.+|+|.+... .....+.+..|+.+++.++||||+++++++.+....++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4578999999999999999999854 5889999998642 22334567889999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|..++. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMS----NYDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999998873 335788889999999999999999987 9999999999999999999999999998764
Q ss_pred CCCccCCceeeeccCcccCceeecCC----CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
..... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||....... ..........
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~i~~~~~--- 264 (370)
T cd05596 194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIMDHKN--- 264 (370)
T ss_pred CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-----HHHHHHcCCC---
Confidence 33211 12235799999999998653 47899999999999999999999986432210 0000000000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCC--CCCHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAAD--RPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 784 (834)
.+ ..........++.+++.+||+.+|++ ||++.|+++
T Consensus 265 ----~~-~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 265 ----SL-TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred ----cC-CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 00 00011123567889999999999987 999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=322.35 Aligned_cols=237 Identities=23% Similarity=0.271 Sum_probs=187.3
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHH-HHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||+||+++.. +++.||+|++.... ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999864 68899999986432 122334455544 56778999999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (323)
T cd05575 81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT 152 (323)
T ss_pred CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence 99988874 3456889999999999999999999987 9999999999999999999999999987542221 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. . .++... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~---~---------~i~~~~---~~~ 215 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--MY---D---------NILNKP---LRL 215 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--HH---H---------HHHcCC---CCC
Confidence 334578999999999999999999999999999999999999986432111 00 0 000000 011
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMS 780 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 780 (834)
+......+.+++.+||+.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 222356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=308.47 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=201.9
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|.+.++||+|++|.||++....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999886533 34467899999999999999999998875 456899999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999988542 2345789999999999999999999987 9999999999999999999999999998764332211
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... ..... . ..
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~----~~~~~-----~-----~~ 222 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLE----QVERG-----Y-----RM 222 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcC-----C-----CC
Confidence 112345778999999999999999999999999999999 888875422111 000 00000 0 00
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..+...+..+.+++.+||+.+|++||++.+|+++|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1122345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=320.66 Aligned_cols=259 Identities=27% Similarity=0.435 Sum_probs=204.6
Q ss_pred cCcccccccccCCcEeEEEEEec--------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 582 (834)
.+|.+.+.||+|+||.||+++.. .+..+|+|.+.... ....+++.+|++++.++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46888999999999999999632 12368999887542 33467899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec
Q 003274 583 EKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~ 649 (834)
..++++||+++|+|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999885421 2235788999999999999999999987 99999999999999
Q ss_pred cCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccc
Q 003274 650 KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLL 728 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~ 728 (834)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||++||||++ |..|+.....+. ..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~ 246 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LF 246 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HH
Confidence 999999999999987654332222222344578999999999999999999999999999998 777765332111 00
Q ss_pred cchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 729 GHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
...... . ....+.....++.+++.+||+.+|++||++.|+++.|+++.
T Consensus 247 ----~~~~~~---------~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 247 ----KLLKEG---------H-RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHcC---------C-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 000000 0 01112234567889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=308.45 Aligned_cols=248 Identities=27% Similarity=0.397 Sum_probs=195.1
Q ss_pred ccccCCcEeEEEEEec---CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 003274 520 KLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
.||+|+||.||+|... .+..||+|.+..... ...+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 355799999876533 33467999999999999999999999885 457899999999999
Q ss_pred cchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC-Cc
Q 003274 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG-NT 674 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~ 674 (834)
|.+++.. ....+++..+++++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++......... ..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998843 3456899999999999999999999987 9999999999999999999999999998654332111 11
Q ss_pred eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... . ........ ....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~~~----------~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--V----MSFIEQGK----------RLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--H----HHHHHCCC----------CCCC
Confidence 11223578999999998899999999999999999996 888876432211 0 00000000 1112
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.....++.+++.+||..+|++||++.+|.+.|+..
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 333456888999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=325.88 Aligned_cols=238 Identities=27% Similarity=0.323 Sum_probs=192.3
Q ss_pred cccccCCcEeEEEEEe----cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 519 CKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++||+|+||.||+++. ..|+.+|+|++.... ......+..|++++.+++||||+++++++...+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 357899999986532 2234567789999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|+|.+++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 999988873 3456899999999999999999999988 9999999999999999999999999988654322 1
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||....... .. . .+... ...
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~---~---------~i~~~---~~~ 216 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE--TM---T---------MILKA---KLG 216 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH--HH---H---------HHHcC---CCC
Confidence 2233578999999999999999999999999999999999999986432110 00 0 00000 011
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCHHH
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTMSD 781 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
.+......+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22234567889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=311.96 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=201.7
Q ss_pred cCcccccccccCCcEeEEEEEecC-c---cEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.+|.+.+.||+|+||.||+|+... + ..||||.+... .....++|..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347788999999999999998643 3 36999998754 344567899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998843 2346899999999999999999999987 99999999999999999999999999876643
Q ss_pred CCccCC-ceeee--ccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 668 DELQGN-TKRIV--GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 668 ~~~~~~-~~~~~--gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... ..... .+..|+|||.+.+..++.++||||||+++|||++ |..|+...... ... .... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~----~~i~-----~~ 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVI----NAIE-----QD 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHH----HHHH-----cC
Confidence 321111 11111 2457999999999999999999999999999886 88887533211 000 0000 00
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ....+...+..+.+++.+||+.+|++||++.+++.+|+++
T Consensus 228 ~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 Y-----RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-----cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0111223346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=309.05 Aligned_cols=249 Identities=30% Similarity=0.410 Sum_probs=198.8
Q ss_pred cccccCCcEeEEEEEecC--c--cEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLFN--G--QEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|++|.||+|.... + ..+|+|.+..... ...+.+..|++++.+++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 479999999999998543 3 3689999977655 566789999999999999999999999988 889999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc-C
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ-G 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 672 (834)
++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999998854322 56899999999999999999999987 999999999999999999999999999876542211 1
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ... ..... .. ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~---~~~~~-------~~---~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILK---KIDKE-------GE---RL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHH---HHHhc-------CC---cC
Confidence 1122456789999999999999999999999999999998 999875322111 000 00000 00 01
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
..+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112223467899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=304.26 Aligned_cols=253 Identities=22% Similarity=0.274 Sum_probs=206.2
Q ss_pred cCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||.|.-|+||.+++.+ +..+|+|++.+.. .+...+...|.+||+.++||.++.|++.++.+...+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 567788899999999999999765 5889999997653 344566788999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC-
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG- 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~- 667 (834)
|||+||+|...++ .+..+.++++.+..++.+|+-||+|||-.| ||.|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~Lrq-kQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQ-KQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHh-hCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999988764 346678999999999999999999999998 99999999999999999999999999754311
Q ss_pred ------C-------------------------C-c---------------------cCCceeeeccCcccCceeecCCCC
Q 003274 668 ------D-------------------------E-L---------------------QGNTKRIVGTYGYMSPEYALDGLF 694 (834)
Q Consensus 668 ------~-------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 694 (834)
. . . ......++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 0 011223689999999999999999
Q ss_pred CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCC
Q 003274 695 SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAA 774 (834)
Q Consensus 695 t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 774 (834)
+.++|+|+|||+|||||.|..||...+.++. +..++...+.-.+.+ ..+..+.+||++.|..||+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--------------l~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--------------LRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhh--------------HHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChh
Confidence 9999999999999999999999987655432 112222221111111 4456889999999999999
Q ss_pred CCCC----HHHHHH
Q 003274 775 DRPT----MSDVVS 784 (834)
Q Consensus 775 ~RPt----~~evl~ 784 (834)
+|.. +.||-+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9998 777754
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=309.60 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=201.8
Q ss_pred HHHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 509 AAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 509 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 345667777789999999999999854 5778999998776666677899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeecccccceecC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~ 666 (834)
+||+++++|..++.........+...+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 999999999998854222112277888899999999999999987 999999999999986 6799999999998664
Q ss_pred CCCccCCceeeeccCcccCceeecCCC--CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... ......+++.|+|||++.... ++.++||||||+++|||++|+.|+........... ... ..
T Consensus 161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-------~~~-~~--- 227 (268)
T cd06624 161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-------KVG-MF--- 227 (268)
T ss_pred cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-------hhh-hh---
Confidence 3221 122245789999999987644 78999999999999999999999764322111000 000 00
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .....+.....++.+++.+||+.+|++||++.|+++
T Consensus 228 --~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 228 --K-IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred --c-cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0 011223334567899999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=318.33 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=200.2
Q ss_pred cCcccccccccCCcEeEEEEEec-Ccc--EEEEEEcccC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 587 (834)
++|++.+.||+|+||.||+|+.. ++. .+|+|.+... .....+.+.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 67888999999999999999854 343 4688877643 233456788999999999 899999999999999999999
Q ss_pred EEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCe
Q 003274 588 LEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
|||+++++|.+++.... ....++++.++.++.|+++||+|||+.+ ++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999885432 1235889999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhh
Q 003274 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||+++..... .......++..|+|||++.+..++.++|||||||++|||++ |..|+....... ...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~---- 234 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LYE---- 234 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH--HHH----
Confidence 99999998643211 11111234678999999988889999999999999999998 888875332211 000
Q ss_pred hhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... ... ....+......+.+++.+||+.+|++||++.++++.|.++
T Consensus 235 ~~~---------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 235 KLP---------QGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HHh---------cCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000 000 0111222345788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=308.30 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=201.4
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|.+.+.||+|++|.||++.. .+++++|+|.+.... ....+.+.+|++++.+++||||+++++++.+....++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788899999999999999985 468899999886432 1234568899999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+||+++++|.+++. ....++...+.+++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999988874 3346888999999999999999999987 9999999999999999999999999998654
Q ss_pred CCCccCC-ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGN-TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.|+....... ..... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~---------~~ 221 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----AIFKI---------AT 221 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----HHHHH---------hc
Confidence 3221111 123457889999999999999999999999999999999999975321110 00000 00
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
... ....+......+.+++.+||..+|++||++.++++.
T Consensus 222 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 QPT-NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred cCC-CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000 112233345678899999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=326.00 Aligned_cols=252 Identities=20% Similarity=0.310 Sum_probs=199.8
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+++. .+++.+|+|+++... ....+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688899999999999999985 468899999987542 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNR--YEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999998843 2356899999999999999999999988 999999999999999999999999999876543
Q ss_pred CccCCceeeeccCcccCceeec------CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~-- 227 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-----TYNNIMNFQRF-- 227 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-----HHHHHHcCCCc--
Confidence 221 222346899999999986 4568899999999999999999999986432211 00001000000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+ ...........+.+++..||+ +|++||++.+++.
T Consensus 228 -~-----~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 -L-----KFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -c-----CCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0 000111234578889999998 9999999999985
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=314.30 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=202.8
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|.+.+.||+|+||.||+|+. .+++.+|+|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5788889999999999999984 568899999987665556678899999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++. ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 9999999873 345789999999999999999999987 99999999999999999999999999876543221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......+++.|+|||.+.+..++.++|||||||++|||++|+.||........ +. ...... .+. .
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~----~~~~~~------~~~---~ 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LY----LIATNG------TPE---L 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HH----HHhcCC------CCC---C
Confidence 11224688999999999998899999999999999999999999864322110 00 000000 000 0
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+......+.+++.+||..+|++||++.++++
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112223457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=306.86 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=203.1
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|.+.+.||+|++|.||+++.. +++.+++|.+... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999854 5889999988643 334567789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+.+++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999988542 2456889999999999999999999987 99999999999999999999999999987654322
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....|++.|+|||++.+..++.++||||||++++||++|+.|+....... .. ..... .. .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~~----~~------~ 218 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--LI----LKIIR----GV------F 218 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHHc----CC------C
Confidence 1 223468899999999999999999999999999999999999986433110 00 00000 00 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+......+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1112234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=306.63 Aligned_cols=260 Identities=24% Similarity=0.313 Sum_probs=192.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-----EEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE-----KIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~~l 586 (834)
-.|...+++|.|+||.||+|.+. ++++||||+.-...+ --..|+++|++++|||||+|+.++....+ ..+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34666789999999999999854 468999998754332 22569999999999999999999875432 358
Q ss_pred EEEecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeeccccccee
Q 003274 587 ILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARM 664 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~~ 664 (834)
|||||+. +|...+.+. ..+..++...+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999987 566666431 22455777777889999999999999987 9999999999999976 9999999999999
Q ss_pred cCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc--hhhhhcccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH--AWDLWKHERVH 741 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~--~~~~~~~~~~~ 741 (834)
+..++.. .+ ..-|..|+|||.+.+. .|+.+.||||.||++.||+-|++.|...... .++... .......+++.
T Consensus 176 L~~~epn--iS-YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPN--IS-YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCc--ee-EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCHHHHh
Confidence 8665432 23 3457899999998865 6999999999999999999999998763321 111111 11011111110
Q ss_pred -------cccccccccCC----CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 -------ELMDPVILQDE----IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 -------~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+...+.+.... .......+..+++.++|+.+|.+|.++.|++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111111 23334568899999999999999999999985
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=307.03 Aligned_cols=250 Identities=35% Similarity=0.527 Sum_probs=203.7
Q ss_pred cccccCCcEeEEEEEecC----ccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||++.... +..+++|.+...... ..+.+.+|++++.+++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999998643 789999999765433 367899999999999999999999999999999999999999
Q ss_pred CCcchhcccccc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 594 KSLDVYLFDPIK------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 594 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
++|.+++..... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999854321 367899999999999999999999987 99999999999999999999999999988765
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
...........++..|+|||.+....++.++||||||++++||++ |..|+...... ++. ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~----~~~~~~-------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVL----EYLRKG-------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHHHcC--------
Confidence 432223334567889999999998899999999999999999999 58887644211 110 010000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
. ....+.....++.+++.+||+.+|++||++.++++.|+
T Consensus 224 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 Y--RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred C--CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0 11122233568899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=311.82 Aligned_cols=239 Identities=23% Similarity=0.352 Sum_probs=187.6
Q ss_pred ccccCCcEeEEEEEecC-------------------------ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeE
Q 003274 520 KLGEGGFGPVYKGRLFN-------------------------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRI 574 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l 574 (834)
.||+|+||.||+|.+.. ...||+|.+.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999876554455678899999999999999999
Q ss_pred EEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC--
Q 003274 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-- 652 (834)
Q Consensus 575 ~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-- 652 (834)
++++.+....++||||+++|+|+.++.. ....+++..+.+++.||++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999988743 2456889999999999999999999987 99999999999997654
Q ss_pred -----CeeecccccceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHh-cCCCCCCCCCCCcc
Q 003274 653 -----NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETL-SSRKNTGVYNTDSF 725 (834)
Q Consensus 653 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~ell-tG~~p~~~~~~~~~ 725 (834)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999998654221 11356788999998875 56899999999999999995 68888754322110
Q ss_pred ccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 726 NLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
..... . ....+.+....+.+++.+||+.+|++||++.+|++.|.
T Consensus 231 ------~~~~~---------~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ------ERFYE---------K---KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ------HHHHH---------h---ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00000 0 00111122346889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=307.73 Aligned_cols=256 Identities=30% Similarity=0.468 Sum_probs=206.7
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..++|.+.++||+|+||.||++...+++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 347899999999999999999998888899999987543 3457799999999999999999999999998999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.+++.|++|||+.+ ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus 83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999998542 2346899999999999999999999987 99999999999999999999999999987654221
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.. .....++..|+|||.+.+..++.++||||||++++||++ |+.|+....... ... .. ....
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~----~~-----~~~~----- 221 (261)
T cd05034 159 TA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLE----QV-----ERGY----- 221 (261)
T ss_pred hh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HH-----HcCC-----
Confidence 11 112234568999999999999999999999999999998 888875322110 000 00 0000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
....+...+.++.+++.+||+.+|++||++.++++.|++
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 011112235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=311.54 Aligned_cols=251 Identities=26% Similarity=0.422 Sum_probs=199.4
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||.||+|... .+..+++|.+........+.+.+|++++..++||||+++++++..+...++|+||+
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34677789999999999999865 47788999987666666778999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|..++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 85 AGGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 99999887743 2356899999999999999999999987 9999999999999999999999999987653221
Q ss_pred CCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.......++..|+|||++. +..++.++|||||||++|||++|++|+........ . ...... ..+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~----~~~~~~------~~~ 226 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-L----LKIAKS------EPP 226 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-H----HHHhhc------CCC
Confidence 1222346889999999984 45678899999999999999999999764321110 0 000000 000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+ ..+.....++.+++.+||+.+|++||++.++++
T Consensus 227 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 TL---AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 112223467899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=318.99 Aligned_cols=241 Identities=23% Similarity=0.313 Sum_probs=191.9
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+.. .++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999864 47899999987542 23345567788888765 899999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 99998873 3356889999999999999999999987 9999999999999999999999999987542221 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ..... . ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~----~~i~~------~-----~~~~ 215 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LF----QSIRM------D-----NPCY 215 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HH----HHHHh------C-----CCCC
Confidence 234578999999999999999999999999999999999999986432111 00 00000 0 0111
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHH-HHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMS-DVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 784 (834)
+.....++.+++.+||+.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 222345788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=327.25 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=198.0
Q ss_pred HHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
...++|++.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++..+...+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999864 5789999998642 2233456889999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|.+++. ...++...+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++..+
T Consensus 120 lv~Ey~~gg~L~~~l~----~~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMS----NYDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999883 335788999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCC----CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||....... ..........
T Consensus 193 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-----~~~~i~~~~~-- 264 (370)
T cd05621 193 DETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-----TYSKIMDHKN-- 264 (370)
T ss_pred ccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-----HHHHHHhCCc--
Confidence 432211 12235799999999998754 37899999999999999999999986432110 0000000000
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAAD--RPTMSDVVSM 785 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 785 (834)
.+ ...........+.+++..|+..++.+ ||++.|+++.
T Consensus 265 -----~~-~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SL-NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----cc-CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 00111123456788999999755543 8899999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.81 Aligned_cols=244 Identities=30% Similarity=0.475 Sum_probs=205.7
Q ss_pred ccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcch
Q 003274 520 KLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDV 598 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (834)
+||+|.||+||-|+..+ ...+|||.+........+.+.+|+.+-+.|+|.|||+++|.+.+++..-+.||.+++|+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999655 45799999988777777889999999999999999999999999999999999999999999
Q ss_pred hcccccccCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeeecccccceecCCCCccCCce
Q 003274 599 YLFDPIKKRLL--DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 599 ~l~~~~~~~~l--~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~ 675 (834)
+|.. +=+++ ++...-.+.+||++||.|||++. |||||||-.||||+ -.|.+||+|||-++.+..- ...+.
T Consensus 662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE 734 (1226)
T KOG4279|consen 662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE 734 (1226)
T ss_pred HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence 9843 33455 67777889999999999999987 99999999999997 4689999999999887542 34556
Q ss_pred eeeccCcccCceeecCC--CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 676 RIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 676 ~~~gt~~y~aPE~~~~~--~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.+.||.-|||||++..+ .|..++|||||||.+.||.||++||-....+..-... +.-......+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk--------------VGmyKvHP~i 800 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK--------------VGMYKVHPPI 800 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh--------------hcceecCCCC
Confidence 68899999999999866 4889999999999999999999998755443221110 0001113456
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
|.+..++...+|++|+.++|.+||+++++++
T Consensus 801 Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 8888999999999999999999999999986
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=329.78 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=193.5
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.|.+.++||+|+||.||+|+. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++.+.+....++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999985 457899999986532 2345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999988843 346888899999999999999999987 9999999999999999999999999975331100
Q ss_pred c---------------------------------------------cCCceeeeccCcccCceeecCCCCCccccchhhH
Q 003274 670 L---------------------------------------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFG 704 (834)
Q Consensus 670 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlG 704 (834)
. ........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0 0001124689999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC---HHH
Q 003274 705 ILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT---MSD 781 (834)
Q Consensus 705 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~e 781 (834)
|+||||++|++||......... ...... .... ..........++.+++.+|+ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~~~-----~~i~~~-------~~~~-~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQ-----MKVINW-------QTSL-HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH-----HHHHcc-------CCCc-CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 9999999999998643221100 000000 0000 00011123456677777766 49999997 777
Q ss_pred HHH
Q 003274 782 VVS 784 (834)
Q Consensus 782 vl~ 784 (834)
+++
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=319.13 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=192.8
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 588 (834)
+|...+.||+|+||.||+++. .+++.||+|++... .....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367778999999999999985 46889999998653 2234456788999998885 577888999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999988873 3356899999999999999999999987 999999999999999999999999998764322
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .++..
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~~------------~i~~~-- 216 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--LFQ------------SIMEH-- 216 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--HHH------------HHHhC--
Confidence 21 1233568999999999999999999999999999999999999986432211 000 00000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTM 779 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
....+.....++.+++.+||+.+|.+|++.
T Consensus 217 -~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 217 -NVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -CCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 011223345678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=309.76 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=194.8
Q ss_pred cccccCCcEeEEEEEecC-cc--EEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLFN-GQ--EVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+..+ +. .+++|.++... ....+.+..|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 469999999999998644 33 57889887532 34456789999999999 899999999999999999999999999
Q ss_pred CCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 594 KSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 594 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
++|.+++.... ....+++..+.+++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999885322 1235789999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+++..... ........+..|+|||++....++.++||||||+++|||++ |..||....... .. ....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--~~----~~~~--- 225 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY----EKLP--- 225 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--HH----HHHh---
Confidence 98642211 11111233567999999999999999999999999999997 888875322111 00 0000
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... ....+......+.+++.+||+.+|.+||++.+++..|+++
T Consensus 226 ------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 226 ------QGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ------CCC-CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 000 0111222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.65 Aligned_cols=251 Identities=21% Similarity=0.302 Sum_probs=195.1
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
+|++.++||+|+||.||+++. ..++.+|||++.... ....+.+.+|++++.+++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688899999999999999985 458899999986432 2334668899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++. +...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLI---RLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 999999999884 3456888889999999999999999988 9999999999999999999999999975331000
Q ss_pred -----------------------------------------ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHH
Q 003274 670 -----------------------------------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILML 708 (834)
Q Consensus 670 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ 708 (834)
.........||+.|+|||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000011246999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCC---CHHHHHH
Q 003274 709 ETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP---TMSDVVS 784 (834)
Q Consensus 709 elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~ 784 (834)
||++|+.||.......... ...... ... ...........+.+++.+|+ .+|.+|+ ++.|+++
T Consensus 236 ell~G~~Pf~~~~~~~~~~-----~i~~~~-------~~~-~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAETQL-----KVINWE-------TTL-HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHHHH-----HHhccC-------ccc-cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999986543211100 000000 000 00011123446677888876 4999999 8888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=319.54 Aligned_cols=237 Identities=22% Similarity=0.283 Sum_probs=186.7
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHH-HHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMM-LIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+++. .+++.+|+|++.... ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999986 457899999986432 122334555554 57788999999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 99987773 3456888899999999999999999987 9999999999999999999999999987532221 22
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... .. .. +... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~----~~--------i~~~---~~~~ 215 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--MY----DN--------ILHK---PLQL 215 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--HH----HH--------HhcC---CCCC
Confidence 334578999999999999999999999999999999999999986432110 00 00 0000 0112
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMS 780 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~ 780 (834)
+......+.+++.+||+.+|.+||+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 223456788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=294.83 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=199.8
Q ss_pred hcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
+++|++.++||+|.|+.|++.. ...|+.+|+|.+... ...+.+++.+|+++-+.|+||||++|+....+.+..+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4788889999999999999986 456889999887532 3447788999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccccceec
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla~~~ 665 (834)
|+|++++|..-+ ..+-..++..+-..++||+++|.|+|.++ |||||+||+|+||-. ..-+||+|||+|..+
T Consensus 90 e~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999996655 23356778888899999999999999998 999999999999954 346899999999998
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
...... ....|||+|||||++...+|+..+|||+.||+||-||.|++||...... .+.+ .+..+. .|
T Consensus 164 ~~g~~~---~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~--rlye----~I~~g~----yd 230 (355)
T KOG0033|consen 164 NDGEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYE----QIKAGA----YD 230 (355)
T ss_pred CCcccc---ccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH--HHHH----HHhccc----cC
Confidence 743322 2357999999999999999999999999999999999999998642211 1110 000000 00
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
- ....=....++..+|+.+||..||.+|.|+.|.+.
T Consensus 231 ~---~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 231 Y---PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred C---CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 0 00001123467889999999999999999998764
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.76 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=198.7
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcc
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
++||+|+||.||++...+++.||+|.+...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999767999999998765433 5568999999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceee
Q 003274 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 677 (834)
+++... ...+++..+..++.+++.+|+|||+++ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988432 335788999999999999999999987 999999999999999999999999999865432222221222
Q ss_pred eccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH
Q 003274 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (834)
..+..|+|||.+.++.++.++||||||+++|||++ |..|+........ ... +.... ....+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~------~~~---------~~~~~-~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT------RER---------IESGY-RMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH------HHH---------HhcCC-CCCCCcc
Confidence 34667999999998999999999999999999999 7777653322110 000 00000 1112223
Q ss_pred HHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 757 MLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4568899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=309.02 Aligned_cols=256 Identities=26% Similarity=0.451 Sum_probs=202.5
Q ss_pred cCcccccccccCCcEeEEEEEec----CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.+|.+.+.||+|+||.||+|+.. .+..+|+|.++... ....+.+..|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56788899999999999999853 23379999986543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRK--HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999843 2346899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccC-CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 668 DELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 668 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... ......++..|+|||.+.+..++.++||||||+++||+++ |..|+....... ... ..... .
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~----~~~~~-----~- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIK----AIEEG-----Y- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHH----HHhCC-----C-
Confidence 32111 1111223568999999999999999999999999999886 998875432211 000 00000 0
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+...+..+.+++.+||+.+|++||+|.++++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011122345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=309.80 Aligned_cols=254 Identities=27% Similarity=0.398 Sum_probs=189.8
Q ss_pred cccccCCcEeEEEEEecC---ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 519 CKLGEGGFGPVYKGRLFN---GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
++||+|+||.||+|+... ...+|+|.+.... ......+.+|+++++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3578899876543 233457889999999999999999999999999999999999999
Q ss_pred Ccchhcccccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 595 SLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 595 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|.+++..... ....++.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999854322 234567888899999999999999987 9999999999999999999999999987643332222
Q ss_pred CceeeeccCcccCceeec-------CCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 673 NTKRIVGTYGYMSPEYAL-------DGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~-------~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
......++..|+|||++. ...++.++|||||||++|||++ |..|+....... .. ..... .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~---~~~~~-~~~~~~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VL---KQVVR-EQDIKLP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HH---HHHhh-ccCccCC
Confidence 222234577899999874 3457889999999999999999 677765332111 00 00000 0011111
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.+ ..+......+.+++..|| .||++||++.+|++.|.
T Consensus 232 ~~-----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KP-----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CC-----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 122234456677888888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=310.49 Aligned_cols=251 Identities=26% Similarity=0.441 Sum_probs=201.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||.||+|+.. +++.+|+|.+........+.+..|+.++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 67888899999999999999864 47899999998766666788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|..++.. ....+++..+..++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 99999887643 2346899999999999999999999987 9999999999999999999999999987643221
Q ss_pred CCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.......+++.|+|||++. ...++.++|||||||++|||++|..|+........ ..... ....+
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~------~~~~~ 233 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIA------KSEPP 233 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-----HHHHh------cCCCc
Confidence 1123356888999999985 44578899999999999999999999754321110 00000 00000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ..+.....++.+++.+||+.+|++||++.++++
T Consensus 234 ~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TL---SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 112233457889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=305.27 Aligned_cols=248 Identities=32% Similarity=0.473 Sum_probs=196.0
Q ss_pred cccccCCcEeEEEEEec--C--ccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF--N--GQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~--~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+|+.. + +..+|+|.+..... ...+++.+|+++++++.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999732 2 26899999876543 34567899999999999999999999876 4568999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC-
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG- 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~- 672 (834)
++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 999999843 236899999999999999999999987 9999999999999999999999999998764332211
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+.. ...... ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~~~----~~~~~~----------~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EVIA----MLESGE----------RL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HHHH----HHHcCC----------cC
Confidence 1111234568999999999999999999999999999998 89987643221 1111 010000 01
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+......+.+++.+||..+|++||++.++++.|+++
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 12223346788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.02 Aligned_cols=249 Identities=24% Similarity=0.399 Sum_probs=203.3
Q ss_pred cCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.++||+|+||.||+|+..+ ++.+++|.+..... .+++.+|++++++++|+||+++++++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678889999999999999998654 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999998742 3457899999999999999999999987 99999999999999999999999999987644321
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......++..|+|||++.+..++.++||||||+++|||++|+.|+........... ......+ ..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-----------~~~~~~~---~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-----------IPNKPPP---TL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-----------hccCCCC---CC
Confidence 12234578899999999999999999999999999999999999864322111000 0000000 01
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+.....++.+++.+||+.+|++||++.|+++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112223457899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=317.97 Aligned_cols=242 Identities=24% Similarity=0.327 Sum_probs=192.2
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+++. .+++.+|+|+++... ....+.+..|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999985 457899999997542 23456688999999888 699999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 99988773 3356899999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccchhhhhcccccccccccccccCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||........ ........... .. ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~---~~~ 221 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------EK---PIR 221 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------hC---CCC
Confidence 2345789999999999999999999999999999999999999964332211 11111111110 00 111
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCH
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTM 779 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
.+......+.+++.+||+.||++||++
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 233345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=305.55 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=204.0
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|.+.++||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 47888999999999999999997778889999886542 345678999999999999999999999887 7789999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998542 2345788999999999999999999987 999999999999999999999999999876433221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......++..|+|||++....++.++|+||||+++||+++ |+.|+....... +. ....... .
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~----~~~~~~~----------~ 221 (260)
T cd05073 159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VI----RALERGY----------R 221 (260)
T ss_pred -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HH----HHHhCCC----------C
Confidence 1122345678999999999999999999999999999998 888875432111 10 0000000 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
...+......+.+++.+||+.+|++||++.++.++|++
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112334678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.31 Aligned_cols=249 Identities=29% Similarity=0.424 Sum_probs=198.9
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEE-eCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV-EQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~-~~~~~~lV~Ey~ 591 (834)
++|.+.+.||+|+||.||++.. .+..+|+|.++.. ...+.+.+|+.++++++|+|++++++++. +.+..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 5788899999999999999975 4788999998643 23567899999999999999999999765 456789999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..+++++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999988532 2335889999999999999999999987 9999999999999999999999999988653322
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+....... +. . ..... . .
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--~~---~-~~~~~---------~-~ 217 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV---P-RVEKG---------Y-K 217 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HH---H-HHhcC---------C-C
Confidence 12234568999999999999999999999999999997 888875322110 00 0 00000 0 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 111223456788999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.24 Aligned_cols=251 Identities=26% Similarity=0.440 Sum_probs=201.3
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.+|++.+.||+|+||.||++...+++.+|+|.+.... .....|.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999987778899999986532 334678999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++.. ....++++.+..++.+++.|++|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRA--QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999988743 2345789999999999999999999987 9999999999999999999999999998764432211
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... .... ....
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~----~~~~--~~~~-------- 220 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE----TINA--GFRL-------- 220 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH----HHhC--CCCC--------
Confidence 111234678999999998999999999999999999998 888875322110 000 0000 0000
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..+......+.+++.+||+.+|++||++.++++.|
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11112346789999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.45 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=192.9
Q ss_pred cccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||.||+++. .+|+.+|+|.+.... ....+.+..|++++.+++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 458999999986421 12234556799999999999999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCcee
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887432 2345889999999999999999999987 9999999999999999999999999998764322 1223
Q ss_pred eeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH
Q 003274 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (834)
..|+..|+|||++.+..++.++|||||||++|||++|+.|+......... .. .. ........ . .....
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~-~~----~~-----~~~~~~~~-~-~~~~~ 221 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK-EE----LK-----RRTLEDEV-K-FEHQN 221 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH-HH----HH-----HHhhcccc-c-ccccc
Confidence 46899999999999999999999999999999999999998643221110 00 00 00000000 0 00112
Q ss_pred HHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 757 MLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
...++.+++.+||+.||++||++.|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 345789999999999999999998776443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=311.49 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=203.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 6788899999999999999985 578999999997665556677899999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++. ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence 9999999873 345788999999999999999999987 999999999999999999999999999875433211
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||........... ..... .+ ..
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----~~~~~------~~---~~ 235 (297)
T cd06656 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----IATNG------TP---EL 235 (297)
T ss_pred --cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----eccCC------CC---CC
Confidence 2234678899999999999999999999999999999999999864322111000 00000 00 00
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+......+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112223456789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.61 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=200.4
Q ss_pred CcccccccccCCcEeEEEEEecCccEEEEEEcccCC------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+|.+.+.||+|+||.||+|...+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999988788999999886432 12345688999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+||+++++|.+++. +...+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILN---RFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999884 2346789999999999999999999987 99999999999999999999999999876532
Q ss_pred CC----ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 668 DE----LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 668 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
.. .........|+..|+|||.+.+..++.++||||||+++|||++|+.|+........ . ..... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~----~~~~~----~~~ 225 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-M----FYIGA----HRG 225 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-H----HHhhh----ccC
Confidence 11 11122234688999999999999999999999999999999999999864321110 0 00000 000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ....+.....++.+++.+||+.+|++||++.++++
T Consensus 226 ~-----~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 L-----MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred C-----CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 01122334567899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=341.44 Aligned_cols=261 Identities=21% Similarity=0.288 Sum_probs=202.4
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+|+.. .++.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57889999999999999999854 58899999986532 223467899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccc--------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 589 EYMPNKSLDVYLFDPIK--------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
||+++++|.+++..... ....++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998753211 234567788999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCCc----------------cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCc
Q 003274 661 LARMFGGDEL----------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS 724 (834)
Q Consensus 661 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~ 724 (834)
+++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123469999999999999999999999999999999999999986422111
Q ss_pred cccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCC-CHHHHHHHHhccc
Q 003274 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP-TMSDVVSMISNEH 790 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~ 790 (834)
. . .. .....+.. .......+..+.+++.+||+.||++|| ++.++++.|+...
T Consensus 239 i--~-------~~---~~i~~P~~--~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 I--S-------YR---DVILSPIE--VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred h--h-------hh---hhccChhh--ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 0 00 00001100 000112345678999999999999995 6777777776653
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.99 Aligned_cols=252 Identities=23% Similarity=0.403 Sum_probs=200.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|.+.++||+|+||.||+++. .+++.+|+|.++.........+.+|+.++..++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 5788889999999999999985 458899999987665555667889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999873 3456899999999999999999999987 9999999999999999999999999987664321
Q ss_pred CCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.......|+..|+|||++. ...++.++|||||||++|||++|+.|+........ ... ...... ..+..
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~-----~~~~~~---~~~~~ 231 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFL-----MTKSNF---QPPKL 231 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHh-----hhccCC---CCCcc
Confidence 1223356899999999874 45688999999999999999999998753221110 000 000000 00000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. .......+.+++.+||+.+|++||++.++++
T Consensus 232 -~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 -KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 1122356889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=312.44 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=203.0
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.+|++.+.||.|++|.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999984 568999999987665556678899999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|..++. ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 9999998873 345899999999999999999999987 999999999999999999999999998765433221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||........ .. .... .. .+. .
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~----~~~~-~~-----~~~---~ 235 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LY----LIAT-NG-----TPE---L 235 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HHHh-cC-----Ccc---c
Confidence 2234688899999999999999999999999999999999999864322110 00 0000 00 000 0
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+......+.+++.+||..+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 112223457889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=332.37 Aligned_cols=261 Identities=18% Similarity=0.299 Sum_probs=191.3
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--------
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-------- 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-------- 581 (834)
..++|.+.++||+|+||.||+|.. ..++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346899999999999999999985 468899999885432 2345799999999999999999887532
Q ss_pred CeEEEEEEecCCCCcchhccc-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-Ceeeccc
Q 003274 582 GEKILILEYMPNKSLDVYLFD-PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDF 659 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DF 659 (834)
...++||||+++ +|..++.. ......+++..+..++.||++||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999986 55555432 234467899999999999999999999988 99999999999999665 7999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|+++.+.... ......||+.|+|||++.+. .++.++|||||||+||||++|.+||....... .+.. ........
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~-i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVR-IIQVLGTP 290 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhCCC
Confidence 9998764322 12234679999999998754 68999999999999999999999986433211 1100 00000000
Q ss_pred c----------ccccccccc----ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 R----------VHELMDPVI----LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ~----------~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ..++.-+.. ....++.....++.+++.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0 000000000 011122233467899999999999999999999985
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=311.83 Aligned_cols=264 Identities=23% Similarity=0.360 Sum_probs=200.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+++.. ++..+|+|.+... .....+++.+|++++.+++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46888999999999999999854 5788899988654 233346688999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++. +...+++..+..++.|+++||+|||+.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLK---KAGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 99999999984 3356889999999999999999999742 39999999999999999999999999987653221
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-cccchhhhhccc-----------
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-LLGHAWDLWKHE----------- 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~----------- 738 (834)
.....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ............
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 22346889999999998888999999999999999999999997533211100 000000000000
Q ss_pred ------cccccccccccc--CCCC-HHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 739 ------RVHELMDPVILQ--DEIP-LPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 739 ------~~~~~~~~~~~~--~~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+..+..... ...+ .....++.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 0000 1134568999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.39 Aligned_cols=238 Identities=26% Similarity=0.449 Sum_probs=189.4
Q ss_pred cccccCCcEeEEEEEecCcc-----------EEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 519 CKLGEGGFGPVYKGRLFNGQ-----------EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+.||+|+||.||+|...+.. .+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999865433 5788887654433 6788999999999999999999999988 788999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-------Ceeecccc
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-------NPKISDFG 660 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~DFG 660 (834)
|||+++|+|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999988532 226899999999999999999999987 99999999999999888 79999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCC--CCCccccchhhHHHHHHHhcC-CCCCCCCCCCccccccchhhhhcc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSS-RKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+........ .....
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~------~~~~~- 220 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK------ERFYQ- 220 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH------HHHHh-
Confidence 9987543 1123567789999999876 789999999999999999995 555543321110 00000
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
. ....+.+....+.+++.+||..+|++||++.++++.|+
T Consensus 221 -------~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -------D----QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -------c----CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 01111222368899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=326.37 Aligned_cols=262 Identities=21% Similarity=0.266 Sum_probs=195.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..+|.+.+.||+|+||.||+++.. .++.||||.... ..+.+|++++++++|+|||++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999864 478899996422 3467899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+. ++|..++.. ....+++..++.++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 95 678777632 2346899999999999999999999987 99999999999999999999999999987644322
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCC-CCc-cccccchhhhhcccccc--cc---
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN-TDS-FNLLGHAWDLWKHERVH--EL--- 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~-~~~-~~~~~~~~~~~~~~~~~--~~--- 743 (834)
........||+.|+|||++.+..++.++|||||||+||||++|..++-... ... ........+........ +.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 222233579999999999999999999999999999999999876542221 111 00000011111110000 00
Q ss_pred ----------------cccccccCCCC--HHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 744 ----------------MDPVILQDEIP--LPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 744 ----------------~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+........ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000000000 0122467899999999999999999999863
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=320.25 Aligned_cols=242 Identities=23% Similarity=0.267 Sum_probs=188.5
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHH-HHHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEM-MLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~-~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+++.. +++.+|+|++.... ......+..|. .+++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999864 56789999986432 12223444444 456778999999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. ....+....+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 99988874 3455778888899999999999999988 9999999999999999999999999997543221 22
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... . +.... ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~----~--------i~~~~---~~~ 215 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MYD----N--------ILNKP---LQL 215 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HHH----H--------HHhCC---cCC
Confidence 334579999999999999999999999999999999999999986432111 000 0 00000 011
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+......+.+++.+||+.+|.+||++.+.+..
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 22334578899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.72 Aligned_cols=255 Identities=29% Similarity=0.434 Sum_probs=202.0
Q ss_pred cCcccccccccCCcEeEEEEEecC-cc----EEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.+|.+.+.||+|+||.||+|.... ++ .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998532 32 689998865543 345678999999999999999999999987 78899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ....+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999998853 2345899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
............++..|+|||.+....++.++||||||+++||+++ |+.|+....... +. .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~----~~~~~-------- 226 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IP----DLLEK-------- 226 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HH----HHHhC--------
Confidence 3322111111224568999999998899999999999999999998 999876432211 00 00000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.. ....+......+.+++.+||..+|++||++.++++.|+++
T Consensus 227 -~~-~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~ 268 (279)
T cd05057 227 -GE-RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM 268 (279)
T ss_pred -CC-CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 0111222345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.12 Aligned_cols=251 Identities=32% Similarity=0.490 Sum_probs=197.9
Q ss_pred cccccCCcEeEEEEEecC-------ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 519 CKLGEGGFGPVYKGRLFN-------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+.||+|+||.||+|+..+ ++.+|+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998532 2578999886543 23466789999999999999999999999999999999999
Q ss_pred cCCCCcchhccccc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-----Ceeeccccc
Q 003274 591 MPNKSLDVYLFDPI----KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-----NPKISDFGL 661 (834)
Q Consensus 591 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-----~~kl~DFGl 661 (834)
+++++|.+++.... ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999985422 2234788999999999999999999887 99999999999999887 899999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
++...............++..|+|||++.+..++.++||||||+++|||++ |..|+...... +... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~----~~~~~~- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQ----HVTAGG- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHH----HHhcCC-
Confidence 987644333222223345788999999999999999999999999999998 88887532211 1000 000000
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
....+...+..+.+++.+||..+|++||++.+|++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 001122345678899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=324.53 Aligned_cols=262 Identities=21% Similarity=0.260 Sum_probs=198.6
Q ss_pred hcCcccccccccCCcEeEEEEEec---CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
..+|.+.++||+|+||.||++... .++.||+|.+... +.+.+|++++++++||||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999743 3578999988643 23568999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|++. ++|..++ .....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 5777776 24467899999999999999999999987 999999999999999999999999999876544
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccchhhhhcccc--------
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGHAWDLWKHER-------- 739 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~-------- 739 (834)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||........ ..+...........
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 333333446799999999999999999999999999999999999999865432210 00000000000000
Q ss_pred ---------cccccccccccCC--CCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 740 ---------VHELMDPVILQDE--IPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 740 ---------~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+...... .......++.+++.+||..||++||++.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 001123567889999999999999999999753
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.43 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=197.9
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC------C
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ------G 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~------~ 582 (834)
+++.|++.+.||+|+||.||+|+.. .++.+|+|++.... .....+..|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 5677888899999999999999854 57889999986543 3456788999999998 799999999998753 4
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||+.+++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999988532 3346889999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
....... .......|+..|+|||++. +..++.++|||||||++|||++|+.|+......... .... .
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-----~~~~-~ 230 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-----FLIP-R 230 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-----HHHh-c
Confidence 8654322 1223356899999999986 346889999999999999999999998532211100 0000 0
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... .........+.+++.+||..+|++||++.++++
T Consensus 231 -----~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 -----NPAPR----LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -----CCCCC----CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00000 111123457889999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=307.08 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=203.0
Q ss_pred cCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
++|.+.+.||+|+||.||+++.. ..+.+++|.+...... ..+.+..|++++++++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 67888999999999999999853 3467999998765433 4578999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhccccccc------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKK------RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 659 (834)
+||||+++++|.+++...... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998543322 26899999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccc
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHE 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|+++........ ......++..|+|||.+.+...+.++||||||+++|||++ |..|+....... ... .....
T Consensus 162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--~~~----~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--VLN----RLQAG 234 (275)
T ss_pred ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--HHH----HHHcC
Confidence 998754332221 2222356778999999988889999999999999999998 677765322211 000 00000
Q ss_pred ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
.. ....+......+.+++.+||+.+|++||++.|++..|.
T Consensus 235 ~~---------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KL---------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred Cc---------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 01112234468899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=318.10 Aligned_cols=193 Identities=25% Similarity=0.337 Sum_probs=164.2
Q ss_pred HHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
....+|.+.+.||+|+||.||+|+.. .++.||+|..... ....|+.++.+++||||+++++++......++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 44568999999999999999999864 4678999975432 2356999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+. ++|..++.. ....+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 577777632 3456899999999999999999999987 999999999999999999999999999753222
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCC
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNT 717 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~ 717 (834)
. ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 222356899999999999999999999999999999999866543
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=314.71 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=196.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+|+.. .++.+|+|.++... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 57888999999999999999854 57789999986543 22345678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 77776632 2345788999999999999999999987 99999999999999999999999999976533221
Q ss_pred cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccc--------hhhhhccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGH--------AWDLWKHERV 740 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~--------~~~~~~~~~~ 740 (834)
......+++.|+|||++.+ ..++.++||||||+++|||++|++||........ ..... .+........
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 1122457899999998865 5689999999999999999999999865432111 00000 0000000000
Q ss_pred ccccc-cccccC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMD-PVILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~-~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+ +..... ........++.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 000000 000123457789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.24 Aligned_cols=261 Identities=23% Similarity=0.307 Sum_probs=196.0
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 585 (834)
+|++.++||+|+||.||+++. .+++.||||++... .....+++.+|+++++.++|+||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999985 46899999998653 2234567889999999999999999999998776 789
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+|+||+. ++|...+. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46766652 3456899999999999999999999987 999999999999999999999999999875
Q ss_pred CCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc-----
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER----- 739 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 739 (834)
...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||........ ............
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence 433221 12224578899999998874 579999999999999999999999865432110 000000000000
Q ss_pred -----ccccc-----cccccc--CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 -----VHELM-----DPVILQ--DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 -----~~~~~-----~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+ .+.... .........++.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000 000000 0111123567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.81 Aligned_cols=250 Identities=21% Similarity=0.347 Sum_probs=201.5
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+|++.++||+|+||.||+++.. +++.+|+|.++.. .....+.+..|+.++++++|+||+++++.+......++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999854 6889999988543 3345577889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....++...+..++.|+++||+|||+.+ |+|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887432 3446789999999999999999999987 99999999999999999999999999987643221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......|++.|+|||++.+..++.++||||||+++|+|++|..||....... . .... .... ..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~---~~~~-~~~~----------~~ 218 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--L---ILKV-CQGS----------YK 218 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--H---HHHH-hcCC----------CC
Confidence 1223568899999999999999999999999999999999999986422110 0 0000 0000 01
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+......+.+++.+||+.||++||++.+++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1122234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.82 Aligned_cols=250 Identities=29% Similarity=0.429 Sum_probs=191.8
Q ss_pred cccccCCcEeEEEEEec----CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEEEEEEecC
Q 003274 519 CKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKILILEYMP 592 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~~ 592 (834)
+.||+|+||.||+|... ....+|+|++... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 47999999999999853 2457999998543 23445788899999999999999999998764 556889999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|..++... ...+++..++.++.|+++||+|||+.+ ++||||||+|||++.++.+||+|||+++.+.......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998432 334677888999999999999999987 9999999999999999999999999998654322111
Q ss_pred --CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCC-CCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 673 --NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR-KNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 673 --~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
......++..|+|||.+.+..++.++||||||+++|||++|. +|+.... ..++... ... . .
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~---~~~-~--------~-- 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVY---LLQ-G--------R-- 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH---Hhc-C--------C--
Confidence 112234577899999999899999999999999999999965 4443211 1111100 000 0 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 0011112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.85 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=202.6
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.+.||+|+||.||+++.. +++.+|+|.+........+.+..|++++++++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467889999999999999999864 5889999999776666677899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 157 (280)
T cd06611 84 CDGGALDSIMLE--LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL- 157 (280)
T ss_pred cCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-
Confidence 999999998743 2346899999999999999999999988 9999999999999999999999999987653321
Q ss_pred cCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.......+++.|+|||.+. ...++.++||||||+++|||++|+.|+........ ...... ...
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~------~~~ 225 (280)
T cd06611 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-----LLKILK------SEP 225 (280)
T ss_pred -cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-----HHHHhc------CCC
Confidence 1223356899999999975 34578899999999999999999999864321110 000000 000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.+ ..+.....++.+++.+||+.+|.+||++.++++
T Consensus 226 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 PTL---DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCc---CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 000 112223457889999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.97 Aligned_cols=264 Identities=27% Similarity=0.339 Sum_probs=196.9
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|++|.||+|+.. +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999864 68899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++ ++|..++........+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 678777754444467899999999999999999999987 99999999999999999999999999976543221
Q ss_pred cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch-------hhhhccc----
Q 003274 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-------WDLWKHE---- 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~-------~~~~~~~---- 738 (834)
......+++.|+|||++.+. .++.++||||||+++|||++|+.|+........ ..... ...+...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence 11223568899999988654 578999999999999999999999864322110 00000 0000000
Q ss_pred ccccccccccc--cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 RVHELMDPVIL--QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........... ..........++.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 00001123457789999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=306.25 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=210.4
Q ss_pred cCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.-|.+.+.||+|.|++|-.++ ...|.+||||++.+.. ......+.+|++.|+.++|||||+|+.+......+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346777899999999999997 4689999999997754 3345678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeecccccceecCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~ 668 (834)
.-.+|+|.+||-. ....+.+..+.+++.||..|+.|+|+.. +|||||||+||.+-+ -|-+||.|||++..+...
T Consensus 98 LGD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred ecCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence 9999999999843 3456899999999999999999999998 999999999998864 589999999999876554
Q ss_pred CccCCceeeeccCcccCceeecCCCCC-ccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .....+|...|.|||++.+..|+ +++|||||||+||-|++|++||+..++.+. +..++|-
T Consensus 173 ~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--------------LTmImDC- 234 (864)
T KOG4717|consen 173 K---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--------------LTMIMDC- 234 (864)
T ss_pred c---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--------------hhhhhcc-
Confidence 3 23346899999999999999886 789999999999999999999986554321 2333333
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+...|.....+..+||..||..||++|.+.+||+.
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 23567778899999999999999999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=322.90 Aligned_cols=258 Identities=20% Similarity=0.225 Sum_probs=199.0
Q ss_pred HHHHHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 003274 507 SVAAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (834)
Q Consensus 507 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 582 (834)
.+....++|.+.+.||+|+||.||+++.. .++.+|+|.+... .....+.+.+|+.+++.++||||+++++.+.++.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445689999999999999999999864 5788999998642 2233456788999999999999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||+++|+|..++. ...++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a 189 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189 (371)
T ss_pred EEEEEEcCCCCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence 9999999999999998873 335788889999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCC----CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDG----LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE 738 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
+.+...... ......||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .........
T Consensus 190 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~~~ 263 (371)
T cd05622 190 MKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-----TYSKIMNHK 263 (371)
T ss_pred eEcCcCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-----HHHHHHcCC
Confidence 876433211 12235799999999998754 37899999999999999999999986432110 000110000
Q ss_pred ccccccccccccCCCCHHHHhHHHHHHHhccccCCCC--CCCHHHHHHH
Q 003274 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAAD--RPTMSDVVSM 785 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~ 785 (834)
... ...........+.+++..||..++.+ ||++.|+++.
T Consensus 264 ~~~--------~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 264 NSL--------TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred Ccc--------cCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 000 00111124567889999999844433 7789988773
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=307.32 Aligned_cols=251 Identities=29% Similarity=0.472 Sum_probs=198.8
Q ss_pred cccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHH--HHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 515 FSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLK--EFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|++.+.||+|+||+||+++... ++.+|+|.+......... ....|+.++.+++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999654 668999999776443322 3456999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++. ....+++..+..++.|+++||++||+.+ |+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999884 4567899999999999999999999987 99999999999999999999999999986511 12
Q ss_pred CCceeeeccCcccCceeec-CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc-c
Q 003274 672 GNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI-L 749 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 749 (834)
.......++..|+|||++. +..++.++||||+|+++++|++|..|+........ ... ......... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--~~~---------~~~~~~~~~~~ 221 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--LEI---------IEKILKRPLPS 221 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--HHH---------HHHHHHTHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhh--hhh---------hhhcccccccc
Confidence 2333456899999999998 88999999999999999999999999875411000 000 000000000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.||++||++.++++
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 222 SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111378999999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=303.69 Aligned_cols=249 Identities=28% Similarity=0.465 Sum_probs=199.5
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcc---------cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQ---------GLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
+|.+.+.||+|++|.||+|.. .+++.+|+|.+...... ..+.+..|+.++.+++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999985 45789999988653221 23568889999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|..++. ....+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999883 3356888999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCCcc----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc
Q 003274 664 MFGGDELQ----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 664 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.||........ .. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~------~ 223 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----IF------K 223 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----HH------H
Confidence 76532211 111234578899999999999999999999999999999999999864321100 00 0
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ....+......+.+++.+||+.+|++||++.|+++
T Consensus 224 ~~~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGENA-----SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhccC-----CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00011 11223334568899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=304.87 Aligned_cols=247 Identities=24% Similarity=0.385 Sum_probs=201.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.+.||.|++|.||+|+.. +++.+|+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999854 58899999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+....
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 999999988743 37899999999999999999999987 9999999999999999999999999998875432
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ . .... ....+.
T Consensus 153 -~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~----~~~~-----~~~~~~--- 217 (274)
T cd06609 153 -SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--L----FLIP-----KNNPPS--- 217 (274)
T ss_pred -cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--H----HHhh-----hcCCCC---
Confidence 122234678899999999998999999999999999999999999864321110 0 0000 000011
Q ss_pred CCCCHH-HHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLP-MLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.. ....+.+++.+||..+|++||++.++++
T Consensus 218 --~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 --LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred --CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1111 3457889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.81 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=199.9
Q ss_pred CcccccccccCCcEeEEEEEecC--ccEEEEEEcccC----------CcccHHHHHHHHHHHhh-cCCCceeeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFN--GQEVAVKRLSSQ----------SGQGLKEFKNEMMLIAE-LQHRNLVRILGCCVE 580 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~H~niv~l~~~~~~ 580 (834)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999999654 678999987532 12234567788888875 699999999999999
Q ss_pred CCeEEEEEEecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccc
Q 003274 581 QGEKILILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 659 (834)
.+..++||||+++++|.+++... .....+++..+++++.|++.||.|||+.. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887432 23456889999999999999999999632 3999999999999999999999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... ..
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~-----~~~~~-~~-- 227 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS-----LATKI-VE-- 227 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH-----HHHHH-hh--
Confidence 9998765432 2233568899999999999899999999999999999999999975322110 00000 00
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
....+. ........+.+++.+||+.||++||++.|+.++++
T Consensus 228 --~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 --AVYEPL-----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --ccCCcC-----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000 01123457889999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=305.18 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=202.1
Q ss_pred hcCcccccccccCCcEeEEEEEecC----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.++||+|+||.||+|...+ ...+|||...... ....+.+.+|+.++++++||||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998543 2468999887654 3456689999999999999999999998875 56789
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQV--NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999843 2335899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....... ....++..|+|||.+....++.++||||||+++|||++ |..||........ .. .. ....
T Consensus 159 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~---~~-~~~~------ 225 (270)
T cd05056 159 DESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IG---RI-ENGE------ 225 (270)
T ss_pred cccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HH---HH-HcCC------
Confidence 4422211 12234568999999988899999999999999999996 9998864332110 00 00 0000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+...+..+.+++.+|+..+|++||++.++++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~ 265 (270)
T cd05056 226 ----RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265 (270)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011223346789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=307.28 Aligned_cols=240 Identities=25% Similarity=0.413 Sum_probs=190.1
Q ss_pred cccccCCcEeEEEEEecC--------ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 519 CKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+.||+|+||.||+|.... ..++|+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 479999999999997532 235888888665555567889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC--------eeecccccc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--------PKISDFGLA 662 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~DFGla 662 (834)
+++|+|..++... ...+++..+++++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998532 336889999999999999999999987 999999999999987765 699999998
Q ss_pred eecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCC-CCCCCCCCCccccccchhhhhccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSR-KNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+........ . ..
T Consensus 156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~----~~------ 217 (258)
T cd05078 156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--L----QF------ 217 (258)
T ss_pred cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--H----HH------
Confidence 754322 22457889999999986 45899999999999999999985 44432211100 0 00
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
... ....+.....++.+++.+||+.+|++||++.++++.|+
T Consensus 218 ---~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 218 ---YED---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ---HHc---cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 11222233457899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=322.92 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=195.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++.. .++.+|+|++... .....+.+..|+.++.+++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999854 5889999998643 2334567888999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. +...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999884 3456899999999999999999999988 999999999999999999999999998754321
Q ss_pred Ccc---------------------------------CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCC
Q 003274 669 ELQ---------------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRK 715 (834)
Q Consensus 669 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~ 715 (834)
... .......||+.|+|||++.+..++.++|||||||+||||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00112469999999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC---HHHHHH
Q 003274 716 NTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT---MSDVVS 784 (834)
Q Consensus 716 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 784 (834)
||........ .. ... .. ...+ ......+...++.+++.+++. +|++|++ +.|+++
T Consensus 235 Pf~~~~~~~~--~~---~i~-~~------~~~~-~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 235 PFCSETPQET--YR---KVM-NW------KETL-VFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCCHHHH--HH---HHH-cC------CCce-ecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence 9864332110 00 000 00 0000 000011234577888888774 9999985 566654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=312.70 Aligned_cols=256 Identities=30% Similarity=0.469 Sum_probs=199.5
Q ss_pred hcCcccccccccCCcEeEEEEEec-Ccc----EEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
.++|...+.||+|+||.||+|... ++. .+|+|.+..... ....++.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 356788899999999999999853 343 578998865432 2344788999999999999999999998754 567
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+++||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.+
T Consensus 85 ~v~e~~~~g~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999988743 2345889999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.............++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ........
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~----- 228 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--I----PDLLEKGE----- 228 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHHHHCCC-----
Confidence 54332222222345778999999999999999999999999999997 888875332111 0 01111000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++..||..+|++||++.++++.|+.+
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 229 -----RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011112345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=307.51 Aligned_cols=260 Identities=24% Similarity=0.340 Sum_probs=200.5
Q ss_pred HHHHHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEE----
Q 003274 506 ASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCV---- 579 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~---- 579 (834)
..+..+.++|++.+.||+|+||.||+++. ..++.+|+|.+.... .....+.+|+.++.++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 44455678999999999999999999985 457899999886532 2335688899999999 6999999999885
Q ss_pred -eCCeEEEEEEecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 580 -EQGEKILILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
.+...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 345689999999999999887532 23356888999999999999999999987 9999999999999999999999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecC-----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchh
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAW 732 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 732 (834)
|||+++........ .....|++.|+|||++.. ..++.++|||||||++|||++|+.|+........ +.
T Consensus 167 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-~~---- 239 (286)
T cd06638 167 DFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-LF---- 239 (286)
T ss_pred cCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-Hh----
Confidence 99999876433221 222468999999999853 4578999999999999999999999764322110 00
Q ss_pred hhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 733 DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
... ....+.. ..+......+.+++.+||+.+|++||++.|+++.
T Consensus 240 ---~~~---~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 240 ---KIP---RNPPPTL---HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---hcc---ccCCCcc---cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 0000000 0111224578899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=312.73 Aligned_cols=251 Identities=24% Similarity=0.303 Sum_probs=208.9
Q ss_pred HhcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcc---cHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQ---GLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 585 (834)
..+.|.+.+.||+|.||.||+++... |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+......+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 34678888999999999999998655 999999999765432 4468999999999998 999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC----CCeeeccccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD----MNPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGl 661 (834)
+|||++.+|.|.+.+... .+++.++..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999988554 3899999999999999999999988 9999999999999643 4799999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... .....+.
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~~- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGDF- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCCC-
Confidence 998765 334566899999999999999999999999999999999999999997544332211 0000000
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+ ....-......+.+++..|+..||.+|+|+.++++
T Consensus 256 -----~f-~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 -----DF-TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -----CC-CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 11 11111223678899999999999999999999987
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.87 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=189.2
Q ss_pred cccccCCcEeEEEEEecCc---cEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 519 CKLGEGGFGPVYKGRLFNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
++||+|+||.||+|+..++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975443 346677765443 334578999999999999999999999999999999999999999
Q ss_pred Ccchhcccccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 595 SLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 595 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
+|.+++..... ....+...+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999854322 234667778899999999999999987 99999999999999999999999999865332222222
Q ss_pred ceeeeccCcccCceeecC-------CCCCccccchhhHHHHHHHhcC-CCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 674 TKRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSS-RKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+...... ... .... .+....+.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~---~~~~-~~~~~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVL---NHVI-KDQQVKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--HHH---HHHH-hhcccccCC
Confidence 233567889999998753 2457899999999999999975 5565432211 100 0111 111122222
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
+.+ .......+.+++..|| .+|++||++.+|++.|.
T Consensus 232 ~~~-----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQL-----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred Ccc-----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222 2223457788999999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=305.39 Aligned_cols=256 Identities=24% Similarity=0.401 Sum_probs=198.8
Q ss_pred cccccccccCCcEeEEEEEec----CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 003274 515 FSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 582 (834)
|.+.++||+|+||.||+|... .++.+|||++... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 556789999999999999753 3688999998654 2334667899999999999999999999886542
Q ss_pred eEEEEEEecCCCCcchhccccc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 659 (834)
..++++||+.+|+|..++.... ....+++....+++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988764321 2235788999999999999999999987 999999999999999999999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccc
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHE 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|+++...............+++.|++||.+....++.++||||||+++|||++ |++|+...... .+.. .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~----~~~~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYN----YLIKG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHH----HHHcC
Confidence 99987644332222222345678999999999999999999999999999999 77877533221 1100 00000
Q ss_pred ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ....+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 232 ~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 N----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0011123446889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=300.75 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=204.7
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||.|+||+||+|.. .++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+..+...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4788899999999999999984 467899999986532 33567899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999854333356899999999999999999999987 99999999999999999999999999987654322
Q ss_pred c--CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 671 Q--GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 671 ~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .......|+..|+|||++... .++.++||||||+++|||++|+.|+........ . ...... ..+.
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~----~~~~~~------~~~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-L----MLTLQN------DPPS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-H----HHHhcC------CCCC
Confidence 2 122334688999999998877 789999999999999999999999864332110 0 000000 0011
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+............+.+++.+||+.||++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1000111233467889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=299.94 Aligned_cols=250 Identities=23% Similarity=0.368 Sum_probs=202.6
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|+..++||+|+||.||.++. .+++.+++|.+... .....+.+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 477889999999999999874 55889999987643 344556789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999988533 2456899999999999999999999987 99999999999999999999999999987644332
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......+++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ..... .... .
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~~-~~~~--------~-- 218 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-----LVVKI-VQGN--------Y-- 218 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHH-HcCC--------C--
Confidence 2233568999999999998889999999999999999999999876422111 00000 0000 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
...+.....++.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 01112335678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=316.85 Aligned_cols=261 Identities=24% Similarity=0.271 Sum_probs=194.3
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 582 (834)
.++|.+.+.||+|+||.||+++. ..++.+|||++... .......+.+|+.++..++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 47899999999999999999985 45889999998643 2334567889999999999999999999986543
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||++++ |...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 100 ~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 100 DVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred eeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 579999999764 444432 24788889999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc--cc-----------c
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN--LL-----------G 729 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~--~~-----------~ 729 (834)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... .. .
T Consensus 171 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 7643322 122346899999999999999999999999999999999999998754321100 00 0
Q ss_pred c----hhhhhccc------cccccccccccc--CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 730 H----AWDLWKHE------RVHELMDPVILQ--DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 730 ~----~~~~~~~~------~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ........ ...+........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 000000000000 0011112457889999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=306.92 Aligned_cols=250 Identities=25% Similarity=0.337 Sum_probs=198.0
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
|+..++||+|+||.||++.. ..++.+|+|.+.... ....+.+..|+.++.+++|+||+++++.+.+....++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 56678999999999999985 468899999986542 22235678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999887432 2345889999999999999999999987 99999999999999999999999999876543221
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||......... .. ........ .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~---------~~~~~~~~--~ 221 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EE---------VERLVKEV--Q 221 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HH---------HHhhhhhh--h
Confidence 12246899999999999999999999999999999999999998643221100 00 00000000 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
...+.....++.+++.+||+.||++||+ +.|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1112223457889999999999999999 778865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=305.45 Aligned_cols=263 Identities=23% Similarity=0.318 Sum_probs=198.9
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|++.++||+|+||.||+++.. +++.+|+|++.... ....+.+.+|+.++.+++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888899999999999999865 58899999886432 2234568899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|..++. ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999998887763 2345899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc--cccchh-------hhhcccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN--LLGHAW-------DLWKHER 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~--~~~~~~-------~~~~~~~ 739 (834)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...... ..+....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1122357889999999876 56889999999999999999999998644321110 000000 0000000
Q ss_pred c-ccccccccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 V-HELMDPVILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~-~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .....+.. ....+ ......+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEP-ETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCc-ccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 00000000 00001 112467889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=306.17 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=199.4
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+.|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++......++||||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 3466678999999999999985 457889999986443 33456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++. ...+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999988873 346889999999999999999999987 99999999999999999999999999977643221
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......++..|+|||++.+..++.++||||||+++|||++|+.|+........ . .. +.... .
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~----~~---------~~~~~-~ 218 (277)
T cd06642 157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--L----FL---------IPKNS-P 218 (277)
T ss_pred --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--H----hh---------hhcCC-C
Confidence 12224578899999999999999999999999999999999998753221110 0 00 00000 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+......+.+++.+||+.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1112234467889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=313.33 Aligned_cols=254 Identities=19% Similarity=0.232 Sum_probs=195.1
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999854 5788999998642 2233456888999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999843 2346889999999999999999999987 999999999999999999999999999876543
Q ss_pred CccCCceeeeccCcccCceeecC-----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
... ......||+.|+|||++.+ +.++.++|||||||+||||++|+.||....... . ..........
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~---~~~i~~~~~~--- 226 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--T---YGKIMNHEER--- 226 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--H---HHHHHcCCCc---
Confidence 221 1223569999999999875 568899999999999999999999986432110 0 0000000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCC--CCCHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAAD--RPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 784 (834)
. .+ .........++.+++.+|+..++++ |+++.++++
T Consensus 227 ~--~~--p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 227 F--QF--PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred c--cC--CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 00 0001123467888999988865543 467888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=313.51 Aligned_cols=255 Identities=20% Similarity=0.253 Sum_probs=194.9
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999854 5889999998642 2234456889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999998842 2346889999999999999999999988 999999999999999999999999999775433
Q ss_pred CccCCceeeeccCcccCceeecC-----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||....... .............
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~-----~~~~i~~~~~~~~- 228 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKEHFQ- 228 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH-----HHHHHHcCCCccc-
Confidence 221 1223468999999999863 457899999999999999999999986322110 0000110000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhcccc--CCCCCCCHHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQE--NAADRPTMSDVVSM 785 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPt~~evl~~ 785 (834)
+ . .........+.+++.+|+.. ++..||++.++++.
T Consensus 229 ----~-~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 ----F-P-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ----C-C-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 0 00111345678888887754 33447899988764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=300.60 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=203.9
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++||||+++++++......+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999854 5788999999776555678899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ....++...+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQV--TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999988743 2256889999999999999999999987 9999999999999999999999999987654321
Q ss_pred cCCceeeeccCcccCceeecCC---CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.......++..|+|||.+.+. .++.++||||||+++|||++|+.|+........ .. .. .. ..+.+.
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~----~~-~~----~~~~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LF----LI-SK----SNFPPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HH----HH-Hh----ccCCCc
Confidence 111234678899999999877 889999999999999999999999864321110 00 00 00 000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .........++.+++.+||..+|.+||++.+|+.
T Consensus 225 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 K--LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0112234567899999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=309.68 Aligned_cols=198 Identities=26% Similarity=0.413 Sum_probs=159.9
Q ss_pred ccccccCCcEeEEEEEec---CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEEEEecC
Q 003274 518 QCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILILEYMP 592 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~ 592 (834)
.++||+|+||.||+|+.. .++.+|+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999854 46789999986532 23457889999999999999999998864 456789999986
Q ss_pred CCCcchhcccc------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe----ccCCCeeecccccc
Q 003274 593 NKSLDVYLFDP------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLA 662 (834)
Q Consensus 593 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGla 662 (834)
+ +|..++... .....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 666655321 12235889999999999999999999988 9999999999999 45678999999999
Q ss_pred eecCCCCcc-CCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCC
Q 003274 663 RMFGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYN 721 (834)
Q Consensus 663 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~ 721 (834)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876543211 12234578999999999876 458999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=311.77 Aligned_cols=264 Identities=19% Similarity=0.231 Sum_probs=192.9
Q ss_pred cccccccC--CcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 517 MQCKLGEG--GFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 517 ~~~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.++||+| +|++||+++. .+|+.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999985 568899999986542 233456788999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc-
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL- 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~- 670 (834)
++|+|.+++... ....+++..+.+++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999988432 2235889999999999999999999987 99999999999999999999999987544321110
Q ss_pred ----cCCceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc---hhhhhcc----
Q 003274 671 ----QGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH---AWDLWKH---- 737 (834)
Q Consensus 671 ----~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~---~~~~~~~---- 737 (834)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||............. .......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 001122356778999999976 468999999999999999999999986433211000000 0000000
Q ss_pred -cc-----ccccccccc----------------ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 -ER-----VHELMDPVI----------------LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 -~~-----~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+. .....+..+ ............+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 000000000 000011223457889999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=305.66 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=191.4
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhc---CCCceeeEEEEEEeC-----C
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQ-----G 582 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~-----~ 582 (834)
+|.+.+.||+|+||.||+++.. +++.+|+|.++... ......+.+|++++.++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999854 58899999986532 22234566777777766 699999999988642 4
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||+.+ +|..++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 57999999985 777776432 2345899999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc----c
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH----E 738 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~----~ 738 (834)
+...... ......||..|+|||++.+..++.++|||||||++|||++|++||........ + ......... .
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~-~-~~~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ-L-GKIFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH-H-HHHHHHhCCCChhh
Confidence 8764322 12234678999999999999999999999999999999999999864322110 0 000000000 0
Q ss_pred cc--cccccccccc------CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 RV--HELMDPVILQ------DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~--~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. .......... ..........+.+++.+||+.||++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000000000 0011123457789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=301.86 Aligned_cols=248 Identities=24% Similarity=0.380 Sum_probs=202.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..|+..++||+|+||.||+|... .++.+|+|.+.... ....+.+.+|+.++.+++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35667789999999999999854 58899999986543 34456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999998873 345888999999999999999999987 99999999999999999999999999987654322
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......++..|+|||++.+..++.++||||||+++|||++|..|+........ . ..+... ..
T Consensus 157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~-------------~~~~~~-~~ 218 (277)
T cd06640 157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--L-------------FLIPKN-NP 218 (277)
T ss_pred --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--h-------------hhhhcC-CC
Confidence 12234578899999999998999999999999999999999999764321110 0 000000 01
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 12233456788999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=305.79 Aligned_cols=253 Identities=23% Similarity=0.391 Sum_probs=200.4
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.+.||+|+||.||+++.. .++.+|+|.+... .....+.+.+|+.++.+++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46788899999999999999865 6889999988654 333456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++........+++..+..++.+++.||.|||+.. +|+|+||||+||+++.++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999988854333447899999999999999999999742 39999999999999999999999999987653322
Q ss_pred cCCceeeeccCcccCceeecCC------CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||....... .... .....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~---------~~~~~ 223 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQ---------LSAIV 223 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHH---------HHHHh
Confidence 2224578899999998654 35889999999999999999999985422111 0000 00011
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ....+.....++.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 224 DGD--PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred hcC--CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 100 11223335678899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=305.41 Aligned_cols=250 Identities=23% Similarity=0.312 Sum_probs=196.8
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
|+..++||+|+||+||++.. .+++.+|+|.+.... ....+.+.+|++++.+++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 56678999999999999985 468899999986542 22345578899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999998887532 2346899999999999999999999987 9999999999999999999999999997654322
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......|+..|+|||.+.+..++.++|+||||+++|||++|..||........ ...... ... .. .
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~------~~~---~~---~ 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDR------RVL---ET---E 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH------hhh---cc---c
Confidence 11234689999999999999999999999999999999999999864322110 000000 000 00 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
...+......+.+++..||+.||++||+ +.+++.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0112223457789999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=300.88 Aligned_cols=250 Identities=26% Similarity=0.414 Sum_probs=194.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 584 (834)
.+|...+.||+|+||.||++.. ..++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999985 458899999886432 22345688999999999999999999998753 567
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++++||+++++|.+++. ....+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK---AYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999998884 3345889999999999999999999887 99999999999999999999999999986
Q ss_pred cCCCCc-cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDEL-QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... ........++..|+|||.+.+..++.++|||||||++|||++|+.||........ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--------------~~~~ 221 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--------------IFKI 221 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--------------HHHH
Confidence 543211 1112234588999999999999999999999999999999999999864321100 0000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... .....+......+..++ +||..+|++||+++||++
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 222 ATQP-TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred hcCC-CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000 01122333344556666 788899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=306.69 Aligned_cols=261 Identities=25% Similarity=0.348 Sum_probs=202.4
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||+||++.. .+++.+|+|.+.... ....+.+.+|++++..++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5788889999999999999985 458899999876543 33457889999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++. ..+.+++.....++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999988873 3356899999999999999999999742 39999999999999999999999999987543221
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ....... ......+.... .
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~-~ 231 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ-DDPMGIL--DLLQQIVQEPP-P 231 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh-hhhhHHH--HHHHHHhhccC-C
Confidence 223568999999999988899999999999999999999999987543321100 0000000 00000110000 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
..........+.+++.+||+.||++||++.|+++..
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 001112445788999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=285.77 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=200.4
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc--------ccHHHHHHHHHHHhhc-CCCceeeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAEL-QHRNLVRILGCCVE 580 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 580 (834)
.-++|...+.||.|..++|-+... ..|++.|+|++..... .-.++-..|+.+|+++ -||+|+.+.++++.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 346777888999999999988864 4588999998854321 1234567799999998 69999999999999
Q ss_pred CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
+.-.++|+|.|+.|.|.++|. ..-.+++++..+|+.|+.+|+.|||..+ |+||||||+|||++++.++||+|||
T Consensus 95 ~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred cchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999983 4567999999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeec------CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
.+..+...+ .....+|||+|+|||.+. ...|+..+|.|+.||+||.||.|.+||-.... ++ ..+.
T Consensus 169 Fa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ----ml--MLR~ 239 (411)
T KOG0599|consen 169 FACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ----ML--MLRM 239 (411)
T ss_pred eeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH----HH--HHHH
Confidence 999876554 345579999999999985 34588999999999999999999999742110 00 0000
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.+++. + + ....=.+......+||.+||+.||.+|.|++|++.
T Consensus 240 ImeGky-q-----F-~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 240 IMEGKY-Q-----F-RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHhccc-c-----c-CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 000000 0 0 00011224567899999999999999999999986
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=298.91 Aligned_cols=251 Identities=34% Similarity=0.534 Sum_probs=200.2
Q ss_pred cccccccccCCcEeEEEEEecC-----ccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 515 FSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
|++.+.||+|+||.||+++..+ +..+|+|.+...... ..+.+..|++++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998643 378999999765433 5678999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 99999999998843211 12899999999999999999999987 999999999999999999999999999877654
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
...... ...+++.|+|||.+.+..++.++||||||++++||++ |+.|+....... ... ......
T Consensus 157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--~~~----~~~~~~-------- 221 (258)
T smart00219 157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--VLE----YLKKGY-------- 221 (258)
T ss_pred cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHhcCC--------
Confidence 322221 2236789999999988899999999999999999998 777765422110 000 000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
....+.....++.+++.+||..+|++|||+.++++.|
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 --RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011222456789999999999999999999998865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=299.34 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=199.7
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+|...+.||+|+||.||+|... +++.+++|.+.... .+..+.+..|++++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999865 78899999886533 23456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+||+++++|.+++. +...+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLK---KYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999884 2345889999999999999999999987 99999999999999999999999999887643
Q ss_pred CCccCCceeeeccCcccCceeecCCC-CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.. ......++..|+|||.+.... ++.++|+||||+++|||++|+.|+........ .... .....
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~---~~~~~---- 219 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-----VFKI---GRSKE---- 219 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-----HHHH---Hhccc----
Confidence 32 123356889999999988776 89999999999999999999999864331110 0000 00000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++.+||+.+|++||++.++++
T Consensus 220 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 ---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 01122233467889999999999999999999974
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=306.02 Aligned_cols=261 Identities=26% Similarity=0.362 Sum_probs=201.5
Q ss_pred cHHHHHHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 003274 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 581 (834)
...++..++++|.+.+.||+|+||.||++.. .+++.+|+|.+.... ...+.+.+|+.++.++ +|||++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 3445555678999999999999999999985 468899999986532 2345678899999999 899999999998754
Q ss_pred -----CeEEEEEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCee
Q 003274 582 -----GEKILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (834)
Q Consensus 582 -----~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 655 (834)
+..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 35899999999999998875322 3456899999999999999999999987 99999999999999999999
Q ss_pred ecccccceecCCCCccCCceeeeccCcccCceeecCC-----CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc
Q 003274 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH 730 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 730 (834)
|+|||+++......... ....|+..|+|||.+... .++.++|||||||++|||++|+.|+....... .+.
T Consensus 169 l~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~~~-- 243 (291)
T cd06639 169 LVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-TLF-- 243 (291)
T ss_pred Eeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-HHH--
Confidence 99999988754322211 224678899999998644 36899999999999999999999986432111 000
Q ss_pred hhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 731 AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. .......+ ..+......+.+++.+||+.+|++||++.|+++
T Consensus 244 --~~-~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 --KI-PRNPPPTL--------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred --HH-hcCCCCCC--------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 00000000 011223357899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=307.86 Aligned_cols=264 Identities=23% Similarity=0.301 Sum_probs=196.4
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57889999999999999999854 57899999986543 23345678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++ ++|..++.. ....+++..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDD--CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 588777643 2345789999999999999999999987 99999999999999999999999999976533221
Q ss_pred cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-cc--------cchhhhhccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-LL--------GHAWDLWKHERV 740 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~--------~~~~~~~~~~~~ 740 (834)
......+++.|+|||.+.+ ..++.++|||||||++|||++|++||......... .. ...+........
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1122356889999998865 45789999999999999999999998644321100 00 000000000000
Q ss_pred ccccc-ccccc---CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMD-PVILQ---DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~-~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+ +.... ..........+.+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000 00000 0001123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=327.90 Aligned_cols=265 Identities=19% Similarity=0.259 Sum_probs=191.5
Q ss_pred HHHHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCC------CceeeEEEEEE
Q 003274 507 SVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH------RNLVRILGCCV 579 (834)
Q Consensus 507 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H------~niv~l~~~~~ 579 (834)
++...+++|.+.++||+|+||+||++.. ..++.||||+++... ...+.+..|++++.+++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 3444568899999999999999999985 457889999986432 233456778888887755 45888998887
Q ss_pred eC-CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCC-----
Q 003274 580 EQ-GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDM----- 652 (834)
Q Consensus 580 ~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~----- 652 (834)
.. .+.++|||++ +++|.+++. +...+++..+..|+.||+.||+|||++ + |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 64 5788999987 667777763 335689999999999999999999974 6 99999999999998765
Q ss_pred -----------CeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCC
Q 003274 653 -----------NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN 721 (834)
Q Consensus 653 -----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~ 721 (834)
.+||+|||++..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998764221 2234679999999999999999999999999999999999999997543
Q ss_pred CCcc-ccccch----hhhhcc----ccccccc------cccc--------ccCC--CCHHHHhHHHHHHHhccccCCCCC
Q 003274 722 TDSF-NLLGHA----WDLWKH----ERVHELM------DPVI--------LQDE--IPLPMLMRYVNVALLCVQENAADR 776 (834)
Q Consensus 722 ~~~~-~~~~~~----~~~~~~----~~~~~~~------~~~~--------~~~~--~~~~~~~~l~~li~~cl~~dP~~R 776 (834)
.... ..+... ...+.. ....++. ++.. .... ........+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 2110 000000 000000 0000000 0000 0000 000123467899999999999999
Q ss_pred CCHHHHHH
Q 003274 777 PTMSDVVS 784 (834)
Q Consensus 777 Pt~~evl~ 784 (834)
||+.|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999986
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=313.75 Aligned_cols=240 Identities=23% Similarity=0.275 Sum_probs=184.9
Q ss_pred cccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhc---CCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 521 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
||+|+||+||+++.. +++.||||++.... ......+..|..++.+. +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999854 58899999986432 12233455666776665 699999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|..++. +...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 99988873 3456899999999999999999999988 9999999999999999999999999987643222 12
Q ss_pred ceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCC
Q 003274 674 TKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... . ........ ..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~----~~~i~~~~------~~~---- 216 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--M----YRNIAFGK------VRF---- 216 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--H----HHHHHcCC------CCC----
Confidence 2335799999999998765 48999999999999999999999985422111 0 00000000 000
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCC----CHHHHHH
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRP----TMSDVVS 784 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RP----t~~evl~ 784 (834)
.......++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0111345778999999999999998 4556554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=299.52 Aligned_cols=247 Identities=27% Similarity=0.433 Sum_probs=197.7
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|.+.+.||+|+||.||++. ..++.+|+|.+.... ..+.+.+|+.++.+++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEecc-cCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 568889999999999999997 467889999986532 346789999999999999999999998765 5799999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ....+++..+++++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 99999998542 2345789999999999999999999987 9999999999999999999999999987643211
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.|+....... . ...... .. ..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~----~~~~~~---------~~-~~ 216 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--V----KECVEK---------GY-RM 216 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--H----HHHHhC---------CC-CC
Confidence 11234568999999999999999999999999999998 888875432111 0 000000 00 01
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
..+...+..+.+++.+||+.+|++||++.++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122234678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.58 Aligned_cols=248 Identities=24% Similarity=0.401 Sum_probs=207.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+-|.+.++||+|+||.|||+.+ ..|+.+|||.+... .+++++..|+.+|++.+.|++|+++|.+.....+++|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 5577889999999999999975 46999999998654 46789999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
..|+..+.+. .++++|.+.++..+++..++||+|||... -+|||||+.||||+.+|.+||+|||.+-.+.+. .
T Consensus 111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--M 183 (502)
T KOG0574|consen 111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--M 183 (502)
T ss_pred CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--H
Confidence 9999999984 35678999999999999999999999876 799999999999999999999999999765432 2
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc-cccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM-DPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 750 (834)
.....+.||+.|||||++..-.|+.++||||||+...||..|++|+.....-.. +.-+. .+.. -
T Consensus 184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------IFMIPT~PPP-T 248 (502)
T KOG0574|consen 184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------IFMIPTKPPP-T 248 (502)
T ss_pred HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------eEeccCCCCC-C
Confidence 233447899999999999999999999999999999999999999763221000 00000 0000 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
-..|.....++.+++++||-.+|++|-|+.++++
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1234456789999999999999999999999876
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.94 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=197.2
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc----------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG----------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 582 (834)
+|.+.+.||+|+||.||+|.. .+++.+|+|.++.... ...+.+..|+.++.+++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999974 4688999998753211 11346788999999999999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 99999999999999998843 256889999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCC--CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+...............|+..|+|||.+.... ++.++||||||+++||+++|..|+....... ....... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~-~~- 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AMFKLGN-KR- 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HHHHhhc-cc-
Confidence 8654322222223356889999999987654 8899999999999999999999975321100 0000000 00
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+ ...........+.+++.+||+.+|++||++.+|++
T Consensus 229 ---~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 ---SAPPI-PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ---cCCcC-CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00000 11111223568899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.67 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=202.8
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|.+.+.||+|+||.||++.. .+++.+|+|.+........+.+.+|+.++++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6788889999999999999974 467899999987655555677899999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++. ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 9999999873 345788999999999999999999987 99999999999999999999999999876543322
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......+++.|+|||.+.+..++.++||||||+++||+++|+.||........ +.. ...... + ..
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~----~~~~~~------~---~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYL----IATNGT------P---EL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eee----hhcCCC------C---CC
Confidence 12234688899999999988999999999999999999999999864322111 000 000000 0 00
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+......+.+++.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122234578899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=307.98 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=199.9
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+++.. .++.||+|.+.... ....+.+.+|++++..++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999854 47899999986543 233567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999984 3356899999999999999999999987 999999999999999999999999998742111
Q ss_pred Cc-------------cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 669 EL-------------QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 669 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
.. ........++..|+|||.+.+..++.++|+||||+++|||++|..||...... .+.. ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~--~~~~----~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFG----QV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HH
Confidence 00 00111235788999999999999999999999999999999999998532211 0000 00
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.. .....+ .........+.+++.+||+.+|++||++.++.+.|+.
T Consensus 229 ~~---~~~~~~-----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 IS---DDIEWP-----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hh---cccCCC-----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 000001 0111234578999999999999999998777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.09 Aligned_cols=245 Identities=24% Similarity=0.351 Sum_probs=197.5
Q ss_pred cccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 003274 517 MQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
....||+|+||.||+++. .+++.+|+|.+........+.+.+|+.++..++||||+++++++..+...++|+||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 345899999999999985 4688999999876555556778999999999999999999999999999999999999999
Q ss_pred cchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCce
Q 003274 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 675 (834)
|..++. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..+..... ...
T Consensus 105 L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 175 (297)
T cd06659 105 LTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRK 175 (297)
T ss_pred HHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--ccc
Confidence 988762 345889999999999999999999987 99999999999999999999999999876543221 122
Q ss_pred eeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCH
Q 003274 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPL 755 (834)
Q Consensus 676 ~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 755 (834)
...|+..|+|||++.+..++.++||||||++++||++|+.|+....... .. ...... .... .....
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~-----~~~~---~~~~~ 241 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AM----KRLRDS-----PPPK---LKNAH 241 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHhcc-----CCCC---ccccC
Confidence 3568999999999999899999999999999999999999986322110 00 000000 0000 01111
Q ss_pred HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 756 PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 756 ~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.....+.+++.+||+.+|++||++.++++
T Consensus 242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 242 KISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 23456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.35 Aligned_cols=249 Identities=23% Similarity=0.375 Sum_probs=199.2
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~E 589 (834)
+|++.+.||+|++|.||+++.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999854 47889999986432 2345678899999999999999999988764 446789999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++... ....+++.++.+++.+++.|+++||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888542 3456899999999999999999999988 9999999999999999999999999998764332
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ......+++.|+|||++.+..++.++||||||++++||++|+.|+...+... ...... ... +
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-----~~~~~~-~~~----~----- 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-----LVYRII-EGK----L----- 219 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHH-hcC----C-----
Confidence 1 2233568899999999999999999999999999999999999876322111 000000 000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+......+.+++.+||+.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1122334568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=306.28 Aligned_cols=264 Identities=22% Similarity=0.323 Sum_probs=198.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|++.++||+|+||.||++... +++.+|+|++..... ...+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888899999999999999865 588999999865432 234578899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|..+.. ....+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999987753 2335899999999999999999999987 9999999999999999999999999998764432
Q ss_pred ccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc--ccccchhh-------hhcccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF--NLLGHAWD-------LWKHER 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~--~~~~~~~~-------~~~~~~ 739 (834)
. ......++..|+|||++.+ ..++.++||||||+++|||++|++|+........ .+...... ......
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 1 1222457889999999875 4578999999999999999999988753321100 00000000 000000
Q ss_pred c-cccccccccc----CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 V-HELMDPVILQ----DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~-~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .....+.... ..........+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 0000000000 0001123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.08 Aligned_cols=198 Identities=27% Similarity=0.367 Sum_probs=170.7
Q ss_pred CcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CC-----ceeeEEEEEEeCCeEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HR-----NLVRILGCCVEQGEKIL 586 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~~l 586 (834)
+|.+.+.||+|.||.|.|+. ...++.||||+++... .-..+...|+.+|..|+ |. |+|++++++...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78999999999999999997 4568999999997653 34566788999999996 53 89999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC--CCeeeccccccee
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--MNPKISDFGLARM 664 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DFGla~~ 664 (834)
|+|.+. .+|.++|... +...++...+..|++||+.||.+||+.+ |||+||||+||||..- ..+||+|||.+..
T Consensus 266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999885 4888888543 4456999999999999999999999887 9999999999999753 4799999999988
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCC
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT 722 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~ 722 (834)
.....+ ....+..|+|||+|.+.+|+.+.|+||||||+.||++|.+.|...++
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 654432 24567899999999999999999999999999999999887765443
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=317.17 Aligned_cols=263 Identities=24% Similarity=0.272 Sum_probs=195.0
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------ 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 581 (834)
..++|.+.+.||+|+||.||++.. ..++.+|||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 347899999999999999999985 458899999987532 23346778899999999999999999988643
Q ss_pred CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
...++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999976 4544442 24788899999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-c-ccc----------
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-N-LLG---------- 729 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~-~~~---------- 729 (834)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ . ...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 12234689999999999999999999999999999999999999864321100 0 000
Q ss_pred -----chhhhhcc-cccccccccccc-------cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 730 -----HAWDLWKH-ERVHELMDPVIL-------QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 730 -----~~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
........ ........+... ...........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 000000000000 001111224578899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=306.43 Aligned_cols=197 Identities=26% Similarity=0.419 Sum_probs=159.2
Q ss_pred cccccCCcEeEEEEEec---CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~Ey~~~ 593 (834)
.+||+|+||.||+|+.. .+..+|+|.+.... ....+.+|++++.+++||||+++++++.. +...++||||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 58999999999999864 35689999986542 23467889999999999999999999854 4577899999876
Q ss_pred CCcchhccc------ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe----ccCCCeeecccccce
Q 003274 594 KSLDVYLFD------PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLAR 663 (834)
Q Consensus 594 gsL~~~l~~------~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGla~ 663 (834)
+|..++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 55555421 112235889999999999999999999987 9999999999999 566799999999998
Q ss_pred ecCCCCcc-CCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCC
Q 003274 664 MFGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYN 721 (834)
Q Consensus 664 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~ 721 (834)
........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76543221 12233578999999999876 458999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=298.58 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=196.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 584 (834)
++|.+.++||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5788899999999999999985 458899999875321 12346788899999999999999999998764 467
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++. ....+++....+++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999998874 2345788889999999999999999987 99999999999999999999999999986
Q ss_pred cCCCCc-cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDEL-QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.|+........ ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--------------~~~~ 221 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--------------IFKI 221 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--------------HHHH
Confidence 543211 1122334688999999999988899999999999999999999999863211100 0000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... .....+......+.+++.+|+. +|++||++.|+++
T Consensus 222 ~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 222 ATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0000 0122344455678889999985 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.99 Aligned_cols=249 Identities=22% Similarity=0.367 Sum_probs=200.7
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|+||.||+++. .+++.+|+|++... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 46889999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+++++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998887432 2335788999999999999999999987 99999999999999999999999999987644321
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......|++.|+|||++.+..++.++||||||++++||++|+.|+....... ..... +... .
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-----~~~~~---------~~~~--~ 218 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-----LVLKI---------IRGS--Y 218 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-----HHHHH---------hcCC--C
Confidence 1123457889999999999999999999999999999999999875322110 00000 0000 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+.....++.+++.+||+.+|++||++.+|++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1122234567899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.51 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=201.6
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEccc--CCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 587 (834)
....|++.++||+||.+.||++...+.+.+|+|++.. ...+...-|++|+.+|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 4567889999999999999999977778899987653 34566788999999999994 99999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||= ..+|..+|.. +...++...+..+..|++.++.++|+++ |||.||||.|+|+ -.|.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k--~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKK--KKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeechhcccCc
Confidence 9974 5588888743 2223332377889999999999999998 9999999999998 567899999999999877
Q ss_pred CCccCCceeeeccCcccCceeecCC-----------CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDG-----------LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
+...-....-+||+.||+||.+... +++.++||||+||+||+|+.|++||+.....
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~------------- 578 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ------------- 578 (677)
T ss_pred cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH-------------
Confidence 7655555556899999999998533 2568999999999999999999999753321
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..++..+.++.-.-.-...+...++.++|+.||..||++||++.|+|+
T Consensus 579 ~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 112344455422111111122234899999999999999999999986
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=303.93 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=201.1
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|++.++||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999865 5789999998653 23345678999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++++.+..++. +...+++..+..++.+|++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887766552 3345889999999999999999999987 9999999999999999999999999998765443
Q ss_pred ccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch----------hhhhccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA----------WDLWKHE 738 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~----------~~~~~~~ 738 (834)
. .......++..|+|||++.+. .++.++||||||+++|||++|++|+........ +.... .......
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccC
Confidence 2 122234678899999999888 889999999999999999999998864322110 00000 0000000
Q ss_pred ------ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 ------RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+..++.......+.....++.+++.+||..+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000000001122223678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=336.53 Aligned_cols=258 Identities=24% Similarity=0.343 Sum_probs=198.4
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 586 (834)
.++|.+.++||+|+||+||+++.. .++.+|+|.+... .......|..|+.++.+|+|||||++++++... ...+|
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 478999999999999999999854 4678899988643 233456789999999999999999999988643 56899
Q ss_pred EEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCEEeccC----------
Q 003274 587 ILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSR----LRIIHRDLKASNVLLDKD---------- 651 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~----~~ivH~Dlk~~NILl~~~---------- 651 (834)
||||+++++|..+|.... ....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.+
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 999999999999885422 23568999999999999999999998542 349999999999999642
Q ss_pred -------CCeeecccccceecCCCCccCCceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCCCCCCC
Q 003274 652 -------MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNTGVYNT 722 (834)
Q Consensus 652 -------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~~~~~~ 722 (834)
..+||+|||++..+..... .....||+.|+|||++.+ ..++.++|||||||+||||++|+.||.....
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~ 248 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN 248 (1021)
T ss_pred ccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence 3489999999987643321 223578999999999864 4589999999999999999999999864321
Q ss_pred CccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003274 723 DSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISN 788 (834)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 788 (834)
.. .+. ...... +.+ .......++.+||..||+.+|.+||++.|++. .+..
T Consensus 249 ~~-qli----~~lk~~-------p~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~ 300 (1021)
T PTZ00266 249 FS-QLI----SELKRG-------PDL----PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN 300 (1021)
T ss_pred HH-HHH----HHHhcC-------CCC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence 10 000 000000 000 01112457899999999999999999999984 4543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=303.40 Aligned_cols=265 Identities=25% Similarity=0.260 Sum_probs=195.7
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++++|.+.++||+|+||.||+|.. .+++.+|+|++..... .....+.+|+.++++++|+||+++++++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999985 4688999999865432 22346788999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+. ++|..++.. ....+++..+..++.|+++||+|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 667666532 2345778888999999999999999987 999999999999999999999999998764332
Q ss_pred CccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc-----------
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK----------- 736 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~----------- 736 (834)
.. ......+++.|+|||++.+. .++.++||||||+++|||++|+.||.........+.. .+....
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCCCChhhhhhhh
Confidence 21 11223568899999998764 5789999999999999999999998754322111110 000000
Q ss_pred -ccccccccccccccC-----CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 -HERVHELMDPVILQD-----EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 -~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
............... .........+.+++.+|++.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 000112457789999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=333.86 Aligned_cols=263 Identities=31% Similarity=0.436 Sum_probs=210.7
Q ss_pred HHHhcCcccccccccCCcEeEEEEEec--------CccEEEEEEcccCCc-ccHHHHHHHHHHHhhc-CCCceeeEEEEE
Q 003274 509 AAATENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL-QHRNLVRILGCC 578 (834)
Q Consensus 509 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~ 578 (834)
+...+++.+.+.||+|.||.|++|... ....||||.++.... ...+.+..|+++|..+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 344566667779999999999999743 145799999986533 4567899999999999 799999999999
Q ss_pred EeCCeEEEEEEecCCCCcchhccccc-----cc--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 003274 579 VEQGEKILILEYMPNKSLDVYLFDPI-----KK--------RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (834)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N 645 (834)
.+++..++|+||+..|+|..+|...+ .. ..+...+++.++.|||.||+||++.. ++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999996544 00 24889999999999999999999987 9999999999
Q ss_pred EEeccCCCeeecccccceecCCCCccCCc-eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCC
Q 003274 646 VLLDKDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTD 723 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~ 723 (834)
||+.++..+||+|||+++......+.... ....-+..|||||.+....|+.|+|||||||+||||+| |..|+......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999987665544321 11113567999999999999999999999999999999 55665431100
Q ss_pred ccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 724 SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+ +.+.+.+.. +-+.|..+..+++++|+.||+.+|++||++.++++.|+..
T Consensus 529 -~~-------------l~~~l~~G~-r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 -EE-------------LLEFLKEGN-RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -HH-------------HHHHHhcCC-CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 01 111111111 2344666788999999999999999999999999999884
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.98 Aligned_cols=255 Identities=18% Similarity=0.230 Sum_probs=194.4
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+++.. .++.+|+|.+.+. .....+.+..|+.++..++|+||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47888999999999999999865 4678999998642 2223445888999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 ey~~~g~L~~~l~~--~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999843 2346889999999999999999999987 999999999999999999999999999765332
Q ss_pred CccCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
.. .......||+.|+|||++. ...++.++|||||||+||||++|+.||....... .......... ..
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~-----~~~~i~~~~~--~~ 227 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-----TYGKIMNHKE--RF 227 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH-----HHHHHhCCCc--cc
Confidence 21 1122357999999999986 3568899999999999999999999986432111 0000100000 00
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCC--CCCCHHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAA--DRPTMSDVVSM 785 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPt~~evl~~ 785 (834)
.+ .........++.+++.+|+..+++ .|+++.|+++.
T Consensus 228 ---~~--p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QF--PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cC--CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 001112345778889988855443 46889988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.09 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=201.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|+..+.||+|++|.||++... +++.+|+|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999865 58899999987653 34456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++... ...++...+.+++.|+++||+|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999988432 2578899999999999999999998 66 9999999999999999999999999987653221
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ....++..|+|||.+.+..++.++||||||+++|||++|+.|+................. ....
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~-- 220 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI---------VNEP-- 220 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH---------hcCC--
Confidence 1 115688899999999999999999999999999999999999864432111111110000 0000
Q ss_pred cCCCCHH-HHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLP-MLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.. ....+.++|.+||..+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0011111 4567899999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=307.04 Aligned_cols=249 Identities=22% Similarity=0.341 Sum_probs=199.1
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.|.....||+|+||.||++.. .++..+|||.+........+.+.+|+.++.+++|+||+++++.+...+..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344446899999999999985 4578999999876555566778999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 103 ~~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 103 GGALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 999988873 335889999999999999999999987 9999999999999999999999999987654322 1
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
......|+..|+|||.+.+..++.++||||||+++|||++|+.|+....... .. .. ....+.+.+ .
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~----~~-----~~~~~~~~~-~-- 239 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AM----RR-----IRDNLPPRV-K-- 239 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HH-----HHhcCCCcc-c--
Confidence 2223568999999999998899999999999999999999999975322110 00 00 001111111 0
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
........+.+++.+||..+|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111234567889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.95 Aligned_cols=253 Identities=25% Similarity=0.434 Sum_probs=200.5
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
+|+..+.||+|++|.||+++. .+++.+|+|.+.... ....+.+..|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999984 568899999986432 1235678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-Ceeecccccceec
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~ 665 (834)
||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999884 3356889999999999999999999987 99999999999998776 5999999999876
Q ss_pred CCCCcc--CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 666 GGDELQ--GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 666 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... .......++..|+|||.+.+..++.++||||+|++++||++|..|+........ ... ..+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~---------~~~~ 223 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LAL---------IFKI 223 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHH---------HHHH
Confidence 543211 112234688999999999988999999999999999999999999753321110 000 0000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ......+.....++.+++.+||+.+|++||++.++++
T Consensus 224 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ASA-TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hcc-CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 0012233345578899999999999999999999973
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=310.77 Aligned_cols=245 Identities=30% Similarity=0.465 Sum_probs=197.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.-|...+.||.|+||.||.++. .+.+.||||++.-. +...+..+..|+..|.+++|||+|.+.|++......+|||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466678999999999999984 56788999998643 3345677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|||-| +-.+++ ...++++.+-++..|+.+.+.||+|||+.+ .||||||+.||||++.|.|||+|||.|.++...
T Consensus 106 EYClG-SAsDll--eVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 106 EYCLG-SASDLL--EVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHhc-cHHHHH--HHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 99954 555555 234567889999999999999999999998 999999999999999999999999999876443
Q ss_pred CccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..++|||.|||||+|. .+.|+-|+||||||++..||.-.++|.-..+ .+...+.+...+.
T Consensus 180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-----AMSALYHIAQNes------ 242 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----AMSALYHIAQNES------ 242 (948)
T ss_pred ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-----HHHHHHHHHhcCC------
Confidence 3478999999999985 6789999999999999999999888853211 1111111111110
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
|.+ ...+....+.+++..||+.-|.+|||..++++
T Consensus 243 PtL----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 PTL----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCC----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111 13345778999999999999999999988775
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=296.12 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=200.6
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|.+.+.||+|+||.||+|.. .+++.+|+|.+..... ...+.+..|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 477789999999999999985 4688999999876544 3677899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ...+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999998843 345788999999999999999999987 99999999999999999999999999987654332
Q ss_pred cCC--ceeeeccCcccCceeecCCC---CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 671 QGN--TKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 671 ~~~--~~~~~gt~~y~aPE~~~~~~---~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
... .....++..|+|||++.+.. ++.++||||||++++||++|+.||......... ..... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~----~~~~~------~~~~ 224 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI----MFHVG------AGHK 224 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH----HHHHh------cCCC
Confidence 111 12346788999999998766 899999999999999999999998643211100 00000 0000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.+ . ........+.+++.+||+.+|++||++.+++.
T Consensus 225 ~~~-~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPI-P--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC-C--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 0 01112456789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=301.11 Aligned_cols=262 Identities=26% Similarity=0.316 Sum_probs=197.1
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcc-----cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+|.+.++||+|+||.||+|... +++.||||++...... ....+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677889999999999999854 6889999998754322 344577899999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+ +++|.+++... ...+++..+..++.||++||+|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 99999988432 236899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc------cc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE------RV 740 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~ 740 (834)
... ......++..|+|||.+.+ ..++.++|||||||+++||++|.+++...... . ............ ..
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-D-QLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-H-HHHHHHHHcCCCchhhhhhc
Confidence 321 1122346788999998854 46789999999999999999997776532211 0 000000000000 00
Q ss_pred ccccccccc--cC-----CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 741 HELMDPVIL--QD-----EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 741 ~~~~~~~~~--~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
....+.... .. .........+.+++.+||+.+|++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000 00 0112235688999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.99 Aligned_cols=261 Identities=24% Similarity=0.296 Sum_probs=194.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------G 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 582 (834)
.++|.+.++||+|+||.||++.. ..++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 47899999999999999999985 45789999998653 233456788999999999999999999987543 3
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||+++ +|...+. ..+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 57999999976 5555542 24788899999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-c-cccc----hhhh--
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-N-LLGH----AWDL-- 734 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~-~~~~----~~~~-- 734 (834)
+...... ......||..|+|||++.+..++.++|||||||+||||++|+.||........ . .... ....
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 250 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8654322 12234689999999999999999999999999999999999999864332110 0 0000 0000
Q ss_pred --------hcccc-------ccccccccccc--CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 --------WKHER-------VHELMDPVILQ--DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 --------~~~~~-------~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+ ..+........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 00000000000 0011112357889999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=295.26 Aligned_cols=250 Identities=28% Similarity=0.420 Sum_probs=205.3
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.+.||+|++|.||+++.. +++.+++|++..... ...+.+.+|+..+.+++|+||+++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999865 489999999876543 4467899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++.. ...+++..+..++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999843 2678999999999999999999999 87 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCc-cccccchhhhhccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS-FNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .+.. ..+....
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~------------~~~~~~~- 219 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM------------QAICDGP- 219 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH------------HHHhcCC-
Confidence 221 23467899999999999999999999999999999999999986543211 0000 0000000
Q ss_pred ccCCCCHH-HHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLP-MLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.. ....+.+++.+||+.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 220 -PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred -CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 0111222 4568899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=299.59 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=199.7
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC------
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG------ 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~------ 582 (834)
++++|++.+.||+|++|.||+|+.. +++.+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4688999999999999999999864 578999999865433 346789999999999 7999999999997655
Q ss_pred eEEEEEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999998875422 2457899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecC-----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
+....... .......|+..|+|||++.. ..++.++||||||++|+||++|+.|+....... .+.
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~-------- 228 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALF-------- 228 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHH--------
Confidence 88654322 11223468899999998753 347789999999999999999999986322111 000
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
++..........+.....++.+++.+||..||++|||+.++++
T Consensus 229 -----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 229 -----KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----HhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000000011112224567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=298.64 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=200.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 588 (834)
++|...+.||.|++|.||++... .++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999864 578999999875432 3456789999999999999999999998653 4689999
Q ss_pred EecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|.+++... .....++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999998876432 23456888999999999999999999987 99999999999999999999999999876533
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....+....... ...........+ ...
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~-~~~ 231 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-LSYIVNMPNPEL-KDE 231 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH-HHHHhcCCchhh-ccC
Confidence 22 123457889999999999999999999999999999999999987543211110000 000000000000 000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.+|++|||+.|+++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 ---PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ---CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0111223567899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=297.60 Aligned_cols=247 Identities=23% Similarity=0.410 Sum_probs=198.2
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccC-CcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~ 588 (834)
.|++.++||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999985 56889999998654 3345567889999999996 999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++. ...+++..+..++.|+++||+|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMK----AGPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999998873 236889999999999999999999987 999999999999999999999999999876544
Q ss_pred CccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. ......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+........ .. . ......+.
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~----~-----~~~~~~~~ 221 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MM----L-----IPKSKPPR 221 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hh----c-----cccCCCCC
Confidence 31 12234688999999988754 578999999999999999999999864322110 00 0 00000011
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+ . ......++.+++.+||+.||++||++.++++
T Consensus 222 ~-~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 L-E---DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred C-C---cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 0 0013457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=313.21 Aligned_cols=259 Identities=25% Similarity=0.319 Sum_probs=192.8
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------ 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------ 581 (834)
..++|.+.+.||+|+||.||++.. ..++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 457899999999999999999985 467899999986532 22345678899999999999999999887643
Q ss_pred CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
...++++|++ +++|..++ ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIV----KCQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999987 77887766 3346899999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh------
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL------ 734 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~------ 734 (834)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ........
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 237 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID--QLKRIMEVVGTPSP 237 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 9875432 223468999999999876 578999999999999999999999986432110 00000000
Q ss_pred -----hccccccccccc--ccccC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 -----WKHERVHELMDP--VILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 -----~~~~~~~~~~~~--~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.........+.. ..... .........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 00000 000011235789999999999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=300.42 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=199.6
Q ss_pred HHHHHHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe--
Q 003274 505 LASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE-- 580 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~-- 580 (834)
+.++..+...|++.+.||+|+||.||+|+. ..++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 334445667899999999999999999985 457899999886543 3446788899999999 79999999999863
Q ss_pred ----CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeee
Q 003274 581 ----QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (834)
Q Consensus 581 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 656 (834)
....+++|||+++|+|.+++... ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.++|
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 45789999999999999988532 2345788889999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCCccCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch
Q 003274 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA 731 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~ 731 (834)
+|||++....... .......|+..|+|||.+. ...++.++|||||||++|||++|+.|+.........
T Consensus 163 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 163 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred eeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 9999987653221 1122356889999999986 356889999999999999999999998543211100
Q ss_pred hhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 732 WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........ ...........+.+++.+||+.||.+||++.|+++
T Consensus 236 ---------~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ---------FLIPRNPP-PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---------hhHhhCCC-CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000000 00111123467899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.52 Aligned_cols=263 Identities=25% Similarity=0.319 Sum_probs=194.8
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.+.||+|++|.||+|+.. +++.||+|.+..... .....+.+|++++++++|+||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888999999999999999864 678999999865432 2234577899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+.+ +|..++... ...+++.....++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888877432 346889999999999999999999987 99999999999999999999999999875432111
Q ss_pred cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc---cc------c
Q 003274 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH---ER------V 740 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~------~ 740 (834)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.........+ ......... .. .
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL-HKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHhcCCCChhhhhhhhhc
Confidence 1112346789999999875 458999999999999999999999986433111100 000000000 00 0
Q ss_pred ---c----cccc-cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 ---H----ELMD-PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ---~----~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .... ..+............+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0000 000000001111257789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=293.67 Aligned_cols=248 Identities=25% Similarity=0.391 Sum_probs=199.7
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|...+.||+|+||.||++.. .+++.+|+|++... .....+.+.+|++++++++||||+++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 46889999998654 233467789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-CeeecccccceecCCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++... ....+++..+.+++.++++||+|||+++ ++|+||+|+||+++.++ .+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998542 2345889999999999999999999987 99999999999998654 58999999998765432
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .... ....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~-----~~~~---------~~~~-- 217 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL-----VLKI---------MSGT-- 217 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH-----HHHH---------HhcC--
Confidence 1 1224678899999999998899999999999999999999999764322110 0000 0000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++.+||+.+|++|||+.|+++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 01112224567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=295.82 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=200.6
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILIL 588 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV~ 588 (834)
+|++.+.||+|+||.||++.. .+++.+|+|.+... .....+++..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477889999999999999984 46789999998643 23345678899999999999999999998764 34678999
Q ss_pred EecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 589 EYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYS--RLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
||+++++|.+++.... ....+++..++.++.++++||+|||..+ ..+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999885422 2457899999999999999999999332 234999999999999999999999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
...... .....+++.|+|||.+.+..++.++||||||+++++|++|+.|+...... .+. ......
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~----~~~~~~------- 225 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL--QLA----SKIKEG------- 225 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH--HHH----HHHhcC-------
Confidence 543321 22346899999999999999999999999999999999999998643311 110 000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
. ....+......+.+++.+||+.+|++||++.+|++.
T Consensus 226 --~-~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 --K-FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --C-CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 112233345688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.42 Aligned_cols=248 Identities=26% Similarity=0.393 Sum_probs=194.8
Q ss_pred cccccccCCcEeEEEEEe-cCccEEEEEEccc----CCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe--EEEEEE
Q 003274 517 MQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSS----QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE--KILILE 589 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~----~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~--~~lV~E 589 (834)
..++||+|+|-+||||.. ..|-+||--.++. ..+...++|..|+.+|+.|+|||||+++.+..+... ..+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 346899999999999974 3466676433321 244566899999999999999999999999987665 789999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeecccccceecCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~~~~~~ 668 (834)
.|..|+|..|+. +.+.++.+.+.+|+.||++||.|||++. ++|+|||||..||+|+.+ |.|||+|.|||......
T Consensus 124 L~TSGtLr~Y~k---k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRK---KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHH---HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999983 4456888999999999999999999986 689999999999999854 89999999999987544
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. ...+.|||.|||||... ..|++.+||||||+.++||.|+..|+........ +......-.+...+..+
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-IYKKV~SGiKP~sl~kV----- 268 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-IYKKVTSGIKPAALSKV----- 268 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-HHHHHHcCCCHHHhhcc-----
Confidence 3 22368999999999877 8899999999999999999999999865443221 11111111111111111
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISN 788 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 788 (834)
...++.++|.+||.. .++||++.|+|. +|..
T Consensus 269 --------~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 269 --------KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE 301 (632)
T ss_pred --------CCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence 134678999999998 999999999986 4544
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=298.75 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=205.7
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
..+.|..-++||+|+||.||-.+. ..|+.+|.|.+.+. ..+.....++|-.+|.+++.+.||.+-..++..+.++|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 446788889999999999999874 45888999988543 34455667899999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+..|.+|+|.-||+.... ..+++++++.++.+|+-||.+||... ||.|||||+|||||+.|+++|+|.|||..+.
T Consensus 263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 9999999999999976433 67999999999999999999999987 9999999999999999999999999999887
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
..+.. ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||....+.. -.+.+|.
T Consensus 339 ~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------------k~eEvdr 400 (591)
T KOG0986|consen 339 EGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------------KREEVDR 400 (591)
T ss_pred CCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------------hHHHHHH
Confidence 65432 22489999999999999999999999999999999999999987433211 1112222
Q ss_pred ccc--cCCCCHHHHhHHHHHHHhccccCCCCCCC
Q 003274 747 VIL--QDEIPLPMLMRYVNVALLCVQENAADRPT 778 (834)
Q Consensus 747 ~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt 778 (834)
..+ ..+++...+++...+....|+.||++|.-
T Consensus 401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 221 22455666788899999999999999974
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=298.55 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=198.9
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|.+.+.||+|+||.||+|+. .+++.+|+|++.... ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 477889999999999999985 468899999987543 33456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+ +++|.+++... ...+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 99999887432 256899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc----------hhhhhccc-
Q 003274 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH----------AWDLWKHE- 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~----------~~~~~~~~- 738 (834)
.......++..|+|||.+.+. .++.++||||+|++++||++|++++....... .+... .+......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcc
Confidence 112234688999999998654 46899999999999999999987765332110 00000 00000000
Q ss_pred ccccccccccc---cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 RVHELMDPVIL---QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+..+... ...........+.+++.+||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 00001123478899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=298.31 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=192.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHH-HhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMML-IAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|+||.||+++.. +|+.||+|+++... .....++..|+.+ ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999864 58999999987542 2233455666665 555689999999999999999999999
Q ss_pred ecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 590 YMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 590 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|++ ++|..++... .....+++..+..++.||+.||+|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6777766432 2335689999999999999999999986 5 99999999999999999999999999986543
Q ss_pred CCccCCceeeeccCcccCceeecC----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+.........+ .... ..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~------~~ 223 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQL----KQVV------EE 223 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHH----HHHH------hc
Confidence 21 1122457889999998865 456899999999999999999999985322211100 0000 00
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+.+ .......++.+++.+||..+|++||++.++++
T Consensus 224 ~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 PSPQL----PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCC----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111 01113457899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=296.53 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=199.1
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
-|.+.++||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++.++...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 466778999999999999985 467899999876432 234567889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|..++. ...+++..+..++.+++.++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998873 346889999999999999999999987 99999999999999999999999999887643321
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......++..|+|||.+.+..++.++|||||||++|||++|..|+....... .. ....... ..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~----~~~~~~~----------~~ 219 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VL----FLIPKNN----------PP 219 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HH----HHHhcCC----------CC
Confidence 1222467889999999998899999999999999999999999975422110 00 0000000 01
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1122234678899999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=302.61 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=193.7
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.++||+|+||.||+++.. +|+.+|+|++.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777889999999999999854 68899999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|..++.. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~- 153 (284)
T cd07839 81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV- 153 (284)
T ss_pred CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-
Confidence 975 67666532 2346899999999999999999999987 9999999999999999999999999998654322
Q ss_pred cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc------ccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE------RVHEL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~ 743 (834)
.......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.........+ .......... ...+.
T Consensus 154 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH-HHHHHHhCCCChHHhHHhhhc
Confidence 111223568899999998764 47899999999999999999998864322211110 0000000000 00000
Q ss_pred ccc--------ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDP--------VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~--------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+. .............++.+++.+||+.||.+|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 00000111123467889999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=301.32 Aligned_cols=243 Identities=26% Similarity=0.355 Sum_probs=199.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999854 58899999986432 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ...++...+..++.|++.||+|||+.+ ++|+||+|+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999988743 356899999999999999999999987 999999999999999999999999999876443
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.....+++.|+|||.+.+...+.++||||||+++|||++|+.|+....... .... +...
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~--------~~~~-- 213 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ------IYEK--------ILEG-- 213 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHH--------HhcC--
Confidence 223468899999999998889999999999999999999999976433110 0000 0000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVV 783 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl 783 (834)
....+......+.+++.+||..+|.+|| ++.|++
T Consensus 214 -~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 214 -KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1112223356888999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=298.24 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=202.8
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++.|+..+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|++++.+++|+||+++++++......++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999865 588999999876544 56778999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++.... ..+++..+..++.+++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999985322 37899999999999999999999987 9999999999999999999999999987654322
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ......++..|+|||++.+..++.++||||||+++|||++|+.|+........ ..... .. ...
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-----~~~~~-~~--------~~~ 234 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-----LFLIT-TK--------GIP 234 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHH-hc--------CCC
Confidence 1 11224578899999999988999999999999999999999999753221110 00000 00 000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00111113457889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=304.94 Aligned_cols=266 Identities=21% Similarity=0.301 Sum_probs=195.8
Q ss_pred CcccccccccCCcEeEEEEEec---CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKI 585 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 585 (834)
.|.+.++||+|+||.||+|+.. .++.+|+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999864 47899999997633 33446778899999999999999999999988 7899
Q ss_pred EEEEecCCCCcchhcccc-cc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc----CCCeeeccc
Q 003274 586 LILEYMPNKSLDVYLFDP-IK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK----DMNPKISDF 659 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~-~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~DF 659 (834)
+||||+++ +|..++... .. ...++...+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 555554322 12 236889999999999999999999987 999999999999999 999999999
Q ss_pred ccceecCCCCc-cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccc-------cc
Q 003274 660 GLARMFGGDEL-QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLL-------GH 730 (834)
Q Consensus 660 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~-------~~ 730 (834)
|+++....... ........++..|+|||.+.+. .++.++||||||++|+||++|++|+.....+..... ..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643322 1122334678899999988664 589999999999999999999999875443220000 00
Q ss_pred hhhhhc------------ccccccccccccccCCCC---------H--HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 731 AWDLWK------------HERVHELMDPVILQDEIP---------L--PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 731 ~~~~~~------------~~~~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...... ........+... ....+ . ....++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFK-TKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhcc-CCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000000000000 00001 0 23457899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.35 Aligned_cols=253 Identities=23% Similarity=0.275 Sum_probs=200.3
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||++... +++.+|+|.+..... ...+.+..|++++.+++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888899999999999999865 488999999875432 24567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+.+++|.+++.. .....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999998743 23456899999999999999999999987 999999999999999999999999998765321
Q ss_pred Ccc---------------------------CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCC
Q 003274 669 ELQ---------------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN 721 (834)
Q Consensus 669 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~ 721 (834)
... .......|+..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 01112467889999999999999999999999999999999999986433
Q ss_pred CCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC----HHHHHH
Q 003274 722 TDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT----MSDVVS 784 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~ 784 (834)
.... + ..+..... ...........+.+++.+||+.+|++||+ +.|++.
T Consensus 237 ~~~~-~-------------~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET-F-------------SNILKKEV-TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH-H-------------HHHhcCCc-cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 2110 0 00111110 00011114568899999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=298.74 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=198.1
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
|...++||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 34456999999999999985 46889999998665555566789999999999999999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999988743 45889999999999999999999987 99999999999999999999999999876543221 1
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ...... ..+.. ..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~----~~~~~~-----~~~~~---~~ 237 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAM----KRIRDN-----LPPKL---KN 237 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHH----HHHHhc-----CCCCC---cc
Confidence 22346889999999999889999999999999999999999997532210 000 000000 00111 01
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1123457899999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=290.14 Aligned_cols=270 Identities=23% Similarity=0.329 Sum_probs=221.3
Q ss_pred cHHHHHHHhcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEE
Q 003274 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILG 576 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~ 576 (834)
...++....+++....++-+|.||.||+|.+ .+.+.|-||.++.. ++-+...++.|...+..+.|||+..+.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3456667778899999999999999999954 33557788888765 3445678999999999999999999999
Q ss_pred EEEeCC-eEEEEEEecCCCCcchhcc-----cccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc
Q 003274 577 CCVEQG-EKILILEYMPNKSLDVYLF-----DPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650 (834)
Q Consensus 577 ~~~~~~-~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~ 650 (834)
++.+.. ..+.+|.++.-|+|..||. +....+.+...+...++.|++.||+|||.++ +||.||.++|++||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 998754 6788999999999999997 4445566788889999999999999999988 999999999999999
Q ss_pred CCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCcccccc
Q 003274 651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLG 729 (834)
Q Consensus 651 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~ 729 (834)
..++||+|=.++|.+...++.........+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm---- 507 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM---- 507 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH----
Confidence 99999999999999887777765555567889999999999999999999999999999998 7777654332211
Q ss_pred chhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 003274 730 HAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLN 792 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
...+.+.. +-..|..++.++..+|.-||...|++||++++++.-|.+.+.+
T Consensus 508 -----------~~ylkdGy-RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 508 -----------EHYLKDGY-RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred -----------HHHHhccc-eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 01111111 1234566788999999999999999999999999988775443
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=289.42 Aligned_cols=249 Identities=28% Similarity=0.452 Sum_probs=202.8
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+|...+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677889999999999999865 688999999977655566789999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++... ...+++..+..++.+++++|+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999887432 257899999999999999999999977 99999999999999999999999999987654332
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.....++..|+|||.+....++.++||||||++++||++|+.|+.......... ....... +.. .
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~-----~~~---~ 218 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIATNGP-----PGL---R 218 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHHhcCC-----CCc---C
Confidence 234568899999999998889999999999999999999999976432111000 0000000 000 0
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+......+.+++.+||+.||++||++.++++
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01112467899999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=288.71 Aligned_cols=251 Identities=26% Similarity=0.401 Sum_probs=205.1
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILIL 588 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 588 (834)
+|...+.||+|++|.||+|... +++.+++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677889999999999999865 688999999866542 4567899999999999999999999999988 8899999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ...+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999998843 237899999999999999999999987 999999999999999999999999999887654
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
..........++..|+|||.+.....+.++||||||++++||++|+.|+........ ..... ....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~---------~~~~- 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA----ALYKI---------GSSG- 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH----HHHhc---------cccC-
Confidence 432122335688999999999988899999999999999999999999875441111 00000 0000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.....+......+.+++.+|++.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 011223334678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=297.78 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=195.1
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|++|.||+|+.. +++.+|||++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999854 68899999886532 22345788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+. ++|..++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5788777432 3456899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cCCceeeeccCcccCceeecCCC-CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc-----------
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE----------- 738 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 738 (834)
......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... .+... .......
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRI-FRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHH-HHHhCCCChhhhhhhhHH
Confidence 112234688999999887654 6899999999999999999999986433211 00000 0000000
Q ss_pred -----ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 -----RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.........+ .........++.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 0001122456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.79 Aligned_cols=246 Identities=29% Similarity=0.428 Sum_probs=193.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
+.|...++||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45788899999999999999854 68899999886432 233457889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+. |++.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 566555532 2346899999999999999999999987 999999999999999999999999998765322
Q ss_pred CccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....++..|+|||++. ...++.++||||||+++|||++|++|+........ ....... . .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~~~~~~-~-----~ 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQN-D-----S 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HHHHhcC-C-----C
Confidence 1245788999999884 45688999999999999999999998753221100 0000000 0 0
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+. ..+......+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PT----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CC----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 1112244578999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=296.33 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=196.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV 587 (834)
++|++.+.||+|+||.||+|+.. +++.+|+|.++... ......+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999865 57899999986543 22234577899999999999999999999877 899999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+.+ +|..++.. ....+++..+..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999974 88777643 2236899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-c-ccc-------chhhhhcc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-N-LLG-------HAWDLWKH 737 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~-~~~-------~~~~~~~~ 737 (834)
... ......+++.|+|||.+.+. .++.++|+||||+++|||++|..|+........ . +.. ..+..+..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 12224578899999998754 468999999999999999999999864332110 0 000 00000000
Q ss_pred ------cccccccccccccCCCCHH-HHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ------ERVHELMDPVILQDEIPLP-MLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ------~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+ ....+.. ....+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000 1112221 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=292.44 Aligned_cols=241 Identities=25% Similarity=0.306 Sum_probs=186.1
Q ss_pred ccccCCcEeEEEEEe-cCccEEEEEEcccCCc---ccHHHHHHHHHHHhh---cCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAE---LQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~---l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
.||+|+||.||+++. .+++.+|+|.+..... .....+.+|..++.. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 4588999998865321 122334455444433 479999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999998874 3456899999999999999999999988 9999999999999999999999999987654322
Q ss_pred CceeeeccCcccCceeec-CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....|+..|+|||.+. +..++.++|||||||++|||++|..||........... .. ..... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-------~~--~~~~~-----~~ 216 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------DR--MTLTV-----NV 216 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-------HH--HhhcC-----Cc
Confidence 12246899999999986 45689999999999999999999999864332211000 00 00000 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
..+.....++.+++.+||+.||++|| +++|+++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 22333456889999999999999999 5988876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=294.83 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=200.8
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
+|.+.+.||+|+||.||+++.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999865 58899999986542 2346789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+.+++|..++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 9999999988843 257889999999999999999999987 9999999999999999999999999988764432
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+........... . ..... .
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~---------~~~~~--~ 217 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI---R---------AKQET--A 217 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHH---H---------HHhcc--c
Confidence 12234678899999999988899999999999999999999999875432111000 0 00000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCH--HHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTM--SDVV 783 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl 783 (834)
....+......+.+++.+||+.+|.+||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 112233345788999999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=298.24 Aligned_cols=263 Identities=25% Similarity=0.325 Sum_probs=194.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~l 586 (834)
.++|++.++||+|+||.||+|+.. +|+.||+|.++.... .....+.+|+.++.+++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367899999999999999999864 588999999864322 2233567899999999999999999998765 46899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+.+ +|.+++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDN--MPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 77777643 2356899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc--cccc--
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH--ERVH-- 741 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~~~-- 741 (834)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|++||....... ........... ....
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE--QLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChhhchh
Confidence 4321 1122345788999999865 568999999999999999999999986433211 00000000000 0000
Q ss_pred ----ccccc-ccccCCC------CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 ----ELMDP-VILQDEI------PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 ----~~~~~-~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... .+..... .......+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0000000 0112456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.17 Aligned_cols=263 Identities=27% Similarity=0.356 Sum_probs=197.6
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+|++.++||+|++|.||+|+.. +++.+|||.+..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999964 588999999875432 23466788999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++ +|.+++........+++..+.+++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777754434456899999999999999999999987 99999999999999999999999999976533211
Q ss_pred CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh--------ccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW--------KHERVHE 742 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 742 (834)
......++..|++||.+.+. .++.++||||||+++|||++|+.|+........ ........ .......
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCc
Confidence 11223568899999988654 578999999999999999999999864432110 00000000 0000000
Q ss_pred cccccccc------CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVILQ------DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........ ..........+.+++.+|++.||.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0011123467889999999999999999999974
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=297.02 Aligned_cols=264 Identities=23% Similarity=0.288 Sum_probs=193.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe-----
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE----- 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~----- 583 (834)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++.++ +||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999854 68899999876542 22345788899999999 56999999999987665
Q ss_pred EEEEEEecCCCCcchhcccccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeecccc
Q 003274 584 KILILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFG 660 (834)
.++||||+++ +|..++..... ...+++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 78777643222 346899999999999999999999987 999999999999998 8999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc-
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE- 738 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 738 (834)
+++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..|+........ +.. ........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~-~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLH-IFKLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHH-HHHHhCCCC
Confidence 9986533211 1112346788999998865 4679999999999999999999998864322110 000 00000000
Q ss_pred -----ccccccc----ccccc---CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 -----RVHELMD----PVILQ---DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 -----~~~~~~~----~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......+ +.... .........++.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 00000 0001123567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=290.30 Aligned_cols=242 Identities=25% Similarity=0.363 Sum_probs=194.8
Q ss_pred cccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||.|++|.||+++.. .++.+|+|.+.... ....+.+.+|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 48899999986532 23456799999999999999999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCcee
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.. ...++...+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 998843 345889999999999999999999987 9999999999999999999999999998765432 1223
Q ss_pred eeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH
Q 003274 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (834)
..++..|+|||.+.+..++.++|+||||+++|||++|..|+.....+..... ....+. ......+..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------------~~~~~~-~~~~~~~~~ 218 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY------------NDILKG-NGKLEFPNY 218 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH------------HHHhcc-CCCCCCCcc
Confidence 4678899999999888899999999999999999999999875442211110 001100 001122223
Q ss_pred HHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 757 MLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
...++.+++.+||+.+|++||+ +.|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 3568899999999999999999 566644
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=307.60 Aligned_cols=202 Identities=28% Similarity=0.442 Sum_probs=177.6
Q ss_pred ccccccccCCcEeEEEEE-ecCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------eEEEE
Q 003274 516 SMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------EKILI 587 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~lV 587 (834)
...+.||+|+||.||+|+ ...|+.||||.++... ....+....|+++|++++|+|||++++.-.+.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 345789999999999999 5679999999997643 345567889999999999999999998866543 67899
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec--cCC--Ceeecccccce
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDM--NPKISDFGLAR 663 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~DFGla~ 663 (834)
||||.+|+|...|.++.+...|++.+.+.++.+++.||.|||+++ |+||||||.||++- ++| .-||+|||.|+
T Consensus 96 mEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar 172 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR 172 (732)
T ss_pred EeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence 999999999999999999999999999999999999999999887 99999999999994 334 46999999999
Q ss_pred ecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCC
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTD 723 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~ 723 (834)
.+..+. ....+.||..|++||.... +.|+..+|.|||||++||..||..||.....+
T Consensus 173 el~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 173 ELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 987655 4566899999999999984 88999999999999999999999999765544
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=295.64 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=193.4
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|...++||+|+||.||+++. .+++.+|+|.+.... ......+.+|+.++.++. |+||+++++++......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 4566678999999999999985 457899999986543 234567889999999996 9999999999999999999999
Q ss_pred ecCCCCcchhccc--ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 590 YMPNKSLDVYLFD--PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 590 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|+.. ++..+... ......+++..+.+++.+++.||+|||+.. +++||||||+||+++.++.+||+|||+++.+..
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9864 44333211 112356899999999999999999999752 399999999999999999999999999976543
Q ss_pred CCccCCceeeeccCcccCceeecCC---CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDG---LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
... .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||...... ........ ...
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~------~~~ 227 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQLTQVV------KGD 227 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHHHhhhc------CCC
Confidence 221 1223578899999999876 6899999999999999999999998643210 00000000 000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.+ ....+.....++.+++.+||+.+|++||++.+|++
T Consensus 228 ~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 228 PPIL-SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCcC-CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 11112234567899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=291.26 Aligned_cols=249 Identities=22% Similarity=0.386 Sum_probs=198.5
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|.+.+.||+|+||.||+|... +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999864 57899999986532 23456788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-CeeecccccceecCCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988532 2335789999999999999999999987 99999999999999886 46999999998764332
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ......|++.|+|||++.+..++.++||||||++++||++|..|+....... ..... .....
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~---------~~~~~- 219 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKI---------CQGYF- 219 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHHH---------hcccC-
Confidence 1 1122458899999999998899999999999999999999999975322111 00000 00000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.+++.+||+.+|++||++.++++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0111223457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=282.72 Aligned_cols=242 Identities=25% Similarity=0.308 Sum_probs=201.9
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
..++|...++||+|.||.|..++- ..++.+|+|++++.. ......-+.|-++|+..+||.+..|...++...++++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 348899999999999999999984 458899999998753 3344556779999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||..+|.|.-+|. +.+.+++.....+-..|..||.|||+++ ||.||||.+|.|||.+|++||+||||++.--
T Consensus 246 VMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999988883 4567888888889999999999999987 9999999999999999999999999998632
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.+...+..++|||.|+|||++....|..++|.|.+||++|||++|+.||...+.+ ++.+++-.
T Consensus 320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---------------kLFeLIl~ 382 (516)
T KOG0690|consen 320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---------------KLFELILM 382 (516)
T ss_pred --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---------------HHHHHHHh
Confidence 2233456689999999999999999999999999999999999999998643322 12222211
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCC
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRP 777 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
. .-.+|.....+...|+...|..||++|.
T Consensus 383 e--d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 E--DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred h--hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1 1234555667788899999999999995
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.97 Aligned_cols=262 Identities=26% Similarity=0.342 Sum_probs=194.1
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|++.++||+|++|.||+|+. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56678999999999999985 468999999986543 223456889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
+ ++|..++... ....+++..+.+++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 6888877432 2246899999999999999999999987 99999999999999999999999999976533211
Q ss_pred CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc-----ccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE-----RVHELMD 745 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 745 (834)
......++..|+|||++.+. .++.++||||||+++|||++|+.||........ +........... ....+.+
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhhchh
Confidence 11122468899999988764 578999999999999999999999864332110 000000000000 0000000
Q ss_pred c--cc------ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 P--VI------LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~--~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .+ ............+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 00 000111123357889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=302.17 Aligned_cols=261 Identities=25% Similarity=0.300 Sum_probs=195.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------G 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 582 (834)
.++|.+.+.||+|+||.||+++. .+++.||+|.+... .....+.+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 47899999999999999999985 46889999998643 233445678899999999999999999988643 3
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||+.+ +|...+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred cEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 57999999964 67666522 2888999999999999999999987 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-------------ccc-
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-------------NLL- 728 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-------------~~~- 728 (834)
+....... .....++..|+|||.+.+..++.++|||||||++|||++|+.||...+.... .+.
T Consensus 166 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 87643321 2224578899999999999999999999999999999999999864321100 000
Q ss_pred --cchhhhhcccc-------cccccccccc---cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 729 --GHAWDLWKHER-------VHELMDPVIL---QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 729 --~~~~~~~~~~~-------~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........... ..+....... ...........+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000 0000000000 00011223557889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=299.91 Aligned_cols=266 Identities=24% Similarity=0.326 Sum_probs=196.6
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC--CeEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ--GEKI 585 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~--~~~~ 585 (834)
.++|++.+.||+|+||.||+|... +++.+|+|++... .......+..|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 467888999999999999999864 5789999988542 233445677899999999 999999999998653 3689
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+. ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 86 lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 86 LVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 9999997 588777632 26788999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCcc---CCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccc-cc-------hh
Q 003274 666 GGDELQ---GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLL-GH-------AW 732 (834)
Q Consensus 666 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~-~~-------~~ 732 (834)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ ... .. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 443321 22233568999999998764 5688999999999999999999999864332110 000 00 00
Q ss_pred hhhcccccccccccccccC-----CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 733 DLWKHERVHELMDPVILQD-----EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..........+++...... ........++.+++.+||+.+|++||++.++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 238 ESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000001111000000 0011135678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=295.27 Aligned_cols=259 Identities=16% Similarity=0.208 Sum_probs=182.5
Q ss_pred hcCcccccccccCCcEeEEEEEecCc----cEEEEEEcccCCcccH-----------HHHHHHHHHHhhcCCCceeeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNG----QEVAVKRLSSQSGQGL-----------KEFKNEMMLIAELQHRNLVRILG 576 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~H~niv~l~~ 576 (834)
.++|.+.++||+|+||.||+|...++ ..+|+|.......... .....+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36799999999999999999986543 4566665432221110 11122334455678999999999
Q ss_pred EEEeCC----eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC
Q 003274 577 CCVEQG----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (834)
Q Consensus 577 ~~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~ 652 (834)
++.... ..++++|++.. ++...+. .....++..+..++.|+++||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876543 34677777643 4444432 1223577888999999999999999987 99999999999999999
Q ss_pred CeeecccccceecCCCCc-----cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcccc
Q 003274 653 NPKISDFGLARMFGGDEL-----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNL 727 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~ 727 (834)
.+||+|||+++.+..... ........||+.|+|||++.+..++.++|||||||+|+||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 999999999987643211 111223469999999999999999999999999999999999999997543221110
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
....... ...+....+ ........+.+++..|++.+|++||++.++++.|
T Consensus 244 ~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 244 HAAKCDF-----IKRLHEGKI----KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhHHHH-----HHHhhhhhh----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 0000000 011111110 1112346789999999999999999999999876
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=295.48 Aligned_cols=266 Identities=24% Similarity=0.347 Sum_probs=191.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-------
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------- 582 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------- 582 (834)
++|++.++||+|+||.||+++.. +++.+|||.+.... ......+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 57899999999999999999854 58899999886432 222345678999999999999999999987654
Q ss_pred -eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 583 -EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
..++||||+.+ +|...+.. ....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 35999999975 67666532 2336899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCcc--CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccchh-----
Q 003274 662 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGHAW----- 732 (834)
Q Consensus 662 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~----- 732 (834)
+..+...... .......++..|+|||.+.+. .++.++||||||+++|||++|++|+........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9876433211 112234578899999988664 478999999999999999999998864332110 0000000
Q ss_pred hhhcccccccccccccccCC---------CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 733 DLWKHERVHELMDPVILQDE---------IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+.........+....... .+......+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000000000000 00112346789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.77 Aligned_cols=268 Identities=23% Similarity=0.332 Sum_probs=197.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----CeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 584 (834)
+++|.+.++||+|+||.||+|+. .+++.||+|.+.... ......+..|+.++.+++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999984 468899999986432 23456688899999999999999999887654 357
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++|+||+.+ +|..++ ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 666655 3356899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc---cc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH---ER 739 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~ 739 (834)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........... +.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCHHH
Confidence 6432211 11223468899999998754 568999999999999999999999985422100 00000000000 00
Q ss_pred ccccccc--------ccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHHH--Hhcc
Q 003274 740 VHELMDP--------VILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVSM--ISNE 789 (834)
Q Consensus 740 ~~~~~~~--------~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~ 789 (834)
...+.+. .......+ .....++.+++.+||+.+|++||++.|+++. ++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000 00000001 1124678899999999999999999999874 5443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=291.70 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=196.0
Q ss_pred cccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEEEE
Q 003274 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILILE 589 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~E 589 (834)
|++.++||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|++++++++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999865 57899999997653 33456788999999999999999999999988 89999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 787776432 246899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc---c---cccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH---E---RVHE 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~---~~~~ 742 (834)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........ .......... . ....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ--LEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCchhhcccccc
Confidence 11 1222356788999998765 4689999999999999999999999864432110 0000000000 0 0000
Q ss_pred -----ccccc-----cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 -----LMDPV-----ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 -----~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+. .............+.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000 0000011112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=294.12 Aligned_cols=243 Identities=22% Similarity=0.333 Sum_probs=195.6
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcc
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
.+||+|+||.||++.. .+++.+|||++........+.+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5899999999999986 468899999986555555677899999999999999999999999999999999999999998
Q ss_pred hhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceee
Q 003274 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI 677 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 677 (834)
+++. ...+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 8763 335789999999999999999999987 99999999999999999999999999876543221 12234
Q ss_pred eccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHH
Q 003274 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPM 757 (834)
Q Consensus 678 ~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 757 (834)
.|++.|+|||.+.+..++.++||||||+++|||++|..|+....... ... .. .....+.+ . .....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~----~~-----~~~~~~~~-~--~~~~~ 242 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMK----MI-----RDNLPPKL-K--NLHKV 242 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HH-----HhhCCccc-C--CcccC
Confidence 68899999999988889999999999999999999999976322110 000 00 00000110 0 01112
Q ss_pred HhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 758 LMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 758 ~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+.+++.+||+.+|.+||++.++++
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 446788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.35 Aligned_cols=244 Identities=23% Similarity=0.314 Sum_probs=195.4
Q ss_pred cccCCcEeEEEEEecC-ccEEEEEEcccCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 521 LGEGGFGPVYKGRLFN-GQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||.||+++... ++.+++|.+..... ...+.+.+|++++.+++||||+++++.+......++|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999754 89999999865433 3556789999999999999999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc------
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL------ 670 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~------ 670 (834)
.+++.. ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 998843 236899999999999999999999987 99999999999999999999999999876543211
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
........++..|+|||.+.....+.++||||||++++||++|..|+....... .. . ..... .
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~---~-~~~~~--------~--- 217 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--IF---Q-NILNG--------K--- 217 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HH---H-HHhcC--------C---
Confidence 112233567889999999998889999999999999999999999986432111 00 0 00000 0
Q ss_pred CCCCHH--HHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 751 DEIPLP--MLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 751 ~~~~~~--~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
...+.. ....+.+++.+||+.+|++||++.++.+.|+
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 001111 2567899999999999999999977766664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-32 Score=295.27 Aligned_cols=246 Identities=29% Similarity=0.422 Sum_probs=193.7
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.|...+.||+|+||.||+++. .+++.+|+|.+.... ....+.+..|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 367778999999999999985 468899999986432 2334578899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+.+ +|.+.+.. ....+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 9975 66666532 3456899999999999999999999987 999999999999999999999999998754321
Q ss_pred ccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
....+++.|+|||++. .+.++.++|||||||++|||++|+.|+........ ........
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~-------- 240 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE-------- 240 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHhcc--------
Confidence 2246788999999974 46789999999999999999999998753221100 00000000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
. ...........+.+++.+||+.+|.+||++.++++.+
T Consensus 241 -~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 241 -S-PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred -C-CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0 0011112345688999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-34 Score=330.46 Aligned_cols=254 Identities=27% Similarity=0.382 Sum_probs=205.4
Q ss_pred HhcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.+-++....+||.|.||.||-+. .++|...|+|.++.. .....+...+|+.++..|+|||+|+++|+-..+++.+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 34456667899999999999997 567888999987644 334556788999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||||++|+|.+.+. .++..++.....+..|++.|++|||+++ ||||||||.||+|+.+|.+|++|||.|..+.+
T Consensus 1313 MEyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred HHHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence 99999999999883 3445666667778899999999999998 99999999999999999999999999998866
Q ss_pred CC--ccCCceeeeccCcccCceeecCCC---CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 668 DE--LQGNTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 668 ~~--~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.. .........||+.|||||++.+.. ..-++||||+|||+.||+||++|+...+.+-.... +..
T Consensus 1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy-~V~---------- 1455 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY-HVA---------- 1455 (1509)
T ss_pred chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-HHh----------
Confidence 52 233344578999999999997654 56889999999999999999999876554321110 000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.. ....+|.....+-.+++.+||+.||++|-++.|+++.
T Consensus 1456 ---~g-h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 ---AG-HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---cc-CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 00 1223444566777899999999999999888888764
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-32 Score=286.97 Aligned_cols=250 Identities=26% Similarity=0.382 Sum_probs=197.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 584 (834)
++|.+.+.||+|+||.||+++. .+++.+|+|.+... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 5788999999999999999985 45889999987432 123456788999999999999999999998764 457
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++++||+++++|.+++. ....+++....+++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999998874 3345788999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
....... .......++..|+|||.+.+..++.++|||||||+++||++|+.|+....... . ..+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~-------------~~~~ 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-A-------------IFKI 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-H-------------HHHH
Confidence 5322111 11223468899999999999889999999999999999999999986321110 0 0000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... .....+......+.+++.+||+ +|..||+..+++.
T Consensus 222 ~~~~-~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ATQP-TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HcCC-CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0000 0122344455788999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=289.95 Aligned_cols=258 Identities=22% Similarity=0.285 Sum_probs=190.6
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeC--CeEEEEEE
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQ--GEKILILE 589 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E 589 (834)
|++.++||+|+||.||+|+. .+++.+|+|+++... .........|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678999999999999985 468899999987542 222234457888999885 99999999999987 88999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.+....
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 477776632 2356899999999999999999999987 999999999999999 999999999998764332
Q ss_pred ccCCceeeeccCcccCceeec-CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhh-----------hhcc
Q 003274 670 LQGNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD-----------LWKH 737 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~-----------~~~~ 737 (834)
.. ....++..|+|||.+. +..++.++|||||||++|||++|..||...+... ....... ....
T Consensus 154 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhcc
Confidence 11 2245788999999764 4567899999999999999999999986433211 0000000 0000
Q ss_pred cccccccccccccC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ERVHELMDPVILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........+..... ......+..+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 001123578999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=285.18 Aligned_cols=250 Identities=23% Similarity=0.397 Sum_probs=203.8
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|.+.+.||+|+||.||++... +++.+|+|++..... ...+.+..|++++++++|+|++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999854 588999999876432 4566789999999999999999999999999999999999
Q ss_pred cCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 591 MPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++.... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999885422 2467899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.......|++.|+|||.+.+..++.++||||+|+++++|++|+.|+....... +. ... ....
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~---~~~---------~~~~-- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE--LA---LKI---------LKGQ-- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH--HH---HHH---------hcCC--
Confidence 12223468889999999999999999999999999999999999975432111 00 000 0000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=299.34 Aligned_cols=245 Identities=24% Similarity=0.388 Sum_probs=206.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
...|.+..+||+|.|+.|..+++ ..+..||||.+.+.. ....+.+.+|+++|..|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 46788999999999999999985 458899999997653 334456889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+.+|.+.+++. +.+......+..+..|+.++++|||+++ |+|||||++||||+.+.++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 135 EYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999984 3444556888889999999999999998 999999999999999999999999999987643
Q ss_pred CccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .....+|++.|.|||++.+..| ++++|+||+|++||-|+.|..||+...-. .+++.
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk-------------------~Lr~r 266 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK-------------------ELRPR 266 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc-------------------cccch
Confidence 2 3445799999999999998876 48999999999999999999998743211 11111
Q ss_pred ccc--CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQ--DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+. -.++.....++.++++++|-.+|.+|++++++-+
T Consensus 267 vl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 267 VLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred heeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 112 2345556678899999999999999999999865
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=284.21 Aligned_cols=247 Identities=29% Similarity=0.412 Sum_probs=201.8
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.+.||+|++|.||+++.. +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999854 578999999876543 4567899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999988743 357899999999999999999999987 99999999999999999999999999987754332
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....++..|+|||...+..++.++||||+|++++||++|+.|+....... . .+... . .. .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~---~~~~~-~-----~~-----~ 216 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--A---LFRIV-Q-----DD-----H 216 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--H---HHHHh-c-----cC-----C
Confidence 1 223467889999999988889999999999999999999999876332110 0 00000 0 00 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+......+.+++.+||..+|++||++.+++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1122234568889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=303.39 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=202.9
Q ss_pred cCcccccccccCCcEeEEEEEecCcc-EEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQ-EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.+.+...||.|+||.|||+..++.. ..|.|.+...+...++.|.-|++||+...||+||+|++.|...+.++++.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 56677789999999999999865433 44678887778888899999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
.||-.+..+.. -.++|.+.++.-+++|++.||.|||++. |||||||+.|||++-+|.++|+|||.+..... ..
T Consensus 112 ~GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CCchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 99999988753 3567999999999999999999999998 99999999999999999999999999865321 12
Q ss_pred CCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.....+.|||.|||||+.. ..+|+.++||||||+.|.||.-+.+|-...+ .+.....+.+.+ . |
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-----pMRVllKiaKSe-P-----P 253 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-----PMRVLLKIAKSE-P-----P 253 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-----hHHHHHHHhhcC-C-----C
Confidence 2334578999999999864 5689999999999999999999888743211 111111110000 0 1
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+ -.|......+.+++..||..||..||++.++++
T Consensus 254 TL---lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 254 TL---LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc---cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 124456778999999999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=300.36 Aligned_cols=266 Identities=22% Similarity=0.323 Sum_probs=197.5
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~ 584 (834)
.++|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 37889999999999999999985 458999999987542 2345677889999999999999999988763 3468
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+. ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888773 3345899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc--CCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-c----cccc----hh
Q 003274 665 FGGDELQ--GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-N----LLGH----AW 732 (834)
Q Consensus 665 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~----~~~~----~~ 732 (834)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||........ . ..+. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 6433211 11123468899999999865 5689999999999999999999999854321100 0 0000 00
Q ss_pred hhhcccccccccccccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 733 DLWKHERVHELMDPVILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.........+..+........+ .....++.+++.+||+.+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000001111111000011111 123568899999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-32 Score=285.98 Aligned_cols=247 Identities=20% Similarity=0.270 Sum_probs=190.3
Q ss_pred HHHHhcCccccccc--ccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 508 VAAATENFSMQCKL--GEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 508 ~~~~~~~f~~~~~l--G~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
.....++|.+.+.+ |+|+||.||+++. .+++.+|+|.+........ |+.....+ +||||+++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 33445677777777 9999999999985 4578899999865322111 22222223 79999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-Ceeecccccc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLA 662 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla 662 (834)
.++||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999998843 337899999999999999999999987 99999999999999998 9999999998
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+...... ...++..|+|||++.+..++.++||||||+++|||++|+.|+.....+........ .
T Consensus 158 ~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~----------~ 221 (267)
T PHA03390 158 KIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL----------K 221 (267)
T ss_pred eecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH----------H
Confidence 8754322 23578999999999999999999999999999999999999874332221111100 0
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC-HHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT-MSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 784 (834)
.... ...........+.+++.+||+.+|.+||+ ++|+++
T Consensus 222 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 222 RQQK---KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhcc---cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 01112234568899999999999999996 688863
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=289.67 Aligned_cols=241 Identities=26% Similarity=0.342 Sum_probs=189.4
Q ss_pred cccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 521 LGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||+||++.. .+++.+|+|.+.... ....+.+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999974 468899999986432 22345678899999999999999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCcee
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.... ...+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence 98885432 246899999999999999999999987 9999999999999999999999999987654321 1122
Q ss_pred eeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH
Q 003274 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (834)
..++..|+|||.+.+..++.++||||||++++||++|+.|+......... ...... .... ....+..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~----~~~~---~~~~~~~ 220 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK------EELKRR----TLEM---AVEYPDK 220 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH------HHHHhc----cccc---cccCCcc
Confidence 45788999999998888999999999999999999999998643321100 000000 0000 1112223
Q ss_pred HHhHHHHHHHhccccCCCCCCCHHH
Q 003274 757 MLMRYVNVALLCVQENAADRPTMSD 781 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
....+.+++.+||+.+|++||+..+
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCc
Confidence 3567899999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=293.70 Aligned_cols=252 Identities=23% Similarity=0.378 Sum_probs=192.0
Q ss_pred cCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCC-cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.+.||+|+||.||+|+... ++.+|||.++... .....++..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 678889999999999999999764 8899999987543 233455677887777775 9999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+.+ ++..++.. ....+++..+.+++.|+++||+|||+.. +|+||||+|+||++++++.+||+|||++..+....
T Consensus 95 ~~~~-~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9854 66555432 2347899999999999999999999742 39999999999999999999999999987654322
Q ss_pred ccCCceeeeccCcccCceeecCCC----CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+.....+.. .. ....... .
T Consensus 170 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~---~~~~~~~-~----- 236 (296)
T cd06618 170 AK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-VL---TKILQEE-P----- 236 (296)
T ss_pred cc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-HH---HHHhcCC-C-----
Confidence 11 1235788999999987554 88999999999999999999999864322110 00 0000000 0
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
+.. ........++.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 PSL---PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CCC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0011234578999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=314.85 Aligned_cols=268 Identities=21% Similarity=0.300 Sum_probs=185.8
Q ss_pred HhcCcccccccccCCcEeEEEEEecC--ccEEEEE------------------EcccCCcccHHHHHHHHHHHhhcCCCc
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN--GQEVAVK------------------RLSSQSGQGLKEFKNEMMLIAELQHRN 570 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~--~~~vavK------------------~l~~~~~~~~~~~~~E~~~l~~l~H~n 570 (834)
..++|.+.++||+|+||.||++.... +...++| .+. ........+.+|++++.+++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34789999999999999999986432 1122222 111 11223456889999999999999
Q ss_pred eeeEEEEEEeCCeEEEEEEecCCCCcchhcccccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 571 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
|+++++++...+..++|+|++.. +|..++..... ........+..++.||+.||+|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999854 56565533211 122345667789999999999999987 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCC-CCCCCCCc-cc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN-TGVYNTDS-FN 726 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p-~~~~~~~~-~~ 726 (834)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||||++|..+ +....... ..
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~ 379 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ 379 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence 99999999999999876543221 12235789999999999999999999999999999999998753 33222111 11
Q ss_pred cccchhhh--hccc------cccccccccccc---CCC-----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 727 LLGHAWDL--WKHE------RVHELMDPVILQ---DEI-----PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 727 ~~~~~~~~--~~~~------~~~~~~~~~~~~---~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+....... ...+ +..+.++..... ... .......+.+++.+||+.||++||++.|+++
T Consensus 380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11000000 0000 000000000000 000 0012346778899999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-32 Score=287.40 Aligned_cols=248 Identities=26% Similarity=0.372 Sum_probs=201.6
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|++.++||+|+||.||+++. .+++.+|+|.+.... .....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999974 467899999986532 33456788899999999999999999999999999999999
Q ss_pred cCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 591 MPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|..++.+.. ....+++..+..++.++++||+|||+.+ ++|+||+|+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999875422 2356899999999999999999999987 9999999999999999999999999998765441
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.....++..|+|||.+.+..++.++|+||||+++|||++|+.|+........ . ..... ..
T Consensus 158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--~----~~~~~--------~~-- 217 (256)
T cd08530 158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--R----YKVQR--------GK-- 217 (256)
T ss_pred ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H----HHHhc--------CC--
Confidence 1223578899999999999999999999999999999999999864332110 0 00000 00
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.....++.+++.+||+.+|++||++.++++
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11122345578999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-32 Score=290.14 Aligned_cols=263 Identities=24% Similarity=0.329 Sum_probs=192.9
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|++.+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57888999999999999999864 68899999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeecccccceecCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~ 668 (834)
|++ ++|..++.. .....+++..+..++.||+.||+|||+.+ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHh-CCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 467666532 12234578888899999999999999987 999999999999985 567999999999765432
Q ss_pred CccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc--cc----c
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE--RV----H 741 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~----~ 741 (834)
. .......+++.|+|||++.+. .++.++||||||+++|||++|++|+....... .+. ......... .. .
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELF-KIFRILGTPNEETWPGVT 232 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHHHhCCCChhhccccc
Confidence 1 111223568899999988764 57899999999999999999999986432211 000 000000000 00 0
Q ss_pred cccc-----cccccC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 ELMD-----PVILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 ~~~~-----~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.+ +..... ........++.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 000000 001123456889999999999999999999985
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=293.79 Aligned_cols=262 Identities=21% Similarity=0.235 Sum_probs=193.1
Q ss_pred cccccccCCcEeEEEEEecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.+.+|.|+++.||+++. +++.+|||++... .....+.+..|++++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344556666666666654 6899999998654 3445678999999999999999999999999999999999999999
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc----
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL---- 670 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~---- 670 (834)
+|.+++... ....+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999988543 2345788999999999999999999987 99999999999999999999999999876532211
Q ss_pred -cCCceeeeccCcccCceeecCC--CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch----hhhhccc-----
Q 003274 671 -QGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA----WDLWKHE----- 738 (834)
Q Consensus 671 -~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~----~~~~~~~----- 738 (834)
........++..|+|||++... .++.++|||||||++|||++|+.||........ +.... .......
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 239 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLY 239 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhh
Confidence 1112234567889999998763 588999999999999999999999874332111 00000 0000000
Q ss_pred --cccc----cccccc---ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 --RVHE----LMDPVI---LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 --~~~~----~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... ..++.. ...........++.+++.+||+.||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 000000 001112233567899999999999999999999976
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=295.41 Aligned_cols=261 Identities=22% Similarity=0.276 Sum_probs=191.6
Q ss_pred cccccC--CcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEG--GFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+| +||+||+++. ..++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467777 9999999985 468999999986532 23456789999999999999999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc--
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ-- 671 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-- 671 (834)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998875432 235888999999999999999999987 999999999999999999999999865433221110
Q ss_pred ---CCceeeeccCcccCceeecCC--CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchh--------------
Q 003274 672 ---GNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAW-------------- 732 (834)
Q Consensus 672 ---~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~-------------- 732 (834)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+...............
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 001112346679999999764 4789999999999999999999998654321110000000
Q ss_pred -hhhcc-----------cc-----cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 733 -DLWKH-----------ER-----VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 733 -~~~~~-----------~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... .. ...+.... ............+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSER-LRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhcccccccccccc-ccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000 00 00000000 011122335678899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=286.10 Aligned_cols=243 Identities=23% Similarity=0.277 Sum_probs=188.4
Q ss_pred cccccCCcEeEEEEEe-cCccEEEEEEcccCCc---ccHHHHHHHHHHHh-hcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLIA-ELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
+.||+|+||.||+|+. .+++.+|+|.+..... .....+..|..++. ..+|+||+++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 4588999999865421 22233455555444 44899999999999999999999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
++|..++. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 99999884 3346889999999999999999999987 99999999999999999999999999876432
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
.....++..|+|||.+.+..++.++||||||+++|||++|..|+....... . ......... . . ....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~----~~~~~~~~~----~--~-~~~~ 216 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--V----FDNILSRRI----N--W-PEEV 216 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--H----HHHHHhccc----C--C-CCcc
Confidence 122457889999999998889999999999999999999999986432211 0 000000000 0 0 0111
Q ss_pred CHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 754 PLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 754 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
.......+.+++.+||+.+|++||++.++.+.|
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 112456789999999999999999887666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=291.86 Aligned_cols=266 Identities=24% Similarity=0.321 Sum_probs=195.1
Q ss_pred HHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG---- 582 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~---- 582 (834)
...++|++.+.||+|+||.||+|+.. +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999964 57899999986542 233456788999999999999999999987654
Q ss_pred ------eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeee
Q 003274 583 ------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (834)
Q Consensus 583 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 656 (834)
..++|+||+++ ++...+.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999987 55555532 2346899999999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+|||++......... ......++..|+|||.+.+ ..++.++|||||||++|||++|++|+....... .+. ......
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~-~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLE-LISRLC 234 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHH-HHHHHh
Confidence 999999876443221 1112345788999998864 457899999999999999999999886432110 000 000000
Q ss_pred ccc-----------ccccccccccc-cC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 KHE-----------RVHELMDPVIL-QD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~-----------~~~~~~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ......+.... .. ......+..+.+++.+||+.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 00000000000 00 000112467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=286.01 Aligned_cols=241 Identities=26% Similarity=0.321 Sum_probs=186.1
Q ss_pred ccccCCcEeEEEEEe-cCccEEEEEEcccCCc---ccHHHHHHHHHHH---hhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLI---AELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l---~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+||+|+||.||+++. ..++.||+|.+..... .....+..|..++ ....||||+++++++......++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 4588999998865321 1222344454443 34579999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|..++. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999988873 3456899999999999999999999987 9999999999999999999999999987653322
Q ss_pred CceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....|+..|+|||.+.++ .++.++||||||+++|||++|+.|+............ ...... ..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~---------~~~~~~-----~~ 216 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---------RMTLTM-----AV 216 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH---------HHhhcc-----CC
Confidence 1224689999999998754 6899999999999999999999998643221110000 000000 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
..+.....++.+++.+||..+|.+|| ++.++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 12222356889999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=317.09 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=185.1
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 582 (834)
-..+|+..+.||+||||.|||++. -+|+.+|||++... +........+|+.++++|+|||||+++....+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 447889999999999999999984 47999999998765 3444567889999999999999999986432110
Q ss_pred --------------------------------------------------------------------------------
Q 003274 583 -------------------------------------------------------------------------------- 582 (834)
Q Consensus 583 -------------------------------------------------------------------------------- 582 (834)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred ---------------------------------eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHH
Q 003274 583 ---------------------------------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629 (834)
Q Consensus 583 ---------------------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH 629 (834)
.+||=||||+...|..++.+..-.. .....++++.+|++||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 1345577777777776663321111 35678899999999999999
Q ss_pred hcCCCCeEecCCCCCCEEeccCCCeeecccccceecC----C------------CCccCCceeeeccCcccCceeecCC-
Q 003274 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG----G------------DELQGNTKRIVGTYGYMSPEYALDG- 692 (834)
Q Consensus 630 ~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~- 692 (834)
+++ ||||||||.||+|+++..|||+|||+|.... . .......+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 9999999999999999999999999998731 0 0011123446899999999999755
Q ss_pred --CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc-cCCCCHHHHhHHHHHHHhcc
Q 003274 693 --LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL-QDEIPLPMLMRYVNVALLCV 769 (834)
Q Consensus 693 --~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl 769 (834)
.|+.|+|+|||||||+||+. ||+...+... . +..+-+..+. ...+..+....-..+|.+++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~-i------------L~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS-I------------LTNLRKGSIPEPADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHH-H------------HHhcccCCCCCCcccccccchHHHHHHHHHh
Confidence 49999999999999999983 4543222110 0 0111111110 01122334455578999999
Q ss_pred ccCCCCCCCHHHHHH
Q 003274 770 QENAADRPTMSDVVS 784 (834)
Q Consensus 770 ~~dP~~RPt~~evl~ 784 (834)
++||++|||+.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999974
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=291.04 Aligned_cols=248 Identities=27% Similarity=0.383 Sum_probs=201.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 587 (834)
++|.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+..|++++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999864 6899999998653 2233467889999999998 99999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++. +...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999884 3347999999999999999999999987 99999999999999999999999999987654
Q ss_pred CCcc------------------CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcccccc
Q 003274 668 DELQ------------------GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG 729 (834)
Q Consensus 668 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~ 729 (834)
.... .......++..|+|||++....++.++||||||++++|+++|+.|+....... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~- 231 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--TF- 231 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--HH-
Confidence 3221 12223467899999999998889999999999999999999999986433110 00
Q ss_pred chhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCH----HHHH
Q 003274 730 HAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTM----SDVV 783 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl 783 (834)
..... .....+......+.+++.+||+.+|++||++ .+++
T Consensus 232 -----------~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 232 -----------QKILK---LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred -----------HHHHh---cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 00000 0112233335678999999999999999999 6664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=287.54 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=194.9
Q ss_pred CcccccccccCCcEeEEEEEe----cCccEEEEEEcccCC----cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 584 (834)
+|++.+.||+|+||.||+++. .+|+.+|+|++.... ....+.+..|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999985 368899999986532 22346788899999999 699999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++. ....+++..+..++.|+++||+|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLS---QRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999884 3356888999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecCC--CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
....... ......|+..|+|||.+... .++.++||||||+++|||++|+.|+........ .......
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~~~--------- 223 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS-QAEISRR--------- 223 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc-HHHHHHH---------
Confidence 6433221 12234688999999998753 478899999999999999999999863221110 0000000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
+... ....+......+.+++.+||+.+|++|| ++.+++.
T Consensus 224 ~~~~---~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 224 ILKS---EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred hhcc---CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 0000 0112223456788999999999999997 5666644
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=297.18 Aligned_cols=264 Identities=21% Similarity=0.302 Sum_probs=195.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----CeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 584 (834)
++|.+.+.||+|+||+||+++. ..++.||||.+... .......+.+|+.++.+++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 5788999999999999999985 45889999998653 233445678899999999999999999988654 357
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++|+||+. ++|..++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 85 YIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 99999996 67877763 3356899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-cccc--------chhhh
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLG--------HAWDL 734 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~--------~~~~~ 734 (834)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|++||...+.... .... ..+..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 64332 11223457889999998865 5689999999999999999999999864321000 0000 00000
Q ss_pred hcccccccccccccccC-----CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 735 WKHERVHELMDPVILQD-----EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.........+....... ........++.+++.+||+.+|++||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000000000000000 0011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=287.69 Aligned_cols=260 Identities=26% Similarity=0.349 Sum_probs=197.0
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|.+.+.||+|++|.||+++. .+++.+++|++..... .....+..|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45678999999999999985 4688999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++ +|..++.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 81 ~~-~l~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 81 DT-DLYKLIKD--RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred CC-CHHHHHHh--hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 75 77777633 2257899999999999999999999987 9999999999999999999999999998775443
Q ss_pred CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc---c---cccc--
Q 003274 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH---E---RVHE-- 742 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~---~~~~-- 742 (834)
.......++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ........... . ...+
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID--QLFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCchHhcccchhhh
Confidence 111223578899999998876 78999999999999999999998875433211 00000000000 0 0000
Q ss_pred ------cccccc-ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 ------LMDPVI-LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ------~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+... ...........++.+++.+||+.||.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 000111234578899999999999999999999974
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=289.16 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=198.9
Q ss_pred CcccccccccCCcEeEEEEEe----cCccEEEEEEcccCC----cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 584 (834)
+|.+.+.||+|++|.||+++. .+++.+|||.++... ....+.+..|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467788999999999999874 356789999986431 22345688999999999 699999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|..++. ....+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLY---QREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHh---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999998874 2346889999999999999999999987 99999999999999999999999999887
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCC--CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
....... ......|+..|+|||.+.+.. .+.++||||||+++|||++|..|+........ ...... .
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~---------~ 223 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISR---------R 223 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHH---------H
Confidence 5433211 112246889999999987665 78999999999999999999999753221110 000000 0
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhc
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~ 788 (834)
.... ....+......+.+++.+||+.+|++|||+.++.+.|+-
T Consensus 224 ~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 ILKS---KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHcc---CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0000 011222334578899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=275.48 Aligned_cols=256 Identities=22% Similarity=0.285 Sum_probs=201.1
Q ss_pred cccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 519 CKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
+.||+|+|+.|--+. +.+|.++|||++.+.......+..+|++++...+ |+||+.|+.+|+++...|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999886 7889999999999988888899999999999995 99999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC---CeeecccccceecCCCC----
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISDFGLARMFGGDE---- 669 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~~~~~~---- 669 (834)
..+|. +...+++.++.++.++||.||.+||.++ |.||||||+|||..... -+||+||.|..-+..+.
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99984 5667999999999999999999999998 99999999999996544 48999999976543211
Q ss_pred -ccCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 670 -LQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 670 -~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
........+|+..|||||+.. ...|+.++|.|||||+||-||+|.+||.......- +|..-..- ....+.
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWdrGe~C-r~CQ~~ 313 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWDRGEVC-RVCQNK 313 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---CccCCCcc-HHHHHH
Confidence 111222357888999999863 34689999999999999999999999976654321 11110000 001111
Q ss_pred cccccccCC--CCHH----HHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQDE--IPLP----MLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~--~~~~----~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+-..+..+. +|.. .+.+..+++...+..++.+|.++.+++.
T Consensus 314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111221222 2322 3567889999999999999999998875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.52 Aligned_cols=247 Identities=31% Similarity=0.434 Sum_probs=193.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
+.|...+.||+|+||.||+|+. .+++.+|+|.+... .....+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 4467778999999999999985 45788999988642 2234457889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+. |++...+.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9997 577666532 2345889999999999999999999987 999999999999999999999999998765432
Q ss_pred CccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....++..|+|||.+. ...++.++|||||||++|||++|+.|+........ . ....... .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~~~~~------~ 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L---YHIAQNE------S 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--H---HHHhhcC------C
Confidence 2246788999999974 45688999999999999999999998753221100 0 0000000 0
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
+ ..........+.+++.+||+.+|++||++.++++.-
T Consensus 232 ~----~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 232 P----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred C----CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0 011123446788999999999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=286.20 Aligned_cols=262 Identities=25% Similarity=0.312 Sum_probs=193.8
Q ss_pred cccccccccCCcEeEEEEEec-CccEEEEEEcccCCc-ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEec
Q 003274 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|.+.+.||+|++|.||+|+.. +++.++||++..... .......+|+..+.+++ |+||+++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567789999999999999965 478899999865432 22234567999999998 999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
+++|.+++.... ...+++..+..++.|++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 888888774322 346899999999999999999999987 99999999999999999999999999987643221
Q ss_pred CCceeeeccCcccCceeec-CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-----cccc-hhhhhcc-cccccc
Q 003274 672 GNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-----LLGH-AWDLWKH-ERVHEL 743 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-----~~~~-~~~~~~~-~~~~~~ 743 (834)
.....++..|+|||++. ...++.++|+||||++++||++|++|+......... ..+. ....+.. ......
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 12245788999999885 456899999999999999999999887543321100 0000 0000000 000000
Q ss_pred ccccccc------CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQ------DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
++..+.. ..........+.+++.+||+.+|++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0000112467899999999999999999999965
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=296.28 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=192.9
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 582 (834)
.++|.+.+.||+|+||.||+|+. .+++.+|||++.... ......+.+|+.++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 37899999999999999999985 468999999986532 223456889999999999999999999987543
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999864 565443 235889999999999999999999987 999999999999999999999999998
Q ss_pred eecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh-------
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL------- 734 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~------- 734 (834)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+ ......
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~-~~~~~~~~~~~~~ 237 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QL-TQILKVTGVPGPE 237 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHHhcCCCCHH
Confidence 764321 122467889999999876 468999999999999999999999986432110 00 000000
Q ss_pred ----hcccccccccc--cccccCCC---CHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 735 ----WKHERVHELMD--PVILQDEI---PLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 735 ----~~~~~~~~~~~--~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
........... +....... .......+.+++.+||+.||++||++.+++. .++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 238 FVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000000 00000000 0012356789999999999999999999985 35554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=283.48 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=192.2
Q ss_pred cccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhc---CCCceeeEEEEEEeCCe-----
Q 003274 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAEL---QHRNLVRILGCCVEQGE----- 583 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~~~~----- 583 (834)
|++.++||+|+||.||+|+.. +++.+|+|++..... .....+.+|+.++.++ +|+||+++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999975 488999999874322 2234566788777766 59999999999988776
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.+++|||+.+ +|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 787776432 2235899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc----
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER---- 739 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 739 (834)
....... .....++..|+|||.+.+..++.++||||||+++|||++|++|+......+ .+ ...........
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QL-DKIFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HH-HHHHHHcCCCChHhc
Confidence 7643321 122357889999999999999999999999999999999998876433211 00 00000000000
Q ss_pred c------ccccccccc--cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 V------HELMDPVIL--QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~------~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ......... ...........+.+++.+||+.||++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 00011123467789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=290.41 Aligned_cols=265 Identities=25% Similarity=0.327 Sum_probs=192.1
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 582 (834)
.++|.+.++||+|+||.||+|+.. +++.+|+|++..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999854 588999998864322 22346788999999999999999999876543
Q ss_pred --eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 583 --EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 583 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
..++|+||+.. +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999875 55555432 2346899999999999999999999987 9999999999999999999999999
Q ss_pred cceecCCCCcc---------CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc
Q 003274 661 LARMFGGDELQ---------GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH 730 (834)
Q Consensus 661 la~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 730 (834)
+++........ .......+++.|+|||.+.+. .++.++||||||+++|||++|++|+........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~--~~~ 238 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ--LHL 238 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH
Confidence 99865432211 111234678889999987654 589999999999999999999999864332110 000
Q ss_pred hhhhhcc---------cccccccccccc-cCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 731 AWDLWKH---------ERVHELMDPVIL-QDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 731 ~~~~~~~---------~~~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....... .......+.... ..... ......+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000000 000000000000 00000 112357889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=288.26 Aligned_cols=243 Identities=28% Similarity=0.438 Sum_probs=189.7
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
|...++||+|+||.||+|+. ..++.+++|.+.... ....+.+..|++++++++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999985 458899999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+. +++.+++.. ....+++..+..++.|++.+|+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 466665532 3456899999999999999999999987 99999999999999999999999999864321
Q ss_pred cCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.....|+..|+|||++. ...++.++||||||+++|||++|.+|+....... ........ .. +.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~~~-~~-----~~ 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQN-DS-----PT 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhc-CC-----CC
Confidence 12346888999999984 4678899999999999999999999875322110 00000000 00 00
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ........+.+++.+||+.+|++||++.+++.
T Consensus 240 ~----~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 L----QSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred C----CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 11112346889999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=290.52 Aligned_cols=263 Identities=23% Similarity=0.349 Sum_probs=195.4
Q ss_pred HHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKI 585 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~ 585 (834)
..+++|.+.++||+|+||.||+++. .+++.+|+|++... .....+.+..|++++.+++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3568899999999999999999984 46889999987543 22345678899999999999999999999876 45789
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+|+||+ +++|..++. ...+++.....++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 457877762 345788888899999999999999987 999999999999999999999999998754
Q ss_pred CCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-----cccc----hhhhh
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-----LLGH----AWDLW 735 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-----~~~~----~~~~~ 735 (834)
... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+. .....
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 321 122356889999998866 57899999999999999999999988643211000 0000 00000
Q ss_pred cccccccccccccccCCCCH-----HHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 736 KHERVHELMDPVILQDEIPL-----PMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+.+.........+. .....+.+++.+||+.+|++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000011100000111111 124688999999999999999999999653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=292.30 Aligned_cols=264 Identities=23% Similarity=0.323 Sum_probs=199.3
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EKI 585 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~ 585 (834)
+|.+.+.||+|++|.||+++.. .++.+|+|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999864 48899999987643 334567899999999999999999999988775 789
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++ +|..++. ....+++..+..++.++++||+|||+.+ |+|+||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 7877763 2347899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCc-cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccc--------hhhh
Q 003274 666 GGDEL-QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGH--------AWDL 734 (834)
Q Consensus 666 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~--------~~~~ 734 (834)
..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||........ ..... .+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 0112334678899999999888 899999999999999999999999865432110 00000 0000
Q ss_pred hcccccccccccccccCC-----CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 WKHERVHELMDPVILQDE-----IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.........+........ ........+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000000000000000000 01113567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=283.18 Aligned_cols=240 Identities=24% Similarity=0.332 Sum_probs=197.9
Q ss_pred cCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 587 (834)
.+|....+||+|+||.|..+..+. .+.+|||++++.. ..+.+--+.|-++|+.. +-|.+++++.+++.-+++|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 578888999999999999997543 5678999998752 33445556788888877 678999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+.+|+|--++ ..-+.+.+..+..++..||-||-+||+++ |+.||||..|||||.+|++||+|||+++.---
T Consensus 429 MEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 9999999997666 34456778888999999999999999998 99999999999999999999999999986322
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. ...+..++||+.|+|||++..++|+.++|.|||||+|||||.|++||+..++++. ...+++.
T Consensus 503 ~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el--------------F~aI~eh- 565 (683)
T KOG0696|consen 503 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--------------FQAIMEH- 565 (683)
T ss_pred C--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH--------------HHHHHHc-
Confidence 2 2345568999999999999999999999999999999999999999986443321 1122222
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCC
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRP 777 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
.-.+|...+.+...++...|...|.+|.
T Consensus 566 --nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 --NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 2246677788889999999999999985
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=274.05 Aligned_cols=204 Identities=26% Similarity=0.381 Sum_probs=168.1
Q ss_pred hcCcccccccccCCcEeEEEEEec---C--ccEEEEEEcccCCcc--cHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF---N--GQEVAVKRLSSQSGQ--GLKEFKNEMMLIAELQHRNLVRILGCCVE-QGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~---~--~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~ 583 (834)
...|+...+||+|.||.|||+.-. + ...+|+|+++..... --....+|+.+++.++||||+.|..++.+ +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357888899999999999999532 2 337899999765321 12456789999999999999999999887 778
Q ss_pred EEEEEEecCCCCcchhcc--cccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC----CCeeec
Q 003274 584 KILILEYMPNKSLDVYLF--DPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD----MNPKIS 657 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~ 657 (834)
.+|++||.++ +|...|+ ...+.+.++...+..|+.||+.|+.|||++= |+||||||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 8999999988 4555553 2334468999999999999999999999875 9999999999999877 899999
Q ss_pred ccccceecCCCCcc-CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCC
Q 003274 658 DFGLARMFGGDELQ-GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGV 719 (834)
Q Consensus 658 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~ 719 (834)
|||+++.+.+.-.. .....++-|..|.|||.+.+. .||.+.|||+.||++.|||+-.+.|..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 99999998654322 234456779999999999876 689999999999999999998887754
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=295.07 Aligned_cols=267 Identities=24% Similarity=0.274 Sum_probs=197.6
Q ss_pred ccHHHHHHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEE
Q 003274 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCV 579 (834)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 579 (834)
....++...+++|.+.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++.+++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34556677889999999999999999999984 568899999986532 223466888999999999999999999886
Q ss_pred eC------CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC
Q 003274 580 EQ------GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (834)
Q Consensus 580 ~~------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 653 (834)
.. ...++++|++ +++|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 43 3467788776 778877662 345899999999999999999999987 999999999999999999
Q ss_pred eeecccccceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch-
Q 003274 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA- 731 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~- 731 (834)
+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .+....
T Consensus 159 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~ 232 (345)
T cd07877 159 LKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILR 232 (345)
T ss_pred EEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999999998764321 223467889999998866 568899999999999999999999985332111 000000
Q ss_pred ---------hhhhccccc---ccccccccccC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 732 ---------WDLWKHERV---HELMDPVILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 732 ---------~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......... ...+.... .. ........++.+++.+|++.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccC-CcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 000000000 00000000 00 000112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=294.03 Aligned_cols=261 Identities=23% Similarity=0.308 Sum_probs=194.0
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----- 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 582 (834)
..++|.+.+.||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 457899999999999999999984 468899999985432 223456889999999999999999999987654
Q ss_pred -eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 583 -EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
..++||||+ +++|..++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999998 678877763 346899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc--ccccc-------h
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF--NLLGH-------A 731 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~--~~~~~-------~ 731 (834)
+...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..... .
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9865332 122457889999999876 4688999999999999999999999864322100 00000 0
Q ss_pred hhhhcccccccccc--cccccC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 732 WDLWKHERVHELMD--PVILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 732 ~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.............. +..... .........+.+++.+|++.||++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000 000000 001123446889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=294.37 Aligned_cols=263 Identities=22% Similarity=0.257 Sum_probs=192.6
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC----------
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ---------- 581 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~---------- 581 (834)
.+|.+.+.||+|+||.||+|+. ..++.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 6788899999999999999985 45889999998766656677889999999999999999999776543
Q ss_pred ----CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeee
Q 003274 582 ----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKI 656 (834)
Q Consensus 582 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl 656 (834)
...++||||++ ++|..++ ....+++..+..++.||++||.|||+.+ |+||||||+||+++ +++.+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVL----EQGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 5787766 2346889999999999999999999987 99999999999997 4567899
Q ss_pred cccccceecCCCCc-cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhh-
Q 003274 657 SDFGLARMFGGDEL-QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD- 733 (834)
Q Consensus 657 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~- 733 (834)
+|||+++....... ........++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .......
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~ 235 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESV 235 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhc
Confidence 99999987533211 111122357889999998754 5688999999999999999999999864322110 0000000
Q ss_pred -hhcc---cccc----cccccccccCCC-----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 734 -LWKH---ERVH----ELMDPVILQDEI-----PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 734 -~~~~---~~~~----~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... .... ..+......... ......++.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0000 000000000000 1123457889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=289.62 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=192.9
Q ss_pred cCcc-cccccccCCcEeEEEEEec-CccEEEEEEcccCCccc--------------HHHHHHHHHHHhhcCCCceeeEEE
Q 003274 513 ENFS-MQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQG--------------LKEFKNEMMLIAELQHRNLVRILG 576 (834)
Q Consensus 513 ~~f~-~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~H~niv~l~~ 576 (834)
++|. +.+.||+|+||+||+++.. .++.||||.+....... ...+.+|++++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3444 4567999999999999854 68899999886532211 124778999999999999999999
Q ss_pred EEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeee
Q 003274 577 CCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (834)
Q Consensus 577 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 656 (834)
++......++||||+. ++|.+++. ....+++.....++.|++.||+|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 58887773 3446889999999999999999999987 999999999999999999999
Q ss_pred cccccceecCCCCc------------cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCC
Q 003274 657 SDFGLARMFGGDEL------------QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTD 723 (834)
Q Consensus 657 ~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~ 723 (834)
+|||+++....... ........++..|+|||.+.+. .++.++||||||+++|||++|++|+......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999987652111 1111123467889999998764 4789999999999999999999998644321
Q ss_pred ccccccchhhhhccccc----c----cccccccc--c---CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 724 SFNLLGHAWDLWKHERV----H----ELMDPVIL--Q---DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~----~----~~~~~~~~--~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .............. . ....+... . .........++.+++.+||+.+|++||++.|++.
T Consensus 241 ~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 D--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred H--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1 00000000000000 0 00000000 0 0001122467889999999999999999999986
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=290.09 Aligned_cols=262 Identities=23% Similarity=0.280 Sum_probs=190.6
Q ss_pred CcccccccccCCcEeEEEEEec-C--ccEEEEEEcccCC--cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC----Ce
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-N--GQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ----GE 583 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~----~~ 583 (834)
+|++.+.||+|+||.||+++.. . ++.+|+|++.... ....+.+.+|++++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778889999999999999854 3 6789999986432 22345688899999999 599999999876533 35
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++++||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688888886 57877763 3456899999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCCcc--CCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch---------
Q 003274 664 MFGGDELQ--GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--------- 731 (834)
Q Consensus 664 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~--------- 731 (834)
........ .......|+..|+|||++.+ ..++.++||||||+++|||++|++|+....... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD--QLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 76432211 11233568999999998765 568999999999999999999999986433110 00000
Q ss_pred --hhhhcccccccccccccccCC-----CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 732 --WDLWKHERVHELMDPVILQDE-----IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 732 --~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..................... ........+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000000000000000 00112457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-32 Score=266.12 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=191.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC-CcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 589 (834)
+++.....||.|..|+|++.+.. .|..+|||.+... +....++++..+.++.+-+ .|.||+.+|||..+....+.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34455678999999999999854 5889999998765 3344566777777777664 8999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
.|.- -++.+|. +..+++++..+-++...+.+||.||.+++ .|+|||+||+|||+|+.|++|++|||++-.+-+..
T Consensus 172 lMs~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 8743 2333332 34456888888899999999999998865 69999999999999999999999999997764433
Q ss_pred ccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
. .++-.|-+.|||||.+. ...|+.++||||||+.|+||.||+.|+.....+-.-+. . ..+ + .. |
T Consensus 247 A---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt-k---vln-~----eP-P 313 (391)
T KOG0983|consen 247 A---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT-K---VLN-E----EP-P 313 (391)
T ss_pred c---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH-H---HHh-c----CC-C
Confidence 2 22346889999999985 44799999999999999999999999886544322111 0 000 0 00 1
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+ .. .......+.+++..||..|+.+||...++++
T Consensus 314 ~L-~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 314 LL-PG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CC-Cc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 11 11 1124568899999999999999999999976
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=282.67 Aligned_cols=261 Identities=27% Similarity=0.360 Sum_probs=195.8
Q ss_pred cccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+..|+.++++++|+||+++++++.+....++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456678999999999999865 48999999987653 334567889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
+ ++|.+++... ...+++..+.+++.++++||+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 5898887432 146899999999999999999999987 99999999999999999999999999987643321
Q ss_pred CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcc--cccc-------chhhhhccc---
Q 003274 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF--NLLG-------HAWDLWKHE--- 738 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~--~~~~-------~~~~~~~~~--- 738 (834)
......++..|+|||.+.+. .++.++||||||++++||++|++|+........ .... ..+......
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 11223457789999998776 889999999999999999999988864332110 0000 000000000
Q ss_pred -ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 -RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
............... ......+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000000000000000 112457899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=281.24 Aligned_cols=249 Identities=25% Similarity=0.340 Sum_probs=192.8
Q ss_pred CcccccccccCCcEeEEEEEecC-ccEEEEEEcccC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+|.+.++||+|+||.||+++... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47788999999999999998543 444555555431 122334577899999999999999999999999999999
Q ss_pred EEecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 588 LEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||+++++|..++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999887532 23457899999999999999999999987 999999999999975 569999999998764
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..|+...... ...... ....
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~-----~~~~~~------~~~~-- 221 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRI------VEGP-- 221 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHH------HcCC--
Confidence 4322 122345788999999998888999999999999999999999987532110 000000 0000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.....++.+++.+||+.+|++||++.|+++
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 ---TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred ---CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11122334568899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=308.40 Aligned_cols=259 Identities=22% Similarity=0.252 Sum_probs=206.3
Q ss_pred HHHHHHHhcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 003274 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 580 (834)
...+....++|.+.++||+|+||.|..+++.. ++.+|+|++++. .......|..|-.+|..-+.+=|+.++..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 34555567999999999999999999999654 778899999873 34456779999999999999999999999999
Q ss_pred CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
...+|||||||+||+|..++.. ...+++..+..++..|.-||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 9999999999999999999843 336999999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeec----C-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL----D-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
.+..+..+.. ......+|||-|.+||++. + +.|+..+|.||+||++||||.|..||... .+++....+.
T Consensus 221 sClkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-----slveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-----SLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-----HHHHHHHHHh
Confidence 9988764332 2233468999999999985 3 67999999999999999999999998531 1222222222
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC---HHHHHH
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT---MSDVVS 784 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~ 784 (834)
.+....... .....+++..+||.+.+. +|+.|.. +.++-.
T Consensus 295 ~hk~~l~FP--------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 295 NHKESLSFP--------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred chhhhcCCC--------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 221111111 112356788899988775 8888887 777643
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=266.66 Aligned_cols=247 Identities=23% Similarity=0.282 Sum_probs=192.8
Q ss_pred HhcCcccc-cccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe----CCe
Q 003274 511 ATENFSMQ-CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE----QGE 583 (834)
Q Consensus 511 ~~~~f~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~ 583 (834)
.+++|.+. ++||-|-.|.|..... ..++++|+|+|... ...++|+++--+. .|||||.+++++.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 35667664 6799999999999875 45889999999643 3457888876666 69999999999864 346
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFG 660 (834)
+++|||.|++|.|...+.+ +....+.+.++..|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999888744 23456899999999999999999999988 999999999999964 5679999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+|+.-.. .......+-|+.|.|||++...+|+...|+||+||++|-||+|.+||..... ..+
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg--~ai------------- 271 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAI------------- 271 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC--ccC-------------
Confidence 9987542 2233335679999999999999999999999999999999999999863221 100
Q ss_pred cccccccccc--CCCCHH----HHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMDPVILQ--DEIPLP----MLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~~~~~~--~~~~~~----~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..-+...+.. -++|.+ .++...++|+.+|..+|++|.|+.++..
T Consensus 272 spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 272 SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 0111111111 122332 2568889999999999999999999853
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=275.62 Aligned_cols=236 Identities=25% Similarity=0.341 Sum_probs=192.4
Q ss_pred cccCCcEeEEEEEec-CccEEEEEEcccCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 521 LGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 521 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
||+|+||.||++... +++.+|+|.+..... ...+.+..|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999864 588999999875432 2456789999999999999999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCcee
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 676 (834)
.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 998843 336899999999999999999999987 9999999999999999999999999998765432 12233
Q ss_pred eeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH
Q 003274 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP 756 (834)
Q Consensus 677 ~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (834)
..++..|+|||.+.+...+.++|+||||+++|||++|+.|+....... ... . +... ....+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~----~--------~~~~---~~~~~~~ 215 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--IYE----K--------ILKD---PLRFPEF 215 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----H--------HhcC---CCCCCCC
Confidence 567889999999998889999999999999999999999986432210 000 0 0000 1122223
Q ss_pred HHhHHHHHHHhccccCCCCCCCHHH
Q 003274 757 MLMRYVNVALLCVQENAADRPTMSD 781 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
....+.+++.+||..||++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 3567899999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=311.29 Aligned_cols=145 Identities=29% Similarity=0.432 Sum_probs=130.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+|... .++.||||+++... ......+..|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999865 68899999986532 223467889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
||+.+++|..++.. ...+++..+++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998842 346888999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=291.43 Aligned_cols=259 Identities=23% Similarity=0.308 Sum_probs=194.4
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe----
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE---- 583 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~---- 583 (834)
..++|.+.+.||+|++|.||+|+.. +++.+|+|++... .....+.+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999864 5789999998653 22234567889999999999999999988776554
Q ss_pred --EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 584 --KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 584 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
.++|+||+ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 568887763 346899999999999999999999987 99999999999999999999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhh-------
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD------- 733 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~------- 733 (834)
+...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~~~i~~~~~~~~~ 237 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHhcCCCCH
Confidence 9865432 222457889999999865 468899999999999999999999986432211 0000000
Q ss_pred ----hhcccccccccccccccCCC-----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 734 ----LWKHERVHELMDPVILQDEI-----PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 734 ----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+........+......... .......+.+++.+||+.+|++|||+.||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 238 ELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000000000000000 0112568899999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=283.36 Aligned_cols=242 Identities=24% Similarity=0.377 Sum_probs=194.7
Q ss_pred ccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 518 QCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
.++||+|.||+||-|++ ++|+.||||++.+. ..+...++++|+.||++++||.||.+...|+..+..+.|||-+.+.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 47899999999999985 57999999998653 4556688999999999999999999999999999999999999655
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC---CCeeecccccceecCCCCcc
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGla~~~~~~~~~ 671 (834)
-|...| . ..++.|++.....++.||+.||+|||.++ |+|.||||+||||... -++||+|||.|++++.....
T Consensus 649 MLEMIL-S-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 649 MLEMIL-S-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred HHHHHH-H-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 554444 2 34567888888889999999999999998 9999999999999754 47999999999999876543
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
..++||+.|+|||++.++.|...-|+||.||++|--|+|.-||....+-.. ++.+..+.-.
T Consensus 724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd----------------QIQNAaFMyP 784 (888)
T KOG4236|consen 724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND----------------QIQNAAFMYP 784 (888)
T ss_pred ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH----------------HhhccccccC
Confidence 346899999999999999999999999999999999999999864332111 1111111111
Q ss_pred CCC-HHHHhHHHHHHHhccccCCCCCCCHHHHH
Q 003274 752 EIP-LPMLMRYVNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 752 ~~~-~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
..| .+.....+++|...|+..-++|-+....+
T Consensus 785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 112 23345778888889998888888876644
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=274.33 Aligned_cols=256 Identities=28% Similarity=0.366 Sum_probs=198.0
Q ss_pred cCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCC-c------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-Ce
Q 003274 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS-G------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GE 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~ 583 (834)
++|-+..+||+|+|+.|||+. +...+-||||+-..+. + .-.+...+|.+|-+.|.||.||++++++.-+ ..
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 567788899999999999997 5678889999754321 1 1134467799999999999999999999754 56
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFG 660 (834)
.+-|+|||++.+|+-+|. ..+.+++.++..|+.||+.||.||.+.. ++|||-||||.||||-. -|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999984 4567899999999999999999999874 78999999999999954 4789999999
Q ss_pred cceecCCCCcc-----CCceeeeccCcccCceeecC----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch
Q 003274 661 LARMFGGDELQ-----GNTKRIVGTYGYMSPEYALD----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA 731 (834)
Q Consensus 661 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~ 731 (834)
|++++..+.+. ..+....||..|++||.+.- ..++.|+||||.||++|..|.|++||+....... ++.
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-ILq-- 695 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-ILQ-- 695 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-HHh--
Confidence 99999776544 23445689999999998852 3588999999999999999999999985433221 111
Q ss_pred hhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHH
Q 003274 732 WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
+.. ++...-..-........+...+|++||+..-++|....++.
T Consensus 696 -----eNT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 696 -----ENT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----hhc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 110 11111001111122345678899999999999998877764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=291.44 Aligned_cols=240 Identities=22% Similarity=0.273 Sum_probs=195.3
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.+++|.+...+|.|+|+.|-++.. ..++..+||++.+.. ....+|+.++.+. +||||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 468889999999999999999874 558899999997652 2234577677666 7999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe-ccCCCeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL-DKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~DFGla~~~~~ 667 (834)
|.+.++-+.+.+. ...... .++..|+.+|+.++.|||+++ ++||||||+|||+ +..++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~---~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIR---SKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHH---hcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877663 222233 777889999999999999988 9999999999999 6899999999999988655
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. ....+-|..|.|||++....|++++|+||||++|||||+|+.|+...+.+. + +.. .
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-e-------------i~~----~ 525 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-E-------------IHT----R 525 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-H-------------HHH----h
Confidence 4 122356889999999999999999999999999999999999987655441 1 111 1
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+....+....+....+|+.+||+.||.+||+|.++..
T Consensus 526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred hcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 1122223445678899999999999999999999964
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=268.46 Aligned_cols=255 Identities=27% Similarity=0.350 Sum_probs=194.8
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc-ccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++++....||.|+||+|+|-.+ +.|+.+|||+++.... ...++++.|.+...+- +.||||+++|.+...+..++.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 4445567899999999999875 4689999999987643 5667888898877666 79999999999999999999999
Q ss_pred ecCCCCcchhcc--cccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 590 YMPNKSLDVYLF--DPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 590 y~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
.|.- ||+.+-. ....+..++++.+-+|.....+||.||.... .|||||+||+||||+..|.+||+|||++-.+.+
T Consensus 144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9953 5554421 1234556888888899999999999998754 699999999999999999999999999876543
Q ss_pred CCccCCceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
... .+.-.|-..|||||.+.. ..|+.++||||||++|+|+.||+.|+...+.-..++ ..... -|
T Consensus 221 SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql----~~Vv~-------gd 286 (361)
T KOG1006|consen 221 SIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQL----CQVVI-------GD 286 (361)
T ss_pred HHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHH----HHHHc-------CC
Confidence 321 122367889999999963 359999999999999999999999987544311111 11111 11
Q ss_pred cc-cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PV-ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+. +.......+....+..+|..|+..|.++||...++.+
T Consensus 287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11 1122222345668899999999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=259.62 Aligned_cols=291 Identities=21% Similarity=0.313 Sum_probs=222.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 586 (834)
..+|.+.++||+|+|+.|..+++. ..+.+|+|++++. ...+.+-...|-.+.... +||.+|-|+.++.....+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 368899999999999999999864 4778999998753 445566677788888877 79999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|.||+++|+|--++ .+.+.++++.+..+...|.-||.|||+.+ |+.||||..|||||.+|.+||.|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999996555 45667999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCc--cccccchhhhhccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS--FNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 744 (834)
.. -..+..++||+.|.|||++.+..|...+|.|+|||+++||+.|+.||+.-..+. .+-.+...+.+.
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-------- 472 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-------- 472 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh--------
Confidence 22 124556899999999999999999999999999999999999999998544322 222222222211
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCC------HHHHH----------HHHhcccCCCCCCCCcccccccccc
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPT------MSDVV----------SMISNEHLNLPFPKKLTFVKGKNVK 808 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl----------~~L~~~~~~l~~p~~~~~~~~~~~~ 808 (834)
.. +-.+|...+.+...+++.-|..||++|.- +.++- ++|++ .++..|=+|.........
T Consensus 473 ek---qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leq--k~v~ppf~p~i~~d~~l~ 547 (593)
T KOG0695|consen 473 EK---QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQ--KQVLPPFQPQITDDYGLD 547 (593)
T ss_pred hh---cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhh--cccCCCCCCccccccCcc
Confidence 11 11345555667788889999999999852 23332 24443 344444456666556666
Q ss_pred CCCCCCCCCCccccc
Q 003274 809 NSSYSTSGTSEICSV 823 (834)
Q Consensus 809 ~~~~~~~~~~~~~s~ 823 (834)
+...+-+.+-++-|+
T Consensus 548 ~fd~qft~e~~qltp 562 (593)
T KOG0695|consen 548 NFDTQFTSEPVQLTP 562 (593)
T ss_pred ccccccccCCcccCC
Confidence 655555555555444
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=269.40 Aligned_cols=222 Identities=19% Similarity=0.112 Sum_probs=177.3
Q ss_pred CCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcchhccc
Q 003274 524 GGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602 (834)
Q Consensus 524 G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 602 (834)
|.+|.||+++. .+++.+|+|++.... .+..|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 88999999985 468899999986542 234555566666899999999999999999999999999999888742
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCc
Q 003274 603 PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682 (834)
Q Consensus 603 ~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (834)
...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||++....... ....++..
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 345899999999999999999999987 9999999999999999999999999887654321 12345678
Q ss_pred ccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHH
Q 003274 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYV 762 (834)
Q Consensus 683 y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 762 (834)
|+|||.+....++.++||||+|+++|||++|+.++........ ... ....+......+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------------~~~-----~~~~~~~~~~~~~ 206 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------------THT-----TLNIPEWVSEEAR 206 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------------ccc-----ccCCcccCCHHHH
Confidence 9999999888899999999999999999999987643221100 000 0012223346788
Q ss_pred HHHHhccccCCCCCCCHHHH
Q 003274 763 NVALLCVQENAADRPTMSDV 782 (834)
Q Consensus 763 ~li~~cl~~dP~~RPt~~ev 782 (834)
+++.+||+.||++||++.+.
T Consensus 207 ~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHccCCHHHhcCCCcc
Confidence 99999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=288.01 Aligned_cols=256 Identities=23% Similarity=0.378 Sum_probs=207.2
Q ss_pred HHHHhcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe-----
Q 003274 508 VAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE----- 580 (834)
Q Consensus 508 ~~~~~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----- 580 (834)
+...++-|++.++||+|.+|.||+++ .++++..|+|++....+ ..++...|.++++.+ .|||++.++|++..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 33456788999999999999999998 56789999999876543 346678899999988 69999999999874
Q ss_pred CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
++.++||||||.+|+.-++..... +..+.|+.+..|++.+++|+.|||... ++|||||-.|||++.++.+||.|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 468999999999999999986554 778999999999999999999999876 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecC-----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
++..+.... .......||+.|||||++.. ..|+..+|+||||++..||--|.+|+.....-.
T Consensus 169 vSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr----------- 235 (953)
T KOG0587|consen 169 VSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR----------- 235 (953)
T ss_pred eeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-----------
Confidence 998764332 33344689999999999964 357899999999999999999999965321100
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
-+..+.......-.-+.....++.++|..||..|.++||++.++++
T Consensus 236 ---aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 236 ---ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0111111111122234556789999999999999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=239.85 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=189.9
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+|...++||+|.||+|||++. +.++.||+|+++... +.-.....+|+-+++.++|.|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 456678999999999999984 457889999886543 23345678999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|.. +|..+. + .-.+.++.+....++.|+++||.++|+++ +.||||||.|.||+.+|++|++|||+++.++-...
T Consensus 83 cdq-dlkkyf-d-slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYF-D-SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHH-H-hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 965 555553 2 23456888999999999999999999998 99999999999999999999999999998754321
Q ss_pred cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCC-CCCCCCCccccccchhhh--hccc---ccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKN-TGVYNTDSFNLLGHAWDL--WKHE---RVHEL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p-~~~~~~~~~~~~~~~~~~--~~~~---~~~~~ 743 (834)
-....+-|..|.+|.++.+. .|+...|+||-||++.|+.....| |...+.+ .++...-+.+ ..++ .+..+
T Consensus 157 --cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred --eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCCccccCCccccC
Confidence 11223568899999998876 589999999999999999875444 4433322 1221111100 0000 12222
Q ss_pred cccccccC--------CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQD--------EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.|...... .+-......=.+++...+.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 22211100 011112234456777778889999999988754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=262.29 Aligned_cols=237 Identities=27% Similarity=0.347 Sum_probs=191.8
Q ss_pred CcEeEEEEEec-CccEEEEEEcccCCccc-HHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcchhccc
Q 003274 525 GFGPVYKGRLF-NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602 (834)
Q Consensus 525 ~fg~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~ 602 (834)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 48999999997765544 68899999999999999999999999999999999999999999998743
Q ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCc
Q 003274 603 PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682 (834)
Q Consensus 603 ~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~ 682 (834)
. ..+++..+..++.+++++++|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 2 22889999999999999999999987 9999999999999999999999999998865432 2233467889
Q ss_pred ccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH-HHhHH
Q 003274 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP-MLMRY 761 (834)
Q Consensus 683 y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l 761 (834)
|++||.+....++.++||||||++++||++|..|+....... .. .+.+............ ...++
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-~~-------------~~~~~~~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-EL-------------FKKIGKPKPPFPPPEWKISPEA 217 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HH-------------HHHHhccCCCCccccccCCHHH
Confidence 999999998899999999999999999999998876421111 00 0000000000000000 44688
Q ss_pred HHHHHhccccCCCCCCCHHHHHH
Q 003274 762 VNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 762 ~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+++.+||..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=265.49 Aligned_cols=261 Identities=20% Similarity=0.230 Sum_probs=198.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcC-C-Cc----eeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-H-RN----LVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~n----iv~l~~~~~~~~~~ 584 (834)
+++|.+..++|+|.||.|.+.... .+..||||+++.- ..-.+..+-|+++++++. + |+ +|.+.+++...++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 688999999999999999999743 3688999998653 334456788999999993 2 33 78888999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc--------------
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-------------- 650 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-------------- 650 (834)
++|+|.+ +-|+.++|.. .+..+++...+..|+.|+++++++||+.. ++|.||||+|||+..
T Consensus 167 Civfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 9999987 5588888843 24467889999999999999999999987 999999999999931
Q ss_pred ------CCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCc
Q 003274 651 ------DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS 724 (834)
Q Consensus 651 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~ 724 (834)
+..+||+|||.|+...... ..++.|..|.|||++.+-.++.++||||+||+|.|+.+|...|...++-+
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999998753322 45788999999999999999999999999999999999999887655221
Q ss_pred ccc--cc--------ch------hhhhccccc--------------ccccccccccCCCCHHHHhHHHHHHHhccccCCC
Q 003274 725 FNL--LG--------HA------WDLWKHERV--------------HELMDPVILQDEIPLPMLMRYVNVALLCVQENAA 774 (834)
Q Consensus 725 ~~~--~~--------~~------~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 774 (834)
++ ++ .. ...+..+++ .+...+....-.....+..+|.+|+..||..||.
T Consensus 317 -HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 317 -HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred -HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 11 00 00 000000000 0000000001112334567899999999999999
Q ss_pred CCCCHHHHHH
Q 003274 775 DRPTMSDVVS 784 (834)
Q Consensus 775 ~RPt~~evl~ 784 (834)
+|+|+.|++.
T Consensus 396 ~RiTl~EAL~ 405 (415)
T KOG0671|consen 396 RRITLREALS 405 (415)
T ss_pred ccccHHHHhc
Confidence 9999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-31 Score=279.80 Aligned_cols=247 Identities=23% Similarity=0.315 Sum_probs=205.3
Q ss_pred cCcccccccccCCcEeEEEEEecCcc-EEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQ-EVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.++.....||-|+||.|=.++..+.. .+|+|.+++. ...+.+....|-.+|...+.|.||+|+-.+.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999998865433 3788887654 4556677889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|-|-+|.|...| +.++.++......++..+.+|+.|||+++ ||.|||||+|.+|+.+|.+||.|||.|+.+...
T Consensus 500 EaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999998 45667888888899999999999999998 999999999999999999999999999998754
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCC-Cccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT-DSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .+-.++||+.|.|||++.+...+.++|.||||+++||||+|.+||...++ ..++ ++-..
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn----------------~ILkG 634 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYN----------------LILKG 634 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHH----------------HHHhh
Confidence 3 34458999999999999999999999999999999999999999975432 1111 11112
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
+..-.+|........++|++.+..+|.+|.- +.+|-+
T Consensus 635 id~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 635 IDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred hhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 2223445556678889999999999999975 556544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-29 Score=281.50 Aligned_cols=264 Identities=19% Similarity=0.241 Sum_probs=180.1
Q ss_pred HhcCcccccccccCCcEeEEEEEe-----------------cCccEEEEEEcccCCcccHHH--------------HHHH
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-----------------FNGQEVAVKRLSSQSGQGLKE--------------FKNE 559 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~E 559 (834)
..++|.+.++||+|+||+||+|.+ ..++.||||++........++ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999963 235689999986543222222 3447
Q ss_pred HHHHhhcCCCce-----eeEEEEEEe--------CCeEEEEEEecCCCCcchhccccc---------------------c
Q 003274 560 MMLIAELQHRNL-----VRILGCCVE--------QGEKILILEYMPNKSLDVYLFDPI---------------------K 605 (834)
Q Consensus 560 ~~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 605 (834)
+.++.+++|.++ ++++++|.. .+..+|||||+++++|.++++... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777888876654 677777753 357899999999999999885321 1
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccC
Q 003274 606 KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685 (834)
Q Consensus 606 ~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 685 (834)
...+++..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123467788899999999999999987 999999999999999999999999999765432211 1112234789999
Q ss_pred ceeecCCCC----------------------CccccchhhHHHHHHHhcCCC-CCCCCCCCccccc--cchhhhhccccc
Q 003274 686 PEYALDGLF----------------------SIKSDVFSFGILMLETLSSRK-NTGVYNTDSFNLL--GHAWDLWKHERV 740 (834)
Q Consensus 686 PE~~~~~~~----------------------t~~sDVwSlGvll~elltG~~-p~~~~~~~~~~~~--~~~~~~~~~~~~ 740 (834)
||.+..... ..+.||||+||+|+||++|.. |+.....-..++. ......++....
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 998864321 134799999999999999874 5432111000000 000011110000
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCC---CCCCCHHHHHH
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENA---ADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~ 784 (834)
...+. ...........+++.++|..+| .+|+|+.|+++
T Consensus 459 -~~~~~-----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 -QKYDF-----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred -cCCCc-----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00000 0111234577889999998765 68999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=292.00 Aligned_cols=265 Identities=19% Similarity=0.187 Sum_probs=165.8
Q ss_pred HhcCcccccccccCCcEeEEEEEecC-----ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEE------EE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGC------CV 579 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~------~~ 579 (834)
..++|.+.++||+|+||.||+|++.+ +..||||++..... .+....| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999998644 68999998764321 1111111 1122222222222211 24
Q ss_pred eCCeEEEEEEecCCCCcchhccccccc-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 003274 580 EQGEKILILEYMPNKSLDVYLFDPIKK-----------------RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (834)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk 642 (834)
...+.++||||+.+++|.+++...... .......+..++.||++||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999998887532110 01122345679999999999999987 9999999
Q ss_pred CCCEEecc-CCCeeecccccceecCCCCccCCceeeeccCcccCceeecCC----------------------CCCcccc
Q 003274 643 ASNVLLDK-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG----------------------LFSIKSD 699 (834)
Q Consensus 643 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~~sD 699 (834)
|+|||++. ++.+||+|||+++.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999865432211 22335789999999966432 2345679
Q ss_pred chhhHHHHHHHhcCCCCCCCCCCCccc-cc--cchhhhhccccccccccccccc-CCCCHHHHhHHHHHHHhccccCCCC
Q 003274 700 VFSFGILMLETLSSRKNTGVYNTDSFN-LL--GHAWDLWKHERVHELMDPVILQ-DEIPLPMLMRYVNVALLCVQENAAD 775 (834)
Q Consensus 700 VwSlGvll~elltG~~p~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~ 775 (834)
||||||+||||+++..+.+........ +. ......+... ......+.+.. .+..........+|+.+||+.||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999866543211000000 00 0000000000 00000000000 0000011224568999999999999
Q ss_pred CCCHHHHHH
Q 003274 776 RPTMSDVVS 784 (834)
Q Consensus 776 RPt~~evl~ 784 (834)
|||+.|+++
T Consensus 441 R~ta~e~L~ 449 (566)
T PLN03225 441 RISAKAALA 449 (566)
T ss_pred CCCHHHHhC
Confidence 999999976
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=282.99 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=188.8
Q ss_pred CcccccccccCCcE-eEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEec
Q 003274 514 NFSMQCKLGEGGFG-PVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 514 ~f~~~~~lG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
-|.-.+.+|.|+-| .||+|. .+|++||||++-.. ..+-..+|+..|+.- +|||||++++.-.++...|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGV-YEGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEe-eCCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 34555788999888 478997 47899999998543 334567899999988 6999999999999999999999999
Q ss_pred CCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---C--CCeeecccccceec
Q 003274 592 PNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---D--MNPKISDFGLARMF 665 (834)
Q Consensus 592 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~--~~~kl~DFGla~~~ 665 (834)
. .+|.+++... ...........+.+..|+++||+|||+.+ ||||||||.||||+. + ..++|+|||+++.+
T Consensus 586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 5 4888888542 11111122445778899999999999977 999999999999976 2 57999999999998
Q ss_pred CCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcC-CCCCCCCCCCccccccchhhhhcccccccc
Q 003274 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-RKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
..+... .......||.+|+|||++....-+.++||||+||++|..++| .+||+..-..+.+++.....+ ..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L-------~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL-------VH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce-------ee
Confidence 655432 234456799999999999999999999999999999999997 789986544433332211111 00
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+ . ...++ +..+||.+|++++|..||++.+|+.
T Consensus 735 L-----~--~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 L-----E--PLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e-----c--cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 1 11111 7789999999999999999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.8e-31 Score=254.64 Aligned_cols=265 Identities=23% Similarity=0.378 Sum_probs=190.0
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--------CC
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--------QG 582 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~~ 582 (834)
.|....+||+|.||.||+++.. .|++||+|++--. .+.-.....+|+++|..++|+|++.++..|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3455679999999999999854 5778898865332 22223456889999999999999999988863 23
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..+|||++|++ +|.-+|.+ ....++..++.++++++..||.|+|... |+|||+|+.|+||+.++.+||+|||++
T Consensus 98 t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 58999999976 56666632 2345888999999999999999999876 999999999999999999999999999
Q ss_pred eecCCCCc--cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-cccc-----chhh
Q 003274 663 RMFGGDEL--QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLG-----HAWD 733 (834)
Q Consensus 663 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~-----~~~~ 733 (834)
+.+...+. ....+..+-|..|.+||.+.+. .|+++.|||.-||++.||+++.+.+....+... .++. ...+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 87643322 2222334569999999998764 699999999999999999999988765443221 1111 1111
Q ss_pred hhccc---ccccccccc-cccCCC--------CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 734 LWKHE---RVHELMDPV-ILQDEI--------PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 734 ~~~~~---~~~~~~~~~-~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.|..- .+.+.+... +.++.. +.....+.++|+..++..||.+|+++++++.
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 11111 111111000 101110 1111237789999999999999999999875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=270.01 Aligned_cols=207 Identities=23% Similarity=0.366 Sum_probs=174.9
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
..-|..++.||-|+||.|..++. +....+|+|.|.+.. .......++|..||+....+=||+|+..|.+++.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 35678889999999999999974 445678999987643 34566789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC-
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG- 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~- 666 (834)
|||+++|++-.+| .+.+.+++..+..++.+++.|+.+.|..| +|||||||.|||||.+|++||.||||+.-+.
T Consensus 708 MdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 9999999998887 45677888888889999999999999887 9999999999999999999999999986431
Q ss_pred --------CCCccCC-------------------------------ceeeeccCcccCceeecCCCCCccccchhhHHHH
Q 003274 667 --------GDELQGN-------------------------------TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707 (834)
Q Consensus 667 --------~~~~~~~-------------------------------~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll 707 (834)
..+.... ...++||+.|+|||++....++..+|.||.||+|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 1000000 0125799999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCc
Q 003274 708 LETLSSRKNTGVYNTDS 724 (834)
Q Consensus 708 ~elltG~~p~~~~~~~~ 724 (834)
|||+.|++||-.....+
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999986544433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-29 Score=236.66 Aligned_cols=210 Identities=28% Similarity=0.378 Sum_probs=170.9
Q ss_pred HHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 003274 509 AAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 509 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 585 (834)
+...+++...+.||+|++|.|-+-++ .+|+.+|+|++... ..+..++.+.|+.+..+- .+|.+|+++|.....+..+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 34446666678999999999988874 67999999998765 344556778888877766 7999999999999999999
Q ss_pred EEEEecCCCCcchhccc-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 586 LILEYMPNKSLDVYLFD-PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+.||.|.- ||+.+-.+ ..++..+++..+-+|+..+.+||.|||++- .++|||+||+||||+.+|++|+||||++-.
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 99999854 67665432 234567888888899999999999999875 699999999999999999999999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeec----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYAL----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS 724 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~ 724 (834)
+.+.... +.-.|-..|||||.+. ...|+.|+||||||+.+.||.+++.|++....+-
T Consensus 199 L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF 259 (282)
T KOG0984|consen 199 LVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPF 259 (282)
T ss_pred ehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHH
Confidence 6543211 1135677899999985 3479999999999999999999999988665543
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-29 Score=227.35 Aligned_cols=110 Identities=48% Similarity=0.772 Sum_probs=81.8
Q ss_pred CCeeEEeeCCCCCCCC--CCceEEEecCCceEEecCCCCeEEEE-cccCCC-CCceEEEccCCCEEEecCCCCCccccce
Q 003274 70 PDTVVWVANRDRPISG--RNAVLTISNNGNLVLLSQTNGTIWST-NVSSDV-KNPVAQLRDDGNLVIRDNSSDSTAESYL 145 (834)
Q Consensus 70 ~~~~vW~anr~~p~~~--~~~~l~~~~~g~l~l~~~~~~~~w~~-~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~ 145 (834)
++||||+|||+.|+.+ ...+|.|+.||+|||+++.|+++|++ ++.+.+ ....|+|+|+|||||++.. +.+|
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~-----~~~l 75 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS-----GNVL 75 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT-----SEEE
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec-----ceEE
Confidence 4699999999999954 35899999999999999999999999 555554 5788999999999999963 4799
Q ss_pred eeccCCCchhhhccccccccccCCCceEEEEcCCCCCCC
Q 003274 146 WQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPS 184 (834)
Q Consensus 146 WqSFd~PtDTlLpg~klg~~~~~g~~~~l~sw~s~~dps 184 (834)
||||||||||+||+|+|+.+..+|....++||++.+|||
T Consensus 76 W~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 76 WQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 999999999999999999988887777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=235.13 Aligned_cols=257 Identities=20% Similarity=0.305 Sum_probs=196.9
Q ss_pred hcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCC--eEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQG--EKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~~lV 587 (834)
.++|++.+++|+|.|+.||.|. ..+.++++||++++.. .+.+++|+.+|..|. ||||++|++...+.. ...||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4789999999999999999997 5678999999997643 467889999999997 999999999988654 56799
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeecccccceecC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~ 666 (834)
+||+.+.+...+- ..+...++...+.++++||.|+|+.| |.|||+||.|++||. ...++|+|+|+|.+..
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998775543 34677788899999999999999998 999999999999985 4679999999998875
Q ss_pred CCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc------
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER------ 739 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~------ 739 (834)
...... -.+.+..|.-||.+.. ..|+.+-|+|||||+|.+|+..+.||-...+...+++..+.-+-..+-
T Consensus 185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 443221 1345677889999864 568999999999999999999999987665555555544322211110
Q ss_pred ccccccccccc---------------CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHH
Q 003274 740 VHELMDPVILQ---------------DEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 740 ~~~~~~~~~~~---------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
-.-.+++.+.. .+...-...+..+++...|..|..+|||++|..
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 00012222110 000111236788999999999999999999984
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=234.03 Aligned_cols=210 Identities=35% Similarity=0.595 Sum_probs=183.0
Q ss_pred cccCCcEeEEEEEecC-ccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcch
Q 003274 521 LGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDV 598 (834)
Q Consensus 521 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (834)
||+|.+|.||+++..+ ++.+++|++...... ..+.+.+|++.+++++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999654 899999999765432 35679999999999999999999999999999999999999999999
Q ss_pred hcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeecccccceecCCCCccCCceee
Q 003274 599 YLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGDELQGNTKRI 677 (834)
Q Consensus 599 ~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~ 677 (834)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 874321 46889999999999999999999987 999999999999999 89999999999987654321 12234
Q ss_pred eccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHH
Q 003274 678 VGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLP 756 (834)
Q Consensus 678 ~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 756 (834)
.+...|++||.+... ..+.++|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999999887 889999999999999998
Q ss_pred HHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 757 MLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 757 ~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
..+.+++..|++.+|++||++.++++.
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 477899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-28 Score=240.22 Aligned_cols=265 Identities=20% Similarity=0.286 Sum_probs=189.6
Q ss_pred cccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----eEEE
Q 003274 515 FSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-----EKIL 586 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-----~~~l 586 (834)
.+-.+-||-|+||.||.++. ++|+.||+|++..- +-...+.+.+|+.+|...+|.|++..++...-.. +.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34457899999999999984 57999999988543 2224567889999999999999999888765443 5677
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|.|.|. .+|...+ .....++...+.-+..||++||+|||+.+ |.||||||.|.|++.+..+||+|||+++...
T Consensus 135 ~TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 888774 4665555 34456788888889999999999999988 9999999999999999999999999999876
Q ss_pred CCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCC-Cccccccchhhhh--------c
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNT-DSFNLLGHAWDLW--------K 736 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~-~~~~~~~~~~~~~--------~ 736 (834)
.++....+. .+-|..|.|||++.+. .|+.+.||||.||++.||+..+-.|...+. +..+++....... -
T Consensus 208 ~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 555444333 4568899999999876 689999999999999999977766654332 2212111100000 0
Q ss_pred ccccccccccccccC--------CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 737 HERVHELMDPVILQD--------EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
++.-.-+++...... .-+.....+...+...++..||++|.+..+.+..+.
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 000001111111000 011122345677888899999999999998876543
|
|
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=211.63 Aligned_cols=109 Identities=34% Similarity=0.779 Sum_probs=104.7
Q ss_pred EeeccCCCcceecccccc-ceeeEEEEeecCCeEEEEEEecCCCeeeEEEECcCCcEEEEEEecCCCcEEEEEeeccCCC
Q 003274 210 TCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVYWYEAYNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYC 288 (834)
Q Consensus 210 ~~~g~w~g~~~~~~~~~~-~~~~~~~~~~n~~~~~~~~~~~~~s~~~r~~L~~~G~l~~~~w~~~~~~W~~~~~~p~~~C 288 (834)
||+|+|||..|.+.|++. +..+.+.|+.+.++.+++|...+.+.++|++|+++|+++++.|+++.+.|...|.+|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 899999999999999987 6788889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCccCCCCCCCccccccceecc
Q 003274 289 GKYGYCGANTICSLDQTPMCECLEGFKLKS 318 (834)
Q Consensus 289 d~~~~CG~~g~C~~~~~~~C~C~~Gf~~~~ 318 (834)
|+|+.||+||+|+.+..+.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988889999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=251.91 Aligned_cols=195 Identities=25% Similarity=0.365 Sum_probs=165.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--------cccHHHHHHHHHHHhhcC---CCceeeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAELQ---HRNLVRILGCCVE 580 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~ 580 (834)
.+|+..+.+|+|+||.|..+.++ +..+|+||.+.+.. +..+-..-.|++||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999865 46689999886532 112223566999999997 9999999999999
Q ss_pred CCeEEEEEEec-CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccc
Q 003274 581 QGEKILILEYM-PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (834)
Q Consensus 581 ~~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 659 (834)
++..||+||-. ++-+|.+++ ..+..+++.++..|..||+.|+++||+++ |||||||-+||.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999976 455666666 34556889999999999999999999998 999999999999999999999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCC
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNT 717 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~ 717 (834)
|.+...... ....++||..|.|||++.+.+| ...-|||++|++||.++....|+
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy 769 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY 769 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence 999876543 3455799999999999999887 56789999999999999877765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=229.64 Aligned_cols=199 Identities=33% Similarity=0.469 Sum_probs=171.9
Q ss_pred cccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 515 FSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
|.+.+.||+|++|.||+++..+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566899999999999999765 889999999766544 67789999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++.++.++|+|||.+........ .
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~ 154 (225)
T smart00221 81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-A 154 (225)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-c
Confidence 999999874321 11789999999999999999999987 99999999999999999999999999988754321 1
Q ss_pred CceeeeccCcccCceee-cCCCCCccccchhhHHHHHHHhcCCCCCCC
Q 003274 673 NTKRIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSRKNTGV 719 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~-~~~~~t~~sDVwSlGvll~elltG~~p~~~ 719 (834)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22335678899999998 677788899999999999999999999853
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=203.41 Aligned_cols=115 Identities=43% Similarity=0.709 Sum_probs=102.3
Q ss_pred eeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCCCCeEEEE
Q 003274 32 SFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (834)
++|.+|++|+|++|.|++|||.+..+...+.+|||+....++||.||++.|. +..+.|.|+.||+|+|+|.+|.+||+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~S 80 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSSRTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWSS 80 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCCCeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEEe
Confidence 4688999999999999999999876545999999987668899999999984 667899999999999999999999999
Q ss_pred cccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCC
Q 003274 112 NVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHP 152 (834)
Q Consensus 112 ~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~P 152 (834)
++.+.....+|+|+|||||||++.. +++||||||||
T Consensus 81 ~~~~~~~~~~~~L~ddGnlvl~~~~-----~~~~W~Sf~~P 116 (116)
T cd00028 81 NTTRVNGNYVLVLLDDGNLVLYDSD-----GNFLWQSFDYP 116 (116)
T ss_pred cccCCCCceEEEEeCCCCEEEECCC-----CCEEEcCCCCC
Confidence 9876445678899999999999974 36899999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.5e-26 Score=241.77 Aligned_cols=203 Identities=22% Similarity=0.257 Sum_probs=171.9
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC------CCceeeEEEEEEeCCe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ------HRNLVRILGCCVEQGE 583 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------H~niv~l~~~~~~~~~ 583 (834)
.-..|.+....|+|-|++|.+|+. ..|+.||||++..+.. -.+.=+.|+++|.+|+ --|.++|+-.|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 347889989999999999999984 3478999999976532 2334477999999995 3479999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeecccccc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLA 662 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla 662 (834)
+|||||-+ ..+|.+.|........|....+..+++|+.-||.+|...+ |+|.||||.|||+++. ..+||||||.|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999987 5688888876666777899999999999999999999887 9999999999999976 56899999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCC
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT 722 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~ 722 (834)
.....++... ..-+..|.|||++.+.+|+...|+||.||.||||.||+..|.....
T Consensus 585 ~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 585 SFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 9877665332 2335679999999999999999999999999999999988765443
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-26 Score=250.93 Aligned_cols=252 Identities=24% Similarity=0.379 Sum_probs=202.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|...+.||+|.||.|||++. ..++..|||.++-.......-..+|+-+++..+|||||.++|.+......++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 47888999999999999999984 56888999999888777788888999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
|.+|+|.+.-+ -..++++-++...++...+|++|||+++ =+|||||-.|||+++.+.+|++|||.+..+...
T Consensus 94 cgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-- 165 (829)
T KOG0576|consen 94 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-- 165 (829)
T ss_pred cCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh--
Confidence 99999987653 4567888899999999999999999998 799999999999999999999999998766432
Q ss_pred cCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCC-CCCCCccccccchhhhhccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTG-VYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
......+.||+.|||||+.. .+.|..++|||++|+...|+---++|.- ..+... .... .....++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-------l~Lm----TkS~~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-------LFLM----TKSGFQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-------HHHh----hccCCCC
Confidence 23344578999999999874 6679999999999999999876665521 111110 0000 0111222
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.-+++ +......+.++++.|+..+|++||++..++.
T Consensus 235 p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 22122 2234568899999999999999999877653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=232.03 Aligned_cols=133 Identities=27% Similarity=0.319 Sum_probs=109.3
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-----CC---ceeeEEEEEEeC-
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----HR---NLVRILGCCVEQ- 581 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~---niv~l~~~~~~~- 581 (834)
..+|.+.++||-|.|++||.+.. .+.+.||+|+.+.. ..-.+....|+++|++++ |+ +||+|+++|...
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 46889999999999999999973 45778999998643 344566789999999984 33 599999999754
Q ss_pred ---CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec
Q 003274 582 ---GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (834)
Q Consensus 582 ---~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~ 649 (834)
.+.+||+|++.. +|..+|.. ...+.++...+.+|++||+.||.|||.++ +|||.||||+|||+.
T Consensus 156 pNG~HVCMVfEvLGd-nLLklI~~-s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGD-NLLKLIKY-SNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhhhh-HHHHHHHH-hCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 589999999855 45555422 24456899999999999999999999988 799999999999993
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=226.66 Aligned_cols=259 Identities=25% Similarity=0.282 Sum_probs=187.2
Q ss_pred cCcccccccccCCcEeEEEEE-ecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------Ce
Q 003274 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------GE 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~~ 583 (834)
.+|.-.+.+|.|.- .|..+. .-.++.||+|++... .....++..+|..++..++|+||++++.++.=. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45555677888887 454443 234789999987543 344556778899999999999999999998643 36
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.|+|||+|.. +|...+. -.++.+....|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+++
T Consensus 96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 7999999954 6666653 34678888999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCC-Cccc----------------
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT-DSFN---------------- 726 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~-~~~~---------------- 726 (834)
..... -..+..+.|..|.|||++.+..+.+.+||||+||++.||++|...|..... +...
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 74432 234456788999999999988899999999999999999999977653221 1100
Q ss_pred cccchhhhhccc------ccccccccccccC--CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 727 LLGHAWDLWKHE------RVHELMDPVILQD--EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 727 ~~~~~~~~~~~~------~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+...+....... ...+.+....... +.+.-....+.+++.+||-.||++|.+++++++
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 011111111100 0011111100000 111223456788999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=216.36 Aligned_cols=253 Identities=18% Similarity=0.304 Sum_probs=187.0
Q ss_pred hcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEE-EEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGC-CVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~-~~~~~~~~lV~ 588 (834)
.+.|.+.+.||+|.||.+-.++++. .+.+++|.+... ....++|.+|...--.| .|.||+.-+++ |+..+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3789999999999999999998654 678999988653 33467899998776666 69999987765 45566778999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec--cCCCeeecccccceecC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDMNPKISDFGLARMFG 666 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGla~~~~ 666 (834)
||++.|+|.+-+ ....+.+....+++.|++.|+.|+|+++ +||||||.+||||- +...+||+|||+.+..+
T Consensus 102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999998766 3356778888899999999999999998 99999999999994 33479999999998754
Q ss_pred CCCccCCceeeeccCcccCceeecCC-----CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
... .+..-+..|.|||..... ...+.+|||.||+++|.+|+|..|+........ .-+.+..|......
T Consensus 175 ~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~--~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 175 TTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK--PYWEWEQWLKRKNP 247 (378)
T ss_pred cee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc--hHHHHHHHhcccCc
Confidence 322 222346679999976432 356889999999999999999999874322211 12223333333322
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHH
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L 786 (834)
.+.+.. ....+.+..+.++-+.+++++|-...++.++.
T Consensus 248 ~~P~~F-------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 ALPKKF-------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCchhh-------cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 221111 12345777888899999999996666665543
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=227.50 Aligned_cols=266 Identities=23% Similarity=0.364 Sum_probs=197.9
Q ss_pred HHHHhcCcccccccccCCcEeEEEEEec----CccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 003274 508 VAAATENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (834)
Q Consensus 508 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 582 (834)
+....+.|...++||+|.|++||++++. ..+.||+|.+...+ ...+..+|+++|..+ -|.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3344578889999999999999999743 46789999987654 346689999999999 5999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeeccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGL 661 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGl 661 (834)
...+|+||+++-...++.. .++..++..+++.+.+||+++|.+| ||||||||.|+|.+. -+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 9999999999998888763 3678889999999999999999998 999999999999985 46789999999
Q ss_pred ceecCCCC-------------cc-----------------------------CCceeeeccCcccCceeec-CCCCCccc
Q 003274 662 ARMFGGDE-------------LQ-----------------------------GNTKRIVGTYGYMSPEYAL-DGLFSIKS 698 (834)
Q Consensus 662 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~-~~~~t~~s 698 (834)
|....... .. .......||++|.|||++. ....+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221000 00 0001246999999999986 45689999
Q ss_pred cchhhHHHHHHHhcCCCCCCCCCCCccccccch---------------hh--hhccccc---------ccccc-ccccc-
Q 003274 699 DVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA---------------WD--LWKHERV---------HELMD-PVILQ- 750 (834)
Q Consensus 699 DVwSlGvll~elltG~~p~~~~~~~~~~~~~~~---------------~~--~~~~~~~---------~~~~~-~~~~~- 750 (834)
||||-||+++.+++++.||-...++...+...+ .. ++..... .+-++ ..+..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999876655443222110 00 1110110 00110 00001
Q ss_pred C-------CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 D-------EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .........+++++.+|++.||.+|.|+++.|+
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0 011112347899999999999999999999975
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=192.46 Aligned_cols=113 Identities=43% Similarity=0.728 Sum_probs=99.4
Q ss_pred eeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCCCCeEEEE
Q 003274 32 SFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWST 111 (834)
Q Consensus 32 ~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~ 111 (834)
+.|..|+.|+|+++.|++|||.+..+ ..+.+|||+..+.++||.|||+.|+.+ .+.|.|+.||+|||++.+|.+||+|
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~S 79 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSSRTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWSS 79 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCCCcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEEe
Confidence 46788999999999999999998654 789999998765789999999999844 4899999999999999999999999
Q ss_pred cccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCC
Q 003274 112 NVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151 (834)
Q Consensus 112 ~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~ 151 (834)
++.......+++|+|+|||||++..+ +++||||||
T Consensus 80 ~t~~~~~~~~~~L~ddGnlvl~~~~~-----~~~W~Sf~~ 114 (114)
T smart00108 80 NTTGANGNYVLVLLDDGNLVIYDSDG-----NFLWQSFDY 114 (114)
T ss_pred cccCCCCceEEEEeCCCCEEEECCCC-----CEEeCCCCC
Confidence 98744566788999999999998743 689999997
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=265.14 Aligned_cols=196 Identities=19% Similarity=0.245 Sum_probs=138.9
Q ss_pred hcCC-CceeeEEEEE-------EeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003274 565 ELQH-RNLVRILGCC-------VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636 (834)
Q Consensus 565 ~l~H-~niv~l~~~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 636 (834)
.++| +||+++++++ .+....++++||+ +++|.++|.. ....+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 5888888877 2334567788887 5599998853 2356899999999999999999999988 9
Q ss_pred EecCCCCCCEEecc-------------------CCCeeecccccceecCCCCc--------------cCCceeeeccCcc
Q 003274 637 IHRDLKASNVLLDK-------------------DMNPKISDFGLARMFGGDEL--------------QGNTKRIVGTYGY 683 (834)
Q Consensus 637 vH~Dlk~~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 683 (834)
+||||||+||||+. ++.+|++|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 45567777777764321000 0001123578899
Q ss_pred cCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHH
Q 003274 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVN 763 (834)
Q Consensus 684 ~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 763 (834)
||||++.+..++.++|||||||+||||++|.+|+..... .. .... ...+.+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~----~~~~----~~~~~~~------~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TM----SSLR----HRVLPPQ------ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HH----HHHH----HhhcChh------hhhcCHHHHH
Confidence 999999999999999999999999999998877532110 00 0000 0001110 0112234568
Q ss_pred HHHhccccCCCCCCCHHHHHH
Q 003274 764 VALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 764 li~~cl~~dP~~RPt~~evl~ 784 (834)
++.+||+.+|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-23 Score=205.70 Aligned_cols=167 Identities=20% Similarity=0.153 Sum_probs=123.8
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 673 (834)
|+|.+++.. .+..+++..++.++.||++||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 678888742 2456999999999999999999999875 999999999999999 99998764322
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 753 (834)
..||+.|||||++.+..++.++|||||||++|||++|+.|+.........+. ..... ... ..+. ....
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~----~~~~~--~~~-~~~~--~~~~ 131 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE----ILLNG--MPA-DDPR--DRSN 131 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH----HHHHH--hcc-CCcc--cccc
Confidence 2578999999999999999999999999999999999999754322111100 00000 000 0000 0011
Q ss_pred CHHHHh--HHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 754 PLPMLM--RYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 754 ~~~~~~--~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+..... ++.+++.+||+.+|++||++.|+++.+...
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 112222 689999999999999999999999877543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=217.52 Aligned_cols=176 Identities=20% Similarity=0.222 Sum_probs=134.5
Q ss_pred HHhcCcccccccccCCcEeEEEEEec--CccEEEEEEcccC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLF--NGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 582 (834)
...++|.+.++||+|+||+||+|+.. +++.+|||++... .....+.|.+|+++|.+++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999854 5777899987533 12235669999999999999999863322 25
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEeccCCCeeeccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL-KASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~DFGl 661 (834)
..++||||+++++|.... . .. ...++.+++++|+|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 689999999999996321 0 01 1467889999999999987 999999 99999999999999999999
Q ss_pred ceecCCCCccC------CceeeeccCcccCceeecCCC------CCccccch
Q 003274 662 ARMFGGDELQG------NTKRIVGTYGYMSPEYALDGL------FSIKSDVF 701 (834)
Q Consensus 662 a~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~------~t~~sDVw 701 (834)
++.+....... ......+++.|+|||.+.... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99775432111 113467888999999986443 23446666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=199.87 Aligned_cols=250 Identities=22% Similarity=0.357 Sum_probs=189.3
Q ss_pred cccccccccCCcEeEEEEEecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+.+.-+|.+...|..|+|++. |..+++|++.... ...-+.|..|.-.|+-+.||||+.++|.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 334458899999999999975 4456677775432 2234578899989988999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
.|+|...|++. ..-..+..++.+++.++|+|++|||+..+ -|..--|.++.|+||++.+++|+- +-+++ .-
T Consensus 271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-ad~kf------sf 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-ADTKF------SF 341 (448)
T ss_pred chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-cccee------ee
Confidence 99999998753 44567888999999999999999999863 234446899999999999988851 11111 00
Q ss_pred CceeeeccCcccCceeecCCCCC---ccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFS---IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t---~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
+.....-.+.||+||.+...+-+ .++|+|||+++||||-|...||.....-+.- .++.-.. +
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------------mkialeg-l 406 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------------MKIALEG-L 406 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------hhhhhcc-c
Confidence 11112346789999999877654 6799999999999999999998754431110 0000011 1
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+..+|......+.+++.-|+..||.+||.+..|+-.|++.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 3345556677889999999999999999999999999875
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.6e-20 Score=198.03 Aligned_cols=260 Identities=29% Similarity=0.395 Sum_probs=196.3
Q ss_pred cccccccccCCcEeEEEEEecCccEEEEEEcccCCcc---cHHHHHHHHHHHhhcCCC-ceeeEEEEEEeCCeEEEEEEe
Q 003274 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ---GLKEFKNEMMLIAELQHR-NLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~H~-niv~l~~~~~~~~~~~lV~Ey 590 (834)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++..++......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999865 88899998765433 367899999999999988 799999999777778999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-CeeecccccceecCCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 669 (834)
+.++++..++........+.......++.|++.++.|+|+.+ ++||||||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999866532111136888999999999999999999998 99999999999999998 79999999998665443
Q ss_pred ccC----CceeeeccCcccCceeecC---CCCCccccchhhHHHHHHHhcCCCCCCCCCCC--ccccccchhhhhccccc
Q 003274 670 LQG----NTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSRKNTGVYNTD--SFNLLGHAWDLWKHERV 740 (834)
Q Consensus 670 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwSlGvll~elltG~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 740 (834)
... ......|+..|+|||.+.+ .......|+||+|++++++++|..|+...... ...... ......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~----~~~~~~- 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK----IILELP- 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH----HHHhcC-
Confidence 221 2345689999999999987 68899999999999999999999996543321 011110 000000
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
........ ...........+.+++..|+..+|..|.++.+....
T Consensus 232 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TPSLASPL-SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cccccccc-CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000000 000002223577889999999999999998887653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.4e-20 Score=199.61 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=189.4
Q ss_pred CcccccccccCCcEeEEEEEecCc--cEEEEEEcccCCcccHHHHHHHHHHHhhcCC----CceeeEEEEE-EeCCeEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFNG--QEVAVKRLSSQSGQGLKEFKNEMMLIAELQH----RNLVRILGCC-VEQGEKIL 586 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H----~niv~l~~~~-~~~~~~~l 586 (834)
+|.+.++||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999985543 4788888765433333378889999999973 5888888888 46778899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-----CCeeeccccc
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-----MNPKISDFGL 661 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~DFGl 661 (834)
||+.+ +.+|.++..... .+.++....++|+.|++.+|.+||+.+ ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99876 678877653322 567999999999999999999999998 9999999999999754 4699999999
Q ss_pred ce--ecCCCCc-----c-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhh
Q 003274 662 AR--MFGGDEL-----Q-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD 733 (834)
Q Consensus 662 a~--~~~~~~~-----~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 733 (834)
++ ....... . .......||..|.+++...+...+.+.|+||++.++.|++.|..|+........ ..
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~------~~ 247 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL------KS 247 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch------HH
Confidence 99 3322211 1 112335699999999999999999999999999999999999988754332111 00
Q ss_pred hhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
............. .......++.++...+-..+..++|....+...|....
T Consensus 248 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 248 KFEKDPRKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHHHhhhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 0000000000000 11112234455555555589999999999998876653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-21 Score=222.96 Aligned_cols=253 Identities=21% Similarity=0.248 Sum_probs=183.1
Q ss_pred cccccccCCcEeEEEEEe-cCccEEEEEEcc----c-CCccc-HHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 517 MQCKLGEGGFGPVYKGRL-FNGQEVAVKRLS----S-QSGQG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~----~-~~~~~-~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
..+++|.|++|.|+.... ......+.|.+. . ..... ...+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 356899999997777652 233333444332 1 11111 1225667777888899999888777777666666699
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++. +|..++- ....+...++..++.|+.+|++|||+.+ |.|||||++|+++..++.+||+|||.+..+....
T Consensus 402 ~~~~-Dlf~~~~---~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVM---SNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHh---cccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 9988773 2246788899999999999999999998 9999999999999999999999999998765433
Q ss_pred cc--CCceeeeccCcccCceeecCCCCCc-cccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 670 LQ--GNTKRIVGTYGYMSPEYALDGLFSI-KSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 670 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~-~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.. .....++|...|+|||.+.+..|+. ..||||.|+++..|++|+.|+.........+... ....... .
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-------~~~~~~~-~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-------NYSDQRN-I 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-------ccccccc-c
Confidence 22 3444578999999999999999875 5899999999999999999987554333221000 0000000 0
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......+......+...++.+||+.+|.+|.|+.+|++
T Consensus 547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001122234567789999999999999999999975
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-19 Score=182.22 Aligned_cols=139 Identities=18% Similarity=0.168 Sum_probs=108.8
Q ss_pred ccccccCCcEeEEEEEecCccEEEEEEcccCCcc--c-------HHH-----------------HHHHHHHHhhcCCCce
Q 003274 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ--G-------LKE-----------------FKNEMMLIAELQHRNL 571 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~E~~~l~~l~H~ni 571 (834)
.+.||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999778999999998654211 1 112 2349999999988776
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCEEecc
Q 003274 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL-HQYSRLRIIHRDLKASNVLLDK 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~Dlk~~NILl~~ 650 (834)
.....+.. ...+|||||++++++...+. ....++.+....++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333322 23489999999987754431 335688999999999999999999 6777 99999999999998
Q ss_pred CCCeeecccccceec
Q 003274 651 DMNPKISDFGLARMF 665 (834)
Q Consensus 651 ~~~~kl~DFGla~~~ 665 (834)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 578999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.5e-20 Score=184.35 Aligned_cols=171 Identities=14% Similarity=0.159 Sum_probs=133.0
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHH---H------HHHHHHHHhhcCCCceeeEEEEEEeC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLK---E------FKNEMMLIAELQHRNLVRILGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~---~------~~~E~~~l~~l~H~niv~l~~~~~~~ 581 (834)
-.++|...++||.|+||.||.... +++.+|||.+........+ . +.+|++.+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 358999999999999999999765 5778999999755332222 2 68899999999999999998886533
Q ss_pred --------CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC
Q 003274 582 --------GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (834)
Q Consensus 582 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 653 (834)
+..+|||||+++.+|.++. .++. ....+++.+++.+|+.+ ++|||+||+||+++.++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 3578999999999997763 1222 24568999999999998 99999999999999988
Q ss_pred eeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHh
Q 003274 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ell 711 (834)
++|+|||.......+... ..+.....+..++|+|+||+.+.-+.
T Consensus 173 i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999998764321110 00234445668999999999987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=176.20 Aligned_cols=141 Identities=20% Similarity=0.229 Sum_probs=112.3
Q ss_pred ccccccCCcEeEEEEEecCccEEEEEEcccCCccc--------------------------HHHHHHHHHHHhhcCCCce
Q 003274 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG--------------------------LKEFKNEMMLIAELQHRNL 571 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~--------------------------~~~~~~E~~~l~~l~H~ni 571 (834)
...||+|+||.||+|+..+|+.||||+++...... ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999997789999999987642110 1224678999999999988
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEecc
Q 003274 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDK 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl~~ 650 (834)
.....+... ..+|||||++++++.... .....++.....+++.+++.++.++|+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~---l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPR---LKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhh---hhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 555444333 348999999988654332 123457788899999999999999999 77 99999999999999
Q ss_pred CCCeeecccccceecCC
Q 003274 651 DMNPKISDFGLARMFGG 667 (834)
Q Consensus 651 ~~~~kl~DFGla~~~~~ 667 (834)
++.++|+|||++..+..
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 89999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=176.89 Aligned_cols=203 Identities=23% Similarity=0.354 Sum_probs=171.3
Q ss_pred hcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.-+|.+.++||+|.||+++.|+ +-+++.||||.-...+ ...++..|.+..+.| ..+.|...+.+-.++-+-.||+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 4689999999999999999998 7789999999754433 235678899999988 57899999988888889999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-----CCeeeccccccee
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-----MNPKISDFGLARM 664 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~DFGla~~ 664 (834)
.+ +-||.++. + .-++.++.+.++.+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.
T Consensus 105 LL-GPSLEDLF-D-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 105 LL-GPSLEDLF-D-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hh-CcCHHHHH-H-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 87 56777664 2 24567899999999999999999999998 9999999999999643 3589999999998
Q ss_pred cCCCCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCC
Q 003274 665 FGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNT 722 (834)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~ 722 (834)
+.+.... .......||.+||+-....+...+.+-|.=|||=++...|-|..|+.....
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 8655432 223456799999999999999999999999999999999999999876543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.1e-20 Score=203.62 Aligned_cols=225 Identities=26% Similarity=0.335 Sum_probs=181.3
Q ss_pred ccccCCcEeEEEEE----ecCccEEEEEEcccCCcc--cHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEecC
Q 003274 520 KLGEGGFGPVYKGR----LFNGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|+|.||.|+.++ .+.|+.+|+|.+++.... .....+.|..++..++ ||.+|+++..+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 47999999999874 345778888888654211 1225677888999996 9999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|.|...+. +...+.......+...++-++.++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-....
T Consensus 81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999987773 3445666777778888999999999988 99999999999999999999999999987643322
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.+||..|||||++. .....+|.||||++++||++|..||.. + .+..++.. .-.
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~---------------~~~~Il~~---~~~ 205 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---D---------------TMKRILKA---ELE 205 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---H---------------HHHHHhhh---ccC
Confidence 28999999999998 778899999999999999999999874 0 01111111 234
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCH
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTM 779 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~ 779 (834)
.|......+.+++..+...+|.+|.-.
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 566677888899999999999999755
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1e-18 Score=170.08 Aligned_cols=261 Identities=18% Similarity=0.261 Sum_probs=191.3
Q ss_pred hcCcccccccccCCcEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E 589 (834)
..+|.+.++||+|+||.+|.|. ..+|.+||||.-+.... ..++..|..+...|+| ..|..+..+..+...-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4689999999999999999997 67899999998655433 3467889999999975 678888888888889999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC---CCeeecccccceecC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGla~~~~ 666 (834)
.+ +-+|.++.. .-.+.++...++-++-|++.-++|+|.++ ++||||||+|+|..-+ ..+.++|||+++.+.
T Consensus 92 LL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 667766652 12345788899999999999999999998 9999999999999644 468999999999875
Q ss_pred CCCc-----cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 667 GDEL-----QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 667 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+... ........||.+|.+-....+...+.+-|+=|+|.+|..+.-|..|+........ ....+.+.+.++.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk---~QKyEkI~EkK~s 242 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK---KQKYEKISEKKMS 242 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhH---HHHHHHHHHhhcC
Confidence 4322 2233456899999998888888889999999999999999999999875432211 0011111111111
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.. + -.. .+.++...+.-|-..--++-|...-+.+.+.-+
T Consensus 243 ~~ie~-L-C~G----~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 243 TPIEV-L-CKG----FPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred CCHHH-H-hCC----CcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 11100 0 111 234666677777777777788877666655433
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=209.02 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=180.1
Q ss_pred CcccccccccCCcEeEEEEEecCccEEEEEEcccCC-cccHHHHHHHHHHHh--hcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS-GQGLKEFKNEMMLIA--ELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~--~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++...+.||++.|=.|.+++.++|. |+||++-+.. .-.++.|+++++-++ .++|||.+++.-......-.|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5677789999999999999988887 8999886654 445666666555444 45899999988776666677888888
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC-CCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG-GDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~-~~~ 669 (834)
..+ +|.+.| ..+..+..-+...|+-|++.||..+|..+ |+|+|||.+||||+.-.=+.|+||..-+... ..+
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 765 454444 23445777888899999999999999998 9999999999999998889999998876442 222
Q ss_pred ccCCceeeecc----CcccCceeecCC----------C-CCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhh
Q 003274 670 LQGNTKRIVGT----YGYMSPEYALDG----------L-FSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWD 733 (834)
Q Consensus 670 ~~~~~~~~~gt----~~y~aPE~~~~~----------~-~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 733 (834)
.......+..| ..|.|||.+... . .+++-||||+||+++||++ |+++|.... +..+ +
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ-----L~aY--r 248 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ-----LLAY--R 248 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH-----HHhH--h
Confidence 22333333333 369999987531 1 5688999999999999998 577765211 1100 0
Q ss_pred hhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.........++.. + +...+.+++..|++.||++|.++++.++.-+++
T Consensus 249 ~~~~~~~e~~Le~------I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 249 SGNADDPEQLLEK------I---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred ccCccCHHHHHHh------C---cCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 0000011111111 1 123678999999999999999999999875554
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=192.66 Aligned_cols=218 Identities=26% Similarity=0.329 Sum_probs=163.4
Q ss_pred HhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 003274 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (834)
Q Consensus 563 l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk 642 (834)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....+++.-...++++|++||+|||.-. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568999999999999999999999999999999999864 3456888889999999999999999864 23999999
Q ss_pred CCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCC-------CCCccccchhhHHHHHHHhcCCC
Q 003274 643 ASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-------LFSIKSDVFSFGILMLETLSSRK 715 (834)
Q Consensus 643 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~~sDVwSlGvll~elltG~~ 715 (834)
+.|+++|....+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998876431111111112245679999998764 14678999999999999999999
Q ss_pred CCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 716 NTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 716 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
||+........ ......... .......|.+.... +...++..++..||..+|++||++.+|...++.+.
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~--~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKK--GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCCh-HHHHHHHHh--cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 98764433221 111111111 11222333331111 23347899999999999999999999999887764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.3e-18 Score=166.87 Aligned_cols=184 Identities=18% Similarity=0.145 Sum_probs=138.3
Q ss_pred cccccccCCcEeEEEEEecCccEEEEEEcccCCcc----cHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEec
Q 003274 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ----GLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 456899999999997764 7788888887654331 1225889999999995 5889999886 4579999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCEEeccCCCeeecccccceecCCCCc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL-KASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
.+.+|...+. . ....++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||++........
T Consensus 81 ~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998854321 0 12357789999999999998 999999 79999999999999999999986543221
Q ss_pred c----C--C-----ceeeeccCcccCceeecCC-CCC-ccccchhhHHHHHHHhcCCCCCC
Q 003274 671 Q----G--N-----TKRIVGTYGYMSPEYALDG-LFS-IKSDVFSFGILMLETLSSRKNTG 718 (834)
Q Consensus 671 ~----~--~-----~~~~~gt~~y~aPE~~~~~-~~t-~~sDVwSlGvll~elltG~~p~~ 718 (834)
. . . ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.+.-
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 0 0112356777777754432 333 56789999999999999998754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.4e-18 Score=175.31 Aligned_cols=233 Identities=20% Similarity=0.231 Sum_probs=150.1
Q ss_pred CcccccccccCCcEeEEEEEecC-ccEEEEEEcccC---CcccHHHHHHHHHHHhhcCC----------CceeeEEEEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH----------RNLVRILGCCV 579 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H----------~niv~l~~~~~ 579 (834)
.+...+.||.|+++.||.++..+ ++++|||.+... .....+++++|...+..+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45567899999999999999754 899999987533 23456778888877766433 12222222222
Q ss_pred e---------CC--------eEEEEEEecCCCCcchhcc---cccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 003274 580 E---------QG--------EKILILEYMPNKSLDVYLF---DPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638 (834)
Q Consensus 580 ~---------~~--------~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 638 (834)
. .. ..+++|+-+ .++|..++. .... ...+....++.+..|+++.+++||+.+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 1 11 235677766 667766642 1111 123445556677789999999999998 999
Q ss_pred cCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecC--------CCCCccccchhhHHHHHHH
Q 003274 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLET 710 (834)
Q Consensus 639 ~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDVwSlGvll~el 710 (834)
+||+|+|++++++|.++|+||+.....+..... ...+..|.+||.... -.++.+.|.|+||++||.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 999999999999999999999988765432211 123577999997643 2578999999999999999
Q ss_pred hcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCC
Q 003274 711 LSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADR 776 (834)
Q Consensus 711 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 776 (834)
++++.|++......... .. -..+. +.++.+..||..+|+.||.+|
T Consensus 244 WC~~lPf~~~~~~~~~~------------------~~--f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEADPE------------------WD--FSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGSTSG------------------GG--GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccccc------------------cc--chhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999987543221100 01 12334 567788999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.4e-17 Score=165.44 Aligned_cols=136 Identities=21% Similarity=0.293 Sum_probs=105.6
Q ss_pred ccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhc-----CCCceeeEEEEEEeCC---eEE-E
Q 003274 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-----QHRNLVRILGCCVEQG---EKI-L 586 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~H~niv~l~~~~~~~~---~~~-l 586 (834)
.-.+.||+|+||.||. +......+||++........+.+.+|+.++..+ .||||+++++++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 333333479988765445567899999999999 5799999999998874 333 7
Q ss_pred EEEe--cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCEEecc----CCCeeeccc
Q 003274 587 ILEY--MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL-LYLHQYSRLRIIHRDLKASNVLLDK----DMNPKISDF 659 (834)
Q Consensus 587 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl-~~LH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~DF 659 (834)
|+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 568999999843 234444 35577777777 9999998 999999999999974 347999995
Q ss_pred ccc
Q 003274 660 GLA 662 (834)
Q Consensus 660 Gla 662 (834)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.5e-17 Score=196.08 Aligned_cols=200 Identities=22% Similarity=0.242 Sum_probs=159.9
Q ss_pred HHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeE
Q 003274 508 VAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEK 584 (834)
Q Consensus 508 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~ 584 (834)
.+...+.|.+.+.||+|+||.||+|...+|+.||+|+=+..+.= +|---.+++.||+ -+-|+.+.....-.+.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 34456889999999999999999999888999999986554321 1222233444554 23455555555667788
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-------CCCeeec
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-------DMNPKIS 657 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-------~~~~kl~ 657 (834)
+||+||.+.|+|.+++. ..+.++|.....++.|+++-+.+||..+ |||+||||+|.||.. ..-++|+
T Consensus 770 ~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred eeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 99999999999999984 6678999999999999999999999988 999999999999942 3458999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCC
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN 716 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p 716 (834)
|||-+..+.--.........++|-.+--+|...+...+.++|.|.|+.+++-||.|+..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999766432222345557789999999999999999999999999999999998854
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-17 Score=135.38 Aligned_cols=66 Identities=53% Similarity=1.104 Sum_probs=59.8
Q ss_pred CCCCCceeEecccCCCCccccccccccChHHHHHHhhccCccccccccccCCCceEEEEccCcccc
Q 003274 336 CTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDS 401 (834)
Q Consensus 336 C~~~~~f~~~~~v~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~g~~c~~w~~~l~~~ 401 (834)
|+.+|+|++|++|++|++....++.++++++|++.|++||||+||+|.+..++++|++|+++|+|+
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeecC
Confidence 555699999999999999887777789999999999999999999998776789999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=163.34 Aligned_cols=150 Identities=17% Similarity=0.165 Sum_probs=115.3
Q ss_pred HHHHHhcCcccccccccCCcEeEEEEE--ecCccEEEEEEcccCCcc------------------------cHHHHHHHH
Q 003274 507 SVAAATENFSMQCKLGEGGFGPVYKGR--LFNGQEVAVKRLSSQSGQ------------------------GLKEFKNEM 560 (834)
Q Consensus 507 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~ 560 (834)
.+......|.+.+.||+|+||.||+|. ..+|+.||+|++...... ....+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 344444568899999999999999998 568999999998653210 012356899
Q ss_pred HHHhhcCCCc--eeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 003274 561 MLIAELQHRN--LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638 (834)
Q Consensus 561 ~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 638 (834)
+.+.++.+.. +.+++++ ...++||||+++.+|..... ....+...+...++.|++.++++||+.+ .|+|
T Consensus 102 ~~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH 172 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVH 172 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence 9999997533 3444443 24589999999988866542 2234556667899999999999999876 4999
Q ss_pred cCCCCCCEEeccCCCeeecccccceecC
Q 003274 639 RDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 639 ~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||||+||+++ ++.++|+|||.+....
T Consensus 173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 173 GDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999 8899999999987643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.7e-16 Score=159.92 Aligned_cols=134 Identities=20% Similarity=0.292 Sum_probs=113.2
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcc--------cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ--------GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
+.||+|++|.||+|+. .|..+++|+....... ....+.+|++++..++|++|.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999986 6788999986543211 124578899999999999998888887778889999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+++++|.+++... .. .+..++.+++.+|++||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999998887321 12 78899999999999999988 99999999999999 88999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=6.3e-16 Score=156.53 Aligned_cols=145 Identities=19% Similarity=0.190 Sum_probs=112.9
Q ss_pred HHHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcc----------------------cHHHHHHHHHHH
Q 003274 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ----------------------GLKEFKNEMMLI 563 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~E~~~l 563 (834)
.++......|.+.+.||+|+||.||++...+|+.+|||++...... ....+..|+.++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444455557888999999999999999878999999986542210 112367789999
Q ss_pred hhcCCCc--eeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 003274 564 AELQHRN--LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL 641 (834)
Q Consensus 564 ~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl 641 (834)
..+.|++ +.+.++ ....++||||+++++|..... ......++.++++++.++|+.+ |+||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 9998874 444443 245689999999999876541 0335678899999999999987 999999
Q ss_pred CCCCEEeccCCCeeecccccceecC
Q 003274 642 KASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 642 k~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||+||++++++.++|+|||++....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-17 Score=179.82 Aligned_cols=172 Identities=24% Similarity=0.323 Sum_probs=130.9
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
.+++.|+.|...+|.++|.........++...+.++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999766666778889999999999999999 55 999999999999999999999999999
Q ss_pred eecCCCC----ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcC-CCCCCCCCCCccccccchhhhhcc
Q 003274 663 RMFGGDE----LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS-RKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 663 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
....... .....+.-.||..||+||.+.+..|+.|+||||||++|+||+.- ...++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------ 465 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------ 465 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------------
Confidence 8776544 22233446799999999999999999999999999999999961 211110
Q ss_pred cccccccccccccCCCCHH---HHhHHHHHHHhccccCCCCCCCHHHH
Q 003274 738 ERVHELMDPVILQDEIPLP---MLMRYVNVALLCVQENAADRPTMSDV 782 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~cl~~dP~~RPt~~ev 782 (834)
.....-++. +.+|.. ....-+.++.+++.+.|.+||++.++
T Consensus 466 ~~t~~d~r~----g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 466 IATLTDIRD----GIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHhhhhhhc----CCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 000011111 111111 11233578899999999999955444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.9e-16 Score=155.91 Aligned_cols=130 Identities=23% Similarity=0.353 Sum_probs=106.7
Q ss_pred ccccCCcEeEEEEEecCccEEEEEEcccCCc--------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.||+|+||.||+|. .++..+++|....... ...+++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 48999999999998 4678899998654321 11356788999999999888766666666677789999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++++|.+.+.... ..++.+++++|++||+.+ ++|+|++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999988763211 078999999999999987 99999999999999 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.3e-15 Score=177.57 Aligned_cols=136 Identities=21% Similarity=0.336 Sum_probs=111.0
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEE-cccCC-------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKR-LSSQS-------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~-------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
..|...++||+|+||.||+|..... .+++|+ +.+.. ....+.+.+|++++.+++|++++....++......
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445678999999999999986544 344443 22111 11235688999999999999999888888887888
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++. ....++.+++++|++||+.+ ++||||||+|||+ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988772 45678999999999999987 9999999999999 678999999999976
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.8e-15 Score=157.19 Aligned_cols=197 Identities=20% Similarity=0.262 Sum_probs=133.1
Q ss_pred CCCceeeEEEEEEe---------------------------CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHH
Q 003274 567 QHRNLVRILGCCVE---------------------------QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQ 619 (834)
Q Consensus 567 ~H~niv~l~~~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 619 (834)
+|||||++.++|.+ ...+|+||.-.+. +|.+++ -....+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl----~~~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYL----WTRHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHH----hcCCCchHHHHHHHH
Confidence 59999999988753 2256888876644 666666 233456667778899
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCCEEec--cCC--CeeecccccceecCCC----CccCCceeeeccCcccCceeecC
Q 003274 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDM--NPKISDFGLARMFGGD----ELQGNTKRIVGTYGYMSPEYALD 691 (834)
Q Consensus 620 ~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~--~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 691 (834)
|+++|+.|||.++ |.|||+|++||||. +|. .+.|+|||.+-.-... .+........|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 99999999999994 333 4789999987542211 11111222456778899998764
Q ss_pred CC------CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHH
Q 003274 692 GL------FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVA 765 (834)
Q Consensus 692 ~~------~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 765 (834)
.+ --.|+|.|+.|.+.||++....||....+-. +.. ..-.+---| ..+......+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~--L~~--------r~Yqe~qLP-----alp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML--LDT--------RTYQESQLP-----ALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe--ech--------hhhhhhhCC-----CCcccCChHHHHHH
Confidence 32 1278999999999999999998886422111 000 000000001 12223345778999
Q ss_pred HhccccCCCCCCCHHHHHHHH
Q 003274 766 LLCVQENAADRPTMSDVVSMI 786 (834)
Q Consensus 766 ~~cl~~dP~~RPt~~evl~~L 786 (834)
...|+.||++|++..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999876554443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-16 Score=181.76 Aligned_cols=209 Identities=22% Similarity=0.259 Sum_probs=143.3
Q ss_pred hcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..+|..++.|..|+||.||.++++. .+.+|+|+- ++.- -.++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccc-ccch----hhhc---cccccCCccee------------------
Confidence 3788999999999999999998654 567888442 2110 0011 22223344444
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC-
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE- 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~- 669 (834)
|+-...+ ...+.++... +.+++|||+.+ |+|||+||+|.+|+.-|.+|+.|||+.+......
T Consensus 136 ---gDc~tll---k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 2222222 1223344332 77899999988 9999999999999999999999999987542110
Q ss_pred ------------ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc
Q 003274 670 ------------LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 670 ------------~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
.....+.++||+.|.|||++....|...+|+|++|+++||.+-|..||.....++. .
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--f--------- 267 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--F--------- 267 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--H---------
Confidence 01122346899999999999999999999999999999999999999875433221 1
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCC
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP 777 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 777 (834)
..++...+...+-......++.+++.+.|+.+|..|-
T Consensus 268 ---g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 268 ---GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ---hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111122212222333456788899999999999995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.8e-14 Score=144.46 Aligned_cols=137 Identities=20% Similarity=0.246 Sum_probs=99.3
Q ss_pred ccccccCCcEeEEEEEecCccEEEEEEcccCCcc--cHHH----------------------HHHHHHHHhhcCCCc--e
Q 003274 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ--GLKE----------------------FKNEMMLIAELQHRN--L 571 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~H~n--i 571 (834)
.+.||+|+||.||++...+++.||||++...... .... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999988653211 1111 135666666664432 4
Q ss_pred eeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEecc
Q 003274 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDK 650 (834)
Q Consensus 572 v~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl~~ 650 (834)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 246899999999654322111100 11 5677899999999999998 76 99999999999999
Q ss_pred CCCeeecccccceecC
Q 003274 651 DMNPKISDFGLARMFG 666 (834)
Q Consensus 651 ~~~~kl~DFGla~~~~ 666 (834)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 9999999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.2e-14 Score=136.53 Aligned_cols=135 Identities=23% Similarity=0.250 Sum_probs=114.9
Q ss_pred cccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCC--CceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH--RNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
+.+.||+|.++.||+++..+ +.+++|....... ...+..|+.++..++| .++.+++.+....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34689999999999999654 7899999865433 4678999999999976 58999999888888899999999988
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
.+..+ +......++.++++++++||.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5566778899999999999986545699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.2e-13 Score=143.51 Aligned_cols=134 Identities=24% Similarity=0.277 Sum_probs=103.7
Q ss_pred cccc-cCCcEeEEEEEecCccEEEEEEcccCC-------------cccHHHHHHHHHHHhhcCCCce--eeEEEEEEeCC
Q 003274 519 CKLG-EGGFGPVYKGRLFNGQEVAVKRLSSQS-------------GQGLKEFKNEMMLIAELQHRNL--VRILGCCVEQG 582 (834)
Q Consensus 519 ~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~H~ni--v~l~~~~~~~~ 582 (834)
..|| .|+.|+||+++.. +..++||++.... ......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 8899999999864 7788999874311 1223567889999999998875 67777654432
Q ss_pred ----eEEEEEEecCC-CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 583 ----EKILILEYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 583 ----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
..++|||++++ .+|.+++.. ..++.. .+.+|+++|++||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 23599999997 688877632 234433 3568999999999998 9999999999999999999999
Q ss_pred cccccee
Q 003274 658 DFGLARM 664 (834)
Q Consensus 658 DFGla~~ 664 (834)
|||.+..
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9999876
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=4.4e-15 Score=172.47 Aligned_cols=255 Identities=21% Similarity=0.261 Sum_probs=188.4
Q ss_pred cCcccccccccCCcEeEEEEEec--CccEEEEEEcccCC--cccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF--NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV 587 (834)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+-..+. |+|++++++........+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666778999999999887643 34466777665442 233344555777777776 99999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCEEeccCC-Ceeecccccceec
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH-QYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMF 665 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~ 665 (834)
.||..++++.+.+... .....+......+..|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999997776311 1113455667778999999999999 766 99999999999999999 9999999999988
Q ss_pred CC-CCccCCceeeec-cCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 666 GG-DELQGNTKRIVG-TYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 666 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.. +.........+| ++.|+|||...+. ......|+||.|+++.-+++|..|.............+.... ....
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~- 251 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRFT- 251 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---cccc-
Confidence 76 444444555678 9999999999884 567889999999999999999999775544332221111100 0000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
...-........++..+++..+|+.|.+.+++-
T Consensus 252 --------~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 252 --------QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --------cCccccCChhhhhcccccccCCchhcccccccc
Confidence 011111234567788888889999999988874
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.4e-12 Score=147.13 Aligned_cols=140 Identities=23% Similarity=0.277 Sum_probs=100.0
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcccH----------------------------------------HHHHH
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGL----------------------------------------KEFKN 558 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~----------------------------------------~~~~~ 558 (834)
+.||+|++|.||+|++.+|+.||||+.+....... -.|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999999999999999865421110 02445
Q ss_pred HHHHHhhcC----CCceeeEEEEE-EeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 003274 559 EMMLIAELQ----HRNLVRILGCC-VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ-GLLYLHQYS 632 (834)
Q Consensus 559 E~~~l~~l~----H~niv~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gl~~LH~~~ 632 (834)
|++.+.+++ |.+-+.+-.++ ...+..+|||||+++++|.+..... .... .+.+++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666555552 33223332222 3345689999999999998875321 1111 23456666665 467889877
Q ss_pred CCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 633 ~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
++|+|+||.||+++.++.++++|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.37 E-value=4.7e-13 Score=111.96 Aligned_cols=71 Identities=20% Similarity=0.299 Sum_probs=58.0
Q ss_pred CCCCCceeEecccCCCCccccccccccChHHHHHHhhc---cCccccccccccCCCceEEEEccCc-cccCCCcccccCc
Q 003274 336 CTRGTQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLK---NCTCKAYANSNVTEGSGCLMWYGDL-LDSRRPIRNFTGQ 411 (834)
Q Consensus 336 C~~~~~f~~~~~v~~pd~~~~~~~~~~s~~~C~~~Cl~---nCsC~A~~~~~~~~g~~c~~w~~~l-~~~~~p~~~~~g~ 411 (834)
|...+.|.++.+|++|++.. ++++||++.|++ ||||+||+|.+. +.||++|+++| ++++.. ...+.
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~--~~gC~~W~~~l~~d~~~~--~~~g~ 74 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA--RKQCLWFPFNSMSGVRKE--FSHGF 74 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC--CCCeEEecCcchhhHHhc--cCCCc
Confidence 34457899999999998864 689999999999 999999999764 35899999999 887742 11278
Q ss_pred eeeec
Q 003274 412 SVYLQ 416 (834)
Q Consensus 412 ~lylr 416 (834)
++|+|
T Consensus 75 ~Ly~r 79 (80)
T cd00129 75 DLYEN 79 (80)
T ss_pred eeEeE
Confidence 89986
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.33 E-value=9.4e-13 Score=134.33 Aligned_cols=205 Identities=20% Similarity=0.199 Sum_probs=140.8
Q ss_pred HHHHhhcCCCceeeEEEEEEeC-----CeEEEEEEecCCCCcchhcccccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003274 560 MMLIAELQHRNLVRILGCCVEQ-----GEKILILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSR 633 (834)
Q Consensus 560 ~~~l~~l~H~niv~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 633 (834)
+.-|-.+.|.|||+++.|..+. .+..++.|||..|++..+|.+..+ ...+......+++.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 3445556799999999988653 357899999999999999975433 345778888899999999999999975
Q ss_pred CCeEecCCCCCCEEeccCCCeeeccccccee--cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHh
Q 003274 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARM--FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711 (834)
Q Consensus 634 ~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ell 711 (834)
++|+|+++..+-|++..++-+|+.--.-... ..............+-++|.|||.-.....+..+|||+||+..+||-
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 7899999999999999999998863211111 00111111222345678999999888888889999999999999998
Q ss_pred cCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 712 SSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 712 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
-+............ ......+....+... .-..++..|++..|..||+|++++.
T Consensus 277 ilEiq~tnseS~~~-------~ee~ia~~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKVE-------VEENIANVIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcceee-------hhhhhhhheeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 76543211110000 000000011111111 1135678899999999999998765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=6.6e-12 Score=139.43 Aligned_cols=249 Identities=23% Similarity=0.290 Sum_probs=178.9
Q ss_pred cCccccccccc--CCcEeEEEEEe---cCccEEEEEEccc--CCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 003274 513 ENFSMQCKLGE--GGFGPVYKGRL---FNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 584 (834)
..|.+.+.+|+ |.+|.||+++. .++..+|+|+-+. ..+.....=.+|+...+++ .|+|.++....+.+++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34566778999 99999999975 4577899997432 2223333335677777777 499999988889999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeeccc
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ----GLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDF 659 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DF 659 (834)
++-.|++. .+|..+.+. ....++...+..+..+..+ |+.++|+.. ++|-|+||.||++..+ ...++.||
T Consensus 194 fiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 99999886 566666532 2334666777777777777 999999988 9999999999999999 89999999
Q ss_pred ccceecCCCCccCCc---eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 660 GLARMFGGDELQGNT---KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 660 Gla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|+...+......... ....|...|++||.. .+.++.+.|+|++|.++.|...+....-..-.. .|.
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W~--- 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS-------SWS--- 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-------Ccc---
Confidence 999998766533222 223578899999954 567889999999999999998877553221100 010
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.++......++-.....++..++.+|++.+|..|++.+++..
T Consensus 337 ------~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 ------QLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------ccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111122222223445566899999999999998887753
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.2e-12 Score=107.10 Aligned_cols=80 Identities=38% Similarity=0.755 Sum_probs=63.1
Q ss_pred CCCCCCC---CceeEecccCCCCccccccccccChHHHHHHhhccCccccccccccCCCceEEEEccCccccCCCccccc
Q 003274 333 SSECTRG---TQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGDLLDSRRPIRNFT 409 (834)
Q Consensus 333 ~~~C~~~---~~f~~~~~v~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~g~~c~~w~~~l~~~~~p~~~~~ 409 (834)
+++|.+. ++|.++.++++|++.... .++++++|++.|++||+|+||+|.+ ++++|.+|.+.+.+.+.+. ..
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~--~~~~C~~~~~~~~~~~~~~--~~ 75 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN--GSGGCLLWNGLLNNLRSLS--SG 75 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC--CCCeEEEEeceecceEeec--CC
Confidence 3456443 689999999999886543 7789999999999999999999975 3578999999998866422 22
Q ss_pred CceeeeccC
Q 003274 410 GQSVYLQVP 418 (834)
Q Consensus 410 g~~lylr~~ 418 (834)
+..+|||++
T Consensus 76 ~~~~yiKv~ 84 (84)
T cd01098 76 GGTLYLRLA 84 (84)
T ss_pred CcEEEEEeC
Confidence 567898874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=3.8e-11 Score=118.11 Aligned_cols=130 Identities=22% Similarity=0.142 Sum_probs=97.6
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceee-EEEEEEeCCeEEEEEEecCCCCcc
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR-ILGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~-l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
+.|+.|.++.||+++.. ++.+++|....... ....+..|+.++..+.+.++++ ++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 57899999999999854 78899999765432 2234678999999997655544 44433 33458999999998885
Q ss_pred hhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 598 VYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS--RLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 598 ~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
... .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 011245678999999999876 23469999999999999 67899999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.17 E-value=8.8e-11 Score=134.03 Aligned_cols=146 Identities=17% Similarity=0.212 Sum_probs=94.8
Q ss_pred cCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCccc----------------------------------HH---
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQG----------------------------------LK--- 554 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~----------------------------------~~--- 554 (834)
..|+. +.||+|++|+||+|++.+ |+.||||++++...+. .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999887 9999999987542110 01
Q ss_pred ---HHHHHHHHHhhcC----CCceeeEEEEEEe-CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHH-HHH
Q 003274 555 ---EFKNEMMLIAELQ----HRNLVRILGCCVE-QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIA-QGL 625 (834)
Q Consensus 555 ---~~~~E~~~l~~l~----H~niv~l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia-~gl 625 (834)
.|..|+..+.+++ +.+.+.+-.++.+ .++.+|||||++++.+.++..- .....+... ++...+ .-+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~~---la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMKL---LAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHHH---HHHHHHHHHH
Confidence 1344554444442 4444444344433 5678999999999999764211 111122111 222111 122
Q ss_pred HHHHhcCCCCeEecCCCCCCEEeccCC----CeeecccccceecCC
Q 003274 626 LYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGLARMFGG 667 (834)
Q Consensus 626 ~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGla~~~~~ 667 (834)
..++..+ ++|+|+||.||+++.++ .+++.|||++..+..
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3334455 99999999999999988 999999999987644
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.5e-09 Score=107.97 Aligned_cols=137 Identities=15% Similarity=0.124 Sum_probs=99.4
Q ss_pred cccccCCcEeEEEEEecC-------ccEEEEEEcccCC----------------------cccHHHH----HHHHHHHhh
Q 003274 519 CKLGEGGFGPVYKGRLFN-------GQEVAVKRLSSQS----------------------GQGLKEF----KNEMMLIAE 565 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~----------------------~~~~~~~----~~E~~~l~~ 565 (834)
..||.|--+.||.|...+ +..+|||+.+... ....+.+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999997543 4799999864210 0112223 379999999
Q ss_pred cCC--CceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCC
Q 003274 566 LQH--RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL-HQYSRLRIIHRDLK 642 (834)
Q Consensus 566 l~H--~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~L-H~~~~~~ivH~Dlk 642 (834)
+.. -++.+++++ ...+|||||+.+..+.... .+...++.+....+..+++.+|..| |..+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~---Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPK---LKDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchh---hhccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 953 456666654 4678999999876442211 1222345556677889999999999 7776 9999999
Q ss_pred CCCEEeccCCCeeecccccceecC
Q 003274 643 ASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 643 ~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
+.|||++ ++.+.|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 5789999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.2e-10 Score=123.47 Aligned_cols=166 Identities=19% Similarity=0.223 Sum_probs=124.0
Q ss_pred ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHH
Q 003274 534 LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEA 613 (834)
Q Consensus 534 ~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 613 (834)
..++.+|.|...+.......+..++-++.|+.++||||++++....+.+..|||+|-+.- |..++.+ +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH------hHHHH
Confidence 456788888888766554455677888899999999999999999999999999997643 3333321 22556
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCC
Q 003274 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693 (834)
Q Consensus 614 ~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 693 (834)
....+.||+.||.+||+.+ .++|++|.-..|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 6678899999999999766 599999999999999999999999999866432221 111111223455666443222
Q ss_pred CCccccchhhHHHHHHHhcC
Q 003274 694 FSIKSDVFSFGILMLETLSS 713 (834)
Q Consensus 694 ~t~~sDVwSlGvll~elltG 713 (834)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 456999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.3e-09 Score=112.13 Aligned_cols=142 Identities=20% Similarity=0.283 Sum_probs=111.2
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCC--CceeeEEEEEEeCC---eEEEEEEecC
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQH--RNLVRILGCCVEQG---EKILILEYMP 592 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~---~~~lV~Ey~~ 592 (834)
+.|+.|..+.||+++..+|+.+++|....... .....+..|++++..+++ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999877778999999765332 235678999999999975 44677777776543 5689999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS---------------------------------------- 632 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~---------------------------------------- 632 (834)
+.++...+.. ..++...+..++.++++.|+.||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765421 34677788888888999998888521
Q ss_pred -------------CCCeEecCCCCCCEEecc--CCCeeeccccccee
Q 003274 633 -------------RLRIIHRDLKASNVLLDK--DMNPKISDFGLARM 664 (834)
Q Consensus 633 -------------~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~ 664 (834)
+..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.6e-09 Score=100.07 Aligned_cols=131 Identities=20% Similarity=0.326 Sum_probs=101.6
Q ss_pred cccccCCcEeEEEEEecCccEEEEEE-cccCCcc-------cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKR-LSSQSGQ-------GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..+++|+-+.+|.+... |.++++|. +.+.-.. ..++.++|++++.+++--.|....-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999653 44566664 3222111 134578899999999766776666677788889999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+++..|.+.+... ...++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998887322 3567777888889999988 99999999999997765 99999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4e-10 Score=125.37 Aligned_cols=245 Identities=19% Similarity=0.210 Sum_probs=173.7
Q ss_pred hcCcccccccccCCcEeEEEEEe--cCccEEEEEEcccCCcccHHH--HHHHHHHHhhc-CCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL--FNGQEVAVKRLSSQSGQGLKE--FKNEMMLIAEL-QHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 586 (834)
+.+|.....||.|.|+.|++... .++..+++|.+.+.......+ -..|+.+...+ .|.+++++...+..-...++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 46788889999999999999763 467889999886643322221 23456555555 58999998888888778889
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeecccccceec
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~~~ 665 (834)
=-||++++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||....+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999987665 34456778888999999999999999887 9999999999999886 88899999998643
Q ss_pred CCCCccCCceeeeccCccc--CceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYM--SPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
.-.. .. ....-+++ +|+......+-.++|++|||.-+.|.+++......... ...+
T Consensus 418 ~~~~----~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------------~~~i 475 (524)
T KOG0601|consen 418 AFSS----GV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------------SLTI 475 (524)
T ss_pred ceec----cc-ccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------------ceee
Confidence 2111 11 12233344 55666677889999999999999999988764332111 0000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
..... ...+... ..+..+...++..++..||.+.+.....+
T Consensus 476 ~~~~~--p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 476 RSGDT--PNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ecccc--cCCCchH-HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 00000 0111111 45666777888999999999888765443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=2.7e-10 Score=132.66 Aligned_cols=250 Identities=18% Similarity=0.199 Sum_probs=171.5
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.-+++.+.+-+-+|.++.++-.+- ..|...++|..... .....+....+-.++-..+||-+++...-+.-....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 447788888899999999998752 22333344433221 11122333333333333456777766655566778899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
+++|+.+++|...|+. ....+.+.....+..+..++.|||... +.|+|++|.|+|+..++..++.|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 9999999999888743 234555556667777889999999875 8999999999999999999999998543221
Q ss_pred CC-------------------------Ccc----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCC
Q 003274 667 GD-------------------------ELQ----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNT 717 (834)
Q Consensus 667 ~~-------------------------~~~----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~ 717 (834)
.- ... .......||+.|.+||...+......+|.|++|++++|.++|.+|+
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 10 000 0122356899999999999999999999999999999999999998
Q ss_pred CCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHH
Q 003274 718 GVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMS 780 (834)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 780 (834)
.....+.. ...++...+.....+.....+..+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~--------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQI--------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhh--------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 64332210 11112222222233444566778888999999999997766
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=9.3e-09 Score=97.90 Aligned_cols=143 Identities=22% Similarity=0.318 Sum_probs=106.0
Q ss_pred cccccccCCcEeEEEEEecCccEEEEEE-cccCCc-------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKR-LSSQSG-------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~-------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
....|-+|+-+.|+++.. .|+...||. +.+..+ -..++.++|++++.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 346888999999999974 577777764 333221 12456788999999997667666666677777788999
Q ss_pred EecCC-CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC---Ceeeccccccee
Q 003274 589 EYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISDFGLARM 664 (834)
Q Consensus 589 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~ 664 (834)
||+++ .++..++....... ...+....++..|-+.+.-||..+ |+|+||.++||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 46777764332222 222333678899999999999988 99999999999997654 458999999854
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.3e-07 Score=99.56 Aligned_cols=140 Identities=19% Similarity=0.124 Sum_probs=100.3
Q ss_pred ccccCCcEeEEEEEecCccEEEEEEcccCCcc-----------cHHHHHHHHHHHhhcCCCc--eeeEEEEEEe-----C
Q 003274 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ-----------GLKEFKNEMMLIAELQHRN--LVRILGCCVE-----Q 581 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~-----~ 581 (834)
.+-+-....|++..+ +|+.+.||+....... ....+.+|.+.+.++...+ ..+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 343334445667654 6788999977443211 1124789999999985433 4455666543 2
Q ss_pred CeEEEEEEecCCC-CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-------CCC
Q 003274 582 GEKILILEYMPNK-SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-------DMN 653 (834)
Q Consensus 582 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-------~~~ 653 (834)
..-+||+|++++. +|.+++.+.. ....+...+..++.++++.++-||..+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3578999999986 7888763211 234556677889999999999999998 999999999999975 468
Q ss_pred eeeccccccee
Q 003274 654 PKISDFGLARM 664 (834)
Q Consensus 654 ~kl~DFGla~~ 664 (834)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.1e-07 Score=94.27 Aligned_cols=126 Identities=25% Similarity=0.272 Sum_probs=82.2
Q ss_pred eEEEEEecCccEEEEEEcccCC--------------c------------ccHHHHHHHHHHHhhcCCC--ceeeEEEEEE
Q 003274 528 PVYKGRLFNGQEVAVKRLSSQS--------------G------------QGLKEFKNEMMLIAELQHR--NLVRILGCCV 579 (834)
Q Consensus 528 ~Vy~~~~~~~~~vavK~l~~~~--------------~------------~~~~~~~~E~~~l~~l~H~--niv~l~~~~~ 579 (834)
.||.|...+|..+|||..+... . ......++|++.|.++..- ++.+++.+.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999864310 0 0123467899999999765 456666442
Q ss_pred eCCeEEEEEEecC--CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEecCCCCCCEEeccCCCeee
Q 003274 580 EQGEKILILEYMP--NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY-LHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (834)
Q Consensus 580 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~-LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 656 (834)
..+|||||++ +..+..+.. ..++.+....++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4579999998 555543321 111133455677777776665 46766 9999999999999988 9999
Q ss_pred cccccceecC
Q 003274 657 SDFGLARMFG 666 (834)
Q Consensus 657 ~DFGla~~~~ 666 (834)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.69 E-value=2.2e-07 Score=101.36 Aligned_cols=169 Identities=19% Similarity=0.260 Sum_probs=128.0
Q ss_pred cEeEEEEE-ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEEEEEEecCC-CCcchh
Q 003274 526 FGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKILILEYMPN-KSLDVY 599 (834)
Q Consensus 526 fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~Ey~~~-gsL~~~ 599 (834)
-.+.||+. -.+|..+++|+++....+.......-+++++++.|+|+|++..++.. +..+++||+|.++ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45788987 35799999999965544444344556788999999999999998873 4578999999975 455444
Q ss_pred cccc------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 600 LFDP------------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 600 l~~~------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
-+.. ......+++.++.++.|++.||.++|+.| +.-+-|.+++||++.+.+++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 3321 22334678899999999999999999998 88899999999999999999998888776654
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCC
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN 716 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p 716 (834)
+.... +. --.+-|.=.||.+++.|.+|...
T Consensus 446 d~~~~----------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPTEP----------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCcc----------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 33110 11 12456888999999999998644
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=6e-07 Score=95.51 Aligned_cols=262 Identities=16% Similarity=0.136 Sum_probs=157.5
Q ss_pred ccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEE----EE---eCCeEEEE
Q 003274 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGC----CV---EQGEKILI 587 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~----~~---~~~~~~lV 587 (834)
...+.||+|+-+.+|-.- +-.-.+.|++.........+ .+..|.+. .||-+-.-+.+ .. ++...-++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 445789999999999653 22233557776543332222 23334444 56644331111 11 11225567
Q ss_pred EEecCCCCcchhccc----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 588 LEYMPNKSLDVYLFD----PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
|..+.+.---..++. ........|.-+++.+..+|.+.+-||..| .+-+|+.++|+|+.+++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 777766532222222 222345789999999999999999999998 8999999999999999999999855443
Q ss_pred ecCCCCccCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcC-CCCCCCCCCC--ccccccchhhhh
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSS-RKNTGVYNTD--SFNLLGHAWDLW 735 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG-~~p~~~~~~~--~~~~~~~~~~~~ 735 (834)
...+.. ...-.+|...|.+||.-. +-.-+...|.|.|||+++|+|.| ++|+...... ...-.+ ..+
T Consensus 166 i~~ng~---~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~I 239 (637)
T COG4248 166 INANGT---LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDI 239 (637)
T ss_pred eccCCc---eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhh
Confidence 322211 111235788999999754 33456889999999999999987 8888654321 111100 001
Q ss_pred ccccccccccccc----ccCCCCHHH-HhHHHHHHHhcccc--CCCCCCCHHHHHHHHhcccC
Q 003274 736 KHERVHELMDPVI----LQDEIPLPM-LMRYVNVALLCVQE--NAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 736 ~~~~~~~~~~~~~----~~~~~~~~~-~~~l~~li~~cl~~--dP~~RPt~~evl~~L~~~~~ 791 (834)
..+.....-+... .....+... ...+..+..+|+.. ++.-||+++.++..|..+..
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1111111111000 012233332 34566677788865 46789999999888766543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.8e-07 Score=91.49 Aligned_cols=136 Identities=22% Similarity=0.221 Sum_probs=95.9
Q ss_pred cccccccccCCcEeEEEEEecCccEEEEEEcccC--------------------C--cccHHHHHHHHHHHhhcCCC--c
Q 003274 515 FSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--------------------S--GQGLKEFKNEMMLIAELQHR--N 570 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--------------------~--~~~~~~~~~E~~~l~~l~H~--n 570 (834)
..+..+||.|--+.||.|....|.++|||.=+.. + .-......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4456799999999999999989999999953211 0 01133467899999999644 6
Q ss_pred eeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc
Q 003274 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650 (834)
Q Consensus 571 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~ 650 (834)
+.+.+++ +...+||||+++-.|...- ++.+..-.++..|++-+.-+-..| |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 6666654 4567999999997663321 122233334444444444333445 999999999999999
Q ss_pred CCCeeecccccceec
Q 003274 651 DMNPKISDFGLARMF 665 (834)
Q Consensus 651 ~~~~kl~DFGla~~~ 665 (834)
||.+.++||--+...
T Consensus 238 dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 238 DGDIVVIDWPQAVPI 252 (304)
T ss_pred CCCEEEEeCcccccC
Confidence 999999999887654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=7.7e-07 Score=101.27 Aligned_cols=145 Identities=17% Similarity=0.218 Sum_probs=96.1
Q ss_pred CcccccccccCCcEeEEEEEecCccEEEEEEcccCCccc------------------------------HH---------
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG------------------------------LK--------- 554 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------------------~~--------- 554 (834)
.|+. +-|+.++-|.||+|++.+|+.||||+.++.-.+. .+
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 4443 5789999999999999999999999976532110 11
Q ss_pred -HHHHHHHHHhhcC-----CCceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHH-HHH
Q 003274 555 -EFKNEMMLIAELQ-----HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG-LLY 627 (834)
Q Consensus 555 -~~~~E~~~l~~l~-----H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g-l~~ 627 (834)
.+..|+.-+.+++ .+++.-..=|..-.++.+|+|||++|-.+.+.... +....+.+. ++..++++ +..
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k~---ia~~~~~~f~~q 280 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRKE---LAELLVRAFLRQ 280 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHHH---HHHHHHHHHHHH
Confidence 1344555555542 33333333333346788999999999999887532 223344333 33333332 122
Q ss_pred HHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 628 LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
+-..+ ++|.|..|.||+++.++.+.+.|||+...+..
T Consensus 281 ~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22234 99999999999999999999999999877644
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.3e-06 Score=88.91 Aligned_cols=107 Identities=24% Similarity=0.240 Sum_probs=85.0
Q ss_pred HHHHHHHHHHHhhcC--CCceeeEEEEEEeCC----eEEEEEEecCCC-CcchhcccccccCCCCHHHHHHHHHHHHHHH
Q 003274 553 LKEFKNEMMLIAELQ--HRNLVRILGCCVEQG----EKILILEYMPNK-SLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625 (834)
Q Consensus 553 ~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl 625 (834)
.....+|...+.++. .-...+.+++..... ..+||+|++++. +|.+++... ..++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHHH
Confidence 346788999888885 344566777766533 458999999884 788887431 1256677889999999999
Q ss_pred HHHHhcCCCCeEecCCCCCCEEeccCC---Ceeecccccceec
Q 003274 626 LYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISDFGLARMF 665 (834)
Q Consensus 626 ~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~~ 665 (834)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999998 99999999999999887 8999999988763
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.41 E-value=9.8e-08 Score=107.92 Aligned_cols=152 Identities=18% Similarity=0.299 Sum_probs=103.9
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC-cc-----C-CceeeeccCcccCceeec
Q 003274 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE-LQ-----G-NTKRIVGTYGYMSPEYAL 690 (834)
Q Consensus 618 ~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~-~~-----~-~~~~~~gt~~y~aPE~~~ 690 (834)
+.+++.||.|+|... ++||++|.|++|.++.++..||+.|+.+....... +. . ...-......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 344669999999865 69999999999999999999999999987654411 11 1 111123456899999999
Q ss_pred CCCCCccccchhhHHHHHHHhcCCCC-CCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhcc
Q 003274 691 DGLFSIKSDVFSFGILMLETLSSRKN-TGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCV 769 (834)
Q Consensus 691 ~~~~t~~sDVwSlGvll~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 769 (834)
+...+.++|+||+|+++|-+..|.++ +......... .. .....+.. ..........++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~----~~-------~~~~~~~~--~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY----SF-------SRNLLNAG--AFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh----hh-------hhcccccc--cccccccCcHHHHHHHHHHh
Confidence 99999999999999999999855544 3322211100 00 00000000 11122334567788888899
Q ss_pred ccCCCCCCCHHHHHH
Q 003274 770 QENAADRPTMSDVVS 784 (834)
Q Consensus 770 ~~dP~~RPt~~evl~ 784 (834)
..++..||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877754
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.40 E-value=2.5e-06 Score=77.54 Aligned_cols=100 Identities=27% Similarity=0.461 Sum_probs=69.2
Q ss_pred CeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEee-CCCCCCCCCCceEEEecCCceEEecCCCCeEEEEcccCC
Q 003274 38 EKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVA-NRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSD 116 (834)
Q Consensus 38 ~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~a-nr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~ 116 (834)
+.+.+.+|.+.|-|..+|+ |.| |+ ...+++|.+ +..... ...+.|.|+.||||||+|.++.++|+|. ..
T Consensus 12 ~p~~~~s~~~~L~l~~dGn-----Lvl-~~-~~~~~iWss~~t~~~~-~~~~~~~L~~~GNlvl~d~~~~~lW~Sf--~~ 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN-----LVL-YD-SNGSVIWSSNNTSGRG-NSGCYLVLQDDGNLVLYDSSGNVLWQSF--DY 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE-----EEE-EE-TTTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEEST--TS
T ss_pred cccccccccccceECCCCe-----EEE-Ec-CCCCEEEEecccCCcc-ccCeEEEEeCCCCEEEEeecceEEEeec--CC
Confidence 3555555899999999987 554 33 235779999 433332 1578999999999999999999999994 33
Q ss_pred CCCceEEEcc--CCCEEEecCCCCCccccceeeccCCCc
Q 003274 117 VKNPVAQLRD--DGNLVIRDNSSDSTAESYLWQSFDHPS 153 (834)
Q Consensus 117 ~~~~~~~l~d--~gnlvl~~~~~~~~~~~~~WqSFd~Pt 153 (834)
...+.+..++ +||++ +... ..+.|.|=+.|+
T Consensus 82 ptdt~L~~q~l~~~~~~-~~~~-----~~~sw~s~~dps 114 (114)
T PF01453_consen 82 PTDTLLPGQKLGDGNVT-GKND-----SLTSWSSNTDPS 114 (114)
T ss_dssp SS-EEEEEET--TSEEE-EEST-----SSEEEESS----
T ss_pred CccEEEeccCcccCCCc-cccc-----eEEeECCCCCCC
Confidence 4567778888 99999 6542 247898866663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=7.4e-06 Score=81.80 Aligned_cols=140 Identities=16% Similarity=0.161 Sum_probs=102.2
Q ss_pred ccccCCcEeEEEEEecCccEEEEEEcccCC------cccHHHHHHHHHHHhhcCC--CceeeEEEEEEeC----CeEEEE
Q 003274 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAELQH--RNLVRILGCCVEQ----GEKILI 587 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~----~~~~lV 587 (834)
--|+||-+-|++..+. |+.+-+|+-...- +-....|.+|+..|.+|.. -.+.+++...... -.-+||
T Consensus 25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEE
Confidence 3567888899987754 4478899865221 3356789999999999953 3345555222221 246899
Q ss_pred EEecCC-CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC--eeeccccccee
Q 003274 588 LEYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--PKISDFGLARM 664 (834)
Q Consensus 588 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGla~~ 664 (834)
+|-+++ -+|.+++.+. .....+...+..++.++++.++-||+.+ +.|+|+.++||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 5677666322 2234567778899999999999999998 999999999999986666 99999988765
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.29 E-value=2.1e-06 Score=78.35 Aligned_cols=87 Identities=26% Similarity=0.371 Sum_probs=60.8
Q ss_pred eEEEecCCceEEecCC-CCeEEEEcccCCCC-CceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccc
Q 003274 89 VLTISNNGNLVLLSQT-NGTIWSTNVSSDVK-NPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (834)
Q Consensus 89 ~l~~~~~g~l~l~~~~-~~~~w~~~~~~~~~-~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~ 166 (834)
.+.++.||+||+++.. +.+||++++..... ...++|+++|||||++..+ .++|+| +|-
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~S-----~t~---------- 82 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDG-----RVVWSS-----NTT---------- 82 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCC-----CEEEEe-----ccc----------
Confidence 4556789999999765 58999999864432 3678999999999998743 579987 111
Q ss_pred cCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEee
Q 003274 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCS 212 (834)
Q Consensus 167 ~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (834)
...|.+.+.|+.+|...++-.++ ...|.+
T Consensus 83 ----------------~~~~~~~~~L~ddGnlvl~~~~~-~~~W~S 111 (114)
T smart00108 83 ----------------GANGNYVLVLLDDGNLVIYDSDG-NFLWQS 111 (114)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCCC-CEEeCC
Confidence 12355777788888776554333 356654
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.26 E-value=1.7e-06 Score=72.90 Aligned_cols=60 Identities=38% Similarity=0.866 Sum_probs=48.7
Q ss_pred CceeEecccCCCCccccccccccChHHHHHHhhc-cCccccccccccCCCceEEEEc-cCccccC
Q 003274 340 TQFKKLDNVKAPDFINVSLNQSMNLEQCAAECLK-NCTCKAYANSNVTEGSGCLMWY-GDLLDSR 402 (834)
Q Consensus 340 ~~f~~~~~v~~pd~~~~~~~~~~s~~~C~~~Cl~-nCsC~A~~~~~~~~g~~c~~w~-~~l~~~~ 402 (834)
..|.+++++.+++..... ....++++|++.|++ +|+|.||+|.. ++.+|.+|. +.+.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~--~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN--GTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC--CCCEEEEeeCCccccce
Confidence 569999999999665433 356799999999999 99999999975 457899999 6665544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.9e-05 Score=81.35 Aligned_cols=133 Identities=17% Similarity=0.150 Sum_probs=86.1
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCc--eeeEEEEEEeCCeEEEEEEecCCCC-
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN--LVRILGCCVEQGEKILILEYMPNKS- 595 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey~~~gs- 595 (834)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+.+....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47999999999984 25567888876533 3355688999999986433 4667777777777889999999973
Q ss_pred cchhcccccccCCCCHHHHHHHHHHHHHH---------------------------------------HHHHHh-cCCCC
Q 003274 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQG---------------------------------------LLYLHQ-YSRLR 635 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~g---------------------------------------l~~LH~-~~~~~ 635 (834)
+...+.. +......++..+++. ..+|.. .....
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211100 001111111111111 122221 12345
Q ss_pred eEecCCCCCCEEeccCCCeeeccccccee
Q 003274 636 IIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 636 ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++|+|+.|.||++++++ +.|+||+.+..
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 78999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.8e-05 Score=78.67 Aligned_cols=154 Identities=18% Similarity=0.214 Sum_probs=104.3
Q ss_pred ccHHHHHHHhcCcccccc---cccCCcEeEEEEEecCccEEEEEEcccCCcc-------------------cH-----HH
Q 003274 503 FSLASVAAATENFSMQCK---LGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ-------------------GL-----KE 555 (834)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~---lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~-----~~ 555 (834)
.+...+....+...+.+. |..|.-+.||+|...++..+|||+++..... .. .-
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 445555555555555554 4577888999998888999999998542110 01 11
Q ss_pred HHHHHHHHhhcC--CCceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003274 556 FKNEMMLIAELQ--HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633 (834)
Q Consensus 556 ~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 633 (834)
..+|+.-|.++. +-.+.+.+++. +-.|||||+....+..- ..+...+..++...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP---~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAP---RLKDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCC---CcccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 355777777773 45555666553 34799999976522111 123333444467778888888888877633
Q ss_pred CCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 634 ~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
++||+||..-|||+. ++.+.|+|||-|....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 499999999999999 8999999999987654
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.5e-06 Score=75.78 Aligned_cols=87 Identities=24% Similarity=0.274 Sum_probs=60.7
Q ss_pred EEEec-CCceEEecCC-CCeEEEEcccCC-CCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccc
Q 003274 90 LTISN-NGNLVLLSQT-NGTIWSTNVSSD-VKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (834)
Q Consensus 90 l~~~~-~g~l~l~~~~-~~~~w~~~~~~~-~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~ 166 (834)
+.++. ||+||+++.. +.+||++|+... .....++|+++|||||++.++ .++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~S~~~--------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSG-----TVVWSSNTT--------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCC-----cEEEEeccc---------------
Confidence 44666 9999999765 589999998652 345678999999999998753 579987211
Q ss_pred cCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeec
Q 003274 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSG 213 (834)
Q Consensus 167 ~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
.+.+.+.+.|+.+|...++-.+ ....|.+.
T Consensus 84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf 113 (116)
T cd00028 84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSF 113 (116)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCC
Confidence 0235677778888777655443 34467654
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.07 E-value=2e-05 Score=89.52 Aligned_cols=141 Identities=19% Similarity=0.221 Sum_probs=92.2
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCccc-------------------------------------HHHHHHHHH
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQG-------------------------------------LKEFKNEMM 561 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~-------------------------------------~~~~~~E~~ 561 (834)
+.||.-+.|.||++++++|+.||||+-++.-++. .=.|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999875432111 001444554
Q ss_pred HHhhc----CCCce---eeEEEEE-EeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 003274 562 LIAEL----QHRNL---VRILGCC-VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633 (834)
Q Consensus 562 ~l~~l----~H~ni---v~l~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~ 633 (834)
-..+. +|-++ |.+=.++ .....++|+||||+|..+.+... .....++...+..-+.++..-+-+-
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~----- 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFK----- 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHh-----
Confidence 44443 35451 1122222 23457899999999999987743 2334455554443333322222222
Q ss_pred CCeEecCCCCCCEEecc----CCCeeecccccceecC
Q 003274 634 LRIIHRDLKASNVLLDK----DMNPKISDFGLARMFG 666 (834)
Q Consensus 634 ~~ivH~Dlk~~NILl~~----~~~~kl~DFGla~~~~ 666 (834)
.+++|.|=.|.||+++. ++.+.+-|||+...+.
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 24999999999999984 6789999999987654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.8e-05 Score=75.73 Aligned_cols=137 Identities=15% Similarity=0.180 Sum_probs=90.8
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHH---------HHHHHHHhhcCC---CceeeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEF---------KNEMMLIAELQH---RNLVRILGCCV 579 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~H---~niv~l~~~~~ 579 (834)
..+|...+++-......|.+-.. +|+.+++|..........+.| .+++..+.+++. -.+..++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 46777777777777777776664 578899998876543333332 234444444432 22223232322
Q ss_pred -----eCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCe
Q 003274 580 -----EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 580 -----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
.....+|+|||++|..|.++.. ++. .++..+++++.-||..| +.|+|..|.|++++.++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 2235679999999998866531 221 24466778899999998 99999999999998554 9
Q ss_pred eeccccccee
Q 003274 655 KISDFGLARM 664 (834)
Q Consensus 655 kl~DFGla~~ 664 (834)
+++||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.4e-05 Score=78.22 Aligned_cols=143 Identities=22% Similarity=0.221 Sum_probs=85.2
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCC--ceeeEEEEEEe---CCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR--NLVRILGCCVE---QGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~~~~---~~~~~lV~Ey~~~ 593 (834)
+.|+.|..+.||+....+ +.+++|..... .....+..|..++..+... .+.+++.+... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 578999999999999776 69999997543 4456788899999888533 35566664433 3356899999999
Q ss_pred CCcchh----------------cc---cc-cccCCCCHHH---------HHHH------------HHHHHH-HHHHHHh-
Q 003274 594 KSLDVY----------------LF---DP-IKKRLLDWEA---------RIRI------------IQGIAQ-GLLYLHQ- 630 (834)
Q Consensus 594 gsL~~~----------------l~---~~-~~~~~l~~~~---------~~~i------------~~~ia~-gl~~LH~- 630 (834)
..+... +. .. .....+.... .... ...+.+ .+..++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 988771 10 00 0000111000 0000 111222 2333332
Q ss_pred ---cCCCCeEecCCCCCCEEec-cCCCeeeccccccee
Q 003274 631 ---YSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARM 664 (834)
Q Consensus 631 ---~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~ 664 (834)
..+..++|+|+.+.|||++ +++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666668999998754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.97 E-value=1.4e-06 Score=97.41 Aligned_cols=184 Identities=15% Similarity=0.102 Sum_probs=131.6
Q ss_pred CcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCeEEEEEEecC
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN-LVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
-+...+..++|+++.++|.+-...+...++.+... ....-++++|.+++||| .++.++-+.......++++++.
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 33444678999999999997433444445655332 34566889999999999 6777777766777889999998
Q ss_pred CC--CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 593 NK--SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 593 ~g--sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
.+ +..... .....+...+...+...-++++++||+.. =+|+| ||+..+ +..|..||+....+....
T Consensus 318 ~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 318 TGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred CCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc-
Confidence 87 222111 11122333444556667788999999754 48998 777655 788999999987765433
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCC
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN 716 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p 716 (834)
..+...+|+.++|||+.....+..+.|+|++|+--.++--|-+|
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 23346789999999999999999999999999876666666555
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.4e-05 Score=78.13 Aligned_cols=141 Identities=16% Similarity=0.141 Sum_probs=86.0
Q ss_pred ccccCCc-EeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEecCCCCcc
Q 003274 520 KLGEGGF-GPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSLD 597 (834)
Q Consensus 520 ~lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~ 597 (834)
.|-.|.. ..||+.... +..+.||+..... ......|++++..+. +--+.+++++....+..++|||++++.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444555 788999754 4788889875432 345678999998884 444567777777666789999999998876
Q ss_pred hhcc-------------------ccc-ccCCCC--HHHHHHHH-H-------------------HHHHHHHHHHh----c
Q 003274 598 VYLF-------------------DPI-KKRLLD--WEARIRII-Q-------------------GIAQGLLYLHQ----Y 631 (834)
Q Consensus 598 ~~l~-------------------~~~-~~~~l~--~~~~~~i~-~-------------------~ia~gl~~LH~----~ 631 (834)
.... ... ...... ........ . .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 000 000000 00000000 0 01111222211 1
Q ss_pred CCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 632 ~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999988889999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.93 E-value=4.2e-05 Score=76.25 Aligned_cols=105 Identities=22% Similarity=0.220 Sum_probs=84.0
Q ss_pred HHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 003274 557 KNEMMLIAELQH-RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635 (834)
Q Consensus 557 ~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ 635 (834)
..|..+++.+++ +++.+++|+| ..++|.||...+++...-.....-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888999976 6999999999 34789999998866432100012234689999999999999999999865556
Q ss_pred eEecCCCCCCEEeccCCCeeecccccceec
Q 003274 636 IIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 636 ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887553
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00036 Score=85.91 Aligned_cols=79 Identities=18% Similarity=0.407 Sum_probs=58.2
Q ss_pred ccccccCCcEeEEEEEecCc---cEEEEEEcccCC-cccHHHHHHHHHHHhhcC-CCce--eeEEEEEEeC---CeEEEE
Q 003274 518 QCKLGEGGFGPVYKGRLFNG---QEVAVKRLSSQS-GQGLKEFKNEMMLIAELQ-HRNL--VRILGCCVEQ---GEKILI 587 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-H~ni--v~l~~~~~~~---~~~~lV 587 (834)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|++++..+. |.++ .+++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876554 467788764432 123456889999999995 6665 7778887664 467899
Q ss_pred EEecCCCCc
Q 003274 588 LEYMPNKSL 596 (834)
Q Consensus 588 ~Ey~~~gsL 596 (834)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00039 Score=69.67 Aligned_cols=136 Identities=17% Similarity=0.227 Sum_probs=92.2
Q ss_pred ccccccCCcEeEEEEEecCccEEEEEEcccCC----------------cccHHHHHHHHHHHhhcC------CCceeeEE
Q 003274 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS----------------GQGLKEFKNEMMLIAELQ------HRNLVRIL 575 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------H~niv~l~ 575 (834)
...||+|+.-.||.- ++.....||+..... ....+++.+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 458999999999964 566677888876554 223566777887777666 78899999
Q ss_pred EEEEeCCeEEEEEEecCC--CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-
Q 003274 576 GCCVEQGEKILILEYMPN--KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM- 652 (834)
Q Consensus 576 ~~~~~~~~~~lV~Ey~~~--gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~- 652 (834)
|...++...-+|+|.+.+ |++..-|.+......++. ...+. +-+-..||-+.+ |+.+|++|+||++....
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~~~~---L~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-ELRQA---LDEFKRYLLDHH---IVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HHHHH---HHHHHHHHHHcC---CeecCCCcccEEEEecCC
Confidence 999999999999998753 333222222223334444 33333 334445666655 99999999999996432
Q ss_pred ---Ceeecc-cccc
Q 003274 653 ---NPKISD-FGLA 662 (834)
Q Consensus 653 ---~~kl~D-FGla 662 (834)
.+.|+| ||-.
T Consensus 157 ~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 157 GEFRLVLIDGLGEK 170 (199)
T ss_pred CceEEEEEeCCCCc
Confidence 477776 4443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00062 Score=73.29 Aligned_cols=78 Identities=15% Similarity=0.126 Sum_probs=57.7
Q ss_pred ccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCC---CceeeEEEEEEe---CCeEEEEEE
Q 003274 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH---RNLVRILGCCVE---QGEKILILE 589 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H---~niv~l~~~~~~---~~~~~lV~E 589 (834)
...+.||.|..+.||+....++ .+.+|..+.. .....+..|++.|+.|.- ..+.++++++.. .+..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3456899999999999875555 4666774331 123578999999999843 467788888754 366899999
Q ss_pred ecCCCCc
Q 003274 590 YMPNKSL 596 (834)
Q Consensus 590 y~~~gsL 596 (834)
++++.++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00043 Score=71.95 Aligned_cols=74 Identities=12% Similarity=0.167 Sum_probs=46.5
Q ss_pred cccccCCcE-eEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCC---ceeeEEEEEEeC---CeEEEEEEec
Q 003274 519 CKLGEGGFG-PVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR---NLVRILGCCVEQ---GEKILILEYM 591 (834)
Q Consensus 519 ~~lG~G~fg-~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~~~---~~~~lV~Ey~ 591 (834)
+.|+.|+.. .||+. +..+++|..+.. .....+..|++++..+... -+.++++..... ...+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 457777666 48875 235777875432 2345788999999888532 233444433322 2348899999
Q ss_pred CCCCcch
Q 003274 592 PNKSLDV 598 (834)
Q Consensus 592 ~~gsL~~ 598 (834)
++.++..
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9988753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00057 Score=70.93 Aligned_cols=141 Identities=17% Similarity=0.195 Sum_probs=82.1
Q ss_pred cccccCCcEeEEEEEecC--ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEecCCCC
Q 003274 519 CKLGEGGFGPVYKGRLFN--GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
+.|..|-...+|+....+ ++.+++|......... -.-..|+.++..+....+ .++++.. + ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~-~---~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATF-Q---NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEe-C---CcEEEEeeCCCc
Confidence 467788888999998654 6788999876432221 223478888888854334 3444433 2 248999999987
Q ss_pred cchhc-----------------cccccc--------CCCC-HHHHHHHHH----------------------HHH---HH
Q 003274 596 LDVYL-----------------FDPIKK--------RLLD-WEARIRIIQ----------------------GIA---QG 624 (834)
Q Consensus 596 L~~~l-----------------~~~~~~--------~~l~-~~~~~~i~~----------------------~ia---~g 624 (834)
+.... +..... .... ++....+.. .+. ..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 63220 110000 0111 122111111 111 11
Q ss_pred H-HHHHhc-CCCCeEecCCCCCCEEecc-CCCeeeccccccee
Q 003274 625 L-LYLHQY-SRLRIIHRDLKASNVLLDK-DMNPKISDFGLARM 664 (834)
Q Consensus 625 l-~~LH~~-~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~ 664 (834)
| +.+... .+..++|+|+.+.|||++. ++.+.|+||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 112111 2346999999999999998 57899999998753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.00059 Score=65.56 Aligned_cols=130 Identities=21% Similarity=0.256 Sum_probs=88.0
Q ss_pred ccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCCC
Q 003274 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
...+.|++|.+|.||.|... |..+|+|+-... .....+..|+++|..++-.++-+=+..+- +-++.|||+.+-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcc
Confidence 34578999999999999854 558888886543 34577899999999998777655433332 3345599999988
Q ss_pred cchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC-CCCEEeccCCCeeeccccccee
Q 003274 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK-ASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk-~~NILl~~~~~~kl~DFGla~~ 664 (834)
|.+.-.. .+-+ -+..+++.-.-|...+ |-|+.|. |..++|-.+..+.|+||.-|+.
T Consensus 99 L~~~~~~------~~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG------GDRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc------ccHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8654311 0112 2233444434444444 8888874 5555666666999999999874
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0012 Score=65.58 Aligned_cols=125 Identities=26% Similarity=0.419 Sum_probs=90.2
Q ss_pred cCcccccccccCCc-EeEEEEEecCccEEEEEEccc---CC---------c---------ccHHHHHHHHHHHhhcC---
Q 003274 513 ENFSMQCKLGEGGF-GPVYKGRLFNGQEVAVKRLSS---QS---------G---------QGLKEFKNEMMLIAELQ--- 567 (834)
Q Consensus 513 ~~f~~~~~lG~G~f-g~Vy~~~~~~~~~vavK~l~~---~~---------~---------~~~~~~~~E~~~l~~l~--- 567 (834)
.+++..+.||.|.- |.|||+++ +|+.+|+|.+.. .. . .-...|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 99999997 467999999321 00 0 11346889999999985
Q ss_pred CCce--eeEEEEEEeCC------------------eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHH
Q 003274 568 HRNL--VRILGCCVEQG------------------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627 (834)
Q Consensus 568 H~ni--v~l~~~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~ 627 (834)
+.++ |+.+|+..-.. .+.||.||++... .+ ..+-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4456 89999974321 2356777665432 11 22345567788888
Q ss_pred HHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 628 LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99887 999999999986 4588999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00071 Score=71.32 Aligned_cols=139 Identities=15% Similarity=0.101 Sum_probs=80.1
Q ss_pred ccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEecCCCCcch
Q 003274 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYMPNKSLDV 598 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL~~ 598 (834)
.+..|-...+|+.. .+++.+++|..........-...+|.+++..+....+ .+++.... ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~-~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIE-HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEE-eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 45567788899887 4567888987654322211134779999998864433 33443332 368999999877643
Q ss_pred h-----------------ccccc-ccCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeEecCCCCCC
Q 003274 599 Y-----------------LFDPI-KKRLLDWEAR-IRIIQG---------IAQGLLYLHQY-----SRLRIIHRDLKASN 645 (834)
Q Consensus 599 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~gl~~LH~~-----~~~~ivH~Dlk~~N 645 (834)
. |+... ....++.... .....+ +.+.+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 01100 0111222211 111111 11112222111 12458999999999
Q ss_pred EEeccCCCeeeccccccee
Q 003274 646 VLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~ 664 (834)
|++++++ +.|+||+.+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0026 Score=68.58 Aligned_cols=143 Identities=19% Similarity=0.151 Sum_probs=87.1
Q ss_pred ccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCC--ceeeEEEE------EEeCCeEEEEEE
Q 003274 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR--NLVRILGC------CVEQGEKILILE 589 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~------~~~~~~~~lV~E 589 (834)
.+.|..|....+|+....+ ..+++|+... ...+....|++++..+.+. .+.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987544 4788898764 2345667788888888533 24444432 223456789999
Q ss_pred ecCCCCcchh----c----------ccccc--------cCCCCHHHHH----------HHHHHHHHHHHHHHh----cCC
Q 003274 590 YMPNKSLDVY----L----------FDPIK--------KRLLDWEARI----------RIIQGIAQGLLYLHQ----YSR 633 (834)
Q Consensus 590 y~~~gsL~~~----l----------~~~~~--------~~~l~~~~~~----------~i~~~ia~gl~~LH~----~~~ 633 (834)
|+++..+... . +.... .....|.... .....+...+.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9999876431 0 00000 0111221111 011123344445443 123
Q ss_pred CCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 634 ~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
..++|+|+.|.||+++++..+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999987789999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0024 Score=70.88 Aligned_cols=75 Identities=15% Similarity=0.208 Sum_probs=54.5
Q ss_pred cccccCCcEeEEEEEecCc-cEEEEEEcccC------C-cccHHHHHHHHHHHhhcC-C--CceeeEEEEEEeCCeEEEE
Q 003274 519 CKLGEGGFGPVYKGRLFNG-QEVAVKRLSSQ------S-GQGLKEFKNEMMLIAELQ-H--RNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV 587 (834)
+.||.|.+..||++...+| +.++||.-... . +...+++..|.+.|..+. + .++.+++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 58999985321 1 234567788888888873 2 346666666 33557899
Q ss_pred EEecCCCC
Q 003274 588 LEYMPNKS 595 (834)
Q Consensus 588 ~Ey~~~gs 595 (834)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0024 Score=77.07 Aligned_cols=196 Identities=18% Similarity=0.190 Sum_probs=133.8
Q ss_pred HHHHHHHHHhhcCCCceeeEEEEEEeCCeEE----EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh
Q 003274 555 EFKNEMMLIAELQHRNLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630 (834)
Q Consensus 555 ~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~ 630 (834)
...-|...+.++.|+|++.++.|-.+....- +..|++..-++...+ ..-..++.+..+.+..++.+|++|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHH
Confidence 3455777888889999999999987654333 334677776666655 344568888899999999999999998
Q ss_pred cCCCCeEecCCCCC---CEEeccCCCeeec--ccccceecCCCCccCCceeeeccCcccCceeecCCCCCcc--ccchhh
Q 003274 631 YSRLRIIHRDLKAS---NVLLDKDMNPKIS--DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIK--SDVFSF 703 (834)
Q Consensus 631 ~~~~~ivH~Dlk~~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~--sDVwSl 703 (834)
.. ..|.-+..+ +--.+.++.+.++ ||+..+.......... ..-+..+.|||.........+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHH
Confidence 75 555444443 4444566677777 8888877654332211 233557888888877766554 799999
Q ss_pred HHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHH
Q 003274 704 GILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 704 Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
|.++..+..|..+..... .+..+++.. ....+......|+..++++|+...+++
T Consensus 379 gll~~~~~~~~~i~~~~~-----------------~~~~~l~~~---------~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSA-----------------VPVSLLDVL---------STSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHHhhhhhcCccccccc-----------------chhhhhccc---------cchhhhhhhhhhcchhhhhccchhhhh
Confidence 999999998776532111 011111111 111556778899999999999999998
Q ss_pred HH
Q 003274 784 SM 785 (834)
Q Consensus 784 ~~ 785 (834)
..
T Consensus 433 ~~ 434 (1351)
T KOG1035|consen 433 TH 434 (1351)
T ss_pred hc
Confidence 75
|
|
| >PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.00067 Score=50.48 Aligned_cols=45 Identities=36% Similarity=0.627 Sum_probs=36.0
Q ss_pred cCCCCCCCCccccccccccCCCCCCCCC-CccccccceeeecccCC
Q 003274 790 HLNLPFPKKLTFVKGKNVKNSSYSTSGT-SEICSVNDVTVSLVSPR 834 (834)
Q Consensus 790 ~~~l~~p~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~~~~~~~~~ 834 (834)
...||.|++|.|+..+.......+++.. ...||+|++++|.++||
T Consensus 3 ~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~SvNevTiT~l~~R 48 (48)
T PF11883_consen 3 TATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSVNEVTITMLEAR 48 (48)
T ss_pred cccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCeeeEEEEeEecC
Confidence 3689999999999998876544333333 38999999999999998
|
; GO: 0004674 protein serine/threonine kinase activity |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0095 Score=64.95 Aligned_cols=142 Identities=19% Similarity=0.181 Sum_probs=78.8
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCC--ceeeEEE------EEEeCCeEEEEEEe
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR--NLVRILG------CCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~------~~~~~~~~~lV~Ey 590 (834)
+.|+.|....+|+....+| .+++|++... ..+....|+.++..|... .+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4567787789999886555 6888987521 223444566666666321 2333332 12235567899999
Q ss_pred cCCCCcchh--------------cccccc--------cCCCCH-HHHHH------------HH-HHHHHHHHHHHhc---
Q 003274 591 MPNKSLDVY--------------LFDPIK--------KRLLDW-EARIR------------II-QGIAQGLLYLHQY--- 631 (834)
Q Consensus 591 ~~~gsL~~~--------------l~~~~~--------~~~l~~-~~~~~------------i~-~~ia~gl~~LH~~--- 631 (834)
+++..+... ++.... ...+.| ..... .+ ..+...++.+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 999865311 010000 001111 11111 11 1111222333211
Q ss_pred -CCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 632 -SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 632 -~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
-+..++|+|+.+.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999766568999998753
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.0033 Score=67.98 Aligned_cols=141 Identities=25% Similarity=0.338 Sum_probs=83.8
Q ss_pred cccccCCcEeEEEEEecC-------ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEe
Q 003274 519 CKLGEGGFGPVYKGRLFN-------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey 590 (834)
+.|..|--..+|+....+ ++.+++|+...... .......|.+++..+....+ .++++++. + .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence 356667777899987654 57899999765432 22345778888888853333 34555543 2 358999
Q ss_pred cCCCCcchh-c----------------ccccccC------CCC--HHHHHH--------------------------HHH
Q 003274 591 MPNKSLDVY-L----------------FDPIKKR------LLD--WEARIR--------------------------IIQ 619 (834)
Q Consensus 591 ~~~gsL~~~-l----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 619 (834)
+++..+... + +...... ..+ +....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998877432 1 1100000 010 111101 111
Q ss_pred HHHHHHHHHHh------cCCCCeEecCCCCCCEEeccC----CCeeeccccccee
Q 003274 620 GIAQGLLYLHQ------YSRLRIIHRDLKASNVLLDKD----MNPKISDFGLARM 664 (834)
Q Consensus 620 ~ia~gl~~LH~------~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGla~~ 664 (834)
.+.+-+..|.. ..+..++|+|+.+.|||++.+ +.++++||..+..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22233334432 244579999999999999985 8899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.023 Score=61.58 Aligned_cols=144 Identities=20% Similarity=0.202 Sum_probs=83.6
Q ss_pred ccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCC--ceeeEEEE------EEeCCeEEEEEE
Q 003274 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR--NLVRILGC------CVEQGEKILILE 589 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~------~~~~~~~~lV~E 589 (834)
.+.++.|....+|+....++ .+++|+..... ..+....|++++..|... .+.+++.. ....+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 35677777789999875544 67788765422 234456677777777422 23444332 122456789999
Q ss_pred ecCCCCcchh--------------ccccccc---------CCCCHHHHH------------HHHHHHHHHHHHHHh----
Q 003274 590 YMPNKSLDVY--------------LFDPIKK---------RLLDWEARI------------RIIQGIAQGLLYLHQ---- 630 (834)
Q Consensus 590 y~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~------------~i~~~ia~gl~~LH~---- 630 (834)
|++|..+... ++..... ....|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 9998665311 0110000 001111110 011123344555532
Q ss_pred cCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 631 ~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
..+..++|+|+.+.||+++.++...|+||+.+..
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 2235699999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0079 Score=64.07 Aligned_cols=75 Identities=17% Similarity=0.226 Sum_probs=49.8
Q ss_pred ccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEEEEecC
Q 003274 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
+..+.|+.|....+|+.+ .+++.+.||.-. ......|..|++-|+.|. -..+.+++++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 344678889999999987 678889999865 234467889999998883 3457788888887778899999998
Q ss_pred CC
Q 003274 593 NK 594 (834)
Q Consensus 593 ~g 594 (834)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.015 Score=64.13 Aligned_cols=140 Identities=18% Similarity=0.259 Sum_probs=82.7
Q ss_pred ccccCCcEeEEEEEecC-----ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCcee-eEEEEEEeCCeEEEEEEecCC
Q 003274 520 KLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
.|-.|-.-.+|+....+ ++.+++|...........+ .+|..++..+..-++. ++++.+.. + .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 45457777889886432 3688999886654443333 7799999988544443 45555533 2 58999987
Q ss_pred CCcchh-c----------------cccc-c--cCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh-c
Q 003274 594 KSLDVY-L----------------FDPI-K--KRLLDWEARIRIIQGI-----------------AQGLLYL----HQ-Y 631 (834)
Q Consensus 594 gsL~~~-l----------------~~~~-~--~~~l~~~~~~~i~~~i-----------------a~gl~~L----H~-~ 631 (834)
.+|... + |... . .....+++..++..++ ...+..| .. .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 776422 1 1100 0 0011223332332211 1112222 21 2
Q ss_pred CCCCeEecCCCCCCEEecc-CCCeeeccccccee
Q 003274 632 SRLRIIHRDLKASNVLLDK-DMNPKISDFGLARM 664 (834)
Q Consensus 632 ~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~ 664 (834)
.+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 2346899999999999986 47899999998754
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.002 Score=53.39 Aligned_cols=52 Identities=19% Similarity=0.334 Sum_probs=37.2
Q ss_pred eEecccCCCCccccccccccChHHHHHHhhccCccccccccccCCCceEEEEccC
Q 003274 343 KKLDNVKAPDFINVSLNQSMNLEQCAAECLKNCTCKAYANSNVTEGSGCLMWYGD 397 (834)
Q Consensus 343 ~~~~~v~~pd~~~~~~~~~~s~~~C~~~Cl~nCsC~A~~~~~~~~g~~c~~w~~~ 397 (834)
..+.++.++.+..... ...+.++|+..|+.+|+|.||.|.. +...|+++.+.
T Consensus 7 ~~~~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~--~~~~C~lk~~~ 58 (73)
T cd01100 7 RQGSNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT--KSKKCFLKSSE 58 (73)
T ss_pred cccCCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC--CCCeEEcccCC
Confidence 3445666665543332 3569999999999999999999973 34679886664
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.025 Score=60.69 Aligned_cols=136 Identities=19% Similarity=0.260 Sum_probs=82.5
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEccc--CCcccHHHHHHHHHHHhhcCC--CceeeEEEEEEeCC--eEEEEEEecC
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSS--QSGQGLKEFKNEMMLIAELQH--RNLVRILGCCVEQG--EKILILEYMP 592 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~--~~~lV~Ey~~ 592 (834)
+.+..|---.+|.... .++++++. ... ..........+|+++|+.+.- .-+.+.+++|.++. ..+.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 3443333333444432 37788888 321 222344556778888888743 23445567777665 7799999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHH-HHHHHHHHHHHh-----------------------------------------
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLHQ----------------------------------------- 630 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~gl~~LH~----------------------------------------- 630 (834)
+..+...+.... .. .+++ ..+++.|+-||+
T Consensus 109 Ge~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 109 GEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred ceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 865433321100 00 1111 234444444442
Q ss_pred ---------c-----CCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 631 ---------Y-----SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 631 ---------~-----~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+ ++..++|+|+.+.||+++.+..+-|.||+++..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 2 235699999999999999998899999999875
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.019 Score=61.54 Aligned_cols=142 Identities=18% Similarity=0.189 Sum_probs=98.8
Q ss_pred ccccccccCCcEeEEEEEecCccEEEEEEcccCC---------------------cc-cH----HHHHHHHHHHhhcCCC
Q 003274 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS---------------------GQ-GL----KEFKNEMMLIAELQHR 569 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---------------------~~-~~----~~~~~E~~~l~~l~H~ 569 (834)
.+...|..|--+.||.+.-.+|..+|||+++-.. .. .. --...|++-|.+|+..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 3446788899999999998899999999874210 00 01 1134578888887654
Q ss_pred ceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec
Q 003274 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (834)
Q Consensus 570 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~ 649 (834)
.|.-.--... ...+|||+|+....... -..+...++...+..+-+++++-|.-|-+.+ ++||.||.--|+|+
T Consensus 227 GIP~PePIlL--k~hVLVM~FlGrdgw~a---PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly- 298 (520)
T KOG2270|consen 227 GIPCPEPILL--KNHVLVMEFLGRDGWAA---PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY- 298 (520)
T ss_pred CCCCCCceee--ecceEeeeeccCCCCcC---cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-
Confidence 4332211111 13479999997544322 2234556777788888899999999998877 59999999999998
Q ss_pred cCCCeeecccccceec
Q 003274 650 KDMNPKISDFGLARMF 665 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~ 665 (834)
.+|.+.|+|-+-+...
T Consensus 299 hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEH 314 (520)
T ss_pred ECCEEEEEEccccccC
Confidence 5678999998877654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.024 Score=60.25 Aligned_cols=31 Identities=26% Similarity=0.538 Sum_probs=25.9
Q ss_pred CCeEecCCCCCCEEeccCCC-eeeccccccee
Q 003274 634 LRIIHRDLKASNVLLDKDMN-PKISDFGLARM 664 (834)
Q Consensus 634 ~~ivH~Dlk~~NILl~~~~~-~kl~DFGla~~ 664 (834)
..++|+|+++.|||++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999999864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.03 E-value=0.047 Score=59.53 Aligned_cols=73 Identities=18% Similarity=0.239 Sum_probs=48.6
Q ss_pred ccccCCcEeEEEEEecCc-cEEEEEEccc-------CCcccHHHHHHHHHHHhhcC--CCcee-eEEEEEEeCCeEEEEE
Q 003274 520 KLGEGGFGPVYKGRLFNG-QEVAVKRLSS-------QSGQGLKEFKNEMMLIAELQ--HRNLV-RILGCCVEQGEKILIL 588 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~~-~~vavK~l~~-------~~~~~~~~~~~E~~~l~~l~--H~niv-~l~~~~~~~~~~~lV~ 588 (834)
.||.|....||++...+| +.|+||.-.. .-+-..++..-|.+.|.... -|..| +++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999997654 5899996431 12334566677888887663 34444 34433 444567999
Q ss_pred EecCCC
Q 003274 589 EYMPNK 594 (834)
Q Consensus 589 Ey~~~g 594 (834)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.011 Score=62.14 Aligned_cols=135 Identities=15% Similarity=0.122 Sum_probs=90.8
Q ss_pred CcccccccccCCcEeEEEEEecCccEEEEEEcccC--------------------Ccc--cHHHHHHHHHHHhhcC-CC-
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--------------------SGQ--GLKEFKNEMMLIAELQ-HR- 569 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--------------------~~~--~~~~~~~E~~~l~~l~-H~- 569 (834)
-+.+.+.||-|.-+.||.+-..+|++.++|.-... ++. +.-...+|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46678899999999999999888999998842110 000 1123466888888884 32
Q ss_pred ceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec
Q 003274 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (834)
Q Consensus 570 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~ 649 (834)
-+.+.+++ +..++|||++.+-.|...- ...+...+..- +..-+--|..+| +||+|..--||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~---lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDD---LMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHH---HHHHHHHHHHcC---ceecccchheeEEe
Confidence 24444544 4568999999887774332 22333333332 222333444455 99999999999999
Q ss_pred cCCCeeeccccccee
Q 003274 650 KDMNPKISDFGLARM 664 (834)
Q Consensus 650 ~~~~~kl~DFGla~~ 664 (834)
+++.++++||--...
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999987544
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.021 Score=58.12 Aligned_cols=31 Identities=39% Similarity=0.582 Sum_probs=22.2
Q ss_pred CCeEecCCCCCCEEe-ccCCCeeeccccccee
Q 003274 634 LRIIHRDLKASNVLL-DKDMNPKISDFGLARM 664 (834)
Q Consensus 634 ~~ivH~Dlk~~NILl-~~~~~~kl~DFGla~~ 664 (834)
..++|+||.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8899999999999864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.71 E-value=0.067 Score=58.57 Aligned_cols=140 Identities=15% Similarity=0.237 Sum_probs=79.9
Q ss_pred ccccCCcEeEEEEEecC----ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEecCCC
Q 003274 520 KLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
.|..|---.+|+....+ +..+++|+.......... -.+|..++..+..-++ .++++++. .+ +|.||+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~Id-R~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVID-RERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEec-hHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 45446667788886443 237889988665433322 2678889998865555 35555553 22 589999777
Q ss_pred Ccchh-------c----------cccc-c--cCCCCHHHHHHHHHHH----------------------HHHHHH----H
Q 003274 595 SLDVY-------L----------FDPI-K--KRLLDWEARIRIIQGI----------------------AQGLLY----L 628 (834)
Q Consensus 595 sL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~~i----------------------a~gl~~----L 628 (834)
.|..- + |... . .....+....++..++ .+-+.. +
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 66321 0 1100 0 0011223222222211 111111 1
Q ss_pred Hh-cCCCCeEecCCCCCCEEecc-CCCeeeccccccee
Q 003274 629 HQ-YSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARM 664 (834)
Q Consensus 629 H~-~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~ 664 (834)
.. ..+..++|+|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 12335899999999999975 57899999998754
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.62 E-value=0.15 Score=56.72 Aligned_cols=73 Identities=11% Similarity=0.072 Sum_probs=50.7
Q ss_pred ccccccCCcEeEEEEEecCccEEEEEEcccCC-------cccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEE
Q 003274 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS-------GQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV 587 (834)
.+.||.|....||+... .++.++||+-.... +....+-..|++.|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46789999999999885 45679999764211 123444455677776663 246777888877 446789
Q ss_pred EEecCC
Q 003274 588 LEYMPN 593 (834)
Q Consensus 588 ~Ey~~~ 593 (834)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 834 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-48 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-41 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-23 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-23 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-21 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-21 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-21 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-20 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-20 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-20 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-20 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-20 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-20 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 9e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-19 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-19 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-19 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-19 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-18 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-18 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-18 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-18 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-18 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-18 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-18 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-18 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-18 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-18 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-18 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-18 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-18 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-17 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-17 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-17 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-17 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-17 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 6e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-17 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-17 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 8e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-17 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 9e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 9e-17 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-17 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-16 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-16 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 5e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 5e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-16 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 9e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-14 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-14 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-13 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-13 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-13 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 7e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-13 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-13 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 8e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-13 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-13 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-12 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-12 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-12 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 7e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 9e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-11 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 9e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 9e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 4e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 8e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 9e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 401 bits (1034), Expect = e-134
Identities = 117/313 (37%), Positives = 180/313 (57%), Gaps = 7/313 (2%)
Query: 484 FGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVK 543
F +V + + L FSL + A++NFS + LG GGFG VYKGRL +G VAVK
Sbjct: 1 FFDVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK 60
Query: 544 RLSSQSGQGLK-EFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602
RL + QG + +F+ E+ +I+ HRNL+R+ G C+ E++L+ YM N S+ L +
Sbjct: 61 RLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 603 PIKKRL-LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661
+ + LDW R RI G A+GL YLH + +IIHRD+KA+N+LLD++ + DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNT---G 718
A++ + T + GT G+++PEY G S K+DVF +G+++LE ++ ++
Sbjct: 181 AKLMDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 719 VYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT 778
+ N D LL L K +++ L+D LQ + + + VALLC Q + +RP
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVDVD-LQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
Query: 779 MSDVVSMISNEHL 791
MS+VV M+ + L
Sbjct: 299 MSEVVRMLEGDGL 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-133
Identities = 100/305 (32%), Positives = 156/305 (51%), Gaps = 19/305 (6%)
Query: 494 KGKDSWLPLFSLASVAAATENFSMQC------KLGEGGFGPVYKGRLFNGQEVAVKRLSS 547
+ D+ FS + T NF + K+GEGGFG VYKG + N VAVK+L++
Sbjct: 6 EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAA 64
Query: 548 ----QSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP 603
+ + ++F E+ ++A+ QH NLV +LG + + L+ YMPN SL L
Sbjct: 65 MVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124
Query: 604 IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663
L W R +I QG A G+ +LH+ IHRD+K++N+LLD+ KISDFGLAR
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD 723
T RIVGT YM+PE L G + KSD++SFG+++LE ++ + +
Sbjct: 182 ASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD-EHRE 239
Query: 724 SFNLLGHAWDLWKHER-VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDV 782
LL ++ E+ + + +D + ++ + +VA C+ E RP + V
Sbjct: 240 PQLLLDIKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKV 297
Query: 783 VSMIS 787
++
Sbjct: 298 QQLLQ 302
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 361 bits (928), Expect = e-118
Identities = 102/286 (35%), Positives = 169/286 (59%), Gaps = 6/286 (2%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMML 562
L + AT NF + +G G FG VYKG L +G +VA+KR + +S QG++EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL-LDWEARIRIIQGI 621
++ +H +LV ++G C E+ E ILI +YM N +L +L+ + + WE R+ I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
A+GL YLH + IIHRD+K+ N+LLD++ PKI+DFG+++ + + + GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN-TDSFNLLGHAWDLWKHERV 740
GY+ PEY + G + KSDV+SFG+++ E L +R + NL A + + ++
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265
Query: 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
+++DP L D+I L ++ + A+ C+ ++ DRP+M DV+ +
Sbjct: 266 EQIVDPN-LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 1e-93
Identities = 71/309 (22%), Positives = 125/309 (40%), Gaps = 30/309 (9%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMML 562
++ + + G FG V+K + + VAVK Q Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 563 IAELQHRNLVRILGCCVE----QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
+ ++H N+++ +G + LI + SL +L K ++ W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 619 QGIAQGLLYLHQ-------YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
+ +A+GL YLH+ + I HRD+K+ NVLL ++ I+DFGLA F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 672 GNTKRIVGTYGYMSPEYALDGL-----FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN 726
G+T VGT YM+PE + ++ D+++ G+++ E L+SR D +
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE-LASRCTAADGPVDEYM 246
Query: 727 LLGHAW-------DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTM 779
L + + VH+ PV+ + C +A R +
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 780 SDVVSMISN 788
V I+
Sbjct: 307 GCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 7e-80
Identities = 74/332 (22%), Positives = 130/332 (39%), Gaps = 41/332 (12%)
Query: 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMML 562
+ + + +N + +G G +G VYKG L + + VAVK S + Q K +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NIYR 60
Query: 563 IAELQHRNLVRILGCCVE-----QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRI 617
+ ++H N+ R + + E +L++EY PN SL YL DW + R+
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRL 116
Query: 618 IQGIAQGLLYLHQ------YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG---- 667
+ +GL YLH + + I HRDL + NVL+ D ISDFGL+ G
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
Query: 668 --DELQGNTKRIVGTYGYMSPEYALDGLFSI--------KSDVFSFGILMLETLSSRKNT 717
E VGT YM+PE L+G ++ + D+++ G++ E +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 718 GVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD---EIP------LPMLMRYVNVALLC 768
+ + ++ H ++ V + + P + C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 769 VQENAADRPTMSDVVSMISNEHLNLPFPKKLT 800
++A R T ++ + K ++
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVS 327
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-64
Identities = 78/323 (24%), Positives = 139/323 (43%), Gaps = 36/323 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ ++ +G G FG V K + + ++VA+K++ S+S K F E+ ++ + H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK-WRAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNIV 64
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C+ L++EY SL L + +QG+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 633 RLRIIHRDLKASNVLLDKDMN-PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+IHRDLK N+LL KI DFG A ++Q + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
+S K DVFS+GI++ E ++ RK ++ W + R P ++++
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK---PFDEIGGPAFRIMWAVHNGTR------PPLIKN 228
Query: 752 EIPLPM--LMRYVNVALLCVQENAADRPTMSDVVSM-------ISNEHLNLPFPKKLTFV 802
+P P+ LM C ++ + RP+M ++V + L +P + +
Sbjct: 229 -LPKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLP 281
Query: 803 KGKNVKNSSYSTSGTSEICSVND 825
G++ + Y D
Sbjct: 282 PGEDGRVEPYVDFAEFYRLWSVD 304
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 9e-64
Identities = 72/279 (25%), Positives = 134/279 (48%), Gaps = 27/279 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRN 570
+ +++ K+G G FG V++ ++G +VAVK L Q + + EF E+ ++ L+H N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V +G + ++ EY+ SL L + LD R+ + +A+G+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN 155
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
I+HR+LK+ N+L+DK K+ DFGL+R+ L +K GT +M+PE
Sbjct: 156 -RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLR 212
Query: 691 DGLFSIKSDVFSFGILMLETLSSRK-NTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
D + KSDV+SFG+++ E + ++ + +G K +R I
Sbjct: 213 DEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-----KCKR------LEIP 261
Query: 750 QDEIPLPM--LMRYVNVALLCVQENAADRPTMSDVVSMI 786
++ + + ++ C RP+ + ++ ++
Sbjct: 262 RN-LNPQVAAIIEG------CWTNEPWKRPSFATIMDLL 293
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 2e-61
Identities = 70/297 (23%), Positives = 119/297 (40%), Gaps = 36/297 (12%)
Query: 520 KLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
LG+G FG K G+ + +K L + + F E+ ++ L+H N+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+ I EY+ +L + W R+ + IA G+ YLH + IIH
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHS---MNIIH 131
Query: 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR------------IVGTYGYMSP 686
RDL + N L+ ++ N ++DFGLAR+ ++ Q R +VG +M+P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746
E + K DVFSFGI++ E + R N G V +D
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCE-IIGRVNADPDYLPRTMDFGLN--------VRGFLDR 242
Query: 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS----MISNEHLNLPFPKKL 799
P + + + C + RP+ + + + +LP +L
Sbjct: 243 -----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQL 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 5e-60
Identities = 72/279 (25%), Positives = 124/279 (44%), Gaps = 38/279 (13%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRL----SSQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
+G GGFG VY+ + G EVAVK Q ++ + E L A L+H N++ +
Sbjct: 14 IIGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
G C+++ L++E+ L+ L + + + + IA+G+ YLH + +
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 636 IIHRDLKASNVLLDKDMNP--------KISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
IIHRDLK+SN+L+ + + KI+DFGLAR + G Y +M+PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAPE 184
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD-LWKHERVHELMDP 746
+FS SDV+S+G+L+ E L+ + + L A+ +
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEV---PF--RGIDGLAVAYGVAMNKLAL------ 233
Query: 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785
IP + + C + RP+ ++++
Sbjct: 234 -----PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 2e-59
Identities = 71/290 (24%), Positives = 133/290 (45%), Gaps = 40/290 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQG-------LKEFKNEMMLIA 564
+ ++G+GGFG V+KGRL + VA+K L +G +EF+ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
L H N+V++ G +++E++P L L D K + W ++R++ IA G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDK-----DMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ Y+ I+HRDL++ N+ L + K++DFGL++ + + ++G
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLG 188
Query: 680 TYGYMSPE--YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD-LWK 736
+ +M+PE A + ++ K+D +SF +++ L+ ++ S+ + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---PFDEYSYGKIKFINMIREE 245
Query: 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
R P IP R NV LC + RP S +V +
Sbjct: 246 GLR------P-----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 6e-59
Identities = 60/285 (21%), Positives = 115/285 (40%), Gaps = 40/285 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRN 570
+ + KL E G ++KGR + G ++ VK L + S + ++F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 571 LVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++ +LG C I +MP SL L + ++D ++ +A+G+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H L I L + +V++D+DM +IS + F + + +++PE
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPE- 178
Query: 689 ALDG----LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
AL +D++SF +L+ E ++ + E+
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTRE------------------VPFADLSNMEIG 220
Query: 745 DPVILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
V L+ IP + + +C+ E+ A RP +V ++
Sbjct: 221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-58
Identities = 75/282 (26%), Positives = 136/282 (48%), Gaps = 30/282 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRN 570
++ ++G G FG VYKG+ ++G +VAVK L+ + Q L+ FKNE+ ++ + +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK-WHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
++ +G I + ++ SL +L + + + I I + A+G+ YLH
Sbjct: 82 ILLFMGYSTAPQLAI-VTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA 138
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE--- 687
IIHRDLK++N+ L +D KI DFGLA +++ G+ +M+PE
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRK-NTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746
+S +SDV++FGI++ E ++ + + + N D + R D
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--------IEMVGRGSLSPDL 247
Query: 747 VILQDEIPLPM--LMRYVNVALLCVQENAADRPTMSDVVSMI 786
++ P M LM C+++ +RP+ +++ I
Sbjct: 248 SKVRSNCPKRMKRLMA------ECLKKKRDERPSFPRILAEI 283
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 5e-57
Identities = 69/301 (22%), Positives = 128/301 (42%), Gaps = 32/301 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAELQHR 569
+ ++ +G+G +G V++G + G+ VAVK SS+ K + E + L+H
Sbjct: 7 ARDITLLECVGKGRYGEVWRGS-WQGENVAVKIFSSRD---EKSWFRETELYNTVMLRHE 62
Query: 570 NLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
N++ + + LI Y SL +D ++ LD + +RI+ IA GL
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGL 118
Query: 626 LYLH-----QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIV 678
+LH + I HRDLK+ N+L+ K+ I+D GLA M ++L V
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 679 GTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS---FNLLG 729
GT YM+PE + D+++FG+++ E + G+ ++++
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 730 H--AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
+ +++ + + P I P L + C +N + R T + ++
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
Query: 788 N 788
Sbjct: 299 K 299
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 8e-57
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 41/283 (14%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGC 577
+G+G FG VY GR ++G EVA++ + + + LK FK E+M + +H N+V +G
Sbjct: 40 LIGKGRFGQVYHGR-WHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRII 637
C+ +I ++L + D K +LD +I Q I +G+ YLH I+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHA---KGIL 152
Query: 638 HRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI---VGTYGYMSPE------- 687
H+DLK+ NV D + I+DFGL + G + ++ G +++PE
Sbjct: 153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 688 --YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
FS SDVF+ G + E + + W + +
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELH-----AREWPFKTQPAEAIIWQMGTGMK------ 260
Query: 746 PVILQDEIPLPM--LMRYVNVALLCVQENAADRPTMSDVVSMI 786
P + Q + + ++ + C +RPT + ++ M+
Sbjct: 261 PNLSQIGMGKEISDILLF------CWAFEQEERPTFTKLMDML 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 70/301 (23%), Positives = 127/301 (42%), Gaps = 34/301 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNE--MMLIAELQHRN 570
+ M ++G+G +G V+ G+ + G++VAVK + + E + ++H N
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGK-WRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHEN 92
Query: 571 LVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
++ + ++ LI +Y N SL +D +K LD ++ +++ GL
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLC 148
Query: 627 YLH-----QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVG 679
+LH + I HRDLK+ N+L+ K+ I+D GLA F +E+ VG
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208
Query: 680 TYGYMSPEYALDGL-------FSIKSDVFSFGILMLETLSSRKNTGV---YNTDSFNLLG 729
T YM PE LD I +D++SFG+++ E + G+ Y +L+
Sbjct: 209 TKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 730 H--AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
+++ + + + P L + + C N A R T V ++
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 788 N 788
Sbjct: 328 K 328
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 2e-54
Identities = 82/327 (25%), Positives = 136/327 (41%), Gaps = 43/327 (13%)
Query: 490 DGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS 549
D G S LPL ++A +Q +G+G FG V++G+ + G+EVAVK SS+
Sbjct: 22 DMTTSGSGSGLPLLVQRTIA---RTIVLQESIGKGRFGEVWRGK-WRGEEVAVKIFSSRE 77
Query: 550 GQGLKEFKNE--MMLIAELQHRNLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDP 603
+ + E + L+H N++ + + L+ +Y + SL FD
Sbjct: 78 ---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDY 130
Query: 604 IKKRLLDWEARIRIIQGIAQGLLYLHQ-----YSRLRIIHRDLKASNVLLDKDMNPKISD 658
+ + + E I++ A GL +LH + I HRDLK+ N+L+ K+ I+D
Sbjct: 131 LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 190
Query: 659 FGLARMF--GGDELQGNTKRIVGTYGYMSPEYALDGL-------FSIKSDVFSFGILMLE 709
GLA D + VGT YM+PE LD ++D+++ G++ E
Sbjct: 191 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 710 TLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD---EIP-----LPMLMRY 761
++ R + G + + L + + V E+ V Q IP L
Sbjct: 250 -IARRCSIG-GIHEDYQLPYYDL-VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 306
Query: 762 VNVALLCVQENAADRPTMSDVVSMISN 788
+ C N A R T + +S
Sbjct: 307 AKIMRECWYANGAARLTALRIKKTLSQ 333
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 2e-50
Identities = 68/286 (23%), Positives = 118/286 (41%), Gaps = 38/286 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRN 570
E+ + ++G G FG V+ GRL + VAVK + +F E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+VR++G C ++ +++E + +L + L + ++++ A G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEY 688
IHRDL A N L+ + KISDFG++R G +++ + +PE
Sbjct: 232 ---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQV--PVKWTAPEA 286
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHE 742
G +S +SDV+SFGIL+ ET S + + N + + L + V
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
LM C RP+ S + + +
Sbjct: 347 LM---------------------EQCWAYEPGQRPSFSTIYQELQS 371
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 7e-50
Identities = 78/301 (25%), Positives = 133/301 (44%), Gaps = 47/301 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
+ +LG+G FG V R G+ VAVK+L + + L++F+ E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 568 HRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
H N+V+ G C G + LI+EY+P SL YL K +D ++ I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE----LQGNTK---RIV 678
YL R IHRDL N+L++ + KI DFGL ++ D+ ++ +
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF-- 182
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-WDLWKH 737
+ +PE + FS+ SDV+SFG+++ E + + + + ++G+
Sbjct: 183 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 738 ERVHELMDPVILQDEIPLP----------MLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
+ EL L++ LP M+M C N RP+ D+ +
Sbjct: 239 FHLIEL-----LKNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVD 287
Query: 788 N 788
Sbjct: 288 Q 288
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 9e-50
Identities = 78/301 (25%), Positives = 133/301 (44%), Gaps = 47/301 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
+ +LG+G FG V R G+ VAVK+L + + L++F+ E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 568 HRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
H N+V+ G C G + LI+EY+P SL YL K +D ++ I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE----LQGNTK---RIV 678
YL R IHRDL N+L++ + KI DFGL ++ D+ ++ +
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF-- 213
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-WDLWKH 737
+ +PE + FS+ SDV+SFG+++ E + + + + ++G+
Sbjct: 214 ----WYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269
Query: 738 ERVHELMDPVILQDEIPLP----------MLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
+ EL L++ LP M+M C N RP+ D+ +
Sbjct: 270 FHLIEL-----LKNNGRLPRPDGCPDEIYMIM------TECWNNNVNQRPSFRDLALRVD 318
Query: 788 N 788
Sbjct: 319 Q 319
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 1e-49
Identities = 84/301 (27%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL 566
LGEG FG V G+ VAVK L + +G Q +K E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 567 QHRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
H ++++ GCC + G L++EY+P SL YL + + + Q I +G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEG 146
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE----LQGNTK---RI 677
+ YLH IHRDL A NVLLD D KI DFGLA+ ++ +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF- 202
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737
+ +PE + F SDV+SFG+ + E L+ ++ T L+G A
Sbjct: 203 -----WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 738 ERVHELMDPVILQDEIPLP----------MLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
R+ EL L+ LP LM C + A+ RPT +++ ++
Sbjct: 258 LRLTEL-----LERGERLPRPDKCPAEVYHLM------KNCWETEASFRPTFENLIPILK 306
Query: 788 N 788
Sbjct: 307 T 307
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 76/300 (25%), Positives = 128/300 (42%), Gaps = 47/300 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL 566
LGEG FG V R G++VAVK L +SG + + K E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 567 QHRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
H N+V+ G C E G LI+E++P+ SL YL P K ++ + +++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE----LQGNTK---RI 677
+ YL + +HRDL A NVL++ + KI DFGL + D+ ++ +
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF- 194
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737
+ +PE + F I SDV+SFG+ + E L+ + ++G
Sbjct: 195 -----WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249
Query: 738 ERVHELMDPVILQDEIPLP----------MLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
R+ L++ LP LM C + ++R + +++
Sbjct: 250 TRLVNT-----LKEGKRLPCPPNCPDEVYQLM------RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 6e-48
Identities = 74/305 (24%), Positives = 129/305 (42%), Gaps = 61/305 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRLSSQSGQGLKEFKNEMMLIAEL 566
+ ++ +LGEG FG V+ +N VAVK L + K+F+ E L+ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLLDWEA 613
QH ++V+ G C + I++ EYM + L+ +L K L
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--EL 670
+ I IA G++YL + +HRDL N L+ ++ KI DFG++R ++ D +
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 191
Query: 671 QGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSF 725
G+T R +M PE + F+ +SDV+SFG+++ E T + + NT+
Sbjct: 192 GGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
Query: 726 NLLGHAWDLWK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSD 781
+ L + + V+++M L C Q R + +
Sbjct: 246 ECITQGRVLERPRVCPKEVYDVM---------------------LGCWQREPQQRLNIKE 284
Query: 782 VVSMI 786
+ ++
Sbjct: 285 IYKIL 289
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 8e-48
Identities = 75/304 (24%), Positives = 131/304 (43%), Gaps = 60/304 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRLSSQSGQGLKEFKNEMMLIAEL 566
+ ++ +LGEG FG V+ N VAVK L S ++F+ E L+ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL------------FDPIKKRLLDWEAR 614
QH+++VR G C E +++ EYM + L+ +L + + L
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--ELQ 671
+ + +A G++YL + L +HRDL N L+ + + KI DFG++R ++ D +
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 672 GNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFN 726
G T R +M PE L F+ +SDV+SFG+++ E T + + NT++ +
Sbjct: 218 GRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271
Query: 727 LLGHAWDLWK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDV 782
+ +L + V+ +M C Q R ++ DV
Sbjct: 272 CITQGRELERPRACPPEVYAIM---------------------RGCWQREPQQRHSIKDV 310
Query: 783 VSMI 786
+ +
Sbjct: 311 HARL 314
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 87/308 (28%), Positives = 131/308 (42%), Gaps = 62/308 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+LGE FG VYKG LF Q VA+K L G +EF++E ML A
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLLDWE 612
LQH N+V +LG + +I Y + L +L D K L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 613 ARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--E 669
+ ++ IA G+ YL S ++H+DL NVL+ +N KISD GL R ++ D +
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 670 LQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDS 724
L GN+ R +M+PE + G FSI SD++S+G+++ E + + G N D
Sbjct: 186 LLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 725 FNLLGHAWDLWK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMS 780
++ + L V+ LM + C E + RP
Sbjct: 240 VEMIRNRQVLPCPDDCPAWVYALM---------------------IECWNEFPSRRPRFK 278
Query: 781 DVVSMISN 788
D+ S +
Sbjct: 279 DIHSRLRA 286
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-47
Identities = 79/324 (24%), Positives = 139/324 (42%), Gaps = 40/324 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF-----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ 567
+ +LG+G FG V R G VAVK+L ++F+ E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 568 HRNLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+V+ G G + L++EY+P+ L +L + LD + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE----LQGNTK---RIV 678
YL R +HRDL A N+L++ + + KI+DFGLA++ D+ ++ +
Sbjct: 141 EYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF-- 195
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE 738
+ +PE D +FS +SDV+SFG+++ E + + + + ++G D+
Sbjct: 196 ----WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251
Query: 739 RVHELMD-------PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791
R+ EL++ P E+ LM LC + DRP+ S + +
Sbjct: 252 RLLELLEEGQRLPAPPACPAEV--HELM------KLCWAPSPQDRPSFSALGPQLDMLWS 303
Query: 792 NLPFPKKLTFVKGKNVKNSSYSTS 815
+ F K+ S S S
Sbjct: 304 GSRGCETHAFTAHPEGKHHSLSFS 327
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 4e-47
Identities = 72/289 (24%), Positives = 120/289 (41%), Gaps = 52/289 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ + +G+G FG V G G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 77
Query: 573 RILGCCVEQGEKILI-LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
++LG VE+ + I EYM SL YL + +L + ++ + + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMS 685
+HRDL A NVL+ +D K+SDFGL + + + +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EA-------SSTQDTGKLPVKWTA 182
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HER 739
PE + FS KSDV+SFGIL+ E S + + D + + +
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 242
Query: 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
V+E+M C +AA RP+ + + +
Sbjct: 243 VYEVM---------------------KNCWHLDAAMRPSFLQLREQLEH 270
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-47
Identities = 74/283 (26%), Positives = 124/283 (43%), Gaps = 40/283 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ + +G+G FG V G + G +VAVK + ++ + F E ++ +L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 573 RILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
++LG VE+ + ++ EYM SL YL + +L + ++ + + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+HRDL A NVL+ +D K+SDFGL + Q K V + +PE +
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPVK---WTAPEALRE 360
Query: 692 GLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHELMD 745
FS KSDV+SFGIL+ E S + + D + + + V+++M
Sbjct: 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVM- 419
Query: 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
C +AA RPT + + +
Sbjct: 420 --------------------KNCWHLDAATRPTFLQLREQLEH 442
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 9e-47
Identities = 82/303 (27%), Positives = 132/303 (43%), Gaps = 56/303 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAE 565
E +M +LG+G FG VY+G + VA+K + + S + EF NE ++ E
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKRLLDWEARIRII 618
++VR+LG + ++I+E M L YL + I++
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 675
IA G+ YL + + +HRDL A N ++ +D KI DFG+ R ++ D G
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLL-- 728
R +MSPE DG+F+ SDV+SFG+++ E TL+ + G+ N +
Sbjct: 202 LPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 729 GHAWDLWKH--ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
G D + + + ELM +C Q N RP+ +++S I
Sbjct: 256 GGLLDKPDNCPDMLFELM---------------------RMCWQYNPKMRPSFLEIISSI 294
Query: 787 SNE 789
E
Sbjct: 295 KEE 297
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-46
Identities = 75/315 (23%), Positives = 126/315 (40%), Gaps = 61/315 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I++
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL----FDPIKKRLLDWEARIRIIQGI 621
H+N+VR +G ++ + +++E M L +L P + L + + + I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGH 730
+ +M PE ++G+F+ K+D +SFG+L+ E +L N + +
Sbjct: 207 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260
Query: 731 AWDLWK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
+ V+ +M C Q DRP + ++ I
Sbjct: 261 GGRMDPPKNCPGPVYRIM---------------------TQCWQHQPEDRPNFAIILERI 299
Query: 787 -----SNEHLNLPFP 796
+ +N P
Sbjct: 300 EYCTQDPDVINTALP 314
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-46
Identities = 80/305 (26%), Positives = 135/305 (44%), Gaps = 50/305 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL--SSQSGQGLKEFKNEMMLIAEL 566
+ LGEG FG V +G L VAVK + + S + ++EF +E + +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 567 QHRNLVRILGCCVEQG-----EKILILEYMPNKSLDVYL---FDPIKKRLLDWEARIRII 618
H N++R+LG C+E + ++IL +M L YL + + + ++ +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--ELQGNTK 675
IA G+ YL S +HRDL A N +L DM ++DFGL++ ++ GD K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAK 210
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWD 733
V +++ E D +++ KSDV++FG+ M E T GV N + ++ L H
Sbjct: 211 MPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR 267
Query: 734 LWK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789
L + + ++E+M C + + DRPT S + +
Sbjct: 268 LKQPEDCLDELYEIM---------------------YSCWRTDPLDRPTFSVLRLQLEKL 306
Query: 790 HLNLP 794
+LP
Sbjct: 307 LESLP 311
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 75/292 (25%), Positives = 119/292 (40%), Gaps = 48/292 (16%)
Query: 520 KLGEGGFGPVYKGRLFNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+G G FG VY G L + AVK L + +F E +++ + H N++ +
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
LG C+ L +L YM + L ++ + + I +A+G+ YL +
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG------YMSPE 687
+ +HRDL A N +LD+ K++DFGLAR D + G +M+ E
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 688 YALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWK----HERVH 741
F+ KSDV+SFG+L+ E T + V D L L + + ++
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 262
Query: 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793
E+M L C A RP+ S++VS IS
Sbjct: 263 EVM---------------------LKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-46
Identities = 77/285 (27%), Positives = 134/285 (47%), Gaps = 38/285 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ E++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 278
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V++LG C + +I E+M +L YL + ++ + + + I+ + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYA 689
+ IHR+L A N L+ ++ K++DFGL+R+ GD T + +PE
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESL 391
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHEL 743
FSIKSDV++FG+L+ E + + G+ + + LL + + + E+V+EL
Sbjct: 392 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451
Query: 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
M C Q N +DRP+ +++
Sbjct: 452 M---------------------RACWQWNPSDRPSFAEIHQAFET 475
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-46
Identities = 78/286 (27%), Positives = 135/286 (47%), Gaps = 40/286 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE--VAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ E++H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPN 70
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
LV++LG C + +I E+M +L YL + ++ + + + I+ + YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL-- 127
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEY 688
+ IHRDL A N L+ ++ K++DFGL+R+ GD K + + +PE
Sbjct: 128 -EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KWTAPES 183
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHE 742
FSIKSDV++FG+L+ E + + G+ + + LL + + + E+V+E
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 243
Query: 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
LM C Q N +DRP+ +++
Sbjct: 244 LM---------------------RACWQWNPSDRPSFAEIHQAFET 268
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-46
Identities = 76/315 (24%), Positives = 126/315 (40%), Gaps = 61/315 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+N ++ LG G FG VY+G++ +VAVK L S Q +F E ++I++
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL----FDPIKKRLLDWEARIRIIQGI 621
H+N+VR +G ++ + ++LE M L +L P + L + + + I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLAR-MFGGD--ELQGNTK 675
A G YL IHRD+ A N LL KI DFG+AR ++ G
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 676 ---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGH 730
+ +M PE ++G+F+ K+D +SFG+L+ E +L N + +
Sbjct: 248 LPVK------WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301
Query: 731 AWDLWK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
+ V+ +M C Q DRP + ++ I
Sbjct: 302 GGRMDPPKNCPGPVYRIM---------------------TQCWQHQPEDRPNFAIILERI 340
Query: 787 -----SNEHLNLPFP 796
+ +N P
Sbjct: 341 EYCTQDPDVINTALP 355
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-46
Identities = 69/304 (22%), Positives = 121/304 (39%), Gaps = 48/304 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
+G+G FG VY G + + A+K L Q ++ F E +L+ L
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80
Query: 568 HRNLVRILGCCVEQGEKILI-LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H N++ ++G + + L YM + L ++ P +R + I +A+G+
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGME 138
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY--GYM 684
YL + + +HRDL A N +LD+ K++DFGLAR E + +
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWK----HE 738
+ E F+ KSDV+SFG+L+ E T + + D + L L + +
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPD 255
Query: 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN--------EH 790
++++M C + + A RPT +V + +
Sbjct: 256 SLYQVM---------------------QQCWEADPAVRPTFRVLVGEVEQIVSALLGDHY 294
Query: 791 LNLP 794
+ LP
Sbjct: 295 VQLP 298
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 4e-46
Identities = 76/284 (26%), Positives = 126/284 (44%), Gaps = 38/284 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ ++G G FG V+ G N +VA+K + + ++F E ++ +L H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 66
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C+EQ L+ E+M + L YL ++ L E + + + +G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
+IHRDL A N L+ ++ K+SDFG+ R D+ TK V + SPE
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFS 178
Query: 691 DGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHELM 744
+S KSDV+SFG+LM E S K N++ + + L+K V+++M
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 238
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
C +E DRP S ++ ++
Sbjct: 239 ---------------------NHCWRERPEDRPAFSRLLRQLAE 261
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-46
Identities = 78/326 (23%), Positives = 139/326 (42%), Gaps = 67/326 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAEL-Q 567
+ Q +GEG FG V K R+ A+KR+ S ++F E+ ++ +L
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------FDPIKKRLLDWEARIRIIQ- 619
H N++ +LG C +G L +EY P+ +L +L DP + + Q
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 620 -----GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+A+G+ YL S+ + IHRDL A N+L+ ++ KI+DFGL+R G + T
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKT 199
Query: 675 K-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNL 727
R +M+ E +++ SDV+S+G+L+ E +L G+ + +
Sbjct: 200 MGRLPVR------WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253
Query: 728 LGHAWDLWK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783
L + L K + V++LM C +E +RP+ + ++
Sbjct: 254 LPQGYRLEKPLNCDDEVYDLM---------------------RQCWREKPYERPSFAQIL 292
Query: 784 SMI------SNEHLNLPFPKKLTFVK 803
+ ++N +K T+
Sbjct: 293 VSLNRMLEERKTYVNTTLYEKFTYAG 318
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 5e-46
Identities = 77/293 (26%), Positives = 132/293 (45%), Gaps = 49/293 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAEL 566
F LG G FG VYKG E VA+K L + S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+ ++ R+LG C+ ++ I + MP L Y+ + K + + + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--- 683
YL R++HRDL A NVL+ + KI+DFGLA++ G +E Y
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179
Query: 684 ------MSPEYALDGLFSIKSDVFSFGILMLETLS--SRKNTGVYNTDSFNLLGHAWDLW 735
M+ E L +++ +SDV+S+G+ + E ++ S+ G+ ++ ++L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------- 232
Query: 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
E+ L P I + + M+M C +A RP +++ S
Sbjct: 233 --EKGERLPQPPICTID--VYMIM------RKCWMIDADSRPKFRELIIEFSK 275
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-46
Identities = 76/284 (26%), Positives = 122/284 (42%), Gaps = 38/284 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E ++ +LG G FG V G+ +VAVK + S EF E + +L H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLV 66
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ G C ++ ++ EY+ N L YL + L+ + + + +G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
+ IHRDL A N L+D+D+ K+SDFG+ R D+ TK V + +PE
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK---WSAPEVFH 178
Query: 691 DGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHELM 744
+S KSDV++FGILM E S K N++ + L++ + ++++M
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM 238
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
C E RPT ++S I
Sbjct: 239 ---------------------YSCWHELPEKRPTFQQLLSSIEP 261
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 7e-46
Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 38/284 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLV 82
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C +Q +I EYM N L YL + + + + + + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMSPEYAL 690
+ +HRDL A N L++ K+SDFGL+R DE +K V + PE +
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV---RWSPPEVLM 194
Query: 691 DGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHELM 744
FS KSD+++FG+LM E S K N+++ + L++ E+V+ +M
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIM 254
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
C E A +RPT ++S I +
Sbjct: 255 ---------------------YSCWHEKADERPTFKILLSNILD 277
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 85/284 (29%), Positives = 132/284 (46%), Gaps = 38/284 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E + +LG G FG V+ G +VAVK L S F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R+ ++ I I EYM N SL +L P L + + IA+G+ ++
Sbjct: 72 RLYAVVTQEPIYI-ITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYAL 690
IHRDL+A+N+L+ ++ KI+DFGLAR+ +E T R + +PE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAIN 183
Query: 691 DGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHELM 744
G F+IKSDV+SFGIL+ E ++ + G+ N + L + + + E +++LM
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
LC +E DRPT + S++ +
Sbjct: 244 ---------------------RLCWKERPEDRPTFDYLRSVLED 266
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 1e-45
Identities = 77/306 (25%), Positives = 131/306 (42%), Gaps = 51/306 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG----QEVAVKRL--SSQSGQGLKEFKNEMMLIAEL 566
+ F++ LG+G FG V + +L +VAVK L + ++EF E + E
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82
Query: 567 QHRNLVRILGCCVEQGEKI------LILEYMPNKSLDVYLFD---PIKKRLLDWEARIRI 617
H ++ +++G + K +IL +M + L +L L + +R
Sbjct: 83 DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD--ELQGNT 674
+ IA G+ YL S IHRDL A N +L +DM ++DFGL+R ++ GD +
Sbjct: 143 MVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCAS 199
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAW 732
K V +++ E D L+++ SDV++FG+ M E T G+ N + +N L
Sbjct: 200 KLPVK---WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN 256
Query: 733 DLWK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
L + E V++LM C + RP+ + + + N
Sbjct: 257 RLKQPPECMEEVYDLM---------------------YQCWSADPKQRPSFTCLRMELEN 295
Query: 789 EHLNLP 794
+L
Sbjct: 296 ILGHLS 301
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-45
Identities = 82/327 (25%), Positives = 140/327 (42%), Gaps = 73/327 (22%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRL-SSQSGQGLKEFKNEMMLI 563
+ ++ LGEG FG V VAVK L + + L + +EM ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLL 609
+ +H+N++ +LG C + G +I+EY +L YL + + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD 668
++ + +A+G+ YL + + IHRDL A NVL+ ++ KI+DFGLAR + D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 669 ELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYN 721
+ T + +M+PE D +++ +SDV+SFG+LM E TL G+
Sbjct: 212 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 722 TDSFNLL--GHAWDLWKH--ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP 777
+ F LL GH D + ++ +M C + RP
Sbjct: 266 EELFKLLKEGHRMDKPANCTNELYMMM---------------------RDCWHAVPSQRP 304
Query: 778 TMSDVVSMI--------SNEHLNLPFP 796
T +V + + E+L+L P
Sbjct: 305 TFKQLVEDLDRILTLTTNEEYLDLSQP 331
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 3e-45
Identities = 74/291 (25%), Positives = 119/291 (40%), Gaps = 46/291 (15%)
Query: 520 KLGEGGFGPVYKGRLFNG----QEVAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+G G FG VY G L + AVK L + +F E +++ + H N++ +
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 575 LGCCVEQGEKIL-ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
LG C+ L +L YM + L ++ + + I +A+G+ +L +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG-----YMSPEY 688
+ +HRDL A N +LD+ K++DFGLAR E + T +M+ E
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK---TGAKLPVKWMALES 267
Query: 689 ALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWK----HERVHE 742
F+ KSDV+SFG+L+ E T + V D L L + + ++E
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYE 327
Query: 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793
+M L C A RP+ S++VS IS
Sbjct: 328 VM---------------------LKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-45
Identities = 75/284 (26%), Positives = 129/284 (45%), Gaps = 38/284 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG G FG V+ +VAVK + S ++ F E ++ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLV 246
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ ++ I I E+M SL +L + I IA+G+ ++
Sbjct: 247 KLHAVVTKEPIYI-ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--MSPEYAL 690
+ IHRDL+A+N+L+ + KI+DFGLAR+ +E T R + +PE
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAIN 358
Query: 691 DGLFSIKSDVFSFGILMLETLSSRKN--TGVYNTDSFNLLGHAWDLWK----HERVHELM 744
G F+IKSDV+SFGIL++E ++ + G+ N + L + + + E ++ +M
Sbjct: 359 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM 418
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ C + +RPT + S++ +
Sbjct: 419 ---------------------MRCWKNRPEERPTFEYIQSVLDD 441
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-45
Identities = 78/311 (25%), Positives = 133/311 (42%), Gaps = 65/311 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRL-SSQSGQGLKEFKNEMMLI 563
+ ++ LGEG FG V VAVK L + + L + +EM ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLL 609
+ +H+N++ +LG C + G +I+EY +L YL + + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD 668
++ + +A+G+ YL + + IHRDL A NVL+ ++ KI+DFGLAR + D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 669 ELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYN 721
+ T + +M+PE D +++ +SDV+SFG+LM E TL G+
Sbjct: 258 YYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311
Query: 722 TDSFNLL--GHAWDLWKH--ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP 777
+ F LL GH D + ++ +M C + RP
Sbjct: 312 EELFKLLKEGHRMDKPANCTNELYMMM---------------------RDCWHAVPSQRP 350
Query: 778 TMSDVVSMISN 788
T +V +
Sbjct: 351 TFKQLVEDLDR 361
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 76/317 (23%), Positives = 130/317 (41%), Gaps = 72/317 (22%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
N +GEG FG V++ R VAVK L S +F+ E L+AE
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL---------------------FDPI 604
+ N+V++LG C L+ EYM L+ +L
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 605 KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR- 663
L ++ I + +A G+ YL S + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 664 MFGGD--ELQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKN 716
++ D + GN R +M PE ++ +SDV+++G+++ E + +
Sbjct: 224 IYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277
Query: 717 TGVYNTDSFNLL--GHAWDLWKHERVHELMD-PVILQDEIPLPM--LMRYVNVALLCVQE 771
G+ + + + G+ ++ P + PL + LMR C +
Sbjct: 278 YGMAHEEVIYYVRDGN------------ILACP----ENCPLELYNLMRL------CWSK 315
Query: 772 NAADRPTMSDVVSMISN 788
ADRP+ + ++
Sbjct: 316 LPADRPSFCSIHRILQR 332
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 68/303 (22%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
++ +G G G V GRL VA+K L + + + ++F +E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H N++R+ G +++ EYM N SLD +L + +++G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRY 166
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY---- 683
L S L +HRDL A NVL+D ++ K+SDFGL+R+ D
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----------DAAYTTT 212
Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--WD 733
+PE FS SDV+SFG++M E L+ G W+
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA---------------YGERPYWN 257
Query: 734 LWKHERVHELMDPVILQDEIPLPM--------LMRYVNVALLCVQENAADRPTMSDVVSM 785
+ + + + + L P PM LM L C ++ A RP S +VS+
Sbjct: 258 MTNRDVISSVEEGYRL----PAPMGCPHALHQLM------LDCWHKDRAQRPRFSQIVSV 307
Query: 786 ISN 788
+
Sbjct: 308 LDA 310
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-44
Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 37/286 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRLSSQSG-QGLKEFKNEMMLIAEL 566
LG G FG V+KG E V +K + +SG Q + + M+ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H ++VR+LG C ++ + +Y+P SL ++ + L + + IA+G+
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMY 129
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL---QGNTKRIVGTYGY 683
YL ++HR+L A NVLL +++DFG+A + D+ K + +
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK---W 183
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741
M+ E G ++ +SDV+S+G+ + E T + G+ + +LL E+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---------EKGE 234
Query: 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
L P I + + M+M C + RPT ++ + +
Sbjct: 235 RLAQPQICTID--VYMVMVK------CWMIDENIRPTFKELANEFT 272
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-44
Identities = 76/282 (26%), Positives = 131/282 (46%), Gaps = 34/282 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ +L+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 242
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ E+ I + EYM SL +L + L + + IA G+ Y+
Sbjct: 243 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
R+ +HRDL+A+N+L+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 356
Query: 693 LFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWK----HERVHELMDP 746
F+IKSDV+SFGIL+ E T G+ N + + + + + E +H+LM
Sbjct: 357 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM-- 414
Query: 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
C ++ +RPT + + + +
Sbjct: 415 -------------------CQCWRKEPEERPTFEYLQAFLED 437
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-44
Identities = 82/314 (26%), Positives = 138/314 (43%), Gaps = 70/314 (22%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG------QEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+N + LGEG FG V K F+ VAVK L + S L++ +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL---------------------FDPI 604
+ H +++++ G C + G +LI+EY SL +L D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 605 KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR- 663
+R L I I+QG+ YL + ++++HRDL A N+L+ + KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 664 MFGGDELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKN 716
++ D ++ + +M+ E D +++ +SDV+SFG+L+ E TL
Sbjct: 200 VYEEDSYVKRSQGRIPVK------WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253
Query: 717 TGVYNTDSFNLL--GHAWDLWKH--ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQEN 772
G+ FNLL GH + + E ++ LM L C ++
Sbjct: 254 PGIPPERLFNLLKTGHRMERPDNCSEEMYRLM---------------------LQCWKQE 292
Query: 773 AADRPTMSDVVSMI 786
RP +D+ +
Sbjct: 293 PDKRPVFADISKDL 306
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-44
Identities = 84/298 (28%), Positives = 135/298 (45%), Gaps = 57/298 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAEL 566
+ Q +G G FG VYKG L VA+K L + + + +F E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H N++R+ G + ++I EYM N +LD +L + K + +++GIA G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 161
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG---- 682
YL + + +HRDL A N+L++ ++ K+SDFGL+R+ D T G
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIP 213
Query: 683 --YMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--WDLWKHE 738
+ +PE F+ SDV+SFGI+M E ++ G W+L HE
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT---------------YGERPYWELSNHE 258
Query: 739 RVHELMDPVILQDEIPLPM--------LMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ + D L P PM LM + C Q+ A RP +D+VS++
Sbjct: 259 VMKAINDGFRL----PTPMDCPSAIYQLM------MQCWQQERARRPKFADIVSILDK 306
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 7e-44
Identities = 76/282 (26%), Positives = 131/282 (46%), Gaps = 34/282 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ +L+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLV 325
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ E+ I + EYM SL +L + L + + IA G+ Y+
Sbjct: 326 QLYAVVSEEPIYI-VTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
R+ +HRDL+A+N+L+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYG 439
Query: 693 LFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWK----HERVHELMDP 746
F+IKSDV+SFGIL+ E T G+ N + + + + + E +H+LM
Sbjct: 440 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM-- 497
Query: 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
C ++ +RPT + + + +
Sbjct: 498 -------------------CQCWRKEPEERPTFEYLQAFLED 520
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 59/300 (19%), Positives = 112/300 (37%), Gaps = 59/300 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------FNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
E+ LG+G F ++KG + EV +K L + F +++
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
+L H++LV G CV E IL+ E++ SLD YL K ++ ++ + + +A
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNP--------KISDFGLARMFGGDELQGNTKR 676
+ +L +IH ++ A N+LL ++ + K+SD G++ +
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175
Query: 677 IVGTYGY-----MSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH 730
+ PE + ++ +D +SFG + E S G
Sbjct: 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS---------------GGD 216
Query: 731 A--WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
L ++ D L P P N+ C+ RP+ ++ +++
Sbjct: 217 KPLSALDSQRKLQFYEDRHQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNS 272
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 43/289 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
E + +GEG FG V++G + + VA+K + S ++F E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H ++V+++G E I I+E L +L +K LD + I ++ L Y
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMS 685
L R +HRD+ A NVL+ + K+ DFGL+R K + +M+
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK---WMA 185
Query: 686 PEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWK----HER 739
PE F+ SDV+ FG+ M E + GV N D + + L
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245
Query: 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
++ LM C + + RP +++ + +S
Sbjct: 246 LYSLM---------------------TKCWAYDPSRRPRFTELKAQLST 273
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-43
Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 49/293 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRL-SSQSGQGLKEFKNEMMLIAEL 566
F LG G FG VYKG E VA+K L + S + KE +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+ ++ R+LG C+ ++ I + MP L Y+ + K + + + IA+G+
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY--- 683
YL R++HRDL A NVL+ + KI+DFGLA++ G +E Y
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE---------KEYHAEGG 179
Query: 684 ------MSPEYALDGLFSIKSDVFSFGILMLETLS--SRKNTGVYNTDSFNLLGHAWDLW 735
M+ E L +++ +SDV+S+G+ + E ++ S+ G+ ++ ++L
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL------- 232
Query: 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
E+ L P I + + M+M + C +A RP +++ S
Sbjct: 233 --EKGERLPQPPICTID--VYMIM------VKCWMIDADSRPKFRELIIEFSK 275
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-43
Identities = 73/296 (24%), Positives = 119/296 (40%), Gaps = 57/296 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
E+ + LGEG FG VY+G N + VAVK + ++F +E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H ++V+++G E+ I I+E P L YL K L + I + + Y
Sbjct: 72 HPHIVKLIGIIEEEPTWI-IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE--LQGNTK---RIVGTYG 682
L + +HRD+ N+L+ K+ DFGL+R ++ T+ +
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------ 179
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--WDLWKHERV 740
+MSPE F+ SDV+ F + M E LS G + L + +
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILS---------------FGKQPFFWLENKDVI 224
Query: 741 HELMDPVILQDEIPLPM--------LMRYVNVALLCVQENAADRPTMSDVVSMISN 788
L L P P LM C + +DRP +++V +S+
Sbjct: 225 GVLEKGDRL----PKPDLCPPVLYTLM------TRCWDYDPSDRPRFTELVCSLSD 270
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 3e-43
Identities = 84/343 (24%), Positives = 144/343 (41%), Gaps = 68/343 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN--------GQEVAVKRL-SSQSGQGLKEFKNEMMLI 563
+ + LGEG FG V +VAVK L S + + L + +EM ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLL 609
+ +H+N++ +LG C + G +I+EY +L YL + L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD 668
+ + +A+G+ YL + + IHRDL A NVL+ +D KI+DFGLAR + D
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 669 --ELQGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYN 721
+ N + + +M+PE D +++ +SDV+SFG+L+ E TL GV
Sbjct: 246 YYKKTTNGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299
Query: 722 TDSFNLL--GHAWDLWKH--ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP 777
+ F LL GH D + ++ +M C + RP
Sbjct: 300 EELFKLLKEGHRMDKPSNCTNELYMMM---------------------RDCWHAVPSQRP 338
Query: 778 TMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSSYSTSGTSEI 820
T +V + + + L +++ + + + Y T +
Sbjct: 339 TFKQLVEDL-DRIVALTSNQEMGYY--HHHHHHDYDIPTTENL 378
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 79/312 (25%), Positives = 129/312 (41%), Gaps = 67/312 (21%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRL-SSQSGQGLKEFKNEMMLIAE 565
+ + LG G FG V + F + VAVK L + + +E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 566 L-QHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYL-------------FDPIKKRLLD 610
+ H N+V +LG C + G + +I+E+ +L YL + + K L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 611 WEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDE 669
E I +A+G+ +L + + IHRDL A N+LL + KI DFGLAR ++ +
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 670 LQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGV-YN 721
+ +M+PE D +++I+SDV+SFG+L+ E +L + GV +
Sbjct: 204 YVRKGDARLPLK------WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257
Query: 722 TDSFNLL--GHAWDLWKHERVHELMD-PVILQDEIPLPM--LMRYVNVALLCVQENAADR 776
+ L G M P D M M C + R
Sbjct: 258 EEFCRRLKEGT------------RMRAP----DYTTPEMYQTMLD------CWHGEPSQR 295
Query: 777 PTMSDVVSMISN 788
PT S++V + N
Sbjct: 296 PTFSELVEHLGN 307
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 4e-43
Identities = 79/295 (26%), Positives = 118/295 (40%), Gaps = 56/295 (18%)
Query: 520 KLGEGGFGPVYKGRLFNG---QEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHRNLVRI 574
+LG G FG V KG + VAVK L + E E ++ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 575 LGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+G C + E L++E L+ YL + R + + I ++ ++ G+ YL
Sbjct: 84 IGIC--EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EE 135
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEYA 689
+HRDL A NVLL KISDFGL++ DE Q + K V + +PE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV---KWYAPECI 192
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--WDLWKHERVHELMDPV 747
FS KSDV+SFG+LM E S G + E L
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFS---------------YGQKPYRGMKGSEVTAMLEKGE 237
Query: 748 ILQDEIPLPM--------LMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794
+ P LM LC + +RP + V + N + ++
Sbjct: 238 RM----GCPAGCPREMYDLM------NLCWTYDVENRPGFAAVELRLRNYYYDVV 282
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 6e-43
Identities = 77/303 (25%), Positives = 128/303 (42%), Gaps = 68/303 (22%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
N S+ +G G FG V GRL + VA+K L + + ++F E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H N++R+ G + +++ EYM N SLD +L + +++GIA G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKY 162
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY---- 683
L S + +HRDL A N+L++ ++ K+SDFGL R+ D
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----------EAAYTTR 208
Query: 684 --------MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--WD 733
SPE F+ SDV+S+GI++ E +S G W+
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS---------------YGERPYWE 253
Query: 734 LWKHERVHELMDPVILQDEIPLPM--------LMRYVNVALLCVQENAADRPTMSDVVSM 785
+ + + + + L P PM LM L C Q++ +RP +VS+
Sbjct: 254 MSNQDVIKAVDEGYRL----PPPMDCPAALYQLM------LDCWQKDRNNRPKFEQIVSI 303
Query: 786 ISN 788
+
Sbjct: 304 LDK 306
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 70/297 (23%), Positives = 114/297 (38%), Gaps = 54/297 (18%)
Query: 517 MQCKLGEGGFGPVYKGRLFNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLV 572
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73
Query: 573 RILGCCVEQGEKILI-LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
R++G C Q E +++ +E L +L K+ + ++ ++ G+ YL
Sbjct: 74 RLIGVC--QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL--- 126
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL----QGNTKRIVGTYGYMSPE 687
+HRDL A NVLL KISDFGL++ G D+ + K + + +PE
Sbjct: 127 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPE 183
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--WDLWKHERVHELMD 745
FS +SDV+S+G+ M E LS G + E + +
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALS---------------YGQKPYKKMKGPEVMAFIEQ 228
Query: 746 PVILQDEIPLPM--------LMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794
+ P LM C DRP V + + +L
Sbjct: 229 GKRM----ECPPECPPELYALM------SDCWIYKWEDRPDFLTVEQRMRACYYSLA 275
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 59/210 (28%), Positives = 89/210 (42%), Gaps = 18/210 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAE 565
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
L HRNL+R+ G + K+ + E P SL L + R +A+G+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 134
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT---YG 682
YL R IHRDL A N+LL KI DFGL R ++ + +
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFA 189
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+ +PE FS SD + FG+ + E +
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFT 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 66/225 (29%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAE 565
N LG G FG V + F + VAVK L S+ + +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-----------FDPIKKRLLDWEA 613
L QH N+V +LG C G ++I EY L +L I
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGDE--L 670
+ +AQG+ +L + IHRD+ A NVLL KI DFGLAR + +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 671 QGNTK---RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712
+GN + + +M+PE D +++++SDV+S+GIL+ E S
Sbjct: 223 KGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 72/305 (23%), Positives = 121/305 (39%), Gaps = 56/305 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAE 565
S LG G FG V + + + VAVK L S + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL---------------FDPIKKRLL 609
L H N+V +LG C G ++I EY L +L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-MFGGD 668
D E + +A+G+ +L + IHRDL A N+LL KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGV-YNTDSF 725
+ +M+PE + +++ +SDV+S+GI + E +L S G+ ++ +
Sbjct: 200 NYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
Query: 726 NLL--GHAWDLWKH--ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSD 781
++ G +H ++++M C + RPT
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIM---------------------KTCWDADPLKRPTFKQ 297
Query: 782 VVSMI 786
+V +I
Sbjct: 298 IVQLI 302
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 9e-42
Identities = 68/316 (21%), Positives = 119/316 (37%), Gaps = 59/316 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+F +G GGFG V+K + +G+ +KR+ + ++ + E+ +A+L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 572 VRILGCCVEQGEKI----------------LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
V GC + +E+ +L+ ++ ++L A
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675
Q I +G+ Y+H ++I+RDLK SN+ L KI DFGL D G
Sbjct: 127 LFEQ-ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND---GKRT 179
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735
R GT YMSPE + + D+++ G+++ E L A
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--------------TA---- 221
Query: 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPF 795
E D + I + + + + DRP S++ L
Sbjct: 222 -FETSKFFTD--LRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI--------LRTLT 270
Query: 796 PKKLTFVKGKNVKNSS 811
K KN ++++
Sbjct: 271 VWK--KSPEKNERHTA 284
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 3e-41
Identities = 68/297 (22%), Positives = 127/297 (42%), Gaps = 49/297 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
E + K+GEG FG + +G++ +K +S S + +E + E+ ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARI-RIIQGIAQGL 625
N+V+ E G ++++Y L F I + L E +I I L
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDL----FKRINAQKGVLFQ-EDQILDWFVQICLAL 138
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
++H +I+HRD+K+ N+ L KD ++ DFG+AR+ +GT Y+S
Sbjct: 139 KHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLS 193
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
PE + ++ KSD+++ G ++ E + + + S L + K
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCTLKH---AFEAGSMKNL-----VLK--------- 236
Query: 746 PVILQDEIPLPMLMRY----VNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKK 798
I+ P P+ + Y ++ + N DRP+++ + L F K
Sbjct: 237 --IISGSFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSI--------LEKGFIAK 282
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 67/317 (21%), Positives = 119/317 (37%), Gaps = 61/317 (19%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+F LG GGFG V++ + + A+KR+ ++ E+ +A+L+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 571 LVRILGCCVEQGEKI------------LILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
+VR +E+ + ++ ++L ++ + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR-- 676
IA+ + +LH ++HRDLK SN+ D K+ DFGL DE +
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 677 --------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLL 728
VGT YMSPE +S K D+FS G+++ E L F+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----------PFST- 229
Query: 729 GHAWDLWKHERVHELMDPVILQDEIPLPMLMRY----VNVALLCVQENAADRPTMSDVVS 784
+ ERV L D + + P P+ + + + + +RP ++
Sbjct: 230 -------QMERVRTLTD--VRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINI-- 277
Query: 785 MISNEHLNLPFPKKLTF 801
+ + L F
Sbjct: 278 ------IENAVFEDLDF 288
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-40
Identities = 67/289 (23%), Positives = 115/289 (39%), Gaps = 43/289 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE----VAVKRL-SSQSGQGLKEFKNEMMLIAELQ 567
E + +GEG FG V++G + + VA+K + S ++F E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H ++V+++G E I I+E L +L +K LD + I ++ L Y
Sbjct: 450 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE--LQGNTKRIVGTYGYMS 685
L R +HRD+ A NVL+ + K+ DFGL+R K + +M+
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI---KWMA 560
Query: 686 PEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGVYNTDSFNLLGHAWDLWK----HER 739
PE F+ SDV+ FG+ M E + GV N D + + L
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 620
Query: 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
++ LM C + + RP +++ + +S
Sbjct: 621 LYSLM---------------------TKCWAYDPSRRPRFTELKAQLST 648
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+F LG+G FG V K R + + A+K++ + L +E+ML+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 571 LVRILGCCVEQGEKI-------------LILEYMPNKSLDVYLFDPIKKR--LLDWEARI 615
+VR +E+ + + +EY N +L +D I +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF---------- 665
R+ + I + L Y+H IIHRDLK N+ +D+ N KI DFGLA+
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 666 --GGDELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 709
N +GT Y++ E G ++ K D++S GI+ E
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 33/288 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSGQGLKEFKNEMMLIAELQH 568
NF ++ K+G G F VY+ L +G VA+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLLY 627
N+++ +E E ++LE L + K++ L E + + + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
+H R++HRD+K +NV + K+ D GL R F ++ +VGT YMSPE
Sbjct: 152 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747
+ ++ KSD++S G L+ E + + + D NL L
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS---PFYGDKMNLY-------------SLC-KK 249
Query: 748 ILQDEI-PLPMLMRY----VNVALLCVQENAADRPTMSDVVSMISNEH 790
I Q + PLP Y + +C+ + RP ++ V + H
Sbjct: 250 IEQCDYPPLPSD-HYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 77/331 (23%), Positives = 125/331 (37%), Gaps = 81/331 (24%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE------VAVKRL-SSQSGQGLKEFKNEMMLIAE 565
EN LG G FG V + + VAVK L + +E+ ++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL--------------------FDPI 604
L H N+V +LG C G LI EY L YL +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 605 KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR- 663
+L +E + +A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 664 MFGGDELQGNTK-----RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKN 716
+ + +M+PE +G+++IKSDV+S+GIL+ E +L
Sbjct: 222 IMSDSNYVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275
Query: 717 TGV-YNTDSFNLL--GHAWDLWKHERVHELMD-PVILQDEIPLPM--LMRYVNVALLCVQ 770
G+ + + + L+ G MD P + +M+ C
Sbjct: 276 PGIPVDANFYKLIQNGF------------KMDQP----FYATEEIYIIMQS------CWA 313
Query: 771 ENAADRPTMSDVVSMI--------SNEHLNL 793
++ RP+ ++ S + + N+
Sbjct: 314 FDSRKRPSFPNLTSFLGCQLADAEEAMYQNV 344
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-40
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 517 MQCKLGEGGFGPVYKGRLFNGQE---VAVKRL-SSQSGQGLKEFKNEMMLIAELQHRNLV 572
+LG G FG V +G ++ VA+K L +E E ++ +L + +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R++G C + + ++E L +L K+ + ++ ++ G+ YL
Sbjct: 400 RLIGVCQAEALML-VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---E 453
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE----LQGNTKRIVGTYGYMSPEY 688
+HR+L A NVLL KISDFGL++ G D+ + K + + +PE
Sbjct: 454 EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL---KWYAPEC 510
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
FS +SDV+S+G+ M E LS
Sbjct: 511 INFRKFSSRSDVWSYGVTMWEALS 534
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-39
Identities = 57/198 (28%), Positives = 91/198 (45%), Gaps = 17/198 (8%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
++G G F VYKG EVA + + + FK E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 577 CCVEQGEK----ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ +L+ E M + +L YL + +++ + + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT-R 148
Query: 633 RLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
IIHRDLK N+ + + KI D GLA + K ++GT +M+PE +
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE 204
Query: 692 GLFSIKSDVFSFGILMLE 709
+ DV++FG+ MLE
Sbjct: 205 K-YDESVDVYAFGMCMLE 221
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-38
Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
E++ + +G G +G K R +G+ + K S + + +E+ L+ EL+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 570 NLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLL 626
N+VR +++ L ++EY L + K+R E + R++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 627 YLHQ--YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H+ ++HRDLK +NV LD N K+ DFGLAR+ D T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
SPE ++ KSD++S G L+ E
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYE 208
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-38
Identities = 65/196 (33%), Positives = 98/196 (50%), Gaps = 15/196 (7%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
LG+G +G VY GR L N +A+K + + + + E+ L L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII--QGIAQGLLYLHQYSRLRII 637
E G + +E +P SL L L D E I Q I +GL YLH +I+
Sbjct: 90 ENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQ-ILEGLKYLHDN---QIV 144
Query: 638 HRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE---YALDGL 693
HRD+K NVL++ KISDFG ++ G + T+ GT YM+PE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEIIDKGPRG- 201
Query: 694 FSIKSDVFSFGILMLE 709
+ +D++S G ++E
Sbjct: 202 YGKAADIWSLGCTIIE 217
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 62/313 (19%), Positives = 124/313 (39%), Gaps = 57/313 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+++ KLGEGGF V L +G A+KR+ Q +E + E + H N+
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88
Query: 572 VRILGCCVEQGEK----ILILEYMPNKSLDVYLFDPIKKRLLDW----EARI-RIIQGIA 622
+R++ C+ + L+L + +L ++ I++ E +I ++ GI
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIERLKDKGNFLTEDQILWLLLGIC 144
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR-----MFGGDELQGNTKRI 677
+GL +H HRDLK +N+LL + P + D G + G +
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 678 --VGTYGYMSPE------YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG 729
T Y +PE + + ++DV+S G ++ + + ++++
Sbjct: 202 AQRCTISYRAPELFSVQSHCVID---ERTDVWSLGCVLYAMM--------FGEGPYDMVF 250
Query: 730 HAWDLWKHERVHELMDPVILQDEIPLPMLMRY----VNVALLCVQENAADRPTMSDVVSM 785
D + +Q+++ +P R+ + + + RP + ++S
Sbjct: 251 QKGDSVA----------LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300
Query: 786 ISNEHLNLPFPKK 798
+ E L P P +
Sbjct: 301 L--EALQPPAPGQ 311
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-38
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRN 570
+S+ ++G GG V++ Q A+K L Q L ++NE+ + +LQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 571 L--VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+R+ + +++E N L+ +L KK + WE + + + + + +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK--KKSIDPWERK-SYWKNMLEAVHTI 143
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
HQ+ I+H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 144 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199
Query: 688 ----------YALDGLFSIKSDVFSFGILMLETLSSR 714
S KSDV+S G ++ +
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 59/202 (29%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAELQH 568
+ LG+GGF ++ + A K + S +E E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGL 625
+++V G E + + ++LE +SL + K K L + EAR ++ I G
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGC 154
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
YLH+ R+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIA 209
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
PE S + DV+S G +M
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIM 231
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 1e-37
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAELQHRNLVRILG 576
LG+GGF ++ + A K + S +E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 577 CCVEQGEKI-LILEYMPNKSLDVYLFDPIK--KRLLDWEARIRIIQGIAQGLLYLHQYSR 633
E + + ++LE +SL + K K L + EAR ++ I G YLH R
Sbjct: 83 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---R 133
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
R+IHRDLK N+ L++D+ KI DFGLA D + + GT Y++PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191
Query: 694 FSIKSDVFSFGILM 707
S + DV+S G +M
Sbjct: 192 HSFEVDVWSIGCIM 205
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 48/294 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAEL-QH 568
++F +LG G +G V+K R +G+ AVK + + E+ ++ QH
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIR-IIQGIAQGL 625
VR+ E G L E L + L EA++ ++ L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-----GPSLQQHCEAWGASLP-EAQVWGYLRDTLLAL 170
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
+LH ++H D+K +N+ L K+ DFGL G + G YM+
Sbjct: 171 AHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMA 224
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH-ERVHELM 744
PE L G + +DVFS G+ +LE + +L E +L
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILE------------------VACNMELPHGGEGWQQLR 265
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKK 798
L E + +V ++ ++ + R T + L LP ++
Sbjct: 266 Q-GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEAL--------LALPVLRQ 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 23/217 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRN 570
+S+ ++G GG V++ Q A+K L Q L ++NE+ + +LQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 571 L--VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+R+ + +++E N L+ +L KK + WE + + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERK-SYWKNMLEAVHTI 124
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
HQ+ I+H DLK +N L+ K+ DFG+A D VGT YM PE
Sbjct: 125 HQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 688 ----------YALDGLFSIKSDVFSFGILMLETLSSR 714
S KSDV+S G ++ +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-37
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 23/210 (10%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAELQHRNL--VRIL 575
++G GG V++ Q A+K L Q L ++NE+ + +LQ + +R+
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
+ +++E N L+ +L KK + WE + + + + + +HQ+
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERK-SYWKNMLEAVHTIHQH---G 175
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-------- 687
I+H DLK +N L+ D K+ DFG+A D VG YM PE
Sbjct: 176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 688 ---YALDGLFSIKSDVFSFGILMLETLSSR 714
S KSDV+S G ++ +
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 7e-37
Identities = 57/200 (28%), Positives = 108/200 (54%), Gaps = 12/200 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ ++ K+G+G G VY + GQEVA+++++ Q + NE++++ E ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLH 629
+V L + E +++EY+ SL D + + +D E +I + + Q L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMD-EGQIAAVCRECLQALEFLH 133
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
++IHRD+K+ N+LL D + K++DFG ++ + +T +VGT +M+PE
Sbjct: 134 S---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVV 188
Query: 690 LDGLFSIKSDVFSFGILMLE 709
+ K D++S GI+ +E
Sbjct: 189 TRKAYGPKVDIWSLGIMAIE 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 70/359 (19%), Positives = 120/359 (33%), Gaps = 104/359 (28%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+F +G GGFG V++ + + A+KR+ ++ E+ +A+L+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 571 LVRILGCCV-----------------------------------------EQGEKILILE 589
+VR + + +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 590 YMPNKSLDVYLF------------DPIKKRLLDWEARI----RIIQGIAQGLLYLHQYSR 633
+ S VYL+ D + +R + I IA+ + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK----------RIVGTYGY 683
++HRDLK SN+ D K+ DFGL DE + VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743
MSPE +S K D+FS G+++ E L +T ERV +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFE-LLYSFSTQ------------------MERVRII 283
Query: 744 MDPVILQDEIPLPMLMRYVNVALL---CVQENAADRPTMSDVVSMISNEHLNLPFPKKL 799
D + + PL +Y ++ + + +RP +D+ + + L
Sbjct: 284 TD--VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDI--------IENAIFENL 332
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 57/200 (28%), Positives = 104/200 (52%), Gaps = 12/200 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
K+GEG G V R +G++VAVK + + Q + NE++++ + QH N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYLH 629
+V + + E +++E++ +L D + + L+ E +I + + + Q L YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLN-EEQIATVCEAVLQALAYLH 158
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+IHRD+K+ ++LL D K+SDFG D + + +VGT +M+PE
Sbjct: 159 A---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVI 213
Query: 690 LDGLFSIKSDVFSFGILMLE 709
L++ + D++S GI+++E
Sbjct: 214 SRSLYATEVDIWSLGIMVIE 233
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 11/199 (5%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRIL 575
KLG GG VY +VA+K + + LK F+ E+ ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
E L++EY+ +L Y+ L + I I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH---DMR 131
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS 695
I+HRD+K N+L+D + KI DFG+A+ L T ++GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATD 190
Query: 696 IKSDVFSFGILMLETLSSR 714
+D++S GI++ E L
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 2e-35
Identities = 66/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKE-FKNEMMLIAELQH 568
E+F + LG+G F VY+ + G EVA+K + + G+ + +NE+ + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIK---KRLLDWEARIRIIQGIAQG 624
+++ + E + L+LE N + +K K + EAR + I G
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEAR-HFMHQIITG 124
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+LYLH + I+HRDL SN+LL ++MN KI+DFGLA + T + GT Y+
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
SPE A ++SDV+S G + L
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLL 206
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 18/210 (8%)
Query: 506 ASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIA 564
+ Q ++G G FG V++ + G + AVK++ + + E++ A
Sbjct: 51 YEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACA 105
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQ 623
L +V + G E + +E + SL + + L E R G +
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLP-EDRALYYLGQALE 161
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKR---IVG 679
GL YLH RI+H D+KA NVLL D + + DFG A D L + I G
Sbjct: 162 GLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 680 TYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
T +M+PE + K D++S +ML
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 14/205 (6%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG-QGLKEFKNEM-MLIAELQHR 569
++ +LG G +G V K R + +GQ +AVKR+ + Q K ++ + + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYL 628
V G +G+ + +E M Y K + + E + I I + L +L
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIP-EDILGKIAVSIVKALEHL 125
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
H S+L +IHRD+K SNVL++ K+ DFG++ D++ + G YM+PE
Sbjct: 126 H--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDID--AGCKPYMAPER 180
Query: 688 ---YALDGLFSIKSDVFSFGILMLE 709
+S+KSD++S GI M+E
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIE 205
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 47/224 (20%), Positives = 85/224 (37%), Gaps = 36/224 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKR--LSSQSGQGLKEFKNEMMLIAEL-Q 567
T F K+G G FG V+K +G A+KR + E+ A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII--QGIAQGL 625
H ++VR E ++ EY SL + + + EA ++ + Q + +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ-VGRGL 128
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNP-------------------KISDFGLARMFG 666
Y+H + ++H D+K SN+ + + P KI D G
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI- 184
Query: 667 GDELQGNTKRIVGTYGYMSPE-YALDGLFSIKSDVFSFGILMLE 709
+ + G +++ E + K+D+F+ + ++
Sbjct: 185 -----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 60/201 (29%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHR 569
E F+ K+G+G FG V+KG + VA+K + + + +++ + E+ ++++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLLYL 628
+ + G ++ + +I+EY+ S D ++ LD E +I I + I +GL YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLD-ETQIATILREILKGLDYL 135
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H + IHRD+KA+NVLL + K++DFG+A +++ NT VGT +M+PE
Sbjct: 136 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEV 190
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+ K+D++S GI +E
Sbjct: 191 IKQSAYDSKADIWSLGITAIE 211
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 58/206 (28%), Positives = 112/206 (54%), Gaps = 17/206 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
E + + +LG+G FG VYK + G A K + ++S + L+++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIRII-QGIAQGLLYL 628
+V++LG G+ +++E+ P ++ + L R L E +I+++ + + + L +L
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIML---ELDRGLT-EPQIQVVCRQMLEALNFL 133
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE- 687
H RIIHRDLKA NVL+ + + +++DFG++ + ++ +GT +M+PE
Sbjct: 134 HS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEV 188
Query: 688 ----YALDGLFSIKSDVFSFGILMLE 709
D + K+D++S GI ++E
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIE 214
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-34
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 29/214 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLV 572
+F + LG G G + +F+ ++VAVKR+ + E+ L+ E +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 573 RILGCCVEQGEKI--LILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLY 627
R C E+ + + +E L + ++++ L E ++Q GL +
Sbjct: 82 RYF--CTEKDRQFQYIAIELCAAT-----LQEYVEQKDFAHLGLEPI-TLLQQTTSGLAH 133
Query: 628 LHQYSRLRIIHRDLKASNVLL-----DKDMNPKISDFGLARMFGGDEL-QGNTKRIVGTY 681
LH L I+HRDLK N+L+ + ISDFGL + + GT
Sbjct: 134 LHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 682 GYMSPEY---ALDGLFSIKSDVFSFGILMLETLS 712
G+++PE + D+FS G + +S
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 62/201 (30%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
E F + KLGEG +G VYK GQ VA+K++ + L+E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIRII-QGIAQGLLYL 628
+V+ G + + +++EY S+ D+ ++ + L E I I Q +GL YL
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLT-EDEIATILQSTLKGLEYL 141
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H +R IHRD+KA N+LL+ + + K++DFG+A + NT ++GT +M+PE
Sbjct: 142 HF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEV 196
Query: 689 ALDGLFSIKSDVFSFGILMLE 709
+ ++ +D++S GI +E
Sbjct: 197 IQEIGYNCVADIWSLGITAIE 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-34
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 13/230 (5%)
Query: 483 EFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVA 541
+ E+ D + + + ++F +LG G G V+K +G +A
Sbjct: 3 KLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMA 62
Query: 542 VKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL 600
K + + + E+ ++ E +V G GE + +E+M SLD
Sbjct: 63 RKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD--- 119
Query: 601 FDPIKKRLLDWEARIRII-QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659
+KK E + + + +GL YL + +I+HRD+K SN+L++ K+ DF
Sbjct: 120 -QVLKKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDF 176
Query: 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
G++ + N+ VGT YMSPE +S++SD++S G+ ++E
Sbjct: 177 GVSGQL--IDSMANS--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 42/203 (20%), Positives = 77/203 (37%), Gaps = 24/203 (11%)
Query: 520 KLGEGGFGPVYKGR--LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILG 576
+ GG G +Y NG+ V +K L + E +AE+ H ++V+I
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 577 CCVEQGEKI-----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+++EY+ +SL L I + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+ +++ DLK N++L ++ K+ D G + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRT 251
Query: 692 GLFSIKSDVFSFGILMLETLSSR 714
G ++ +D+++ G +
Sbjct: 252 GP-TVATDIYTVGRTLAALTLDL 273
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 15/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG-QGLKEFKNEM-MLIAELQHR 569
E+ ++G G +G V K +GQ +AVKR+ S + K+ ++ +++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVY-LFDPIKKRLLDWEARIRII-QGIAQGLLY 627
+V+ G +G+ + +E M Y + ++ E + I + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP-EEILGKITLATVKALNH 140
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L L+IIHRD+K SN+LLD+ N K+ DFG++ + G YM+PE
Sbjct: 141 LK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD---AGCRPYMAPE 195
Query: 688 ----YALDGLFSIKSDVFSFGILMLE 709
A + ++SDV+S GI + E
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 54/244 (22%), Positives = 92/244 (37%), Gaps = 37/244 (15%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRIL 575
+G GG G VY+ + VA+K +S + E LQ ++V I
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
G+ + + + L L ++ L + I++ I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAH---AAG 154
Query: 636 IIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL-QGNTKRIVGTYGYMSPEYALDGLF 694
HRD+K N+L+ D + DFG+A ++L Q VGT YM+PE +
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN--TVGTLYYMAPERFSESHA 212
Query: 695 SIKSDVFSFGILMLETLSSRKNTGV--YNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752
+ ++D+++ ++ E L TG Y D ++ + H +
Sbjct: 213 TYRADIYALTCVLYECL-----TGSPPYQGDQLSV------MGAH-----------INQA 250
Query: 753 IPLP 756
IP P
Sbjct: 251 IPRP 254
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 26/236 (11%)
Query: 485 GEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK 543
G GK G + A + ++G G G V+K R G +AVK
Sbjct: 1 GSSGSSGKQTGYLT----IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVK 56
Query: 544 RLSSQSG-QGLKEFKNEM-MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL- 600
++ + K ++ +++ +V+ G + + + +E M + +
Sbjct: 57 QMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKR 116
Query: 601 -FDPIKKRLLDWEARIRII-QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658
PI E + + I + L YL + +IHRD+K SN+LLD+ K+ D
Sbjct: 117 MQGPIP------ERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCD 168
Query: 659 FGLARMFGGDELQGNTKRIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLE 709
FG++ D+ + G YM+PE + I++DV+S GI ++E
Sbjct: 169 FGISGRL-VDDKAKDR--SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 15/204 (7%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG---LKEFKNEMMLIAELQHRNLVRIL 575
LG GG V+ R L + ++VAVK L + + F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 576 --GCCVEQGEKI--LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
G + +++EY+ +L + + + + I +I Q L + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH-- 133
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG-NTKRIVGTYGYMSPEYAL 690
+ IIHRD+K +N+++ K+ DFG+AR T ++GT Y+SPE A
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 691 DGLFSIKSDVFSFGILMLETLSSR 714
+SDV+S G ++ E L+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQ 567
E+F + LG+G FG VY R + +A+K L ++G + + E+ + + L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGV-EHQLRREVEIQSHLR 67
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQGL 625
H N++R+ G + LILEY P ++ + ++K + + I +A L
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTA-TYITELANAL 122
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
Y H R+IHRD+K N+LL KI+DFG + + GT Y+
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D--LCGTLDYLP 175
Query: 686 PEYALDGLFSIKSDVFSFGILMLETL 711
PE + K D++S G+L E L
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-33
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + +L+
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII-QGIAQGLL 626
H N ++ GC + + L++EY + D+ + K+ L E I + G QGL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQ-EVEIAAVTHGALQGLA 168
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL-ARMFGGDELQGNTKR--IVGTYGY 683
YLH +IHRD+KA N+LL + K+ DFG + M VGT +
Sbjct: 169 YLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM---------APANSFVGTPYW 216
Query: 684 MSPE---YALDGLFSIKSDVFSFGILMLE 709
M+PE +G + K DV+S GI +E
Sbjct: 217 MAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 47/216 (21%), Positives = 90/216 (41%), Gaps = 22/216 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+ + LG+G V++GR G A+K + + + E ++ +L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVRILGC--CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V++ K+LI+E+ P SL L +P L + +++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ I+HR++K N++ D K++DFG AR DE + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 685 SPE--------YALDGLFSIKSDVFSFGILMLETLS 712
P+ + D++S G+ +
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 59/209 (28%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+++ +Q +G G V ++VA+KR++ + + E E+ +++ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 571 LVRILGCCVEQGEKILILEYMPNKSL-----DVYLFDPIKKRLLDWEARIRII-QGIAQG 624
+V V + E L+++ + S+ + K +LD E+ I I + + +G
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEG 133
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL-ARMFGGDELQGNTKR--IVGTY 681
L YLH + IHRD+KA N+LL +D + +I+DFG+ A + G ++ N R VGT
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 682 GYMSPEYALDGL-FSIKSDVFSFGILMLE 709
+M+PE + K+D++SFGI +E
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-32
Identities = 58/224 (25%), Positives = 90/224 (40%), Gaps = 40/224 (17%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAELQHRNLVRILGCC 578
LG G G V F G+ VAVKR+ E+ +L H N++R C
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY--C 76
Query: 579 VEQGEK--ILILEYMPNKSLDVYL-----FDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
E ++ + LE N +L + D K ++ +++ IA G+ +LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLHS- 133
Query: 632 SRLRIIHRDLKASNVLLD-------------KDMNPKISDFGLARMFGGDE--LQGNTKR 676
L+IIHRDLK N+L+ +++ ISDFGL + + + N
Sbjct: 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNN 191
Query: 677 IVGTYGYMSPEYALDGLFSI-------KSDVFSFGILMLETLSS 713
GT G+ +PE + D+FS G + LS
Sbjct: 192 PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-31
Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
+ + LG+G V++GR G A+K + + + E ++ +L H+N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 571 LVRILGC--CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V++ K+LI+E+ P SL L +P L + +++ + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 629 HQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ I+HR++K N++ D K++DFG AR DE + GT Y+
Sbjct: 129 RE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYL 182
Query: 685 SPE--------YALDGLFSIKSDVFSFGILM 707
P+ + D++S G+
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 25/213 (11%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGC 577
L EGGF VY+ + + +G+E A+KRL S + + E+ + +L H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 578 CVEQGEK-------ILILEYMPNKSLDVYLFDPIKKRLLDWEARI-RIIQGIAQGLLYLH 629
E+ L+L + L +L + L + +I + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS-CDTVLKIFYQTCRAVQHMH 153
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRI----------VG 679
+ IIHRDLK N+LL K+ DFG A + +
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 680 TYGYMSPE-YALDGLFSI--KSDVFSFGILMLE 709
T Y +PE L F I K D+++ G ++
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL 245
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 130 bits (327), Expect = 2e-31
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNL 571
+ M+ +LG GGFG V + G++VA+K+ + +E + E+ ++ +L H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 572 VRIL------GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLD-WEARIRIIQGIAQG 624
V +L +EY L YL L R ++ I+
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSA 133
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
L YLH+ RIIHRDLK N++L + + KI D G A+ EL VGT
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTL 187
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILM 707
Y++PE +++ D +SFG L
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLA 213
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 22/221 (9%)
Query: 504 SLASVAAATENFSMQCKLGEG--GFGPVYKGR-LFNGQEVAVKR--LSSQSGQGLKEFKN 558
++S + + +G+G V R G+ V V+R L + S + + +
Sbjct: 16 GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75
Query: 559 EMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW--EARIR 616
E+ + H N+V + E ++ +M S D I +D E I
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA----KDLICTHFMDGMNELAIA 131
Query: 617 II-QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT- 674
I QG+ + L Y+H + +HR +KAS++L+ D +S +
Sbjct: 132 YILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 675 ----KRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLE 709
K V ++SPE L + KSD++S GI E
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE 229
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 6e-31
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQ 567
++F + LG+G FG VY R N +A+K L + G + + E+ + + L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLR 72
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQGL 625
H N++R+ ++ L+LE+ P L + ++K R + + ++ +A L
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADAL 127
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
Y H ++IHRD+K N+L+ KI+DFG + T + GT Y+
Sbjct: 128 HYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR--RT--MCGTLDYLP 180
Query: 686 PEYALDGLFSIKSDVFSFGILMLETL 711
PE K D++ G+L E L
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFL 206
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 24/213 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHR 569
F + +G G +G VYKGR + GQ A+K + +G +E K E+ ++ + HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 570 NLVRILGCCVEQGEKI------LILEYMPNKSL-DVYLFDPIKKRLLDWEARIRII-QGI 621
N+ G +++ L++E+ S+ D+ K L E I I + I
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNTLK-EEWIAYICREI 138
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+GL +LHQ ++IHRD+K NVLL ++ K+ DFG++ + NT +GT
Sbjct: 139 LRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTP 193
Query: 682 GYMSPE-----YALDGLFSIKSDVFSFGILMLE 709
+M+PE D + KSD++S GI +E
Sbjct: 194 YWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 39/227 (17%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLS-----------------SQSGQGLKE 555
++ + L +G F + + + A+K+ +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 556 FKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL------FDPIKKRLL 609
FKNE+ +I ++++ + G E +I EYM N S+ + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ II+ + Y+H + I HRD+K SN+L+DK+ K+SDFG + +
Sbjct: 150 IQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
Query: 670 LQGNTKRIVGTYGYMSPE-----YALDGLFSIKSDVFSFGILMLETL 711
++G GTY +M PE + +G K D++S GI +
Sbjct: 207 IKG----SRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMF 246
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-30
Identities = 35/302 (11%), Positives = 79/302 (26%), Gaps = 64/302 (21%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH-------- 568
LG+ + G+ V +K+ K E++ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 569 --------RNLVRILGCC-----VEQGEKILILEY---MPNKSLDV-----YLFDPIKK- 606
+LV+ + +L P ++ L
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 607 RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ L AR+++ + + L LH ++H L+ +++LD+ ++ F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 261
Query: 667 GDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYN 721
G R + L + D ++ G+ +
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW-----CADL- 315
Query: 722 TDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSD 781
+ + I + +P +R + L + DR
Sbjct: 316 ------------PNTDDAALGGSEW-IFRSCKNIPQPVRALLEGFL--RYPKEDRLLPLQ 360
Query: 782 VV 783
+
Sbjct: 361 AM 362
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
E +++ C LG+G FG V K + QE AVK + +S + E+ L+ +L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N++++ + ++ E L FD I +KR + +A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
Y+H+ I+HRDLK N+LL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 52/202 (25%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ ++++ +G G +G V A K++ + + FK E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYL 628
++R+ + + L++E LF+ + K+ + +A RI++ + + Y
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYC 122
Query: 629 HQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
H+ L + HRDLK N L D K+ DFGLA F ++ + VGT Y+S
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVS 176
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
P+ L+GL+ + D +S G++M
Sbjct: 177 PQ-VLEGLYGPECDEWSAGVMM 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHR 569
+ F + KLG G FG V+ +G E +K ++ +S +++ + E+ ++ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW------EARIRIIQGIAQ 623
N+++I + +++E L + I +++ +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL----LERIVSAQARGKALSEGYVA-ELMKQMMN 135
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
L Y H ++H+DLK N+L KI DFGLA +F DE GT
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILM 707
YM+PE + K D++S G++M
Sbjct: 190 ALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 34/223 (15%), Positives = 65/223 (29%), Gaps = 30/223 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR------LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAE 565
++ + LGEG F VY+ N Q+ +K + M +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK------RLLDWEARIRIIQ 619
++ + Q +L+ E + L + I +++ I
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLL-----------DKDMNPKISDFGLARMFGGD 668
+ + +H IIH D+K N +L D + D G +
Sbjct: 180 RMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
T G+ E + ++ + D F + L
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-29
Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
E +++ C LG+G FG V K + QE AVK + +S + E+ L+ +L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N++++ + ++ E L FD I +KR + +A RII+ + G+
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGIT 135
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
Y+H+ I+HRDLK N+LL +KD + KI DFGL+ F + K +GT Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYY 189
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L G + K DV+S G+++
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-29
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
+E + KLG G +G V R E A+K + +S S + E+ ++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N++++ ++ L++E L FD I + + + +A II+ + G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
YLH+ I+HRDLK N+LL +KD KI DFGL+ +F + K +GT Y
Sbjct: 151 YLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYY 204
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
++PE L + K DV+S G+++
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 22/198 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQHRNLVRIL 575
LGEG +G V + AVK L + G K E+ L+ L+H+N+++++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 576 G-CCVEQGEKI-LILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYS 632
E+ +K+ +++EY + + D + +KR +A + GL YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAH-GYFCQLIDGLEYLH--- 126
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-- 690
I+H+D+K N+LL KIS G+A + G+ + PE A
Sbjct: 127 SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186
Query: 691 ---DGLFSIKSDVFSFGI 705
G K D++S G+
Sbjct: 187 DTFSGF---KVDIWSAGV 201
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
+ + K+GEG +G V+K + + VA+KR+ L + E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
EL+H+N+VR+ + L+ E+ + L Y D L + + Q + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF-DSCNGDLDPEIVKSFLFQ-LLK 112
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL + H ++HRDLK N+L++++ K+++FGLAR F G ++ + +V T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWY 167
Query: 684 MSPEYAL-DGLFSIKSDVFSFGILMLETLSSRK 715
P+ L+S D++S G + E ++ +
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-29
Identities = 66/205 (32%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQ 567
++ + Q LG+G FG V + GQE AVK +S + + E+ L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGL 625
H N++++ ++G L+ E L FD I +KR + +A RII+ + G+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGI 139
Query: 626 LYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
Y+H+ +I+HRDLK N+LL KD N +I DFGL+ F + K +GT
Sbjct: 140 TYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAY 193
Query: 683 YMSPEYALDGLFSIKSDVFSFGILM 707
Y++PE L G + K DV+S G+++
Sbjct: 194 YIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 57/187 (30%), Positives = 91/187 (48%), Gaps = 19/187 (10%)
Query: 510 AATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-----LKEFKNEMMLI 563
+++ F KLG G + VYKG G VA+K + S +G ++E L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LM 57
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPN---KSLDVYLFDPIKKRLLDWEARIRIIQG 620
EL+H N+VR+ + + L+ E+M N K +D + L + Q
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ- 116
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ QGL + H+ +I+HRDLK N+L++K K+ DFGLAR F G + + +V T
Sbjct: 117 LLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-T 171
Query: 681 YGYMSPE 687
Y +P+
Sbjct: 172 LWYRAPD 178
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 61/183 (33%), Positives = 95/183 (51%), Gaps = 22/183 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ VA+KR+ L E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
EL H N+V ++ + L+ E+M K L L D K L D + +I + Q + +G
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVL-DENKTGLQDSQIKIYLYQ-LLRG 131
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ + HQ+ RI+HRDLK N+L++ D K++DFGLAR F G ++ T +V T Y
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYR 186
Query: 685 SPE 687
+P+
Sbjct: 187 APD 189
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 56/184 (30%), Positives = 93/184 (50%), Gaps = 22/184 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
ENF K+GEG +G VYK R G+ VA+K++ L E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
EL H N+V++L + + L+ E++ + L ++ + + + Q + Q
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQ-LLQ 114
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL + H + R++HRDLK N+L++ + K++DFGLAR F G ++ T +V T Y
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWY 169
Query: 684 MSPE 687
+PE
Sbjct: 170 RAPE 173
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (293), Expect = 2e-28
Identities = 23/249 (9%), Positives = 54/249 (21%), Gaps = 43/249 (17%)
Query: 501 PLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL---SSQSGQGLKEF 556
+ ++ + L G V+ R + ++ A+K + S L+
Sbjct: 50 ETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERL 109
Query: 557 KNEMMLIAELQHRNLVRILGCC--------------------------VEQGEKILILEY 590
A L + +L++
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169
Query: 591 MP---NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647
F + + A + + + L ++H N+
Sbjct: 170 ASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLF 226
Query: 648 LDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGI 705
+ D + D G Y E+ F+ + + G+
Sbjct: 227 IMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 706 LMLETLSSR 714
+
Sbjct: 282 SIYRVWCLF 290
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 62/195 (31%), Positives = 91/195 (46%), Gaps = 23/195 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
LGEG +G V + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
E + L LEY L FD I + + +A+ R + G++YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGI 126
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------YAL 690
HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-- 184
Query: 691 DGLFSIKSDVFSFGI 705
DV+S GI
Sbjct: 185 HAE---PVDVWSCGI 196
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 52/211 (24%), Positives = 85/211 (40%), Gaps = 25/211 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAE 565
+ + + +G+G F V + GQ+ AVK + +S G ++ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW------EARIRIIQ 619
L+H ++V +L G ++ E+M L I KR A ++
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVAS-HYMR 137
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKR 676
I + L Y H IIHRD+K VLL + K+ FG+A G
Sbjct: 138 QILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGG 192
Query: 677 IVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
VGT +M+PE + DV+ G+++
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 54/183 (29%), Positives = 95/183 (51%), Gaps = 22/183 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLIA 564
E + K+GEG +G VYK + G+ A+K++ L++ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624
EL+H N+V++ + +L+ E++ + L L D + L A+ ++Q + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL-DVCEGGLESVTAKSFLLQ-LLNG 112
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ Y H R++HRDLK N+L++++ KI+DFGLAR F G ++ T IV T Y
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYR 167
Query: 685 SPE 687
+P+
Sbjct: 168 APD 170
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 32/211 (15%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQS---GQGLKEFKNEMMLIA 564
+S LG G FG V+ +EV VK ++ L + E+ +++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
++H N++++L QG L++E + LD LF I RL + A I + +
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGS-GLD--LFAFIDRHPRLDEPLAS-YIFRQLV 140
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
+ YL IIHRD+K N+++ +D K+ DFG A +L GT
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIE 194
Query: 683 YMSPE------YALDGLFSIKSDVFSFGILM 707
Y +PE Y G + +++S G+ +
Sbjct: 195 YCAPEVLMGNPY--RGP---ELEMWSLGVTL 220
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 29/199 (14%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHRNLVRILGC 577
+G+G F V R + G+EVA+K + + + L++ E+ ++ L H N+V++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 578 CVEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+E + + LI+EY + FD + R+ + EAR + I + Y H +
Sbjct: 83 -IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEAR-SKFRQIVSAVQYCH---QK 133
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------Y 688
RI+HRDLKA N+LLD DMN KI+DFG + F G Y +PE Y
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKY 190
Query: 689 ALDGLFSIKSDVFSFGILM 707
DG + DV+S G+++
Sbjct: 191 --DGP---EVDVWSLGVIL 204
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 58/200 (29%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
S LG G FG V+K G ++A K + ++ + +E KNE+ ++ +L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR---LLDWEARIRIIQGIAQGLLYLH 629
++ + + +L++EY+ LFD I L + + I ++ I +G+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDT-ILFMKQICEGIRHMH 204
Query: 630 QYSRLRIIHRDLKASNVLL-DKDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
Q + I+H DLK N+L ++D KI DFGLAR + E K GT +++PE
Sbjct: 205 Q---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPE 258
Query: 688 YALDGLFSIKSDVFSFGILM 707
S +D++S G++
Sbjct: 259 VVNYDFVSFPTDMWSVGVIA 278
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 62/195 (31%), Positives = 91/195 (46%), Gaps = 23/195 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
LGEG +G V + VAVK + + E K E+ + L H N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
E + L LEY L FD I + + +A+ R + G++YLH + I
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQ-RFFHQLMAGVVYLH---GIGI 126
Query: 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------YAL 690
HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF-- 184
Query: 691 DGLFSIKSDVFSFGI 705
DV+S GI
Sbjct: 185 HAE---PVDVWSCGI 196
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-27
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 496 KDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--------RLS 546
+D+ LP S EN+ + LG G V + +E AVK S
Sbjct: 2 RDAALP--GSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFS 59
Query: 547 SQSGQGLKE-FKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI 604
++ Q L+E E+ ++ ++ H N++++ L+ + M L FD +
Sbjct: 60 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYL 115
Query: 605 --KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662
K L + E R +I++ + + + LH+ L I+HRDLK N+LLD DMN K++DFG +
Sbjct: 116 TEKVTLSEKETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 663 RMFGGDELQGNTKRIVGTYGYMSPE 687
E + + GT Y++PE
Sbjct: 172 CQLDPGEK---LREVCGTPSYLAPE 193
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-------------SQSGQGLKEFK 557
E++ KLG G +G V + E A+K + + +E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 558 NEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARI 615
NE+ L+ L H N++++ ++ L+ E+ L F+ I + + + +A
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA- 149
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQG 672
I++ I G+ YLH+ I+HRD+K N+LL + +N KI DFGL+ F D
Sbjct: 150 NIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL- 205
Query: 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
+ +GT Y++PE L ++ K DV+S G++M
Sbjct: 206 --RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 51/181 (28%), Positives = 88/181 (48%), Gaps = 18/181 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-----LKEFKNEMMLIAEL 566
E + KLGEG + VYKG+ VA+K + + +G ++E L+ +L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDL 57
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+H N+V + + L+ EY+ +K L YL D + ++ + Q + +GL
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL-DDCGNIINMHNVKLFLFQ-LLRGLA 114
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
Y H+ +++HRDLK N+L+++ K++DFGLAR + +V T Y P
Sbjct: 115 YCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPP 169
Query: 687 E 687
+
Sbjct: 170 D 170
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ + + +LG G FG V++ G+ K +++ KNE+ ++ +L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYL 628
L+ + ++ E +LILE++ LFD I + I ++ +GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 629 HQYSRLRIIHRDLKASNVLL-DKDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
H+ I+H D+K N++ K + KI DFGLA DE K T + +P
Sbjct: 166 HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAP 219
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E +D+++ G+L
Sbjct: 220 EIVDREPVGFYTDMWAIGVLG 240
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/184 (28%), Positives = 86/184 (46%), Gaps = 19/184 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + +LQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N+VR+ E+ L+ + + L F+ I ++ + +A IQ I + +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 119
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 120 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 173
Query: 684 MSPE 687
+SPE
Sbjct: 174 LSPE 177
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 18/202 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ F LG G F V+ + G+ A+K + +NE+ ++ +++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYL 628
+V + L+++ + LFD I + + +A +IQ + + YL
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-LVIQQVLSAVKYL 122
Query: 629 HQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
H+ I+HRDLK N+L +++ I+DFGL++M + GT GY++
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYVA 175
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
PE +S D +S G++
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVIT 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 50/190 (26%), Positives = 85/190 (44%), Gaps = 26/190 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE---FKNEMML 562
+ + M LG G G V ++VA+K + + S + + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQG 620
+ +L H +++I + + ++LE M L FD + KRL + +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 122
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRI 677
+ + YLH IIHRDLK NVLL ++D KI+DFG +++ G L + +
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 176
Query: 678 VGTYGYMSPE 687
GT Y++PE
Sbjct: 177 CGTPTYLAPE 186
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 58/181 (32%), Positives = 91/181 (50%), Gaps = 14/181 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKN----EMMLIAEL 566
+ + LGEG F VYK R Q VA+K++ K+ E+ L+ EL
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H N++ +L + L+ ++M L+V + D L + ++ QGL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDN-SLVLTPSHIKAYMLM-TLQGLE 126
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YLHQ+ I+HRDLK +N+LLD++ K++DFGLA+ F G + T ++V T Y +P
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQVV-TRWYRAP 181
Query: 687 E 687
E
Sbjct: 182 E 182
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 30/237 (12%), Positives = 70/237 (29%), Gaps = 54/237 (22%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSS---QSGQGLKEFKNEMMLIAELQ--------- 567
LG+ + G+ V +K+ K E++ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 568 ----------------HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI-----KK 606
+ ++R+ + Y +S + +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 607 RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ L AR+++ + + L LH Y ++H L+ +++LD+ ++ F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256
Query: 667 GDELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLS 712
G + G+ PE L + D ++ G+++
Sbjct: 257 -----GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 48/188 (25%), Positives = 87/188 (46%), Gaps = 23/188 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-------RLSSQSGQGLKE-FKNEMML 562
+ + + +G G V + G E AVK RLS + + ++E + E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 563 IAEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQ 619
+ ++ H +++ ++ L+ + M L FD + K L + E R I++
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETR-SIMR 207
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG 679
+ + + +LH I+HRDLK N+LLD +M ++SDFG + E + + G
Sbjct: 208 SLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCG 261
Query: 680 TYGYMSPE 687
T GY++PE
Sbjct: 262 TPGYLAPE 269
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 24/209 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
+++ M +LG G F V K R G+E A K RLSS +E + E+ ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
E++H N++ + + + +LILE + LFD + K+ L + EA + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEAT-QFLKQIL 118
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDELQGNTKRIV 678
G+ YLH RI H DLK N++L + K+ DFG+A K I
Sbjct: 119 DGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIF 172
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILM 707
GT +++PE +++D++S G++
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 1e-26
Identities = 47/249 (18%), Positives = 88/249 (35%), Gaps = 60/249 (24%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKEFKNEMMLIAE 565
+ + ++ +G+G +G V A+K ++ + + ++ K E+ L+ +
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI---------- 615
L H N+ R+ ++ L++E L D + + D +
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL----LDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 616 -------------------------------RIIQGIAQGLLYLHQYSRLRIIHRDLKAS 644
I++ I L YLH I HRD+K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPE 197
Query: 645 NVLL--DKDMNPKISDFGLARMFGGDELQGNT--KRIVGTYGYMSPE--YALDGLFSIKS 698
N L +K K+ DFGL++ F GT +++PE + + K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 699 DVFSFGILM 707
D +S G+L+
Sbjct: 258 DAWSAGVLL 266
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-26
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 26/190 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS--------SQSGQGLKEFKNEMML 562
+ + M LG G G V ++VA++ +S ++ + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQG 620
+ +L H +++I + + ++LE M L FD + KRL + +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCK-LYFYQ 247
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRI 677
+ + YLH+ IIHRDLK NVLL ++D KI+DFG +++ G L + +
Sbjct: 248 MLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTL 301
Query: 678 VGTYGYMSPE 687
GT Y++PE
Sbjct: 302 CGTPTYLAPE 311
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 26/201 (12%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS----------SQSGQGLKEFKNEMMLIAELQHR 569
LG+GGFG V+ G L + +VA+K + S S E + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLY 627
++R+L Q +L+LE P + D LFD I K L + +R + + +
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSR-CFFGQVVAAIQH 154
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
H ++HRD+K N+L+D K+ DFG + + GT Y P
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPP 207
Query: 687 EYALDGLFS-IKSDVFSFGIL 706
E+ + + + V+S GIL
Sbjct: 208 EWISRHQYHALPATVWSLGIL 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 52/188 (27%), Positives = 89/188 (47%), Gaps = 27/188 (14%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN-EMMLIAELQHRN 570
++ +G G FG V++ +L EVA+K++ K FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 571 LVRILGCCVEQGEKI------LILEYMPNKSLDVY----LFDPIKKRLLDWEARIRIIQG 620
+V + G+K L+LEY+P VY + +K+ + ++ + Q
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKLYMYQ- 149
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKRIVG 679
+ + L Y+H + I HRD+K N+LLD K+ DFG A++ + N I
Sbjct: 150 LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPNVSYICS 204
Query: 680 TYGYMSPE 687
Y Y +PE
Sbjct: 205 RY-YRAPE 211
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
+ + + +LG G F V K R G E A K + + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
++ H N++ + + + +LILE + LFD + K+ L + EA I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEA-TSFIKQIL 125
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDELQGNTKRIV 678
G+ YLH +I H DLK N++L + K+ DFGLA K I
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILM 707
GT +++PE +++D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
+ + + +LG G F V K R G E A K + + +E + E+ ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
++ H N++ + + + +LILE + LFD + K+ L + EA I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEA-TSFIKQIL 125
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLL-DKDMNP---KISDFGLARMFGGDELQGNTKRIV 678
G+ YLH +I H DLK N++L DK++ K+ DFGLA K I
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIF 179
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILM 707
GT +++PE +++D++S G++
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-26
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
++N+ ++ +LG+G F V + G E A K + S + ++ + E + +LQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N+VR+ E+ L+ + + L F+ I ++ + +A IQ I + +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFYSEADAS-HCIQQILESIA 142
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
Y H I+HR+LK N+LL K K++DFGLA E GT GY
Sbjct: 143 YCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGY 196
Query: 684 MSPEYALDGLFSIKSDVFSFGILM 707
+SPE +S D+++ G+++
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 24/209 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK-----RLSSQSGQGLKE-FKNEMMLIA 564
+ + +LG G F V K R G + A K R S +E + E+ ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
E+QH N++ + + + ILILE + LFD + K+ L + EA ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEA-TEFLKQIL 124
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARMFGGDELQGNTKRIV 678
G+ YLH L+I H DLK N++L KI DFGLA K I
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 178
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILM 707
GT +++PE +++D++S G++
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-26
Identities = 60/351 (17%), Positives = 115/351 (32%), Gaps = 49/351 (13%)
Query: 383 SNVTEGSGCLMWYGDLLDSRRPIRNFTGQSVYLQVPTSESGNKKLLWILVVLVLPLVLLP 442
N+ + + L W LD + N+T + E+ W
Sbjct: 19 ENILDEAVILSWKPPALDGGSLVTNYT-------IEKREAMGGS--WSPCAKSRYTYTTI 69
Query: 443 SF------YIFCRR---------------RRKCKEKETENTETNQDLLAFDINMGITTRT 481
Y F E + D I
Sbjct: 70 EGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDV----DEQGKIVRGK 125
Query: 482 NEFGEVNGDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEV 540
+ + P +++ + +LG G FG V++ G
Sbjct: 126 GTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNF 185
Query: 541 AVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYL 600
A K + + + + E+ ++ L+H LV + + E ++I E+M L
Sbjct: 186 AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS----GGEL 241
Query: 601 FDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL-DKDMNP-KI 656
F+ + + + + + ++ + +GL ++H+ +H DLK N++ K N K+
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKL 298
Query: 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707
DFGL + + K GT + +PE A +D++S G+L
Sbjct: 299 IDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 49/185 (26%), Positives = 78/185 (42%), Gaps = 25/185 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
E + K+GEG +G V+K R GQ VA+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVY-LFDPIKKRLLDWEARIRIIQGIA 622
+L+H NLV +L + L+ EY V D ++ + + + Q
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSITWQ-TL 112
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
Q + + H++ IHRD+K N+L+ K K+ DFG AR+ + T
Sbjct: 113 QAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVA-TRW 167
Query: 683 YMSPE 687
Y SPE
Sbjct: 168 YRSPE 172
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 49/221 (22%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLS-------------------SQSGQGLKEFKNEM 560
+G+G +G V + A+K LS + G + + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 561 MLIAE-------LQHRNLVRILGCCVEQGEK---ILILEYMPNKSLDVYLFD-PIKKRLL 609
+ + L H N+V+ L ++ + ++ E + + + P K L
Sbjct: 81 EQVYQEIAILKKLDHPNVVK-LVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF-GGD 668
+ +AR Q + +G+ YLH +IIHRD+K SN+L+ +D + KI+DFG++ F G D
Sbjct: 136 EDQAR-FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD 191
Query: 669 ELQGNTKRIVGTYGYMSPEYALDGLFSI----KSDVFSFGI 705
L VGT +M+PE +L I DV++ G+
Sbjct: 192 AL---LSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGV 228
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 30/209 (14%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAEL 566
+ + LG GGFG VY G + + VA+K + E++L+ ++
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 567 QHR--NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIA 622
++R+L +LILE P D LFD I + L + AR +
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVL 159
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+ + + H ++HRD+K N+L+D + K+ DFG + GT
Sbjct: 160 EAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTR 212
Query: 682 GYMSPEYAL----DGLFSIKSDVFSFGIL 706
Y PE+ G + V+S GIL
Sbjct: 213 VYSPPEWIRYHRYHGR---SAAVWSLGIL 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMM---------L 562
E + +GEG +G V K R G+ VA+K+ L+ ++M+ L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKL 77
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIA 622
+ +L+H NLV +L C ++ L+ E++ + ++ L + L + + Q I
Sbjct: 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL-ELFPNGLDYQVVQKYLFQ-II 134
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
G+ + H + IIHRD+K N+L+ + K+ DFG AR + + T
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYDDEVA-TRW 189
Query: 683 YMSPE 687
Y +PE
Sbjct: 190 YRAPE 194
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/189 (29%), Positives = 81/189 (42%), Gaps = 29/189 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
+ + KLGEG +G VYK + VA+KR+ L+ + E+ L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
ELQHRN++ + LI EY L Y+ + + + Q +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDK--NPDVSMRVIKSFLYQ-LIN 143
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-----KISDFGLARMFGGDELQGNTKRIV 678
G+ + H R +HRDLK N+LL KI DFGLAR F G ++ T I+
Sbjct: 144 GVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII 199
Query: 679 GTYGYMSPE 687
T Y PE
Sbjct: 200 -TLWYRPPE 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 41/202 (20%), Positives = 82/202 (40%), Gaps = 18/202 (8%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
E + + LG G FG V++ + + K + G K E+ ++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRN 62
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW---EARIRIIQGIAQGLLY 627
++ + E ++I E++ +F+ I + E + + + + L +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREI-VSYVHQVCEALQF 117
Query: 628 LHQYSRLRIIHRDLKASNVLL--DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
LH I H D++ N++ + KI +FG AR + + + Y +
Sbjct: 118 LHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYA 171
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
PE + S +D++S G L+
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLV 193
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 62/200 (31%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVK---RLSSQSGQGLKEFKNEMMLIAELQHRNLVRILG 576
LG G FG V G G +VAVK R +S + + K E+ + +H +++++
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 577 CCVEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+ +++EY+ L FD I R+ + EAR R+ Q I + Y H R
Sbjct: 79 V-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCH---R 129
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------ 687
++HRDLK NVLLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 186
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + D++S G+++
Sbjct: 187 Y--AGP---EVDIWSCGVIL 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-25
Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 29/217 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKN-EMMLIAELQHR 569
+++ +G G FG VY+ +L +G+ VA+K++ K FKN E+ ++ +L H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 570 NLVRILGCCVEQGEKI------LILEYMPNKSLDVY----LFDPIKKRLLDWEARIRIIQ 619
N+VR+ GEK L+L+Y+P VY + K+ L ++ + Q
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVIYVKLYMYQ 164
Query: 620 GIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNTKRIV 678
+ + L Y+H I HRD+K N+LLD D K+ DFG A+ E N I
Sbjct: 165 -LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYIC 218
Query: 679 GTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSR 714
Y Y +PE ++ DV+S G ++ E L +
Sbjct: 219 SRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-25
Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 18/184 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQH 568
TE + + +LG+G F V + + GQE A + S + ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLL 626
N+VR+ E+G LI + + L F+ I ++ + +A IQ I + +L
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEADAS-HCIQQILEAVL 124
Query: 627 YLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
+ HQ + ++HR+LK N+LL K K++DFGLA G+ Q GT GY
Sbjct: 125 HCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGY 179
Query: 684 MSPE 687
+SPE
Sbjct: 180 LSPE 183
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 46/189 (24%), Positives = 86/189 (45%), Gaps = 30/189 (15%)
Query: 519 CKLGEGGFGPVYKGR---LFNGQEVAVKRLS----SQSGQGLKEFKNEMMLIAELQHRNL 571
CK+G G +G VYK + + ++ A+K++ S S E+ L+ EL+H N+
Sbjct: 27 CKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR------EIALLRELKHPNV 80
Query: 572 VRILGCCVEQGEKI--LILEYMPN---KSLDVYLFDPIKKRLLDWEARIR--IIQGIAQG 624
+ + + ++ L+ +Y + + + K+ + + ++ I G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNP----KISDFGLARMFG--GDELQGNTKRIV 678
+ YLH ++HRDLK +N+L+ + KI+D G AR+F L +V
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 679 GTYGYMSPE 687
T+ Y +PE
Sbjct: 198 -TFWYRAPE 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 22/199 (11%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR-NLVRIL 575
+LG G F V + GQE A K + + E +E+ ++ + ++ +
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDW----EARIRIIQGIAQGLLYLHQY 631
E ILILEY + F L + + R+I+ I +G+ YLHQ
Sbjct: 96 EVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSENDVI-RLIKQILEGVYYLHQ- 149
Query: 632 SRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
I+H DLK N+LL + KI DFG++R G + I+GT Y++PE
Sbjct: 150 --NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEI 204
Query: 689 ALDGLFSIKSDVFSFGILM 707
+ +D+++ GI+
Sbjct: 205 LNYDPITTATDMWNIGIIA 223
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 51/179 (28%), Positives = 73/179 (40%), Gaps = 20/179 (11%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCC 578
LGEG V L QE AVK + Q G E+ ++ + Q HRN++ ++
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
E+ L+ E M S+ I KR + EA ++Q +A L +LH I
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELEAS-VVVQDVASALDFLHN---KGI 132
Query: 637 IHRDLKASNVLL---DKDMNPKISDFGLARMF-----GGDELQGNTKRIVGTYGYMSPE 687
HRDLK N+L ++ KI DF L G+ YM+PE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 30/193 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKN----EMMLIAEL 566
+ F ++ G+G FG V G+ G VA+K++ F+N M +A L
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-----PRFRNRELQIMQDLAVL 76
Query: 567 QHRNLVRILGCCVEQGEK-------ILILEYMPNKSLDVY----LFDPIKKRLLDWEARI 615
H N+V++ GE+ +++EY+P ++ + + ++
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPILIKV 133
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP-KISDFGLARMFGGDELQGNT 674
+ Q + + + LH S + + HRD+K NVL+++ K+ DFG A+ E N
Sbjct: 134 FLFQ-LIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NV 189
Query: 675 KRIVGTYGYMSPE 687
I Y Y +PE
Sbjct: 190 AYICSRY-YRAPE 201
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 3e-24
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 30/200 (15%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILG 576
LG G FG V G+ G +VAVK L+ Q S + + + E+ + +H +++++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 577 CCVEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+ I +++EY+ L FD I RL + E+R R+ Q I G+ Y H R
Sbjct: 84 V-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESR-RLFQQILSGVDYCH---R 134
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------ 687
++HRDLK NVLLD MN KI+DFGL+ M E + G+ Y +PE
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRL 191
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + D++S G+++
Sbjct: 192 Y--AGP---EVDIWSSGVIL 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 45/201 (22%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN--------EMMLI 563
+ K+G+G FG V+K R GQ+VA+K++ ++ K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 564 AELQHRNLVRILGCCVEQGEKI--------LILEYMPN------KSLDVYLFDPIKKRLL 609
L+H N+V ++ C + L+ ++ + ++ V KR++
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG--- 666
+ GL Y+H+ +I+HRD+KA+NVL+ +D K++DFGLAR F
Sbjct: 131 --------QM-LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 667 GDELQGNTKRIVGTYGYMSPE 687
+ T R+V T Y PE
Sbjct: 179 NSQPNRYTNRVV-TLWYRPPE 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 63/200 (31%), Positives = 98/200 (49%), Gaps = 31/200 (15%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQ--SGQGLKE-FKNEMMLIAELQHRNLVRILG 576
LGEG FG V Q+VA+K +S Q + + E+ + L+H +++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 577 CCVEQGEKI-LILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+ I +++EY + LFD I KKR+ + E R R Q I + Y H R
Sbjct: 77 V-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGR-RFFQQIICAIEYCH---R 126
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------ 687
+I+HRDLK N+LLD ++N KI+DFGL+ + K G+ Y +PE
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKL 183
Query: 688 YALDGLFSIKSDVFSFGILM 707
Y G + DV+S GI++
Sbjct: 184 Y--AGP---EVDVWSCGIVL 198
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 23/172 (13%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKN----EMMLI 563
AT + ++G G +G VYK R +G VA+K R+ + G G E+ L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGG-GGGGLPISTVREVALL 65
Query: 564 AELQ---HRNLVRILGCCVEQGEKI-----LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
L+ H N+VR++ C L+ E++ ++ L YL D L I
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLP-AETI 122
Query: 616 R-IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
+ +++ +GL +LH I+HRDLK N+L+ K++DFGLAR++
Sbjct: 123 KDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
E+F LGEG F V R +E A+K L + + E +++ L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 569 RNLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKK--RLLDWEARIRIIQGIAQG 624
V++ Q ++ L L Y N L I+K + R + I
Sbjct: 90 PFFVKLYFTF--QDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAE-IVSA 142
Query: 625 LLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
L YLH IIHRDLK N+LL++DM+ +I+DFG A++ + Q VGT Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLS 712
SPE + SD+++ G ++ + ++
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
++ F ++ +LG G VY+ + + A+K L + K + E+ ++ L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYL 628
++++ E L+LE + L FD I K + +A ++ I + + YL
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA-DAVKQILEAVAYL 164
Query: 629 HQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
H+ I+HRDLK N+L D KI+DFGL+++ L K + GT GY +
Sbjct: 165 HE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCA 218
Query: 686 PEYALDGLFSIKSDVFSFGILM 707
PE + + D++S GI+
Sbjct: 219 PEILRGCAYGPEVDMWSVGIIT 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 51/201 (25%), Positives = 80/201 (39%), Gaps = 30/201 (14%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNE-MMLIAELQHRNLVRILGC 577
LG G G V + GQ+ A+K L + + E ++V IL
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDV 90
Query: 578 CVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDW----EARIRIIQGIAQGLLYLH 629
+I+E M L F I++R EA I++ I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 630 QYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
I HRD+K N+L +KD K++DFG A+ + LQ T Y++P
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT----PCYTPYYVAP 198
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E + D++S G++M
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIM 219
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 20/183 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
T+ + ++ +G G + + E AVK + +E +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYL 628
++ + + ++ E M L D I +K + EA ++ I + + YL
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSEREAS-AVLFTITKTVEYL 132
Query: 629 HQYSRLRIIHRDLKASNVLL-DKDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H ++HRDLK SN+L D+ NP +I DFG A+ + G T ++
Sbjct: 133 HA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE--NGLLMTPCYTANFV 187
Query: 685 SPE 687
+PE
Sbjct: 188 APE 190
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 46/172 (26%), Positives = 89/172 (51%), Gaps = 29/172 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR--LFNGQEVAVKRLSSQSGQGLKEFKN--------EMML 562
+ + ++GEG +G V+K R G+ VA+KR+ ++ + E+ +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 563 IAELQ---HRNLVRILGCCV----EQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEAR 614
+ L+ H N+VR+ C ++ K+ L+ E++ ++ L YL D + + + E
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666
++ + +GL +LH + R++HRDLK N+L+ K++DFGLAR++
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 59/197 (29%), Positives = 85/197 (43%), Gaps = 30/197 (15%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQHRNLVRILGCC 578
+G G FG R + VAVK + G + E + E++ L+H N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636
+ +I+EY L ++ I R + EAR Q + G+ Y H ++I
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEAR-FFFQQLLSGVSYCH---SMQI 137
Query: 637 IHRDLKASNVLLDKD--MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE------Y 688
HRDLK N LLD KI DFG ++ K VGT Y++PE Y
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLRQEY 194
Query: 689 ALDGLFSIKSDVFSFGI 705
DG +DV+S G+
Sbjct: 195 --DGK---IADVWSCGV 206
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 50/195 (25%), Positives = 88/195 (45%), Gaps = 20/195 (10%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGC 577
LGEG F K + Q AVK +S + + E+ + + H N+V++
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKR--LLDWEARIRIIQGIAQGLLYLHQYSRLR 635
+Q L++E + L F+ IKK+ + EA I++ + + ++H +
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETEAS-YIMRKLVSAVSHMHD---VG 126
Query: 636 IIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
++HRDLK N+L + ++ KI DFG AR+ D K T Y +PE
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAPELLNQN 184
Query: 693 LFSIKSDVFSFGILM 707
+ D++S G+++
Sbjct: 185 GYDESCDLWSLGVIL 199
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 7e-22
Identities = 63/254 (24%), Positives = 105/254 (41%), Gaps = 35/254 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAE------ 565
+ F LG GGFG V+ ++ ++ A K+L+ + LK+ K + E
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR---LKKRKGYQGAMVEKKILAK 241
Query: 566 LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQ 623
+ R +V L E + L++ M + ++++ + E R I
Sbjct: 242 VHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS 300
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL +LHQ II+RDLK NVLLD D N +ISD GLA + TK GT G+
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGF 355
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-WDLWKHERVHE 742
M+PE L + D F+ G+ + E ++ + + ++
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIA----------------ARGPFRARGEKVENK 399
Query: 743 LMDPVILQDEIPLP 756
+ +L+ + P
Sbjct: 400 ELKQRVLEQAVTYP 413
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-22
Identities = 27/201 (13%), Positives = 60/201 (29%), Gaps = 45/201 (22%)
Query: 520 KLGEGGFGPVYKG---RLFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVR 573
G ++ L ++VA+ + Q L+E + + ++ + + R
Sbjct: 38 FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+L + +++ E++ SL + A IR +Q +A H R
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQ----EVADTSPSPVGA-IRAMQSLAAAADAAH---R 147
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL 693
+ S V + D + ++ M
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------ 179
Query: 694 FSIKSDVFSFGILMLETLSSR 714
+ + D+ G + L +R
Sbjct: 180 -NPQDDIRGIGASLYALLVNR 199
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 1e-21
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 28/212 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMMLIAE------ 565
+FS+ +G GGFG VY R + ++ A+K L + +K + E + + E
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETLALNERIMLSL 245
Query: 566 ---LQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQG 620
+V + +K+ IL+ M L +L + + EA +R
Sbjct: 246 VSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFS-EADMRFYAAE 300
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
I GL ++H +++RDLK +N+LLD+ + +ISD GLA F + VGT
Sbjct: 301 IILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
Query: 681 YGYMSPEYALDGLFSIKS-DVFSFGILMLETL 711
+GYM+PE G+ S D FS G ++ + L
Sbjct: 354 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 45/201 (22%), Positives = 79/201 (39%), Gaps = 29/201 (14%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGC 577
LG G G V + ++ A+K L + + E+ L ++VRI+
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123
Query: 578 CVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDW----EARIRIIQGIAQGLLYLH 629
+++E + L F I+ R EA I++ I + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 178
Query: 630 QYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
+ I HRD+K N+L + K++DFG A+ + T Y++P
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAP 232
Query: 687 EYALDGLFSIKSDVFSFGILM 707
E + D++S G++M
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIM 253
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 6e-21
Identities = 61/250 (24%), Positives = 106/250 (42%), Gaps = 30/250 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQ---SGQGLKEFKNEMMLIAELQH 568
F LG+GGFG V ++ ++ A K+L + +G NE ++ ++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
R +V L E + + L+L M L +++ + + A + I GL
Sbjct: 244 RFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLED 301
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH R RI++RDLK N+LLD + +ISD GLA + K VGT GYM+PE
Sbjct: 302 LH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE 355
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-WDLWKHERVHELMDP 746
+ ++ D ++ G L+ E ++ G + + K + E ++
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIA----------------GQSPFQQRKKKIKREEVER 399
Query: 747 VILQDEIPLP 756
++ +
Sbjct: 400 LVKEVPEEYS 409
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 75/358 (20%), Positives = 122/358 (34%), Gaps = 109/358 (30%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQG-LKEFKNEM----- 560
+ + LG G FG V + F + VAVK L + + +E+
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 561 ---------------------MLIAEL-QHRNLVRIL-------------GCCVEQGEKI 585
M+I E + NL L G QG+
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 586 LILEYMPNKS-LDVYLFDPIKKRLLDWEAR------------------------IRIIQG 620
+ + K LD E + I
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL---QGNTKRI 677
+A+G+ +L + + IHRDL A N+LL + KI DFGLAR D +G+ +
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 678 VGTYGYMSPEYALDGLFSIKSDVFSFGILMLE--TLSSRKNTGV-YNTDSFNLLGHAWDL 734
+ +M+PE D +++I+SDV+SFG+L+ E +L + GV + + L +
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 315
Query: 735 WK----HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+++ M L C + RPT S++V + N
Sbjct: 316 RAPDYTTPEMYQTM---------------------LDCWHGEPSQRPTFSELVEHLGN 352
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-20
Identities = 50/249 (20%), Positives = 100/249 (40%), Gaps = 61/249 (24%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKN-EMMLIAELQHR 569
++ +S+ LG G FG V + +G+ A+K++ +KN E+ ++ L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKVLDHV 60
Query: 570 NLVRILGCCVEQGEKI--------------------------------------LILEYM 591
N+++++ G++ +I+EY+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 592 PNKSLDVY----LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647
P ++ F + + I I Q + + + ++H L I HRD+K N+L
Sbjct: 121 P---DTLHKVLKSFIRSGRSIPMNLISIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLL 173
Query: 648 LD-KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGI 705
++ KD K+ DFG A+ + + I + Y +PE L ++ D++S G
Sbjct: 174 VNSKDNTLKLCDFGSAKKL--IPSEPSVAYICSRF-YRAPELMLGATEYTPSIDLWSIGC 230
Query: 706 LMLETLSSR 714
+ E + +
Sbjct: 231 VFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 35/219 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + +G G G V + VA+K+LS + F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELV 76
Query: 562 LIAELQHRNLVRIL-----GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
L+ + H+N++ +L +E+ + + +++E M D L I+ L
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSY 131
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ Q + G+ +LH IIHRDLK SN+++ D KI DFGLAR G +
Sbjct: 132 LLYQ-MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 186
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
V T Y +PE L + D++S G +M E +
Sbjct: 187 --VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 3e-19
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + +G G G V + VA+K+LS + F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-------RPFQNQTHAKRAYRELV 113
Query: 562 LIAELQHRNLVRIL------GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
L+ + H+N++ +L E + L++E M D L I+ L
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ Q + G+ +LH IIHRDLK SN+++ D KI DFGLAR G +
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MT 221
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
V T Y +PE L + D++S G +M E + +
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 48/210 (22%), Positives = 95/210 (45%), Gaps = 21/210 (10%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HR 569
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGP 91
Query: 570 NLVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
N++ + + + L+ E++ N + L D++ R + + I + L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE-ILKALDY 145
Query: 628 LHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
H S I+HRD+K NV++D + ++ D+GLA Q R+ Y + P
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVASRY-FKGP 199
Query: 687 EYALDGLFSIKS-DVFSFGILMLETLSSRK 715
E +D S D++S G ++ + ++
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 3e-18
Identities = 45/199 (22%), Positives = 89/199 (44%), Gaps = 41/199 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + ++ +G G +G V + + VA+K++ + F++ E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIA 104
Query: 562 LIAELQHRNLVRILGCCV----EQGEKI-LILEYMPN------KSLDVYLFDPIKKRLLD 610
++ L H ++V++L + E+ +++ ++LE + ++ VYL + K LL
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLL- 162
Query: 611 WEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
+ G+ Y+H S I+HRDLK +N L+++D + K+ DFGLAR E
Sbjct: 163 -------YN-LLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
Query: 671 QGNTKRIVGTYGYMSPEYA 689
+ I M+
Sbjct: 212 GNSQLPISPREDDMNLVTF 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 38/220 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + +G G +G V +G++VA+K+LS + F++ E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLS-------RPFQSEIFAKRAYRELL 75
Query: 562 LIAELQHRNLVRIL-----GCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
L+ +QH N++ +L + L++ +M L + + + + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130
Query: 616 RIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK 675
+ Q + +GL Y+H ++HRDLK N+ +++D KI DFGLAR E+ G
Sbjct: 131 LVYQ-MLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGY-- 183
Query: 676 RIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSR 714
V T Y +PE L ++ D++S G +M E L+ +
Sbjct: 184 --VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ LG GG G V+ + VA+K++ Q +K E+ +I L H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDP---------IKKRLLDWEARIR-IIQG 620
+V++ G ++ + VY+ +++ L E R +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL-EEHARLFMYQ 128
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGN--TKRI 677
+ +GL Y+H + ++HRDLK +N+ ++ +D+ KI DFGLAR+ ++ +
Sbjct: 129 LLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 678 VGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSR 714
V T Y SP L ++ D+++ G + E L+ +
Sbjct: 186 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
E+F + +G G FG V +L N +V A+K L+ E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
+ + L + + L+++Y L + L + RL + AR + + + +
Sbjct: 134 KWITT-LHYAFQDDNNLYLVMDYYVGGDL-LTLLSKFEDRLPEEMARFYLAE-MVIAIDS 190
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
+HQ L +HRD+K N+L+D + + +++DFG D + VGT Y+SPE
Sbjct: 191 VHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPE 246
Query: 688 YALDGLFSIKS-----DVFSFGILMLETL 711
D +S G+ M E L
Sbjct: 247 ILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 52/204 (25%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
+ F LG G FG V + +G A+K L Q LK+ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
LV++ + +++EY+ + +L R + AR Q I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRFSEPHARFYAAQ-IVLTFEYL 157
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H +I+RDLK N+L+D+ +++DFG A+ ++G T + GT ++PE
Sbjct: 158 HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
L ++ D ++ G+L+ E +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 49/227 (21%), Positives = 85/227 (37%), Gaps = 40/227 (17%)
Query: 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKE--FKN---------EM 560
+++Q + G +G V G G VA+KR+ + G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 561 MLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP---------IKKRLLDW 611
L+ H N++ + + + + +YL I + +
Sbjct: 81 RLLNHFHHPNILGLRD---------IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVI 131
Query: 612 -EARIR--IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
I+ + I GL LH+ ++HRDL N+LL + + I DF LAR D
Sbjct: 132 SPQHIQYFMYH-ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 669 ELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSR 714
N V Y +PE + F+ D++S G +M E + +
Sbjct: 188 A---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 19/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
++F + +G G F V ++ +V A+K ++ E F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
R + + L + + L++EY L + L +R+ AR + + I +
Sbjct: 121 RWITQ-LHFAFQDENYLYLVMEYYVGGDL-LTLLSKFGERIPAEMARFYLAE-IVMAIDS 177
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
+H+ L +HRD+K N+LLD+ + +++DFG D + VGT Y+SPE
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR-SLVAVGTPDYLSPE 233
Query: 688 -------YALDGLFSIKSDVFSFGILMLETL 711
G + + D ++ G+ E
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 41/224 (18%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
++ +GEG +G V N VA+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 562 LIAELQHRNLVRILGC----CVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIR 616
++ +H N++ I +EQ + + ++ + M + L+ +K + L I
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLS-NDHIC 131
Query: 617 --IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+ Q I +GL Y+H S ++HRDLK SN+LL+ + KI DFGLAR+ D +T
Sbjct: 132 YFLYQ-ILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPDHDHT 185
Query: 675 KRI---VGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSR 714
+ V T Y +PE L+ ++ D++S G ++ E LS+R
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 37/156 (23%), Positives = 62/156 (39%), Gaps = 26/156 (16%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNE-MMLIAELQHRNLVRILGC 577
LG G G V + ++ A+K L + + E + Q ++VRI+
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 578 CVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDW----EARIRIIQGIAQGLLYLH 629
+++E + L F I+ R EA I++ I + + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREAS-EIMKSIGEAIQYLH 134
Query: 630 QYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLA 662
+ I HRD+K N+L + K++DFG A
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 79.2 bits (194), Expect = 5e-16
Identities = 37/203 (18%), Positives = 63/203 (31%), Gaps = 46/203 (22%)
Query: 507 SVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRL--------SSQSGQGLKEFKN 558
S TE K+GEG FG V++ + VA+K + + + +E
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILP 72
Query: 559 EMMLIAELQ---------HRNLVRILGCCVEQGE--KILILEYM--------PNKSLDVY 599
E+++ EL + + QG +L+ + N D +
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 600 ----------------LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643
+ ++ +L I+ + L LR HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 644 SNVLLDKDMNPKISDFGLARMFG 666
NVLL K K+ +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSST 213
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 55/223 (24%), Positives = 96/223 (43%), Gaps = 43/223 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ +G G +G V G +VA+K+L + F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLY-------RPFQSELFAKRAYRELR 76
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP---------IKKRLLDWE 612
L+ ++H N++ +L + + + D YL P +K L +
Sbjct: 77 LLKHMRHENVIGLL--------DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128
Query: 613 ARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672
++ + +GL Y+H IIHRDLK N+ +++D KI DFGLAR E+ G
Sbjct: 129 RIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEMTG 184
Query: 673 NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSR 714
V T Y +PE L+ ++ D++S G +M E ++ +
Sbjct: 185 Y----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 7e-16
Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKE---FKNEMMLIAELQH 568
E++ + +G G FG V R + ++V A+K LS + F E ++A
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
+V+ L + + +++EYMP L + + + AR + + L
Sbjct: 129 PWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAE-VVLALDA 183
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
+H + IHRD+K N+LLDK + K++DFG + + VGT Y+SPE
Sbjct: 184 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPE 239
Query: 688 ----YALDGLFSIKSDVFSFGILMLETL 711
DG + + D +S G+ + E L
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEML 267
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 8e-16
Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKN---EMMLIAELQH 568
++F + +G+G FG V + + A+K ++ Q E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLL 626
LV L + E + ++++ + L +L + E +++ I + L
Sbjct: 75 PFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHLQ---QNVHFK-EETVKLFICELVMALD 129
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YL RIIHRD+K N+LLD+ + I+DF +A M + + GT YM+P
Sbjct: 130 YLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 687 EYALDGLFSIKS---DVFSFGILMLETLSSR 714
E + S D +S G+ E L R
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 38/194 (19%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ +F ++ LGEG +G V G+ VA+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 562 LIAELQHRNLVRILGC----CVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIR 616
++ +H N++ I E ++ +I E M L I ++L + I+
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLS-DDHIQ 115
Query: 617 --IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
I Q + + LH + +IHRDLK SN+L++ + + K+ DFGLAR+ DE +
Sbjct: 116 YFIYQ-TLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DESAADN 169
Query: 675 KRIVGTYGYMSPEY 688
G M E+
Sbjct: 170 SEPTGQQSGMV-EF 182
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 41/198 (20%), Positives = 79/198 (39%), Gaps = 33/198 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+N+ ++ +G G +G VY + VA+K+++ + F++ E+
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREIT 77
Query: 562 LIAELQHRNLVRILGCCVEQGEKI-----LILEYMPNKSLDVYLFDPIKKRLLDWEARIR 616
++ L+ ++R+ + ++LE D L K + E I+
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLKKLFKTPIFLTEEHIK 132
Query: 617 --IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+ + G ++H IIHRDLK +N LL++D + K+ DFGLAR ++
Sbjct: 133 TILYN-LLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 675 KRIVGTYGYMSPEYALDG 692
+ L
Sbjct: 189 NDLEENEEPGPHNKNLKK 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 75.6 bits (187), Expect = 6e-15
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 15/204 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
++F + LG G FG V+ R NG+ A+K L + LK+ +E ++++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++R+ G + + +I++Y+ L L +R + A+ + + L YL
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAE-VCLALEYL 122
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H II+RDLK N+LLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 123 HSKD---IIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLS 712
++ D +SFGIL+ E L+
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-15
Identities = 64/224 (28%), Positives = 101/224 (45%), Gaps = 45/224 (20%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
E + +G G +G V G VAVK+LS + F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-------RPFQSIIHAKRTYRELR 80
Query: 562 LIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDP---------IKKRLLDWE 612
L+ ++H N++ +L + + DVYL +K + L +
Sbjct: 81 LLKHMKHENVIGLL--------DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT-D 131
Query: 613 ARIR-IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671
++ +I I +GL Y+H IIHRDLK SN+ +++D KI DFGLAR DE+
Sbjct: 132 DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT-ADEMT 187
Query: 672 GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSR 714
G V T Y +PE L+ ++ D++S G +M E L+ R
Sbjct: 188 GY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 32/197 (16%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN---------EMM 561
+ + KLG+G +G V+K G+ VAVK++ F+N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIM 60
Query: 562 LIAELQ-HRNLVRILGCCV-EQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIR-- 616
++ EL H N+V +L + + L+ +YM + L I+ +L+ +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILE-PVHKQYV 114
Query: 617 IIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR 676
+ Q + + + YLH S ++HRD+K SN+LL+ + + K++DFGL+R F N
Sbjct: 115 VYQ-LIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 677 IVGTYGYMSPEYALDGL 693
+ + + L
Sbjct: 171 LSINENTENFDDDQPIL 187
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
F LG+G FG V + A+K L + E E ++ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLL 626
L L + +++ ++EY L +L ++R+ E R R I L
Sbjct: 208 PFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLS---RERVFS-EDRARFYGAEIVSALD 262
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
YLH S +++RDLK N++LDKD + KI+DFGL + + G K GT Y+
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT----MKTFCGTPEYL 316
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETL 711
+PE D + D + G++M E +
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 2e-14
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 36/216 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSSQSGQGLKEF---KNEMMLIAE 565
F + LG+G FG V+ + +G + A+K L K ++ + E
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKME 76
Query: 566 ---LQHRN---LVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI- 617
L N +V+ L + K+ LIL+++ L F + K ++ E ++
Sbjct: 77 RDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFY 131
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTK 675
+ +A L +LH L II+RDLK N+LLD++ + K++DFGL++ + +
Sbjct: 132 LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK----AY 184
Query: 676 RIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
GT YM+PE + +D +SFG+LM E L
Sbjct: 185 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 62/253 (24%), Positives = 109/253 (43%), Gaps = 31/253 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
++F + +G G + V RL + A+K + + ++
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
H LV L C + ++ ++EY+ L ++ ++R L E R I+ L
Sbjct: 69 HPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP-EEHARFYSAEISLAL 123
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGY 683
YLH+ II+RDLK NVLLD + + K++D+G+ + + GD T GT Y
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNY 176
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743
++PE + D ++ G+LM E ++ R F+++G + D L
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSS-DNPDQNTEDYL 227
Query: 744 MDPVILQDEIPLP 756
VIL+ +I +P
Sbjct: 228 FQ-VILEKQIRIP 239
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 5e-14
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEF---KNEMMLIAELQH 568
+F LG+G FG V R A+K L + E E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGLL 626
L L + +++ ++EY L F ++R+ E R R I L
Sbjct: 65 PFLTA-LKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFT-EERARFYGAEIVSALE 119
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGYM 684
YLH +++RD+K N++LDKD + KI+DFGL + + G K GT Y+
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----TMKTFCGTPEYL 172
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSR 714
+PE D + D + G++M E + R
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
+F +G+G FG V R + AVK L ++ KE K+ M L+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIAQGL 625
H LV L + +K+ +L+Y+ L F +++ E R R IA L
Sbjct: 98 HPFLVG-LHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAEIASAL 152
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGY 683
YLH L I++RDLK N+LLD + ++DFGL + + T GT Y
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS----TTSTFCGTPEY 205
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETL 711
++PE + D + G ++ E L
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEML 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 61/253 (24%), Positives = 109/253 (43%), Gaps = 31/253 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
++F + +G G + V RL + A++ + + ++
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
H LV L C + ++ ++EY+ L ++ ++R L E R I+ L
Sbjct: 112 HPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQ---RQRKLP-EEHARFYSAEISLAL 166
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGY 683
YLH+ II+RDLK NVLLD + + K++D+G+ + + GD T GT Y
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT----TSTFCGTPNY 219
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743
++PE + D ++ G+LM E ++ R F+++G + D L
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRS--------PFDIVGSS-DNPDQNTEDYL 270
Query: 744 MDPVILQDEIPLP 756
VIL+ +I +P
Sbjct: 271 FQ-VILEKQIRIP 282
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 8e-14
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
L + L C + +++ ++EY+ L I++ E IA GL
Sbjct: 401 PPFLTQ-LHSCFQTMDRLYFVMEYVNGG----DLMYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGY 683
+L II+RDLK NV+LD + + KI+DFG+ + ++ G TK GT Y
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDY 508
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETL 711
++PE + D ++FG+L+ E L
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 56/208 (26%), Positives = 91/208 (43%), Gaps = 21/208 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
+F+ LG+G FG V E+ AVK L + + M+ L +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
L + L C + +++ ++EY+ L I++ E IA GL
Sbjct: 80 PPFLTQ-LHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGY 683
+L II+RDLK NV+LD + + KI+DFG+ + ++ G TK GT Y
Sbjct: 135 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV----TTKTFCGTPDY 187
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETL 711
++PE + D ++FG+L+ E L
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEML 215
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 9e-14
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEM----MLIAELQ 567
E+F + LG+G FG V+ + A+K L + + M +L +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
H L + C + E + ++EY+ L ++ D +R I GL
Sbjct: 77 HPFLTH-MFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFD-LSRATFYAAEIILGL 131
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGTYGY 683
+LH I++RDLK N+LLDKD + KI+DFG+ + M G T GT Y
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA----KTNTFCGTPDY 184
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETL 711
++PE L ++ D +SFG+L+ E L
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEML 212
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 1e-13
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 24/211 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSSQS-GQGLKEF---KNEMMLIA 564
E F + LG+GG+G V++ R G A+K L + K+ K E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 565 ELQHRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRI-IQGIA 622
E++H +V L + G K+ LILEY+ L F +++ + E + I+
Sbjct: 77 EVKHPFIVD-LIYAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAEIS 131
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR--MFGGDELQGNTKRIVGT 680
L +LHQ II+RDLK N++L+ + K++DFGL + + G T GT
Sbjct: 132 MALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV----THTFCGT 184
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETL 711
YM+PE + + D +S G LM + L
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDML 215
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV-AVKRLSSQSGQGLKEFKNEMM----LIAELQ 567
+NF LG+G FG V R+ ++ AVK L + + M L
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 568 HRNLVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQG-IAQGL 625
H L + L CC + +++ ++E++ L I+K EAR R I L
Sbjct: 83 HPFLTQ-LFCCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA--RMFGGDELQGNTKRIVGTYGY 683
++LH II+RDLK NVLLD + + K++DFG+ + G T GT Y
Sbjct: 138 MFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT----TATFCGTPDY 190
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
++PE + L+ D ++ G+L+ E L
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-13
Identities = 21/126 (16%), Positives = 46/126 (36%), Gaps = 19/126 (15%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+ +T + G+ L + L ++ T VW +N
Sbjct: 2 NLLTNGEGLYAGQSLDVE--PYHFIMQEDCN-----LVLYDH---STSVWASNTGIL-GK 50
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
+ + ++GN V+ ++W+++ N V L++DGN+VI + +
Sbjct: 51 KGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------I 102
Query: 146 WQSFDH 151
W + +
Sbjct: 103 WSTGTY 108
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-12
Identities = 28/128 (21%), Positives = 49/128 (38%), Gaps = 19/128 (14%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+++++ + + G L + L ++ VW +N G
Sbjct: 2 NSLSSPNSLFTGHSL-EVGPSYRLIMQGDCN-----FVLYDS---GKPVWASNTGGL--G 50
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
LT+ NNGNLV+ Q+N IW T + + V L+ D N+VI +
Sbjct: 51 SGCRLTLHNNGNLVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGPV--------V 102
Query: 146 WQSFDHPS 153
W + P+
Sbjct: 103 WATGSGPA 110
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 7e-12
Identities = 27/124 (21%), Positives = 52/124 (41%), Gaps = 18/124 (14%)
Query: 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPIS 84
+D + + + G L + + L ++ + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN---NRAVWASGTNGK-- 48
Query: 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESY 144
VL + N+GNLV+ S + IW++N + N L+ D N+VI DNS+++
Sbjct: 49 ASGCVLKMQNDGNLVIYSG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNA----- 102
Query: 145 LWQS 148
+W +
Sbjct: 103 IWAT 106
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 9e-05
Identities = 18/69 (26%), Positives = 34/69 (49%), Gaps = 1/69 (1%)
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAE 142
++ + I N+ NLVL N +W++ + V ++++DGNLVI S A
Sbjct: 16 LAEGGYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGSRAIWAS 74
Query: 143 SYLWQSFDH 151
+ Q+ ++
Sbjct: 75 NTNRQNGNY 83
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 52/218 (23%), Positives = 87/218 (39%), Gaps = 44/218 (20%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFK-------NEMMLIAELQH 568
KLG G F V+ + + N VA+K + E K + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 569 RNLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEAR---IRIIQGI 621
+++++L +G ++ E L L IKK +E R + ++ I
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKK----YEHRGIPLIYVKQI 136
Query: 622 AQ----GLLYLHQYSRLRIIHRDLKASNVLLDKDMNP------KISDFGLARMFGGDELQ 671
++ GL Y+H R IIH D+K NVL++ +P KI+D G A + +
Sbjct: 137 SKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHY- 192
Query: 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
+ T Y SPE L + +D++S L+ E
Sbjct: 193 ---TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFE 227
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-11
Identities = 24/123 (19%), Positives = 41/123 (33%), Gaps = 20/123 (16%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+ + + + L + + L + L + +W +N DR G
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCN-----LVKYQN---GRQIWASNTDR--RG 50
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
LT+ ++GNLV+ N +W + D L+ DG VI L
Sbjct: 51 SGCRLTLLSDGNLVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGPV--------L 102
Query: 146 WQS 148
W
Sbjct: 103 WSL 105
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 68/266 (25%), Positives = 109/266 (40%), Gaps = 55/266 (20%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEV----AVKRLSSQSGQGLKEF-----------K 557
ENF + LG G +G V+ R +G + A+K L K +
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-------KATIVQKAKTTEHTR 106
Query: 558 NEMMLIAELQHRN-LVRILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARI 615
E ++ ++ LV L + K+ LIL+Y+ L +L ++ E +
Sbjct: 107 TERQVLEHIRQSPFLVT-LHYAFQTETKLHLILDYINGGELFTHLS---QRERFT-EHEV 161
Query: 616 RI-IQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+I + I L +LH+ L II+RD+K N+LLD + + ++DFGL++ F DE +
Sbjct: 162 QIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-A 217
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDV--FSFGILMLETLSSRKNTGVYNTDSFNLLGHA- 731
GT YM+P+ G V +S G+LM E L G +
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE----------------LLTGASP 261
Query: 732 -WDLWKHERVHELMDPVILQDEIPLP 756
+ E+ IL+ E P P
Sbjct: 262 FTVDGEKNSQAEISR-RILKSEPPYP 286
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-11
Identities = 18/78 (23%), Positives = 34/78 (43%), Gaps = 10/78 (12%)
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNL 130
+ +W N G + +G LV+++ N T+W + V+ + V L+ D N+
Sbjct: 48 NNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
Query: 131 VIRDNSSDSTAESYLWQS 148
VI ++ LW +
Sbjct: 106 VIYGDA--------LWAT 115
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-08
Identities = 20/88 (22%), Positives = 31/88 (35%), Gaps = 6/88 (6%)
Query: 61 YLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNP 120
+ P + + + + + NLVL N IW+TN
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLVL-YDNNNPIWATNTGGLGNGC 63
Query: 121 VAQLRDDGNLVIRDNSSDSTAESYLWQS 148
A L+ DG LV+ N + +WQS
Sbjct: 64 RAVLQPDGVLVVITNEN-----VTVWQS 86
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 3e-11
Identities = 65/491 (13%), Positives = 141/491 (28%), Gaps = 174/491 (35%)
Query: 397 DLLDSRRPIRNFTGQSV--YLQVPTSESGNKKLLWIL-------VVLVLPLVLLPSF-YI 446
D+ D + I + + + + + SG +L W L V + VL ++ ++
Sbjct: 37 DVQDMPKSI--LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFL 94
Query: 447 FCRRRRKCKEKE--TENTETNQDLLAFDINMGIT----TRTNEFGEVN------------ 488
+ + ++ T +D L ++ N +R + ++
Sbjct: 95 MSPIKTEQRQPSMMTRMYIEQRDRL-YNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNV 153
Query: 489 ------GDGKDKGKDSWLPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAV 542
G GK +W+ ++ +QCK+ F +
Sbjct: 154 LIDGVLGSGK-----TWV-------ALDVCLSYKVQCKMDFKIF---W------------ 186
Query: 543 KRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFD 602
L+ LK + ++ LQ L+ + ++ N
Sbjct: 187 --LN------LKNCNSPETVLEMLQ--KLLYQIDPNWTSRS-----DHSSN--------- 222
Query: 603 PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI----SD 658
IK R+ +A +R LL Y ++ +++ + +++ KI
Sbjct: 223 -IKLRIHSIQAELRR-------LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRF 274
Query: 659 FGLARMFGGDELQGNTK---RIVGTYGYMSPEYALDGLFS--IKSDVFS----------F 703
+ D L T + ++P+ L +
Sbjct: 275 KQVT-----DFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDLPREVLTTNPR 328
Query: 704 GILML-ETLSSRKNTGVYNTDSFNLLGHAWDLWKH---ERVHELM-------DP------ 746
+ ++ E++ T WD WKH +++ ++ +P
Sbjct: 329 RLSIIAESIRDGLAT--------------WDNWKHVNCDKLTTIIESSLNVLEPAEYRKM 374
Query: 747 ----VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFV 802
+ +P LL + V ++ N+ L V
Sbjct: 375 FDRLSVFPPSAHIPT-------ILLSLIWFDVI----KSDVMVVVNKLHK----YSL--V 417
Query: 803 KGKNVKNSSYS 813
+ K K S+ S
Sbjct: 418 E-KQPKESTIS 427
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.2 bits (111), Expect = 2e-05
Identities = 41/304 (13%), Positives = 94/304 (30%), Gaps = 93/304 (30%)
Query: 15 FLFSMKASLAADTMTTASFIR--DGEKLTSSSQRFELGFFSPGKSKSRY--LGIWFRRVP 70
S+ A D + T + + +KLT+ + L P + + + L + F P
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESS-LNVLEPAEYRKMFDRLSV-F---P 382
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNL 130
+ I +L++ IW + SDV V +L L
Sbjct: 383 PSA--------HIP--TILLSL---------------IWFDVIKSDVMVVVNKLHKYS-L 416
Query: 131 VIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLER-LLSSWQSA-----EDPS 184
V + + + ++ ++K+ + + L R ++ + +D
Sbjct: 417 VEKQPKEST---ISI-----P---SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465
Query: 185 PGR-----YTYGLDIHVLP-----KMCTFN----------GSVKFTCSGQWDGTGFVSAL 224
P Y++ + H+ +M F ++ + W+ +G +
Sbjct: 466 PPYLDQYFYSH-IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTA-WNASGSILNT 523
Query: 225 SYTNFIYKQFMTENKD----------EFVYWYEA--YNRP--SIMTLKL-NPSGFV---- 265
YK ++ +N +F+ E ++ + L +
Sbjct: 524 LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEA 583
Query: 266 TRQI 269
+Q+
Sbjct: 584 HKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 1e-04
Identities = 40/336 (11%), Positives = 87/336 (25%), Gaps = 116/336 (34%)
Query: 14 IFLFSM----KASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRV 69
+ + + K +A D S + +
Sbjct: 153 VLIDGVLGSGKTWVALDVC--------------LSYKVQCKM------------------ 180
Query: 70 PDTVVW--VANRDRPISGRNAVLTISNN------GNLV-LLSQTNGTIWSTNVSSDVKNP 120
+ W + N + P VL + N ++ +
Sbjct: 181 DFKIFWLNLKNCNSP----ETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 121 VAQLRDDGN-LVIRDNSSDSTAESYLWQSFDHPSDTLL--QDMKLGWDFKSGLERLLSSW 177
+ + + N L++ N ++ W +F+ LL + ++ DF S +
Sbjct: 237 LLKSKPYENCLLVLLNVQNAK----AWNAFNLSCKILLTTRFKQVT-DFLSAATT---TH 288
Query: 178 QSAEDPSPG-----------RYTYGLDIHVLPK-MCTFNGSVKFTCS----------GQW 215
S + S +Y LP+ + T N S W
Sbjct: 289 ISLDHHSMTLTPDEVKSLLLKYL-DCRPQDLPREVLTTN---PRRLSIIAESIRDGLATW 344
Query: 216 DGT-------------GFVSALSYTNF--IYKQFMTENKDEFV-------YWYEA-YNRP 252
D ++ L + ++ + + W++ +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV 404
Query: 253 SIMTLKLNPSGFVTRQIWDENSNKWDELFSVPDQYC 288
++ KL+ V +Q E++ S+P Y
Sbjct: 405 MVVVNKLHKYSLVEKQ-PKEST------ISIPSIYL 433
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 45/187 (24%), Positives = 80/187 (42%), Gaps = 26/187 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQH- 568
+ + K+G G FG +Y G + G+EVA+K + ++ Q E K + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK----IYKMMQGG 64
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+ I C E ++++E + SL+ LF+ R + + + + + Y+
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLE-DLFN-FCSRKFSLKTVLLLADQMISRIEYI 121
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPK---ISDFGLARMFGGDELQGNT-------KRIV 678
H + IHRD+K N L+ I DFGLA+ + + + + K +
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY--RDARTHQHIPYRENKNLT 176
Query: 679 GTYGYMS 685
GT Y S
Sbjct: 177 GTARYAS 183
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 4e-11
Identities = 27/123 (21%), Positives = 48/123 (39%), Gaps = 20/123 (16%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+ + + + GE L + R+ L ++ D +W N
Sbjct: 2 NILYSGETLSPGEFLNN--GRYVFIMQEDCN-----LVLYDV---DKPIWATNTGGL--D 49
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
R L++ ++GNLV+ S N IW++N + N V L+ D N+VI +
Sbjct: 50 RRCHLSMQSDGNLVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGTA--------R 101
Query: 146 WQS 148
W +
Sbjct: 102 WAT 104
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 7e-11
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 22/185 (11%)
Query: 514 NFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
NF + K+G G FG + G+ L+ + VA+K +S + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIP 68
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ ++LE + SL+ LFD + R + + I + + Y+H +
Sbjct: 69 QVYYFGPCGKYNAMVLELL-GPSLE-DLFD-LCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 633 RLRIIHRDLKASNVLLDKDMNPK-----ISDFGLARMFGGDELQGNT-------KRIVGT 680
+I+RD+K N L+ + N I DF LA+ + + + K + GT
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY--IDPETKKHIPYREHKSLTGT 180
Query: 681 YGYMS 685
YMS
Sbjct: 181 ARYMS 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 31/201 (15%), Positives = 75/201 (37%), Gaps = 34/201 (16%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR---------LFNGQEVAVKRLSSQSGQGLKEFK------ 557
+ ++ G +Y+ Q+ ++K L ++ G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 558 -----NEMMLIAELQHRNLVRILGCCVEQGE-KILILEYMPNKSLDVYLFDPIKKRLLDW 611
N+ + + +G V Q + + L+L + +SL D K +L
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ-SALDVSPKHVLSE 158
Query: 612 EARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI--SDFGLARMF--GG 667
+ +++ + L +LH+ +H ++ A N+ +D + ++ + +G A + G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 668 DEL---QGNTKRIVGTYGYMS 685
+ +G+ G ++S
Sbjct: 216 KHVAYVEGSRSPHEGDLEFIS 236
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 40/187 (21%), Positives = 82/187 (43%), Gaps = 24/187 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
++ + ++GEG FG +++G L N Q+VA+K S + Q E++ +L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---T 66
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
+ + E +L+++ + SL+ L D + R + + + + +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLE-DLLD-LCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPK-----ISDFGLARMFGGDELQGN------TKRIV 678
+ S +++RD+K N L+ + + + DFG+ + + D + K +
Sbjct: 124 EKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY-RDPVTKQHIPYREKKNLS 179
Query: 679 GTYGYMS 685
GT YMS
Sbjct: 180 GTARYMS 186
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 45/179 (25%), Positives = 78/179 (43%), Gaps = 24/179 (13%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRNLV-RIL 575
K+G G FG +Y G + +EVA+K + ++ Q L E K + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNVR 69
Query: 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLR 635
VE +L+++ + SL+ LF+ ++ L + + + + + ++H S
Sbjct: 70 WFGVEGDYNVLVMDLL-GPSLE-DLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS--- 123
Query: 636 IIHRDLKASNVLLDKDMNPK---ISDFGLARMFGGDELQG------NTKRIVGTYGYMS 685
+HRD+K N L+ I DFGLA+ + D K + GT Y S
Sbjct: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY-RDTSTHQHIPYRENKNLTGTARYAS 181
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 5e-10
Identities = 24/118 (20%), Positives = 42/118 (35%), Gaps = 15/118 (12%)
Query: 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRP 82
L + + + + L + F+L Y G W +
Sbjct: 1 LGTNYLLSGQTLDTEGHLKNG--DFDLVMQDDCNL-VLYNGNW-----QSNTAN------ 46
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDST 140
+GR+ LT+++ G LV+ + T+W + S N A + DG LV+ S
Sbjct: 47 -NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGPSVFKI 103
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 38/198 (19%), Positives = 75/198 (37%), Gaps = 42/198 (21%)
Query: 520 KLGEGGFGPVYKGRLFNGQ------EVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR 573
+G+GGFG +Y + + + VK S +G E K Q + +R
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 574 IL-------------GCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRII 618
G + G+ +I++ L +++ KR + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ-KIYEANAKRF-----SRKTV 154
Query: 619 QGIAQGLL----YLHQYSRLRIIHRDLKASNVLLDKDMNPKI--SDFGLARMFGGDEL-- 670
++ +L Y+H++ +H D+KASN+LL+ ++ D+GLA + + +
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
Query: 671 ---QGNTKRIVGTYGYMS 685
+ GT + S
Sbjct: 212 AYAADPKRCHDGTIEFTS 229
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 1e-09
Identities = 23/110 (20%), Positives = 43/110 (39%), Gaps = 13/110 (11%)
Query: 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRP 82
+ + + + +LT+ + +L L ++ W +N
Sbjct: 4 FTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLY----GGKYGWQSNTHG- 51
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVI 132
+G + L +++ G L++ TIWS+ SS V L+DDG VI
Sbjct: 52 -NGEHCFLRLNHKGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-07
Identities = 16/71 (22%), Positives = 31/71 (43%), Gaps = 7/71 (9%)
Query: 78 NRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSS 137
D ++ +N L + + NLVL W +N + ++ +L G L+I+D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYGGK--YGWQSNTHGNGEHCFLRLNHKGELIIKDDDF 73
Query: 138 DSTAESYLWQS 148
+ +W S
Sbjct: 74 KT-----IWSS 79
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-09
Identities = 15/125 (12%), Positives = 45/125 (36%), Gaps = 18/125 (14%)
Query: 24 AADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPI 83
+ + ++ + D +L + + + L + + +VW +
Sbjct: 5 VRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKGSKTNIVWESGTSG-- 54
Query: 84 SGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAES 143
G++ + + ++G L + T++ +N + V L+ +G V+ +
Sbjct: 55 RGQHCFMRLGHSGELDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYGPA------- 107
Query: 144 YLWQS 148
+W +
Sbjct: 108 -VWST 111
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 22/206 (10%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFK--NEMMLIAELQH 568
+ + +G+G FG V K + VA+K + ++ Q E + M
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRIIQGIAQGL 625
+V + + + L+ E L L+D ++ R + + Q + L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGY 683
L+L L IIH DLK N+LL KI DFG + G + + I + Y
Sbjct: 171 LFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS-CQLGQRI---YQYIQSRF-Y 224
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLE 709
SPE L + + D++S G +++E
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 37/199 (18%), Positives = 72/199 (36%), Gaps = 47/199 (23%)
Query: 520 KLGEGGFGPVYKG-RLFNGQEVA---VKRLSSQSGQGLKEFKNEMML-----IAELQHRN 570
K+G GGFG +Y ++ A VK ++G E K + I + R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 571 LVRILG----------CCVEQGEKILILEYMPNKSLDVYLFDPIKK-------RLLDWEA 613
+ LG + + +++E + L + +L
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKSTVLQLGI--- 158
Query: 614 RIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI--SDFGLARMFGGDEL- 670
R++ + Y+H+ +H D+KA+N+LL ++ +D+GL+ + +
Sbjct: 159 --RMLDVLE----YIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 671 ----QGNTKRIVGTYGYMS 685
+ K GT + S
Sbjct: 210 KQYQENPRKGHNGTIEFTS 228
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 3e-08
Identities = 19/79 (24%), Positives = 29/79 (36%), Gaps = 10/79 (12%)
Query: 70 PDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGN 129
D VW N G + NG + +L+ N +W++ S V L+ D N
Sbjct: 167 RDDRVWSTNTAGK--GTGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRN 224
Query: 130 LVIRDNSSDSTAESYLWQS 148
L I + LW +
Sbjct: 225 LAIYGGA--------LWTT 235
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 44.9 bits (105), Expect = 5e-05
Identities = 17/90 (18%), Positives = 36/90 (40%), Gaps = 6/90 (6%)
Query: 65 WFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQL 124
+ + D + + + L++ + NLVL + +WSTN + A L
Sbjct: 129 YSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVL-FDRDDRVWSTNTAGKGTGCRAVL 187
Query: 125 RDDGNLVIRDNSSDSTAESYLWQSFDHPSD 154
+ +G + + N + + +W S + S
Sbjct: 188 QPNGRMDVLTNQNIA-----VWTSGNSRSA 212
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 41.1 bits (95), Expect = 7e-04
Identities = 19/123 (15%), Positives = 37/123 (30%), Gaps = 9/123 (7%)
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNL 130
D VW +N + ++G LV+L+ N WS+ + N V L+ D +
Sbjct: 44 DVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTV 100
Query: 131 VIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTY 190
I + S + G + + + + Y
Sbjct: 101 TIYGPGLWDSGTSNKGSVVVA------NNGNSILYSTQGNDNHPQTLHATQSLQLSPYRL 154
Query: 191 GLD 193
++
Sbjct: 155 SME 157
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 32/204 (15%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHR------N 570
+G+G FG V K Q VA+K + ++ Q +E + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRIIQGIAQGLLY 627
++ +L + + E L + L++ IKK + + I Q L
Sbjct: 161 VIHMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
LH + RIIH DLK N+LL + K+ DFG + + + + + Y +
Sbjct: 216 LH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CYEHQRVY----TYIQSRFYRA 267
Query: 686 PEYALDGLFSIKSDVFSFGILMLE 709
PE L + + D++S G ++ E
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAE 291
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 13/81 (16%), Positives = 30/81 (37%), Gaps = 8/81 (9%)
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAE 142
+S +A + + NLVL + + +N + +L + G L I +S++
Sbjct: 17 LSYESAAFVMQGDCNLVLYN--EAGGFQSNTHGRGVDCTLRLNNRGQLEIHSANSNTPV- 73
Query: 143 SYLWQSFDHPSDT----LLQD 159
+++ + L
Sbjct: 74 -WVYPRSVNTVRGNYAATLGP 93
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-05
Identities = 15/81 (18%), Positives = 33/81 (40%), Gaps = 13/81 (16%)
Query: 71 DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGT---IWSTNVSSDVKNPVAQLRDD 127
+ + +N G + L ++N G L + S + T ++ +V++ N A L D
Sbjct: 37 EAGGFQSNTHG--RGVDCTLRLNNRGQLEIHSANSNTPVWVYPRSVNTVRGNYAATLGPD 94
Query: 128 GNLVIRDNSSDSTAESYLWQS 148
++ I + +W +
Sbjct: 95 QHVTIYGPA--------IWST 107
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.9 bits (115), Expect = 3e-06
Identities = 17/117 (14%), Positives = 32/117 (27%), Gaps = 15/117 (12%)
Query: 42 SSSQRFELGFFSPGKSKSRYLGIWFRRVP----DTVVWVANRDRPISGRNAVLTISNNGN 97
+ G + V W A +GN
Sbjct: 150 APGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQ---GKGAVRAVFQGDGN 206
Query: 98 LVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSD 154
LV+ N +W ++ + + V +L+ +G++ I D +W F
Sbjct: 207 LVVYGAGNAVLWHSH-TGGHASAVLRLQANGSIAILDEKP-------VWARFGFQPT 255
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.0 bits (110), Expect = 1e-05
Identities = 33/171 (19%), Positives = 53/171 (30%), Gaps = 20/171 (11%)
Query: 21 ASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRD 80
+ + + G+ L S +QRF+L G L I VWVAN
Sbjct: 10 NGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQD---NGATVWVANEQ 61
Query: 81 RPISG------RNAVLTISNNGNLVLLSQTNGTIW-----STNVSSDVKNPVAQLRDDGN 129
+P S + A L L + +W + + L+DDGN
Sbjct: 62 QPFSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGN 121
Query: 130 LVIRDNSSDSTAESYLWQSFDH-PSDTLLQDMKLGWDFKSGLERLLSSWQS 179
+V+ D+ + + S L +L G +Q
Sbjct: 122 IVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQG 172
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 50/266 (18%), Positives = 85/266 (31%), Gaps = 90/266 (33%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVK---RLSSQSGQGLKEFKNEMML--IAELQ-----H 568
KLG G F V+ + + VA+K + L E + +L +
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIR---LLKSVRNSDPNDPNR 100
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEAR-----------IRI 617
+V++L G N + +F+ + LL W + +I
Sbjct: 101 EMVVQLLDDFKISG---------VNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 618 IQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----------------------------- 648
IQ + QGL YLH ++ RIIH D+K N+LL
Sbjct: 152 IQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSA 209
Query: 649 --------------------DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
+ + KI+D G A + + T Y S E
Sbjct: 210 VSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC-WVHKHFTE----DIQTRQYRSLEV 264
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSR 714
+ ++ +D++S + E +
Sbjct: 265 LIGSGYNTPADIWSTACMAFELATGD 290
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 46/235 (19%), Positives = 78/235 (33%), Gaps = 64/235 (27%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQH- 568
+ + LGEG FG V + +VA+K + + E I L+
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-------INVLKKI 73
Query: 569 --------RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRI 617
V + G + E L F+ +K+ + +
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCIAFE-----LLGKNTFEFLKENNFQPYP----LPH 124
Query: 618 IQGIAQGLL----YLHQYSRLRIIHRDLKASNVLLDKDMNP------------------- 654
++ +A L +LH ++ H DLK N+L
Sbjct: 125 VRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSI 181
Query: 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
+++DFG A F + IV T Y PE L+ ++ DV+S G ++ E
Sbjct: 182 RVADFGSA-TFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 51/231 (22%), Positives = 85/231 (36%), Gaps = 52/231 (22%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHR- 569
F + K+G+G FG V + + N + AVK + + E ++ ++Q+
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDD 92
Query: 570 ----NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRIIQGIA 622
N+V+ G + LI E L L++ I + I I+
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFH----IEDIKLYC 143
Query: 623 QGLL----YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR-- 676
+L YL ++ + H DLK N+LLD K G TK
Sbjct: 144 IEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 677 ------------------IVGTYGYMSPEYALDGLFSIKSDVFSFGILMLE 709
I+ T Y +PE L+ + + SD++SFG ++ E
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 7e-05
Identities = 52/236 (22%), Positives = 85/236 (36%), Gaps = 66/236 (27%)
Query: 515 FSMQCKLGEGGFGPVYKG--RLFNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQH- 568
+ + LGEG FG V + G+ VAVK + + E I L+H
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-------IQVLEHL 68
Query: 569 --------RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK---RLLDWEARIRI 617
V++L G ++ E L + +D IK+ +
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICIVFE-----LLGLSTYDFIKENGFLPFR----LDH 119
Query: 618 IQGIAQGLL----YLHQYSRLRIIHRDLKASNVLLDKDMNP------------------- 654
I+ +A + +LH ++ H DLK N+L +
Sbjct: 120 IRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLE 709
K+ DFG A + + +V T Y +PE L L +S DV+S G +++E
Sbjct: 177 KVVDFGSA-TYDDEHH----STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIE 226
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 31/149 (20%), Positives = 55/149 (36%), Gaps = 30/149 (20%)
Query: 529 VYKGRLFNGQEVAVK--RLSSQSGQGLKE--------FKNEMMLIAELQHRNLVRILGCC 578
V+ E VK ++ S + +KE F + A + R L ++ G
Sbjct: 106 VFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA 165
Query: 579 V----EQGEKILILEYMPNKSL-DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
V +++E + K L V + +P +LD L + ++
Sbjct: 166 VPKVYAWEGNAVLMELIDAKELYRVRVENP--DEVLD------------MILEEVAKFYH 211
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLA 662
I+H DL NVL+ ++ I DF +
Sbjct: 212 RGIVHGDLSQYNVLVSEEG-IWIIDFPQS 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.85 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.82 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.8 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.77 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.75 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.71 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.63 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.61 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.6 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.59 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.54 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.52 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.32 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.23 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.15 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.08 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.99 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.98 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.97 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.87 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.76 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.69 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.45 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.44 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.38 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.25 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.19 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.82 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.3 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.24 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.05 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.01 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.86 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.83 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.48 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.41 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.02 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.96 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.28 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.69 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 89.56 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-53 Score=453.08 Aligned_cols=261 Identities=26% Similarity=0.435 Sum_probs=216.9
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 367889999999999999999863 46789999998777777788999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhccccc----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCee
Q 003274 586 LILEYMPNKSLDVYLFDPI----------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 655 (834)
||||||++|+|.++|.... ....++|.++++|+.|||+||+|||+++ |+||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999995421 2356999999999999999999999987 99999999999999999999
Q ss_pred ecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhh
Q 003274 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||...... ++. ..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--~~~----~~ 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVI----EC 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHH----HH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHH----HH
Confidence 999999997755444333344679999999999999999999999999999999998 89998653321 111 01
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
...+. ....+...+.++.+|+.+||+.||++||||.||++.|+++..
T Consensus 243 i~~~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11110 112334456789999999999999999999999999988743
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-52 Score=454.66 Aligned_cols=260 Identities=26% Similarity=0.426 Sum_probs=209.2
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++++|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 367888899999999999999864 47889999998777777788999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhccccc------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC
Q 003274 586 LILEYMPNKSLDVYLFDPI------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN 653 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~ 653 (834)
||||||++|+|.++|.... ....++|.++++|+.|||+||+|||+++ |+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 9999999999999986432 2346999999999999999999999987 999999999999999999
Q ss_pred eeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchh
Q 003274 654 PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAW 732 (834)
Q Consensus 654 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 732 (834)
+||+|||+++.+.............||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~---- 270 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AI---- 270 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HH----
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HH----
Confidence 99999999998765554444455689999999999999999999999999999999999 899986433211 11
Q ss_pred hhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 733 DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.....+. ....+...+.++.+|+.+||+.||++||||.||++.|+.+.
T Consensus 271 ~~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 271 DCITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 0111100 11233445678899999999999999999999999998874
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=447.55 Aligned_cols=258 Identities=29% Similarity=0.450 Sum_probs=213.6
Q ss_pred cCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
.++.+.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 45667789999999999999863 46789999997653 334678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC
Q 003274 586 LILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~ 652 (834)
||||||++|+|.++|.... ....++|.++++|+.|||+||+|||+++ |+||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 9999999999999985421 2356999999999999999999999987 99999999999999999
Q ss_pred CeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccch
Q 003274 653 NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHA 731 (834)
Q Consensus 653 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~ 731 (834)
.+||+|||+++.+...+.........||+.|||||++.++.|+.++|||||||+||||+| |+.||...... ++..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~--~~~~-- 258 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVVE-- 258 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH--HHHH--
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH--HHHH--
Confidence 999999999998765544444555689999999999999999999999999999999998 88998643321 1111
Q ss_pred hhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 732 WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 732 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+. ....+...+.++.+|+.+||+.||++||||.||++.|+..
T Consensus 259 --~i~~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 259 --MIRNRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHcCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111110 1123444567899999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-51 Score=438.94 Aligned_cols=265 Identities=26% Similarity=0.417 Sum_probs=206.5
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.++||+|+||+||+|++. ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 367888999999999999999864 35999998653 33456789999999999999999999999865 56899999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||++|+|.++|.. ....+++.++++|+.|||+||+|||+++ |+||||||+||||++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999853 3456999999999999999999999987 9999999999999999999999999998765444
Q ss_pred ccCCceeeeccCcccCceeecC---CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
........+||+.|||||++.+ ..|+.++|||||||+||||+||+.||........ + ....... ...+
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~----~~~~~~~----~~~p 257 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-I----IFMVGRG----YASP 257 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H----HHHHHTT----CCCC
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-H----HHHHhcC----CCCC
Confidence 3334455689999999999964 4699999999999999999999999864332110 0 0011000 1111
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPK 797 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~ 797 (834)
.+ ...+...+..+.+|+.+||+.||++||||.||++.|+.+. .+.|+
T Consensus 258 ~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~--~~lpk 304 (307)
T 3omv_A 258 DL--SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ--HSLPK 304 (307)
T ss_dssp CS--TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH--TTCCC
T ss_pred Cc--ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh--ccCCC
Confidence 11 1223345678899999999999999999999999998763 34443
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=429.20 Aligned_cols=272 Identities=25% Similarity=0.310 Sum_probs=203.4
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----eEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----EKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV~ 588 (834)
++|.+.++||+|+||+||+|++ .|+.||||+++..... ...+..|+..+.+++|||||+++++|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999987 5899999999654321 222345666667889999999999998764 579999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-----RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
|||++|+|.++|. ...++++.+++++.|+++||+|||++. .++|+||||||+||||+.++.+||+|||+++
T Consensus 81 Ey~~~gsL~~~l~----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 9999999999984 346899999999999999999999862 3459999999999999999999999999998
Q ss_pred ecCCCCcc--CCceeeeccCcccCceeecCC------CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch----
Q 003274 664 MFGGDELQ--GNTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA---- 731 (834)
Q Consensus 664 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~---- 731 (834)
........ ......+||+.|||||++.+. .++.++|||||||+||||+||++|++.............
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 87543321 223346799999999999764 467899999999999999999988765433221111110
Q ss_pred -hhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 732 -WDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 732 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
..........+.+++.+.......+....+.+|+.+||+.||++||||.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 00000000111222222111122345678899999999999999999999999998763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=437.86 Aligned_cols=268 Identities=28% Similarity=0.404 Sum_probs=217.7
Q ss_pred cHHHHHHHhcCcccccccccCCcEeEEEEEecC------ccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCC-CceeeEE
Q 003274 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQH-RNLVRIL 575 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H-~niv~l~ 575 (834)
.....+...++|++.++||+|+||+||+|+... ++.||||++..... ...+.|.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 334445567899999999999999999998532 46899999976543 345679999999999965 8999999
Q ss_pred EEEEeC-CeEEEEEEecCCCCcchhcccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 003274 576 GCCVEQ-GEKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDL 641 (834)
Q Consensus 576 ~~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dl 641 (834)
|+|.+. +..+||||||++|+|.++|..... ...+++.+++.++.|||+||+|||+++ ||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence 999775 568999999999999999964322 345899999999999999999999998 999999
Q ss_pred CCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCC
Q 003274 642 KASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVY 720 (834)
Q Consensus 642 k~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~ 720 (834)
||+||||++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765544444445689999999999999999999999999999999998 89998654
Q ss_pred CCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 721 NTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..... + ......+ . ....+.....++.+++.+||+.||++|||+.||++.|+++
T Consensus 292 ~~~~~-~----~~~i~~g---------~-~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KIDEE-F----CRRLKEG---------T-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSHH-H----HHHHHHT---------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHH-H----HHHHHcC---------C-CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 32211 1 0111111 0 1123334566889999999999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=430.22 Aligned_cols=263 Identities=22% Similarity=0.240 Sum_probs=209.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|.+.++||+|+||.||+|+. .+|+.||||+++.... ..+|+.++++++|||||++++++.+++..+||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 5688889999999999999985 4589999999975422 246999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-CeeecccccceecCCCCc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 670 (834)
++|+|.++|. +.+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+.....
T Consensus 133 ~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999984 3467999999999999999999999988 99999999999999987 699999999998754332
Q ss_pred cC---CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 671 QG---NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 671 ~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|++||........ .. ....... .
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~---~i~~~~~-------~ 274 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CL---KIASEPP-------P 274 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HH---HHHHSCC-------G
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HH---HHHcCCC-------C
Confidence 21 22346799999999999999999999999999999999999999975432211 10 0100000 0
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCcc
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLT 800 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~~~ 800 (834)
....+......+.+++.+||+.||++|||+.|+++.|.....++..-+.|+
T Consensus 275 --~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw 325 (336)
T 4g3f_A 275 --IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPW 325 (336)
T ss_dssp --GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCS
T ss_pred --chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCC
Confidence 011233445688999999999999999999999998876544433333333
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=430.53 Aligned_cols=249 Identities=22% Similarity=0.315 Sum_probs=208.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+.+..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999864 68999999997665566677899999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 154 ~gg~L~~~l~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-- 224 (346)
T 4fih_A 154 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 224 (346)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--
T ss_pred CCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--
Confidence 9999999883 346999999999999999999999998 9999999999999999999999999999875433
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ... ..+.. ...+. .
T Consensus 225 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~----~~i~~-----~~~~~---~ 290 (346)
T 4fih_A 225 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAM----KMIRD-----NLPPR---L 290 (346)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH----HHHHH-----SSCCC---C
T ss_pred CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHH----HHHHc-----CCCCC---C
Confidence 2234468999999999999999999999999999999999999998643211 111 00000 00011 1
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........++.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 291 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234568899999999999999999999975
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=430.32 Aligned_cols=250 Identities=23% Similarity=0.385 Sum_probs=202.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+.+..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 7899999999999999999985 46899999998654 33456789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
||++|+|.++|.. .+...+++.+++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999843 23446789999999999999999999998 9999999999999999999999999998764321
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+. .... .. ..
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~---~~i~-~~--------~~- 242 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NLV---LKII-SG--------SF- 242 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH---HHHH-HT--------CC-
T ss_pred --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHH---HHHH-cC--------CC-
Confidence 1223467999999999999999999999999999999999999999643221 111 0010 00 00
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1122334568899999999999999999999986
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=423.47 Aligned_cols=248 Identities=25% Similarity=0.332 Sum_probs=210.0
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||+||+++. .+++.||||++.+. .....+.+.+|+++|++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6799999999999999999985 56899999999653 2345678999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. +.+.+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999983 4567999999999999999999999998 999999999999999999999999999987655
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.........+||+.|||||++.+..|+.++||||+||+||||++|+.||...+.. .+.. .....
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~----~i~~~---------- 249 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LIFA----KIIKL---------- 249 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHT----------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHH----HHHcC----------
Confidence 4444455678999999999999999999999999999999999999999643211 1110 00000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
...++.....++.+|+.+||+.||++|||+.|++
T Consensus 250 -~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 250 -EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred -CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 0122333456789999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=415.23 Aligned_cols=246 Identities=26% Similarity=0.424 Sum_probs=196.1
Q ss_pred ccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEEEEE
Q 003274 516 SMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKILIL 588 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV~ 588 (834)
.+.++||+|+||+||+|+.. .++.||+|++... .....+.|.+|++++++++|||||++++++.. ....+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999854 5889999998653 33445779999999999999999999999875 34579999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~~~ 667 (834)
|||++|+|.+++. +...+++..+..++.||++||+|||+++ ++|+||||||+||||+ .++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999984 4567999999999999999999999875 3599999999999998 479999999999986432
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||....... .+ ....... ..+.
T Consensus 185 ~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-~~----~~~i~~~-----~~~~ 249 (290)
T 3fpq_A 185 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QI----YRRVTSG-----VKPA 249 (290)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HH----HHHHTTT-----CCCG
T ss_pred C----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-HH----HHHHHcC-----CCCC
Confidence 2 2345689999999998865 69999999999999999999999986432211 01 0011000 0010
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+.....++.+|+.+||+.||++|||+.|+++
T Consensus 250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111122357889999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=431.66 Aligned_cols=249 Identities=22% Similarity=0.324 Sum_probs=208.9
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 5799999999999999999986 468999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+++. ...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 231 ~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-- 301 (423)
T 4fie_A 231 EGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 301 (423)
T ss_dssp TTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--
T ss_pred CCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--
Confidence 9999999873 346999999999999999999999998 9999999999999999999999999999875432
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... ... ..+.. ...+.+
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~----~~i~~-----~~~~~~--- 367 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAM----KMIRD-----NLPPRL--- 367 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH----HHHHH-----SCCCCC---
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHH----HHHHc-----CCCCCC---
Confidence 2234468999999999999999999999999999999999999998642211 111 01100 001111
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........++.+|+.+||+.||++|||+.|+++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 112234568899999999999999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=404.49 Aligned_cols=245 Identities=24% Similarity=0.387 Sum_probs=190.7
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||+||+++. .+|+.||||++.+.. ....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999985 468999999986542 334567999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+ +|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 678888873 4467999999999999999999999998 999999999999999999999999999876433
Q ss_pred CccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. .....+||+.|||||++.+..+ +.++||||+||+||||++|+.||...... .+.. .....
T Consensus 166 ~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~----~i~~~--------- 227 (275)
T 3hyh_A 166 N---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFK----NISNG--------- 227 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HHHHT---------
T ss_pred C---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHH----HHHcC---------
Confidence 2 2234689999999999998876 58999999999999999999998642211 1110 00000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 228 --~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 --VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 01122334567899999999999999999999987
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-48 Score=412.86 Aligned_cols=247 Identities=25% Similarity=0.335 Sum_probs=196.8
Q ss_pred cCcccccccccCCcEeEEEEEec----CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|++.++||+|+||+||+++.. .++.||||+++... ......+.+|+++|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999752 46789999986542 2334578899999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||||++|+|.+++. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999984 4467999999999999999999999998 9999999999999999999999999998754
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...+... +.. . +...
T Consensus 178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~----~--------i~~~ 241 (304)
T 3ubd_A 178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--TMT----M--------ILKA 241 (304)
T ss_dssp ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----H--------HHHC
T ss_pred CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--HHH----H--------HHcC
Confidence 3322 2234689999999999999999999999999999999999999996432211 110 0 0000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTM-----SDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 784 (834)
....+...+.++.+++.+||+.||++|||+ +|+++
T Consensus 242 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 ---KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ---CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 112233445688999999999999999984 56653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=399.93 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=188.6
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--------
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-------- 582 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-------- 582 (834)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 4689999999999999999985 468999999986543 334567999999999999999999999987654
Q ss_pred ----eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecc
Q 003274 583 ----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658 (834)
Q Consensus 583 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 658 (834)
..++|||||++|+|.+++.........++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999865444445677788999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCccC----------CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccc
Q 003274 659 FGLARMFGGDELQG----------NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLL 728 (834)
Q Consensus 659 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 728 (834)
||+|+.+....... .....+||+.|||||++.+..|+.++|||||||+||||++ ||.... +..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~----~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM----ERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc----HHH
Confidence 99998875432211 1223579999999999999999999999999999999996 543110 000
Q ss_pred cchhhhhcccccccccccccccCCCC---HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 729 GHAWDLWKHERVHELMDPVILQDEIP---LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. . ...+. ....+ ......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~----~-----~~~~~-----~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 R----T-----LTDVR-----NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp H----H-----HHHHH-----TTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H----H-----HHHHh-----cCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 0 00000 11112 122345678999999999999999999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=383.13 Aligned_cols=279 Identities=36% Similarity=0.617 Sum_probs=234.3
Q ss_pred HHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 507 SVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 507 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++...+++|.+.+.||+|+||.||+|+..+++.||||++........+.+.+|++++++++||||+++++++.+.+..++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 34456789999999999999999999988899999999987766777889999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 587 ILEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
||||+++|+|.+++..... ...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 189 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG 189 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9999999999999864322 236899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCC-ccccccchhhhhccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD-SFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.............||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ......+.............+
T Consensus 190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
T 2qkw_B 190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV 269 (321)
T ss_dssp SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence 5433333334457899999999999999999999999999999999999998754432 222333333333334445555
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
++.+ ....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 270 ~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 270 DPNL-ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSC-TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Chhh-ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 5544 3455677888999999999999999999999999999876
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=394.20 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=199.9
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe------CCe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE------QGE 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 583 (834)
++|.+.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 6799999999999999999985 468999999996542 3345678899999999999999999999764 357
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.|||||||+ |+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999996 67888874 4567999999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCCc--cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh------
Q 003274 664 MFGGDEL--QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL------ 734 (834)
Q Consensus 664 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~------ 734 (834)
.+..... .......+||+.|||||++.+. .++.++||||+||+||||++|++||...+... ........
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMMVLGTPSP 284 (398)
T ss_dssp CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCG
T ss_pred ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCCCCh
Confidence 7644321 2233446899999999998875 56999999999999999999999997543211 10000000
Q ss_pred --h---cccccccccccccccCCCCH-----HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 --W---KHERVHELMDPVILQDEIPL-----PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 --~---~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+ ........+.........+. ....++.+|+.+||+.||++|||+.|+++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0 00000000000000011111 12457889999999999999999999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=388.46 Aligned_cols=201 Identities=23% Similarity=0.358 Sum_probs=171.7
Q ss_pred HHhcCcccccccccCCcEeEEEEEec----CccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 584 (834)
.-.+.|++.++||+|+||+||+|+.. .++.||||++.... ...++.+|+++|..+ +|||||++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 34578999999999999999999742 46899999986543 345688999999998 699999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeecccccce
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLAR 663 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~ 663 (834)
++||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999998872 4899999999999999999999998 9999999999999877 799999999998
Q ss_pred ecCCCCcc--------------------------CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCC
Q 003274 664 MFGGDELQ--------------------------GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKN 716 (834)
Q Consensus 664 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p 716 (834)
........ ......+||+.|||||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 76432210 112235799999999999876 589999999999999999999999
Q ss_pred CCCCC
Q 003274 717 TGVYN 721 (834)
Q Consensus 717 ~~~~~ 721 (834)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 86443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=379.27 Aligned_cols=289 Identities=38% Similarity=0.641 Sum_probs=237.4
Q ss_pred cCcccHHHHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCc-ccHHHHHHHHHHHhhcCCCceeeEEEEE
Q 003274 500 LPLFSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAELQHRNLVRILGCC 578 (834)
Q Consensus 500 l~~~~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~H~niv~l~~~~ 578 (834)
+..+++.++....++|.+.++||+|+||.||+|+..+++.||||++..... .....+.+|++++.+++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 456888999999999999999999999999999988899999999976432 2334789999999999999999999999
Q ss_pred EeCCeEEEEEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 579 VEQGEKILILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
......++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+....+|+||||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 99999999999999999999986543 33459999999999999999999999832339999999999999999999999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCC---CCccccccchhhh
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN---TDSFNLLGHAWDL 734 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~---~~~~~~~~~~~~~ 734 (834)
|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.... ........+....
T Consensus 177 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987654332 22233569999999999999999999999999999999999999986321 1222233333333
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
..........+... ....+......+.+++.+||+.||++|||+.||++.|++..
T Consensus 256 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 256 LKEKKLEALVDVDL-QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp TSSCCSTTSSCTTC-TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred hhchhhhhhcChhh-ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 34444445555444 45567778899999999999999999999999999998753
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=397.48 Aligned_cols=248 Identities=25% Similarity=0.302 Sum_probs=200.0
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHH---HHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKN---EMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
++|.+.++||+|+||.||+++. .+|+.||||++.+.. ......+.+ ++.++..++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 7899999999999999999985 458999999986431 122233344 456667779999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
||||||++|+|..+|. +...+++..+..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999984 4567999999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... ....+||+.|||||++.. ..|+.++|||||||+||||++|++||..........+ ... ..
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i---~~~--------i~ 407 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRM--------TL 407 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH---HHH--------HH
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHh--------hc
Confidence 5432 234689999999999974 5799999999999999999999999964332211000 000 00
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
.. ....+...+.++.+|+.+||+.||++|++ +.||++
T Consensus 408 ~~---~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 408 TM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HC---CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CC---CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00 11233345678899999999999999998 677764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=402.03 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=208.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|.+.++||+|+||.||+++. .+|+.||+|++........+.+.+|+++|+.++|||||++++++.+....+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 6899999999999999999985 468999999997766666778999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC--CCeeecccccceecCCCC
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--MNPKISDFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DFGla~~~~~~~ 669 (834)
++|+|.++|.. +...+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999988843 3356899999999999999999999998 9999999999999854 899999999999875432
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... ... ....... .+
T Consensus 312 ---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~~~----~i~~~~~------~~- 375 (573)
T 3uto_A 312 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLR----NVKSCDW------NM- 375 (573)
T ss_dssp ---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH----HHHTTCC------CC-
T ss_pred ---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHH----HHHhCCC------CC-
Confidence 2344689999999999999999999999999999999999999986433211 100 0000000 00
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+|+.+||+.||++|||+.|+++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111123467889999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=362.10 Aligned_cols=282 Identities=34% Similarity=0.530 Sum_probs=228.8
Q ss_pred cCcccHHHHHHHhcCcccc------cccccCCcEeEEEEEecCccEEEEEEcccCC----cccHHHHHHHHHHHhhcCCC
Q 003274 500 LPLFSLASVAAATENFSMQ------CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAELQHR 569 (834)
Q Consensus 500 l~~~~~~~~~~~~~~f~~~------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~ 569 (834)
...|++.++..++++|... +.||+|+||.||+|+. +++.||||++.... ....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568999999999999887 8999999999999985 68899999986532 33467799999999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec
Q 003274 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD 649 (834)
Q Consensus 570 niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~ 649 (834)
||+++++++.+.+..++||||+++++|.+++........+++..+..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 999999999999999999999999999999865555567999999999999999999999988 99999999999999
Q ss_pred cCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcccccc
Q 003274 650 KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG 729 (834)
Q Consensus 650 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~ 729 (834)
.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.|+........ +..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~ 245 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-LLD 245 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-TTH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-HHH
Confidence 999999999999987654332222334578999999998765 589999999999999999999999875443221 111
Q ss_pred chhhhhc-ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 730 HAWDLWK-HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 730 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....... .......++..+ ...+......+.+++.+||+.||++||++.+|++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 246 IKEEIEDEEKTIEDYIDKKM--NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHTTSCCHHHHSCSSC--SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHhhhhhhhhhhhccccc--cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111 111122222222 234566778899999999999999999999999999876
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=369.10 Aligned_cols=268 Identities=27% Similarity=0.429 Sum_probs=206.6
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
..++|.+.++||+|+||.||+|+. .++.||||++.... ....+++.+|++++++++||||+++++++......++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 357899999999999999999986 68899999987543 334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++........+++..++.++.|+++||+|||+.+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 99999999999865444445999999999999999999999875 34999999999999999999999999999865433
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. . +....
T Consensus 193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~----~---------~~~~~ 255 (309)
T 3p86_A 193 F--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VA----A---------VGFKC 255 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HH----H---------HHHSC
T ss_pred c--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----H---------HHhcC
Confidence 2 122335789999999999999999999999999999999999999864332110 00 0 00000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPK 797 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~ 797 (834)
.....+......+.+++.+||+.||++||++.++++.|+.+......|+
T Consensus 256 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~ 304 (309)
T 3p86_A 256 KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP 304 (309)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence 0112333445678999999999999999999999999998865554443
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=364.19 Aligned_cols=260 Identities=24% Similarity=0.417 Sum_probs=213.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|.+.++||+|+||.||+++.. +++.||+|++........+.+.+|++++.+++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 67889999999999999999864 58899999987766677788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHH--CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999843 2456899999999999999999999998 999999999999999999999999999876543321
Q ss_pred CC------------ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc
Q 003274 672 GN------------TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 672 ~~------------~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..|+..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-------- 236 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-------- 236 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH--------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh--------
Confidence 11 1135799999999999999999999999999999999999988765433221111100
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
.... ....+......+.+++.+||+.||++||++.++++.|+++..
T Consensus 237 -~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 237 -RGFL-----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp -HHHH-----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -hccc-----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0011 111223344578999999999999999999999999988753
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=359.38 Aligned_cols=232 Identities=18% Similarity=0.189 Sum_probs=180.5
Q ss_pred cccccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCC----CceEEEecCCc
Q 003274 22 SLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGR----NAVLTISNNGN 97 (834)
Q Consensus 22 ~~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~----~~~l~~~~~g~ 97 (834)
+++.|+|.+|++|.+|++|+|++|+|+||||.++ ++|+ |+ ..+ |||+|||++|+.++ +++|+|+.||+
T Consensus 11 ~~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~-~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD-NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp CTTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE-TTE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred cccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC-CCC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 5678999999999999999999999999999654 5676 76 445 99999999999765 78999999999
Q ss_pred eEE--ecCCCCeEEEEcccCC-----CCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccccCCC
Q 003274 98 LVL--LSQTNGTIWSTNVSSD-----VKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGL 170 (834)
Q Consensus 98 l~l--~~~~~~~~w~~~~~~~-----~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~~~g~ 170 (834)
||| .|++|.+||+|+++.. ..+..|+|+|+|||||++ + .+|||| |||||||||||+|.++++|.
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~--~-----~~lWqS--~ptdtlLpg~~~~~~l~~g~ 153 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD--S-----LALWNG--TPAIPLVPGAIDSLLLAPGS 153 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE--E-----EEEEES--CTTSCCCCSCTTCEEECSSE
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC--C-----ceeeCc--ccccccccccccccccccCc
Confidence 999 7888999999997642 245789999999999998 2 589999 99999999999999999987
Q ss_pred ceEEEEcCCCCCCCCCceeecccccCCceEEEec-CCeeeEeeccCCCcceecccccc-ceeeEEEEeecCCeEEEEEEe
Q 003274 171 ERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFN-GSVKFTCSGQWDGTGFVSALSYT-NFIYKQFMTENKDEFVYWYEA 248 (834)
Q Consensus 171 ~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~-~~~~~~~~g~w~g~~~~~~~~~~-~~~~~~~~~~n~~~~~~~~~~ 248 (834)
. | ++.+||++|.|++++++++. +++++ ++..||++|.|++.... ..+. ...+ ..+..+...+.++++.
T Consensus 154 ~--L---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~--l~l~~dGnL-vl~d~~~~~vWsS~t~ 223 (276)
T 3m7h_A 154 E--L---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVR--AVFQGDGNL-VVYGAGNAVLWHSHTG 223 (276)
T ss_dssp E--E---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCE--EEECTTSCE-EEECTTSCEEEECSCT
T ss_pred c--c---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEE--EEEcCCCeE-EEEeCCCcEEEEecCC
Confidence 6 5 67899999999999999985 33444 56899999999864311 1111 1111 1122222333333322
Q ss_pred cCCCeeeEEEECcCCcEEEEEEecCCCcEEEEEeecc
Q 003274 249 YNRPSIMTLKLNPSGFVTRQIWDENSNKWDELFSVPD 285 (834)
Q Consensus 249 ~~~s~~~r~~L~~~G~l~~~~w~~~~~~W~~~~~~p~ 285 (834)
....+|++|+.||++++|.| ...|..++..|.
T Consensus 224 --~~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~~P~ 255 (276)
T 3m7h_A 224 --GHASAVLRLQANGSIAILDE---KPVWARFGFQPT 255 (276)
T ss_dssp --TCTTCEEEECTTSCEEEEEE---EEEEESSSCCTT
T ss_pred --CCCCEEEEEcCCccEEEEcC---CCeEEccCccCC
Confidence 23358999999999999998 345766666554
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=374.60 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=213.2
Q ss_pred hcCcccccccccCCcEeEEEEEe--------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL--------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~--------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 581 (834)
.++|.+.+.||+|+||.||+|+. ..+..||||+++... ....+.+.+|++++.++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 47899999999999999999975 235679999997653 34467899999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 582 GEKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999985432 1245899999999999999999999998 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCcccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+....... +
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--~ 314 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 314 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--H
Confidence 9999999999999998765443333444567889999999999999999999999999999999 888886433211 1
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ...... . ....+.....++.+++.+||+.||++||++.|+++.|+++
T Consensus 315 ~----~~~~~~---------~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 315 F----KLLKEG---------H-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp H----HHHHTT---------C-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H----HHHhcC---------C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 000000 0 1122334556889999999999999999999999999876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=369.05 Aligned_cols=269 Identities=25% Similarity=0.341 Sum_probs=208.4
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----eEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----EKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~lV 587 (834)
.++|.+.++||+|+||.||+|+.. ++.||||++.... .....+..|+.++.+++||||+++++++.... ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 478999999999999999999865 7899999996543 33445667999999999999999999998754 46999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEecCCCCCCEEeccCCCeeec
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY----------SRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~----------~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
|||+++|+|.+++. ...+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLK----ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 99999999999983 34589999999999999999999987 6 9999999999999999999999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCC-----CCCccccchhhHHHHHHHhcCCCCCCCCCCCcccccc-ch
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-----LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG-HA 731 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~-~~ 731 (834)
|||+++.+.............||+.|+|||++.+. .++.++|||||||++|||++|+.||............ ..
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999887655443334446799999999999863 5667899999999999999999998754332211100 00
Q ss_pred hhhhccccc-----ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 732 WDLWKHERV-----HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 732 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
......... .....+.+...........++.+++.+||+.||++|||+.||++.|+++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000000000 0111111111111223456799999999999999999999999999876
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=360.40 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=208.3
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.++||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 36899999999999999999984 56899999999766666677899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 99999999883 346899999999999999999999998 99999999999999999999999999987654332
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........ .+ .
T Consensus 172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~~~------~~---~ 235 (297)
T 3fxz_A 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LYLIATNG------TP---E 235 (297)
T ss_dssp --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHHC------SC---C
T ss_pred --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhCC------CC---C
Confidence 22335799999999999999999999999999999999999999864321110 00000000 00 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+......+.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1123334567899999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=359.99 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=214.6
Q ss_pred cccHHHHHHHhcC----------cccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCc
Q 003274 502 LFSLASVAAATEN----------FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570 (834)
Q Consensus 502 ~~~~~~~~~~~~~----------f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n 570 (834)
.++.+++..+++. |...++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n 103 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence 4677787777764 677789999999999999965 68999999998776667788999999999999999
Q ss_pred eeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc
Q 003274 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK 650 (834)
Q Consensus 571 iv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~ 650 (834)
|+++++++...+..++||||+++++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.
T Consensus 104 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp BCCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred cceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999873 346899999999999999999999987 999999999999999
Q ss_pred CCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc
Q 003274 651 DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH 730 (834)
Q Consensus 651 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~ 730 (834)
++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ...
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~-- 250 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAM-- 250 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHH--
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHH--
Confidence 99999999999987654322 223457999999999999999999999999999999999999998643211 000
Q ss_pred hhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 731 AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... .....+.+ .........+.+++.+||+.||++||++.|+++
T Consensus 251 --~~~-----~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 251 --KRL-----RDSPPPKL---KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp --HHH-----HHSSCCCC---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHH-----hcCCCCCc---CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 00001110 112233467899999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=375.32 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=210.8
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.+.||+|+||.||+|+.. +++.||||.++... ....+.|.+|++++++++||||+++++++...+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 478899999999999999999975 68899999987543 2334578999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999843 3346899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.........+++.|+|||.+.+..++.++|||||||+||||++ |..|+....... . ....... .
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~----~~~~~~~---------~ 332 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--T----REFVEKG---------G 332 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--H----HHHHHTT---------C
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--H----HHHHHcC---------C
Confidence 3222222346788999999999999999999999999999998 888876432211 0 0000000 0
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 333 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 333 -RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 1112333456889999999999999999999999999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=362.42 Aligned_cols=259 Identities=27% Similarity=0.424 Sum_probs=208.9
Q ss_pred hcCcccccccccCCcEeEEEEEec----CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.++||+|+||.||+|+.. .+..||||+++.. .....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 367899999999999999999863 3456999999765 33455779999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999843 3356899999999999999999999998 9999999999999999999999999999875
Q ss_pred CCCccC-CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 667 GDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ... ..
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~----~~--------- 267 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--VIS----SV--------- 267 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHH----HH---------
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--HHH----HH---------
Confidence 432211 1222346788999999999999999999999999999999 999986432211 000 00
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
.... ....+......+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 268 ~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 268 EEGY-RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCC-CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0000 112233445688999999999999999999999999998743
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=369.70 Aligned_cols=269 Identities=28% Similarity=0.400 Sum_probs=215.3
Q ss_pred ccHHHHHHHhcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeE
Q 003274 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRI 574 (834)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l 574 (834)
+.........++|.+.++||+|+||.||+|+. .+++.||||+++... ....+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44555566778999999999999999999973 346799999997643 33456799999999999 79999999
Q ss_pred EEEEEeCCe-EEEEEEecCCCCcchhcccccc------------------------------------------------
Q 003274 575 LGCCVEQGE-KILILEYMPNKSLDVYLFDPIK------------------------------------------------ 605 (834)
Q Consensus 575 ~~~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~------------------------------------------------ 605 (834)
++++.+.+. .++||||+++|+|.+++.....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999988654 8999999999999999864322
Q ss_pred ---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 606 ---------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 606 ---------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
...+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122889999999999999999999998 99999999999999999999999999987654433
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||........ + ........
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~----~~~~~~~~---------- 313 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F----CRRLKEGT---------- 313 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-H----HHHHHHTC----------
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-H----HHHHHcCC----------
Confidence 333344678999999999999999999999999999999998 9999864332211 0 00000000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+.....++.+++.+||+.||++||++.|+++.|+++
T Consensus 314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1112233456789999999999999999999999999876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=356.12 Aligned_cols=252 Identities=26% Similarity=0.326 Sum_probs=203.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 68999999999999999999864 68899999986543 22346688999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 99999999884 3456899999999999999999999988 99999999999999999999999999987644333
Q ss_pred cCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||............+ .... .
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----~~~~--~------- 226 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKK--T------- 226 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH-----HTTC--T-------
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH-----hccc--c-------
Confidence 333344679999999999987775 789999999999999999999987544322211110 0000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 227 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00111223467789999999999999999999975
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=361.73 Aligned_cols=276 Identities=26% Similarity=0.411 Sum_probs=208.9
Q ss_pred hcCcccccccccCCcEeEEEEEe-----cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 584 (834)
.++|++.++||+|+||.||+++. .+++.||||++........+.+.+|++++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 37889999999999999999984 35889999999877666778899999999999999999999998654 468
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 9999999999999998432 345899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch-hhhhccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-WDLWKHERVHE 742 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 742 (834)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+........ ..........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 243 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence 6543221 122234567889999999999999999999999999999999988764321110000000 00000000001
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 793 (834)
.+.... ....+.....++.+++.+||+.||++|||+.|+++.|+++..++
T Consensus 244 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 244 LLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHhccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 111110 11223345678999999999999999999999999998875443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=360.06 Aligned_cols=256 Identities=27% Similarity=0.429 Sum_probs=202.5
Q ss_pred cCcccccccccCCcEeEEEEEec-Ccc----EEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|.+.++||+|+||.||+|+.. +++ +||+|.+... .....+++.+|+.++++++||||+++++++.+. ..++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEE
Confidence 67899999999999999999853 344 4688888643 334567899999999999999999999999876 4789
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHH--STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999998853 3456899999999999999999999997 9999999999999999999999999999876
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........ ...+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------~~~~~ 233 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---------------SSILE 233 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---------------HHHHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---------------HHHHH
Confidence 5544333344567889999999999999999999999999999999 9999865332211 00110
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ....+......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 234 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 234 KGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp TTC-CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred cCC-CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 000 11223334568899999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=359.52 Aligned_cols=247 Identities=26% Similarity=0.394 Sum_probs=205.7
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999986 57899999998654 3345667899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999884 3456899999999999999999999998 999999999999999999999999999876433
Q ss_pred CccCCceeeeccCcccCceeecCCCCC-ccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. ......||+.|+|||++.+..++ .++|||||||++|||++|+.||....... +. ... ...
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~----~~i--------~~~- 229 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--LR----ERV--------LRG- 229 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHH--------HHC-
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--HH----HHH--------HhC-
Confidence 2 22345799999999999988875 89999999999999999999986432111 00 000 000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.....++.+++.+||+.||++|||+.|+++
T Consensus 230 --~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 --KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11223334567899999999999999999999975
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.52 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=199.0
Q ss_pred cCcccccccccCCcEeEEEEEec----CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
++|.+.++||+|+||.||+|+.. .+..||||+++.. .....+.|.+|+.++.+++||||+++++++.+....++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 67899999999999999999864 5778999999764 334557899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999853 3446899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCccC-CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 668 DELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 668 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... ......+++.|+|||++.+..++.++||||||++||||++ |+.|+....... .. ..+.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--~~-------------~~i~ 264 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--VI-------------KAVD 264 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--HH-------------HHHH
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HH-------------HHHH
Confidence 32211 1222345788999999999999999999999999999998 999986432111 00 0011
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
... ....+......+.+++.+||+.||++||++.+|++.|+++..
T Consensus 265 ~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 265 EGY-RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp TTE-ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCC-CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 111 112233455788999999999999999999999999988743
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=349.16 Aligned_cols=254 Identities=27% Similarity=0.427 Sum_probs=209.9
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|.+.+.||+|+||.||+++..+++.||+|++.... ...+.+.+|++++.+++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 6789999999999999999998889999999997543 345679999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~- 162 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 162 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence 9999999843 3346899999999999999999999998 999999999999999999999999999876443221
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ... ... ..
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~~----~~~-----~~~-----~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VVE----DIS-----TGF-----RL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HHH-----TTC-----CC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HHH----HHh-----cCc-----cC
Confidence 1222356788999999999999999999999999999999 888886432211 000 000 000 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+......+.+++.+||+.||++||++.++++.|+++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 12223356789999999999999999999999999876
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=351.34 Aligned_cols=262 Identities=27% Similarity=0.348 Sum_probs=200.9
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhh--cCCCceeeEEEEEEeC----CeEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAE--LQHRNLVRILGCCVEQ----GEKI 585 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~----~~~~ 585 (834)
.++|.+.++||+|+||.||+|+. +++.||||++... ..+.+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 47899999999999999999986 6899999998653 34556677777776 7999999999997653 4579
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH--------QYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
+||||+++|+|.+++. ...+++..+++++.|+++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999983 346899999999999999999999 665 9999999999999999999999
Q ss_pred ccccceecCCCCcc--CCceeeeccCcccCceeecCC------CCCccccchhhHHHHHHHhcC----------CCCCCC
Q 003274 658 DFGLARMFGGDELQ--GNTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSS----------RKNTGV 719 (834)
Q Consensus 658 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwSlGvll~elltG----------~~p~~~ 719 (834)
|||+++........ .......||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99999876543221 112234799999999999877 456799999999999999999 666543
Q ss_pred CCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 720 YNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
........... .... ......+.+.....+......+.+++.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDPSFEDM-RKVV----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSCCHHHH-HHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCcchhhh-hHHH----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 32221111000 0000 00011111111112234567899999999999999999999999999875
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=376.14 Aligned_cols=258 Identities=28% Similarity=0.414 Sum_probs=211.7
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..++|.+.++||+|+||.||+|+..+++.||||+++... ...+.|.+|+.++++++||||+++++++. .+..++||||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred chHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 457899999999999999999998888999999997643 45788999999999999999999999986 6678999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~ 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 339 (454)
T ss_dssp CTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce
Confidence 9999999998532 2346889999999999999999999998 99999999999999999999999999987654322
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.. .....+|+.|+|||++....++.++|||||||+||||++ |+.||....... ... ..... .
T Consensus 340 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~----~i~~~---------~- 402 (454)
T 1qcf_A 340 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIR----ALERG---------Y- 402 (454)
T ss_dssp HT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH----HHHHT---------C-
T ss_pred ec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHH----HHHcC---------C-
Confidence 11 122346789999999999999999999999999999999 999986432211 100 00000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
....+...+.++.+++.+||+.||++|||+.+|++.|+++..
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 111233445688999999999999999999999999998743
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=366.83 Aligned_cols=262 Identities=28% Similarity=0.423 Sum_probs=214.0
Q ss_pred HhcCcccccccccCCcEeEEEEEec--------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE 580 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~ 580 (834)
..++|.+.++||+|+||.||+|+.. .+..||||++.... ....+.+.+|++++.++ +||||+++++++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3478999999999999999999842 34679999997653 34457799999999999 99999999999999
Q ss_pred CCeEEEEEEecCCCCcchhcccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEE
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVL 647 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NIL 647 (834)
.+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999854321 245899999999999999999999997 999999999999
Q ss_pred eccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccc
Q 003274 648 LDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFN 726 (834)
Q Consensus 648 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~ 726 (834)
|+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.|+.......
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-- 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987765443333444567899999999999999999999999999999999 888876432211
Q ss_pred cccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 727 LLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
+. ....... ....+.....++.+++.+||+.||++||++.||++.|+++..
T Consensus 302 ~~----~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 302 LF----KLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp HH----HHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HHHHcCC----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 10 0110000 111223345688999999999999999999999999988743
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.48 Aligned_cols=256 Identities=28% Similarity=0.417 Sum_probs=211.0
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|.+.+.||+|+||.||+++..++..||||++.... ...+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 47889999999999999999998888899999997543 34577999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 86 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999843 2346899999999999999999999998 999999999999999999999999999876544322
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........ . ... ... . .
T Consensus 161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~---~~~-~~~--~--------~ 223 (268)
T 3sxs_A 161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--V---LKV-SQG--H--------R 223 (268)
T ss_dssp E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--H---HHH-HTT--C--------C
T ss_pred c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--H---HHH-HcC--C--------C
Confidence 1 122346778999999999999999999999999999999 9989864332110 0 000 000 0 0
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
...+......+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1112223457899999999999999999999999998873
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=360.48 Aligned_cols=265 Identities=28% Similarity=0.410 Sum_probs=210.7
Q ss_pred HhcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 582 (834)
..++|.+.+.||+|+||.||+|+. ..++.||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 357899999999999999999985 246689999997542 33457899999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 003274 583 EKILILEYMPNKSLDVYLFDPIK--------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk 642 (834)
..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 99999999999999999854322 134899999999999999999999988 9999999
Q ss_pred CCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCC
Q 003274 643 ASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYN 721 (834)
Q Consensus 643 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~ 721 (834)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++||||++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999987654433223334567889999999999999999999999999999998 999986543
Q ss_pred CCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 003274 722 TDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 793 (834)
.... . ..... ... ....+......+.+++.+||+.||++||++.++++.|+.+....
T Consensus 280 ~~~~-~----~~~~~---------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDAN-F----YKLIQ---------NGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSHH-H----HHHHH---------TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHHH-H----HHHHh---------cCC-CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 2211 0 00000 000 11223334568899999999999999999999999998874433
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=360.95 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=214.0
Q ss_pred HHHhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 003274 509 AAATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (834)
Q Consensus 509 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 581 (834)
....++|.+.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++.+++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 345689999999999999999999864 35889999997653 33457799999999999999999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIK---------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRD 640 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~D 640 (834)
+..++||||+++++|.+++..... ...+++.+++.++.||++||+|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999854211 256899999999999999999999998 99999
Q ss_pred CCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCC
Q 003274 641 LKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGV 719 (834)
Q Consensus 641 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~ 719 (834)
|||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999987654433333344568999999999999999999999999999999999 9988864
Q ss_pred CCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 720 YNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
..... .. ........ ...+......+.+++.+||+.||++||++.++++.|+++..
T Consensus 280 ~~~~~--~~----~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 280 MAHEE--VI----YYVRDGNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp SCHHH--HH----HHHHTTCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CChHH--HH----HHHhCCCc----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 32211 00 00000100 11223345688999999999999999999999999998743
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=355.81 Aligned_cols=259 Identities=27% Similarity=0.443 Sum_probs=212.5
Q ss_pred hcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|+||.||+++. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 47899999999999999999985 345789999997543 34557889999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccccc---------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 003274 585 ILILEYMPNKSLDVYLFDPIK---------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~ 643 (834)
++||||+++++|.+++..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence 999999999999999854322 234889999999999999999999988 99999999
Q ss_pred CCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCC
Q 003274 644 SNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNT 722 (834)
Q Consensus 644 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~ 722 (834)
+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999988755443333334567889999999999999999999999999999999 9998864332
Q ss_pred CccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 723 DSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... ........ ....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 259 ~~~------~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 259 ERL------FNLLKTGH----------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGH------HHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHH------HHHhhcCC----------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 110 00111000 1112233456889999999999999999999999999876
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.48 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=205.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+++.. +++.||+|+++.. .....+.+.+|+.++.+++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 68999999999999999999864 5899999999653 2345677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999998883 3457899999999999999999999998 999999999999999999999999999864322
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ... ...
T Consensus 159 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~----~~i--------~~~-- 220 (337)
T 1o6l_A 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LF----ELI--------LME-- 220 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHH--------HHC--
T ss_pred C--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--HH----HHH--------HcC--
Confidence 2 22334689999999999999999999999999999999999999986432111 00 000 000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
....+.....++.+++.+||+.||++|| ++.|+++
T Consensus 221 -~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 221 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1122334456889999999999999999 8999976
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=377.01 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=212.6
Q ss_pred hcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.++||+|+||.||+|+... ++.||||+++... ...++|.+|+.+|++++||||+++++++......++||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4678999999999999999999764 7899999997643 3567899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 373 (495)
T 1opk_A 298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373 (495)
T ss_dssp CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence 9999999998532 3356899999999999999999999998 99999999999999999999999999998654332
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.. .....+++.|+|||++.+..++.++|||||||+||||++ |+.|+....... . ... +....
T Consensus 374 ~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~----~~~---------~~~~~- 436 (495)
T 1opk_A 374 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YEL---------LEKDY- 436 (495)
T ss_dssp EC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--H----HHH---------HHTTC-
T ss_pred ee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--H----HHH---------HHcCC-
Confidence 21 122346789999999999999999999999999999999 888876433211 0 001 11111
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....+......+.+++.+||+.||++||++.+|++.|+++.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11223345578899999999999999999999999999874
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=372.50 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=207.1
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..++|.+.++||+|+||.||+|+..++..||||+++... ...+.|.+|++++++++||||+++++++.+ +..++||||
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 347789999999999999999998888899999997643 345789999999999999999999999876 678999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999998532 3356899999999999999999999988 99999999999999999999999999987654332
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ......++..|+|||.+.+..++.++||||||++||||++ |+.|+....... .. ...... .
T Consensus 336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--~~----~~i~~~---------~- 398 (452)
T 1fmk_A 336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL----DQVERG---------Y- 398 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH----HHHHTT---------C-
T ss_pred e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcC---------C-
Confidence 2 1223456789999999999999999999999999999999 888876432111 00 000000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 793 (834)
....+......+.+++.+||+.||++|||+.++++.|+++....
T Consensus 399 ~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 399 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 11223345568899999999999999999999999999875443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=366.39 Aligned_cols=260 Identities=27% Similarity=0.419 Sum_probs=209.4
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|.+.++||+|+||.||+|+.. .++.||||++... .......+.+|+.++.+++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 367899999999999999999843 4668999999654 344556789999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhccccc----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC---Ceeec
Q 003274 585 ILILEYMPNKSLDVYLFDPI----KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKIS 657 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 657 (834)
++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999985432 2245899999999999999999999998 99999999999999555 59999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhc
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++.+.............||+.|+|||++.+..++.++|||||||+||||++ |+.||....... +. ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~----~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL----EFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH----HHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHH
Confidence 9999986543332333334567899999999999999999999999999999998 888886432211 00 0000
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ....+......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 301 ~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 301 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 000 11123334567899999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=360.40 Aligned_cols=275 Identities=25% Similarity=0.384 Sum_probs=213.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-----cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEE--eCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV--EQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~ 584 (834)
.++|.+.++||+|+||.||+++. ..++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 37899999999999999999983 468899999998776666778999999999999999999999987 45568
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999999843 2346899999999999999999999987 99999999999999999999999999998
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....+..................+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 7543221 122234678889999999999999999999999999999999998753221110000000000000001111
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLN 792 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
+.... ....+......+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 257 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 257 LEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11111 1223344567899999999999999999999999999987443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=345.49 Aligned_cols=253 Identities=28% Similarity=0.479 Sum_probs=197.5
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCC----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+|+.. ++.+|||++.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 67899999999999999999864 8899999986543 233577899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc--------CCCeeecccc
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--------DMNPKISDFG 660 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~--------~~~~kl~DFG 660 (834)
||+++++|.+++. ...+++..+..++.|+++||+|||+++..+|+||||||+|||++. ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999998873 457899999999999999999999987666999999999999986 7789999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+++...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .....
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~----- 227 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----AYGVA----- 227 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-----HHHHH-----
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHhhh-----
Confidence 998754332 2234689999999999999999999999999999999999999864332110 00000
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
... .....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 228 ----~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 ----MNK-LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ----TSC-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ----cCC-CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 000 01122334456889999999999999999999999999763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=356.92 Aligned_cols=262 Identities=24% Similarity=0.402 Sum_probs=195.7
Q ss_pred HhcCcccccccccCCcEeEEEEEecCcc----EEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQ----EVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~----~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
..++|.+.+.||+|+||.||+|+..... .||||++... .....+.+.+|++++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3478999999999999999999854432 7999999764 344567899999999999999999999999887655
Q ss_pred ------EEEEEecCCCCcchhcccccc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCee
Q 003274 585 ------ILILEYMPNKSLDVYLFDPIK---KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (834)
Q Consensus 585 ------~lV~Ey~~~gsL~~~l~~~~~---~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 655 (834)
++||||+++|+|.+++..... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence 999999999999999854322 225899999999999999999999998 99999999999999999999
Q ss_pred ecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhh
Q 003274 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.|+........ . ..
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~----~~ 251 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--Y----NY 251 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H----HH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--H----HH
Confidence 999999987755443333334567889999999999999999999999999999999 8888864332110 0 00
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
..... ....+......+.+++.+||+.||++||++.++++.|+++..
T Consensus 252 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 252 LIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp HHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00000 111233345688999999999999999999999999998743
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=358.18 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=205.1
Q ss_pred cCcccccccccCCcEeEEEEEec-Ccc----EEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|.+.++||+|+||.||+|+.. +++ +||+|.+.... ....+.+.+|+.++.+++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 67899999999999999999854 344 38888875432 334466788999999999999999999886 567899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 92 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHS--SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHH--ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 9999999999999853 2456889999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
............||..|+|||++.+..++.++||||||+++|||++ |+.||........ . .......
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~------ 234 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--P----DLLEKGE------ 234 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--H----HHHHTTC------
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--H----HHHHcCC------
Confidence 5544444445678889999999999999999999999999999999 9999875432211 0 0000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
....+......+.+++.+||+.||++||++.++++.|+++..
T Consensus 235 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 ----RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ----BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ----CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111122234567889999999999999999999999988743
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=359.99 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=203.1
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.++||+|+||.||+++.. +++.+|+|++++.. ....+.+..|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 368999999999999999999865 57899999987542 23445688999999887 89999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999998884 3457999999999999999999999998 9999999999999999999999999998633
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc---cccchhhhhcccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN---LLGHAWDLWKHERVHEL 743 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 743 (834)
... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||......... .........
T Consensus 205 ~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-------- 274 (396)
T 4dc2_A 205 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------- 274 (396)
T ss_dssp CTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--------
T ss_pred cCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--------
Confidence 222 2234468999999999999999999999999999999999999999643321110 000000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCH------HHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTM------SDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 784 (834)
... ....+.....++.+++.+||+.||++||++ .|+++
T Consensus 275 ~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 275 LEK---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp HHC---CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred hcc---ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 000 112334456688999999999999999985 56654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=352.78 Aligned_cols=261 Identities=27% Similarity=0.394 Sum_probs=212.6
Q ss_pred hcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCCc-ccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
.++|.+.+.||+|+||.||+|+. ..++.||||++..... ...+.+.+|+.++.++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 47899999999999999999974 3467999999976533 3457799999999999 99999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccc---------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 584 KILILEYMPNKSLDVYLFDPIK---------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
.++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 9999999999999999854321 225899999999999999999999997 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCcccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+........ .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-~ 257 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-F 257 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-H
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-H
Confidence 9999999999999988765443323334567889999999999999999999999999999999 8988865432211 0
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.... .... ....+......+.+++.+||+.||++||++.|+++.|+++.
T Consensus 258 ----~~~~---------~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 258 ----YKMI---------KEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp ----HHHH---------HHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHh---------ccCC-CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 0000 0000 11112234568899999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=347.67 Aligned_cols=255 Identities=27% Similarity=0.410 Sum_probs=207.5
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|.+.+.||+|+||.||+++..+++.||||++.... ...+++.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 47899999999999999999998888899999997543 34577999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 102 ~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 102 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp TTCBHHHHHHC--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999999854 2346899999999999999999999998 999999999999999999999999999876443221
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ . . . +.... .
T Consensus 177 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~---~-~-----~~~~~-----~ 239 (283)
T 3gen_A 177 S-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--A---E-H-----IAQGL-----R 239 (283)
T ss_dssp S-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--H---H-H-----HHTTC-----C
T ss_pred c-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--H---H-H-----Hhccc-----C
Confidence 1 122346788999999999999999999999999999998 9999864332110 0 0 0 00000 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+......+.+++.+||+.+|++||++.++++.|.++
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 112222346789999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=352.93 Aligned_cols=263 Identities=19% Similarity=0.223 Sum_probs=208.6
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.++||+|+||.||+|+. .+++.||||++..... .+.+..|++++.++ +||||+++++++......++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 36899999999999999999985 5789999999865432 34688999999999 99999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC-----eeeccccccee
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-----PKISDFGLARM 664 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DFGla~~ 664 (834)
|+ +++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 99999988432 457999999999999999999999998 999999999999998887 99999999997
Q ss_pred cCCCCccC-----CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc
Q 003274 665 FGGDELQG-----NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 665 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.....+... ... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~--~~~-~~i~~~~ 236 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLK--ERY-QKIGDTK 236 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHH--HHH-HHHHHHH
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHH--HHH-HHHHhhh
Confidence 65433211 123467999999999999999999999999999999999999998754332210 000 0000000
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLN 792 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
.. ........ ..+ ++.+++..||+.||.+||++.+|++.|+++...
T Consensus 237 ~~--~~~~~~~~----~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 237 RA--TPIEVLCE----NFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp HH--SCHHHHTT----TCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cc--CCHHHHhc----cCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 00 00000000 112 889999999999999999999999999876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.18 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=205.6
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+++. ..++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 6799999999999999999985 468899999985432 334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 91 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 91 EYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp ECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred eCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 9999999999984 3457999999999999999999999998 999999999999999999999999999876433
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ....... .... .
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~-----~~~~-~ 232 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHIQD-----SVPN-V 232 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHHSS-----CCCC-H
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhhc-----cCCC-c
Confidence 21 223345799999999999999999999999999999999999999864332110 0000000 0000 0
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCC-CHHHHHHHHhcccC
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRP-TMSDVVSMISNEHL 791 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~ 791 (834)
....+...+..+.+++.+||+.||++|| ++.++.+.|+.+..
T Consensus 233 -~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 -TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0011222346789999999999999998 99999999988743
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=347.02 Aligned_cols=270 Identities=20% Similarity=0.293 Sum_probs=213.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--eEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG--EKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~ 588 (834)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 67899999999999999999865 48899999997543 344677889999999999999999999998765 779999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe----ccCCCeeeccccccee
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARM 664 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGla~~ 664 (834)
||+++++|.+++........+++..++.++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976555556999999999999999999999998 9999999999999 7788899999999988
Q ss_pred cCCCCccCCceeeeccCcccCceeec--------CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYAL--------DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.......... ........
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~ 241 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKIIT 241 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHHHhc
Confidence 754332 22356899999999986 5789999999999999999999999986443322110 00000000
Q ss_pred cc---c---cccccc-------cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 737 HE---R---VHELMD-------PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 737 ~~---~---~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.. . ...... ...............+.+++.+||+.||++||++.|+++...+.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 00 0 000000 00111234556778899999999999999999999999988776
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=368.55 Aligned_cols=251 Identities=28% Similarity=0.410 Sum_probs=206.4
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-eEEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG-EKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~-~~~lV~E 589 (834)
..++|.+.++||+|+||.||+|+.. ++.||||+++... ..+.|.+|++++++++||||+++++++.+.. ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3478899999999999999999864 7899999997643 4578999999999999999999999988765 7899999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 343 (450)
T ss_dssp CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence 99999999998532 2334789999999999999999999998 9999999999999999999999999998643221
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
....+++.|+|||++.+..++.++||||||++||||++ |+.|+........ . .....+ .
T Consensus 344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~----~~i~~~---------~ 403 (450)
T 1k9a_A 344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--V----PRVEKG---------Y 403 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--H----HHHHTT---------C
T ss_pred -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--H----HHHHcC---------C
Confidence 12356889999999999999999999999999999998 9999865432211 0 000000 0
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+...+..+.++|.+||+.||++|||+.++++.|+++
T Consensus 404 -~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 404 -KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1122334557889999999999999999999999999876
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=349.35 Aligned_cols=263 Identities=25% Similarity=0.424 Sum_probs=204.8
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|.+.+.||+|+||.||+++.. ++.||||++... ...+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 67889999999999999999864 788999998643 34578999999999999999999999876 35899999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC-eeecccccceecCCCCcc
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-PKISDFGLARMFGGDELQ 671 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~-~kl~DFGla~~~~~~~~~ 671 (834)
+++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999865444456889999999999999999999943334999999999999998887 799999999765432
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||........... +.... . . ..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~-~-----~-----~~ 223 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM---WAVHN-G-----T-----RP 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHH---HHHHT-T-----C-----CC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHH---HHHhc-C-----C-----CC
Confidence 2234689999999999999999999999999999999999999875433221110 00000 0 0 01
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCCCc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKL 799 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~~~ 799 (834)
.........+.+++.+||+.||++||++.++++.|+.+...++.+..+
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 112223457889999999999999999999999999886655544433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=359.27 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=201.1
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 585 (834)
..++|.+.++||+|+||.||+++.. +++.||||+++.. .....+.+..|.+++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999864 5889999998753 234456788999999998 7999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999998884 3456999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. . ++.
T Consensus 175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~----~--------i~~ 238 (353)
T 3txo_A 175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--LFE----A--------ILN 238 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----H--------HHH
T ss_pred ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--HHH----H--------HHc
Confidence 3222 22334689999999999999999999999999999999999999986433211 000 0 000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCH------HHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTM------SDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 784 (834)
. ....+......+.+++.+||+.||++||++ .|+++
T Consensus 239 ~---~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 239 D---EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp C---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred C---CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0 112233345678999999999999999998 77765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=346.52 Aligned_cols=248 Identities=20% Similarity=0.285 Sum_probs=195.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc--------------------------ccHHHHHHHHHHHhh
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--------------------------QGLKEFKNEMMLIAE 565 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~ 565 (834)
++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6899999999999999999985 4688999999865421 123568999999999
Q ss_pred cCCCceeeEEEEEEe--CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 003274 566 LQHRNLVRILGCCVE--QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643 (834)
Q Consensus 566 l~H~niv~l~~~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~ 643 (834)
++||||+++++++.+ ....++||||+++++|.+++ ....+++..+..++.||++||+|||+++ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999987 56889999999999998765 3457999999999999999999999998 99999999
Q ss_pred CCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCC---CCccccchhhHHHHHHHhcCCCCCCCC
Q 003274 644 SNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSRKNTGVY 720 (834)
Q Consensus 644 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwSlGvll~elltG~~p~~~~ 720 (834)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999987654322 123357899999999998765 478999999999999999999998642
Q ss_pred CCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 721 NTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 721 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... .+. ....... . ...........+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~--~~~----~~~~~~~----~-----~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIM--CLH----SKIKSQA----L-----EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHH--HHH----HHHHHCC----C-----CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHH--HHH----HHHhccc----C-----CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 000 0000000 0 00011123467899999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.87 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=210.1
Q ss_pred HhcCcccccccccCCcEeEEEEEecC------ccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 582 (834)
..++|.+.+.||+|+||.||+|+... ...||+|.+.... ....+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 45789999999999999999998532 2479999997653 23456799999999999 8999999999999999
Q ss_pred eEEEEEEecCCCCcchhcccccc-----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC
Q 003274 583 EKILILEYMPNKSLDVYLFDPIK-----------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD 651 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~ 651 (834)
..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 99999999999999999854221 345799999999999999999999987 9999999999999999
Q ss_pred CCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccc
Q 003274 652 MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGH 730 (834)
Q Consensus 652 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~ 730 (834)
+.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |..|+........ .
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~--- 276 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-F--- 276 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-H---
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-H---
Confidence 9999999999987654332222333567889999999999999999999999999999998 8888764332211 0
Q ss_pred hhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 731 AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 731 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..... ... ....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 277 -~~~~~---------~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 277 -YKLVK---------DGY-QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp -HHHHH---------HTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHh---------cCC-CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 00000 000 1111222356789999999999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=352.79 Aligned_cols=251 Identities=23% Similarity=0.286 Sum_probs=204.4
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.+.|.+.++||+|+||.||+++.. +|+.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 478999999999999999999864 588999999875432 1357899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC----Ceeecccc
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFG 660 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFG 660 (834)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999999984 3457899999999999999999999988 99999999999998877 79999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+++.+.... ......||+.|+|||++.+..++.++|||||||++|||++|..||....... ... .......
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~~~----~i~~~~~ 235 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLA----NITAVSY 235 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH----HHHTTCC
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhcCC
Confidence 998875432 2233579999999999999999999999999999999999999986432211 000 0000000
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..++.. .......+.+++.+||..||++|||+.|+++
T Consensus 236 --~~~~~~-----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 236 --DFDEEF-----FSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp --CCCHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --CCCchh-----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0112457889999999999999999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=347.13 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=200.5
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||+||+++..+++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 21 ~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp CEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 7899999999999999999998889999999986542 22356789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 101 MEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 985 67666633 3446899999999999999999999998 9999999999999999999999999998764332
Q ss_pred cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc------ccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV------HEL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 743 (834)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ............ .+.
T Consensus 174 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~ 250 (311)
T 3niz_A 174 -RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFSILGTPNPREWPQVQEL 250 (311)
T ss_dssp -C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHHHHCCCCTTTSGGGTTS
T ss_pred -ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHCCCChHHhhhhhcc
Confidence 12233468999999999876 56899999999999999999999999754433210 000000000000 000
Q ss_pred ---ccccc-ccCCC-----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 ---MDPVI-LQDEI-----PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 ---~~~~~-~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ..... ......++.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 00000 1112457889999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=352.44 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=199.7
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE------ 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 583 (834)
.++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 367899999999999999999975 78999999987543 3456789999999999999999999999876542
Q ss_pred ---------------------------------------------------EEEEEEecCCCCcchhcccccccCCCCHH
Q 003274 584 ---------------------------------------------------KILILEYMPNKSLDVYLFDPIKKRLLDWE 612 (834)
Q Consensus 584 ---------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~ 612 (834)
.++||||+++++|.+++..........+.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 79999999999999999765555667788
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc----------CCceeeeccCc
Q 003274 613 ARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ----------GNTKRIVGTYG 682 (834)
Q Consensus 613 ~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 682 (834)
.++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999988 999999999999999999999999999987654211 11233569999
Q ss_pred ccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCC---HHHHh
Q 003274 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIP---LPMLM 759 (834)
Q Consensus 683 y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 759 (834)
|+|||++.+..++.++||||||+++|||++|..|+... .. .. ... .....+ .....
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~----~~-------~~-----~~~-----~~~~~~~~~~~~~~ 300 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER----VR-------II-----TDV-----RNLKFPLLFTQKYP 300 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH----HH-------HH-----HHH-----HTTCCCHHHHHHCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH----HH-------HH-----HHh-----hccCCCcccccCCh
Confidence 99999999999999999999999999999987653100 00 00 000 011111 22345
Q ss_pred HHHHHHHhccccCCCCCCCHHHHHH
Q 003274 760 RYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 760 ~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.+++.+||+.||++||++.|+++
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhh
Confidence 7789999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=355.37 Aligned_cols=270 Identities=29% Similarity=0.400 Sum_probs=209.0
Q ss_pred CcccccccccCCcEeEEEEEe-----cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKI 585 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~ 585 (834)
.|.+.++||+|+||.||++.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 348899999999999988863 257899999997653 34467799999999999999999999999884 5789
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++++|.+++. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 112 lv~e~~~~~~L~~~l~----~~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLP----RHSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EEECCCTTCBHHHHGG----GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEecccCCcHHHHHh----hCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999983 335899999999999999999999998 999999999999999999999999999987
Q ss_pred CCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
...... .......+|..|+|||++.+..++.++||||||+++|||++|+.|+........................+.+
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence 543321 1223346788899999999999999999999999999999999987543221111111100000111111111
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
.... ....+.....++.+++.+||+.||++||++.|+++.|+++..
T Consensus 265 ~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 265 ERGE-RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccc-CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111 122334456789999999999999999999999999988743
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=351.25 Aligned_cols=271 Identities=25% Similarity=0.396 Sum_probs=206.9
Q ss_pred cCcccccccccCCcEeEEEEEe-----cCccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~ 584 (834)
+.|.+.++||+|+||.||+++. ..++.||||++... .....+.+.+|++++.+++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5688899999999999999983 46889999999754 334567899999999999999999999999876 668
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999843 3356899999999999999999999988 99999999999999999999999999988
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
....... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+..........................
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence 7544321 222334678889999999999999999999999999999999987532110000000000000000000111
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
+.... ....+......+.+++.+||+.||++|||+.++++.|+++
T Consensus 256 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 256 LKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred HhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 11110 1122334557899999999999999999999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=351.08 Aligned_cols=248 Identities=26% Similarity=0.355 Sum_probs=194.6
Q ss_pred hcCcccccccccCCcEeEEEEEe----cCccEEEEEEcccCC----cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
.++|.+.++||+|+||.||+++. .+++.||+|+++... ......+.+|+.++++++||||+++++++...+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 36899999999999999999986 468999999987542 2345568899999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999998884 3456899999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... .+
T Consensus 170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~------------~i 233 (327)
T 3a62_A 170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK--TID------------KI 233 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH------------HH
T ss_pred ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH--HHH------------HH
Confidence 6432221 1233578999999999999999999999999999999999999986432111 000 00
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
+.. ....+.....++.+++.+||+.||++|| ++.|+++
T Consensus 234 ~~~---~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 234 LKC---KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHT---CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HhC---CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 000 1112333456889999999999999999 7778876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=353.49 Aligned_cols=260 Identities=27% Similarity=0.441 Sum_probs=211.3
Q ss_pred hcCcccccccccCCcEeEEEEEec--------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 581 (834)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 478999999999999999999853 46789999997643 34567799999999999 899999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
+..++||||+++|+|.+++..... ...+++..++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999864321 234899999999999999999999998 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCcccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... +
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~ 268 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--L 268 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--H
Confidence 9999999999999998765443333334567889999999999999999999999999999999 888876432111 0
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
. ....... ....+......+.+++.+||+.||++||++.|+++.|+++.
T Consensus 269 ~----~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~ 317 (334)
T 2pvf_A 269 F----KLLKEGH----------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317 (334)
T ss_dssp H----HHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H----HHHhcCC----------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 0 0000000 11122334567899999999999999999999999998874
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=348.07 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=204.7
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.+.||+|+||.||+++.. +++.+|+|.+... ....+.+.+|+.++..++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 368999999999999999999864 5789999998654 33456789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc--CCCeeecccccceecCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~~~~~ 668 (834)
+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999998843 2346899999999999999999999998 999999999999987 789999999999887543
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. ......||+.|+|||++.+..++.++||||||+++|||++|..||....... ... .+....
T Consensus 158 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~------------~i~~~~- 219 (321)
T 1tki_A 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIE------------NIMNAE- 219 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH------------HHHHTC-
T ss_pred C---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH--HHH------------HHHcCC-
Confidence 2 2344679999999999999999999999999999999999999986432211 000 000000
Q ss_pred ccCCCCH----HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPL----PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+. ....++.+++.+||+.||++|||+.|+++
T Consensus 220 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 220 --YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --CCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111 22467899999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.52 Aligned_cols=252 Identities=22% Similarity=0.374 Sum_probs=204.8
Q ss_pred hcCcccccccccCCcEeEEEEEecC-c-------cEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN-G-------QEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
.++|.+.+.||+|+||.||+|+... + ..||+|++........+.+.+|+.++.+++||||+++++++...+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3688999999999999999998543 2 5799999977666677889999999999999999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC--------ee
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--------PK 655 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~--------~k 655 (834)
.++||||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999853 2344899999999999999999999998 999999999999999887 99
Q ss_pred ecccccceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+........ . ...
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~----~~~ 230 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-K----LQF 230 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-H----HHH
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-H----HHH
Confidence 999999865432 223468999999999987 7799999999999999999996554332111100 0 000
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
.. .....+.....++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 231 ~~------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YE------------DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HH------------TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hh------------ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 00 0111222234578899999999999999999999999998743
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=350.39 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=202.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999985 568899999986431 223457899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+ +|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 89 E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 688888773 3456999999999999999999999998 999999999999999999999999999876543
Q ss_pred CccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ .+.+...
T Consensus 162 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~~~ 223 (336)
T 3h4j_B 162 NF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVNSC 223 (336)
T ss_dssp BT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCCSS
T ss_pred cc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHHcC
Confidence 32 233579999999999988876 7899999999999999999999864322110 0000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++.+||+.||++|||+.|+++
T Consensus 224 --~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 224 --VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp --CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred --CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11223334567899999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=342.98 Aligned_cols=264 Identities=17% Similarity=0.205 Sum_probs=210.5
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.+.||+|+||.||+|+. .+++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 36799999999999999999985 678999999986443 335678999999999 89999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC-----eeeccccccee
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-----PKISDFGLARM 664 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DFGla~~ 664 (834)
|+ +++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999843 2346899999999999999999999987 999999999999987776 99999999998
Q ss_pred cCCCCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-cccchhhhhccc
Q 003274 665 FGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-LLGHAWDLWKHE 738 (834)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~ 738 (834)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...... ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~----~~ 236 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG----EK 236 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH----HH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH----hh
Confidence 7544321 1233457999999999999999999999999999999999999998754322111 000000 00
Q ss_pred ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 003274 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 793 (834)
... ...+. .....+..+.+++.+||+.||++||++.+|++.|+++..++
T Consensus 237 ~~~-~~~~~-----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 237 KQS-TPLRE-----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHH-SCHHH-----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccC-ccHHH-----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 000 00000 01123468899999999999999999999999998875443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.85 Aligned_cols=262 Identities=27% Similarity=0.420 Sum_probs=212.0
Q ss_pred HHHhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 003274 509 AAATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (834)
Q Consensus 509 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 581 (834)
....++|.+.+.||+|+||.||+|+.. .++.||||.+.... ......+.+|+.++++++||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 100 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 100 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC
Confidence 345688999999999999999999754 36789999997543 23456789999999999999999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCe
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIK-------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
+..++||||+++|+|.+++..... ...+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeE
Confidence 999999999999999999854221 145789999999999999999999998 9999999999999999999
Q ss_pred eecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhh
Q 003274 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .. .
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~----~ 251 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VL----R 251 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HH----H
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--HH----H
Confidence 9999999987654433233333467889999999999999999999999999999999 788876432111 00 0
Q ss_pred hhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...... ....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 252 ~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 252 FVMEGG----------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHcCC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 000000 0112233456789999999999999999999999999886
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=348.98 Aligned_cols=273 Identities=24% Similarity=0.330 Sum_probs=199.6
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhc--CCCceeeEEEEEEeC----CeE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL--QHRNLVRILGCCVEQ----GEK 584 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~H~niv~l~~~~~~~----~~~ 584 (834)
..++|.+.++||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++... ...
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 3478999999999999999999865 899999998543 234455566666554 899999999999987 688
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEeccCCCeeeccc
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-----RLRIIHRDLKASNVLLDKDMNPKISDF 659 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~DF 659 (834)
++||||+++|+|.+++. ...+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+||
T Consensus 111 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLK----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp EEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEEeccCCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 99999999999999983 346899999999999999999999871 113999999999999999999999999
Q ss_pred ccceecCCCCccC--CceeeeccCcccCceeecCCCCCcc------ccchhhHHHHHHHhcCCCCCCCCCCCccccccc-
Q 003274 660 GLARMFGGDELQG--NTKRIVGTYGYMSPEYALDGLFSIK------SDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH- 730 (834)
Q Consensus 660 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~------sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~- 730 (834)
|+++.+....... ......||+.|+|||++.+...+.+ +|||||||++|||++|..|+.............
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998765433221 1123579999999999988776665 999999999999999954443211111000000
Q ss_pred ----hhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 731 ----AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 731 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
...............+.+...........++.+++.+||+.||++||++.||++.|+++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 0000000000011111110111122566789999999999999999999999999988743
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=343.95 Aligned_cols=260 Identities=27% Similarity=0.444 Sum_probs=195.8
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.++||+|+||.||+|+.. ..+|||+++... ....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999853 459999986543 34457799999999999999999999965 5567899999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 9999999998843 3456899999999999999999999988 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.........||+.|+|||++. +..++.++||||||+++|||++|+.||........ + ......... .+
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~~~~~----~~ 245 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-I----IEMVGRGSL----SP 245 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH-H----HHHHHHTSC----CC
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH-H----HHHhccccc----Cc
Confidence 333334467999999999986 66789999999999999999999999865332211 0 011111111 01
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
. ........+.++.+++.+||+.||++||++.++++.|+++.
T Consensus 246 ~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 D--LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C--TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c--hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 01122234568899999999999999999999999999874
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=352.22 Aligned_cols=257 Identities=27% Similarity=0.416 Sum_probs=200.6
Q ss_pred cCcccccccccCCcEeEEEEEec-Ccc----EEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|.+.++||+|+||.||+|+.. +++ +||+|.+... .....+.+.+|+.++.+++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 68999999999999999999853 344 4688877543 3446678999999999999999999999998764 889
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+||+.+|+|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~~~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999998843 2456899999999999999999999998 9999999999999999999999999998875
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ . ..+.
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--~-------------~~~~ 233 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--S-------------SILE 233 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H-------------HHHH
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--H-------------HHHH
Confidence 4443333334457889999999999999999999999999999999 9999865432211 0 0000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
... ....+.....++.+++.+||+.||++||++.|+++.|+++..
T Consensus 234 ~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 234 KGE-RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp TTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred cCC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 000 111233345678999999999999999999999999998743
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.12 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=199.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999864 58899999986543 2335778899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|++++.+..+. .....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 99864444333 23456999999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccCCceeeeccCcccCceeecCCC-CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc------cccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE------RVHE 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~ 742 (834)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..|+......... ........... ....
T Consensus 156 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCTTTCTTGGG
T ss_pred --ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhhhhhhcc
Confidence 1223357899999999998766 899999999999999999988875432221111 11000000000 0000
Q ss_pred ccc--------cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMD--------PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+ ...............+.+++.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 000 000001112234567889999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=342.77 Aligned_cols=255 Identities=23% Similarity=0.355 Sum_probs=195.7
Q ss_pred hcCcccccccccCCcEeEEEEEecC----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 4688999999999999999998643 4579999987543 344567999999999999999999999984 567899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999843 2346899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||....... ... ......
T Consensus 168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--~~~----~i~~~~------ 234 (281)
T 1mp8_A 168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG----RIENGE------ 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHHTTC------
T ss_pred ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--HHH----HHHcCC------
Confidence 43322 1223456789999999999999999999999999999997 888886433211 100 000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 0112233456889999999999999999999999999876
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=347.80 Aligned_cols=244 Identities=26% Similarity=0.345 Sum_probs=204.4
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+++.. +|+.||+|+++... ....+.+.+|+.++..++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67999999999999999999864 68999999986532 234567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999984 3456899999999999999999999987 999999999999999999999999999876432
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. . .++...
T Consensus 160 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~---~---------~i~~~~- 219 (318)
T 1fot_A 160 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TY---E---------KILNAE- 219 (318)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---H---------HHHHCC-
T ss_pred -----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH---H---------HHHhCC-
Confidence 233579999999999999999999999999999999999999986432110 00 0 001000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
...+.....++.+++.+||+.||++|| ++.|+++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 112333456889999999999999999 8899885
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=339.47 Aligned_cols=255 Identities=27% Similarity=0.522 Sum_probs=204.2
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcc-------cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQ-------GLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
.++|.+.+.||+|+||.||+|+. .+++.||||++...... ..+.+.+|++++.+++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 37899999999999999999986 46889999998654322 1267899999999999999999999986654
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC-----eeecc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN-----PKISD 658 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~D 658 (834)
++||||+++++|.+++.. ....+++..+..++.|+++||+|||+++ .+|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 799999999999888743 3457899999999999999999999875 34999999999999988776 99999
Q ss_pred cccceecCCCCccCCceeeeccCcccCceee--cCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYA--LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
||+++.... ......||+.|+|||++ ....++.++||||||+++|||++|+.||.............. .
T Consensus 173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~----~ 243 (287)
T 4f0f_A 173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI----R 243 (287)
T ss_dssp CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH----H
T ss_pred CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH----h
Confidence 999975432 23345789999999998 455688999999999999999999999875443321111000 0
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.. . .....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 244 ~~--------~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EE--------G-LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HS--------C-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cc--------C-CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 00 0 01122334456889999999999999999999999999764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=340.03 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=209.4
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|.+.+.||+|+||.||+++..+++.||+|++..... ..+.+.+|++++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 367889999999999999999988889999999976433 4478999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999843 2356899999999999999999999998 999999999999999999999999999876432211
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
......++..|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ...... . .
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~----~~i~~~-----~-----~ 223 (267)
T 3t9t_A 161 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VV----EDISTG-----F-----R 223 (267)
T ss_dssp -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----HHHHTT-----C-----C
T ss_pred -ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--HH----HHHhcC-----C-----c
Confidence 1122356788999999999999999999999999999999 888876432111 00 000000 0 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+......+.+++.+||+.||++||++.++++.|+++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 111223456789999999999999999999999999876
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=339.57 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=199.2
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+++...++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5789999999999999999998789999999986543 22346788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++ +|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 986 88777742 2356899999999999999999999988 9999999999999999999999999998764322
Q ss_pred cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc--------ccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK--------HERVH 741 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~ 741 (834)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......... .....
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHHCCCChhhchhhhcc
Confidence 112234689999999999764 589999999999999999999999865432110 000000000 00000
Q ss_pred cccccccc------cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 ELMDPVIL------QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 ~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...++... ..........++.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00111100 00111223567889999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.25 Aligned_cols=250 Identities=24% Similarity=0.302 Sum_probs=203.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
+.|.+.+.||+|+||.||+++.. +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++......+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 67899999999999999999864 588999999865432 24678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC----Ceeeccccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGl 661 (834)
+||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999984 3456899999999999999999999988 99999999999999887 899999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... ...... .
T Consensus 165 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~----~~~~~~-~ 234 (326)
T 2y0a_A 165 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLA----NVSAVN-Y 234 (326)
T ss_dssp CEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH----HHHHTC-C
T ss_pred CeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHH----HHHhcC-C
Confidence 98875432 2233579999999999999999999999999999999999999986432111 000 000000 0
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .... ........+.+++.+||+.||++|||+.|+++
T Consensus 235 ~-~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 E-FEDE-----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp C-CCHH-----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred C-cCcc-----ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0000 00112457889999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=349.34 Aligned_cols=267 Identities=28% Similarity=0.397 Sum_probs=213.2
Q ss_pred HHHHHHHhcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCCc-ccHHHHHHHHHHHhhc-CCCceeeEEE
Q 003274 505 LASVAAATENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL-QHRNLVRILG 576 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~ 576 (834)
........++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 344445568999999999999999999974 3468999999976533 3456789999999999 7999999999
Q ss_pred EEEeCC-eEEEEEEecCCCCcchhcccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCC
Q 003274 577 CCVEQG-EKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLK 642 (834)
Q Consensus 577 ~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk 642 (834)
++...+ ..++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ |+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCc
Confidence 998765 58999999999999999854322 223789999999999999999999988 9999999
Q ss_pred CCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCC
Q 003274 643 ASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYN 721 (834)
Q Consensus 643 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~ 721 (834)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654433323334567899999999999999999999999999999998 999986533
Q ss_pred CCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 722 TDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 722 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.... + ........ ....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 256 ~~~~-~----~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDEE-F----CRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSHH-H----HHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHH-H----HHHhccCc----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2211 0 00000000 0112223456789999999999999999999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=348.38 Aligned_cols=266 Identities=26% Similarity=0.434 Sum_probs=200.2
Q ss_pred HHhcCcccccccccCCcEeEEEEEec----CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE 583 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~ 583 (834)
...++|.+.+.||+|+||.||+|+.. .++.||||++... .....+.+.+|+.++.+++||||+++++++.+...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 34578999999999999999999753 3558999998754 23345779999999999999999999999987653
Q ss_pred -----EEEEEEecCCCCcchhcccc---cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCee
Q 003274 584 -----KILILEYMPNKSLDVYLFDP---IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (834)
Q Consensus 584 -----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 655 (834)
.++||||+++++|..++... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 49999999999999988432 23456999999999999999999999987 99999999999999999999
Q ss_pred ecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhh
Q 003274 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+........ . ..
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~----~~ 261 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--Y----DY 261 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H----HH
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--H----HH
Confidence 999999987655443333344567889999999999999999999999999999999 8888764332110 0 00
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 794 (834)
..... ....+......+.+++.+||+.||++||++.++++.|+++...+|
T Consensus 262 ~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 262 LLHGH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHTTC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHcCC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 00000 111223345678999999999999999999999999988754443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=352.77 Aligned_cols=251 Identities=25% Similarity=0.355 Sum_probs=197.2
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCC--CceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQH--RNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H--~niv~l~~~~~~~~~~~lV 587 (834)
.+.|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| |||+++++++......++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998654 33445779999999999976 9999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|| +.+++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+..
T Consensus 88 ~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 57889999884 3457899999999999999999999998 99999999999997 67899999999987755
Q ss_pred CCccCCceeeeccCcccCceeecC-----------CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
...........||+.|+|||++.+ ..++.++|||||||+||||++|+.||.........
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---------- 229 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK---------- 229 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----------
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----------
Confidence 443333344679999999999865 67899999999999999999999998643221100
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+++.. ....+.....++.+++.+||+.||++|||+.|+++
T Consensus 230 ---~~~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 230 ---LHAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp ---HHHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---HHHHhcCCc-ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 111111111 11222223457889999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=351.70 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=203.0
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
+.|.+.+.||+|+||.||+++. .+++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 6799999999999999999985 46899999998532 12246789999999999999999999999999999999
Q ss_pred EEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC---eeecccccc
Q 003274 587 ILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGLA 662 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGla 662 (834)
||||+++++|.+++.... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988775432 2345899999999999999999999998 999999999999987655 999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+........ .....||+.|+|||++.+..++.++|||||||+||||++|+.||...... +. ........
T Consensus 181 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~----~~i~~~~~-- 249 (351)
T 3c0i_A 181 IQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER---LF----EGIIKGKY-- 249 (351)
T ss_dssp EECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH---HH----HHHHHTCC--
T ss_pred eEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH---HH----HHHHcCCC--
Confidence 887543321 23357999999999999999999999999999999999999998642210 00 00000000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+.. . .....++.+++.+||+.||++||++.|+++
T Consensus 250 ~~~~~~-~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KMNPRQ-W----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCHHH-H----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCccc-c----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0 112467899999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.33 Aligned_cols=249 Identities=23% Similarity=0.338 Sum_probs=204.1
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+++.. +++.||+|++... .....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999854 5789999998643 2344677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+.+|+|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 95 e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999884 3456999999999999999999999998 999999999999999999999999999876543
Q ss_pred CccCCceeeeccCcccCceeecC---CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
. ......||+.|+|||++.. ..++.++|||||||+||||++|+.||........... .... .
T Consensus 169 ~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~---~~~~--------~- 233 (384)
T 4fr4_A 169 T---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI---VHTF--------E- 233 (384)
T ss_dssp C---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHH---HHHH--------H-
T ss_pred C---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHH---HHHH--------h-
Confidence 2 2334679999999999874 4589999999999999999999999864332221100 0000 0
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCC-HHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPT-MSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~ 784 (834)
.. ....+......+.+++.+||+.||++||+ +.++.+
T Consensus 234 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 TT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred hc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 00 11223344568899999999999999998 777664
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.04 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=203.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 587 (834)
++|.+.++||+|+||.||+++.. +++.||+|++.... ....+.+..|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 67899999999999999999864 58899999997542 33456688999999988 899999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999998884 3456899999999999999999999998 99999999999999999999999999986432
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc---cccchhhhhccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN---LLGHAWDLWKHERVHELM 744 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 744 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ......... .
T Consensus 163 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--------~ 232 (345)
T 3a8x_A 163 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------L 232 (345)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--------H
T ss_pred CC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--------H
Confidence 22 2233468999999999999999999999999999999999999998643221100 000000000 0
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCH------HHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTM------SDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~ 784 (834)
.. ....+.....++.+++.+||+.||++||++ .|+++
T Consensus 233 ~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 233 EK---QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp HC---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred cC---CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 00 112233455688999999999999999995 56654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=363.25 Aligned_cols=262 Identities=19% Similarity=0.244 Sum_probs=207.4
Q ss_pred HHHHHHHhcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 003274 505 LASVAAATENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVE 580 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~ 580 (834)
+.++....++|.+.++||+|+||+||+++... ++.||||++.+.. ....+.+.+|+.++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44455567899999999999999999999754 7889999986521 2223458899999999999999999999999
Q ss_pred CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
.+..++||||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999853 2456999999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+++........ .....+||+.|+|||++. ...++.++|||||||+||||++|+.||....... ... ...
T Consensus 221 la~~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~--~~~---~i~ 294 (437)
T 4aw2_A 221 SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYG---KIM 294 (437)
T ss_dssp TCEECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH---HHH
T ss_pred hhhhcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH--HHH---hhh
Confidence 99876543321 122357999999999997 5679999999999999999999999986432211 000 000
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCC--CCCHHHHHH
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAAD--RPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 784 (834)
.... ... ..........++.+++.+||..+|++ ||++.|+++
T Consensus 295 ~~~~--~~~-----~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 295 NHKE--RFQ-----FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp THHH--HCC-----CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hccc--ccc-----CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 0000 000 00111124567889999999888888 999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=341.31 Aligned_cols=257 Identities=31% Similarity=0.447 Sum_probs=209.1
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|.+.+.||+|+||.||+|+..+++.||||.+.... ...+.+.+|++++.+++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 47899999999999999999998888899999996543 34678999999999999999999999986 45689999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++++|.+++... ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 999999998532 2236899999999999999999999998 999999999999999999999999999887543322
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 750 (834)
. .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ... ..... . .
T Consensus 166 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~----~~~~~-----~-----~ 228 (279)
T 1qpc_A 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQ----NLERG-----Y-----R 228 (279)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH----HHHTT-----C-----C
T ss_pred c-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--HHH----HHhcc-----c-----C
Confidence 1 122356789999999999999999999999999999999 888876432211 000 00000 0 1
Q ss_pred CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 751 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
...+......+.+++.+||+.||++||++.++++.|+++..
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 11222345688999999999999999999999999988743
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=374.66 Aligned_cols=258 Identities=28% Similarity=0.448 Sum_probs=210.7
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
..++|.+.++||+|+||.||+|+..++..||||+++... ...+.|.+|+++|++++||||+++++++.+ +..++||||
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 347789999999999999999998888899999997643 345789999999999999999999999876 678999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999998532 2346899999999999999999999988 99999999999999999999999999987653321
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ......++..|+|||++.+..++.++|||||||+||||++ |+.||......+ .. ...... .
T Consensus 419 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--~~----~~i~~~---------~- 481 (535)
T 2h8h_A 419 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL----DQVERG---------Y- 481 (535)
T ss_dssp H-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--HH----HHHHTT---------C-
T ss_pred e-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcC---------C-
Confidence 1 1122346789999999999999999999999999999999 888876432111 00 000000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
....+......+.++|.+||+.||++||++.+|+++|+++..
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 111233445688999999999999999999999999998743
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.76 Aligned_cols=267 Identities=16% Similarity=0.194 Sum_probs=200.6
Q ss_pred hcCcccccccccCCcEeEEEEEec----CccEEEEEEcccCCcc-----------cHHHHHHHHHHHhhcCCCceeeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQSGQ-----------GLKEFKNEMMLIAELQHRNLVRILG 576 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~H~niv~l~~ 576 (834)
.++|.+.++||+|+||.||+|+.. .+..+|||++...... ..+.+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999865 5778999998754321 1234667888999999999999999
Q ss_pred EEEe----CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC
Q 003274 577 CCVE----QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM 652 (834)
Q Consensus 577 ~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~ 652 (834)
++.. ....++||||+ +++|.+++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67899999999 9999999843 337999999999999999999999997 99999999999999887
Q ss_pred --CeeecccccceecCCCCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc
Q 003274 653 --NPKISDFGLARMFGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF 725 (834)
Q Consensus 653 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~ 725 (834)
.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876433211 111345789999999999999999999999999999999999999864322211
Q ss_pred ccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 726 NLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 726 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
....... . ....+...+...........++.+++.+||+.||++||++.+|++.|++...
T Consensus 269 ~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 AVQTAKT-N-----LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHH-H-----HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHHH-h-----hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 1110000 0 0000000000000011234588999999999999999999999999988643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=355.37 Aligned_cols=271 Identities=17% Similarity=0.204 Sum_probs=206.0
Q ss_pred hcCcccccccccCCcEeEEEEEecC------ccEEEEEEcccCCccc-----------HHHHHHHHHHHhhcCCCceeeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQG-----------LKEFKNEMMLIAELQHRNLVRI 574 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~H~niv~l 574 (834)
.++|.+.++||+|+||.||+|+... ++.||||++....... ...+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999998654 4789999986543211 1123445566777789999999
Q ss_pred EEEEEeC----CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-
Q 003274 575 LGCCVEQ----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD- 649 (834)
Q Consensus 575 ~~~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~- 649 (834)
++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+++ |+||||||+||||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 9999875 4589999999 9999998843 3357999999999999999999999997 99999999999999
Q ss_pred -cCCCeeecccccceecCCCCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCC
Q 003274 650 -KDMNPKISDFGLARMFGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTD 723 (834)
Q Consensus 650 -~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~ 723 (834)
.++.+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.....+
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8899999999999876543221 1113346999999999999999999999999999999999999998743322
Q ss_pred ccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 003274 724 SFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794 (834)
Q Consensus 724 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 794 (834)
.. ........ ......+++++.+... ..+.++.+++..||+.+|++||++.++++.|+++..++.
T Consensus 268 ~~-~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~ 332 (364)
T 3op5_A 268 PK-YVRDSKIR-YRENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG 332 (364)
T ss_dssp HH-HHHHHHHH-HHHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HH-HHHHHHHH-hhhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 11 11000000 0111222333332111 234578999999999999999999999999988754443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.65 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=203.2
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
-.++|.+.++||+|+||.||++.. .+|+.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 357899999999999999999985 568899999986543 23456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec---cCCCeeeccccccee
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARM 664 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~ 664 (834)
|||+++|+|.+.+. ....+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 89 ~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999988874 3456999999999999999999999998 99999999999998 467899999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
...... ......||+.|+|||++.+..++.++|||||||++|||++|++||....... +. ........ ..
T Consensus 163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~----~~i~~~~~-~~- 232 (444)
T 3soa_A 163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LY----QQIKAGAY-DF- 232 (444)
T ss_dssp CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HHHHHTCC-CC-
T ss_pred ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HH----HHHHhCCC-CC-
Confidence 654322 1233579999999999999999999999999999999999999986432111 10 00000000 00
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+++.+||+.||++|||+.|+++
T Consensus 233 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 -----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00001123467899999999999999999999987
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.72 Aligned_cols=244 Identities=23% Similarity=0.283 Sum_probs=192.4
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||+||+|+.. +++.||||++.... ......+..|+..+.++ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999865 68999999986542 23334556666666666 8999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHH--HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 6688887743 2456999999999999999999999987 999999999999999999999999999876543
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..++..... +....... ..+.
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---------~~~~~~~~----~~~~- 272 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---------WQQLRQGY----LPPE- 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---------HHHHTTTC----CCHH-
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---------HHHHhccC----CCcc-
Confidence 2 2233468999999998876 789999999999999999999766532110 00110000 0000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.....++.+++.+||+.||++|||+.|+++
T Consensus 273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11123468899999999999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=351.93 Aligned_cols=252 Identities=21% Similarity=0.275 Sum_probs=206.4
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.++||+|+||.||+|+.. +++.+|+|++..........+.+|++++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 368999999999999999999864 5889999999766555567899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc--CCCeeecccccceecCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--DMNPKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~~~~~ 668 (834)
+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998843 2346899999999999999999999998 999999999999974 477999999999887543
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..... . .... ...
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~---i-~~~~------~~~ 269 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQN---V-KRCD------WEF 269 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH---H-HHCC------CCC
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHH---H-HhCC------CCC
Confidence 2 233457999999999999999999999999999999999999998643211 10000 0 0000 000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+++.+||+.||++|||+.|+++
T Consensus 270 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 270 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 11111233567899999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=347.05 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=195.7
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe----E
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE----K 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~----~ 584 (834)
++|.+.++||+|+||.||+++. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 6899999999999999999985 568899999997643 2335678999999999999999999999876543 4
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++. ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred EEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999984 3456899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ........ .
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~----~ 236 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVRED----P 236 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHCC----C
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhcCC----C
Confidence 6543221 223345789999999999999999999999999999999999999864332110 00000000 0
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHH-HHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV-SMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~~~ 789 (834)
..+.. .......++.+++.+||+.||++||+..+++ +.|.+.
T Consensus 237 ~~~~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 237 IPPSA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCHHH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCccc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00000 0111346788999999999999999766654 555554
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=352.94 Aligned_cols=249 Identities=23% Similarity=0.330 Sum_probs=204.2
Q ss_pred HHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~ 584 (834)
...++|.+.++||+|+||.||+++.. +++.||||+++... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34589999999999999999999964 58899999997532 33456788899999987 999999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 94 ~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp EEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999884 3456899999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ......
T Consensus 168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~----~~i~~~------ 233 (345)
T 1xjd_A 168 NMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LF----HSIRMD------ 233 (345)
T ss_dssp CCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHC------
T ss_pred cccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HH----HHHHhC------
Confidence 43222 12344689999999999999999999999999999999999999986432211 10 000000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHH-HHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMS-DVV 783 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl 783 (834)
....+.....++.+++.+||+.||++||++. +++
T Consensus 234 -----~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 -----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1112333456889999999999999999997 665
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.35 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=212.0
Q ss_pred HhcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
..++|.+.+.||+|+||.||+|+... ++.||+|.+... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 35789999999999999999998654 788999999653 3456789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 99999999998532 3456899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+........ . +.+....
T Consensus 166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--~-------------~~~~~~~ 229 (288)
T 3kfa_A 166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y-------------ELLEKDY 229 (288)
T ss_dssp S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--H-------------HHHHTTC
T ss_pred c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--H-------------HHHhccC
Confidence 2 12223457889999999999999999999999999999999 8888764332110 0 0000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....+......+.+++.+||+.||++||++.++++.|+++.
T Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 230 -RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 11223334568899999999999999999999999998763
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.29 Aligned_cols=244 Identities=20% Similarity=0.262 Sum_probs=204.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999864 68899999986532 234677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999884 3356899999999999999999999988 999999999999999999999999999876432
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ......
T Consensus 195 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~----~~i~~~---------- 253 (350)
T 1rdq_E 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--IY----EKIVSG---------- 253 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHC----------
T ss_pred -----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--HH----HHHHcC----------
Confidence 233579999999999999999999999999999999999999986432110 00 000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
....+.....++.+++.+||+.||++||+ +.|+++
T Consensus 254 -~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 -KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 01123334568899999999999999998 888875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=349.63 Aligned_cols=264 Identities=21% Similarity=0.236 Sum_probs=194.6
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEe--------
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVE-------- 580 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~-------- 580 (834)
...+|.+.++||+|+||.||+++. .+++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346899999999999999999985 468899999987766666778999999999996 9999999999953
Q ss_pred CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
....++||||+. |+|.+++........+++..++.++.||+.||+|||+.+ .+|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345799999996 788888865445567999999999999999999999874 349999999999999999999999999
Q ss_pred cceecCCCCccC----------CceeeeccCcccCceee---cCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcccc
Q 003274 661 LARMFGGDELQG----------NTKRIVGTYGYMSPEYA---LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNL 727 (834)
Q Consensus 661 la~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~ 727 (834)
+++......... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--- 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR--- 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---
Confidence 998765432111 11134689999999998 56778999999999999999999999986422111
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCC
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPF 795 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~ 795 (834)
.+.... ...........+.+++.+||+.||++||++.|+++.|+.+....+.
T Consensus 261 ---------------~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 261 ---------------IVNGKY-SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp --------------------C-CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred ---------------hhcCcc-cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence 000000 0111122234678999999999999999999999999887644443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=351.90 Aligned_cols=251 Identities=22% Similarity=0.313 Sum_probs=203.3
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.++|.+.++||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 478999999999999999999864 58899999986542 334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC---Ceeecccccceec
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~~ 665 (834)
||+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 108 e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~ 181 (362)
T 2bdw_A 108 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 181 (362)
T ss_dssp CCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCC
T ss_pred ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEe
Confidence 9999999988874 3456899999999999999999999998 99999999999998654 5999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ........ ..
T Consensus 182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~----~~i~~~~~-~~-- 249 (362)
T 2bdw_A 182 NDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLY----AQIKAGAY-DY-- 249 (362)
T ss_dssp TTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHTCC-CC--
T ss_pred cCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHH----HHHHhCCC-CC--
Confidence 5432 123357999999999999999999999999999999999999998643211 000 00000000 00
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+++.+||+.||++||++.|+++
T Consensus 250 ----~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ----CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00001123467899999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.24 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=204.0
Q ss_pred HhcCcccccccccCCcEeEEEEEecC-ccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 585 (834)
..++|.+.++||+|+||.||+++... ++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999999654 789999998753 234556788999999988 8999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999884 3356899999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... +.. .++.
T Consensus 172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~~------------~i~~ 235 (353)
T 2i0e_A 172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQ------------SIME 235 (353)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH------------HHHH
T ss_pred ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--HHH------------HHHh
Confidence 3222 12334689999999999999999999999999999999999999986432111 100 0000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
. ....+.....++.+++.+||+.||++||+ +.++++
T Consensus 236 ~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 236 H---NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp C---CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred C---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 0 11223345568899999999999999995 467664
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=355.80 Aligned_cols=250 Identities=24% Similarity=0.353 Sum_probs=197.0
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcC--CCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||++....++.||||++... .....+.+.+|+.++.+++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 569999999999999999999878999999998654 3345678999999999996 599999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
| +.+++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 67889999884 3347889999999999999999999987 99999999999995 589999999999876544
Q ss_pred CccCCceeeeccCcccCceeecC-----------CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
..........||+.|+|||++.+ ..++.++|||||||+||||++|+.||.........
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----------- 276 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----------- 276 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH-----------
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH-----------
Confidence 33223334579999999999865 46899999999999999999999998643221100
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...++++.. ....+......+.+++.+||+.||++||++.|+++
T Consensus 277 --~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 277 --LHAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp --HHHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --HHHHhCccc-cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 111111111 11112222457889999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=338.81 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=209.0
Q ss_pred cCccccc-ccccCCcEeEEEEEec---CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQC-KLGEGGFGPVYKGRLF---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
++|.+.+ .||+|+||.||+|+.. .++.||||+++... ....+.+.+|++++.+++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 5566666 9999999999999743 57789999997643 34567899999999999999999999999 55679999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999998853 3456899999999999999999999998 99999999999999999999999999988754
Q ss_pred CCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 668 DELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 668 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... ... ......
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~----~i~~~~------ 230 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMA----FIEQGK------ 230 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHH----HHHTTC------
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHH----HHhcCC------
Confidence 3321 12223456889999999998999999999999999999998 999986433211 100 000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 793 (834)
....+......+.+++.+||+.||++||++.++++.|+++....
T Consensus 231 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 231 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11223344568899999999999999999999999998875433
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=334.25 Aligned_cols=253 Identities=26% Similarity=0.344 Sum_probs=205.6
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 367999999999999999999864 68899999986443 3345788999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999884 3456899999999999999999999988 9999999999999999999999999998764333
Q ss_pred ccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.........||+.|+|||++.+..+ +.++||||||+++|||++|+.||............ +.....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-----~~~~~~-------- 226 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT-------- 226 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHH-----HHTTCT--------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----hhhccc--------
Confidence 2223344578999999999987765 78999999999999999999998754432211110 000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.||++|||+.|+++
T Consensus 227 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 227 -YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00011223457889999999999999999999964
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=353.14 Aligned_cols=274 Identities=19% Similarity=0.245 Sum_probs=206.2
Q ss_pred hcCcccccccccC--CcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEG--GFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.++||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4789999999999 99999999965 68999999987543 3345678889999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999998532 2356899999999999999999999998 9999999999999999999999999987643
Q ss_pred CCC-----ccCCceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh---hc
Q 003274 667 GDE-----LQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL---WK 736 (834)
Q Consensus 667 ~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~---~~ 736 (834)
... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||................. ..
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 259 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD 259 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence 211 1111222468999999999987 6799999999999999999999999975443221100000000 00
Q ss_pred c-----cc-------------cccccc---c-----ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH--Hhc
Q 003274 737 H-----ER-------------VHELMD---P-----VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM--ISN 788 (834)
Q Consensus 737 ~-----~~-------------~~~~~~---~-----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~ 788 (834)
. .. ....+. + .......+......+.+++.+||+.||++|||+.|+++. +.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~ 339 (389)
T 3gni_B 260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 339 (389)
T ss_dssp ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence 0 00 000000 0 000001122335678999999999999999999999863 544
Q ss_pred c
Q 003274 789 E 789 (834)
Q Consensus 789 ~ 789 (834)
+
T Consensus 340 ~ 340 (389)
T 3gni_B 340 I 340 (389)
T ss_dssp C
T ss_pred H
Confidence 3
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.00 Aligned_cols=252 Identities=22% Similarity=0.369 Sum_probs=204.1
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC--CeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ--GEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~--~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+|+.. ++.+|||++.... ....+.+.+|+.++.+++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 67889999999999999999974 8899999987643 34456799999999999999999999999887 7889999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ .+|+||||||+|||++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999998542 2336899999999999999999999864 3599999999999999999999999888754322
Q ss_pred CccCCceeeeccCcccCceeecCCCCCc---cccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSI---KSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~---~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....||+.|+|||.+.+..++. ++||||||+++|||++|+.||........ ...... ...
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~-----~~~- 228 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----GMKVAL-----EGL- 228 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-----HHHHHH-----SCC-
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-----HHHHHh-----cCC-
Confidence 1246799999999998765554 89999999999999999999864322110 000000 000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.||++|||+.|+++.|+++
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 229 ----RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 1122333456889999999999999999999999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=361.00 Aligned_cols=258 Identities=20% Similarity=0.228 Sum_probs=205.9
Q ss_pred HHHHHHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 003274 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 581 (834)
.++....++|.+.++||+|+||.||+++.. +++.||+|++.+. .....+.+.+|+.++..++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 344456689999999999999999999865 5789999998652 122345688999999999999999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
...++||||+++|+|..++. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMS----NYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999883 346899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCC----CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGL----FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH 737 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 737 (834)
++.+...... .....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||....... .. ......
T Consensus 215 a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~---~~i~~~ 288 (410)
T 3v8s_A 215 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--TY---SKIMNH 288 (410)
T ss_dssp CEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---HHHHTH
T ss_pred eEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh--HH---HHHHhc
Confidence 9876543221 122457999999999998765 8899999999999999999999986432111 00 000000
Q ss_pred cccccccccccccCCCCHHHHhHHHHHHHhccccCCCC--CCCHHHHHH
Q 003274 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAAD--RPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~ 784 (834)
.. .+ ..........++.+++.+||..+|++ ||++.||++
T Consensus 289 ~~-------~~-~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 289 KN-------SL-TFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HH-------HC-CCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cc-------cc-cCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 00 00 00011123567899999999999988 999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.05 Aligned_cols=264 Identities=20% Similarity=0.239 Sum_probs=206.9
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 585 (834)
..++|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 347899999999999999999986 5789999999877666677889999999999999999999999873 34789
Q ss_pred EEEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 586 LILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 9999999999999885422 2467899999999999999999999997 99999999999999999999999999876
Q ss_pred cCCCCccC-------CceeeeccCcccCceeecCCC---CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 665 FGGDELQG-------NTKRIVGTYGYMSPEYALDGL---FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 665 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||...........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------ 257 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA------ 257 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH------
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh------
Confidence 53211100 011235699999999987654 78999999999999999999999753211110000
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
..+.... ...........+.+++.+||+.||++||++.++++.|+.+..
T Consensus 258 -------~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 258 -------LAVQNQL-SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -------HHHHCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -------HHhhccC-CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 0000000 111122335678999999999999999999999999998743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=358.19 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=206.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67899999999999999999864 68999999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999984 3456999999999999999999999987 999999999999999999999999999886543
Q ss_pred CccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... +. ... .+..
T Consensus 170 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~----~~i--------~~~~ 232 (476)
T 2y94_A 170 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LF----KKI--------CDGI 232 (476)
T ss_dssp CC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HH----HHH--------HTTC
T ss_pred cc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HH----HHH--------hcCC
Confidence 32 233579999999999998765 789999999999999999999986432211 10 000 0000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISN 788 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 788 (834)
...+.....++.+++.+||+.||++|||+.|+++ .+.+
T Consensus 233 ---~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 233 ---FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ---cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 0112233467899999999999999999999987 4544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=334.06 Aligned_cols=248 Identities=28% Similarity=0.457 Sum_probs=183.8
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 6799999999999999999986 578999999986432 223567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999998843 2356899999999999999999999998 999999999999999999999999999876432
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ .......
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~-- 227 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT--------------LNKVVLA-- 227 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------------CCSS--
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH--------------HHHHhhc--
Confidence 21 12235689999999999999999999999999999999999999864332110 0000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.....++.+++.+||+.||++||++.++++
T Consensus 228 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 -DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01122234567899999999999999999999964
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=347.48 Aligned_cols=258 Identities=28% Similarity=0.443 Sum_probs=201.8
Q ss_pred cCcccccccccCCcEeEEEEEecC-----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|.+.++||+|+||.||+|+... +..||||++.... ......+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 678888999999999999998543 3469999997543 3345678999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999843 3356899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCccC-CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 667 GDELQG-NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 667 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....... +. ......
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~----~~~~~~------ 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VM----KAINDG------ 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----HHHHTT------
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--HH----HHHHCC------
Confidence 432211 1222346789999999999999999999999999999999 999985432111 00 000000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
. ....+......+.+++.+||+.||++||++.++++.|+++..
T Consensus 267 ---~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 267 ---F-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ---C-CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---C-cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 111223345688999999999999999999999999988743
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.16 Aligned_cols=263 Identities=20% Similarity=0.248 Sum_probs=200.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
-++|.+.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 378999999999999999999864 688999999875432 2346789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999884 3356899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... + ...... ....+
T Consensus 187 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~----~~~~~~----~~~~~- 254 (309)
T 2h34_A 187 EKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV--M----GAHINQ----AIPRP- 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--H----HHHHHS----CCCCG-
T ss_pred cccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH--H----HHHhcc----CCCCc-
Confidence 3221 2233568999999999999999999999999999999999999986432110 0 000000 00000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCC-CHHHHHHHHhcccCCCCC
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRP-TMSDVVSMISNEHLNLPF 795 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~~~~l~~ 795 (834)
...+......+.+++.+||+.||++|| ++.++++.|++.......
T Consensus 255 ---~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 255 ---STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp ---GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred ---cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 011223345788999999999999999 999999999987544443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=348.06 Aligned_cols=251 Identities=22% Similarity=0.285 Sum_probs=188.9
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
..++|.+.++||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++.+++||||+++++++.+....++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3478999999999999999999965 47899999997543 34678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccccceecC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla~~~~ 666 (834)
|+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 999999999884 3456899999999999999999999988 999999999999975 8899999999998764
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ......... ..
T Consensus 203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~~i~~~~~-~~--- 270 (349)
T 2w4o_A 203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-----FRRILNCEY-YF--- 270 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-----HHHHHTTCC-CC---
T ss_pred ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-----HHHHHhCCC-cc---
Confidence 332 223357899999999999999999999999999999999999998643322110 000000000 00
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+++.+||+.||++||++.|+++
T Consensus 271 ---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 271 ---ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp ---CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111233567899999999999999999999986
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=353.92 Aligned_cols=261 Identities=28% Similarity=0.401 Sum_probs=196.8
Q ss_pred cCcccccccccCCcEeEEEEEec--C--ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF--N--GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~--~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l 586 (834)
..|.+.++||+|+||.||+|+.. + +..||||.++... ....+.|.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 35677889999999999999853 2 2468999986543 3456789999999999999999999999765 457899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 169 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999843 3456889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCccC--CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 667 GDELQG--NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 667 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+|+........ .. ......
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~----~~~~~~---- 313 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TV----YLLQGR---- 313 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HH----HHHTTC----
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HH----HHHcCC----
Confidence 433211 1223457889999999999999999999999999999999 5666654332211 00 000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 794 (834)
....+......+.+++.+||+.||++||++.|+++.|+++...+.
T Consensus 314 ------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 011122345678999999999999999999999999998755544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=349.47 Aligned_cols=252 Identities=21% Similarity=0.255 Sum_probs=193.3
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.++||+|+||.||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999865 68899999996543 2346788999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC--eeecccccceecCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--PKISDFGLARMFGGD 668 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGla~~~~~~ 668 (834)
+++|+|.+++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999998883 3456999999999999999999999988 999999999999987765 999999999753322
Q ss_pred CccCCceeeeccCcccCceeecCCCCCcc-ccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIK-SDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~-sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ...... .+....
T Consensus 172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~---------~~~~~~ 238 (361)
T 3uc3_A 172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQ---------RILSVK 238 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHH---------HHHTTC
T ss_pred C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHH---------HHhcCC
Confidence 1 2233579999999999988888765 8999999999999999999875433211 000000 000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ...........+.+++.+||+.||++|||+.|+++
T Consensus 239 ~-~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 239 Y-SIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp C-CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred C-CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 0 00111123467889999999999999999999987
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.28 Aligned_cols=264 Identities=22% Similarity=0.250 Sum_probs=198.4
Q ss_pred cCcccc-cccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQ-CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 589 (834)
+.|.+. ++||+|+||.||+++. .+++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 7899999999999984 46899999999776666678899999999995 79999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC---eeecccccceecC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGla~~~~ 666 (834)
|+++++|.+++.. ...+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+|||+++...
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999843 356899999999999999999999997 999999999999998776 9999999998654
Q ss_pred CCCc-----cCCceeeeccCcccCceeecC-----CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 667 GDEL-----QGNTKRIVGTYGYMSPEYALD-----GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 667 ~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
.... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...................
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 111223468999999999875 568999999999999999999999987544322100000000000
Q ss_pred ccccccccccccccCCCCH----HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HERVHELMDPVILQDEIPL----PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.....+.+... ....+. .....+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 246 QNMLFESIQEG--KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHhcc--CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 00000000000 001111 13457899999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=356.75 Aligned_cols=262 Identities=19% Similarity=0.240 Sum_probs=206.3
Q ss_pred cHHHHHHHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEE
Q 003274 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCV 579 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~ 579 (834)
.+.+.....++|.+.++||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.+++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34445556789999999999999999999864 68999999986532 223456889999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccc
Q 003274 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (834)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 659 (834)
+.+..++||||+++|+|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~--~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSK--FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHH--HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999843 2346899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeec-------CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchh
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYAL-------DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAW 732 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~ 732 (834)
|+++........ .....+||+.|+|||++. ...++.++|||||||++|||++|+.||....... ...
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~--- 280 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE--TYG--- 280 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH---
T ss_pred hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH--HHH---
Confidence 999876543221 122357999999999997 4678999999999999999999999986432211 000
Q ss_pred hhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCC---CCHHHHHH
Q 003274 733 DLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADR---PTMSDVVS 784 (834)
Q Consensus 733 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~ 784 (834)
...... . .+.....+.....++.+++.+||. +|++| |++.|+++
T Consensus 281 ~i~~~~---~----~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 281 KIVHYK---E----HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHTHH---H----HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHhcc---c----CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000000 0 000001112345688999999999 99998 68999976
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=373.21 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=202.8
Q ss_pred cCccccc-ccccCCcEeEEEEEec---CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQC-KLGEGGFGPVYKGRLF---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
+++.+.+ +||+|+||.||+|... ++..||||+++... ....++|.+|+++|.+++|||||++++++.. +..++|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 4444444 7999999999999753 46789999997653 3456889999999999999999999999976 569999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++.. ....+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 414 ~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EEeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999853 3456899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 668 DELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 668 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....... .. .......
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~----~~i~~~~------ 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGK------ 556 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HH----HHHHTTC------
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HH----HHHHcCC------
Confidence 3211 11222345789999999999999999999999999999998 999987533211 11 0010000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....+.....++.++|.+||+.||++||++.+|++.|+.+.
T Consensus 557 ----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 557 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp ----CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11223345678999999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=350.25 Aligned_cols=248 Identities=26% Similarity=0.321 Sum_probs=196.8
Q ss_pred ccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCCC
Q 003274 516 SMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNK 594 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~g 594 (834)
...+.||+|+||.||+|+. .+|+.||+|+++.......+.+.+|++++.+++||||+++++++.+.+..++||||++++
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3357899999999999985 468999999998766566788999999999999999999999999999999999999999
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe--ccCCCeeecccccceecCCCCccC
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL--DKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 172 ~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~-- 244 (373)
T 2x4f_A 172 ELFDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244 (373)
T ss_dssp EEHHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred cHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence 99888743 3346899999999999999999999998 9999999999999 5677899999999998754332
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||....... .. ....... .... ..
T Consensus 245 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~---~~i~~~~--~~~~------~~ 310 (373)
T 2x4f_A 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TL---NNILACR--WDLE------DE 310 (373)
T ss_dssp -CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---HHHHHTC--CCSC------SG
T ss_pred -cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HH---HHHHhcc--CCCC------hh
Confidence 223469999999999999999999999999999999999999986433211 00 0000000 0000 00
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.......++.+++.+||+.||++||++.|+++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 01123467899999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.10 Aligned_cols=253 Identities=15% Similarity=0.149 Sum_probs=205.2
Q ss_pred HhcCcccccccccCCcEeEEEEE------ecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGR------LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 581 (834)
..++|.+.++||+|+||.||+|+ ...++.||||++... ...++..|++++.+++ |+||+++++++...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45789999999999999999993 456889999999654 3456788888888886 99999999999999
Q ss_pred CeEEEEEEecCCCCcchhccccc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---------
Q 003274 582 GEKILILEYMPNKSLDVYLFDPI--KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--------- 650 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~--------- 650 (834)
+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+||||+.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999985322 3457999999999999999999999987 999999999999998
Q ss_pred --CCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccc
Q 003274 651 --DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLL 728 (834)
Q Consensus 651 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~ 728 (834)
++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 8999999999998764322222334457999999999999999999999999999999999999997532211100
Q ss_pred cchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCC-CCHHHHHHHHhccc
Q 003274 729 GHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADR-PTMSDVVSMISNEH 790 (834)
Q Consensus 729 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~~~ 790 (834)
+...+ .. ......+.+++..|++.+|.+| |++.++.+.|++..
T Consensus 295 ---------------~~~~~-~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 295 ---------------PEGLF-RR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp ---------------ECSCC-TT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred ---------------echhc-cc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00111 11 1234567889999999999999 67888888887753
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=343.41 Aligned_cols=267 Identities=23% Similarity=0.359 Sum_probs=201.4
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 6799999999999999999985 56899999998753 2334567899999999999999999999999999999999
Q ss_pred EecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999885322 3456899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........+.. ...... .+
T Consensus 189 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~-----~~- 256 (310)
T 2wqm_A 189 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----KIEQCD-----YP- 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHH----HHHTTC-----SC-
T ss_pred CCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHH----Hhhccc-----CC-
Confidence 321 122356899999999999999999999999999999999999998643322111110 000000 00
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCCCCC
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPK 797 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~p~ 797 (834)
.........++.+++.+||+.||++||++.+|++.|+++....+.|+
T Consensus 257 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 257 ---PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ---CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ---CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 01112234678999999999999999999999999998865555444
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=337.12 Aligned_cols=255 Identities=25% Similarity=0.381 Sum_probs=202.8
Q ss_pred hcCcccccccccCCcEeEEEEEecC----ccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.+.||+|+||.||+|+..+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4789999999999999999998533 346999999765 33456789999999999999999999999765 46789
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999843 3356899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........ .. ......
T Consensus 165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~--~~----~~~~~~------ 231 (281)
T 3cc6_A 165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV--IG----VLEKGD------ 231 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH--HH----HHHHTC------
T ss_pred ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH--HH----HHhcCC------
Confidence 43321 1223456889999999999999999999999999999998 9999864332111 00 000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 232 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 232 ----RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 0111223346789999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=342.83 Aligned_cols=265 Identities=27% Similarity=0.370 Sum_probs=188.7
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.++||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 46789999999999999999985 458899999986543 2345678999999999999999999999999999999999
Q ss_pred ecCCCCcchhccccc---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 590 YMPNKSLDVYLFDPI---KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|++ ++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 58888874321 1245899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh--------hcc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL--------WKH 737 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~--------~~~ 737 (834)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....... +..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ--LKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCTTTCGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChhHhhh
Confidence 3221 2223478999999999976 4689999999999999999999999875432110 0000000 000
Q ss_pred cccccccccccc-----------cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ERVHELMDPVIL-----------QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........+.+. ..........++.+++.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000000 00011123457899999999999999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=345.94 Aligned_cols=243 Identities=21% Similarity=0.322 Sum_probs=202.4
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc--------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 581 (834)
..++|.+.++||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 347899999999999999999984 5688999999875421 1334678899999999999999999999999
Q ss_pred CeEEEEEEecCCC-CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 582 GEKILILEYMPNK-SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 582 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
+..++||||+..| +|..++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 8888873 3446999999999999999999999998 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 998865433 2234579999999999988876 88999999999999999999998532110
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
.... ...+.....++.+++.+||+.||++||++.++++.
T Consensus 237 ----~~~~---~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 237 ----VEAA---IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----TTTC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----Hhhc---cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01122234678999999999999999999999873
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=351.58 Aligned_cols=271 Identities=20% Similarity=0.288 Sum_probs=213.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--eEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG--EKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~~lV~ 588 (834)
++|.+.++||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 67899999999999999999865 48899999997543 344677889999999999999999999998765 779999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe----ccCCCeeeccccccee
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKISDFGLARM 664 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGla~~ 664 (834)
||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976555555999999999999999999999998 9999999999999 7778899999999988
Q ss_pred cCCCCccCCceeeeccCcccCceeecC--------CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALD--------GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ........
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~-~~~~~~~~ 241 (396)
T 4eut_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYKIIT 241 (396)
T ss_dssp CCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH-HHHHHHHH
T ss_pred ccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH-HHHHHHhc
Confidence 754332 223568999999999875 567889999999999999999999986543322110 00000000
Q ss_pred ccc------cccccc-------cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 737 HER------VHELMD-------PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 737 ~~~------~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ...... ...............+.+++.+||+.||++||++.|+++.+.++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il 308 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence 000 000000 000112344567788999999999999999999999999887764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=338.43 Aligned_cols=261 Identities=28% Similarity=0.399 Sum_probs=204.3
Q ss_pred cCcccccccccCCcEeEEEEEecC----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~l 586 (834)
..|.+.++||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 568888999999999999998543 2368999987543 3445779999999999999999999998654 567899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999843 3456899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcc--CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCC-CCCCCCCCCccccccchhhhhcccccccc
Q 003274 667 GDELQ--GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR-KNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 667 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
..... .......+|+.|+|||.+.+..++.++||||||+++|||++|. +|+........ .. ... ...
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~---~~~-~~~---- 249 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TV---YLL-QGR---- 249 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HH---HHH-TTC----
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HH---HHh-cCC----
Confidence 43321 1223346788999999999999999999999999999999954 55543222111 00 000 000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 794 (834)
....+......+.+++.+||+.||++||++.|+++.|+++..++.
T Consensus 250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 011122234578999999999999999999999999998755443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=338.94 Aligned_cols=261 Identities=26% Similarity=0.335 Sum_probs=205.4
Q ss_pred CcccccccccCCcEeEEEEEecC----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE-EEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK-ILI 587 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~-~lV 587 (834)
.|...++||+|+||.||+|+..+ +..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998432 3379999987543 34567899999999999999999999999876655 999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+.+++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999853 3456899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCc--cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 668 DEL--QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 668 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
... ........+|+.|+|||.+.+..++.++||||||+++|||++|..|+....... .... ......
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~----~~~~~~------ 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTH----FLAQGR------ 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHH----HHHTTC------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHH----HhhcCC------
Confidence 332 122233567899999999999999999999999999999999665543221111 1000 000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 794 (834)
....+......+.+++.+||+.||++|||+.++++.|+++...+.
T Consensus 246 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 ----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111222345678999999999999999999999999988754443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.86 Aligned_cols=256 Identities=28% Similarity=0.395 Sum_probs=204.4
Q ss_pred hcCccccc-ccccCCcEeEEEEEe---cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 512 TENFSMQC-KLGEGGFGPVYKGRL---FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 512 ~~~f~~~~-~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
.++|.+.+ .||+|+||.||+|.. ..++.||||++.... ....+++.+|++++.+++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 36788877 999999999999953 346889999997543 22357899999999999999999999999 667889
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++++|.+++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999843 456899999999999999999999998 999999999999999999999999999877
Q ss_pred CCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. .......
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~----~~~~~~~---- 237 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT----AMLEKGE---- 237 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH----HHHHTTC----
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH----HHHHcCC----
Confidence 543321 11222346789999999999999999999999999999999 999986432211 00 0000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....+......+.+++.+||+.||++||++.++++.|+++.
T Consensus 238 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 238 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11223344568899999999999999999999999998864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.31 Aligned_cols=264 Identities=20% Similarity=0.263 Sum_probs=206.5
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEE-EeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC-VEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~E 589 (834)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+.++.+++|++++..+..+ .+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 47899999999999999999985 6789999999865432 35689999999999988866666555 56678899999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe---ccCCCeeecccccceecC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~ 666 (834)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999998842 2456899999999999999999999998 9999999999999 588999999999998875
Q ss_pred CCCccC-----CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccchhhhhccccc
Q 003274 667 GDELQG-----NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGHAWDLWKHERV 740 (834)
Q Consensus 667 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 740 (834)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~ 235 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----ISEKKM 235 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH----HHHHHH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh----hccccc
Confidence 543211 12345799999999999999999999999999999999999999875432211 11100 000000
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 793 (834)
.. ..+. .....+.++.+++.+||+.||++||++.++++.|+++....
T Consensus 236 ~~-~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 236 ST-PIEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HS-CHHH-----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CC-chHH-----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 00 0000 01122457899999999999999999999999998875443
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=363.53 Aligned_cols=248 Identities=23% Similarity=0.291 Sum_probs=195.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.++|.+.++||+|+||.||+++. .+++.||||++... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999985 46889999998653 233456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||+++|+|..++. ....+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999998883 34578999999999999999999998 76 9999999999999999999999999998643
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... .......||+.|+|||++.+..++.++|||||||+||||++|+.||....... +.. .. ...
T Consensus 301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~----~i--------~~~ 364 (446)
T 4ejn_A 301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFE----LI--------LME 364 (446)
T ss_dssp C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HH--------HHC
T ss_pred CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHH----HH--------HhC
Confidence 322 12334679999999999999999999999999999999999999986432211 000 00 000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
....+.....++.+++.+||+.||++|| ++.|+++
T Consensus 365 ---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 ---EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 1122333456889999999999999999 9999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.29 Aligned_cols=271 Identities=27% Similarity=0.377 Sum_probs=195.8
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHH--HhhcCCCceeeEEEEEEe-----CCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMML--IAELQHRNLVRILGCCVE-----QGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~H~niv~l~~~~~~-----~~~~ 584 (834)
.++|.+.++||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 37899999999999999999976 68999999986432 3344455544 445899999999986643 2256
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCEEeccCCCeeecc
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS------RLRIIHRDLKASNVLLDKDMNPKISD 658 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------~~~ivH~Dlk~~NILl~~~~~~kl~D 658 (834)
++||||+++|+|.+++. ....++..+.+++.||++||+|||+.. ..+|+||||||+|||++.++.+||+|
T Consensus 88 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLS----LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCCCcHHHHHh----hcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 89999999999999983 334589999999999999999999881 01399999999999999999999999
Q ss_pred cccceecCCCCcc------CCceeeeccCcccCceeecC-------CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc
Q 003274 659 FGLARMFGGDELQ------GNTKRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF 725 (834)
Q Consensus 659 FGla~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~ 725 (834)
||+++.+...... .......||+.|+|||++.+ ..++.++|||||||++|||++|..|+........
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 9999877543211 11223468999999999987 4567899999999999999999776543222111
Q ss_pred ccccchhhhhccc---ccc-----ccccccccc-CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 726 NLLGHAWDLWKHE---RVH-----ELMDPVILQ-DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 726 ~~~~~~~~~~~~~---~~~-----~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
............. ... ....+.+.. ..........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 0000000000000 000 000111100 0112235568999999999999999999999999998873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=332.33 Aligned_cols=246 Identities=21% Similarity=0.309 Sum_probs=203.7
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.++||+|+||.||+|+.. ++..+|+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 367999999999999999999865 4678999999776666678899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe---ccCCCeeecccccceecCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~~ 667 (834)
+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++.....
T Consensus 88 ~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999988874 3456899999999999999999999998 9999999999999 7889999999999987654
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. ......||+.|+|||++.+. ++.++||||||+++|||++|+.||........ . ......
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--~----~~~~~~--------- 222 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--M----LKIREG--------- 222 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H----HHHHHC---------
T ss_pred cc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--H----HHHHhC---------
Confidence 33 22335689999999988654 99999999999999999999999864332110 0 000000
Q ss_pred cccCCCCH----HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPL----PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+. .....+.+++.+||+.||++||++.++++
T Consensus 223 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 223 --TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111 12467899999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.24 Aligned_cols=272 Identities=27% Similarity=0.425 Sum_probs=209.4
Q ss_pred hcCcccccccccCCcEeEEEEEe-----cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC--eE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-----FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG--EK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~--~~ 584 (834)
.++|.+.++||+|+||.||+++. .+++.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 36788999999999999999983 368899999998766666788999999999999999999999987654 78
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHH--STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999999843 2345899999999999999999999987 99999999999999999999999999988
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhh-hhccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD-LWKHERVHE 742 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 742 (834)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....+.......... ........+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 7543221 11222456788999999999999999999999999999999998865321100000000000 000000011
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.... ....+.....++.+++.+||+.||++||++.|+++.|+++
T Consensus 275 ~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 275 LLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HhhcCC-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111100 1112334457899999999999999999999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=341.62 Aligned_cols=266 Identities=25% Similarity=0.320 Sum_probs=205.1
Q ss_pred HHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhh--cCCCceeeEEEEEEeCC----
Q 003274 509 AAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAE--LQHRNLVRILGCCVEQG---- 582 (834)
Q Consensus 509 ~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~H~niv~l~~~~~~~~---- 582 (834)
....++|.+.+.||+|+||.||+|+. .++.||||++... ..+.+..|++++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 34457899999999999999999986 5899999998643 34667889998887 68999999999998876
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCEEeccCCCe
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH--------QYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--------~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
..++||||+++|+|.+++. ...+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+
T Consensus 114 ~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CEEEEECCCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred eeEEEEeecCCCcHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 7899999999999999983 346899999999999999999999 555 9999999999999999999
Q ss_pred eecccccceecCCCCccC--CceeeeccCcccCceeecCC------CCCccccchhhHHHHHHHhcC----------CCC
Q 003274 655 KISDFGLARMFGGDELQG--NTKRIVGTYGYMSPEYALDG------LFSIKSDVFSFGILMLETLSS----------RKN 716 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~t~~sDVwSlGvll~elltG----------~~p 716 (834)
||+|||+++......... ......||+.|+|||++.+. .++.++||||||+++|||++| +.|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998765433211 22335789999999999876 334789999999999999999 445
Q ss_pred CCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 717 TGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
|............. .... ......+.+............+.+++.+||+.||++||++.||++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 267 YYDLVPSDPSVEEM-RKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp TTTTSCSSCCHHHH-HHHH----TTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccccCcCcccHHHH-HHHH----HHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 44322111110000 0000 011111111111112355678999999999999999999999999998874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=336.08 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=203.7
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE---------- 580 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 580 (834)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 467999999999999999999965 68999999987543 356789999999999999999998864
Q ss_pred ------CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCe
Q 003274 581 ------QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 581 ------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
....++||||+++++|.+++... ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 34579999999999999998532 3457899999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|..|+.... .....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~ 230 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTD 230 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHH
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHH
Confidence 9999999988754332 223468999999999999999999999999999999999988753100 00000
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
+. ....+......+.+++.+||+.||++||++.|+++.|..+.
T Consensus 231 --------~~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 --------LR-----DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp --------HH-----TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred --------hh-----cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 00 11112223456789999999999999999999999998874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=334.57 Aligned_cols=263 Identities=20% Similarity=0.275 Sum_probs=202.3
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEE-EeCCeEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC-VEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~-~~~~~~~lV~ 588 (834)
..++|.+.+.||+|+||.||+|+. .+++.||||++..... .+.+..|+.++.+++|++++..+..+ ......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 347899999999999999999985 6688999998754332 24578899999999988877666655 5677889999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe---ccCCCeeecccccceec
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~ 665 (834)
||+ +++|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999998842 2456899999999999999999999998 9999999999999 78999999999999987
Q ss_pred CCCCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccchhhhhcccc
Q 003274 666 GGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGHAWDLWKHER 739 (834)
Q Consensus 666 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~ 739 (834)
...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~~~ 234 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI----SEKK 234 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH----HHHH
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh----hccc
Confidence 554321 122345789999999999999999999999999999999999999875433221 110000 0000
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
..... +. .....+..+.+++.+||+.||++||++.++++.|+++..
T Consensus 235 ~~~~~-~~-----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 235 MSTPI-EV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp HHSCH-HH-----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ccchh-hh-----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 00000 00 001124578999999999999999999999999988753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=346.06 Aligned_cols=266 Identities=20% Similarity=0.211 Sum_probs=203.1
Q ss_pred HHHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC-----CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 003274 508 VAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-----SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (834)
Q Consensus 508 ~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 581 (834)
+....++|.+.++||+|+||.||+++. .+++.||+|++... .....+.+.+|++++.+++||||+++++++.+.
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345568899999999999999999986 45789999998643 334567899999999999999999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccccc-------------------------------------cCCCCHHHHHHHHHHHHHH
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIK-------------------------------------KRLLDWEARIRIIQGIAQG 624 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~g 624 (834)
+..++||||+++|+|.+++..... ...+++..+..++.||++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 999999999999999998842110 1224567788999999999
Q ss_pred HHHHHhcCCCCeEecCCCCCCEEeccCC--CeeecccccceecCCCCc--cCCceeeeccCcccCceeecC--CCCCccc
Q 003274 625 LLYLHQYSRLRIIHRDLKASNVLLDKDM--NPKISDFGLARMFGGDEL--QGNTKRIVGTYGYMSPEYALD--GLFSIKS 698 (834)
Q Consensus 625 l~~LH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~t~~s 698 (834)
|+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999998 99999999999998776 899999999987643221 112234578999999999975 6789999
Q ss_pred cchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC
Q 003274 699 DVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT 778 (834)
Q Consensus 699 DVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 778 (834)
||||||+++|||++|+.||........ ......... .. ...........+.+++.+||+.||++||+
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~--~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT-----ISQVLNKKL--CF------ENPNYNVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHHCCC--CT------TSGGGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH-----HHHHHhccc--cc------CCcccccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999999864332110 000100000 00 00001123467899999999999999999
Q ss_pred HHHHHH--HHhcc
Q 003274 779 MSDVVS--MISNE 789 (834)
Q Consensus 779 ~~evl~--~L~~~ 789 (834)
+.|+++ .+.+.
T Consensus 325 ~~~~l~hp~~~~~ 337 (345)
T 3hko_A 325 AMRALQHPWISQF 337 (345)
T ss_dssp HHHHHHSHHHHTT
T ss_pred HHHHhcChhhccC
Confidence 999987 44443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=339.05 Aligned_cols=261 Identities=25% Similarity=0.315 Sum_probs=198.0
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.++||+|+||.||+++.. +++.||||++..... ...+.+.+|++++.+++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 67899999999999999999864 488999998865432 235678899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|..++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 83 YCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp CCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred eCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 999999988763 3456899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-cccc--------hhhhhcccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-LLGH--------AWDLWKHER 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~--------~~~~~~~~~ 739 (834)
. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... .... ....+....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 D--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred c--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 1 1233578999999999976 67899999999999999999999998654322110 0000 000000000
Q ss_pred c---ccccccccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 V---HELMDPVILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~---~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ....++. ...+ ......+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 235 YFSGVKIPDPE---DMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGTTCCCCCCS---SCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccCcCCCcc---ccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 0000000 0000 123456889999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=347.89 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=204.1
Q ss_pred hcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|+||.||+|+. .+++.||||++... .......+.+|+.++.+++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 37899999999999999999973 34678999999654 334556789999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeec
Q 003274 585 ILILEYMPNKSLDVYLFDPIK----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKIS 657 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~ 657 (834)
++||||+++++|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999854321 245899999999999999999999998 999999999999984 4569999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhc
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .. ....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~----~~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL----EFVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH----HHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HH----HHHh
Confidence 9999986644333333334567899999999999999999999999999999998 888876432111 00 0000
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ....+......+.+++.+||+.||++||++.++++.|..+.
T Consensus 260 ~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 260 SGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 000 11122234567899999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=334.79 Aligned_cols=246 Identities=26% Similarity=0.366 Sum_probs=200.5
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 478999999999999999999854 46789999985432 22356789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999998884 3356899999999999999999999987 99999999999999999999999999865433
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ . .....
T Consensus 162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~---------- 221 (279)
T 3fdn_A 162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET--Y----KRISR---------- 221 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H----HHHHH----------
T ss_pred cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH--H----HHHHh----------
Confidence 22 2335789999999999999999999999999999999999999864321110 0 00000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.....+......+.+++.+||+.||++||++.|+++
T Consensus 222 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 222 -VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 011223334567889999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=341.68 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=204.7
Q ss_pred cCcccccccccCCcEeEEEEEec-CccE--EEEEEcccC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQE--VAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~--vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 587 (834)
++|.+.+.||+|+||.||+++.. ++.. +|+|.+... .....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999853 4554 499988653 334556789999999999 899999999999999999999
Q ss_pred EEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCe
Q 003274 588 LEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
|||+++++|.+++.... ....+++..++.++.||++||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999985432 2346899999999999999999999988 9999999999999999999
Q ss_pred eecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhh
Q 003274 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... +. .
T Consensus 182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--~~----~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--LY----E 252 (327)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----H
T ss_pred EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--HH----H
Confidence 99999999753221 12223456889999999999999999999999999999998 999986432211 00 0
Q ss_pred hhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCC
Q 003274 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLN 792 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~ 792 (834)
... ... ....+......+.+++.+||+.||++||++.|+++.|+++..+
T Consensus 253 ~~~---------~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 253 KLP---------QGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HGG---------GTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred Hhh---------cCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 000 000 1122333456889999999999999999999999999887543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=342.31 Aligned_cols=252 Identities=23% Similarity=0.326 Sum_probs=207.1
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.++|.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 478999999999999999999864 4788999998654 233457789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999998873 3457899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......
T Consensus 194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~--------- 256 (335)
T 2owb_A 194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKN--------- 256 (335)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHT---------
T ss_pred Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhcC---------
Confidence 321 22335789999999999999999999999999999999999999864322110 0000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISN 788 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 788 (834)
....+......+.+++.+||+.||++||++.|+++ .+.+
T Consensus 257 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 257 --EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred --CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 01122233457889999999999999999999986 4544
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=335.01 Aligned_cols=253 Identities=26% Similarity=0.403 Sum_probs=200.9
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|....+||+|+||.||+|+. .+++.||||.+........+.+.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556999999999999985 467899999998766666788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-CCCeeecccccceecCCCCc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~~~ 670 (834)
++++|.+++........+++..+..++.|+++||+|||+.+ |+|+||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999865434446778999999999999999999987 999999999999987 89999999999987654321
Q ss_pred cCCceeeeccCcccCceeecCCC--CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
......||+.|+|||++.+.. ++.++||||||+++|||++|+.||............ . .. ...
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~----~~-~~~---- 243 (295)
T 2clq_A 179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFK----V----GM-FKV---- 243 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHH----H----HH-HCC----
T ss_pred --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHh----h----cc-ccc----
Confidence 123357899999999997654 889999999999999999999998643221110000 0 00 000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.....++.+++.+||+.||++||++.++++
T Consensus 244 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 -HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11223344568899999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=372.17 Aligned_cols=249 Identities=29% Similarity=0.392 Sum_probs=198.7
Q ss_pred cccccCCcEeEEEEEe---cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRL---FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||.||+|.. ..++.||||+++... ....+++.+|++++.+++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999964 346789999997643 2346789999999999999999999999964 568999999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc-cC
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL-QG 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~ 672 (834)
|+|.+++. ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999984 3456899999999999999999999998 99999999999999999999999999987754332 12
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||....... . .+.+.... ..
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~-------------~~~i~~~~-~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--V-------------TAMLEKGE-RM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H-------------HHHHHTTC-CC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--H-------------HHHHHcCC-CC
Confidence 2233456889999999999999999999999999999998 999986433211 0 00010000 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
..+.....++.+++.+||+.||++||++.+|++.|+++.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 223345578999999999999999999999999998753
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=346.14 Aligned_cols=245 Identities=30% Similarity=0.444 Sum_probs=198.6
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
+.|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 5588899999999999999985 578999999986542 233467899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+. |+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence 9997 577666632 3457899999999999999999999998 999999999999999999999999999865432
Q ss_pred CccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
....||+.|+|||++. ...++.++|||||||++|||++|+.|+....... ......... .
T Consensus 208 ------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~------~ 270 (348)
T 1u5q_A 208 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-----ALYHIAQNE------S 270 (348)
T ss_dssp ------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHSC------C
T ss_pred ------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhcC------C
Confidence 2357899999999984 5779999999999999999999999986432110 000111000 0
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.. .+......+.+++.+||+.||++|||+.++++
T Consensus 271 ~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 271 PAL----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCC----CCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 111 11223457889999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=341.57 Aligned_cols=248 Identities=21% Similarity=0.233 Sum_probs=177.8
Q ss_pred cccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 519 CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
++||+|+||.||+++.. +++.||||++... ....+.+|+.++.+++ ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 78999999999999864 5889999998643 3467789999999997 99999999999999999999999999999
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC---CeeecccccceecCCCCccCC
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISDFGLARMFGGDELQGN 673 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 673 (834)
.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 94 ~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~ 165 (325)
T 3kn6_A 94 FERIK---KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--P 165 (325)
T ss_dssp HHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--c
Confidence 99884 3457999999999999999999999988 99999999999998765 899999999987644322 2
Q ss_pred ceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-cccchhhhhcccccccccccccccCC
Q 003274 674 TKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-LLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 674 ~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... .............. .. ...
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~-~~~ 238 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SF-EGE 238 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CC-CSH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CC-Ccc
Confidence 23356899999999999999999999999999999999999998754322110 00000000000000 00 000
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.......++.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 00123568899999999999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=351.60 Aligned_cols=245 Identities=23% Similarity=0.276 Sum_probs=191.6
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHH-HhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMML-IAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.++||+|+||.||+++.. +++.+|||++.... ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 368999999999999999999865 47889999996543 2234556677776 567899999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999998884 3456889999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. . .++..
T Consensus 191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--~~----~--------~i~~~ 254 (373)
T 2r5t_A 191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MY----D--------NILNK 254 (373)
T ss_dssp CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--HH----H--------HHHHS
T ss_pred cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--HH----H--------HHHhc
Confidence 222 22334689999999999999999999999999999999999999986432111 00 0 00000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSD 781 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
. ...+......+.+++.+||+.||++||++.+
T Consensus 255 ~---~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 255 P---LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp C---CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred c---cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0 1122234567899999999999999999854
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.59 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=203.2
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.++|.+.++||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 478999999999999999999864 58899999986542 334567889999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC---eeecccccceec
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGla~~~ 665 (834)
||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++...
T Consensus 85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 9999999988873 3456899999999999999999999998 999999999999987655 999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... .. ........ ..
T Consensus 159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~----~~~~~~~~-~~-- 226 (284)
T 3kk8_A 159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LY----AQIKAGAY-DY-- 226 (284)
T ss_dssp CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHTCC-CC--
T ss_pred ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HH----HHHHhccc-cC--
Confidence 54332 223578999999999999999999999999999999999999986432211 00 00000000 00
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+++.+||+.||++||++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 227 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00011123467889999999999999999999976
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=335.99 Aligned_cols=251 Identities=22% Similarity=0.348 Sum_probs=197.7
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+++. .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 6799999999999999999986 458899999986543 34567899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe---ccCCCeeecccccceecC
Q 003274 591 MPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFG 666 (834)
Q Consensus 591 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~ 666 (834)
+++++|.+++... .....+++..+..++.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999888543 23467999999999999999999999998 9999999999999 456889999999998764
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... ......||+.|+|||++. ..++.++||||||+++|||++|+.||........ .. ..... .+
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~----~~~~~------~~ 242 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQ----KATYK------EP 242 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHC------CC
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--Hh----hhccC------Cc
Confidence 432 223357899999999876 5689999999999999999999999864332110 00 00000 00
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. .....+....+.+++.+||+.||++||++.|+++
T Consensus 243 ~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 243 NY--AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CC--CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc--ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0001113457889999999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=346.10 Aligned_cols=206 Identities=26% Similarity=0.294 Sum_probs=177.2
Q ss_pred HHHHHHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-----CCceeeEEEEE
Q 003274 505 LASVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----HRNLVRILGCC 578 (834)
Q Consensus 505 ~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----H~niv~l~~~~ 578 (834)
+.......++|.+.++||+|+||.||+++. .+++.||||++... ....+.+..|+.++.+++ ||||+++++++
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~ 105 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF 105 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence 333334468999999999999999999986 46889999999643 334566788999999996 99999999999
Q ss_pred EeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc--------
Q 003274 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-------- 650 (834)
Q Consensus 579 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-------- 650 (834)
...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 106 ~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 106 MYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEE
T ss_pred eECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccccc
Confidence 9999999999999 99999988532 2335899999999999999999999988 999999999999975
Q ss_pred -----------------CCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcC
Q 003274 651 -----------------DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSS 713 (834)
Q Consensus 651 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG 713 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 255 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence 789999999999875432 2235789999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 003274 714 RKNTGVYN 721 (834)
Q Consensus 714 ~~p~~~~~ 721 (834)
+.||....
T Consensus 256 ~~pf~~~~ 263 (360)
T 3llt_A 256 SLLFRTHE 263 (360)
T ss_dssp SCSCCCSS
T ss_pred CCCCCCCc
Confidence 99987543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.54 Aligned_cols=245 Identities=21% Similarity=0.335 Sum_probs=198.9
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 587 (834)
.++|.+.+.||+|+||.||+++.. +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 478999999999999999999865 6899999998754 233456788999999999 999999999999999999999
Q ss_pred EEecCCCCcchhcccccc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC---------------
Q 003274 588 LEYMPNKSLDVYLFDPIK-KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--------------- 651 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~--------------- 651 (834)
|||+++++|.+++..... ...+++..+..++.||++||+|||+++ |+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999854322 256899999999999999999999998 9999999999999844
Q ss_pred ----CCeeecccccceecCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccc
Q 003274 652 ----MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN 726 (834)
Q Consensus 652 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~ 726 (834)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|||++|.+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999998865432 23589999999999876 667899999999999999999877532110
Q ss_pred cccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 727 LLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........ ....+......+.+++.+||+.||++||++.|+++
T Consensus 237 -----~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----WHEIRQGR----------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHTTC----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHcCC----------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 00111110 01122234567899999999999999999999974
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=334.65 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=197.9
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-CeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey 590 (834)
.++|.+.+.||+|+||.||+++. .++.||||+++.. ...+.+.+|++++.+++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 47899999999999999999986 4889999998754 3457899999999999999999999997655 478999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 171 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence 9999999998432 2234889999999999999999999988 9999999999999999999999999998654321
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+....... .. ...... .
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~----~~~~~~-----~----- 231 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VV----PRVEKG-----Y----- 231 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HH----HHHTTT-----C-----
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HH----HHHhcC-----C-----
Confidence 22357889999999999999999999999999999998 999886433211 00 000000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.||++||++.|+++.|+++
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 1122233456889999999999999999999999999876
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.99 Aligned_cols=251 Identities=23% Similarity=0.283 Sum_probs=204.1
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|.+.+.||+|+||.||+++.. +++.||||.+..... ...+.+.+|+.++.+++||||+++++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 367999999999999999999864 588999999865432 1367899999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC----Ceeecccc
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFG 660 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFG 660 (834)
++||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHH---TCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999984 3456899999999999999999999998 99999999999999888 79999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+++....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... .....
T Consensus 165 ~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~i~~~-- 233 (321)
T 2a2a_A 165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLA----NITSV-- 233 (321)
T ss_dssp TCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH----HHHTT--
T ss_pred cceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHhc--
Confidence 9988654321 233568999999999999999999999999999999999999986432211 000 00000
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.....+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 234 SYDFDEEF-----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCCCCHHH-----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccccChhh-----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000 0122457889999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.19 Aligned_cols=264 Identities=25% Similarity=0.351 Sum_probs=197.5
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-----cccHHHHHHHHHHHhhcC---CCceeeEEEEEEeC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-----GQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~ 581 (834)
..++|.+.++||+|+||+||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999985 568899999986432 122346677888877774 99999999999876
Q ss_pred C-----eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeee
Q 003274 582 G-----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKI 656 (834)
Q Consensus 582 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl 656 (834)
. ..++||||+. ++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 5799999997 5998887532 2234899999999999999999999998 999999999999999999999
Q ss_pred cccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|++||....... ..........
T Consensus 162 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~ 236 (308)
T 3g33_A 162 ADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIG 236 (308)
T ss_dssp CSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHHC
T ss_pred eeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhC
Confidence 9999998764322 2233578999999999999999999999999999999999999986533211 1100000000
Q ss_pred cc---c---ccccccccccc-CCC-----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HE---R---VHELMDPVILQ-DEI-----PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~---~---~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. . ........+.. ... .......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00 0 00000000000 000 1123467899999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=348.52 Aligned_cols=266 Identities=15% Similarity=0.174 Sum_probs=206.9
Q ss_pred hcCcccccccccCCcEeEEEEEecC---------ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceee---------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN---------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVR--------- 573 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~--------- 573 (834)
.++|.+.+.||+|+||.||+|+... ++.||||++... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998653 789999998654 46789999999999999988
Q ss_pred ------EEEEEEe-CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 003274 574 ------ILGCCVE-QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNV 646 (834)
Q Consensus 574 ------l~~~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NI 646 (834)
+++++.. ....++||||+ +++|.+++... ....+++..++.++.||++||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67889999999 99999998532 2467999999999999999999999998 99999999999
Q ss_pred EeccCC--CeeecccccceecCCCCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCC
Q 003274 647 LLDKDM--NPKISDFGLARMFGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGV 719 (834)
Q Consensus 647 Ll~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~ 719 (834)
|++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++||||||++||||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 9999999999876533211 112334789999999999999999999999999999999999999875
Q ss_pred CCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 003274 720 YNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793 (834)
Q Consensus 720 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 793 (834)
.......+........ ........... .......++.+++.+||+.||++||++.++++.|+++..+.
T Consensus 271 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFV--DKPGPFVGPCG----HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp GTTCHHHHHHHHHHHH--HSCCCEECTTS----CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCcCHHHHHHHHHhcc--CChhhhhhhcc----ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 4322221111111000 00111111110 01122467899999999999999999999999998875443
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=354.44 Aligned_cols=255 Identities=25% Similarity=0.335 Sum_probs=207.1
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.++|.+.++||+|+||.||+++.. +|+.||+|++.... ....+.+..|++++.+++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 378899999999999999999964 58999999986532 23456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 588 LEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|||+++|+|..++.... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999885432 2446999999999999999999999998 9999999999999999999999999998865
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ... .. .+...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~-~~--------~i~~~ 408 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KEL-KQ--------RVLEQ 408 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHH-HH--------HHHHC
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHH-HH--------HHhhc
Confidence 4332 223358999999999999999999999999999999999999998754321110 000 00 00000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTM-----SDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 784 (834)
....+......+.+++.+||+.||++||++ .++++
T Consensus 409 ---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 ---AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ---ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 112233445688999999999999999975 56654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=350.96 Aligned_cols=264 Identities=24% Similarity=0.355 Sum_probs=190.9
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCC--eE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQG--EK 584 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~--~~ 584 (834)
..++|.+.++||+|+||.||+|+. .+++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 457899999999999999999985 46889999998643 3344567889999999997 999999999998654 68
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||++ ++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEECCS-EEHHHHHH----HTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecccC-cCHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99999998 57877773 357899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCC-------------------ccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCc
Q 003274 665 FGGDE-------------------LQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS 724 (834)
Q Consensus 665 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~ 724 (834)
+.... .........||+.|+|||++.+ ..++.++|||||||+||||++|++||.......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 64311 0112233579999999999986 679999999999999999999999987543211
Q ss_pred cccccchhhhhcccc---ccc--------ccc---------c------------ccccCCCCHHHHhHHHHHHHhccccC
Q 003274 725 FNLLGHAWDLWKHER---VHE--------LMD---------P------------VILQDEIPLPMLMRYVNVALLCVQEN 772 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~---~~~--------~~~---------~------------~~~~~~~~~~~~~~l~~li~~cl~~d 772 (834)
............. ... .+. . .+...........++.+++.+||+.|
T Consensus 239 --~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 239 --QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp --HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred --HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 0000000000000 000 000 0 00000001123457899999999999
Q ss_pred CCCCCCHHHHHH
Q 003274 773 AADRPTMSDVVS 784 (834)
Q Consensus 773 P~~RPt~~evl~ 784 (834)
|++|||+.|+++
T Consensus 317 P~~R~t~~e~l~ 328 (388)
T 3oz6_A 317 PNKRISANDALK 328 (388)
T ss_dssp GGGSCCHHHHTT
T ss_pred cccCCCHHHHhC
Confidence 999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=345.27 Aligned_cols=251 Identities=18% Similarity=0.212 Sum_probs=190.5
Q ss_pred cCcccc-cccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe----CCeEE
Q 003274 513 ENFSMQ-CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE----QGEKI 585 (834)
Q Consensus 513 ~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~ 585 (834)
++|.+. ++||+|+||.||+++.. +++.||||++... ..+.+|+.++.++ +||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 567665 68999999999999864 5889999998632 4577888887555 89999999999875 56789
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLA 662 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla 662 (834)
+||||+++|+|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999998542 2346899999999999999999999987 999999999999997 789999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... ............ .
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~~-~ 285 (400)
T 1nxk_A 212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQY-E 285 (400)
T ss_dssp EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTCC-C
T ss_pred cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCcc-c
Confidence 8764322 223457899999999999999999999999999999999999998653321110 000000000000 0
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ..........++.+++.+||+.||++|||+.|+++
T Consensus 286 ~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 286 F------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp C------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C------CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0 00011224567899999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=345.05 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=202.4
Q ss_pred cCcccccccccCCcEeEEEEEe----cCccEEEEEEcccCC----cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
++|.+.++||+|+||.||+++. .+++.||||+++... ....+.+.+|++++.++ +||||+++++++.....
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999986 368999999986532 23446678899999999 69999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999984 3356899999999999999999999987 9999999999999999999999999998
Q ss_pred ecCCCCccCCceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
.+...... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||......... .......
T Consensus 208 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~------- 278 (355)
T 1vzo_A 208 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI------- 278 (355)
T ss_dssp ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH-------
T ss_pred ecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHH-------
Confidence 76433221 2233579999999999985 35789999999999999999999998644322110 0000000
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHHH
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVSM 785 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~ 785 (834)
... ....+......+.+++.+||+.||++|| ++.|+++.
T Consensus 279 --~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 279 --LKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --HHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --hcc---CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 000 1122334456788999999999999999 99999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=359.04 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=207.2
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.++|.+.++||+|+||.||+++.. +|+.||||++... .....+.+.+|++++.+++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999864 6899999998653 233456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|..++... ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999988542 2345899999999999999999999998 99999999999999999999999999988654
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. ......||+.|+|||++.+..++.++|||||||+||||++|+.||......... .. +...+...
T Consensus 339 ~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~---------i~~~i~~~ 404 (576)
T 2acx_A 339 GQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EE---------VERLVKEV 404 (576)
T ss_dssp TC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HH---------HHHHHHHC
T ss_pred Cc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HH---------HHHHhhcc
Confidence 32 223357999999999999999999999999999999999999998754321110 00 00000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
....+.....++.+++.+||+.||++|| ++.|+++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 1122334456889999999999999999 7888875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=334.27 Aligned_cols=248 Identities=25% Similarity=0.382 Sum_probs=205.5
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.+.|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 36789999999999999999985 468899999986543 3456789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999873 356899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... .. ...... .
T Consensus 174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~~~-----~----- 235 (303)
T 3a7i_A 174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VL----FLIPKN-----N----- 235 (303)
T ss_dssp C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH----HHHHHS-----C-----
T ss_pred c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HH----HHhhcC-----C-----
Confidence 2 2233578999999999999999999999999999999999999986432111 00 000000 0
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 01112223457899999999999999999999976
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=369.78 Aligned_cols=249 Identities=24% Similarity=0.320 Sum_probs=205.9
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~ 585 (834)
..++|.+.++||+|+||.||+++.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999864 5788999998753 234456788999999988 7999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
|||||+++|+|..++. ....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999884 3356999999999999999999999998 999999999999999999999999999864
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||....... +. ..++.
T Consensus 493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--~~------------~~i~~ 556 (674)
T 3pfq_A 493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LF------------QSIME 556 (674)
T ss_dssp CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH------------HHHHS
T ss_pred ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--HH------------HHHHh
Confidence 3322 22344689999999999999999999999999999999999999986432211 10 00111
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCH-----HHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTM-----SDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~ 784 (834)
. ...++.....++.+|+.+||+.||++||++ .||++
T Consensus 557 ~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 557 H---NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp S---CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred C---CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 112334456788999999999999999997 77764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=330.52 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=205.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67999999999999999999864 57889999986432 223567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQ---KHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999998884 3356899999999999999999999987 999999999999999999999999999765432
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. .....|++.|+|||++.+..++.++||||||+++|||++|+.||........ ... +...
T Consensus 168 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~---------~~~~-- 227 (284)
T 2vgo_A 168 R----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-----HRR---------IVNV-- 227 (284)
T ss_dssp C----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHH---------HHTT--
T ss_pred c----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-----HHH---------Hhcc--
Confidence 2 2235789999999999999999999999999999999999999864322110 000 0000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
....+......+.+++.+||+.||++||++.++++ .+...
T Consensus 228 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 228 -DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 01122334567899999999999999999999986 44443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.61 Aligned_cols=267 Identities=23% Similarity=0.311 Sum_probs=195.3
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+|+.. +++.||||++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999865 6889999998654322 222456799999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
++ |+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDD--CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 98 578777743 3456899999999999999999999998 9999999999999999999999999998654322
Q ss_pred cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc---cccccc---
Q 003274 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH---ERVHEL--- 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 743 (834)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .......... ......
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGC
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHhchhhhcc
Confidence 12223468999999999876 5789999999999999999999999875432111 0000000000 000000
Q ss_pred ------cccccccC---CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 744 ------MDPVILQD---EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 744 ------~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
..+..... ........++.+++.+||+.||++|||+.|+++ .+.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00000000 001123457889999999999999999999987 44444
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.98 Aligned_cols=248 Identities=24% Similarity=0.322 Sum_probs=204.9
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.++|.+.+.||+|+||.||+++.. +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 367899999999999999999865 4788999998654 233456789999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999998873 3457899999999999999999999998 99999999999999999999999999987643
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........ ...... .
T Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~--------~- 230 (294)
T 2rku_A 168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKK--------N- 230 (294)
T ss_dssp TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHT--------T-
T ss_pred Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhh--------c-
Confidence 321 22335789999999999999999999999999999999999999864332110 000000 0
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++.+||+.||++||++.|+++
T Consensus 231 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 231 --EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 01122234467889999999999999999999986
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=350.50 Aligned_cols=200 Identities=26% Similarity=0.392 Sum_probs=167.2
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Ce
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 583 (834)
.++|.+.++||+|+||.||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 37899999999999999999985 45789999999753 233457789999999999999999999999876 57
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+. ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999987 58888873 3456999999999999999999999998 9999999999999999999999999999
Q ss_pred ecCCCCcc--------------------CCceeeeccCcccCceee-cCCCCCccccchhhHHHHHHHhcCCCCCC
Q 003274 664 MFGGDELQ--------------------GNTKRIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSSRKNTG 718 (834)
Q Consensus 664 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~sDVwSlGvll~elltG~~p~~ 718 (834)
........ .......||+.|+|||++ ....++.++|||||||+||||++|..|+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 87543211 123456789999999986 56679999999999999999998665544
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=337.52 Aligned_cols=256 Identities=23% Similarity=0.290 Sum_probs=202.0
Q ss_pred HHHhcCcccc-cccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 509 AAATENFSMQ-CKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 509 ~~~~~~f~~~-~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
..-.+.|.+. ++||+|+||.||+++.. +++.||||++.... ......+.+|+.++.++ +||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3445677776 88999999999999864 58999999987542 33467899999999999 57999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccc
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFG 660 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFG 660 (834)
.++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 99999999999999988432 3456899999999999999999999998 999999999999987 7899999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. ......
T Consensus 180 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~----~i~~~~- 249 (327)
T 3lm5_A 180 MSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--YL----NISQVN- 249 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHTC-
T ss_pred cccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HH----HHHhcc-
Confidence 998765432 12335799999999999999999999999999999999999999864332110 00 000000
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ...........+.+++.+||+.||++|||+.|+++
T Consensus 250 -----~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 -----VDY-SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp -----CCC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -----ccc-CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 000 11112234567889999999999999999999976
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=352.14 Aligned_cols=242 Identities=13% Similarity=0.160 Sum_probs=189.5
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHH---HHHhhcCCCceeeEE-------EE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEM---MLIAELQHRNLVRIL-------GC 577 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~H~niv~l~-------~~ 577 (834)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999995 56899999998743 334567899999 455556899999998 66
Q ss_pred EEeCCe-----------------EEEEEEecCCCCcchhcccccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003274 578 CVEQGE-----------------KILILEYMPNKSLDVYLFDPIK----KRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636 (834)
Q Consensus 578 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 636 (834)
+...+. .++||||+ +|+|.+++..... ...+++..++.|+.||++||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 6899999853211 122446888899999999999999998 9
Q ss_pred EecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCC-----------CCCccccchhhHH
Q 003274 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-----------LFSIKSDVFSFGI 705 (834)
Q Consensus 637 vH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~~sDVwSlGv 705 (834)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986432 2233567 999999999887 8999999999999
Q ss_pred HHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 706 LMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 706 ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+||||++|+.||........ ...+.. . ......++.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~--------------~~~~~~-~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG--------------SEWIFR-S------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC--------------SGGGGS-S------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc--------------hhhhhh-h------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999864332110 000000 0 0122457889999999999999999999985
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.63 Aligned_cols=264 Identities=24% Similarity=0.309 Sum_probs=192.4
Q ss_pred HHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
...++|.+.++||+|+||.||+++. .+++.||||++..... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3457899999999999999999984 4688999999965432 234567899999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-----cCCCeeeccccc
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-----KDMNPKISDFGL 661 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-----~~~~~kl~DFGl 661 (834)
||||+++ +|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+
T Consensus 111 v~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 111 IFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp EEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred EEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999984 8888873 3446899999999999999999999998 99999999999994 455699999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc---c
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK---H 737 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~---~ 737 (834)
++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ......... .
T Consensus 184 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 184 ARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ--LFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCT
T ss_pred ccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH--HHHHHHHhCCCch
Confidence 98764332 122334689999999999875 589999999999999999999999865332110 000000000 0
Q ss_pred cc---cccc--c---ccccccC----CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ER---VHEL--M---DPVILQD----EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ~~---~~~~--~---~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. .... . .+..... ..+.....++.+++.+||+.||++|||+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00 0000 0 0000000 001113467889999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=339.64 Aligned_cols=251 Identities=17% Similarity=0.237 Sum_probs=199.6
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.+.||+|+||.||+++.. +++.||||++..... ...+|++++.++ +||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 478999999999999999999864 588999999976433 235688888888 79999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC----CCeeecccccceec
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD----MNPKISDFGLARMF 665 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGla~~~ 665 (834)
|+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+..+ +.+||+|||+++..
T Consensus 97 ~~~gg~L~~~i~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKIL---RQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHH---TCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 999999998884 3456899999999999999999999998 9999999999998543 35999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....+.... ..........
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~~~~i~~~~~----- 240 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE---ILARIGSGKF----- 240 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH---HHHHHHHCCC-----
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH---HHHHHccCCc-----
Confidence 54321 2233578999999999998889999999999999999999999987533221110 0000000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+ ..........++.+++.+||+.||++||++.|+++
T Consensus 241 -~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 -SL-SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp -CC-CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -cc-CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 11112234568899999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=348.79 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=191.0
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~ 581 (834)
..++|.+.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++. .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence 458999999999999999999985 457899999986532 122335889999999999999999999975 4
Q ss_pred CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC---Ceeecc
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NPKISD 658 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~D 658 (834)
+..++||||+++|+|.+++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++ .+||+|
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 56899999999999988874 3456899999999999999999999988 99999999999997544 599999
Q ss_pred cccceecCCCCccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
||+++...... ......||+.|+|||++. ...++.++|||||||+||||++|+.||........ +. ...
T Consensus 286 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~----~~i 357 (419)
T 3i6u_A 286 FGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LK----DQI 357 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-HH----HHH
T ss_pred cccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-HH----HHH
Confidence 99998765332 223467999999999985 36788999999999999999999999865332211 00 000
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ... +.. .......+.+++.+||+.||++||++.|+++
T Consensus 358 ~~~~~-~~~-~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 TSGKY-NFI-PEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HTTCC-CCC-HHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCC-CCC-chh-----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 000 000 0113467899999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=333.69 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=201.5
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.++|.+.+.||+|+||.||+++.. +++.||+|.+........+.+.+|+.++.+++||||+++++++.+....++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 367899999999999999999864 6899999999765544556789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe---ccCCCeeecccccceecCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~~ 667 (834)
+++++|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 88 ~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 88 VSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999988874 3456899999999999999999999988 9999999999999 7889999999999976433
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... +. ........ ..
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~----~~i~~~~~-~~---- 226 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LF----EKIKEGYY-EF---- 226 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HH----HHHHHCCC-CC----
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HH----HHHHcCCC-CC----
Confidence 2 1223468999999999999999999999999999999999999986432111 00 00000000 00
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...........+.+++.+||+.||++||++.|+++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 227 --ESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp --CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred --CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11112234567899999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=334.28 Aligned_cols=257 Identities=27% Similarity=0.374 Sum_probs=197.4
Q ss_pred hcCcccccccccCCcEeEEEEEec--Ccc--EEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF--NGQ--EVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~--~~~--~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|.+.++||+|+||.||+|+.. +++ .||||+++.. .....+.+.+|++++.+++||||+++++++.... .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 368999999999999999999853 233 6899998754 2345678999999999999999999999998764 8
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|.+++.. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHh--ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 999999999999998853 2356899999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccc
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+....... .. .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~---~~~~~~~---- 241 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--IL---HKIDKEG---- 241 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH---HHHHTSC----
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--HH---HHHHccC----
Confidence 7543321 12223457889999999999999999999999999999999 999986432211 00 0000000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
. ....+......+.+++.+||+.||++||++.++++.|+++
T Consensus 242 -~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 242 -E-----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp -C-----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -C-----CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 0 1111223456889999999999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=354.07 Aligned_cols=194 Identities=25% Similarity=0.388 Sum_probs=153.8
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----CeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 584 (834)
++|.+.++||+|+||.||+|+.. +++.||||++... .....+.+.+|++++.+++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 68999999999999999999854 6889999998653 233457789999999999999999999999543 578
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+. ++|..++. ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.
T Consensus 133 ~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 99999985 68887773 3456999999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc-------------------------CCceeeeccCcccCceee-cCCCCCccccchhhHHHHHHHhcC
Q 003274 665 FGGDELQ-------------------------GNTKRIVGTYGYMSPEYA-LDGLFSIKSDVFSFGILMLETLSS 713 (834)
Q Consensus 665 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~~sDVwSlGvll~elltG 713 (834)
....... ......+||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6432211 122345789999999986 566799999999999999999994
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=330.79 Aligned_cols=249 Identities=26% Similarity=0.406 Sum_probs=197.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 585 (834)
+.|.+.++||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 4577888999999999999985 45778999998654 23456779999999999999999999999875 34689
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeeeccccccee
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARM 664 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~ 664 (834)
+||||+++++|.+++. ....+++..+..++.|++.||+|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999984 3366899999999999999999999875 3499999999999998 789999999999976
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... ......||+.|+|||++. +.++.++||||||+++|||++|+.||........ . ....... .
T Consensus 182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~----~~~~~~~-----~ 246 (290)
T 1t4h_A 182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-I----YRRVTSG-----V 246 (290)
T ss_dssp CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-H----HHHHTTT-----C
T ss_pred cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-H----HHHHhcc-----C
Confidence 4332 233457899999999876 4599999999999999999999999864332111 0 0000000 0
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+. ..+.....++.+++.+||+.||++||++.|+++
T Consensus 247 ~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Ccc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000 111122357899999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=328.44 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=200.6
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
++|.+.+.||+|+||.||+++.. +++.+|+|.+..... ...+.+.+|+.++.+++||||+++++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57899999999999999999865 588999999865421 24678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC----Ceeeccccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGl 661 (834)
+||||+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 9999999999999884 3457899999999999999999999987 99999999999998877 899999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... .. .......
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~~~~~~-- 227 (283)
T 3bhy_A 159 AHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TL----TNISAVN-- 227 (283)
T ss_dssp CEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HHHHTTC--
T ss_pred ceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HH----HHhHhcc--
Confidence 98764432 1233568999999999999999999999999999999999999986432111 00 0000000
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....... .......+.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 228 YDFDEEY-----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCCHHH-----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCcchh-----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0000000 0112457889999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=346.46 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=203.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||.||+++.. +++.||+|++... .....+.+.+|+.++.+++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 67999999999999999999865 6889999998765 334457799999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
+++++|.+++. ....+++..+..++.+++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 113 MDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 99999999984 345689999999999999999999985 6 999999999999999999999999998765321
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc----------h--------
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH----------A-------- 731 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~----------~-------- 731 (834)
......||+.|+|||++.+..++.++||||||+++|||++|+.||............. .
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 1233578999999999999999999999999999999999999986533211100000 0
Q ss_pred ------hhhhcccccccccccccc---cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 732 ------WDLWKHERVHELMDPVIL---QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 732 ------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........+.++.... ..........++.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000000000000110000 00111223567899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.99 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=198.9
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
.+.|.+.+.||+|+||.||+|+.. +++.+|+|++........+.+.+|++++.+++||||+++++++...+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 478999999999999999999965 4889999999877666778899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++++|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 999999988743 2456899999999999999999999987 9999999999999999999999999976432111
Q ss_pred cCCceeeeccCcccCceee-----cCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYA-----LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~-----~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.......||+.|+|||++ ....++.++||||||+++|||++|+.|+........ ....... ..
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~-~~----- 239 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKS-DP----- 239 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHS-CC-----
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----HHHHhcc-CC-----
Confidence 112234689999999998 467789999999999999999999999864332110 0000000 00
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+ ....+......+.+++.+||+.||++||++.++++
T Consensus 240 ~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 P---TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp C---CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c---ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 00112233567899999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=354.84 Aligned_cols=259 Identities=24% Similarity=0.281 Sum_probs=192.8
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------G 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 582 (834)
.++|.+.++||+|+||.||+++. ..++.||||++... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 37899999999999999999985 45889999999754 334467789999999999999999999999754 3
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||++++ |...+. ..+++..+..++.||++||+|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999876 444442 24889999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhh--------h
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD--------L 734 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~--------~ 734 (834)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||...+... ....... .
T Consensus 212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCPEF 286 (464)
T ss_dssp -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHH
T ss_pred eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHHH
Confidence 8764432 2334679999999999999999999999999999999999999987543211 0000000 0
Q ss_pred hccc--ccccccc---------------cccccCC--CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 WKHE--RVHELMD---------------PVILQDE--IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~~~~--~~~~~~~---------------~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+... .....+. ..+.... .......++.+|+.+||+.||++|||+.|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000 0000000 0000000 00112567899999999999999999999987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=336.05 Aligned_cols=265 Identities=23% Similarity=0.368 Sum_probs=187.3
Q ss_pred HHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
...++|.+.+.||+|+||.||+++. .+++.||||++.... ....+++.+|+.++.+++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3457899999999999999999984 468899999986543 33456788999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccc-----cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 588 LEYMPNKSLDVYLFDP-----IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
|||+++++|.+++... .....+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999988531 12456899999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCc---cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc
Q 003274 663 RMFGGDEL---QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE 738 (834)
Q Consensus 663 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
........ ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||.......... .... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-----~~~~-~ 242 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM-----LTLQ-N 242 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH-----HHHT-S
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH-----HHhc-c
Confidence 87643221 112233578999999999876 568999999999999999999999987543321100 0000 0
Q ss_pred ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... .................+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPS-LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCC-TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCc-cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000 00000011112223457889999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=337.44 Aligned_cols=257 Identities=20% Similarity=0.301 Sum_probs=204.4
Q ss_pred HHHHHHhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--------ccHHHHHHHHHHHhhc-CCCceeeEE
Q 003274 506 ASVAAATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAEL-QHRNLVRIL 575 (834)
Q Consensus 506 ~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~H~niv~l~ 575 (834)
.......++|.+.+.||+|+||.||+++.. +|+.||||++..... ...+.+.+|+.++.++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 334445578999999999999999999975 689999999865431 1245688999999999 799999999
Q ss_pred EEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCee
Q 003274 576 GCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPK 655 (834)
Q Consensus 576 ~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~k 655 (834)
+++...+..++||||+++++|.+++. ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999884 3456899999999999999999999988 99999999999999999999
Q ss_pred ecccccceecCCCCccCCceeeeccCcccCceeecC------CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcccccc
Q 003274 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD------GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG 729 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~ 729 (834)
|+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 241 l~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~- 314 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--ML- 314 (365)
T ss_dssp ECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-
T ss_pred EEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HH-
Confidence 99999998775432 2233579999999999863 368899999999999999999999986422110 00
Q ss_pred chhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 730 HAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 730 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........ ....+. . ......+.+++.+||+.||++||++.|+++
T Consensus 315 ---~~i~~~~~-~~~~~~--~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 ---RMIMEGQY-QFSSPE--W----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp ---HHHHHTCC-CCCHHH--H----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---HHHHhCCC-CCCCcc--c----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00000000 000000 0 012356889999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=333.15 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=202.9
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 586 (834)
.++|.+.+.||+|+||.||+++.. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 368999999999999999999864 68899999986542 3445679999999999999999999998854 568899
Q ss_pred EEEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 587 ILEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYS--RLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999985432 2345899999999999999999999876 2349999999999999999999999999998
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... +. .......
T Consensus 165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~i~~~~---- 232 (279)
T 2w5a_A 165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LA----GKIREGK---- 232 (279)
T ss_dssp HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHTC----
T ss_pred eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HH----HHHhhcc----
Confidence 7643221 1123468999999999999999999999999999999999999986432111 00 0000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
....+.....++.+++.+||+.||++||++.|+++.+.
T Consensus 233 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 233 ------FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred ------cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 01122334568899999999999999999999987653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=337.88 Aligned_cols=265 Identities=24% Similarity=0.347 Sum_probs=197.9
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe--------C
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE--------Q 581 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 581 (834)
++|.+.++||+|+||.||+++. .+++.||||++.... ......+.+|++++.+++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6799999999999999999986 568999999986543 2234578899999999999999999999987 4
Q ss_pred CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
+..++||||+++ +|...+.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999986 56555532 2345899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCc--cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-cccc-------
Q 003274 662 ARMFGGDEL--QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-LLGH------- 730 (834)
Q Consensus 662 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-~~~~------- 730 (834)
++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .+..
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 987653221 122234578999999999876 56899999999999999999999998754321110 0000
Q ss_pred -hhhhhcccccccccccccccCCCCHH-------HHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 731 -AWDLWKHERVHELMDPVILQDEIPLP-------MLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 731 -~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.........+.+.... ....... ....+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccccccchhhccccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000000000000000000 0001111 1346889999999999999999999986
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=336.08 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=198.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.++||+|+||.||+++.. +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 68999999999999999999864 488999999865432 234568899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|..++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 105 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 105 FVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp CCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred cCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 999999988763 3446899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccc--cc-------cchhhhhcccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN--LL-------GHAWDLWKHER 739 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~--~~-------~~~~~~~~~~~ 739 (834)
. ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......... .. ......+....
T Consensus 179 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 E--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred c--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 1 12234689999999999875 7899999999999999999999998754321110 00 00000000000
Q ss_pred -cccccccccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 -VHELMDPVILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 -~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
......+.+ ....+ ......+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEI-KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCC-SSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccc-cccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000001111 00111 123568899999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.55 Aligned_cols=253 Identities=10% Similarity=0.066 Sum_probs=182.9
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc---ccHHHHHHHHHHHhhc--CCCceeeEE-------EEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAEL--QHRNLVRIL-------GCCV 579 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l--~H~niv~l~-------~~~~ 579 (834)
.+|.+.++||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++..+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 5688999999999999999985 4689999999976532 3456678886555555 699988755 4554
Q ss_pred eCC-----------------eEEEEEEecCCCCcchhcccccccCCCCHHHH------HHHHHHHHHHHHHHHhcCCCCe
Q 003274 580 EQG-----------------EKILILEYMPNKSLDVYLFDPIKKRLLDWEAR------IRIIQGIAQGLLYLHQYSRLRI 636 (834)
Q Consensus 580 ~~~-----------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gl~~LH~~~~~~i 636 (834)
..+ ..++||||++ |+|.+++... ...+.+..+ ..++.||++||+|||+++ |
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i 215 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG---L 215 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence 332 3799999999 8999998542 234455556 788899999999999998 9
Q ss_pred EecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCC
Q 003274 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSR 714 (834)
Q Consensus 637 vH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~ 714 (834)
+||||||+||||+.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||+||||++|+
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998764321 13456799999999987 78999999999999999999999
Q ss_pred CCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 715 KNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 715 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.||............ ............ ...........+.+++.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSWK-------RPSLRVPGTDSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCCC-------BCCTTSCCCCSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccchh-------hhhhhhcccccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 998755332211100 000000000000 00111234568899999999999999999999964
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=326.28 Aligned_cols=246 Identities=26% Similarity=0.399 Sum_probs=195.4
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 68999999999999999999865 68999999986532 234567899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++. ....+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 91 e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 91 EYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp ECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred eccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 9999999999884 3356899999999999999999999998 999999999999999999999999999876543
Q ss_pred CccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.|+....... . .......
T Consensus 165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~----~~~~~~~--------- 226 (276)
T 2h6d_A 165 EF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--L----FKKIRGG--------- 226 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHHHHHC---------
T ss_pred cc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--H----HHHhhcC---------
Confidence 21 223468999999999988765 689999999999999999999986422110 0 0000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++.+||+.||++||++.|+++
T Consensus 227 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 227 --VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00122233467889999999999999999999987
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.68 Aligned_cols=256 Identities=19% Similarity=0.272 Sum_probs=200.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEe--CCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVE--QGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~--~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+|+. .+++.||||++... ..+.+.+|+.++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 7899999999999999999985 56889999998643 3467899999999997 9999999999998 66789999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-CeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~ 667 (834)
||+++++|..++. .+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999988872 3889999999999999999999998 99999999999999776 899999999987654
Q ss_pred CCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchh--------hhhccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAW--------DLWKHE 738 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~ 738 (834)
... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.........+..... ......
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 332 223468999999999887 67999999999999999999999998543322111111000 000000
Q ss_pred c--------------cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 R--------------VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ........ ...........++.+++.+||+.||++|||+.|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERF-VHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGG-CCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhh-ccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0 00000000 011122224678899999999999999999999986
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=331.00 Aligned_cols=251 Identities=25% Similarity=0.395 Sum_probs=200.2
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
..++|.+.+.||+|+||.||+|+.. +|+.||||.+.... ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4578999999999999999999865 48899999987543 45778999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 9999999998842 3457899999999999999999999988 9999999999999999999999999998765432
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ..... .. ..+
T Consensus 180 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~-~~-----~~~--- 243 (314)
T 3com_A 180 A--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----IFMIP-TN-----PPP--- 243 (314)
T ss_dssp S--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHH-HS-----CCC---
T ss_pred c--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHh-cC-----CCc---
Confidence 1 22335789999999999999999999999999999999999999864321110 00000 00 000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+......+.+++.+||+.||++||++.++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00112223467899999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=337.50 Aligned_cols=258 Identities=22% Similarity=0.338 Sum_probs=203.2
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcc-----------------cHHHHHHHHHHHhhcCCCceeeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQ-----------------GLKEFKNEMMLIAELQHRNLVRIL 575 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------~~~~~~~E~~~l~~l~H~niv~l~ 575 (834)
++|.+.+.||+|+||.||+++. +++.||||++...... ..+.+.+|+.++.+++||||++++
T Consensus 31 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 31 NDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp TTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred CceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 6899999999999999999998 8999999998643211 117899999999999999999999
Q ss_pred EEEEeCCeEEEEEEecCCCCcchh------cccccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEe
Q 003274 576 GCCVEQGEKILILEYMPNKSLDVY------LFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 576 ~~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl 648 (834)
+++.+.+..++||||+++++|.++ +.. .....+++..+..++.|++.||+|||+ .+ |+||||||+|||+
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 999999999999999999999998 422 125679999999999999999999998 77 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCC-CCCc-cccchhhHHHHHHHhcCCCCCCCCCCCccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSI-KSDVFSFGILMLETLSSRKNTGVYNTDSFN 726 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-~sDVwSlGvll~elltG~~p~~~~~~~~~~ 726 (834)
+.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||........
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~- 260 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE- 260 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence 99999999999999876443 22335689999999999887 6766 99999999999999999999875443111
Q ss_pred cccchhhhhcccccc------cccccccc--cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 727 LLGHAWDLWKHERVH------ELMDPVIL--QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 727 ~~~~~~~~~~~~~~~------~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ........ ....+... ...........+.+++.+||+.||++||++.|+++
T Consensus 261 ~~~----~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 LFN----NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHH----HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHH----HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 100 00000000 00000000 00011234568899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=336.68 Aligned_cols=265 Identities=26% Similarity=0.340 Sum_probs=195.8
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcc-----cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
..++|.+.+.||+|+||.||+++.. +|+.||||++...... ..+.+.+|++++.+++||||+++++++...+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3478999999999999999999864 5889999998653221 234688999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++ +|..++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999999986 77777643 3346888999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc-----
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE----- 738 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 738 (834)
+..... ......||+.|+|||++.+. .++.++|||||||++|||++|.+|+....... ............
T Consensus 162 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~~~~~ 237 (346)
T 1ua2_A 162 FGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQW 237 (346)
T ss_dssp TTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTS
T ss_pred ccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCChhhh
Confidence 643321 22335789999999999764 58999999999999999999999876433211 000000000000
Q ss_pred -cccccccccccc--CCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHHH
Q 003274 739 -RVHELMDPVILQ--DEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVSM 785 (834)
Q Consensus 739 -~~~~~~~~~~~~--~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~ 785 (834)
......+..... ...+ .....++.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000000000000 0111 1234688999999999999999999999873
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.22 Aligned_cols=255 Identities=21% Similarity=0.251 Sum_probs=200.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC----cccHHHHHHHHHHHhhcCCCceeeEEEEEE--eCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAELQHRNLVRILGCCV--EQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H~niv~l~~~~~--~~~~~~ 585 (834)
++|.+.+.||+|+||.||+++. .+++.+|+|++.... ....+.+.+|++++++++||||+++++++. +....+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY 84 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence 6899999999999999999985 457899999986532 234578999999999999999999999984 455789
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||++++ |.+++.. .....+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 85 lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 85 MVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 999999987 5555532 23456899999999999999999999998 999999999999999999999999999887
Q ss_pred CCCCccCCceeeeccCcccCceeecCCC--CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGL--FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
.............||+.|+|||++.+.. ++.++||||||+++|||++|+.|+....... .. ......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~i~~~----- 228 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--LF----ENIGKG----- 228 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HHHHHC-----
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--HH----HHHhcC-----
Confidence 5433333333456899999999987654 4789999999999999999999986432110 00 000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
....+......+.+++.+||+.||++||++.|+++ .+.+.
T Consensus 229 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 229 ------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 01122234567889999999999999999999996 45443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.68 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=199.9
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
..++|.+.+.||+|+||.||+|+... .+|+|++.... ....+.+.+|+.++.+++||||+++++++......++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35789999999999999999998643 59999986542 334466888999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. ....+++..+..++.||++||+|||+++ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 109 e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 109 SLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp BCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred ecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999853 2346899999999999999999999998 99999999999998 689999999998765322
Q ss_pred C---ccCCceeeeccCcccCceeecC---------CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 669 E---LQGNTKRIVGTYGYMSPEYALD---------GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 669 ~---~~~~~~~~~gt~~y~aPE~~~~---------~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
. .........|++.|+|||++.+ ..++.++||||||+++|||++|+.||.....+.. . ...
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~-- 255 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI--I---WQM-- 255 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH--H---HHH--
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H---HHh--
Confidence 1 1122233468999999999874 4578999999999999999999999864322110 0 000
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCC
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l 793 (834)
.....+.. .......++.+++.+||+.||++||++.+++++|+++....
T Consensus 256 ----~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 ----GTGMKPNL----SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp ----HTTCCCCC----CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred ----ccCCCCCC----CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 00011111 11123457889999999999999999999999999875443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=347.09 Aligned_cols=261 Identities=20% Similarity=0.275 Sum_probs=205.7
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.++||+|+||.||+|+. .+++.||||++..... .+++..|++++..++| ++|..+..++.+....+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 37899999999999999999985 5689999998765432 2457899999999976 566667777788889999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe---ccCCCeeecccccceecC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~ 666 (834)
|+ +++|.+++.. ....+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999998842 2456999999999999999999999998 9999999999999 688999999999999875
Q ss_pred CCCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccchhhhhccccc
Q 003274 667 GDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGHAWDLWKHERV 740 (834)
Q Consensus 667 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 740 (834)
..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||........ .... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~----~i~~~~~ 233 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE----KISEKKV 233 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH----HHHHHHH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH----HHhhccc
Confidence 54321 122246799999999999999999999999999999999999999875443221 1100 0000001
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
...+... ......++.+++..||+.+|++||++.+|+++|+++.
T Consensus 234 ~~~~~~l------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 234 ATSIEAL------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HSCHHHH------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccHHHH------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1111000 0112457899999999999999999999999988763
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=330.27 Aligned_cols=252 Identities=26% Similarity=0.355 Sum_probs=186.9
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc--ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG--QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.++|.+.++||+|+||.||+++. .+++.||||++..... ...+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 47899999999999999999985 5688999999975422 22334455555678889999999999999999999999
Q ss_pred EecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 589 EYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||+++ +|.+++... .....+++..+..++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99984 777766432 2345799999999999999999999998 7 9999999999999999999999999998764
Q ss_pred CCCccCCceeeeccCcccCceee----cCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.... .....||+.|+|||++ .+..++.++||||||+++|||++|+.|+.........+.. .
T Consensus 162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~-------- 226 (290)
T 3fme_A 162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQ----V-------- 226 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHH----H--------
T ss_pred cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHH----H--------
Confidence 4321 2224689999999996 5667899999999999999999999998643322111100 0
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.... ..........++.+++.+||+.||++|||+.|+++
T Consensus 227 -~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 227 -VEEPS-PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -HHSCC-CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -hccCC-CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 00000 01111223567899999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=331.77 Aligned_cols=253 Identities=25% Similarity=0.350 Sum_probs=196.9
Q ss_pred HHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcC--CCceeeEEEEEEeCCeEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~ 585 (834)
...++|.+.+.||+|+||.||+++..+++.||||++... .....+.+.+|++++.+++ ||||+++++++......+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345789999999999999999999888999999998654 2345678999999999997 599999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||| +.+++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++ ++.+||+|||+++..
T Consensus 105 lv~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEE-CCeEEEeeccccccc
Confidence 9999 67889999884 3457899999999999999999999997 99999999999996 489999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecC-----------CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALD-----------GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
.............||+.|+|||++.+ ..++.++||||||+++|||++|+.||.........
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-------- 248 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-------- 248 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH--------
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHH--------
Confidence 54433323334578999999999875 47889999999999999999999998643221110
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+++.. ....+......+.+++.+||+.||++||++.|+++
T Consensus 249 -----~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 249 -----LHAIIDPNH-EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp -----HHHHHCTTS-CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -----HHHHHhccc-ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 011111111 11122223457889999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=344.38 Aligned_cols=260 Identities=20% Similarity=0.269 Sum_probs=195.4
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe------EEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE------KIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------~~l 586 (834)
.+|.+.++||+|+||.||+++...+..+|+|++..... ...+|+++++.++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 57899999999999999999987777899998865332 22469999999999999999999976543 789
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeeecccccceec
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~ 665 (834)
||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+||||+ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999988655544332334567999999999999999999999998 99999999999999 7999999999999886
Q ss_pred CCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc-------
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH------- 737 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------- 737 (834)
..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||........ +... ......
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i-~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEI-IKVLGTPSREQIK 267 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH-HHHHCCCCHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH-HHHhCCCCHHHHH
Confidence 44332 2234689999999998765 589999999999999999999999875432110 0000 000000
Q ss_pred ---cccccccccccc----cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ---ERVHELMDPVIL----QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ---~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+..-+... ....+.....++.+++.+||+.||++|||+.|+++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000000000000 00111223468899999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=339.16 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=196.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 582 (834)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|++++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 36799999999999999999986 46899999998653 2334567899999999999999999999998653
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 469999999 789988873 356899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh-------
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL------- 734 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~------- 734 (834)
+..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||....... ........
T Consensus 176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPPAE 248 (367)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCHH
Confidence 875432 223578999999999887 789999999999999999999999987533211 00000000
Q ss_pred ----hcccccccccc--ccccc---CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 735 ----WKHERVHELMD--PVILQ---DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 735 ----~~~~~~~~~~~--~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
.........+. +.... ..........+.+++.+||+.||++|||+.|+++ .+.+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 00000000000 00000 0111223567899999999999999999999987 45443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=350.98 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=200.6
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.++|.+.++||+|+||+||+++.. +++.||||++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 367999999999999999999864 6889999998643 2335678999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec---cCCCeeecccccceec
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~ 665 (834)
||+++++|.+.+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 101 e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999988873 3456899999999999999999999998 99999999999995 4567999999999876
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.||....... ... ........
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~----~i~~~~~~---- 240 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILK----RVETGKYA---- 240 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHTCCC----
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhCCCC----
Confidence 4432 2233579999999999876 59999999999999999999999986432211 100 00000000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ..........++.+++.+||+.||++|||+.|+++
T Consensus 241 ~---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 241 F---DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp S---CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred C---CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 00001123467899999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=353.07 Aligned_cols=250 Identities=26% Similarity=0.341 Sum_probs=203.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
.++|.+.++||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367999999999999999999864 68999999986532 34567899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe---ccCCCeeeccccccee
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---DKDMNPKISDFGLARM 664 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~ 664 (834)
|||+.+|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999988874 3456899999999999999999999998 9999999999999 5678999999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
+.... ......||+.|+|||++.+ .++.++|||||||++|||++|++||....... ... ........
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~----~i~~~~~~--- 245 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILK----KVEKGKYT--- 245 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----HHHHCCCC---
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HHHcCCCC---
Confidence 65432 2233579999999999876 69999999999999999999999986433211 100 00000000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ...........+.+++.+||+.||++|||+.|+++
T Consensus 246 -~---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 -F---ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp -C---CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -C---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 0 00001123567899999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=340.09 Aligned_cols=261 Identities=20% Similarity=0.244 Sum_probs=199.9
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC--------CCceeeEEEEEE----
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ--------HRNLVRILGCCV---- 579 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------H~niv~l~~~~~---- 579 (834)
++|.+.++||+|+||.||+++. .+++.||||++... ....+.+.+|++++.+++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~ 115 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC
Confidence 7899999999999999999985 46889999999643 344577899999999995 788999999998
Q ss_pred eCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCC------
Q 003274 580 EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDM------ 652 (834)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~------ 652 (834)
.....++||||+ +++|.+.+.. .....+++..+..++.||++||+|||++ + |+||||||+||||+.++
T Consensus 116 ~~~~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 116 NGTHICMVFEVL-GHHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TEEEEEEEECCC-CCBHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCceEEEEEecc-CccHHHHHHh-cccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 456889999999 5555555432 1235689999999999999999999998 7 99999999999998775
Q ss_pred -------------------------------------------CeeecccccceecCCCCccCCceeeeccCcccCceee
Q 003274 653 -------------------------------------------NPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689 (834)
Q Consensus 653 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 689 (834)
.+||+|||+++..... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 8999999999876432 2234789999999999
Q ss_pred cCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc----cccchhhhhc--------cc-----------cccccc--
Q 003274 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN----LLGHAWDLWK--------HE-----------RVHELM-- 744 (834)
Q Consensus 690 ~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~----~~~~~~~~~~--------~~-----------~~~~~~-- 744 (834)
.+..++.++|||||||+||||++|+.||......... .......... .. ....+.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999754432211 0000000000 00 000000
Q ss_pred ------ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 ------DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.........+......+.+|+.+||+.||++|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000011235566778999999999999999999999975
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=312.91 Aligned_cols=217 Identities=15% Similarity=0.171 Sum_probs=169.9
Q ss_pred ccccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEec
Q 003274 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLS 102 (834)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (834)
++.|+|.+|++|.+|++| ++|.|+|||+.+|+ +.+ |.. +++||+|||+.| ..++|+|+.||||||+|
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gn-----l~l-y~~--~~~vW~an~~~~---~~~~l~l~~dGnLvl~d 72 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVL-FDS--DVRVWASNTAGA---TGCRAVLQSDGLLVILT 72 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSC-----EEE-EES--SSEEECCCCCSC---SCCBCCBCSSSCBCCBC
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCc-----EEE-EEC--CEEEEECCCCCC---CCeEEEEcCCCcEEEEc
Confidence 566999999999999999 59999999998876 334 443 699999999988 57899999999999999
Q ss_pred CCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhh-hccccccccc-cCCC-----ceEEE
Q 003274 103 QTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTL-LQDMKLGWDF-KSGL-----ERLLS 175 (834)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTl-Lpg~klg~~~-~~g~-----~~~l~ 175 (834)
++|.+||+|++....+.+.|+|+|+|||||++. ++||||||||||+ ||+| |.|. .+|+ ++.|+
T Consensus 73 ~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~~--------~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~ 142 (236)
T 1dlp_A 73 AQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH 142 (236)
T ss_dssp TTTCCSCCCCCCCCSSCCEEEECSSSCEEEECS--------EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC
T ss_pred CCCcEEEeCCccccCCcEEEEEeCCCCEEEecC--------CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE
Confidence 999999999986555567899999999999953 6999999999887 6665 5555 5555 56777
Q ss_pred EcCCCCCCCCCceeecccccCCceEEEecCCeeeEeeccCCCcceeccccccceeeEEEEeecCCeEEEEEEecCCCeee
Q 003274 176 SWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGTGFVSALSYTNFIYKQFMTENKDEFVYWYEAYNRPSIM 255 (834)
Q Consensus 176 sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~w~g~~~~~~~~~~~~~~~~~~~~n~~~~~~~~~~~~~s~~~ 255 (834)
+.+||++|.|+++++++| +++++++...||++++|++. +...+.+......+.+..++++++.+|...+. ..+
T Consensus 143 ---s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~-~~~ 215 (236)
T 1dlp_A 143 ---ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSA-GRY 215 (236)
T ss_dssp ---SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSS-SCC
T ss_pred ---cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCC-CCE
Confidence 488999999999999988 67788888899999999753 44445554222212233345555555554333 468
Q ss_pred EEEECcCCcEEEEE
Q 003274 256 TLKLNPSGFVTRQI 269 (834)
Q Consensus 256 r~~L~~~G~l~~~~ 269 (834)
|++|++||++++|.
T Consensus 216 rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 216 VFVLQPDRNLAIYG 229 (236)
T ss_dssp EEEECSSSCEEEEC
T ss_pred EEEEcCCCcEEEeC
Confidence 99999999999984
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=338.32 Aligned_cols=271 Identities=21% Similarity=0.254 Sum_probs=199.0
Q ss_pred ccHHHHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCc-----------ccHHHHHHHHHHHhhcCCCce
Q 003274 503 FSLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG-----------QGLKEFKNEMMLIAELQHRNL 571 (834)
Q Consensus 503 ~~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~H~ni 571 (834)
....++....++|.+.++||+|+||.||+|+..+++.||||++..... ...+.+.+|++++.+++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 345667778899999999999999999999988899999999864322 123779999999999999999
Q ss_pred eeEEEEEEeC-----CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCE
Q 003274 572 VRILGCCVEQ-----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNV 646 (834)
Q Consensus 572 v~l~~~~~~~-----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NI 646 (834)
+++++++... ...++||||++ |+|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 165 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNI 165 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHE
Confidence 9999998543 36799999998 577777642 3456899999999999999999999998 99999999999
Q ss_pred EeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc
Q 003274 647 LLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF 725 (834)
Q Consensus 647 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~ 725 (834)
|++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~- 241 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN- 241 (362)
T ss_dssp EECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred EEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence 99999999999999998643322 2233578999999999887 679999999999999999999999987533211
Q ss_pred ccccchhhhhcc-----------cccccccccccccC------CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 726 NLLGHAWDLWKH-----------ERVHELMDPVILQD------EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 726 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........... ......+....... .........+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 00000000000 00000000000000 011122457899999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.21 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=202.1
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---------cccHHHHHHHHHHHhhcC-CCceeeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---------GQGLKEFKNEMMLIAELQ-HRNLVRILGCCVE 580 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~ 580 (834)
.++|.+.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 478999999999999999999864 58899999986542 123456889999999995 9999999999999
Q ss_pred CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 581 QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 581 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
....++||||+++++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999984 3457899999999999999999999988 9999999999999999999999999
Q ss_pred cceecCCCCccCCceeeeccCcccCceeec------CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 661 LARMFGGDELQGNTKRIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 661 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.|+....... .. ..
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~----~~ 240 (298)
T 1phk_A 170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--ML----RM 240 (298)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HH
T ss_pred chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HH----HH
Confidence 998765432 223356899999999985 5578999999999999999999999986432111 00 00
Q ss_pred hcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...... . . ...........+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~-~-----~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 241 IMSGNY-Q-----F-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHTCC-C-----C-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhcCCc-c-----c-CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 000000 0 0 00111234567899999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=349.24 Aligned_cols=246 Identities=25% Similarity=0.359 Sum_probs=199.1
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc-------------ccHHHHHHHHHHHhhcCCCceeeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-------------QGLKEFKNEMMLIAELQHRNLVRILGC 577 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 577 (834)
.++|.+.++||+|+||+||+++.. +++.+|||++..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 478999999999999999999864 578999999865321 335678999999999999999999999
Q ss_pred EEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC---Ce
Q 003274 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM---NP 654 (834)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~---~~ 654 (834)
+.+....++||||+++|+|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 999999999999999999988873 3456999999999999999999999998 99999999999998776 69
Q ss_pred eecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|||++|+.||....... +. ..
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~----~~ 258 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--II----KK 258 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HH
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HH
Confidence 999999998875432 223357999999999987 569999999999999999999999987433211 00 00
Q ss_pred hcccccccccccccccCCCC----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 WKHERVHELMDPVILQDEIP----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ...+ .....++.+++.+||+.||++|||+.|+++
T Consensus 259 i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGK-----------YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCC-----------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCC-----------CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000 0011 112467899999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=349.40 Aligned_cols=250 Identities=23% Similarity=0.331 Sum_probs=197.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.+.|.+.++||+|+||.||+++.. .++.+|+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 357999999999999999999864 67899999987542 334577899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC---CCeeecccccceec
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARMF 665 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGla~~~ 665 (834)
||+++|+|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.. +.+||+|||+++..
T Consensus 116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999988873 3456899999999999999999999998 9999999999999764 55999999999886
Q ss_pred CCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||....... +. ........ ....
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~----~~i~~~~~-~~~~ 258 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--IL----RKVEKGKY-TFDS 258 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHTCC-CCCS
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HH----HHHHhCCC-CCCc
Confidence 5432 223357999999999876 569999999999999999999999986433211 10 00000000 0000
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+. .......+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PE------WKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GG------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hh------cccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00 0123457889999999999999999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=336.07 Aligned_cols=260 Identities=23% Similarity=0.291 Sum_probs=190.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------e
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------E 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~ 583 (834)
++|.+.+.||+|+||.||+++. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.... .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 6899999999999999999985 46889999998653 2334567889999999999999999999998665 7
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 105 VYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred eEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 8999999985 6766652 34889999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-c-cccc----hhhhhcc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-N-LLGH----AWDLWKH 737 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~-~~~~----~~~~~~~ 737 (834)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . +... .......
T Consensus 176 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 176 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 252 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTT
T ss_pred cccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence 764322 22335789999999999999999999999999999999999999865432110 0 0000 0000000
Q ss_pred ----------c-------ccccccccccccCC--CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ----------E-------RVHELMDPVILQDE--IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ----------~-------~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .............. ........+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0 00000000000000 01123568899999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=364.00 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=204.0
Q ss_pred HHhcCcccccccccCCcEeEEEEEecC----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
...++|.+.+.||+|+||.||+|+... +..||||++.... ....+.+.+|+.++.+++||||+++++++. .+..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 345789999999999999999998632 4579999987543 334577999999999999999999999985 4578
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++|+|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp EEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred EEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 999999999999999843 2346899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....... ... ......
T Consensus 541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~~----~i~~~~---- 609 (656)
T 2j0j_A 541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG----RIENGE---- 609 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHH----HHHHTC----
T ss_pred cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HHH----HHHcCC----
Confidence 6543322 1223456789999999999999999999999999999997 888886432211 100 000000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+......+.+++.+||+.||++||++.++++.|+++
T Consensus 610 ------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 610 ------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112333456889999999999999999999999999875
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=330.16 Aligned_cols=251 Identities=22% Similarity=0.311 Sum_probs=195.3
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~ 582 (834)
.++|.+.+.||+|+||.||+++.. +++.||||++.... ......+.+|++++.+++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 468999999999999999999864 57899999986532 122345889999999999999999999987654
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC---eeeccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDF 659 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DF 659 (834)
.++||||+++++|.+++. ....+++..+..++.||++||+|||+++ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 899999999999998874 3456899999999999999999999988 999999999999987664 999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ +. ....
T Consensus 162 g~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~----~~~~ 233 (322)
T 2ycf_A 162 GHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-LK----DQIT 233 (322)
T ss_dssp TTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-HH----HHHH
T ss_pred ccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-HH----HHHH
Confidence 9998764332 122356899999999974 56789999999999999999999999865432211 00 0000
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... . .+.. .......+.+++.+||+.||++||++.++++
T Consensus 234 ~~~~~-~-~~~~-----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 SGKYN-F-IPEV-----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HTCCC-C-CHHH-----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCccc-c-Cchh-----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0 0000 0113467899999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=342.03 Aligned_cols=199 Identities=22% Similarity=0.276 Sum_probs=171.2
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhc------CCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL------QHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~H~niv~l~~~~~~~~~~ 584 (834)
..+|.+.++||+|+||.||+|+.. .++.||||++... ....+.+.+|++++..+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 367999999999999999999854 5889999999653 33446778899888887 577999999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC--eeecccccc
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN--PKISDFGLA 662 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGla 662 (834)
++||||+. ++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+||||+.++. +||+|||++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 5888877432 2345899999999999999999999998 999999999999999987 999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCC
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN 721 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~ 721 (834)
+..... .....||+.|+|||++.+..++.++|||||||+||||++|++||....
T Consensus 250 ~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 250 CYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 765432 223578999999999999999999999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=334.42 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=196.4
Q ss_pred HHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe------C
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE------Q 581 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~------~ 581 (834)
...++|.+.+.||+|+||.||+|+. .+++.||||++.... ...+.+.+|+.++.++ +||||+++++++.. .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 99 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 99 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence 3568899999999999999999986 468899999986543 3457889999999999 89999999999987 4
Q ss_pred CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
...++||||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||||+|||++.++.+||+|||+
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 100 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp CEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 6789999999999999998542 3457899999999999999999999998 99999999999999999999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
+....... .......||+.|+|||++. +..++.++||||||+++|||++|+.|+........ ......
T Consensus 176 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~ 248 (326)
T 2x7f_A 176 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIPR 248 (326)
T ss_dssp TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHH
T ss_pred ceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-----HHHhhc
Confidence 98764322 1223357899999999987 56789999999999999999999999854321110 000000
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ..+.. .+......+.+++.+||+.||++||++.++++
T Consensus 249 -~-----~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 -N-----PAPRL----KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -S-----CCCCC----SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -C-----ccccC----CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 00111 11223457899999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=344.69 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=191.9
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------eEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------EKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~ 585 (834)
.+|.+.++||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 56889999999999999999974 58999999986532 22347999999999999999999986432 367
Q ss_pred EEEEecCCCCcchhccc-ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeecccccce
Q 003274 586 LILEYMPNKSLDVYLFD-PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLAR 663 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~ 663 (834)
+||||+++ +|...+.. ......+++..+..++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 44444422 223467999999999999999999999987 9999999999999965 568999999999
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhh-------hh
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWD-------LW 735 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~-------~~ 735 (834)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||....... .+...... .+
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHH
Confidence 7654322 2235789999999999765 79999999999999999999999987533211 11100000 00
Q ss_pred cc--cccccccccccccC----CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 KH--ERVHELMDPVILQD----EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~--~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ....+...+.+... .++.....++.+|+.+||+.||++||++.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00 00000000110000 011223468899999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=334.98 Aligned_cols=263 Identities=23% Similarity=0.320 Sum_probs=200.0
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----CeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 584 (834)
.++|.+.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 368999999999999999999854 67899999997543 33457789999999999999999999999765 368
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+. ++|.+++ ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l----~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLL----KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999998 4887777 3346899999999999999999999998 99999999999999999999999999987
Q ss_pred cCCCCcc-CCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc---c
Q 003274 665 FGGDELQ-GNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE---R 739 (834)
Q Consensus 665 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~ 739 (834)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ........... .
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQED 255 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHCSCCHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhCCCCHHH
Confidence 6543221 12234579999999998754 5589999999999999999999999865432211 00000000000 0
Q ss_pred cc--------cccccccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 VH--------ELMDPVILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~--------~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ............+ .....++.+++.+||+.||++|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000000001111 123457899999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.83 Aligned_cols=262 Identities=23% Similarity=0.312 Sum_probs=193.5
Q ss_pred cCcccccccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEE------------
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV------------ 579 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~------------ 579 (834)
++|.+.+.||+|+||.||+|+... ++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 678999999999999999998654 8899999998766667788999999999999999999999874
Q ss_pred --eCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeee
Q 003274 580 --EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKI 656 (834)
Q Consensus 580 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl 656 (834)
+....++||||++ |+|.+++. ...+++..+..++.|+++||+|||+++ |+||||||+|||++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999998 68988873 356899999999999999999999998 99999999999997 5679999
Q ss_pred cccccceecCCCCc-cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 657 SDFGLARMFGGDEL-QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 657 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++|||++|+.||........ .......
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~ 240 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLILES 240 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHh
Confidence 99999987643221 112233457899999998865 6899999999999999999999999875432110 0000000
Q ss_pred h---ccc---ccccc----cccccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 W---KHE---RVHEL----MDPVILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~---~~~---~~~~~----~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ... ..... +.........+ .....++.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0 000 00000 00000000111 123567899999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=335.83 Aligned_cols=258 Identities=26% Similarity=0.322 Sum_probs=182.9
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ------G 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~------~ 582 (834)
.++|.+.+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 37899999999999999999984 56889999998653 233456788999999999999999999999754 5
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
..++|+||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 688888773 356999999999999999999999988 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh------
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW------ 735 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~------ 735 (834)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .........
T Consensus 180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~ 252 (367)
T 2fst_X 180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAE 252 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHH
T ss_pred cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHH
Confidence 875432 233578999999999887 689999999999999999999999986543211 000000000
Q ss_pred -----cccccccccccccccCCCCH-----HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 -----KHERVHELMDPVILQDEIPL-----PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 -----~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........+.........+. .....+.+|+.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000000000001111 12457899999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=335.56 Aligned_cols=269 Identities=19% Similarity=0.227 Sum_probs=189.8
Q ss_pred HHHHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe--
Q 003274 507 SVAAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE-- 583 (834)
Q Consensus 507 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-- 583 (834)
......++|.+.++||+|+||.||+|+. .+++.||||++.... .....+.+|++.+..++||||+++++++...+.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 4456678999999999999999999986 458899999986543 334566788889999999999999999976543
Q ss_pred -----EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCEEecc-CCCee
Q 003274 584 -----KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH--QYSRLRIIHRDLKASNVLLDK-DMNPK 655 (834)
Q Consensus 584 -----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH--~~~~~~ivH~Dlk~~NILl~~-~~~~k 655 (834)
.++||||++++.+..+.........+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+|
T Consensus 96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k 172 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK 172 (360)
T ss_dssp TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence 7899999987543332222234567899999999999999999999 776 999999999999997 89999
Q ss_pred ecccccceecCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh
Q 003274 656 ISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734 (834)
Q Consensus 656 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 734 (834)
|+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .......
T Consensus 173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~ 247 (360)
T 3e3p_A 173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRV 247 (360)
T ss_dssp ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH
T ss_pred EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHH
Confidence 999999987654332 2234689999999998765 489999999999999999999999875432110 0000000
Q ss_pred h--------ccccc-cccccccc--------ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 W--------KHERV-HELMDPVI--------LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ~--------~~~~~-~~~~~~~~--------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ..... ....+... ...........++.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 00000 00000000 001112224568999999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=328.26 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=201.3
Q ss_pred cCcccccccccCCcEeEEEEEe--cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCc------eeeEEEEEEeCCeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL--FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN------LVRILGCCVEQGEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~ 584 (834)
++|.+.++||+|+||.||++.. .+++.||||+++.. ....+.+.+|++++..++|++ ++++++++...+..
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~ 92 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI 92 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence 6899999999999999999985 36889999999653 344577899999999997654 99999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc--------------
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-------------- 650 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-------------- 650 (834)
++||||+ +++|.+++... ....+++..+..++.||++||+|||+++ |+||||||+|||++.
T Consensus 93 ~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 93 CIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 9999999 88998887432 2246889999999999999999999998 999999999999987
Q ss_pred -----CCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc
Q 003274 651 -----DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF 725 (834)
Q Consensus 651 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~ 725 (834)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999875432 2235789999999999999999999999999999999999999875432210
Q ss_pred c-cccch-----hhhhcccc---------------------cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC
Q 003274 726 N-LLGHA-----WDLWKHER---------------------VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT 778 (834)
Q Consensus 726 ~-~~~~~-----~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 778 (834)
. ..... ........ ......+..............+.+++.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 0 00000 00000000 000000000011123345678999999999999999999
Q ss_pred HHHHHH
Q 003274 779 MSDVVS 784 (834)
Q Consensus 779 ~~evl~ 784 (834)
+.|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=339.02 Aligned_cols=263 Identities=20% Similarity=0.271 Sum_probs=194.9
Q ss_pred HHHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----
Q 003274 509 AAATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----- 582 (834)
Q Consensus 509 ~~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----- 582 (834)
....++|.+.++||+|+||.||+|+. .+++.||||++..... ...+|+++++.++||||+++++++....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 34568899999999999999999985 5689999999865432 2347999999999999999999985432
Q ss_pred ---------------------------------eEEEEEEecCCCCcchhcccc-cccCCCCHHHHHHHHHHHHHHHHHH
Q 003274 583 ---------------------------------EKILILEYMPNKSLDVYLFDP-IKKRLLDWEARIRIIQGIAQGLLYL 628 (834)
Q Consensus 583 ---------------------------------~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gl~~L 628 (834)
..++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3789999998 5777666432 2346799999999999999999999
Q ss_pred HhcCCCCeEecCCCCCCEEec-cCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHH
Q 003274 629 HQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGIL 706 (834)
Q Consensus 629 H~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvl 706 (834)
|+.+ |+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||++.+. .++.++|||||||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9987 99999999999998 688999999999997654332 2234689999999998875 48999999999999
Q ss_pred HHHHhcCCCCCCCCCCCccccccchhhhhcc----------cccccccccccc----cCCCCHHHHhHHHHHHHhccccC
Q 003274 707 MLETLSSRKNTGVYNTDSFNLLGHAWDLWKH----------ERVHELMDPVIL----QDEIPLPMLMRYVNVALLCVQEN 772 (834)
Q Consensus 707 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~d 772 (834)
+|||++|+.||........ +. ........ ....+..-+... ....+......+.+++.+||+.|
T Consensus 232 l~ell~g~~pf~~~~~~~~-~~-~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 309 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQ-LV-RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE 309 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHH-HH-HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred HHHHHhCCCCCCCCChHHH-HH-HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence 9999999999875332110 00 00000000 000000000000 00122234567899999999999
Q ss_pred CCCCCCHHHHHH
Q 003274 773 AADRPTMSDVVS 784 (834)
Q Consensus 773 P~~RPt~~evl~ 784 (834)
|++|||+.|+++
T Consensus 310 P~~R~t~~e~l~ 321 (383)
T 3eb0_A 310 PDLRINPYEAMA 321 (383)
T ss_dssp GGGSCCHHHHHT
T ss_pred hhhCCCHHHHhc
Confidence 999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=331.64 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=197.9
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----CeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~~ 584 (834)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 378999999999999999999864 58899999996543 33456788999999999999999999998764 678
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+. ++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 58887763 356899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCCccC--------CceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 665 FGGDELQG--------NTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 665 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~ 239 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL--LLIFGII 239 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHh
Confidence 65332111 1223468999999998764 78999999999999999999999998754321100 0000000
Q ss_pred c------------ccccccccccccccCCC-----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 K------------HERVHELMDPVILQDEI-----PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 ~------------~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .....+.+......... ......++.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0 00000000000000000 1123467889999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=325.82 Aligned_cols=264 Identities=25% Similarity=0.366 Sum_probs=199.1
Q ss_pred HhcCcccccccccCCcEeEEEEEe--cCccEEEEEEcccCC--cccHHHHHHHHHHHhhc---CCCceeeEEEEEE----
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL--FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL---QHRNLVRILGCCV---- 579 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~---- 579 (834)
..++|.+.+.||+|+||.||+++. .+++.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999986 467899999986432 22234567788877776 8999999999997
Q ss_pred -eCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecc
Q 003274 580 -EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISD 658 (834)
Q Consensus 580 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 658 (834)
.....++||||+. |+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 6998887432 2345899999999999999999999998 99999999999999999999999
Q ss_pred cccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc-
Q 003274 659 FGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH- 737 (834)
Q Consensus 659 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~- 737 (834)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCC
Confidence 99998754322 2233578999999999999999999999999999999999999987543211 00000000000
Q ss_pred --cc-c--ccccccccc------cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 --ER-V--HELMDPVIL------QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 --~~-~--~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. . ......... ...........+.+++.+||+.||++||++.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 0 000000000 00111223567889999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=326.94 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=177.9
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHH-HHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMM-LIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|.+.+.||+|+||.||+++.. +++.||||++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 78899999999999999999864 68899999997643 233445566666 6777899999999999999999999999
Q ss_pred ecCCCCcchhcccc--cccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 590 YMPNKSLDVYLFDP--IKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
|+++ +|.+++... .....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9985 776665321 1246789999999999999999999998 7 9999999999999999999999999998764
Q ss_pred CCCccCCceeeeccCcccCceee----cCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYA----LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||.........+.. ...
T Consensus 178 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----------~~~ 244 (327)
T 3aln_A 178 DSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ----------VVK 244 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC----------CCC
T ss_pred ccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH----------Hhc
Confidence 332 12224689999999998 5667899999999999999999999998643321111000 000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+.+ ...........+.+++.+||+.||++||++.++++
T Consensus 245 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 245 GDPPQL-SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SCCCCC-CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC-CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000001 11111223567899999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=338.51 Aligned_cols=266 Identities=21% Similarity=0.321 Sum_probs=181.3
Q ss_pred cCccc-ccccccCCcEeEEEEEec---CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEE
Q 003274 513 ENFSM-QCKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKIL 586 (834)
Q Consensus 513 ~~f~~-~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~l 586 (834)
+.|.+ .++||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++++++||||+++++++.. ....++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 44655 458999999999999865 47899999997543 23568899999999999999999999964 668899
Q ss_pred EEEecCCCCcchhccccc------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe----ccCCCeee
Q 003274 587 ILEYMPNKSLDVYLFDPI------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL----DKDMNPKI 656 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl----~~~~~~kl 656 (834)
||||+.+ +|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||| +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 6666653211 2235899999999999999999999998 9999999999999 67899999
Q ss_pred cccccceecCCCCc-cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccc-------c
Q 003274 657 SDFGLARMFGGDEL-QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN-------L 727 (834)
Q Consensus 657 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~-------~ 727 (834)
+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||+||||++|++||.....+... .
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987654321 1223346789999999999874 5999999999999999999999999654332100 0
Q ss_pred ccchhhhhccc------cccc----------ccccccccC-------CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 728 LGHAWDLWKHE------RVHE----------LMDPVILQD-------EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 728 ~~~~~~~~~~~------~~~~----------~~~~~~~~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+.......... .... ......... .........+.+|+.+||+.||++|||+.|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0000 000000000 000111457889999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=321.61 Aligned_cols=252 Identities=25% Similarity=0.395 Sum_probs=191.5
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE---------- 580 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~---------- 580 (834)
.++|.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46799999999999999999985 46899999998643 3445778999999999999999999999865
Q ss_pred ---CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 581 ---QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 581 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
....++||||+++++|.+++.. ....+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3567999999999999999853 2345788999999999999999999998 9999999999999999999999
Q ss_pred ccccceecCCCCc------------cCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCc
Q 003274 658 DFGLARMFGGDEL------------QGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDS 724 (834)
Q Consensus 658 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~ 724 (834)
|||+++....... ........||+.|+|||++.+. .++.++||||||+++|||++ |+..... .
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~-~ 234 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME-R 234 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-H
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-H
Confidence 9999987643210 1122345689999999999865 78999999999999999998 3321100 0
Q ss_pred cccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... ..... ....+ ....+......+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~----~~~~~------~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNIL----KKLRS------VSIEF-PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHH----HHHHS------TTCCC-CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHH----Hhccc------ccccc-CccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 0000 00000 00000 11233344567899999999999999999999986
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=320.15 Aligned_cols=251 Identities=25% Similarity=0.344 Sum_probs=200.7
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
..++|.+.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++......++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 3478999999999999999999864 68899999986532 34567899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC---CCeeeccccccee
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD---MNPKISDFGLARM 664 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGla~~ 664 (834)
|||+++++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 100 ~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 100 GELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EEccCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999988874 3356899999999999999999999998 9999999999999764 4799999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
...... .....||+.|+|||.+.+ .++.++||||||+++|||++|+.|+...... ... .........
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~----~~~~~~~~~--- 240 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY--DIL----KRVETGKYA--- 240 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHHHHCCCC---
T ss_pred ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH--HHH----HHHHcCCCC---
Confidence 644321 223468999999998875 4899999999999999999999998643211 110 000000000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ........++.+++.+||+.||++||++.|+++
T Consensus 241 -~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 241 -FDL---PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CCS---GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCc---hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 000123457899999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-36 Score=338.83 Aligned_cols=253 Identities=24% Similarity=0.301 Sum_probs=187.2
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|++++.++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345566889999999998776678999999998643 345678999999987 8999999999999999999999999
Q ss_pred CCCCcchhcccccccC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-------------CCe
Q 003274 592 PNKSLDVYLFDPIKKR----LLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-------------MNP 654 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-------------~~~ 654 (834)
. |+|.+++....... ...+..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 69999885432111 1133346789999999999999988 9999999999999754 489
Q ss_pred eecccccceecCCCCcc--CCceeeeccCcccCceeecC-------CCCCccccchhhHHHHHHHhc-CCCCCCCCCCCc
Q 003274 655 KISDFGLARMFGGDELQ--GNTKRIVGTYGYMSPEYALD-------GLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDS 724 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~ 724 (834)
||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||+......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987543321 12234579999999999976 678999999999999999999 899986432211
Q ss_pred cccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 725 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.... .. .................++.+++.+||+.||++||++.||++
T Consensus 248 ~~i~-------~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 SNII-------RG-----IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH-------HT-----CCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHh-------cC-----CCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1110 00 000000011123455678999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=331.64 Aligned_cols=257 Identities=21% Similarity=0.308 Sum_probs=194.2
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE----
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK---- 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~---- 584 (834)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 36899999999999999999985 468899999997542 33457789999999999999999999999877654
Q ss_pred --EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 585 --ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 585 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
++||||+. ++|..++ ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999998 5777665 234899999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh------
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW------ 735 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~------ 735 (834)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .........
T Consensus 192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~ 264 (371)
T 4exu_A 192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTE 264 (371)
T ss_dssp -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHH
T ss_pred cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCcHH
Confidence 865432 223468999999999887 789999999999999999999999987533211 000000000
Q ss_pred -----cccccccccccccccCCC-----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 -----KHERVHELMDPVILQDEI-----PLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 -----~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.................. .......+.+++.+||+.||++|||+.|+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 000000000000000000 1123568899999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.17 Aligned_cols=256 Identities=19% Similarity=0.214 Sum_probs=174.4
Q ss_pred hcCccccc-ccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEE
Q 003274 512 TENFSMQC-KLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKI 585 (834)
Q Consensus 512 ~~~f~~~~-~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~ 585 (834)
.++|.+.+ +||+|+||.||+++.. +++.||||++.... ....+....+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 47888854 6999999999999865 68999999986531 222223334566799999999999876 44589
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLA 662 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla 662 (834)
+||||+++|+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999998542 2346899999999999999999999998 999999999999976 455999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... ....... ...
T Consensus 179 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~---~~~ 249 (336)
T 3fhr_A 179 KETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP--GMKRRIR---LGQ 249 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred eeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh--hHHHhhh---ccc
Confidence 8764322 223568999999999999999999999999999999999999986443221100 0000000 000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhc
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISN 788 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~ 788 (834)
... ..........++.+++.+||+.||++|||+.|+++ .+.+
T Consensus 250 ---~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 250 ---YGF-PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp ----CC-CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred ---ccc-CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 000 00111234567899999999999999999999997 4544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=324.56 Aligned_cols=242 Identities=21% Similarity=0.381 Sum_probs=191.4
Q ss_pred HHhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc------ccHHHHHHHHHHHhhc----CCCceeeEEEEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAEL----QHRNLVRILGCC 578 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l----~H~niv~l~~~~ 578 (834)
...++|.+.+.||+|+||.||+|+. .+++.||||++..... .....+..|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999985 4688999999965432 1233466799999998 899999999999
Q ss_pred EeCCeEEEEEEe-cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeee
Q 003274 579 VEQGEKILILEY-MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKI 656 (834)
Q Consensus 579 ~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl 656 (834)
...+..++|||| +.+++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++ .++.+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEE
Confidence 999999999999 789999998843 456899999999999999999999998 99999999999999 8899999
Q ss_pred cccccceecCCCCccCCceeeeccCcccCceeecCCCCC-ccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 657 SDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFS-IKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 657 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||..... .
T Consensus 182 ~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----------~- 245 (312)
T 2iwi_A 182 IDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----------I- 245 (312)
T ss_dssp CCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------H-
T ss_pred EEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----------H-
Confidence 9999998875432 2335689999999999877664 589999999999999999999853110 0
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
... ....+......+.+++.+||+.||++||++.|+++
T Consensus 246 --------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 --------LEA---ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp --------HHT---CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------hhh---ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01122234567889999999999999999999987
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=328.37 Aligned_cols=261 Identities=19% Similarity=0.284 Sum_probs=198.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-----------CCceeeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----------HRNLVRILGCCVE 580 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~ 580 (834)
++|.+.++||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++.+++ ||||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 6899999999999999999985 56889999999643 334567889999999886 8999999999986
Q ss_pred CC----eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEecc-----
Q 003274 581 QG----EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDK----- 650 (834)
Q Consensus 581 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~----- 650 (834)
.+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++.
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 789999999 88999887432 234589999999999999999999997 7 999999999999953
Q ss_pred -CCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc---
Q 003274 651 -DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN--- 726 (834)
Q Consensus 651 -~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~--- 726 (834)
.+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 347999999999876432 22347899999999999999999999999999999999999998754321110
Q ss_pred -cccchhhh------------------hccccccccccc---------ccccCCCCHHHHhHHHHHHHhccccCCCCCCC
Q 003274 727 -LLGHAWDL------------------WKHERVHELMDP---------VILQDEIPLPMLMRYVNVALLCVQENAADRPT 778 (834)
Q Consensus 727 -~~~~~~~~------------------~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 778 (834)
........ +........+.. .......+.....++.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 00000000 000000000000 00012345567789999999999999999999
Q ss_pred HHHHHH
Q 003274 779 MSDVVS 784 (834)
Q Consensus 779 ~~evl~ 784 (834)
+.|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=327.19 Aligned_cols=241 Identities=21% Similarity=0.329 Sum_probs=198.1
Q ss_pred HhcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcc------cHHHHHHHHHHHhhcC--CCceeeEEEEEEeC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQ------GLKEFKNEMMLIAELQ--HRNLVRILGCCVEQ 581 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~ 581 (834)
..++|.+.++||+|+||.||+|+. .+++.||||++...... ..+.+..|+.++.+++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 347899999999999999999984 56889999998654221 2245678999999996 59999999999999
Q ss_pred CeEEEEEEecCC-CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeeeccc
Q 003274 582 GEKILILEYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDF 659 (834)
Q Consensus 582 ~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DF 659 (834)
+..++||||+.+ ++|.+++. ....+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCC
T ss_pred CcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999999986 89988884 3457899999999999999999999988 99999999999999 7899999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccc
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE 738 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 738 (834)
|+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||..... ... .
T Consensus 195 g~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----------~~~-~ 258 (320)
T 3a99_A 195 GSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIR-G 258 (320)
T ss_dssp TTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHH-C
T ss_pred cccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----------hhc-c
Confidence 9998865432 223568999999999987765 6889999999999999999999853210 000 0
Q ss_pred ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ...+.....++.+++.+||+.||++||++.|+++
T Consensus 259 ~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 259 Q-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111223457889999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=326.82 Aligned_cols=256 Identities=22% Similarity=0.308 Sum_probs=194.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe------
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE------ 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~------ 583 (834)
++|.+.+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 6788999999999999999986 468999999986542 2335678999999999999999999999987654
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+. ++|..++. ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 58877662 24899999999999999999999998 9999999999999999999999999998
Q ss_pred ecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh--------
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL-------- 734 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~-------- 734 (834)
..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGTEF 247 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCHHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence 65322 223578999999999887 678999999999999999999999986533211 00000000
Q ss_pred ---hcccc----ccccccc-ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 ---WKHER----VHELMDP-VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ---~~~~~----~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ...+... ..............+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 0000000 00001112234568899999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.74 Aligned_cols=261 Identities=19% Similarity=0.248 Sum_probs=197.7
Q ss_pred cCcccccccccCCcEeEEEEEec-C-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCc------eeeEEEEEEeCCeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-N-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN------LVRILGCCVEQGEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n------iv~l~~~~~~~~~~ 584 (834)
++|.+.+.||+|+||.||+++.. . ++.||||+++.. ....+.+..|+.++.+++|++ ++.+++++...+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 78999999999999999999853 3 368999999653 344567889999999997766 99999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe----------------
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL---------------- 648 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl---------------- 648 (834)
++||||+ +++|.+++.. .....+++..+..++.||++||+|||+++ |+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKE-NNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEECC-CCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEecc-CCChHHHHHh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 9999999 5566666532 22346899999999999999999999987 9999999999999
Q ss_pred ---ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc
Q 003274 649 ---DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF 725 (834)
Q Consensus 649 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~ 725 (834)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 67889999999999875432 2235789999999999999999999999999999999999999875432110
Q ss_pred c-cccc--------hhhhhccccc------------------ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCC
Q 003274 726 N-LLGH--------AWDLWKHERV------------------HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPT 778 (834)
Q Consensus 726 ~-~~~~--------~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt 778 (834)
. .... .......... .+...+..............+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 0 0000 0000000000 00000000001122234568899999999999999999
Q ss_pred HHHHHH
Q 003274 779 MSDVVS 784 (834)
Q Consensus 779 ~~evl~ 784 (834)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999964
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=328.59 Aligned_cols=201 Identities=25% Similarity=0.336 Sum_probs=169.9
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CC-----ceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HR-----NLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~-----niv~l~~~~~~~~~~ 584 (834)
.++|.+.++||+|+||.||+|+.. +++.||||+++.. ....+++..|++++..++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 478999999999999999999854 5789999999743 334567788999998885 55 499999999999999
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec--cCCCeeecccccc
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDMNPKISDFGLA 662 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGla 662 (834)
++||||++ ++|.+++... ....+++..+..++.|++.||+|||++ ..+|+||||||+||||+ .++.+||+|||++
T Consensus 132 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999996 5888887432 224589999999999999999999953 12499999999999995 4788999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCC
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYN 721 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~ 721 (834)
+..... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 886432 223578999999999999999999999999999999999999987543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=334.38 Aligned_cols=251 Identities=22% Similarity=0.279 Sum_probs=186.9
Q ss_pred HhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV~E 589 (834)
...+|.+.++||+|+||+|+.....+++.||||++..... ..+.+|+++++++ +||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3457888999999999996655567899999999865432 2356899999999 89999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-----CCCeeeccccccee
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-----DMNPKISDFGLARM 664 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGla~~ 664 (834)
|+. |+|.+++... ...+....++.++.||++||+|||+.+ |+||||||+||||+. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 997 5898887532 223444566789999999999999998 999999999999953 23578999999987
Q ss_pred cCCCCc-cCCceeeeccCcccCceeec---CCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccc
Q 003274 665 FGGDEL-QGNTKRIVGTYGYMSPEYAL---DGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 665 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
...... ........||+.|+|||++. ...++.++|||||||++|||++ |..||+......... .....
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-------~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-------LLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-------HTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-------HhccC
Confidence 654321 12233467999999999997 4567889999999999999999 888875332211100 00000
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. .............+.+++.+||+.||++||++.|+++
T Consensus 246 ~-------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 S-------LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-------CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred C-------ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 0011112334566889999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.89 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=178.2
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcc--cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQ--GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
.++|.+.+.||+|+||.||+++.. +++.||||++...... ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 368899999999999999999864 6899999998754322 2234455556788889999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
||+ ++.+..+. . .....+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~-~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLK-K-RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHH-H-HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHH-H-HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 44444333 2 2245689999999999999999999985 7 99999999999999999999999999977644
Q ss_pred CCccCCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.. ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ ... .... ..
T Consensus 178 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~---~~~~-~~--- 246 (318)
T 2dyl_A 178 DK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VLT---KVLQ-EE--- 246 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HHH---HHHH-SC---
T ss_pred Cc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HHH---HHhc-cC---
Confidence 32 122346899999999984 56789999999999999999999999864322111 000 0000 00
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+.+ ........++.+++.+||+.||++||++.++++
T Consensus 247 --~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 247 --PPLL---PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCCC---CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCC---CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0000 001123457889999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=345.17 Aligned_cols=259 Identities=24% Similarity=0.307 Sum_probs=199.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe------CCeE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE------QGEK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~~ 584 (834)
++|.+.++||+|+||.||++.. .+|+.||||++... .....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999985 45889999998754 34456779999999999999999999999765 6678
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCC---eeeccccc
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMN---PKISDFGL 661 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGl 661 (834)
++||||+++|+|.+++........+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999866555557899999999999999999999988 999999999999997765 99999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc----
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH---- 737 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---- 737 (834)
+........ .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .+.......
T Consensus 171 a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~----~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 171 AKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV----QWHGKVREKSNEH 243 (676)
T ss_dssp CCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH----HSSTTCC------
T ss_pred ccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh----hhhhhhhcccchh
Confidence 987654332 233578999999999999999999999999999999999999986432110 000000000
Q ss_pred ----cccccc--cccc-cccCCCCHHHHhHHHHHHHhccccCCCCCCCHHH
Q 003274 738 ----ERVHEL--MDPV-ILQDEIPLPMLMRYVNVALLCVQENAADRPTMSD 781 (834)
Q Consensus 738 ----~~~~~~--~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
...... .... .............+.+++.+||+.||++|||+.|
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 000000 0000 0012234456788999999999999999999977
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=306.70 Aligned_cols=231 Identities=15% Similarity=0.095 Sum_probs=183.3
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCc---ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.+.||+|+||.||+|+.. .++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999865 489999999976532 33477999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. . ....++.+++.|+++||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 99999999999832 2 355678899999999999999998 9999999999999999999998443
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
|++ .++.++|||||||+||||++|+.||......... ......... ....+.
T Consensus 175 --------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~--~~~~~~~~~----~~~~~~- 226 (286)
T 3uqc_A 175 --------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL--APAERDTAG----QPIEPA- 226 (286)
T ss_dssp --------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS--EECCBCTTS----CBCCHH-
T ss_pred --------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh--HHHHHHhcc----CCCChh-
Confidence 333 3689999999999999999999998754332110 000000000 000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
........++.+++.+||+.||++| |+.|+++.|++...
T Consensus 227 ---~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 227 ---DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp ---HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred ---hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 0111234578999999999999999 99999999988643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=345.63 Aligned_cols=238 Identities=21% Similarity=0.315 Sum_probs=192.1
Q ss_pred cCcccccccccCCcEeEEEEEec--CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCe-----E
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF--NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGE-----K 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~-----~ 584 (834)
++|.+.++||+|+||.||+++.. +++.||||++.... ....+.+.+|++++.+++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 68999999999999999999864 58999999986543 3445678999999999999999999999988765 7
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+|||||+++++|.+++.. .+++..++.++.||++||.|||+++ |+||||||+|||++.+ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887632 6899999999999999999999998 9999999999999986 999999999987
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... ....||+.|+|||++.+.. +.++|||||||+||||++|.+|+...... .+.
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~------------------~~~ 285 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD------------------GLP 285 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS------------------SCC
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc------------------ccc
Confidence 6432 3357999999999987665 89999999999999999998775421100 000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCC-HHHHHHHHhcc
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPT-MSDVVSMISNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~~~ 789 (834)
...........+.+++.+||+.||++||+ +.++.+.|..+
T Consensus 286 -----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00111123457889999999999999995 55566555543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-33 Score=299.60 Aligned_cols=226 Identities=19% Similarity=0.256 Sum_probs=177.6
Q ss_pred cCcccc-cccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHH-hhcCCCceeeEEEEEEe----CCeEE
Q 003274 513 ENFSMQ-CKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLI-AELQHRNLVRILGCCVE----QGEKI 585 (834)
Q Consensus 513 ~~f~~~-~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~H~niv~l~~~~~~----~~~~~ 585 (834)
++|.+. ++||+|+||.||+++. .+++.||+|++... ..+.+|+.++ +.++||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567776 7899999999999985 56889999998642 4677889888 45599999999999987 66789
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLA 662 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla 662 (834)
+||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999998542 2346899999999999999999999998 999999999999998 789999999998
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.... +..++.++|||||||++|||++|+.||.......... ....
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~~~ 212 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GMKT 212 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CSCC
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HHHH
Confidence 7532 2456789999999999999999999986433211000 0000
Q ss_pred ccccccccCCCC----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVILQDEIP----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.+... ....+ .....++.+++.+||+.||++||++.|+++
T Consensus 213 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 213 RIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp SSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000 01111 123568899999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-34 Score=321.01 Aligned_cols=241 Identities=13% Similarity=0.142 Sum_probs=179.1
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc---ccHHHHHHHHHHHhhcCC-Cce---------eeEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---QGLKEFKNEMMLIAELQH-RNL---------VRILGC 577 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~H-~ni---------v~l~~~ 577 (834)
+..|...++||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.++..++| +|. +.....
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 35678889999999999999994 5689999999874322 336789999999999987 221 111111
Q ss_pred ------------EEe-----CCeEEEEEEecCCCCcchhccc----ccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 003274 578 ------------CVE-----QGEKILILEYMPNKSLDVYLFD----PIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRI 636 (834)
Q Consensus 578 ------------~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~i 636 (834)
... ....+++|++ .+++|.+++.. ......+++..++.++.||++||+|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 111 1234666665 46888888731 122445788899999999999999999988 9
Q ss_pred EecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceee----------cCCCCCccccchhhHHH
Q 003274 637 IHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA----------LDGLFSIKSDVFSFGIL 706 (834)
Q Consensus 637 vH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~~sDVwSlGvl 706 (834)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999875432 233467 999999999 56678999999999999
Q ss_pred HHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHH
Q 003274 707 MLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 707 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl 783 (834)
||||++|+.||....... .....+ ... ...+..+.+++.+||+.||++||++.+++
T Consensus 307 l~elltg~~Pf~~~~~~~------------------~~~~~~-~~~--~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG------------------GSEWIF-RSC--KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS------------------CSGGGG-SSC--CCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhh------------------hHHHHH-hhc--ccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999986432211 000111 100 01236789999999999999999976664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=312.44 Aligned_cols=241 Identities=16% Similarity=0.172 Sum_probs=184.3
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCC--------cccHHHHHHHHHHHhhcC---------CCceeeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--------GQGLKEFKNEMMLIAELQ---------HRNLVRI 574 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------H~niv~l 574 (834)
.++|.+.++||+|+||.||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999986 68999999997542 233478899999999986 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHH
Q 003274 575 LGCCV------------------------------EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQG 624 (834)
Q Consensus 575 ~~~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 624 (834)
.+.+. ..+..++||||+++|++.+.+. ...+++..+..++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence 77653 2678999999999998766662 2568999999999999999
Q ss_pred HHHHH-hcCCCCeEecCCCCCCEEeccCC--------------------CeeecccccceecCCCCccCCceeeeccCcc
Q 003274 625 LLYLH-QYSRLRIIHRDLKASNVLLDKDM--------------------NPKISDFGLARMFGGDELQGNTKRIVGTYGY 683 (834)
Q Consensus 625 l~~LH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 683 (834)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y 243 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence 99999 887 99999999999999887 8999999999876432 34799999
Q ss_pred cCceeecCCCCCccccchhhHHH-HHHHhcCCCCCCCCCCCccccccchhhhhcccccc-cccccccccCCCCHHHHhHH
Q 003274 684 MSPEYALDGLFSIKSDVFSFGIL-MLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH-ELMDPVILQDEIPLPMLMRY 761 (834)
Q Consensus 684 ~aPE~~~~~~~t~~sDVwSlGvl-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l 761 (834)
+|||++.+.. +.++|||||+++ .+++++|..|+.... +.... ..... ..................++
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL--------WLHYL--TDKMLKQMTFKTKCNTPAMKQIKRKI 312 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH--------HHHHH--HHHHHHTCCCSSCCCSHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh--------hhhHH--HHhhhhhhccCcccchhhhhhcCHHH
Confidence 9999998776 999999998777 777888888863100 00000 00000 00000000011123456789
Q ss_pred HHHHHhccccCCCCCCCHHHHH
Q 003274 762 VNVALLCVQENAADRPTMSDVV 783 (834)
Q Consensus 762 ~~li~~cl~~dP~~RPt~~evl 783 (834)
.+|+.+||+.| |+.|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999966 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.9e-28 Score=280.01 Aligned_cols=185 Identities=18% Similarity=0.173 Sum_probs=131.2
Q ss_pred ccccCCcEeEEEEE-ecCccEEEEEEcccCC----------cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 003274 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQS----------GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 587 (834)
..+.|++|.+..++ ..-|+.+|+|.+.... ....++|.+|+++|+++ +|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677777777665 3458899999986531 23456799999999999 799999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||++|++|.+.|. ....++.. +|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999984 34456654 58899999999999998 99999999999999999999999999987654
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCC
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN 716 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p 716 (834)
... .....+||+.|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 332 2334689999999999875 467789999999999888766543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-25 Score=256.41 Aligned_cols=184 Identities=19% Similarity=0.205 Sum_probs=146.0
Q ss_pred cccccccCCcEeEEEEEecCccEEEEEEcccCCc--------ccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG--------QGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
..++||+|+||.||+++ ..++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 35689999999999995 4578889997644321 12345899999999999999997777777888889999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+++.....
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 5689999999999999988 999999999999999 9999999999987543
Q ss_pred CccC-----CceeeeccCcccCceeecC--CCCCccccchhhHHHHHHHhcCCCCC
Q 003274 669 ELQG-----NTKRIVGTYGYMSPEYALD--GLFSIKSDVFSFGILMLETLSSRKNT 717 (834)
Q Consensus 669 ~~~~-----~~~~~~gt~~y~aPE~~~~--~~~t~~sDVwSlGvll~elltG~~p~ 717 (834)
.... ......||+.|||||++.. ..|+..+|+|+..+-..+-+.++.++
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 2211 1234679999999999987 66888999999999988888766553
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-22 Score=177.39 Aligned_cols=105 Identities=17% Similarity=0.392 Sum_probs=93.3
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||.|.+||+|.| |.|.|.|+.+|| +.++. ..++||+|||+.|. ...+.|+|+.||||||+|++
T Consensus 1 kn~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvly~---~~~~vW~ant~~~~-~~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 1 RNILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVLYD---HSTSTWASNTEIGG-KSGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CCEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEEEE---CCEEEEEecCCCCC-CccEEEEEeCCccEEEECCC
Confidence 378999999999999988 889999999998 67753 35899999999997 45689999999999999999
Q ss_pred CCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
|.+||+|++++....+.|+|+|+||||||+. .||||
T Consensus 70 ~~~vWss~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTRGSGNYILILQDDGNVIIYGS--------DIWST 105 (105)
T ss_dssp CCEEEECCCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred cEEEEEecCCCCCCCEEEEEeCCCeEEEECC--------cEecC
Confidence 9999999987766778899999999999974 49998
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.7e-22 Score=210.70 Aligned_cols=154 Identities=19% Similarity=0.129 Sum_probs=122.9
Q ss_pred cHHHHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCc------------------ccHHHHHHHHHHHhh
Q 003274 504 SLASVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG------------------QGLKEFKNEMMLIAE 565 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~ 565 (834)
.+..+......|.+.+.||+|+||.||+|+..+|+.||||.++.... .....+.+|++++.+
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34445556677778899999999999999987799999999864321 134568999999999
Q ss_pred cCCCceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 003274 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASN 645 (834)
Q Consensus 566 l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~N 645 (834)
++| +++.+++.. +..++||||+++++|.+ +.. .....++.|+++||+|||+.+ |+||||||+|
T Consensus 161 l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~N 223 (282)
T 1zar_A 161 LQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYN 223 (282)
T ss_dssp TTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTS
T ss_pred ccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHH
Confidence 994 555554433 56699999999999987 411 224579999999999999988 9999999999
Q ss_pred EEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeec
Q 003274 646 VLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690 (834)
Q Consensus 646 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 690 (834)
||++ ++.+||+|||+++. +..++|||++.
T Consensus 224 ILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 9999 99999999999864 34578898875
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-21 Score=172.32 Aligned_cols=110 Identities=25% Similarity=0.479 Sum_probs=97.0
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||.|.+|++|+ ++|.|.|+|+.+|+ + ++|+ ..++||.||++.| +.++.|+|+.||||||+|.+
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn-----l-vl~~--~~~~vW~sn~~~~--~~~~~l~l~~dGNLVl~~~~ 69 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN-----F-VLYD--SGKPVWASNTGGL--GSGCRLTLHNNGNLVIYDQS 69 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC-----E-EEEE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc-----E-EEEE--CCEEEEECCCCCC--CCcEEEEEeCCCCEEEECCC
Confidence 37899999999999999 99999999999987 3 6676 4799999999876 45689999999999999999
Q ss_pred CCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCc
Q 003274 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPS 153 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~Pt 153 (834)
|.+||+|++....+...++|+|+|||||++. ++||||+||.
T Consensus 70 ~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~ 110 (110)
T 3a0c_A 70 NRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP--------VVWATGSGPA 110 (110)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEECSCCC-
T ss_pred CcEEEecCCCCCCCCEEEEEeCCccEEEECC--------CEecCCCcCC
Confidence 9999999987666677899999999999974 4999999984
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=6.9e-21 Score=173.27 Aligned_cols=108 Identities=19% Similarity=0.366 Sum_probs=96.1
Q ss_pred ccccccCCceeccCCCeEE--eCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEE
Q 003274 23 LAADTMTTASFIRDGEKLT--SSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVL 100 (834)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~--s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l 100 (834)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+|+ -+||++ .++||+||++.| +.++.|+|+.||||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~--~~~vW~sn~~~~--~~~~~l~l~~dGNLVl 75 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN--NNPIWATNTGGL--GNGCRAVLQPDGVLVV 75 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET--TEEEEECCCTTS--CSSCEEEECTTSCEEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC--CEEEEeCCCccC--CCceEEEEccCCEEEE
Confidence 4578999999999999999 999999999999986 257875 799999999876 5578999999999999
Q ss_pred ecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 101 LSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 101 ~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
+|++|.+||+|++....+...++|+|+|||||++. ++|||
T Consensus 76 ~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~~--------~~W~S 115 (119)
T 1b2p_A 76 ITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWAT 115 (119)
T ss_dssp ECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEES--------EEEEC
T ss_pred EeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEECc--------cEeCC
Confidence 99999999999987666677899999999999973 59998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=5.3e-20 Score=166.92 Aligned_cols=110 Identities=22% Similarity=0.414 Sum_probs=95.2
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||+|.+|++|+ +|.|+|+|+.+|+ +. +|+ ..++||.||++.| +.++.|+|+.||||||+|.+
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn-----lv-ly~--~~~~vW~sn~~~~--~~~~~l~l~~~GnLvl~d~~ 69 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN-----LV-KYQ--NGRQIWASNTDRR--GSGCRLTLLSDGNLVIYDHN 69 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC-----EE-EEE--TTEEEEECSCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc-----EE-EEe--CCEEEEeCCCCCC--CCceEEEECCCCcEEEECCC
Confidence 48999999999999998 7999999998886 22 355 4799999999988 45789999999999999998
Q ss_pred CCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCch
Q 003274 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSD 154 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtD 154 (834)
+.+||+|++....+...++|+|+|||||++. ++||||.++..
T Consensus 70 ~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~--------~~W~S~~~~~~ 111 (115)
T 2dpf_A 70 NNDVWGSACWGDNGKYALVLQKDGRFVIYGP--------VLWSLGPNGCR 111 (115)
T ss_dssp CCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEECSSTTCBC
T ss_pred ceEEEEcCCCCCCCCEEEEEeCCCeEEEECC--------CEEECCCCCCc
Confidence 9999999987555667899999999999953 59999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.82 E-value=6.1e-20 Score=165.76 Aligned_cols=110 Identities=25% Similarity=0.477 Sum_probs=94.4
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
+|+|.+||.|.+|++| .+|.|+|+|+.+|+ + +||+. .++||.||++.+ +.++.|+|+.||||||+| +
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn-----l-vl~~~--~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d-~ 67 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN-----L-VLYDN--NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS-G 67 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC-----E-EEEET--TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-T
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc-----E-EEEEC--CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-C
Confidence 4899999999999999 57999999999987 2 45665 689999999753 456899999999999999 8
Q ss_pred CCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCC
Q 003274 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHP 152 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~P 152 (834)
+.++|+|.+....+...++|+++|||||++.. +.++||||+|.
T Consensus 68 ~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~~-----~~~~W~S~~~~ 110 (112)
T 1xd5_A 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS-----NNAIWATHTNV 110 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTT-----SCEEEECCCCC
T ss_pred CEEEEECCccCCCCCEEEEEeCCCcEEEECCC-----CceEEECCCcc
Confidence 88999999776666788999999999999753 26899999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-19 Score=160.63 Aligned_cols=104 Identities=26% Similarity=0.472 Sum_probs=90.0
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.++|.+||.|.+|++|+ +|.|.|+|+.+|+ +.+ |+. .++||.+|++.+ +..+.|+|+.||||||+|.+
T Consensus 1 ~ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-y~~--~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 1 DNILYSGETLSPGEFLN--NGRYVFIMQEDCN-----LVL-YDV--DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEE-EET--TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCCcCCCCEeCCCCEEE--CCCEEEEEcCCCc-----EEE-EeC--CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 37899999999999997 7999999999987 333 554 689999999876 45789999999999999999
Q ss_pred CCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
+.++|+|++.+....++|+|+|+||||||++ ++|||
T Consensus 69 ~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~--------~~W~s 104 (109)
T 3dzw_A 69 NNPIWASNTGGENGNYVCVLQKDRNVVIYGT--------ARWAT 104 (109)
T ss_dssp SCEEEECCCCCSSSCEEEEECTTSCEEEEES--------CCCCC
T ss_pred CCEEEECCCCCCCCCEEEEEeCCCEEEEECC--------CEEeC
Confidence 9999999987655567899999999999985 49998
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=155.51 Aligned_cols=106 Identities=22% Similarity=0.373 Sum_probs=90.1
Q ss_pred cccccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEe
Q 003274 22 SLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLL 101 (834)
Q Consensus 22 ~~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~ 101 (834)
.+|.|+|.+||.|.+|+.|+| |.|.|.|+.+|+ +.+ |+. .+||.+|++.. +..+.|+|+.||||||+
T Consensus 3 ~~~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----Lvl-~~~---~~vW~snt~~~--~~~~~l~l~~dGNLvl~ 69 (110)
T 3r0e_B 3 PFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVL-YGG---KYGWQSNTHGN--GEHCFLRLNHKGELIIK 69 (110)
T ss_dssp CCBTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----EEE-ECS---SSCEECCCTTS--SSSCEEEECTTSCEEEE
T ss_pred ccccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----EEE-ECC---eEEEECCCcCC--CcCEEEEEeCCCcEEEE
Confidence 357899999999999999998 569998888886 555 544 58999999763 45689999999999999
Q ss_pred cCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 102 SQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 102 ~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
|.+|.++|+|++.+..+.+.|+|+||||||||++ .+|+|
T Consensus 70 d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~~--------~~W~t 108 (110)
T 3r0e_B 70 DDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYGP--------AIFET 108 (110)
T ss_dssp CTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred eCCCCEEEEcCCcCCCCCEEEEEcCCccEEEecC--------CEecC
Confidence 9999999999986555567899999999999974 49997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.75 E-value=7.6e-18 Score=151.87 Aligned_cols=108 Identities=15% Similarity=0.329 Sum_probs=92.1
Q ss_pred ccccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEec
Q 003274 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLS 102 (834)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (834)
.+.|+|.+||.|.+|+.|.+ |.|.|.|+.+|+ |.++ .....++||.+|+..+ +..+.|.|+.||||||+|
T Consensus 4 ~~~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL~-~~~~~~~vWssnt~~~--~~~~~l~l~~dGNLVl~d 73 (113)
T 3mez_B 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVLT-KGSKTNIVWESGTSGR--GQHCFMRLGHSGELDITD 73 (113)
T ss_dssp CCSSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEE-ETTTTEEEEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred ccCCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEEE-ECCCCEEEEECCcccC--CcCEEEEEeCCCcEEEEC
Confidence 36799999999999999975 889999999987 6664 3224689999999865 456899999999999999
Q ss_pred CCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 103 QTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
.+|.++|+|++.+..+.+.|+|+|+||||||+. .+|+|
T Consensus 74 ~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~~--------~~W~s 111 (113)
T 3mez_B 74 DRLNTVFVSNTVGQEGDYVLILQINGQAVVYGP--------AVWST 111 (113)
T ss_dssp TTSCEEEECSCCCSSSCCEEEECTTSCEEEECS--------EEEES
T ss_pred CCCCEEEECCCcCCCCCEEEEEcCCceEEEecC--------CEecC
Confidence 999999999987655567899999999999973 59998
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.6e-18 Score=179.01 Aligned_cols=137 Identities=16% Similarity=0.193 Sum_probs=105.7
Q ss_pred CcccccccccCCcEeEEEEEe-cCccE--EEEEEcccCCcc------------------------cHHHHHHHHHHHhhc
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQE--VAVKRLSSQSGQ------------------------GLKEFKNEMMLIAEL 566 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l 566 (834)
-|.+.+.||+|+||.||+|+. .+|+. ||||+++..... ....+.+|+.++.++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 356788999999999999987 67888 999987543111 113678999999999
Q ss_pred CCCce--eeEEEEEEeCCeEEEEEEecCC-C----CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEe
Q 003274 567 QHRNL--VRILGCCVEQGEKILILEYMPN-K----SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH-QYSRLRIIH 638 (834)
Q Consensus 567 ~H~ni--v~l~~~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH-~~~~~~ivH 638 (834)
+|+++ ..++.+ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88764 344432 356899999952 4 44443311 224467789999999999999 887 999
Q ss_pred cCCCCCCEEeccCCCeeecccccceec
Q 003274 639 RDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 639 ~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999765
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.1e-17 Score=147.77 Aligned_cols=109 Identities=22% Similarity=0.409 Sum_probs=90.9
Q ss_pred ccccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEec
Q 003274 23 LAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLS 102 (834)
Q Consensus 23 ~~~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~ 102 (834)
+|.|||.+||.|.+|+.| .+|.|.|.|+.+|+ +.+ |.. +|.+|+..+ +.++.|+|+.||||||+|
T Consensus 1 ~~~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN-----Lvl-~~~-----~Wssnt~~~--~~~~~l~l~~dGnLvl~d 65 (109)
T 3r0e_A 1 LGTNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN-----LVL-YNG-----NWQSNTANN--GRDCKLTLTDYGELVIKN 65 (109)
T ss_dssp CCCSEEETTCEECTTCEE--EETTEEEEECTTSC-----EEE-ETT-----TEECCCTTS--CSSCEEEECTTSCEEEEC
T ss_pred CccCCcCCCCCcCCCCEe--ECCCEEEEEecCCe-----EEE-EeC-----eEEcCCCCC--CCcEEEEEcCCCeEEEEe
Confidence 478999999999999999 46999999999987 333 432 799998765 457899999999999999
Q ss_pred CCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhcc
Q 003274 103 QTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQD 159 (834)
Q Consensus 103 ~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg 159 (834)
.++.++|++++.+....+.|+|+||||||||+. .+|+| .|.+||
T Consensus 66 ~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~~--------~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 66 GDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFGP--------SVFKI-----DPWVRG 109 (109)
T ss_dssp TTSCEEEECCCCCSSSCCEEEEETTTEEEEECS--------EEEEE-----CTTSCC
T ss_pred CCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEec--------CEECC-----CCccCC
Confidence 999999999987655567899999999999973 59998 555543
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.63 E-value=9.4e-16 Score=138.23 Aligned_cols=93 Identities=24% Similarity=0.398 Sum_probs=77.4
Q ss_pred CCCceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccc
Q 003274 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGW 164 (834)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~ 164 (834)
+...+|.|+.||+|||++. +.+||++++.+......|+|+++|||||++ .+ .++||||+
T Consensus 18 ~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d-~~-----~~~W~S~~-------------- 76 (112)
T 1xd5_A 18 EGGYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS-GS-----RAIWASNT-------------- 76 (112)
T ss_dssp ETTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE-TT-----EEEEECCC--------------
T ss_pred CCCEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc-CC-----EEEEECCc--------------
Confidence 4567899999999999987 789999998755456789999999999998 42 68999993
Q ss_pred cccCCCceEEEEcCCCCCCCCCceeecccccCCceEEEec-CCeeeEeeccCCC
Q 003274 165 DFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFN-GSVKFTCSGQWDG 217 (834)
Q Consensus 165 ~~~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~-~~~~~~~~g~w~g 217 (834)
+|++|.|++.++++|. ++++. +...||++++|+|
T Consensus 77 -----------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 -----------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp -----------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred -----------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 5567899999999998 44444 5778999999987
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.61 E-value=2.1e-15 Score=135.24 Aligned_cols=103 Identities=18% Similarity=0.312 Sum_probs=85.0
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||.|.+|+.|. +|.|.|.|+.+|+ +.+ |... . ||.+|+..+ +..+.|+|+.||||||+|.+
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn-----Lvl-~~~~--~-vW~snt~~~--~~~~~l~l~~dGNLVl~~~~ 68 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN-----LVL-YNEA--G-GFQSNTHGR--GVDCTLRLNNRGQLEIHSAN 68 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC-----EEE-ECSS--C-CEECCCTTS--CSSCEEEECTTSCEEEECSS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe-----EEE-ECCC--C-EEECCcccC--CcCEEEEEcCCCcEEEEeCC
Confidence 58999999999999994 6999999999987 444 4432 3 999998766 45689999999999999988
Q ss_pred CC-eEEEEccc--CCCCCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 105 NG-TIWSTNVS--SDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 105 ~~-~~w~~~~~--~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
+. ++|+|++. .....+.++|++|||||||+. .+|+|
T Consensus 69 ~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~~--------~~W~s 107 (111)
T 3mez_A 69 SNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYGP--------AIWST 107 (111)
T ss_dssp CSSCSEEESSSCCCCSSCCEEEECTTSCEEEECS--------EEEEC
T ss_pred CCEEEEEeccccCCCCcCEEEEECCCCeEEEecc--------CEEcc
Confidence 76 59999964 233467899999999999973 59998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=2.3e-15 Score=134.93 Aligned_cols=90 Identities=22% Similarity=0.362 Sum_probs=74.6
Q ss_pred CCCceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccc
Q 003274 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGW 164 (834)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~ 164 (834)
+...+|.|+.||||||++ .+++||++++.+......++|+++|||||++.+ +.++||||
T Consensus 19 ~~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~~-----~~~~W~S~--------------- 77 (110)
T 3a0c_A 19 GPSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQS-----NRVIWQTK--------------- 77 (110)
T ss_dssp TTTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECC---------------
T ss_pred CCCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECCC-----CcEEEecC---------------
Confidence 346789999999999998 589999999876555678999999999999864 36899999
Q ss_pred cccCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeeccC
Q 003274 165 DFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQW 215 (834)
Q Consensus 165 ~~~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~w 215 (834)
+++++|.|++.++++|. ++++++ .||+++.+
T Consensus 78 ----------------t~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 78 ----------------TNGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp ----------------CCCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred ----------------CCCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 35677999999999987 455665 79999865
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.59 E-value=6.3e-16 Score=168.52 Aligned_cols=145 Identities=13% Similarity=0.143 Sum_probs=103.0
Q ss_pred HHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCc--------------ccHHH--------HHHHHHHHh
Q 003274 507 SVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG--------------QGLKE--------FKNEMMLIA 564 (834)
Q Consensus 507 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--------------~~~~~--------~~~E~~~l~ 564 (834)
.+....--|.+.+.||+|+||.||+|...+|+.||||+++.... ..... ...|...|.
T Consensus 89 ~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 89 THAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 34444445899999999999999999988899999998753210 00111 234566666
Q ss_pred hcCCCceeeEEEEEEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 003274 565 ELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKAS 644 (834)
Q Consensus 565 ~l~H~niv~l~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~ 644 (834)
++.+.++.-..-+... ..+|||||++++.|..+.. .+....++.|++.+|.|||+.+ ||||||||.
T Consensus 169 rL~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~ 234 (397)
T 4gyi_A 169 ALYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---LIHGDFNEF 234 (397)
T ss_dssp HHHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTT
T ss_pred HHHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHH
Confidence 6644443221111112 2379999999988865531 1234568899999999999987 999999999
Q ss_pred CEEeccCCC----------eeecccccceec
Q 003274 645 NVLLDKDMN----------PKISDFGLARMF 665 (834)
Q Consensus 645 NILl~~~~~----------~kl~DFGla~~~ 665 (834)
||||++++. +.|+||+-+...
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999988773 899999987654
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.54 E-value=2e-14 Score=130.57 Aligned_cols=87 Identities=25% Similarity=0.327 Sum_probs=72.6
Q ss_pred CceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccc
Q 003274 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~ 166 (834)
...|.|+.||||||++. +++||++++........++|+|+|||||++.+ +.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~~-----~~~lW~S~----------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE-----NVTVWQSP----------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECS-----------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeCC-----CcEEEcCC-----------------
Confidence 56799999999999987 89999999876555678999999999999864 36899999
Q ss_pred cCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeecc
Q 003274 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (834)
Q Consensus 167 ~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
+||++|.|++.++++|. +++++ ..||++|+
T Consensus 88 --------------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 --------------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp --------------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred --------------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 46778999999999998 44554 38999885
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.52 E-value=3.5e-14 Score=128.52 Aligned_cols=91 Identities=26% Similarity=0.330 Sum_probs=75.2
Q ss_pred CceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccc
Q 003274 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~ 166 (834)
...|.|+.||||||++ .+++||++++........++|+++|||||++.+ +.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~~-----~~~vW~S~~~--------------- 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDHN-----NNDVWGSACW--------------- 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECTT-----CCEEEECCCC---------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECCC-----ceEEEEcCCC---------------
Confidence 5678999999999998 578999999865545678899999999999863 3689999997
Q ss_pred cCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeeccCCCc
Q 003274 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQWDGT 218 (834)
Q Consensus 167 ~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~w~g~ 218 (834)
+++|.|++.++++|. +++++. .||++++|...
T Consensus 80 ----------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 ----------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp ----------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred ----------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 356789999999997 455654 89999999754
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=4.5e-12 Score=132.63 Aligned_cols=111 Identities=21% Similarity=0.431 Sum_probs=87.2
Q ss_pred ccccccCCcee----ccCCCeEEeC----CCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEec
Q 003274 23 LAADTMTTASF----IRDGEKLTSS----SQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISN 94 (834)
Q Consensus 23 ~~~~~l~~~~~----l~~~~~l~s~----~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~ 94 (834)
..+||+.||+. |..|+.|.|+ .|.|.|.|...|+ +.+| ++ ..+++|.+++..+ +. +.|.|+.
T Consensus 134 ~ptdtlLpg~~~~~~l~~g~~L~S~~dps~G~fsl~l~~dGn-----lvLy-~~-~~~~yW~Sgt~~~--~~-~~l~l~~ 203 (276)
T 3m7h_A 134 TPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQGDGN-----LVAY-GP-NGAATWNAGTQGK--GA-VRAVFQG 203 (276)
T ss_dssp CTTSCCCCSCTTCEEECSSEEECTTCEEEETTEEEEECTTSC-----EEEE-CT-TSSEEEECCCTTT--TC-CEEEECT
T ss_pred ccccccccccccccccccCcccccCCCCCCceEEEeecCCce-----EEEE-eC-CCeEEEECCCCCC--cc-EEEEEcC
Confidence 35689999998 8888888654 4666666655542 3343 22 3589999998876 33 7899999
Q ss_pred CCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCC
Q 003274 95 NGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151 (834)
Q Consensus 95 ~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~ 151 (834)
||+|+++|.++.++|++++.+. ....|+|+++||||||+. +++||||||
T Consensus 204 dGnLvl~d~~~~~vWsS~t~~~-~~~rl~Ld~dGnLvly~~-------~~~Wqsf~~ 252 (276)
T 3m7h_A 204 DGNLVVYGAGNAVLWHSHTGGH-ASAVLRLQANGSIAILDE-------KPVWARFGF 252 (276)
T ss_dssp TSCEEEECTTSCEEEECSCTTC-TTCEEEECTTSCEEEEEE-------EEEEESSSC
T ss_pred CCeEEEEeCCCcEEEEecCCCC-CCEEEEEcCCccEEEEcC-------CCeEEccCc
Confidence 9999999998899999997654 357899999999999975 369999998
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.23 E-value=3e-11 Score=126.34 Aligned_cols=146 Identities=16% Similarity=0.116 Sum_probs=114.8
Q ss_pred HHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEE
Q 003274 510 AATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 510 ~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~ 588 (834)
..-+.|.+...++.|+.+.||+... +++.+++|+...........+.+|+++++.+. |..+.++++++...+..++||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3446788888899999999999974 46899999986532223346889999999994 678889999999989999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY------------------------------------- 631 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~------------------------------------- 631 (834)
||+++.+|...+. +......++.+++++|+.||+.
T Consensus 90 e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 90 SEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp ECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876531 1122347888999999999981
Q ss_pred -------------------CCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 632 -------------------SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 632 -------------------~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
.+..++|+|+++.|||++.+..+.|+||+.+..
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114589999999999998766667999998753
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.23 E-value=2.4e-11 Score=109.18 Aligned_cols=93 Identities=19% Similarity=0.279 Sum_probs=69.9
Q ss_pred CCCCCCceEEEecCCceEEecC-CCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccc
Q 003274 82 PISGRNAVLTISNNGNLVLLSQ-TNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDM 160 (834)
Q Consensus 82 p~~~~~~~l~~~~~g~l~l~~~-~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~ 160 (834)
|+.+...+|.|+.||||||++. .+.++|++++.+...+..++|+++|||||++.++ .++|||=.+
T Consensus 20 ~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~~~-----~~iW~S~t~--------- 85 (113)
T 3mez_B 20 QLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDDRL-----NTVFVSNTV--------- 85 (113)
T ss_dssp EEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEECSCC---------
T ss_pred EeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECCCC-----CEEEECCCc---------
Confidence 3334567899999999999998 4899999998755456788999999999998642 579998211
Q ss_pred cccccccCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeecc
Q 003274 161 KLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (834)
Q Consensus 161 klg~~~~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
-..|.|.+.++.+|...++ + ...|.+|+
T Consensus 86 ----------------------~~~~~~~~~L~~dGnlvly--~--~~~W~s~~ 113 (113)
T 3mez_B 86 ----------------------GQEGDYVLILQINGQAVVY--G--PAVWSTAA 113 (113)
T ss_dssp ----------------------CSSSCCEEEECTTSCEEEE--C--SEEEESCC
T ss_pred ----------------------CCCCCEEEEEcCCceEEEe--c--CCEecCCC
Confidence 0124578888888877654 3 57887764
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.15 E-value=9.4e-11 Score=104.90 Aligned_cols=90 Identities=17% Similarity=0.220 Sum_probs=68.7
Q ss_pred CCCceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccc
Q 003274 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGW 164 (834)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~ 164 (834)
.....|.|+.||||||++.++ +|++++.+......++|+++|||||++..+ +.++|||.-+
T Consensus 19 ~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~~----~~~vW~S~t~------------- 79 (111)
T 3mez_A 19 YESAAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSANS----NTPVWVYPRS------------- 79 (111)
T ss_dssp ETTEEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSSC----SSCSEEESSS-------------
T ss_pred cCCEEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCCC----CEEEEEeccc-------------
Confidence 346789999999999999877 999998765556789999999999998742 2359999621
Q ss_pred cccCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeec
Q 003274 165 DFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSG 213 (834)
Q Consensus 165 ~~~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
.....|.|.+.++.+|...++ . ..+|.++
T Consensus 80 ----------------~~~~~~~~~l~Lq~dGNlvly--~--~~~W~s~ 108 (111)
T 3mez_A 80 ----------------VNTVRGNYAATLGPDQHVTIY--G--PAIWSTP 108 (111)
T ss_dssp ----------------CCCCSSCCEEEECTTSCEEEE--C--SEEEECC
T ss_pred ----------------cCCCCcCEEEEECCCCeEEEe--c--cCEEccC
Confidence 011347788999999887755 2 5688775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.08 E-value=1.7e-10 Score=120.15 Aligned_cols=138 Identities=18% Similarity=0.186 Sum_probs=102.9
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCc--eeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN--LVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~~~~~~~~~~lV~Ey 590 (834)
.++.+..+.+.|..+.||++...+|+.+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 345554344466679999998777888999997543 2345788999999996544 45688888888889999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-------------------------------------- 632 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-------------------------------------- 632 (834)
+++.+|. ... .. ...++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 97 VPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred cCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 9998884 211 11 2356778888888888643
Q ss_pred -----------------CCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 633 -----------------RLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 633 -----------------~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+..++|+|++|.|||++.+..++|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12399999999999998776677999999754
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.99 E-value=1e-09 Score=97.93 Aligned_cols=85 Identities=21% Similarity=0.337 Sum_probs=64.1
Q ss_pred CceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccc
Q 003274 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~ 166 (834)
+..|.|+.||||||++. .++|++++.+......++|+++|||||++.++ .++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~~~~~~l~l~~dGNLvl~d~~~-----~~iW~S~t~~-------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGNGEHCFLRLNHKGELIIKDDDF-----KTIWSSRSSS-------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTSSSSCEEEECTTSCEEEECTTC-----CEEEECCCCC--------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCCCcCEEEEEeCCCcEEEEeCCC-----CEEEEcCCcC--------------
Confidence 47899999999999986 69999998765555788999999999998643 6899984210
Q ss_pred cCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeec
Q 003274 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSG 213 (834)
Q Consensus 167 ~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
..|.|.+.++.+|...++ + ...|.+|
T Consensus 84 -----------------~~~~~~~~L~~dGNlvly--~--~~~W~t~ 109 (110)
T 3r0e_B 84 -----------------KQGEYVLILQDDGFGVIY--G--PAIFETS 109 (110)
T ss_dssp -----------------SSSCCEEEECTTSCEEEE--C--SEEEESC
T ss_pred -----------------CCCCEEEEEcCCccEEEe--c--CCEecCC
Confidence 123477788888876654 3 3677765
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=1.4e-09 Score=96.95 Aligned_cols=57 Identities=28% Similarity=0.475 Sum_probs=48.3
Q ss_pred CceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeecc
Q 003274 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSF 149 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSF 149 (834)
...|.|+.||||||++. +.++|++++.+......++|+++|||||++.++ .++|||.
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~~~-----~~~W~S~ 76 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSPRN-----NPIWASN 76 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECTTS-----CEEEECC
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECCCC-----CEEEECC
Confidence 57799999999999987 789999998765456788999999999998642 5899984
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.97 E-value=1.1e-09 Score=97.46 Aligned_cols=87 Identities=22% Similarity=0.345 Sum_probs=66.1
Q ss_pred CCCceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccc
Q 003274 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGW 164 (834)
Q Consensus 85 ~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~ 164 (834)
+....|.|+.||||||+++ +|+|++.+......++|+++|||||++.++ .++|+|-..
T Consensus 20 ~g~~~L~~q~dGNLvl~~~----~Wssnt~~~~~~~~l~l~~dGnLvl~d~~~-----~~vWss~t~------------- 77 (109)
T 3r0e_A 20 NGDFDLVMQDDCNLVLYNG----NWQSNTANNGRDCKLTLTDYGELVIKNGDG-----STVWKSGAQ------------- 77 (109)
T ss_dssp ETTEEEEECTTSCEEEETT----TEECCCTTSCSSCEEEECTTSCEEEECTTS-----CEEEECCCC-------------
T ss_pred CCCEEEEEecCCeEEEEeC----eEEcCCCCCCCcEEEEEcCCCeEEEEeCCC-----CEEEcCCCc-------------
Confidence 4467899999999999984 899998765556788999999999998642 579976210
Q ss_pred cccCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeeccC
Q 003274 165 DFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQW 215 (834)
Q Consensus 165 ~~~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~w 215 (834)
...+.|.+.++.+|...++ . ...|.++.|
T Consensus 78 ------------------~~~~~~~~~L~~dGNlvly--~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 ------------------SVKGNYAAVVHPDGRLVVF--G--PSVFKIDPW 106 (109)
T ss_dssp ------------------CSSSCCEEEEETTTEEEEE--C--SEEEEECTT
T ss_pred ------------------CCCcCEEEEEcCCCeEEEE--e--cCEECCCCc
Confidence 0235677888888876654 3 578999876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.87 E-value=7.1e-09 Score=113.62 Aligned_cols=142 Identities=15% Similarity=0.236 Sum_probs=107.6
Q ss_pred cccccccCCcEeEEEEEecCccEEEEEEcc--cCC-cccHHHHHHHHHHHhhcC--CCceeeEEEEEEeC---CeEEEEE
Q 003274 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLS--SQS-GQGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQ---GEKILIL 588 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~---~~~~lV~ 588 (834)
..+.|+.|.++.||+.+.. +..+++|+.. ... ......+.+|+.+++.+. +..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3467999999999999865 4678889875 322 122356788999999996 45688899988776 4589999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS------------------------------------ 632 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~------------------------------------ 632 (834)
||+++..+.+.. -..++..++..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 999998884322 123678888899999999999999731
Q ss_pred -------------------CCCeEecCCCCCCEEeccCCC--eeeccccccee
Q 003274 633 -------------------RLRIIHRDLKASNVLLDKDMN--PKISDFGLARM 664 (834)
Q Consensus 633 -------------------~~~ivH~Dlk~~NILl~~~~~--~kl~DFGla~~ 664 (834)
...++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999875
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.76 E-value=3.3e-08 Score=87.23 Aligned_cols=56 Identities=30% Similarity=0.505 Sum_probs=45.7
Q ss_pred CceEEEecCCceEEecCCCCeEEEEcccCCC-CCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDV-KNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
.-+|.|+.||||||++ .+.+||++++.... ....++|+++|||||+|.++ +++|+|
T Consensus 20 ~y~l~~q~DgNLvly~-~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~~~-----~~vWss 76 (105)
T 4h3o_A 20 PYHFIMQDDCNLVLYD-HSTSTWASNTEIGGKSGCSAVLQSDGNFVVYDSSG-----RSLWAS 76 (105)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCSCEEEECTTSCEEEECTTC-----CEEEEC
T ss_pred CEEEEECCCCeEEEEE-CCEEEEEecCCCCCCccEEEEEeCCccEEEECCCc-----EEEEEe
Confidence 3568899999999998 46899999986433 34678999999999998753 689987
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.69 E-value=6.1e-09 Score=111.36 Aligned_cols=186 Identities=17% Similarity=0.183 Sum_probs=121.5
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCc--eeeEEEEEEeCC---eEEEEEEecC
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRN--LVRILGCCVEQG---EKILILEYMP 592 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~n--iv~l~~~~~~~~---~~~lV~Ey~~ 592 (834)
+.++.|....||+.. ..+++|+.... .....+..|++++..+ .+.. +.+++....... ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999873 56889986432 3456789999999988 3433 344444433332 3488999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY----------------------------------------- 631 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~----------------------------------------- 631 (834)
+..|..... ..++.+++..++.++++.++.||+.
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988864321 2467777888888899988888861
Q ss_pred --------------CCCCeEecCCCCCCEEecc--CCCeeecccccceecCCCCccCCce------------eeeccCcc
Q 003274 632 --------------SRLRIIHRDLKASNVLLDK--DMNPKISDFGLARMFGGDELQGNTK------------RIVGTYGY 683 (834)
Q Consensus 632 --------------~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~~------------~~~gt~~y 683 (834)
....++|+|+++.||+++. +..+.|+||+.+..-.......... .+....+.
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1245899999999999998 5568899999987632210000000 00000111
Q ss_pred cC-ceeecCCCCCccccchhhHHHHHHHhcCCCCC
Q 003274 684 MS-PEYALDGLFSIKSDVFSFGILMLETLSSRKNT 717 (834)
Q Consensus 684 ~a-PE~~~~~~~t~~sDVwSlGvll~elltG~~p~ 717 (834)
.. |+.... .....+.|+++.++|++.+|+.++
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 221110 122368999999999999988653
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.44 E-value=4.6e-07 Score=92.72 Aligned_cols=105 Identities=22% Similarity=0.383 Sum_probs=78.1
Q ss_pred cccccCCce-------eccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCC
Q 003274 24 AADTMTTAS-------FIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNG 96 (834)
Q Consensus 24 ~~~~l~~~~-------~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g 96 (834)
..|+|.+|| .|..++.+. +|.|.|.|.+.|+ +-+|.. ..++|.++.... +.++.++|+.+|
T Consensus 124 g~d~L~~gq~~~~~~~~L~s~~d~s--~G~~~l~l~~dG~-----LvL~~~---~~~~W~s~~~~~--~~~~~~~L~~~G 191 (236)
T 1dlp_A 124 GNSILYSTQGNDNHPQTLHATQSLQ--LSPYRLSMETDCN-----LVLFDR---DDRVWSTNTAGK--GTGCRAVLQPNG 191 (236)
T ss_dssp CCEECCCC--CCCCCCEECSSCCCB--CSSCEEEEETTTE-----EEEEBT---TBCCSCCCCCSS--CSSCEEEEETTT
T ss_pred cceEEecCCcCCCccceEEcCcEee--cCcEEEEECCCCc-----EEEEcC---CEeEEeCCCcCC--CCceEEEECCCC
Confidence 457778888 666666654 6899999987763 555532 257898775432 235789999999
Q ss_pred ceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 97 NLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 97 ~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
+|++++.++.++|.+.+........++|.++|||+++.. .+|+|
T Consensus 192 nl~ly~~~~~~vw~s~~~~~~~~~rl~Ld~dG~l~ly~~--------~~W~s 235 (236)
T 1dlp_A 192 RMDVLTNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 235 (236)
T ss_dssp EEEEEETTTEEEEECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred cEEEEeCCCcEEEEeCCCCCCCCEEEEEcCCCcEEEeCC--------CCccC
Confidence 999999888899999865444567889999999999963 48986
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=6.1e-06 Score=87.98 Aligned_cols=135 Identities=22% Similarity=0.210 Sum_probs=95.2
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCC---ceeeEEEEEE-eCCeEEEEEEecCCC
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR---NLVRILGCCV-EQGEKILILEYMPNK 594 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~---niv~l~~~~~-~~~~~~lV~Ey~~~g 594 (834)
+.++.|....||+. ++.+++|+.. .......+..|+++|..+.+. .+.+++.+.. ..+..++|||++++.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46888999999987 5778888853 223456789999999999652 3556666664 445678999999998
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY------------------------------------------- 631 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~------------------------------------------- 631 (834)
.+..... ..++..++..++.++++.|+.||+.
T Consensus 99 ~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 8865321 1234455555556666666655542
Q ss_pred --------------CCCCeEecCCCCCCEEecc---CCC-eeeccccccee
Q 003274 632 --------------SRLRIIHRDLKASNVLLDK---DMN-PKISDFGLARM 664 (834)
Q Consensus 632 --------------~~~~ivH~Dlk~~NILl~~---~~~-~kl~DFGla~~ 664 (834)
.+..++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999987 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=4.8e-06 Score=90.80 Aligned_cols=81 Identities=7% Similarity=0.009 Sum_probs=57.9
Q ss_pred cccc-ccCCcEeEEEEEec-------CccEEEEEEcccCC---cccHHHHHHHHHHHhhcC-C--CceeeEEEEEEeC--
Q 003274 518 QCKL-GEGGFGPVYKGRLF-------NGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQ-H--RNLVRILGCCVEQ-- 581 (834)
Q Consensus 518 ~~~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~-- 581 (834)
.+.| +.|....+|+.... +++.+++|+..... ......+..|+.+++.+. + ..+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998754 26788999865432 101245788999999884 3 3567788887665
Q ss_pred -CeEEEEEEecCCCCcch
Q 003274 582 -GEKILILEYMPNKSLDV 598 (834)
Q Consensus 582 -~~~~lV~Ey~~~gsL~~ 598 (834)
+..++||||+++..+..
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35789999999887754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.17 E-value=6.3e-06 Score=86.00 Aligned_cols=135 Identities=19% Similarity=0.176 Sum_probs=96.9
Q ss_pred ccccCCcE-eEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 520 KLGEGGFG-PVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 520 ~lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
.+..|..| .||+.... ++..+++|+-... ....+..|...|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68988754 4667899986432 3456888999999884 44577889999999999999999999887
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY--------------------------------------------- 631 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~--------------------------------------------- 631 (834)
.+.... .......+..++++.|+.||+.
T Consensus 108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 654311 1122334566666777777742
Q ss_pred ----------CCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 632 ----------SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 632 ----------~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
.+..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112389999999999999887778999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.82 E-value=4.9e-05 Score=81.95 Aligned_cols=141 Identities=16% Similarity=0.161 Sum_probs=81.5
Q ss_pred cccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC--CCceeeEEE------EEEeCCeEEEEEEe
Q 003274 519 CKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ--HRNLVRILG------CCVEQGEKILILEY 590 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~------~~~~~~~~~lV~Ey 590 (834)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.++..|. .-.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3566677889999987655 5889988652 234445666666553 112333332 12346678999999
Q ss_pred cCCCCcch--------------hcccccc-----------cCCCCHHHH-------------------------------
Q 003274 591 MPNKSLDV--------------YLFDPIK-----------KRLLDWEAR------------------------------- 614 (834)
Q Consensus 591 ~~~gsL~~--------------~l~~~~~-----------~~~l~~~~~------------------------------- 614 (834)
+++..+.. .++.... .....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 99876531 0111000 001123211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 615 IRIIQGIAQGLLYLHQ----------YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 615 ~~i~~~ia~gl~~LH~----------~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
..+...+.+++++|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223445666663 1245699999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.81 E-value=5.7e-05 Score=83.55 Aligned_cols=75 Identities=12% Similarity=0.186 Sum_probs=50.4
Q ss_pred ccccccCCcEeEEEEEec-CccEEEEEEcccCCc-------ccHHHHHHHHHHHhhcCC--Ccee-eEEEEEEeCCeEEE
Q 003274 518 QCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSG-------QGLKEFKNEMMLIAELQH--RNLV-RILGCCVEQGEKIL 586 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~H--~niv-~l~~~~~~~~~~~l 586 (834)
.+.||.|..+.||+++.. +++.++||....... ...+.+..|.+++..+.+ +..+ +++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357999999999999753 468899997643211 234567889999988842 4444 45543 3455689
Q ss_pred EEEecCCC
Q 003274 587 ILEYMPNK 594 (834)
Q Consensus 587 V~Ey~~~g 594 (834)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00013 Score=76.89 Aligned_cols=81 Identities=16% Similarity=0.219 Sum_probs=60.8
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-C--CceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-H--RNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H--~niv~l~~~~~~~~~~~lV~E 589 (834)
..+...+.+|.|..+.||+.++.+|+.++||+...........|..|++.|+.|. . --+.+++++. ..++|||
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 4566667899999999999999999999999876554444567889999999884 2 1244455442 3478999
Q ss_pred ecCCCCcc
Q 003274 590 YMPNKSLD 597 (834)
Q Consensus 590 y~~~gsL~ 597 (834)
|++.+...
T Consensus 91 ~l~~~~~~ 98 (288)
T 3f7w_A 91 WVDERPPT 98 (288)
T ss_dssp CCCCCCCC
T ss_pred eecccCCC
Confidence 99877653
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00026 Score=75.23 Aligned_cols=139 Identities=22% Similarity=0.139 Sum_probs=93.3
Q ss_pred cccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC---CCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 517 MQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ---HRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 517 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
..+.|+.|....+|+... +++.+++|+.... ....+..|++.|+.|. ...+.+++.+....+..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 346789999999999985 5678889986532 3567889999999883 36688899988888899999999999
Q ss_pred CCcchh-----------cccccc-------------------cCCCCHHHHH---HHHH----------------HHHHH
Q 003274 594 KSLDVY-----------LFDPIK-------------------KRLLDWEARI---RIIQ----------------GIAQG 624 (834)
Q Consensus 594 gsL~~~-----------l~~~~~-------------------~~~l~~~~~~---~i~~----------------~ia~g 624 (834)
..+..- |+.... .-.-+|.+.. ++.. .+.+.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 876321 111100 0012454321 1111 11111
Q ss_pred -HHHHHh-cCCCCeEecCCCCCCEEeccCCCeeecccc
Q 003274 625 -LLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFG 660 (834)
Q Consensus 625 -l~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 660 (834)
...|.. ..++.++|+|+.+.||+++.++ +.|.||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2346799999999999999887 8899973
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.30 E-value=0.00076 Score=75.05 Aligned_cols=77 Identities=12% Similarity=0.088 Sum_probs=46.7
Q ss_pred CCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeec--cCcccCceeecCC---CCCccccchhhHHHH
Q 003274 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVG--TYGYMSPEYALDG---LFSIKSDVFSFGILM 707 (834)
Q Consensus 633 ~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~t~~sDVwSlGvll 707 (834)
...++|+|+++.|||++.++ ++|+||+.+..-.... ....... ...|.+|+..... .-....++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~---Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF---DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH---HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH---HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45699999999999998876 9999999987532110 0000111 1345666544311 112234556777777
Q ss_pred HHHhcC
Q 003274 708 LETLSS 713 (834)
Q Consensus 708 ~elltG 713 (834)
|+.+.+
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777664
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.24 E-value=0.0015 Score=69.53 Aligned_cols=158 Identities=13% Similarity=0.106 Sum_probs=87.2
Q ss_pred cHHHHHHHhcCccc-----ccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCc--eeeEEE
Q 003274 504 SLASVAAATENFSM-----QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN--LVRILG 576 (834)
Q Consensus 504 ~~~~~~~~~~~f~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n--iv~l~~ 576 (834)
+.+++...-..|.+ .+.|+.|....+|+....+| .+++|..... ...+.+..|+.++..+.... +.+++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 33444444444543 24566788889999986655 6889988652 12245567888887774212 233332
Q ss_pred E------EEeCCeEEEEEEecCCCCcchh--------------ccccccc---------CCCCHHHHHH-----------
Q 003274 577 C------CVEQGEKILILEYMPNKSLDVY--------------LFDPIKK---------RLLDWEARIR----------- 616 (834)
Q Consensus 577 ~------~~~~~~~~lV~Ey~~~gsL~~~--------------l~~~~~~---------~~l~~~~~~~----------- 616 (834)
. ....+..++++||+++..+... ++..... ....|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 1 1234567899999998765321 1110000 0011222110
Q ss_pred -HHHHHHHHHHHHHhc----CCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 617 -IIQGIAQGLLYLHQY----SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 617 -i~~~ia~gl~~LH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+...+.+.++.++.. .+..++|+|+.+.|||++.+..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011234455555532 234699999999999999876668999998753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.0019 Score=68.15 Aligned_cols=128 Identities=16% Similarity=0.167 Sum_probs=76.2
Q ss_pred ccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEec-CCCC
Q 003274 518 QCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYM-PNKS 595 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~-~~gs 595 (834)
.+.|+.|....+|+. +.+++|+........ .....|+.+++.+....+ .+++++ ....-++|+||+ ++..
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 467889999999998 568888876532221 123568888887743333 455544 343457899999 5555
Q ss_pred cchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 003274 596 LDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ--------------------------------------------- 630 (834)
Q Consensus 596 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~--------------------------------------------- 630 (834)
+....... +..++.++++.|+-||+
T Consensus 95 l~~~~~~~----------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~ 164 (301)
T 3dxq_A 95 MSPEKFKT----------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRS 164 (301)
T ss_dssp CCHHHHHH----------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHH
T ss_pred CCHhhHhh----------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHH
Confidence 53210000 00011222222222221
Q ss_pred -----cCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 631 -----YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 631 -----~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
..+..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 165 ~l~~~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 165 ALAAHPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp HHHSSCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHhcCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 22345899999999999 6677889999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0024 Score=68.26 Aligned_cols=141 Identities=13% Similarity=0.140 Sum_probs=82.4
Q ss_pred ccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCC--ceeeEEEE-----EEeCCeEEEEEEecC
Q 003274 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHR--NLVRILGC-----CVEQGEKILILEYMP 592 (834)
Q Consensus 520 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~--niv~l~~~-----~~~~~~~~lV~Ey~~ 592 (834)
.|+ |....||+....+|+.+++|...... ...+.+..|..++..+... .+.+++.. ....+..++|||+++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~ 110 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 110 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecC
Confidence 466 77889999877677789999986432 2345677788888887422 23444432 122456688999998
Q ss_pred CCCcch----h----------ccccc------ccCCCCHHHH----HHH---------------HHHHHHHHHHHHh---
Q 003274 593 NKSLDV----Y----------LFDPI------KKRLLDWEAR----IRI---------------IQGIAQGLLYLHQ--- 630 (834)
Q Consensus 593 ~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i---------------~~~ia~gl~~LH~--- 630 (834)
+..+.. . ++... .....++... ..+ ...+.+.++.+..
T Consensus 111 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 190 (328)
T 1zyl_A 111 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 190 (328)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhh
Confidence 865531 0 01000 0011222111 001 1111122333322
Q ss_pred -cCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 631 -YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 631 -~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
..+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 191 ~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 191 EDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp SCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1234589999999999999 4 899999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0025 Score=71.02 Aligned_cols=72 Identities=18% Similarity=0.289 Sum_probs=49.9
Q ss_pred cccccCCcEeEEEEEecC--------ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEE
Q 003274 519 CKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILE 589 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E 589 (834)
+.|+.|....+|+....+ ++.+++|+.... ...+.+..|+.++..+...++ .++++.+.. .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence 568888889999998653 478999987432 112456689999998853333 566665532 38999
Q ss_pred ecCCCCc
Q 003274 590 YMPNKSL 596 (834)
Q Consensus 590 y~~~gsL 596 (834)
|+++..|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0027 Score=69.27 Aligned_cols=141 Identities=18% Similarity=0.222 Sum_probs=83.4
Q ss_pred cccccCCcEeEEEEEec--------CccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEE
Q 003274 519 CKLGEGGFGPVYKGRLF--------NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 589 (834)
+.|..|-...+|+.... +++.+++|+.... ........+|.++++.|. +.-..++++++.. .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46767878889998764 2478999986432 234556678999998884 3333566666543 29999
Q ss_pred ecCCCCcchh-c----------------ccc--cccCCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 003274 590 YMPNKSLDVY-L----------------FDP--IKKRLLD--WEARIRIIQGIAQ-------------------GLLYLH 629 (834)
Q Consensus 590 y~~~gsL~~~-l----------------~~~--~~~~~l~--~~~~~~i~~~ia~-------------------gl~~LH 629 (834)
|+++..|..- + +.. .-.+... +.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 1 000 0011122 3444444443321 233332
Q ss_pred ----h-cCCCCeEecCCCCCCEEeccC----CCeeeccccccee
Q 003274 630 ----Q-YSRLRIIHRDLKASNVLLDKD----MNPKISDFGLARM 664 (834)
Q Consensus 630 ----~-~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGla~~ 664 (834)
. ..+..++|+|+.+.||+++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 223468999999999999876 7899999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0043 Score=66.43 Aligned_cols=141 Identities=16% Similarity=0.146 Sum_probs=72.8
Q ss_pred cccccCCcEe-EEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-C-CceeeEEEEEEeCCeEEEEEEecCCCC
Q 003274 519 CKLGEGGFGP-VYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-H-RNLVRILGCCVEQGEKILILEYMPNKS 595 (834)
Q Consensus 519 ~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H-~niv~l~~~~~~~~~~~lV~Ey~~~gs 595 (834)
+.|+.|.... +|+....+++.+++|....... +.+..|+.++..+. + -.+.+++.+..+.+ +++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 3565554444 6677654467777876543221 23456777777773 2 23556666644333 78999997765
Q ss_pred cchhcccc---------------------cc--cCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 003274 596 LDVYLFDP---------------------IK--KRLLDWEARI-------R-------------IIQGIAQGLLYLH--- 629 (834)
Q Consensus 596 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~~ia~gl~~LH--- 629 (834)
+.+.+... .. ...++..... . ....+.+.+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54322100 00 0011111100 0 0011112222221
Q ss_pred hcCCCCeEecCCCCCCEEeccC----CCeeeccccccee
Q 003274 630 QYSRLRIIHRDLKASNVLLDKD----MNPKISDFGLARM 664 (834)
Q Consensus 630 ~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGla~~ 664 (834)
...+..++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1124569999999999999875 6789999999865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0062 Score=68.22 Aligned_cols=74 Identities=14% Similarity=0.118 Sum_probs=48.6
Q ss_pred cccccCCcEeEEEEEecC-ccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 519 CKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
+.|+.|-...+|+....+ ++.+++|+.......... -..|..++..|...++ .++++.+. + .+||||+++..|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-R~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-REREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-HHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-HHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 578888889999998765 478889987543222211 2579999999965445 46666662 2 259999987655
Q ss_pred c
Q 003274 597 D 597 (834)
Q Consensus 597 ~ 597 (834)
.
T Consensus 189 ~ 189 (458)
T 2qg7_A 189 S 189 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0056 Score=66.62 Aligned_cols=73 Identities=12% Similarity=0.114 Sum_probs=44.7
Q ss_pred cccccCCcEeEEEEEecCc---------cEEEEEEcccCCcccHHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCeEEEEE
Q 003274 519 CKLGEGGFGPVYKGRLFNG---------QEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN-LVRILGCCVEQGEKILIL 588 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~~---------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~n-iv~l~~~~~~~~~~~lV~ 588 (834)
+.|+.|....+|+....++ +.+++|+....... ......|.+++..+...+ ..++++.. . -.+||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 4677888889999986542 68888887543221 122367888888884333 34566543 2 36899
Q ss_pred EecCCCCc
Q 003274 589 EYMPNKSL 596 (834)
Q Consensus 589 Ey~~~gsL 596 (834)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.41 E-value=0.016 Score=62.28 Aligned_cols=32 Identities=25% Similarity=0.409 Sum_probs=28.2
Q ss_pred CCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 633 ~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 35699999999999999888899999988764
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.02 E-value=0.018 Score=56.67 Aligned_cols=98 Identities=14% Similarity=0.101 Sum_probs=62.8
Q ss_pred CcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccCCc
Q 003274 595 SLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674 (834)
Q Consensus 595 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 674 (834)
+|.+.|. ..+.++++++++.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-----------
Confidence 5666663 45678999999999999999987762211 01 1222356899999999988764 1110
Q ss_pred eeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc
Q 003274 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS 712 (834)
Q Consensus 675 ~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt 712 (834)
.....+.|||... ...+.+.=|||||++||..+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123466888653 455688899999999999884
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.19 Score=55.31 Aligned_cols=140 Identities=15% Similarity=0.135 Sum_probs=83.7
Q ss_pred cccccCCcEeEEEEEecC--------ccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEEEEEE
Q 003274 519 CKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~lV~E 589 (834)
+.|..|-...+|+....+ ++.+++|+......... .-.+|.++++.+. +.-..++++.+ . -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 467778888999998653 57899998754332222 2357888888884 33234555533 2 378999
Q ss_pred ecCCCCcchh-c----------------ccc-c---------ccCCCCHHHHHHHHHHH-------------------HH
Q 003274 590 YMPNKSLDVY-L----------------FDP-I---------KKRLLDWEARIRIIQGI-------------------AQ 623 (834)
Q Consensus 590 y~~~gsL~~~-l----------------~~~-~---------~~~~l~~~~~~~i~~~i-------------------a~ 623 (834)
|+++..|..- + +.. . ...+.-+..+.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998765321 0 100 0 01111233333333221 22
Q ss_pred HHHHHH---------------------hcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 624 GLLYLH---------------------QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 624 gl~~LH---------------------~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
.+.+|. ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 233332 112346899999999999 8888999999999864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.69 E-value=0.26 Score=53.97 Aligned_cols=30 Identities=23% Similarity=0.391 Sum_probs=25.4
Q ss_pred CeEecCCCCCCEEe------ccCCCeeeccccccee
Q 003274 635 RIIHRDLKASNVLL------DKDMNPKISDFGLARM 664 (834)
Q Consensus 635 ~ivH~Dlk~~NILl------~~~~~~kl~DFGla~~ 664 (834)
.++|+|+.+.|||+ +++..++++||..|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998864
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=89.56 E-value=19 Score=36.43 Aligned_cols=74 Identities=12% Similarity=0.281 Sum_probs=44.0
Q ss_pred EEEEEEeecCCeeEEeeCCCCC--CC----CCCceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEec
Q 003274 61 YLGIWFRRVPDTVVWVANRDRP--IS----GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRD 134 (834)
Q Consensus 61 ~~~iw~~~~~~~~vW~anr~~p--~~----~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~ 134 (834)
.+.+| +....+++|...+..+ +. .+++.+-++.++.+..+|.+|..+|.-..........+..+.+||+++-+
T Consensus 16 ~v~~~-d~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~~ 94 (276)
T 3no2_A 16 KIAII-NKDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVAW 94 (276)
T ss_dssp EEEEE-ETTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEEE
T ss_pred EEEEE-ECCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEEe
Confidence 34554 3335678888766431 10 12334444555666677888999999876322223345677888888765
Q ss_pred C
Q 003274 135 N 135 (834)
Q Consensus 135 ~ 135 (834)
.
T Consensus 95 ~ 95 (276)
T 3no2_A 95 C 95 (276)
T ss_dssp E
T ss_pred c
Confidence 4
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 834 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-71 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-66 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-63 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-62 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-61 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-61 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-61 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-43 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-42 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 7e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-25 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 2e-22 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-16 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-10 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 3e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 5e-14 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 3e-13 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 5e-05 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 4e-10 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 3e-71
Identities = 65/285 (22%), Positives = 132/285 (46%), Gaps = 20/285 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
++ ++G G FG VYKG+ V + +++ + Q L+ FKNE+ ++ + +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+G + ++ ++ SL +L + + I I + AQG+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHA-- 122
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL-- 690
IIHRDLK++N+ L +D+ KI DFGLA + +++ G+ +M+PE
Sbjct: 123 -KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 691 -DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
+S +SDV++FGI++ E ++ + ++ + + + L +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIFMVGRGYLSPDL-- 231
Query: 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794
++ + C+++ +RP +++ I +LP
Sbjct: 232 -SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 3e-67
Identities = 67/291 (23%), Positives = 117/291 (40%), Gaps = 28/291 (9%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCV 579
+G+G FG V++G+ G+EVAVK SS+ + + E+ L+H N++ +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67
Query: 580 EQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ----- 630
+ L+ +Y + S LFD + + + E I++ A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF--GGDELQGNTKRIVGTYGYMSPEY 688
+ I HRDLK+ N+L+ K+ I+D GLA D + VGT YM+PE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 689 ALDGL------FSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-----NLLGHAWDLWKH 737
D + ++D+++ G++ E G++ + + +
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 738 ERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ + P I L + C N A R T + +S
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (563), Expect = 8e-67
Identities = 71/275 (25%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ ++G G FG V+ G N +VA+K + + ++F E ++ +L H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C+EQ L+ E+M + L YL ++ L E + + + +G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+IHRDL A N L+ ++ K+SDFG+ R D+ ++ + SPE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFS 177
Query: 693 LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752
+S KSDV+SFG+LM E S K ++S + L P +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-------EVVEDISTGFRLYKPRLASTH 230
Query: 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
+ + C +E DRP S ++ ++
Sbjct: 231 V--------YQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 3e-66
Identities = 82/276 (29%), Positives = 131/276 (47%), Gaps = 22/276 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E + +LG G FG V+ G +VAVK L Q F E L+ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
R+ Q +I EYM N SL +L P +L + + IA+G+ ++ +
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKL-TINKLLDMAAQIAEGMAFIEE-- 127
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
IHRDL+A+N+L+ ++ KI+DFGLAR+ +E + +PE G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185
Query: 693 LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752
F+IKSDV+SFGIL+ E ++ + + + + + ER + ++ P D
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPEVIQNLERGYRMVRP----DN 234
Query: 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
P + + LC +E DRPT + S++ +
Sbjct: 235 CPEEL----YQLMRLCWKERPEDRPTFDYLRSVLED 266
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 6e-65
Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 22/276 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
++ + +LG G FG V G+ +VA+K + S EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ G C +Q +I EYM N L YL + + + + + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+ +HRDL A N L++ K+SDFGL+R DE + + PE +
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYS 176
Query: 693 LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752
FS KSD+++FG+LM E S K + ++ + L P + ++
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMP-------YERFTNSETAEHIAQGLRLYRPHLASEK 229
Query: 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ + C E A +RPT ++S I +
Sbjct: 230 V--------YTIMYSCWHEKADERPTFKILLSNILD 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 9e-63
Identities = 66/301 (21%), Positives = 121/301 (40%), Gaps = 38/301 (12%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGL-KEFKNEMMLIAELQH 568
++F +LG G G V+K +G +A K + + + + E+ ++ E
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
+V G GE + +E+M SLD L K + + ++ + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
+ +I+HRD+K SN+L++ K+ DFG++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSR------------------------KNTGVYNTDS 724
+S++SD++S G+ ++E R + T
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234
Query: 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALL---CVQENAADRPTMSD 781
L + D + EL+D ++ + LP + + C+ +N A+R +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294
Query: 782 V 782
+
Sbjct: 295 L 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-62
Identities = 71/288 (24%), Positives = 129/288 (44%), Gaps = 26/288 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
E+ ++ KLG+G FG V+ G VA+K L + + F E ++ +L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 573 RILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
++ + ++ EYM SL +L + L + + IA G+ Y+ +
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM- 132
Query: 633 RLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDG 692
+HRDL+A+N+L+ +++ K++DFGLAR+ +E + +PE AL G
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189
Query: 693 LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752
F+IKSDV+SFGIL+ E + + + E++D V
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV-----------------PYPGMVNREVLDQVERGYR 232
Query: 753 IPLP--MLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKK 798
+P P ++ C ++ +RPT + + + + + +
Sbjct: 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-62
Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 34/282 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+ + +G+G FG V G G +VAVK + + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 573 RILGCCVEQGEKI-LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
++LG VE+ + ++ EYM SL YL + +L + ++ + + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+HRDL A NVL+ +D K+SDFGL + E + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALRE 174
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
FS KSDV+SFGIL+ E S + + + +++ V
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVP-----------------YPRIPLKDVVPRVEKGY 217
Query: 752 EIPLP--MLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791
++ P V C +AA RP+ + + EH+
Sbjct: 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL--EHI 257
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (529), Expect = 1e-61
Identities = 74/277 (26%), Positives = 131/277 (47%), Gaps = 22/277 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+ +M+ KLG G +G VY+G VAVK L + + ++EF E ++ E++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V++LG C + +I E+M +L YL + ++ + + + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLE-- 132
Query: 632 SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
+ IHRDL A N L+ ++ K++DFGL+R+ GD + + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
FSIKSDV++FG+L+ E + + + +V+EL++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSP--------------YPGIDLSQVYELLEK-DYRM 235
Query: 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
E P + + C Q N +DRP+ +++
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (527), Expect = 3e-61
Identities = 70/303 (23%), Positives = 129/303 (42%), Gaps = 41/303 (13%)
Query: 503 FSLASVAAATENFS---------MQCKLGEGGFGPVYKGRLF----NGQEVAVKRL-SSQ 548
F+ A F+ ++ +G G FG V G L VA+K L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 549 SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL 608
+ + ++F +E ++ + H N++ + G + ++I E+M N SLD +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 609 LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668
+ +++GIA G+ YL +HRDL A N+L++ ++ K+SDFGL+R D
Sbjct: 126 -TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 669 ELQGNTKRIVG---TYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF 725
+G + +PE F+ SDV+S+GI+M E
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE---------------- 225
Query: 726 NLLGHAWDLWKHERVHELMDPVILQDEIPLPMLM--RYVNVALLCVQENAADRPTMSDVV 783
++ + + ++++ + +P PM + L C Q++ RP +V
Sbjct: 226 -VMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 784 SMI 786
+ +
Sbjct: 285 NTL 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 207 bits (527), Expect = 3e-61
Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 46/302 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQSGQGL-KEFKNEMMLIAE 565
N +GEG FG V++ R VAVK L ++ + +F+ E L+AE
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL----------------- 608
+ N+V++LG C L+ EYM L+ +L +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 609 ----LDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
L ++ I + +A G+ YL + + +HRDL N L+ ++M KI+DFGL+R
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS 724
+ +M PE ++ +SDV+++G+++ E S
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-------- 241
Query: 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784
+ + E ++ + D IL P + N+ LC + ADRP+ +
Sbjct: 242 -----PYYGMAHEEVIYYVRDGNIL--ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
Query: 785 MI 786
++
Sbjct: 295 IL 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 8e-61
Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 31/291 (10%)
Query: 511 ATENFSMQ-CKLGEGGFGPVYKGRLF---NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAE 565
+N + +LG G FG V +G +VA+K L + + +E E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
L + +VR++G C + +L++E L +L K+ + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYM 684
YL + +HRDL A NVLL KISDFGL++ G D+ + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
+PE FS +SDV+S+G+ M E LS + +K + E+M
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQK-----------------PYKKMKGPEVM 222
Query: 745 DPVILQDEIPLPMLM--RYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793
+ + P + C DRP V + + +L
Sbjct: 223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 8e-60
Identities = 71/281 (25%), Positives = 118/281 (41%), Gaps = 30/281 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHR 569
E++ + +G G +G K R +G+ + K L S + + +E+ L+ EL+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 570 NLVRILGCCVEQGEKIL--ILEYMPNKSLDVYLFDPIKKR-LLDWEARIRIIQGIAQGLL 626
N+VR +++ L ++EY L + K+R LD E +R++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 627 YLHQYSR--LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
H+ S ++HRDLK +NV LD N K+ DFGLAR+ D K VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYM 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
SPE ++ KSD++S G L+ E L + EL
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYE------------------LCALMPPFTAFSQKELA 223
Query: 745 DPVILQDEIPLPMLM--RYVNVALLCVQENAADRPTMSDVV 783
+ +P + + RP++ +++
Sbjct: 224 GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (516), Expect = 2e-59
Identities = 74/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQ 567
+ FS ++G G FG VY R + N + VA+K++S QS + ++ E+ + +L+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H N ++ GC + + L++EY + D+ + K+ L + G QGL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAY 130
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH +IHRD+KA N+LL + K+ DFG A + VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 688 YAL---DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
L +G + K DV+S GI +E + ++N ++ + L + +
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK--PPLFNMNAMSAL---------YHIAQNE 230
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784
P + N C+Q+ DRPT ++
Sbjct: 231 SPALQSGHWSEYF----RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 73/275 (26%), Positives = 118/275 (42%), Gaps = 28/275 (10%)
Query: 520 KLGEGGFGPVYKGRLFN---GQEVAVKRLSSQSGQG--LKEFKNEMMLIAELQHRNLVRI 574
+LG G FG V KG + VAVK L +++ E E ++ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 575 LGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+G C E +L++E L+ YL + R + + I ++ ++ G+ YL +
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 635 RIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTK-RIVGTYGYMSPEYALDGL 693
+HRDL A NVLL KISDFGL++ DE + + +PE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 694 FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEI 753
FS KSDV+SFG+LM E S + + K V +++ +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQ--------------KPYRGMKGSEVTAMLEKG-ERMGC 231
Query: 754 PLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
P ++ LC + +RP + V + N
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-59
Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 26/288 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS-SQSGQGLKEFKNEMMLIAELQHRN 570
E++ + LGEG +G V + VAVK + ++ + K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V+ G E + L LEY L + + R + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+ I HRD+K N+LLD+ N KISDFGLA +F + + ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 691 DGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
F + DV+S GI++ L G D + + WK ++ + I
Sbjct: 179 RREFHAEPVDVWSCGIVLTAML-----AGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI- 232
Query: 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPK 797
D PL +L + + EN + R T+ D+ + N P K
Sbjct: 233 -DSAPLALLHK-------ILVENPSARITIPDIK---KDRWYNKPLKK 269
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-59
Identities = 70/276 (25%), Positives = 119/276 (43%), Gaps = 28/276 (10%)
Query: 520 KLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHRNLVRI 574
+G G FG VY G L + AVK L+ + G + +F E +++ + H N++ +
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 575 LGCCVE-QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
LG C+ +G +++L YM + L + + + I +A+G+ +
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNF--IRNETHNPTVKDLIGFGLQVAKGM---KFLAS 148
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR--IVGTYGYMSPEYALD 691
+ +HRDL A N +LD+ K++DFGLAR E + +M+ E
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 208
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
F+ KSDV+SFG+L+ E ++ + + + L+ P D
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFDITVYLLQGRRLLQPEYCPD 261
Query: 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787
+ V L C A RP+ S++VS IS
Sbjct: 262 PL--------YEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-59
Identities = 68/300 (22%), Positives = 113/300 (37%), Gaps = 40/300 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQG-LKEFKNEMMLIAE 565
S LG G FG V + + VAVK L + + +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL---------------L 609
L H N+V +LG C G ++I EY L +L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
D E + +A+G+ +L IHRDL A N+LL KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG 729
+M+PE + +++ +SDV+S+GI + E S +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS------------- 246
Query: 730 HAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789
+ + ++++ + P ++ C + RPT +V +I +
Sbjct: 247 PYPGMPVDSKFYKMIKEG-FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 6e-59
Identities = 76/305 (24%), Positives = 119/305 (39%), Gaps = 45/305 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAE 565
EN LG G FG V +VAVK L ++ + +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 566 L-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKK------------------ 606
L H N+V +LG C G LI EY L YL +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 607 --RLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664
+L +E + +A+G+ +L +HRDL A NVL+ KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS 724
D +M+PE +G+++IKSDV+S+GIL+ E S N
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP------- 266
Query: 725 FNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784
+ + + +K + MD P + C ++ RP+ ++ S
Sbjct: 267 YPGIPVDANFYKLIQNGFKMD-------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 785 MISNE 789
+ +
Sbjct: 320 FLGCQ 324
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 1e-58
Identities = 61/281 (21%), Positives = 121/281 (43%), Gaps = 35/281 (12%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRN 570
+ + + +LG+G FG VYK + A K + ++S + L+++ E+ ++A H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V++L + +++E+ ++D + + +R L + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHD 128
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
+IIHRDLKA N+L D + K++DFG++ + ++ +GT +M+PE +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVM 183
Query: 691 -----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
D + K+DV+S GI ++E ++
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEP------------------PHHELNPMRVLL 225
Query: 746 PVILQDEIPLPMLMRY----VNVALLCVQENAADRPTMSDV 782
+ + L R+ + C+++N R T S +
Sbjct: 226 KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 2e-58
Identities = 66/273 (24%), Positives = 120/273 (43%), Gaps = 31/273 (11%)
Query: 520 KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILG 576
++G G F VYKG EVA L + + + FK E ++ LQH N+VR
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 577 CCVEQGEK----ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS 632
+ +L+ E M + +L YL + +++ + + I +GL +LH +
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 633 RLRIIHRDLKASNVLL-DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
IIHRDLK N+ + + KI D GLA + K ++GT +M+PE +
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEM-YE 186
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
+ DV++FG+ MLE +S ++ +A +++ V + P
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYP--------YSECQNAAQIYRR--VTSGVKPASFDK 236
Query: 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784
+ + C+++N +R ++ D+++
Sbjct: 237 VAIPEV----KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 3e-58
Identities = 77/281 (27%), Positives = 130/281 (46%), Gaps = 27/281 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRLSSQSGQG-LKEFKNEMMLIAEL 566
+ Q +G G FG VYKG L VA+K L + + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
H N++R+ G + ++I EYM N +LD +L + K + +++GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMS 685
YL + +HRDL A N+L++ ++ K+SDFGL+R+ D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 686 PEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745
PE F+ SDV+SFGI+M E ++ + W+L HE + + D
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------PYWELSNHEVMKAIND 228
Query: 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
+ P+ + + C Q+ A RP +D+VS++
Sbjct: 229 G--FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-57
Identities = 67/278 (24%), Positives = 112/278 (40%), Gaps = 35/278 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQH 568
E+F + LG+G FG VY R + +A+K L + + + E+ + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
N++R+ G + LILEY P ++ L K D + I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H R+IHRD+K N+LL KI+DFG + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748
+ K D++S G+L E L + ++ E I
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP------------------PFEANTYQETYK-RI 216
Query: 749 LQDEIPLPMLM--RYVNVALLCVQENAADRPTMSDVVS 784
+ E P + ++ ++ N + RP + +V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-56
Identities = 72/314 (22%), Positives = 134/314 (42%), Gaps = 45/314 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNG---QEVAVKRLS-SQSGQGLKEFKNEMMLIAEL-Q 567
+ Q +GEG FG V K R+ + A+KR+ S ++F E+ ++ +L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYL-------------FDPIKKRLLDWEAR 614
H N++ +LG C +G L +EY P+ +L +L L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 615 IRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT 674
+ +A+G+ YL Q + IHRDL A N+L+ ++ KI+DFGL+R
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KK 183
Query: 675 KRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL 734
+M+ E +++ SDV+S+G+L+ E +S + + A
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-------TPYCGMTCAELY 236
Query: 735 WKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS------N 788
K + + L P+ DE+ ++ C +E +RP+ + ++ ++
Sbjct: 237 EKLPQGYRLEKPLNCDDEV--------YDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 789 EHLNLPFPKKLTFV 802
++N +K T+
Sbjct: 289 TYVNTTLYEKFTYA 302
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 2e-56
Identities = 72/309 (23%), Positives = 133/309 (43%), Gaps = 29/309 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQE-----VAVKRLS-SQSGQGLKEFKNEMMLIAEL 566
F LG G FG VYKG E VA+K L + S + KE +E ++A +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 567 QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
+ ++ R+LG C+ LI + MP L Y+ + K + + + IA+G+
Sbjct: 69 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 125
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSP 686
YL R++HRDL A NVL+ + KI+DFGLA++ G +E + + + +M+
Sbjct: 126 YLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 687 EYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746
E L +++ +SDV+S+G+ + E ++ +D + +++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSILEK 228
Query: 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKN 806
+ P + + + C +A RP +++ + + L +
Sbjct: 229 G-ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRYLVIQGDER 285
Query: 807 VKNSSYSTS 815
+ S + S
Sbjct: 286 MHLPSPTDS 294
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-56
Identities = 68/282 (24%), Positives = 105/282 (37%), Gaps = 28/282 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAE 565
++ + KLG+G FG V +G VAVK L + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
L HRNL+R+ G ++ E P SL L + R +A+G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG-NTKRIVGTYGYM 684
YL R IHRDL A N+LL KI DFGL R ++ + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
+PE FS SD + FG+ + E + + W ++ +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ--------------EPWIGLNGSQILHKI 227
Query: 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMI 786
D + P NV + C DRPT + +
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 4e-56
Identities = 77/303 (25%), Positives = 131/303 (43%), Gaps = 34/303 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLS-SQSGQGLKEFKNEMMLIAE 565
E +M +LG+G FG VY+G VA+K ++ + S + EF NE ++ E
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRL-------LDWEARIRII 618
++VR+LG + ++I+E M L YL I++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 619 QGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIV 678
IA G+ YL+ + +HRDL A N ++ +D KI DFG+ R + + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 679 GTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHE 738
+MSPE DG+F+ SDV+SFG+++ E + + + +E
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE--------------QPYQGLSNE 242
Query: 739 RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKK 798
+V + L D P + +C Q N RP+ +++S I E P ++
Sbjct: 243 QVLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE--MEPGFRE 299
Query: 799 LTF 801
++F
Sbjct: 300 VSF 302
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 1e-55
Identities = 62/284 (21%), Positives = 122/284 (42%), Gaps = 32/284 (11%)
Query: 504 SLASVAAATENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMML 562
S+ SV + ++ K+G+G G VY + GQEVA+++++ Q + NE+++
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 563 IAELQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIA 622
+ E ++ N+V L + E +++EY+ S L D + + +D + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECL 126
Query: 623 QGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYG 682
Q L +LH ++IHRD+K+ N+LL D + K++DFG + Q +VGT
Sbjct: 127 QALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPY 181
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742
+M+PE + K D++S GI+ +E + + +E
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------------------PYLNENPLR 223
Query: 743 LMDPVILQDEIPLPMLMRY----VNVALLCVQENAADRPTMSDV 782
+ + L + + C+ + R + ++
Sbjct: 224 ALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-54
Identities = 60/283 (21%), Positives = 116/283 (40%), Gaps = 31/283 (10%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQSGQGLKE-FKNEMMLIAELQ 567
E + +GEG FG V++G + VA+K + + ++E F E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H ++V+++G E +I+E L +L LD + I ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
L R +HRD+ A NVL+ + K+ DFGL+R + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPE 179
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747
F+ SDV+ FG+ M E L ++ + ++++ +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGV-----------------KPFQGVKNNDVIGRI 222
Query: 748 ILQDEIPLP--MLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ +P+P ++ C + + RP +++ + +S
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST 265
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 3e-53
Identities = 75/298 (25%), Positives = 120/298 (40%), Gaps = 39/298 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQG-LKEFKNEM-MLIA 564
+ + LG G FG V + F + VAVK L + + +E+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 565 ELQHRNLVRILGCCVEQGEKILIL-EYMPNKSLDVYLF-------------DPIKKRLLD 610
H N+V +LG C + G ++++ E+ +L YL + + K L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 611 WEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670
E I +A+G+ +L + IHRDL A N+LL + KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH 730
+M+PE D +++I+SDV+SFG+L+ E S + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-------LGASPYPGVKI 242
Query: 731 AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ + + M P L C + RPT S++V + N
Sbjct: 243 DEEFCRRLKEGTRM-------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 5e-52
Identities = 72/299 (24%), Positives = 123/299 (41%), Gaps = 41/299 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRL--------FNGQEVAVKRLSSQ-SGQGLKEFKNEMMLI 563
+ + LGEG FG V +VAVK L S + + L + +EM ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 564 AEL-QHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLF-------------DPIKKRLL 609
+ +H+N++ +LG C + G +I+EY +L YL + L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 610 DWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669
+ + +A+G+ YL + IHRDL A NVL+ +D KI+DFGLAR +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLG 729
T +M+PE D +++ +SDV+SFG+L+ E + + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-------YPGVP 242
Query: 730 HAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ H + P +E+ + C + RPT +V +
Sbjct: 243 VEELFKLLKEGHRMDKPSNCTNEL--------YMMMRDCWHAVPSQRPTFKQLVEDLDR 293
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 3e-51
Identities = 66/295 (22%), Positives = 113/295 (38%), Gaps = 33/295 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQH 568
E+F LGEG F V R L +E A+K L + E +++ L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
V++ + + L Y N L Y+ K D I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H IIHRDLK N+LL++DM+ +I+DFG A++ + Q VGT Y+SPE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748
+ SD+++ G ++ + ++ ++ + + I
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLP------------------PFRAGNEYLIFQK-I 222
Query: 749 LQDEIPLP--MLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTF 801
++ E P + ++ + +A R ++ PF + +T+
Sbjct: 223 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG--YGPLKAHPFFESVTW 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 2e-50
Identities = 51/278 (18%), Positives = 102/278 (36%), Gaps = 34/278 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+++ + +LG G FG V++ G A K + + + + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
V + + E ++I E+M L + D + + + + ++ + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 632 SRLRIIHRDLKASNVLLDKDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+H DLK N++ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVA 197
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
+D++S G+L LS + E E + V
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLS------------------PFGGENDDETLRNVKS 239
Query: 750 QDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDV 782
D ++ + + R T+
Sbjct: 240 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (446), Expect = 2e-49
Identities = 59/292 (20%), Positives = 110/292 (37%), Gaps = 36/292 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
+ + + +LG G FG V++ G+ K +++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+ + ++ E +LILE++ L + + + I ++ +GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 632 SRLRIIHRDLKASNVLLDKDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
I+H D+K N++ + KI DFGLA DE+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
+D+++ G+L LS + E E + V
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLS------------------PFAGEDDLETLQNVKR 242
Query: 750 QDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDVVSM--ISNEHLNLP 794
D V+ +Q+ R T+ D + + +H NL
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLT 294
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 6e-47
Identities = 65/289 (22%), Positives = 117/289 (40%), Gaps = 21/289 (7%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHR 569
++ +GEG +G V N VA+K++S Q + E+ ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N++ I + + Y+ + L+ +K + L + + I +GL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNT-KRIVGTYGYMSPEY 688
++HRDLK SN+LL+ + KI DFGLAR+ D V T Y +PE
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 689 ALDGLFSIKS-DVFSFGILMLETLSSR-----KNTGVYNTDSFNLLG----HAWDLWKHE 738
L+ KS D++S G ++ E LS+R K+ +LG + +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 739 RVHELMDPVILQDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDV 782
+ + + ++++P L + L + N R +
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (410), Expect = 2e-45
Identities = 62/286 (21%), Positives = 114/286 (39%), Gaps = 39/286 (13%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQ 567
++ + + LG GG V+ R L ++VAVK L ++ F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 568 HRNLVRILGCCVEQGEKI----LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
H +V + + +++EY+ +L + + + + I +I Q
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG-GDELQGNTKRIVGTYG 682
L + H + IIHRD+K +N+++ K+ DFG+AR T ++GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 683 YMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742
Y+SPE A +SDV+S G ++ E L+ + +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP------------------PFTGDSPVS 221
Query: 743 LMDPVILQDEIPLPMLMRYV-----NVALLCVQENAADRP-TMSDV 782
+ + +D IP + V L + +N +R T +++
Sbjct: 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 8e-45
Identities = 46/278 (16%), Positives = 104/278 (37%), Gaps = 35/278 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
E + + LG G FG V++ + + K + + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNI 63
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+ + E ++I E++ + + L+ + + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 632 SRLRIIHRDLKASNVLLDKDMNP--KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
I H D++ N++ + KI +FG AR + N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
+ S +D++S G L+ LS + E ++++ ++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGIN------------------PFLAETNQQIIENIMN 217
Query: 750 QDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDV 782
+ + +++ + + + R T S+
Sbjct: 218 AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (408), Expect = 9e-45
Identities = 52/279 (18%), Positives = 101/279 (36%), Gaps = 33/279 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQG-LKEFKNEMMLIAELQHR 569
+ + + LG G F V + VA+K ++ ++ +G +NE+ ++ +++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V + G LI++ + L + ++K R+I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
+ + LD+D ISDFGL++M + GT GY++PE
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPEVL 181
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
+S D +S G++ L + E +L + IL
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYP------------------PFYDENDAKLFE-QIL 222
Query: 750 QDEIPLPMLMR------YVNVALLCVQENAADRPTMSDV 782
+ E + ++++ R T
Sbjct: 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 160 bits (405), Expect = 2e-44
Identities = 50/287 (17%), Positives = 106/287 (36%), Gaps = 27/287 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL 571
++ + ++GEG FG +++G L N Q+VA+K +S + ++E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 572 VRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY 631
+ + ++G +++ + SL+ L R + + + + +H+
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHE- 119
Query: 632 SRLRIIHRDLKASNVLLDKDMNP-----KISDFGLARMFGGDELQGN-----TKRIVGTY 681
+++RD+K N L+ + + + DFG+ + + + + K + GT
Sbjct: 120 --KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741
YMS L S + D+ + G + + L + L A + K+ER+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP--------WQGLKAATNKQKYERIG 229
Query: 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
E L E+ + P + + S
Sbjct: 230 EKKQSTPL-RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 158 bits (401), Expect = 4e-44
Identities = 64/308 (20%), Positives = 123/308 (39%), Gaps = 57/308 (18%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--------SSQSGQGLKE-FKNEMML 562
EN+ + LG G V + +E AVK + S++ Q L+E E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 563 IAELQ-HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGI 621
+ ++ H N++++ L+ + M L YL +K L + +I++ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTY 681
+ + LH +L I+HRDLK N+LLD DMN K++DFG + E + + GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTP 173
Query: 682 GYMSPEYALDGL------FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735
Y++PE + + + D++S G++M L+ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------------------PF 215
Query: 736 KHERVHELMDPVILQD-EIPLPMLMRY----VNVALLCVQENAADRPTMSDVVSMISNEH 790
H + ++ ++ + + P Y ++ + R T +
Sbjct: 216 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA-------- 267
Query: 791 LNLPFPKK 798
L PF ++
Sbjct: 268 LAHPFFQQ 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 2e-43
Identities = 64/296 (21%), Positives = 108/296 (36%), Gaps = 41/296 (13%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKN----EMMLIAELQ 567
E+F + LG+G FG V+ Q A+K L + + + +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 568 HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLY 627
H L + + ++EY+ L ++ D I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 628 LHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
LH I++RDLK N+LLDKD + KI+DFG+ + + + NT GT Y++PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 688 YALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747
L ++ D +SFG+L+ E L + + + EL
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS------------------PFHGQDEEELFHS- 214
Query: 748 ILQDEIPLPMLMRYVNVALL--CVQENAADRPTMSDVVSMISNEHLNLPFPKKLTF 801
I D P + LL R + + P +++ +
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI-------RQHPLFREINW 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 3e-43
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS---SQSGQGLKEFKNEMMLIAELQH 568
++F + LG G FG V+ R NG+ A+K L + ++ +E ++++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++R+ G + + +I++Y+ LF ++K + A+ L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGG----ELFSLLRKSQRFPNPVAKFY--AAEVCLAL 117
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
II+RDLK N+LLDK+ + KI+DFG A+ + T + GT Y++PE
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEV 172
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSRK 715
++ D +SFGIL+ E L+
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (401), Expect = 3e-43
Identities = 65/276 (23%), Positives = 110/276 (39%), Gaps = 34/276 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNE---MMLIAE 565
+FS+ +G GGFG VY R G+ A+K L + QG NE + L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+V + + IL+ M L +L + + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
++H +++RDLK +N+LLD+ + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744
PE G+ + +D FS G ++ + L + K + HE+
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH---------------SPFRQHKTKDKHEID 218
Query: 745 D-PVILQDEIPLPMLMRYVNVALLCVQENAADRPTM 779
+ + E+P ++ +Q + R
Sbjct: 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (395), Expect = 3e-43
Identities = 56/278 (20%), Positives = 100/278 (35%), Gaps = 25/278 (8%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
K+G G FG +Y G + G+EVA+K ++ + E + +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 579 VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638
+G+ +++ + SL+ R + + + + + Y+H IH
Sbjct: 72 GAEGDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIH 126
Query: 639 RDLKASNVL---LDKDMNPKISDFGLARMFGGDELQGN-----TKRIVGTYGYMSPEYAL 690
RD+K N L K I DFGLA+ + + K + GT Y S L
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186
Query: 691 DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQ 750
S + D+ S G +++ + L A K+ER+ E
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLP--------WQGLKAATKRQKYERISE-KKMSTPI 237
Query: 751 DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISN 788
+ + + C D+P S + + N
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 152 bits (384), Expect = 7e-42
Identities = 58/285 (20%), Positives = 120/285 (42%), Gaps = 23/285 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHRN 570
E + K+GEG +G VYK + G+ A+K RL + E+ ++ EL+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 571 LVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ 630
+V++ + +L+ E++ + + L+ + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 631 YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYAL 690
R++HRDLK N+L++++ KI+DFGLAR FG + + T Y +P+ +
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 691 -DGLFSIKSDVFSFGILMLETLSSRK-NTGVYNTDSFNLL------GHAWDLWKHERVHE 742
+S D++S G + E ++ GV D + ++ + + +
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 743 LMDPVILQDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDV 782
+ + +P ++ ++ + + ++ + R T
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-41
Identities = 63/292 (21%), Positives = 118/292 (40%), Gaps = 26/292 (8%)
Query: 511 ATENFSMQCKLGEGGFGPVYKGR--LFNGQEVAVKRLSSQSGQG--LKEFKNE---MMLI 563
A + + ++GEG +G V+K R G+ VA+KR+ Q+G+ E + +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 564 AELQHRNLVRILGCCVEQGEKILILEYMPNKSLD---VYLFDPIKKRLLDWEARIRIIQG 620
+H N+VR+ C + + +D D + + + E ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 621 IAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGT 680
+ +GL +LH R++HRDLK N+L+ K++DFGLAR++ Q +V T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVT 178
Query: 681 YGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN-TGVYNTDS----FNLLGHAWDLW 735
Y +PE L ++ D++S G + E + G + D +++G +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDV 782
V + P+ + ++ C+ N A R +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 3e-41
Identities = 74/307 (24%), Positives = 126/307 (41%), Gaps = 37/307 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
ENF K+GEG +G VYK R G+ VA+K RL +++ E+ L+ EL H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+V++L + + L+ E++ D + + + QGL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE-Y 688
+ R++HRDLK N+L++ + K++DFGLAR FG V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS--------FNLLG----HAWDLWK 736
+S D++S G + E ++ R ++ DS F LG W
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRA---LFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 231
Query: 737 HERVHELMDPVILQ---DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNL 793
++ P + ++ P+ ++ + + R + L
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA--------LAH 283
Query: 794 PFPKKLT 800
PF + +T
Sbjct: 284 PFFQDVT 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-41
Identities = 72/298 (24%), Positives = 112/298 (37%), Gaps = 28/298 (9%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKE-----FKNEMMLIAELQHRNLVR 573
LGEG F VYK R Q VA+K++ K+ E+ L+ EL H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 574 ILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSR 633
+L + L+ ++M + +L + QGL YLHQ+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVII---KDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 634 LRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD-G 692
I+HRDLK +N+LLD++ K++DFGLA+ FG V T Y +PE
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGAR 176
Query: 693 LFSIKSDVFSFGILMLETLS------SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746
++ + D+++ G ++ E L + L + W
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 747 VILQDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDVVSM--ISNEHLNLPFPK 797
IPL + LL N R T + + M SN P +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 5e-40
Identities = 61/286 (21%), Positives = 107/286 (37%), Gaps = 43/286 (15%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL------SSQSGQGLKEFKNEMMLIAE 565
+ + +LG G F V K R G + A K + SS+ G ++ + E+ ++ E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 566 LQHRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
+QH N++ + + + ILILE + L +K L E ++ I G
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELF---DFLAEKESLTEEEATEFLKQILNG- 125
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNP----KISDFGLARMFGGDELQGNTKRIVGTY 681
++ L+I H DLK N++L P KI DFGLA K I GT
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 682 GYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741
+++PE +++D++S G++ LS + +
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGA------------------SPFLGDTKQ 222
Query: 742 ELMDPVILQDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDV 782
E + V + + + ++ R T+ D
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 9e-40
Identities = 69/315 (21%), Positives = 123/315 (39%), Gaps = 42/315 (13%)
Query: 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV 572
+++ +G G FG VY+ +L +G+ VA+K++ + E+ ++ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 573 RILGCCVEQGEK------ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLL 626
R+ GEK L+L+Y+P V K+ L + + + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 627 YLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYMS 685
Y+H I HRD+K N+LLD D K+ DFG A+ E + + + Y +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 686 PEYALDGL-FSIKSDVFSFGILMLETLSSRKNTGVYNTDS--------FNLLGHAWDLWK 736
PE ++ DV+S G ++ E L + ++ DS +LG
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 737 HERVHELMDPVILQ-DEIPLPMLMRYVN----VALL--CVQENAADRPTMSDV-----VS 784
E + Q P + R +AL ++ R T +
Sbjct: 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307
Query: 785 MISNEHLNLPFPKKL 799
+ + ++ LP +
Sbjct: 308 ELRDPNVKLPNGRDT 322
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 52/279 (18%), Positives = 96/279 (34%), Gaps = 43/279 (15%)
Query: 515 FSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ------ 567
+ + LG GGFG VY G + + VA+K + E N + E+
Sbjct: 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65
Query: 568 --HRNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
++R+L +LILE ++ L E + + +
Sbjct: 66 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAV 123
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
+ H ++HRD+K N+L+D + K+ DFG + GT Y
Sbjct: 124 RHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYS 176
Query: 685 SPEYAL-DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743
PE+ + V+S GIL+ + + ++H+ +
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------------PFEHDE-EII 217
Query: 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDV 782
V + + ++ C+ +DRPT ++
Sbjct: 218 RGQVFFRQRVSSEC----QHLIRWCLALRPSDRPTFEEI 252
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 7e-39
Identities = 67/299 (22%), Positives = 120/299 (40%), Gaps = 35/299 (11%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHR 569
+ K+G+G FG V+K R GQ+VA+K++ ++ E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 570 NLVRILGCCVEQGEKI--------LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGI 621
N+V ++ C + L+ ++ + + +K R++Q +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 622 AQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR--IVG 679
GL Y+H+ +I+HRD+KA+NVL+ +D K++DFGLAR F + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 680 TYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSRK-NTGVYNTDSFNLL--------G 729
T Y PE L + + D++ G +M E + G L+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 730 HAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALL------CVQENAADRPTMSDV 782
W + ++E ++ V Q L YV + + A R D
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 9e-39
Identities = 54/304 (17%), Positives = 108/304 (35%), Gaps = 43/304 (14%)
Query: 521 LGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEM-MLIAELQHRNLVRILGCC 578
LG G G V + ++ A+K L + + E+ + Q ++VRI+
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74
Query: 579 ----VEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRL 634
+ ++++E + L + D + I++ I + + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-TEREASEIMKSIGEAIQYLHS---I 130
Query: 635 RIIHRDLKASNVLLDKDMNP---KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALD 691
I HRD+K N+L K++DFG A+ T Y++PE
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187
Query: 692 GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751
+ D++S G++M G S + L + + R+ + P
Sbjct: 188 EKYDKSCDMWSLGVIMYIL-----LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS 242
Query: 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLPFPKKLTFVKGKNVKNSS 811
E+ + + ++ R T+++ +N P+ ++ V +
Sbjct: 243 EVSEEV----KMLIRNLLKTEPTQRMTITEF--------MNHPW-----IMQSTKVPQTP 285
Query: 812 YSTS 815
TS
Sbjct: 286 LHTS 289
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-38
Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 33/273 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH 568
+F LG+G FG V R G+ A+K L + + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
L + ++EY LF + + + E R R A+ + L
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGG----ELFFHLSRERVFTEERARFY--GAEIVSAL 118
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
+++RD+K N++LDKD + KI+DFGL + D K GT Y++PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEV 176
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748
D + D + G++M E + R + ++ L + +I
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL------------------PFYNQDHERLFE-LI 217
Query: 749 LQDEIPLPMLMRYVNVALL--CVQENAADRPTM 779
L +EI P + +LL ++++ R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 4e-37
Identities = 60/287 (20%), Positives = 112/287 (39%), Gaps = 25/287 (8%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVK--RLSSQSGQGLKEFKNEMMLIAELQHR 569
+ + K+GEG +G V+K + + VA+K RL E+ L+ EL+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 570 NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLH 629
N+VR+ + L+ E+ + LD E + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 630 QYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYA 689
++HRDLK N+L++++ K+++FGLAR F G ++ + +V +
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLF 174
Query: 690 LDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749
L+S D++S G + E + D + L + L + L
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELA-NAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 750 QDEIPLPMLMRYVNVALL--------------CVQENAADRPTMSDV 782
D P PM ++ + ++ N R + +
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 3e-36
Identities = 61/311 (19%), Positives = 119/311 (38%), Gaps = 45/311 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRL--SSQSGQGLKEFKNEMMLIAELQHR 569
+ +G G +G V G +VA+K+L QS K E+ L+ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 570 NLVRILGCCVEQG------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
N++ +L + L++ +M + +K L + ++ + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL-----MKHEKLGEDRIQFLVYQMLK 132
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL Y+H IIHRDLK N+ +++D KI DFGLAR + V T Y
Sbjct: 133 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTRWY 184
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSSR-----KNTGVYNTDSFNLLG----HAWD 733
+PE L+ + ++ D++S G +M E ++ + + + + G
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244
Query: 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDVVSMISN 788
+ + M + ++ ++ + + + +A R T +
Sbjct: 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA------ 298
Query: 789 EHLNLPFPKKL 799
L P+ + L
Sbjct: 299 --LAHPYFESL 307
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (337), Expect = 7e-35
Identities = 47/206 (22%), Positives = 87/206 (42%), Gaps = 15/206 (7%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQH 568
+ F LG G FG V + +G A+K L Q + ++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 569 RNLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
LV++ + +++EY+ + +L + I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 629 HQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEY 688
H L +I+RDLK N+L+D+ +++DFG A+ +G T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEI 209
Query: 689 ALDGLFSIKSDVFSFGILMLETLSSR 714
L ++ D ++ G+L+ E +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 130 bits (327), Expect = 8e-34
Identities = 52/297 (17%), Positives = 116/297 (39%), Gaps = 42/297 (14%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRN 570
+++ + KLG G + V++ + N ++V VK L K+ K E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 571 LVRILGCCVEQGEK--ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYL 628
++ + + + L+ E++ N + L D++ R + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIR-FYMYEILKALDYC 145
Query: 629 HQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPE 687
H + I+HRD+K NV++D + ++ D+GLA + + V + + PE
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 688 YALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDS------FNLLGHAWDLWKHERV 740
+D ++ D++S G ++ + ++ + + +LG ++
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 741 HELMDPVILQ----------DEIPLPMLMRYVNVALL-----CVQENAADRPTMSDV 782
+ +DP + V+ L ++ + R T +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-33
Identities = 69/302 (22%), Positives = 125/302 (41%), Gaps = 38/302 (12%)
Query: 513 ENFSMQCKLGEGGFGPVYKGRLF----NGQEVAVKRLS----SQSGQGLKEFKNEMMLIA 564
ENF + LG G +G V+ R G+ A+K L Q + + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 565 ELQHR-NLVRILGCCVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
++ LV + + + LIL+Y+ L +L ++R + E +I + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ--RERFTEHEVQIYV----GE 137
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
+L L +L II+RD+K N+LLD + + ++DFGL++ F DE + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 684 MSPEYALDGL--FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741
M+P+ G D +S G+LM E L+ + + +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA---------------SPFTVDGEKNSQ 241
Query: 742 ELMDPVILQDEIPLPMLMRYVNVALL--CVQENAADRPTMSDVVSMISNEHLNLPFPKKL 799
+ IL+ E P P M + L+ + ++ R ++E F +K+
Sbjct: 242 AEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRD---ADEIKEHLFFQKI 298
Query: 800 TF 801
+
Sbjct: 299 NW 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 513 ENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAELQHR 569
+ + +G G G V + VA+K+LS Q+ K E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 570 NLVRILGCCVEQG------EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
N++ +L Q + L++E M V + LD E ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
G+ +LH IIHRDLK SN+++ D KI DFGLAR G + V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 684 MSPEYALDGLFSIKSDVFSFGILMLETLSSR 714
+PE L + D++S G +M E + +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 4e-30
Identities = 66/294 (22%), Positives = 115/294 (39%), Gaps = 35/294 (11%)
Query: 512 TENFSMQCKLGEGGFGPVYKGR-LFNGQEVAVKRLS--SQSGQGLKEFKNEMMLIAELQH 568
E + +G G +G V G VAVK+LS QS K E+ L+ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 569 RNLVRILGCCVEQ-----GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQ 623
N++ +L + ++ ++ L+ + +K + L + +I I +
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN----NIVKCQKLTDDHVQFLIYQILR 132
Query: 624 GLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGY 683
GL Y+H IIHRDLK SN+ +++D KI DFGLAR V T Y
Sbjct: 133 GLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWY 184
Query: 684 MSPEYALDGL-FSIKSDVFSFGILMLETLSSR-----KNTGVYNTDSFNLLG----HAWD 733
+PE L+ + ++ D++S G +M E L+ R + L+G
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244
Query: 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALL-----CVQENAADRPTMSDV 782
E + + ++ + N + + ++ R T +
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (285), Expect = 6e-28
Identities = 42/210 (20%), Positives = 82/210 (39%), Gaps = 18/210 (8%)
Query: 520 KLGEGGFGPVYKGR-LFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCC 578
KLG G F V+ + + N VA+K + + ++E+ L+ + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 579 VEQGEKIL-------------ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
K+L ++ + + L + R + +I + + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDK-DMNPKISDFGLARMFGGDELQGNTKRIVGTYGYM 684
Y+H+ R IIH D+K NVL++ D + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 685 SPEYALDGLFSIKSDVFSFGILMLETLSSR 714
SPE L + +D++S L+ E ++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 102 bits (255), Expect = 1e-25
Identities = 37/205 (18%), Positives = 70/205 (34%), Gaps = 35/205 (17%)
Query: 520 KLGEGGFGPVYKGRLFNGQEVAVK--RLSSQSGQGLK--------EFKNEMMLIAELQHR 569
+GEG V+ E VK ++ S + +K F + A + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 570 NLVRILGCCV----EQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGL 625
L ++ G V +++E + K + + E ++ I + +
Sbjct: 67 ALQKLQGLAVPKVYAWEGNAVLMELIDAK----------ELYRVRVENPDEVLDMILEEV 116
Query: 626 LYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKR-IVGTYGYM 684
+ I+H DL NVL+ + I DF + G + + +R + Y
Sbjct: 117 AKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYF 172
Query: 685 SPEYALDGLFSIKSDVFSFGILMLE 709
S Y + D+ S +L+
Sbjct: 173 SRTY------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 90.8 bits (225), Expect = 2e-22
Identities = 22/118 (18%), Positives = 49/118 (41%), Gaps = 13/118 (11%)
Query: 34 IRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTIS 93
+ +GE L + Q ++ + + L ++ T VW +N + +
Sbjct: 4 LTNGEGL-YAGQSLDVEPYHFIMQEDCNLVLYDH---STSVWASNTGILG-KKGCKAVLQ 58
Query: 94 NNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151
++GN V+ ++W+++ N V L++DGN+VI + +W + +
Sbjct: 59 SDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD--------IWSTGTY 108
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 71.9 bits (176), Expect = 9e-16
Identities = 17/97 (17%), Positives = 36/97 (37%), Gaps = 9/97 (9%)
Query: 64 IWFRRVP-DTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVA 122
I + D + + + L++ + NLVL + + +WSTN + A
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRA 70
Query: 123 QLRDDGNLVIRDNSSDSTAESYLWQSFD--HPSDTLL 157
L+ +G + + N + +W S + +
Sbjct: 71 VLQPNGRMDVLTNQN-----IAVWTSGNSRSAGRYVF 102
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.3 bits (133), Expect = 6e-10
Identities = 22/99 (22%), Positives = 38/99 (38%), Gaps = 5/99 (5%)
Query: 42 SSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLL 101
++Q +L + L ++ R D VW N G + NG + +L
Sbjct: 27 HATQSLQLSPYRLSMETDCNLVLFDR---DDRVWSTNT--AGKGTGCRAVLQPNGRMDVL 81
Query: 102 SQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDST 140
+ N +W++ S V L+ D NL I + +T
Sbjct: 82 TNQNIAVWTSGNSRSAGRYVFVLQPDRNLAIYGGALWTT 120
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 70.4 bits (172), Expect = 2e-15
Identities = 27/126 (21%), Positives = 46/126 (36%), Gaps = 20/126 (15%)
Query: 26 DTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISG 85
+ + + + GE L F L ++ D +W N
Sbjct: 2 NILYSGETLSTGEFLNY--GSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--S 49
Query: 86 RNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYL 145
R+ L++ +GNLV+ + +N IW++N N V L+ D N+VI
Sbjct: 50 RSCFLSMQTDGNLVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGTD--------R 101
Query: 146 WQSFDH 151
W + H
Sbjct: 102 WATGTH 107
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 38.8 bits (90), Expect = 3e-04
Identities = 18/80 (22%), Positives = 35/80 (43%), Gaps = 1/80 (1%)
Query: 83 ISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAE 142
++ + V + + NLVL + IW+TN ++ ++ DGNLV+ + S+
Sbjct: 16 LNYGSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSNKPIWA 74
Query: 143 SYLWQSFDHPSDTLLQDMKL 162
S + L +D +
Sbjct: 75 SNTGGQNGNYVCILQKDRNV 94
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 66.7 bits (162), Expect = 5e-14
Identities = 25/130 (19%), Positives = 49/130 (37%), Gaps = 18/130 (13%)
Query: 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPIS 84
+D + + + G L + + + VW + +
Sbjct: 1 SDRLNSGHQLDTGGSLAEG--GYLFIIQNDCNLVLYD--------NNRAVWASGTNGK-- 48
Query: 85 GRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESY 144
VL + N+GNLV+ + IW++N + N L+ D N+VI DNS+ +
Sbjct: 49 ASGCVLKMQNDGNLVIY-SGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NA 102
Query: 145 LWQSFDHPSD 154
+W + + +
Sbjct: 103 IWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 65.0 bits (158), Expect = 3e-13
Identities = 19/109 (17%), Positives = 41/109 (37%), Gaps = 18/109 (16%)
Query: 40 LTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLV 99
+ + + + L ++ + +W N G + +G LV
Sbjct: 25 ILFGTHVYRFIMQTDCN-----LVLY---DNNNPIWATNTGGL--GNGCRAVLQPDGVLV 74
Query: 100 LLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148
+++ N T+W + V+ + V L+ D N+VI ++ LW +
Sbjct: 75 VITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYGDA--------LWAT 115
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 41.2 bits (96), Expect = 5e-05
Identities = 21/102 (20%), Positives = 35/102 (34%), Gaps = 1/102 (0%)
Query: 61 YLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNP 120
+ P + + + + + NLV L N IW+TN
Sbjct: 5 FSKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCNLV-LYDNNNPIWATNTGGLGNGC 63
Query: 121 VAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKL 162
A L+ DG LV+ N + + +S + H L D +
Sbjct: 64 RAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNV 105
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.7 bits (134), Expect = 4e-10
Identities = 23/126 (18%), Positives = 39/126 (30%), Gaps = 20/126 (15%)
Query: 16 LFSM-KASLAADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVV 74
LF + T+ A + F S L ++ D V
Sbjct: 4 LFGLSHEGSHPQTLHAAQSLELS--------SFRFTMQSDCN-----LVLFD---SDVRV 47
Query: 75 WVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRD 134
W +N + ++G LV+L+ N WS+ + N V L+ D + I
Sbjct: 48 WASNTA---GATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG 104
Query: 135 NSSDST 140
+
Sbjct: 105 PGLWDS 110
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 51.1 bits (122), Expect = 2e-08
Identities = 22/131 (16%), Positives = 38/131 (29%), Gaps = 39/131 (29%)
Query: 64 IWFRRVPD-TVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVA 122
I F + + + + + + T+ ++ NLVL + +W++N + A
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAGA-TGCRA 60
Query: 123 QLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAED 182
L+ DG LVI + W S
Sbjct: 61 VLQSDGLLVILTAQNTIR------------------------------------WSSGTK 84
Query: 183 PSPGRYTYGLD 193
S G Y L
Sbjct: 85 GSIGNYVLVLQ 95
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 834 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.86 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.86 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.84 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.67 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.6 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.51 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.46 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.35 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.91 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.87 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.69 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.53 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.4 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.43 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.47 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.88 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.98 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=418.55 Aligned_cols=264 Identities=27% Similarity=0.432 Sum_probs=206.3
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.++||+|+||+||+|+.. ..||||+++.. .....+.|.+|++++.+++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367899999999999999999854 46999998654 34566889999999999999999999998754 56899999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|.+++.. ....+++..++.++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999853 3356999999999999999999999987 9999999999999999999999999998875544
Q ss_pred ccCCceeeeccCcccCceeecC---CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.........||+.|||||++.+ ..++.++|||||||+||||++|+.||........ + ....... ...+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~----~~~~~~~----~~~p 229 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-I----IFMVGRG----YLSP 229 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-H----HHHHHHT----SCCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-H----HHHHhcC----CCCC
Confidence 3344455689999999999864 4589999999999999999999999865332111 0 0011111 0111
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 794 (834)
.+ ...+...+.++.+++.+||+.||++||||.||++.|+.+...+|
T Consensus 230 ~~--~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 230 DL--SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLP 275 (276)
T ss_dssp CG--GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred cc--hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCC
Confidence 11 11223345688999999999999999999999999998765554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=414.07 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=200.5
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.++||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++++|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788899999999999999999888999999997643 445789999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|+|.+++.. ....++++.++.++.|||+||+|||+.+ |+||||||+||||++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999998743 3456899999999999999999999987 9999999999999999999999999998775443222
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCC-CCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRK-NTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....||+.|+|||++.+..++.++|||||||+||||+++.. |+..... .++.. ..... . ..
T Consensus 159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~----~i~~~---------~-~~ 221 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVE----DISTG---------F-RL 221 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHH----HHHHT---------C-CC
T ss_pred -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHH----HHHhc---------C-CC
Confidence 223578999999999999999999999999999999999654 4432111 11110 00000 0 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.....++.+++.+||+.||++||||+||++.|+++
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 22333456889999999999999999999999999876
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-49 Score=411.69 Aligned_cols=252 Identities=27% Similarity=0.350 Sum_probs=204.9
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 6799999999999999999986 468999999986543 23446789999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.+++. +...+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 99999999984 3457999999999999999999999998 99999999999999999999999999998754443
Q ss_pred cCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.......+||+.|||||++.+..+ +.++|||||||+||||++|+.||............ ......
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-----~~~~~~--------- 224 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKT--------- 224 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-----HHTTCT---------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-----HhcCCC---------
Confidence 334445689999999999988876 57899999999999999999999754432211110 000000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00111223467889999999999999999999853
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=411.21 Aligned_cols=256 Identities=30% Similarity=0.441 Sum_probs=208.5
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++|++.++||+|+||.||+|++.+++.||||+++... ...++|.+|++++++++|||||++++++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 46889999999999999999999888999999997543 456789999999999999999999998754 5679999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+++... ....+++..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence 999999887543 3346899999999999999999999987 999999999999999999999999999987654322
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
. .....||+.|||||++.++.++.++|||||||+||||+||..|+....... .+.. .... -. ..
T Consensus 166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-~~~~----~i~~-----~~-----~~ 229 (272)
T d1qpca_ 166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQ----NLER-----GY-----RM 229 (272)
T ss_dssp C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHH----HHHT-----TC-----CC
T ss_pred c-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHh-----cC-----CC
Confidence 2 223578999999999999999999999999999999999765543222111 1110 0000 00 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+...+.++.+|+.+||+.||++||||.||+++|++.
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 12333456889999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-48 Score=415.65 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=198.7
Q ss_pred cCcccccccccCCcEeEEEEEecC-c---cEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-G---QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV 587 (834)
++|++.++||+|+||+||+|+... + ..||||++... .....+.|.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777899999999999998643 2 26899998654 344567899999999999999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|.+++.. ....+++.++++++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998743 3456899999999999999999999987 99999999999999999999999999998754
Q ss_pred CCccC---CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 668 DELQG---NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 668 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
..... ......||+.|||||.+.+..++.++|||||||+||||+| |++||...... ++.. ...
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~----~i~------- 247 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVIN----AIE------- 247 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHH-------
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH--HHHH----HHH-------
Confidence 43222 1222457999999999999999999999999999999998 88888643321 1110 000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ....+...+.++.+++.+||+.||++||||.||++.|+++.
T Consensus 248 --~~~-~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 248 --QDY-RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp --TTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --cCC-CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 000 11233445678899999999999999999999999998763
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-49 Score=415.90 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=212.7
Q ss_pred HhcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
..++|++.++||+|+||+||+|+.. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+++..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 3478999999999999999999865 5889999999754 3456789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+++|+|..++... ....+++..++.++.||++||+|||+++ |+||||||+||||++++.+||+|||+++......
T Consensus 94 ~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred cccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999998532 3457899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.. ......|++.|+|||++.+..++.++|||||||+||||++|..|+...... ..+ .+.+....
T Consensus 170 ~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-~~~-------------~~~i~~~~- 233 (287)
T d1opja_ 170 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQV-------------YELLEKDY- 233 (287)
T ss_dssp SE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHH-------------HHHHHTTC-
T ss_pred ce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH-HHH-------------HHHHhcCC-
Confidence 22 222346899999999999999999999999999999999977665322111 100 01111111
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
....+...+.++.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11233345678999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-48 Score=402.70 Aligned_cols=254 Identities=27% Similarity=0.412 Sum_probs=213.2
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.++||+|+||+||+|+.++++.||||+++... ...++|++|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6889999999999999999999888899999997643 345789999999999999999999999999999999999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|+|..++.. ....+++..+.+++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.......
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999988743 3456889999999999999999999987 9999999999999999999999999998765543332
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||+.....+ +.. .... .. ..
T Consensus 158 -~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~----~i~~---------~~-~~ 220 (258)
T d1k2pa_ 158 -SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAE----HIAQ---------GL-RL 220 (258)
T ss_dssp -CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHH----HHHT---------TC-CC
T ss_pred -ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHH----HHHh---------CC-CC
Confidence 233568999999999999999999999999999999998 788887543221 110 0000 00 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+.....++.+++.+||+.||++|||+.|+++.|.++
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 22334456889999999999999999999999998653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-48 Score=409.48 Aligned_cols=249 Identities=23% Similarity=0.374 Sum_probs=208.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 5799999999999999999985 568999999997666566788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|..++. ...+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 9999988763 356999999999999999999999998 99999999999999999999999999998754332
Q ss_pred CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 672 GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......||+.|+|||++.+..++.++|||||||+||||++|+.||....... .......... + ..
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~~~~~~~~------~---~~ 236 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNGT------P---EL 236 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----HHHHHHHHCS------C---CC
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH-----HHHHHHhCCC------C---CC
Confidence 2334579999999999999999999999999999999999999986432111 0000100000 0 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..+.....++.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 123334578899999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-48 Score=402.83 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=206.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.+.||+|+||+||+|+.. +++.||+|++... .....+.+.+|++++++++|||||++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 67999999999999999999864 5889999998643 2334677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. +...+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999884 4457999999999999999999999988 999999999999999999999999999875432
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
......||+.|||||++.+..++.++|||||||+||||++|+.||....... .. ..... .
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~----~~i~~--------~-- 219 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TY----KRISR--------V-- 219 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HHHHT--------T--
T ss_pred ----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--HH----HHHHc--------C--
Confidence 2334679999999999999999999999999999999999999986432111 10 00000 0
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 220 -~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11223334568899999999999999999999975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-48 Score=415.84 Aligned_cols=258 Identities=29% Similarity=0.444 Sum_probs=207.9
Q ss_pred hcCcccccccccCCcEeEEEEEecC------ccEEEEEEcccC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN------GQEVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||+||+|+... ...||||.+... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 4789999999999999999998542 236999998654 334456789999999998 89999999999999999
Q ss_pred EEEEEEecCCCCcchhcccccc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 003274 584 KILILEYMPNKSLDVYLFDPIK--------------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKA 643 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~ 643 (834)
.++||||+++|+|.++|..... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999854321 245899999999999999999999987 99999999
Q ss_pred CCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCC
Q 003274 644 SNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNT 722 (834)
Q Consensus 644 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~ 722 (834)
+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987654443333334678999999999999999999999999999999998 8999865433
Q ss_pred CccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHh
Q 003274 723 DSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMIS 787 (834)
Q Consensus 723 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~ 787 (834)
... + ... +.... ....+...+.++.+||.+||+.||++|||+.||++.|.
T Consensus 273 ~~~-~----~~~---------~~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DAN-F----YKL---------IQNGF-KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHH-H----HHH---------HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH-H----HHH---------HhcCC-CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 1 011 11110 11233345678999999999999999999999999985
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=404.95 Aligned_cols=260 Identities=27% Similarity=0.431 Sum_probs=206.4
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMP 592 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~ 592 (834)
++|++.+.||+|+||.||+|++.+++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence 689999999999999999999988889999999654 3455789999999999999999999999854 56899999999
Q ss_pred CCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCccC
Q 003274 593 NKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQG 672 (834)
Q Consensus 593 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 672 (834)
+|+|..++... ....+++.+++.++.||++||+|||+++ |+||||||+||||+.++++||+|||+++.+......
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence 99999887543 3456999999999999999999999988 999999999999999999999999999876543322
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccccCC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDE 752 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 752 (834)
......||+.|+|||++.++.++.++|||||||+||||++|..|+....... .+... ... .. ...
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-~~~~~----i~~---------~~-~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQ----VER---------GY-RMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HHHHH----HHT---------TC-CCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-HHHHH----HHh---------cC-CCC
Confidence 2233568999999999999999999999999999999999776654322211 11110 000 00 112
Q ss_pred CCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccCCCC
Q 003274 753 IPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHLNLP 794 (834)
Q Consensus 753 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~ 794 (834)
.+.....++.+++.+||+.||++||+|.+|+++|++.....+
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 333455688999999999999999999999999998754443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=404.59 Aligned_cols=256 Identities=26% Similarity=0.393 Sum_probs=208.4
Q ss_pred hcCccccc-ccccCCcEeEEEEEec---CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQC-KLGEGGFGPVYKGRLF---NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~-~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|.+.+ +||+|+||+||+|... ++..||||+++... ....++|.+|+++|++++|||||++++++.. +..++
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35677777 4999999999999753 35579999997653 3456789999999999999999999999865 56899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|.+++.. .+..+++..+++++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 86 vmE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 9999999999998743 3457899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 667 GDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
..... .......||+.|+|||++.++.++.++|||||||+||||+| |+.||......+ +. .....+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~----~~i~~~~----- 229 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VM----AFIEQGK----- 229 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HH----HHHHTTC-----
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HH----HHHHcCC-----
Confidence 54322 22334568999999999999999999999999999999998 899987543211 11 0111110
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+...+.++.+|+.+||+.||++||||.+|++.|+..
T Consensus 230 -----~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 230 -----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp -----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1123344567889999999999999999999999998765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=407.74 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=206.8
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
+.|++.++||+|+||+||+|+. .+++.||||++........+.+.+|++++++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 5789999999999999999986 468899999998777777788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|..++.+ ....+++..+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--
Confidence 99999988743 3456999999999999999999999998 9999999999999999999999999998653221
Q ss_pred CCceeeeccCcccCceeec-----CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 672 GNTKRIVGTYGYMSPEYAL-----DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.......||+.|+|||++. +..|+.++|||||||+||||++|+.||....... .. ...... .. +
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~---~~i~~~-~~-----~ 233 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VL---LKIAKS-EP-----P 233 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HH---HHHHHS-CC-----C
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HH---HHHHcC-CC-----C
Confidence 1122357999999999984 5568999999999999999999999986533211 10 001000 00 0
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 234 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 ---TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122344568899999999999999999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=404.60 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=201.1
Q ss_pred cCcccccccccCCcEeEEEEEecCc-----cEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNG-----QEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
+.|++.++||+|+||.||+|++..+ ..||||++.... ....++|.+|++++.+++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 5688889999999999999986542 479999986543 3345679999999999999999999999999999999
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+.++++..++.. ....+++.++++++.||++||+|||+.+ |+||||||+||||+.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999887632 3457999999999999999999999987 9999999999999999999999999998875
Q ss_pred CCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... .......||+.|||||++.++.++.++|||||||+||||++|..|+....... .+. +.+.
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-~~~-------------~~i~ 227 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVM-------------KAIN 227 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHH-------------HHHH
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-HHH-------------HHHh
Confidence 43322 22233568999999999999999999999999999999999766543222111 111 0111
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ....+...+.++.+|+.+||+.||++||||.||+++|+++.
T Consensus 228 ~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 228 DGF-RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp TTC-CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ccC-CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 111 12233445678999999999999999999999999998763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-48 Score=405.16 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=195.7
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe--CCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE--QGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--~~~~~lV 587 (834)
++|++.+.||+|+||+||+|+. .+|+.||||++.... +...+.+.+|++++++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999985 468899999986543 3345678999999999999999999999865 4568999
Q ss_pred EEecCCCCcchhccccc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC--CCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 588 LEYMPNKSLDVYLFDPI-KKRLLDWEARIRIIQGIAQGLLYLHQYSR--LRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gl~~LH~~~~--~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
|||+++|+|.+++.... ....+++..++.++.||+.||+|||+++. .+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999885432 34679999999999999999999998652 3599999999999999999999999999988
Q ss_pred cCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 665 FGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 665 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
+..... ......||+.|||||++.+..++.++|||||||+||||++|+.||...... ++. .......
T Consensus 164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~----~~i~~~~----- 230 (269)
T d2java1 164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELA----GKIREGK----- 230 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHH----HHHHHTC-----
T ss_pred cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHH----HHHHcCC-----
Confidence 654322 233468999999999999999999999999999999999999998643221 111 0011110
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 231 -----~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 231 -----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 01223334568899999999999999999999964
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=402.83 Aligned_cols=248 Identities=29% Similarity=0.398 Sum_probs=199.3
Q ss_pred cccccCCcEeEEEEEecC---ccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEecCC
Q 003274 519 CKLGEGGFGPVYKGRLFN---GQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYMPN 593 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~~~ 593 (834)
++||+|+||+||+|.+.+ ++.||||+++... ....++|.+|+++|++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 479999999999998543 5689999996542 3345689999999999999999999999864 567899999999
Q ss_pred CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc-C
Q 003274 594 KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ-G 672 (834)
Q Consensus 594 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~ 672 (834)
|+|.+++. ....+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999884 4456999999999999999999999987 999999999999999999999999999987544322 2
Q ss_pred CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccccC
Q 003274 673 NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVILQD 751 (834)
Q Consensus 673 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 751 (834)
......||+.|||||.+.+..++.++|||||||++|||++ |+.||....... +. .....+. ..
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~----~~i~~~~----------~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VT----AMLEKGE----------RM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH----HHHHTTC----------CC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HH----HHHHcCC----------CC
Confidence 2334578999999999999999999999999999999998 899986432211 11 0111100 11
Q ss_pred CCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 752 EIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 752 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
..+...+.++.+|+.+||+.||++|||+.+|+++|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 23334567889999999999999999999999988764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-47 Score=403.92 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=204.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||+||+|+. .+++.||||++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999986 46899999998643 2345577999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|.+++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhh---ccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999998873 4567999999999999999999999998 999999999999999999999999999987654
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
..........||+.|||||++.+..++.++|||||||+||||++|+.||...+... +.. . +...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~----~--------i~~~-- 225 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--IFQ----K--------IIKL-- 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----H--------HHTT--
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--HHH----H--------HHcC--
Confidence 43444445689999999999999999999999999999999999999986432111 100 0 0000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+.....++.+++.+||+.||++|||+.|++.
T Consensus 226 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 226 -EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 01223334567899999999999999999998743
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=395.52 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=196.0
Q ss_pred cccccccccCCcEeEEEEEec-CccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe----CCeEEEE
Q 003274 515 FSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE----QGEKILI 587 (834)
Q Consensus 515 f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~----~~~~~lV 587 (834)
|.+.++||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++.. ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 356678999999999999864 5789999998654 33445679999999999999999999999875 3457999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec-cCCCeeecccccceecC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD-KDMNPKISDFGLARMFG 666 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~~ 666 (834)
|||+++|+|.+++. +...+++..+..++.||++||+|||+++ .+|+||||||+||||+ +++.+||+|||+++...
T Consensus 91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999984 3467999999999999999999999875 4599999999999996 57899999999998643
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
.. ......||+.|||||++.+ .++.++|||||||+||||++|+.||....... .+. ...... ..+
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~----~~i~~~-----~~~ 231 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIY----RRVTSG-----VKP 231 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHH----HHHTTT-----CCC
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-HHH----HHHHcC-----CCC
Confidence 32 2345689999999998865 59999999999999999999999986432211 010 000000 000
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ..+.....++.+++.+||+.||++|||+.|+++
T Consensus 232 ~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 232 A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 0 111223456889999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-47 Score=406.90 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=213.4
Q ss_pred HHHHHhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCCcc-cHHHHHHHHHHHhhcCCCceeeEEEEEE
Q 003274 507 SVAAATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQSGQ-GLKEFKNEMMLIAELQHRNLVRILGCCV 579 (834)
Q Consensus 507 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~H~niv~l~~~~~ 579 (834)
+++..+++|++.++||+|+||+||+|+.. +++.||||+++..... ..++|.+|++++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445688999999999999999999853 4578999999765433 4567999999999999999999999999
Q ss_pred eCCeEEEEEEecCCCCcchhccccc---------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 003274 580 EQGEKILILEYMPNKSLDVYLFDPI---------------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIH 638 (834)
Q Consensus 580 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH 638 (834)
..+..++||||+++|+|.+++.... ....+++..++.|+.|+++||+|||+++ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999985321 1235889999999999999999999988 999
Q ss_pred cCCCCCCEEeccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCC-CCC
Q 003274 639 RDLKASNVLLDKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR-KNT 717 (834)
Q Consensus 639 ~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~-~p~ 717 (834)
|||||+||||+.++.+||+|||+++.+.............||+.|+|||.+.+..++.++|||||||+||||++|. +|+
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998775544444444567899999999999999999999999999999999986 455
Q ss_pred CCCCCCccccccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 718 GVYNTDSFNLLGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
......+ +. .....+. ....+...+.++.+|+.+||+.+|++||||.||+++|+++
T Consensus 244 ~~~~~~e--~~----~~v~~~~----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 244 YGMAHEE--VI----YYVRDGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTSCHHH--HH----HHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCHHH--HH----HHHHcCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 5332211 11 0111111 1122334456889999999999999999999999999876
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=408.51 Aligned_cols=263 Identities=24% Similarity=0.335 Sum_probs=205.3
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|++.++||+|+||+||+|+. .+|+.||+|+++... ....+.+.+|+.+|++++|||||++++++.+.++.++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 47899999999999999999985 468999999987543 3345679999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQY-SRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|+++|+|.+++. +...+++..+..++.|+++||.|||++ + |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999984 345699999999999999999999974 6 999999999999999999999999999875432
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc------------
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK------------ 736 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~------------ 736 (834)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...................
T Consensus 159 ----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 159 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp ----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred ----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2234689999999999999999999999999999999999999997544322111000000000
Q ss_pred --------c----ccccccccccccc---CCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 --------H----ERVHELMDPVILQ---DEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 --------~----~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
. ....+..+..... .......+.++.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0 0000000000000 0001112457899999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=400.53 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=203.5
Q ss_pred cCcccccccccCCcEeEEEEEec-Ccc----EEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQ----EVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
++|++.++||+|+||+||+|+.. +|+ +||+|+++.. ..+..++|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 56999999999999999999853 343 6899988653 345677899999999999999999999999875 5778
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
++||+.+|+|.+++.. ....+++..+++++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999887743 4567999999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
............||+.|+|||++.++.++.++|||||||+||||+| |.+|+....... +. .. +.
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~----~~---------i~ 227 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--IS----SI---------LE 227 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HH----HH---------HH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HH----HH---------HH
Confidence 5554444445678999999999999999999999999999999998 778876433221 10 01 10
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
... ....+...+.++.+++.+||+.||++|||+.||++.|..+.
T Consensus 228 ~~~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 228 KGE-RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCC-CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 000 11223345678899999999999999999999999887653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-46 Score=399.54 Aligned_cols=245 Identities=29% Similarity=0.437 Sum_probs=200.8
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
+.|+..++||+|+||+||+|+. .+++.||||++.... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4589999999999999999985 568899999987543 234467899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
|||++|+|..++. ....+++..+..++.||++||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999976652 4467999999999999999999999998 99999999999999999999999999986533
Q ss_pred CccCCceeeeccCcccCceeecC---CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALD---GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
.....||+.|||||++.+ ..|+.++|||||||++|||++|+.||....... . ....... ..
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~--~---~~~i~~~------~~ 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--A---LYHIAQN------ES 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--H---HHHHHHS------CC
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH--H---HHHHHhC------CC
Confidence 223579999999999864 468999999999999999999999986432111 0 0001000 00
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+. ..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 232 ~~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PA----LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CC----CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC----CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 112233568899999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=388.69 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=198.5
Q ss_pred hcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-CeEEEEEEe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-GEKILILEY 590 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-~~~~lV~Ey 590 (834)
.++|++.++||+|+||.||+|+. .|++||||+++.. ...+.|.+|++++++++||||++++|++.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 36788899999999999999997 4789999999654 3457899999999999999999999999654 568999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+++|+|.++|... ....+++..+++|+.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 9999999998542 2346899999999999999999999987 999999999999999999999999999875432
Q ss_pred cCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
.....+|..|+|||++.+..++.++|||||||++|||++ |++|+....... +... .... .
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~----i~~~-----~----- 217 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPR----VEKG-----Y----- 217 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHH----HTTT-----C-----
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHH----HHcC-----C-----
Confidence 223467899999999999999999999999999999998 577665432211 1110 0000 1
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+.....++.+|+.+||+.||++||||.+++++|+++
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1223334456889999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.1e-45 Score=400.23 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=208.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|.+.++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 6899999999999999999985 468999999998776666788999999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc--CCCeeecccccceecCCCC
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK--DMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~~~~~~ 669 (834)
++|+|.+++.. ....+++..+..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+++.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999988843 3456999999999999999999999998 999999999999964 6789999999999875432
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
......||+.|||||++.+..++.++|||||||++|||++|+.||....... ... .. ..... ..
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--~~~---~i-~~~~~------~~- 244 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLR---NV-KSCDW------NM- 244 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HH-HHTCC------CS-
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH--HHH---HH-HhCCC------CC-
Confidence 2344689999999999999999999999999999999999999986432211 110 00 00000 00
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..........++.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111223467899999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=396.00 Aligned_cols=261 Identities=29% Similarity=0.420 Sum_probs=201.1
Q ss_pred HhcCcccccccccCCcEeEEEEEec------CccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 003274 511 ATENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQG 582 (834)
Q Consensus 511 ~~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~ 582 (834)
..++|.+.++||+|+||.||+|+.. .++.||||+++... ....+.+..|..++.++ +|+||+.+++++.+.+
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence 4578999999999999999999843 35689999997543 33456788888888887 6899999999987654
Q ss_pred -eEEEEEEecCCCCcchhcccccc-------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 583 -EKILILEYMPNKSLDVYLFDPIK-------------KRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 583 -~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+++ |+||||||+||||
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence 68999999999999999854321 345899999999999999999999988 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCC-CCCCCCCCCcccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR-KNTGVYNTDSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~-~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +|+........ +
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~-~ 246 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-F 246 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-H
T ss_pred CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-H
Confidence 999999999999998776554444444568999999999999999999999999999999999975 46653322211 1
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
......+. ....+.....++.+++.+||+.||++|||+.||++.|+++
T Consensus 247 ----~~~~~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 247 ----CRRLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp ----HHHHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHHhcCC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 01111110 1122333456889999999999999999999999999876
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-46 Score=395.95 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=189.9
Q ss_pred hcCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
.+.|++.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 367999999999999999999864 58899999987543 2334568899999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec---cCCCeeecccccceecC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARMFG 666 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~~ 666 (834)
|+++|+|.+++. ....+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++...
T Consensus 88 ~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999984 3457999999999999999999999998 99999999999994 57899999999998764
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDP 746 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 746 (834)
... .....+||+.|||||++.+..++.++|||||||+||||++|+.||....... +.. .... .. .
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~---~i~~-~~------~ 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFE---QILK-AE------Y 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH---HHHT-TC------C
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHH---HHhc-cC------C
Confidence 432 2234579999999999999999999999999999999999999986432111 100 0000 00 0
Q ss_pred ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 747 VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 747 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ........+.++.+++.+||+.||++|||+.|+++
T Consensus 227 ~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 EF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC-CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00 11112234567899999999999999999999987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-45 Score=398.58 Aligned_cols=256 Identities=21% Similarity=0.273 Sum_probs=210.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|++.++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 6799999999999999999985 568999999997766556678899999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec--cCCCeeecccccceecCCCC
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD--KDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGla~~~~~~~ 669 (834)
++|+|.+++.. ....+++.++..|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999887632 3446899999999999999999999988 99999999999998 67899999999999875432
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
......||+.|+|||++.+..++.++|||||||+||||++|+.||....... ... ...... ...
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~----~i~~~~------~~~- 247 (352)
T d1koba_ 184 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQ----NVKRCD------WEF- 247 (352)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHH----HHHHCC------CCC-
T ss_pred ---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHH----HHHhCC------CCC-
Confidence 2344679999999999999999999999999999999999999986432211 100 000000 000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
........+.++.+|+.+||+.||++|||+.|+++ .+++.
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 11112234567899999999999999999999987 35443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=388.81 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=196.9
Q ss_pred hcCcccccccccCCcEeEEEEEecC----ccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKIL 586 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~l 586 (834)
.++|++.++||+|+||.||+|+... +..||||.++... ....+.|.+|++++++++|||||++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4689999999999999999998543 3578999986543 334567999999999999999999999986 467899
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
||||+++|+|..++. .....+++..++.++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 85 v~E~~~~g~l~~~~~--~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQ--VRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHH--HTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhh--ccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 999999999998863 23457899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccccc
Q 003274 667 GDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHELMD 745 (834)
Q Consensus 667 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 745 (834)
..... ......||+.|+|||++.+..++.++|||||||+||||++ |.+|+....... +.. ......
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~----~i~~~~------ 226 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIG----RIENGE------ 226 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHH----HHHTTC------
T ss_pred CCcce-eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHH----HHHcCC------
Confidence 43322 2334578999999999999999999999999999999998 788876433221 110 001100
Q ss_pred cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 746 PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 746 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+...+.++.+|+.+||+.||++|||+.||++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 227 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1122334557889999999999999999999999998765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=395.39 Aligned_cols=260 Identities=27% Similarity=0.397 Sum_probs=212.4
Q ss_pred hcCcccccccccCCcEeEEEEEe------cCccEEEEEEcccCC-cccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCe
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL------FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~ 583 (834)
.++|++.++||+|+||.||+|++ ..++.||||+++... .....+|.+|+.++.++ +|||||++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 47899999999999999999975 346789999997643 33456799999999999 69999999999999999
Q ss_pred EEEEEEecCCCCcchhccccc---------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 584 KILILEYMPNKSLDVYLFDPI---------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
.++||||+++|+|.+++.... ....+++..+++++.||++||+|||+++ |+||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999985432 2336899999999999999999999998 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCC-CCCCCCCcccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKN-TGVYNTDSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p-~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............||+.|+|||.+.+..++.++|||||||+||||++++.| +....... .+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-~~ 257 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-KF 257 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-HH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-HH
Confidence 99999999999999987655444444556899999999999999999999999999999999995544 43322211 11
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+++.... ....+...+.++.+|+.+||+.||++||||.||+++|++.
T Consensus 258 -------------~~~i~~~~-~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 258 -------------YKMIKEGF-RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp -------------HHHHHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -------------HHHHhcCC-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 01111111 1222334557899999999999999999999999999865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=388.46 Aligned_cols=256 Identities=27% Similarity=0.356 Sum_probs=197.4
Q ss_pred cCcccccccccCCcEeEEEEEecC----ccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN----GQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
++|++.+.||+|+||.||+|+... ...||||+++.. .....++|.+|+.++++++|||||+++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 679999999999999999998532 247899998754 23445789999999999999999999999965 4678
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|++.+++.. ....+++..+++++.|||+||+|||+++ |+||||||+||||+.++.+||+|||+++.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999887743 3456999999999999999999999987 999999999999999999999999999987
Q ss_pred CCCCcc-CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 666 GGDELQ-GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 666 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
...... .......||..|+|||.+.+..++.++|||||||++|||++ |+.||....... .. ......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~--~~---~~i~~~------ 230 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--IL---HKIDKE------ 230 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH---HHHHTS------
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH--HH---HHHHhC------
Confidence 554322 22334567889999999999999999999999999999998 899986432211 10 011010
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.. ....+...+..+.+++.+||+.||++||||.||+++|.+.
T Consensus 231 ---~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 ---GE-RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CC-CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00 1122233456889999999999999999999999999764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=392.18 Aligned_cols=269 Identities=25% Similarity=0.337 Sum_probs=201.2
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHH--HHHHHhhcCCCceeeEEEEEEeCC----eEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKN--EMMLIAELQHRNLVRILGCCVEQG----EKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~--E~~~l~~l~H~niv~l~~~~~~~~----~~~l 586 (834)
++|.+.++||+|+||.||+|++ +|+.||||+++... .+.+.. |+..+.+++|||||++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 5678889999999999999986 68899999986532 233344 555556789999999999998754 5799
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS-----RLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
||||+++|+|..+|. ...++|..+++++.|+|.||+|||+.. ..+|+||||||+||||+.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~----~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHH----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 999999999999994 346899999999999999999999741 24599999999999999999999999999
Q ss_pred ceecCCCCcc--CCceeeeccCcccCceeecCCC------CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc---
Q 003274 662 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALDGL------FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH--- 730 (834)
Q Consensus 662 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~--- 730 (834)
++........ .......||+.|+|||++.+.. ++.++|||||||+||||++|..|++............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9987543321 2233467999999999987643 6789999999999999999998876544322111110
Q ss_pred --hhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 731 --AWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 731 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...........+.+++.+.....+.+....+.+++.+||+.||++|||+.||++.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 00000111111122222211111233556799999999999999999999999999876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=392.78 Aligned_cols=259 Identities=28% Similarity=0.427 Sum_probs=208.8
Q ss_pred hcCcccccccccCCcEeEEEEEecC--------ccEEEEEEcccCCc-ccHHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLFN--------GQEVAVKRLSSQSG-QGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQ 581 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~ 581 (834)
.++|.+.++||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4789999999999999999997422 34799999976543 4457889999999998 899999999999999
Q ss_pred CeEEEEEEecCCCCcchhccccc-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEe
Q 003274 582 GEKILILEYMPNKSLDVYLFDPI-------------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLL 648 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl 648 (834)
+..++||||+++|+|.+++.... ....+++..+++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999985432 1245899999999999999999999998 9999999999999
Q ss_pred ccCCCeeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhc-CCCCCCCCCCCcccc
Q 003274 649 DKDMNPKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLS-SRKNTGVYNTDSFNL 727 (834)
Q Consensus 649 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~ellt-G~~p~~~~~~~~~~~ 727 (834)
+.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |.+|+.....+.
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~--- 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--- 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH---
Confidence 9999999999999998766554445555678999999999999999999999999999999998 677775333211
Q ss_pred ccchhhhhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 728 LGHAWDLWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 728 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
....+..+. ....+...+.++.+|+.+||+.||++|||+.||++.|+++
T Consensus 246 ---~~~~i~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 246 ---LFKLLKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp ---HHHHHHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHcCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111111110 1122334456899999999999999999999999999876
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=384.35 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=204.0
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC------cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS------GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
+.|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 6799999999999999999986 568999999986432 224678999999999999999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC----Ceeeccccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM----NPKISDFGL 661 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGl 661 (834)
+|||||++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 9999999999999984 3457999999999999999999999998 99999999999998776 499999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
++....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||....... ... .. .....
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~---~i-~~~~~- 233 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLA---NV-SAVNY- 233 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---HH-HTTCC-
T ss_pred hhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HHH---HH-HhcCC-
Confidence 988754332 223578999999999999999999999999999999999999986432211 000 00 00000
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 234 -----~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 -----EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp -----CC-CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CC-CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00001123457889999999999999999999975
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-45 Score=390.87 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=205.0
Q ss_pred cCcccccccccCCcEeEEEEEecC-cc--EEEEEEcccC-CcccHHHHHHHHHHHhhc-CCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFN-GQ--EVAVKRLSSQ-SGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~~~~~~lV 587 (834)
++|++.++||+|+||+||+|++.+ +. .||||+++.. .....+.|.+|+++|.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 788999999999999999998643 33 5788887643 344567899999999999 799999999999999999999
Q ss_pred EEecCCCCcchhcccc-------------cccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCe
Q 003274 588 LEYMPNKSLDVYLFDP-------------IKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNP 654 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~ 654 (834)
|||+++|+|.++|+.. .....+++..+.+++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999998643 23467999999999999999999999987 9999999999999999999
Q ss_pred eecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCC-CCCCCCCCccccccchhh
Q 003274 655 KISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRK-NTGVYNTDSFNLLGHAWD 733 (834)
Q Consensus 655 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~-p~~~~~~~~~~~~~~~~~ 733 (834)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|.. |+...... .+..
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~--~~~~---- 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYE---- 237 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--HHHH----
Confidence 999999998653322 2223568999999999999999999999999999999999765 55432211 1110
Q ss_pred hhcccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 734 LWKHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 734 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
.... .. ....+...+.++.+|+.+||+.||++||||.||++.|+++..
T Consensus 238 ~i~~---------~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 238 KLPQ---------GY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp HGGG---------TC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHh---------cC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0000 00 112334456789999999999999999999999999988743
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=392.55 Aligned_cols=247 Identities=24% Similarity=0.311 Sum_probs=207.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|.+.++||+|+||.||+++. .+|+.||||++++. .....+.+.+|+.+|++++||||+++++++.+....++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 6899999999999999999985 56899999998653 2335677899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~---~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhh---cccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999998873 4567899999999999999999999998 999999999999999999999999999876433
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
. ......+||+.|+|||++.+..|+.++|||||||+||||++|++||...+... +. ......
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~----~~i~~~---------- 220 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LF----ELILME---------- 220 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHC----------
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HH----HHHhcC----------
Confidence 2 22334689999999999999999999999999999999999999986433211 10 000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
...++...+.++.+|+.+||+.||++||+ +.|+++
T Consensus 221 -~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 11233445567899999999999999995 788875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=387.23 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=203.0
Q ss_pred ccccccCCcEeEEEEEecCc----cEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe-CCeEEEEEEec
Q 003274 518 QCKLGEGGFGPVYKGRLFNG----QEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE-QGEKILILEYM 591 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~-~~~~~lV~Ey~ 591 (834)
.++||+|+||+||+|++.++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999986442 26899999753 44556789999999999999999999999876 45889999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
++|+|.+++.. ....+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++.+......
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999998743 3446788999999999999999999987 999999999999999999999999999987544322
Q ss_pred C--CceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 672 G--NTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 672 ~--~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
. ......||+.|+|||.+....++.++||||||++||||++|+.|+....... ++.. ... .+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-~~~~---~i~-~g~---------- 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITV---YLL-QGR---------- 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHH---HHH-TTC----------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-HHHH---HHH-cCC----------
Confidence 2 2233568999999999999999999999999999999999887765322111 1111 000 000
Q ss_pred cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcccC
Q 003274 750 QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEHL 791 (834)
Q Consensus 750 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~ 791 (834)
....+.....++.++|.+||+.||++||+|.||++.|+++..
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111223345688999999999999999999999999998743
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-44 Score=388.24 Aligned_cols=244 Identities=26% Similarity=0.363 Sum_probs=205.0
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999996 46899999998643 2345678999999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+++|+|..++ .....+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHH---HHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccc---cccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999998887 34566889999999999999999999988 999999999999999999999999999886533
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...+... .. ..+...
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~------------~~i~~~-- 216 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TY------------EKILNA-- 216 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH------------HHHHHC--
T ss_pred -----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--HH------------HHHHcC--
Confidence 234689999999999999999999999999999999999999986432111 00 000000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
....+.....++.+++.+||+.||.+|| ++.++++
T Consensus 217 -~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1122333456789999999999999996 8999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=389.52 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=211.3
Q ss_pred hcCcccccccccCCcEeEEEEEec------CccEEEEEEcccC-CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRLF------NGQEVAVKRLSSQ-SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEK 584 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~ 584 (834)
.++|.+.++||+|+||+||+|++. .++.||||+++.. .......|.+|++++++++|||||++++++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 378899999999999999999753 3578999999754 334456799999999999999999999999999999
Q ss_pred EEEEEecCCCCcchhccccc-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 585 ILILEYMPNKSLDVYLFDPI-------KKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
++||||+++|+|..++.... ....+++..+.+++.|+|+||+|||+++ |+||||||+||||++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 99999999999999885321 1234789999999999999999999987 9999999999999999999999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCC-CCCCCCCCCccccccchhhhhc
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSR-KNTGVYNTDSFNLLGHAWDLWK 736 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~ 736 (834)
|||+++.+.............||+.|+|||.+.+..++.++||||||++||||++|. +|+......+ .. ...
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--~~----~~i- 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--VL----RFV- 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--HH----HHH-
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--HH----HHH-
Confidence 999998776554444444557899999999999999999999999999999999986 5554322111 00 011
Q ss_pred ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 737 HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 737 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
.+.. ....+...+..+.+++.+||+.+|++||||.+|+++|++.
T Consensus 249 -------~~~~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 249 -------MEGG--LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp -------HTTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -------HhCC--CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 1111 1112333456899999999999999999999999999876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.4e-44 Score=388.24 Aligned_cols=244 Identities=20% Similarity=0.261 Sum_probs=205.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC---CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ---SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~ 588 (834)
++|++.++||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 6899999999999999999986 46899999998643 2344577899999999999999999999999999999999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGD 668 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 668 (834)
||+.+|+|..++. +...+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999998883 3457999999999999999999999998 999999999999999999999999999986532
Q ss_pred CccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccccccc
Q 003274 669 ELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVI 748 (834)
Q Consensus 669 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 748 (834)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...... .+.. .. ...
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~----~i--------~~~-- 253 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYE----KI--------VSG-- 253 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH----HH--------HHC--
T ss_pred -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHHH----HH--------hcC--
Confidence 23368999999999999999999999999999999999999998643211 1100 00 000
Q ss_pred ccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 749 LQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 749 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
....+.....++.+++.+||+.||++|+ ++.|+++
T Consensus 254 -~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 -KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1122334456889999999999999994 8999986
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.6e-44 Score=379.32 Aligned_cols=258 Identities=24% Similarity=0.327 Sum_probs=200.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC---cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----eE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS---GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----EK 584 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~ 584 (834)
++|.+.+.||+|+||+||+|+. .+|+.||||+++... ....+.|.+|++++++++|||||++++++.... ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 6799999999999999999985 568999999997543 234567999999999999999999999998654 37
Q ss_pred EEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 585 ILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 585 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
++||||+++++|..++. ....+++.++..++.||++||+|||+++ |+||||||+||||+.++..+|+|||.+..
T Consensus 87 ~lvmE~~~g~~L~~~~~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEECCCCCEehhhhc---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 89999999999998873 4457999999999999999999999988 99999999999999999999999999887
Q ss_pred cCCCC-ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccc
Q 003274 665 FGGDE-LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHEL 743 (834)
Q Consensus 665 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 743 (834)
..... .........||+.|+|||++.+..++.++|||||||+||||++|+.||....... ...........
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-----~~~~~~~~~~~--- 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-----VAYQHVREDPI--- 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHCCCC---
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-----HHHHHHhcCCC---
Confidence 64332 2223344679999999999999999999999999999999999999986432111 00111111000
Q ss_pred cccccccCCCCHHHHhHHHHHHHhccccCCCCCC-CHHHHHHHHhcc
Q 003274 744 MDPVILQDEIPLPMLMRYVNVALLCVQENAADRP-TMSDVVSMISNE 789 (834)
Q Consensus 744 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~ 789 (834)
.+. ......+.++.+++.+||+.||++|| +++++++.|.++
T Consensus 233 -~~~----~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 -PPS----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -CGG----GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -CCc----hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 000 11122346789999999999999999 899999888765
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-43 Score=374.18 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=203.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc---------ccHHHHHHHHHHHhhcC-CCceeeEEEEEEeC
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG---------QGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQ 581 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~ 581 (834)
++|++.+.||+|+||+||+++. .+++.+|||++..... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999985 5689999999865431 12346889999999996 99999999999999
Q ss_pred CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
+..+|||||+++|+|.+++. ....+++..+..++.||++||+|||+++ |+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 99999999999999999984 3457999999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeec------CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhh
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYAL------DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLW 735 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 735 (834)
++.+.... ......||+.|+|||++. ...++.++||||+||+||||++|+.||....... .. ...
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~~----~~i 227 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--ML----RMI 227 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHH
T ss_pred eeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--HH----HHH
Confidence 99875433 223357999999999985 3457899999999999999999999987433211 00 000
Q ss_pred cccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 736 KHERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 736 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... + . ........+.++.+++.+||+.||++||++.|+++
T Consensus 228 ~~~~~-~-----~-~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MSGNY-Q-----F-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHTCC-C-----C-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HhCCC-C-----C-CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000 0 0 11112234568999999999999999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=386.52 Aligned_cols=247 Identities=23% Similarity=0.340 Sum_probs=203.2
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccC---CcccHHHHHHHHHHHh-hcCCCceeeEEEEEEeCCeEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQ---SGQGLKEFKNEMMLIA-ELQHRNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~~E~~~l~-~l~H~niv~l~~~~~~~~~~~lV 587 (834)
++|.+.++||+|+||+||+|+.. +++.||||++++. .....+.+..|..++. .++|||||++++++.+++..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999864 6899999999643 2334566777777765 57999999999999999999999
Q ss_pred EEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCC
Q 003274 588 LEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGG 667 (834)
Q Consensus 588 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 667 (834)
|||+++|+|..++. ....+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999984 4456899999999999999999999998 99999999999999999999999999987644
Q ss_pred CCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPV 747 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 747 (834)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ......
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~----~~i~~~--------- 218 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LF----HSIRMD--------- 218 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HHHHHC---------
T ss_pred cc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HH----HHHHcC---------
Confidence 32 22334679999999999999999999999999999999999999986433211 10 000000
Q ss_pred cccCCCCHHHHhHHHHHHHhccccCCCCCCCHH-HHHH
Q 003274 748 ILQDEIPLPMLMRYVNVALLCVQENAADRPTMS-DVVS 784 (834)
Q Consensus 748 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~ 784 (834)
....+.....++.+|+.+||+.||++||++. |+++
T Consensus 219 --~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1122333456789999999999999999995 6753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-43 Score=387.58 Aligned_cols=248 Identities=25% Similarity=0.303 Sum_probs=199.1
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC---cccHHHHHH---HHHHHhhcCCCceeeEEEEEEeCCeEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS---GQGLKEFKN---EMMLIAELQHRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~---E~~~l~~l~H~niv~l~~~~~~~~~~~ 585 (834)
++|.+.++||+|+||.||+|+.. +|+.||||++.... ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 68999999999999999999864 68999999985421 122233444 466777778999999999999999999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceec
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMF 665 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 665 (834)
+||||+++|+|..++. +...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999984 4467889999999999999999999998 999999999999999999999999999977
Q ss_pred CCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccccc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELM 744 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 744 (834)
.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||........... .. ...
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------~~-----~~~ 222 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI------DR-----MTL 222 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH------HH-----HSS
T ss_pred CCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH------HH-----hcc
Confidence 5432 233579999999999974 5689999999999999999999999975433221100 00 000
Q ss_pred ccccccCCCCHHHHhHHHHHHHhccccCCCCCCC-----HHHHHH
Q 003274 745 DPVILQDEIPLPMLMRYVNVALLCVQENAADRPT-----MSDVVS 784 (834)
Q Consensus 745 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~ 784 (834)
.. ....+.....++.+++.+||+.||++||| +.|+++
T Consensus 223 ~~---~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 223 TM---AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SC---CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred cC---CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00 11122334567899999999999999999 688875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=377.78 Aligned_cols=246 Identities=18% Similarity=0.270 Sum_probs=203.5
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
++|.+.++||+|+||+||+|+.. +++.||||.++... .....+.+|+++|++++|||||++++++.+.+..++|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 78999999999999999999864 68899999997643 33456889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC--CCeeecccccceecCCCC
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD--MNPKISDFGLARMFGGDE 669 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DFGla~~~~~~~ 669 (834)
++|+|.+++.. ....+++.++..++.||++||+|||+++ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999998843 2346899999999999999999999988 9999999999999854 589999999998764432
Q ss_pred ccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccccccccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHELMDPVIL 749 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 749 (834)
......+|+.|+|||.+.+..++.++|||||||+||||++|+.||....... .. . .++...
T Consensus 159 ---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~~---~---------~i~~~~-- 219 (321)
T d1tkia_ 159 ---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--II---E---------NIMNAE-- 219 (321)
T ss_dssp ---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH---H---------HHHHTC--
T ss_pred ---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH--HH---H---------HHHhCC--
Confidence 2334578999999999999999999999999999999999999986433211 00 0 000000
Q ss_pred cCCCCH----HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 750 QDEIPL----PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 750 ~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
...+. ..+.++.+++.+||+.||++|||+.|+++
T Consensus 220 -~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 220 -YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111 13457899999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-43 Score=376.01 Aligned_cols=257 Identities=26% Similarity=0.306 Sum_probs=194.1
Q ss_pred ccccccCCcEeEEEEEe-cCccEEEEEEcccCCcc-----cHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEec
Q 003274 518 QCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQ-----GLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEYM 591 (834)
Q Consensus 518 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey~ 591 (834)
.++||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++|||||++++++...+..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999985 45899999998654221 2356889999999999999999999999999999999999
Q ss_pred CCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCcc
Q 003274 592 PNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDELQ 671 (834)
Q Consensus 592 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 671 (834)
.++++..++ .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 998877665 34567889999999999999999999998 999999999999999999999999999876543322
Q ss_pred CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc---c---cccccc
Q 003274 672 GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH---E---RVHELM 744 (834)
Q Consensus 672 ~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~---~~~~~~ 744 (834)
.....||+.|+|||++... .++.++|||||||++|||++|.+||....... ........... . ......
T Consensus 157 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp --CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred --ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccchhccc
Confidence 2235799999999998754 68999999999999999999999986433211 10000000000 0 000000
Q ss_pred ccccc--cCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 745 DPVIL--QDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 745 ~~~~~--~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... ....+ .....++.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000 00111 122467899999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-43 Score=374.43 Aligned_cols=268 Identities=24% Similarity=0.320 Sum_probs=202.1
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
|+|++.++||+|+||+||+|+. .+|+.||||+++... ....+++.+|++++++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999985 568999999996542 2345789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
|+.++.+.... ......+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~--~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMD--ASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHH--HTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCchhhhhh--hhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99866554332 224456999999999999999999999998 9999999999999999999999999998765433
Q ss_pred ccCCceeeeccCcccCceeecCCC-CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc------ccccc
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH------ERVHE 742 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~ 742 (834)
. ......||+.|+|||.+.... ++.++|||||||++|||++|+.||....... ........... .....
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 232 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS 232 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGG
T ss_pred c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccc
Confidence 2 223357999999999887665 5799999999999999999999986433211 00000000000 00000
Q ss_pred ccc--ccc-ccCCC-----CHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 743 LMD--PVI-LQDEI-----PLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 743 ~~~--~~~-~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
..+ ... ..... ......++.+++.+||+.||++|||+.|+++ .|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 000 000 00000 1123467899999999999999999999998 36554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=378.50 Aligned_cols=250 Identities=18% Similarity=0.194 Sum_probs=197.0
Q ss_pred cCccccc-ccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhc-CCCceeeEEEEEEe----CCeEE
Q 003274 513 ENFSMQC-KLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAEL-QHRNLVRILGCCVE----QGEKI 585 (834)
Q Consensus 513 ~~f~~~~-~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~H~niv~l~~~~~~----~~~~~ 585 (834)
++|.+.+ +||+|+||+||+|+. .+++.||||+++.. +.+.+|+.++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 6788764 699999999999985 56899999998642 4678899987765 89999999999875 45689
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc---CCCeeecccccc
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK---DMNPKISDFGLA 662 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla 662 (834)
+|||||++|+|.+++... ....+++.++..++.||+.||+|||+++ |+||||||+|||++. ++.+||+|||++
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999998532 2346899999999999999999999998 999999999999985 567999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
+....... .....||+.|||||++.+..|+.++|||||||+||||++|+.||........ ..... ..
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~~~~--------~~ 228 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMK--------TR 228 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------C
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--HHHHH--------HH
Confidence 88754332 2335799999999999999999999999999999999999999864332110 00000 00
Q ss_pred ccccccc-cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 743 LMDPVIL-QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 743 ~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+...... ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0000000 00011223568999999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.4e-42 Score=367.15 Aligned_cols=262 Identities=22% Similarity=0.330 Sum_probs=201.2
Q ss_pred cCcccccccccCCcEeEEEEEecCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~Ey 590 (834)
++|.+.++||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.+|++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999998889999999986543 33457899999999999999999999999999999999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCCc
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDEL 670 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 670 (834)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 9988777665 34567999999999999999999999987 99999999999999999999999999987654332
Q ss_pred cCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcc------cccccc
Q 003274 671 QGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKH------ERVHEL 743 (834)
Q Consensus 671 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~ 743 (834)
......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ........... ....+.
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCChhhccchhhh
Confidence 2233468999999999875 457999999999999999999999986433211 00000000000 000000
Q ss_pred --ccccc-c-----cCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 744 --MDPVI-L-----QDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 744 --~~~~~-~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..... . ...........+.+++.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0 01112223467889999999999999999999973
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-43 Score=369.49 Aligned_cols=239 Identities=21% Similarity=0.336 Sum_probs=194.8
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCc------ccHHHHHHHHHHHhhcC--CCceeeEEEEEEeCCe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSG------QGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQGE 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~ 583 (834)
++|.+.++||+|+||+||+|+. .+|+.||||++..... ....++.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999985 5689999999864321 12234678999999996 8999999999999999
Q ss_pred EEEEEEecCC-CCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccC-CCeeeccccc
Q 003274 584 KILILEYMPN-KSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKD-MNPKISDFGL 661 (834)
Q Consensus 584 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGl 661 (834)
.++||||+.+ +++.+++ .....++++++..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~---~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHH---HHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 5666665 24567999999999999999999999998 9999999999999855 7999999999
Q ss_pred ceecCCCCccCCceeeeccCcccCceeecCCCC-CccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccc
Q 003274 662 ARMFGGDELQGNTKRIVGTYGYMSPEYALDGLF-SIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERV 740 (834)
Q Consensus 662 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 740 (834)
++...... .....||+.|+|||++.+..+ +.++|||||||+||||++|+.||..... ... .
T Consensus 158 a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----------i~~-~-- 219 (273)
T d1xwsa_ 158 GALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----------IIR-G-- 219 (273)
T ss_dssp CEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----------HHH-C--
T ss_pred ceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----------Hhh-c--
Confidence 98754332 234679999999999987765 5779999999999999999999863210 000 0
Q ss_pred ccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 741 HELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 741 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....+...+.++.+++.+||+.||++|||+.|+++
T Consensus 220 ---------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ---------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 00112223467899999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-42 Score=366.14 Aligned_cols=263 Identities=24% Similarity=0.367 Sum_probs=196.6
Q ss_pred hcCcccccccccCCcEeEEEEEe-cC-ccEEEEEEcccCC--cccHHHHHHHHHHHhhc---CCCceeeEEEEEEe----
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FN-GQEVAVKRLSSQS--GQGLKEFKNEMMLIAEL---QHRNLVRILGCCVE---- 580 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~-~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~H~niv~l~~~~~~---- 580 (834)
.++|++.++||+|+||+||+|+. .+ ++.||||+++... ......+.+|+.+++.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999986 33 5679999986432 22234566788877766 79999999999863
Q ss_pred -CCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccc
Q 003274 581 -QGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDF 659 (834)
Q Consensus 581 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 659 (834)
....+++|||+.++++..... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 246799999999987754432 34566899999999999999999999988 999999999999999999999999
Q ss_pred ccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhh-----
Q 003274 660 GLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDL----- 734 (834)
Q Consensus 660 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~----- 734 (834)
|+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ........
T Consensus 161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCC
T ss_pred hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCc
Confidence 9988654322 2334679999999999999999999999999999999999999997543211 00000000
Q ss_pred ---hccc-cc-cccccccc--ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 735 ---WKHE-RV-HELMDPVI--LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 735 ---~~~~-~~-~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
+... .. ........ ............+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 00 00000000 000112223467889999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=364.58 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=195.9
Q ss_pred CcccccccccCCcEeEEEEEec-CccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------eEEE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------EKIL 586 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------~~~l 586 (834)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+++|++++||||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999964 689999999965432 2347999999999999999999986532 4789
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-Ceeecccccceec
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMF 665 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~ 665 (834)
||||++++.+..+.........+++..+..++.||++||+|||+++ |+||||||+||||+.++ .+||+|||+++.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987755544433345567999999999999999999999987 99999999999999775 8999999999887
Q ss_pred CCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch-------hhhhcc
Q 003274 666 GGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA-------WDLWKH 737 (834)
Q Consensus 666 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~-------~~~~~~ 737 (834)
...... ....||+.|+|||.+.+ ..++.++||||+||++|||++|++||........ +.... ...+..
T Consensus 174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHH
T ss_pred cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhh
Confidence 544322 23578999999998875 5789999999999999999999999865432110 00000 000000
Q ss_pred c--cccccccccc----ccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 738 E--RVHELMDPVI----LQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 738 ~--~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
. ......-+.. ...........++.+|+.+||+.||++|||+.|+++ .++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 0 0000000000 000111223557899999999999999999999986 34443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-40 Score=360.07 Aligned_cols=265 Identities=23% Similarity=0.315 Sum_probs=195.7
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEe--------C
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVE--------Q 581 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~--------~ 581 (834)
++|++.++||+|+||+||+|+. .+|+.||||++... .+...+++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999995 57899999998543 33345678999999999999999999999865 3
Q ss_pred CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeeccccc
Q 003274 582 GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGL 661 (834)
Q Consensus 582 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 661 (834)
...++||||+.++.+..+. .....++...+..++.||++||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 4679999999988776554 34456889999999999999999999988 99999999999999999999999999
Q ss_pred ceecCCCCcc--CCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-ccccchh-----
Q 003274 662 ARMFGGDELQ--GNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLGHAW----- 732 (834)
Q Consensus 662 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~~~~----- 732 (834)
++.+...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ .......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9877543322 122235799999999998765 689999999999999999999999864332111 0000000
Q ss_pred ---hhhcccccccccccccccCCCCH-------HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 733 ---DLWKHERVHELMDPVILQDEIPL-------PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 733 ---~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
................ ...... .....+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCS-SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhccccchhhhhhhhcccc-cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 0000000000000000 001111 11346788999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-40 Score=355.58 Aligned_cols=260 Identities=20% Similarity=0.263 Sum_probs=196.3
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCcee-eEEEEEEeCCeEEEEEEe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNLV-RILGCCVEQGEKILILEY 590 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~niv-~l~~~~~~~~~~~lV~Ey 590 (834)
++|++.++||+|+||.||+|+. .+|+.||||++..... .+++..|++++++++|+|++ .+..+..+....++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 5799999999999999999985 5689999998865432 24578999999999877654 555666778888999999
Q ss_pred cCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEec---cCCCeeecccccceecCC
Q 003274 591 MPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLD---KDMNPKISDFGLARMFGG 667 (834)
Q Consensus 591 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~~~ 667 (834)
+.+ +|...+. .....+++..+..++.|+++||+|||+++ |+||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 LGP-SLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CCC-BHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred cCC-chhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 954 5544442 23457999999999999999999999998 99999999999985 456799999999998754
Q ss_pred CCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhccccccc
Q 003274 668 DELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVHE 742 (834)
Q Consensus 668 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 742 (834)
.... .......||+.|||||.+.+..++.++|||||||++|||++|+.||............ ... ......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~--~~~-~~~~~~- 234 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY--ERI-SEKKMS- 234 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H--HHH-HHHHHH-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH--HHh-hcccCC-
Confidence 3321 2233467999999999999999999999999999999999999998754432211100 000 000000
Q ss_pred ccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhcc
Q 003274 743 LMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNE 789 (834)
Q Consensus 743 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~ 789 (834)
...+. .....+.++.+++..||+.+|++||++.++.+.|+..
T Consensus 235 ~~~~~-----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 235 TPIEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp SCHHH-----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred CChhH-----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 00000 0112346789999999999999999999998888765
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-40 Score=350.61 Aligned_cols=263 Identities=21% Similarity=0.271 Sum_probs=203.5
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCCeEEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~~~~lV~E 589 (834)
++|++.++||+|+||+||+|+. .+++.||||+++... ....+++.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999995 568899999986542 3446789999999999999999999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecCCCC
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFGGDE 669 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 669 (834)
++.+++|..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999887763 4567889999999999999999999988 9999999999999999999999999999875433
Q ss_pred ccCCceeeeccCcccCceeecCCC-CCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhc------------
Q 003274 670 LQGNTKRIVGTYGYMSPEYALDGL-FSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWK------------ 736 (834)
Q Consensus 670 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~------------ 736 (834)
.. .....+++.|+|||.+.... ++.++|||||||++|||++|+.|+.........+ ........
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL-KRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH-HHHHHHHCCCCTTTCTTGGG
T ss_pred cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH-HHHHhhcCCCChhhhhhhhh
Confidence 22 22245788999999987665 6999999999999999999999864332211111 00000000
Q ss_pred --ccccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 737 --HERVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 737 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
........................+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000011122334567889999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.4e-40 Score=350.30 Aligned_cols=262 Identities=16% Similarity=0.211 Sum_probs=204.4
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCeEEEEEE
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGEKILILE 589 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~~~lV~E 589 (834)
.++|.+.++||+|+||+||+|+. .+|+.||||++.... ..+.+.+|++++..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 36899999999999999999985 468899999886543 23457889999999965 899999999999999999999
Q ss_pred ecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEecc-----CCCeeeccccccee
Q 003274 590 YMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDK-----DMNPKISDFGLARM 664 (834)
Q Consensus 590 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGla~~ 664 (834)
|+ +++|..++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 6888887632 3456899999999999999999999998 999999999999974 57899999999998
Q ss_pred cCCCCcc-----CCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc
Q 003274 665 FGGDELQ-----GNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER 739 (834)
Q Consensus 665 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 739 (834)
+...... .......||+.|||||++.+..++.++|||||||++|||++|+.||........... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~---~~~i~~~~ 232 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK---YERIGEKK 232 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH---HHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH---HHHHHhcc
Confidence 7543211 123346799999999999999999999999999999999999999975433221100 00000000
Q ss_pred cccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHHHHhccc
Q 003274 740 VHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVSMISNEH 790 (834)
Q Consensus 740 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~ 790 (834)
.. ...+.+ .. ..+.++.+++..|+..+|++||+++.+.+.|+++.
T Consensus 233 ~~-~~~~~l-~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 233 QS-TPLREL-CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HH-SCHHHH-TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred CC-CChHHh-cC----CCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 00 000000 11 12357889999999999999999999988887653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-39 Score=352.95 Aligned_cols=257 Identities=19% Similarity=0.299 Sum_probs=197.4
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeC--CeEEEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQ--GEKILIL 588 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~--~~~~lV~ 588 (834)
++|++.++||+|+||+||+|+. .+++.||||+++.. ..+++.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 6899999999999999999986 56899999998653 3467889999999995 99999999999854 5689999
Q ss_pred EecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCC-CeeecccccceecCC
Q 003274 589 EYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDM-NPKISDFGLARMFGG 667 (834)
Q Consensus 589 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~ 667 (834)
||+.+++|..+. +.+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997653 35899999999999999999999998 99999999999998655 699999999988754
Q ss_pred CCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccch--------hhhhccc
Q 003274 668 DELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHA--------WDLWKHE 738 (834)
Q Consensus 668 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~--------~~~~~~~ 738 (834)
... .....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.............. .......
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~ 259 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence 332 2335789999999998765 579999999999999999999999865443221100000 0000000
Q ss_pred ------ccccccc-------cccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 739 ------RVHELMD-------PVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 739 ------~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
....... ..............++.+|+.+||+.||++|||++|+++
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000 000011112233567899999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=354.95 Aligned_cols=252 Identities=23% Similarity=0.313 Sum_probs=201.2
Q ss_pred cCcccccccccCCcEeEEEEEe----cCccEEEEEEcccCC----cccHHHHHHHHHHHhhcCC-CceeeEEEEEEeCCe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL----FNGQEVAVKRLSSQS----GQGLKEFKNEMMLIAELQH-RNLVRILGCCVEQGE 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~H-~niv~l~~~~~~~~~ 583 (834)
++|++.++||+|+||+||+|+. ..|+.||||.++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999974 247899999986432 2345678899999999966 899999999999999
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.+++|||+.+|+|.+++. ....++...+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999883 4456788999999999999999999988 9999999999999999999999999998
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCC--CCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccccc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDG--LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHERVH 741 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 741 (834)
.+....... .....|++.|+|||.+.+. .++.++|||||||+||||++|+.||........ ........
T Consensus 178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~~~~------ 248 (322)
T d1vzoa_ 178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRI------ 248 (322)
T ss_dssp ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHH------
T ss_pred hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhc------
Confidence 765433222 2335789999999999754 478899999999999999999999865433221 00000000
Q ss_pred cccccccccCCCCHHHHhHHHHHHHhccccCCCCCC-----CHHHHHH
Q 003274 742 ELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRP-----TMSDVVS 784 (834)
Q Consensus 742 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~ 784 (834)
... ....+.....++.+++.+||+.||++|| |++|+++
T Consensus 249 --~~~---~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 --LKS---EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp --HHC---CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred --ccC---CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 000 1122334567899999999999999999 4788876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-40 Score=361.28 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=196.2
Q ss_pred cCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC-cccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC----eEEE
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS-GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG----EKIL 586 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~----~~~l 586 (834)
++|.+.++||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 5799999999999999999985 578999999997543 334567899999999999999999999997653 3456
Q ss_pred EEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccceecC
Q 003274 587 ILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLARMFG 666 (834)
Q Consensus 587 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 666 (834)
+++|+.+|+|.+++. ...+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 l~~~~~~g~L~~~l~----~~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 667788999999883 346899999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCcc-CCceeeeccCcccCceeec-CCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccchhhhhcccc-----
Q 003274 667 GDELQ-GNTKRIVGTYGYMSPEYAL-DGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGHAWDLWKHER----- 739 (834)
Q Consensus 667 ~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 739 (834)
..... .......||+.|+|||++. ...++.++||||+||++|||++|+.||........ ............
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQEDLN 238 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHHhhhccCCChhhhh
Confidence 43322 2234467999999999985 45678999999999999999999999864332110 000000000000
Q ss_pred ------cccccccccccCCCCH-----HHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 740 ------VHELMDPVILQDEIPL-----PMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 740 ------~~~~~~~~~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
..............+. ....++.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000011111 12357889999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=359.83 Aligned_cols=262 Identities=24% Similarity=0.302 Sum_probs=194.0
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccC--CcccHHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQ--SGQGLKEFKNEMMLIAELQHRNLVRILGCCVEQG------ 582 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~~------ 582 (834)
.++|.+.++||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 36899999999999999999985 46899999999753 2334567899999999999999999999998654
Q ss_pred eEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccc
Q 003274 583 EKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLA 662 (834)
Q Consensus 583 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 662 (834)
+.++||||+ +.+|..++ +...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 579999999 45565554 3457999999999999999999999998 999999999999999999999999999
Q ss_pred eecCCCCccCCceeeeccCcccCceeecC-CCCCccccchhhHHHHHHHhcCCCCCCCCCCCccccccc----------h
Q 003274 663 RMFGGDELQGNTKRIVGTYGYMSPEYALD-GLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFNLLGH----------A 731 (834)
Q Consensus 663 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~~~~~----------~ 731 (834)
+..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........ +... .
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ-LKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCHHH
T ss_pred eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH-HHHHHhccCCCcHHH
Confidence 876432 233578999999999876 4578999999999999999999999865432110 0000 0
Q ss_pred hhhhccc-------ccccccccccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 732 WDLWKHE-------RVHELMDPVILQDEIPLPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 732 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
....... ...+...... ..........+.+|+.+||+.||++|||+.|+++ .|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HhhhcchhhhhhhccCCcccccch--HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 0000000 0000000000 0111223457789999999999999999999987 36554
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-38 Score=346.88 Aligned_cols=260 Identities=23% Similarity=0.261 Sum_probs=188.8
Q ss_pred cCcccccccccCCcEeEEEEEec-CccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEe------CCe
Q 003274 513 ENFSMQCKLGEGGFGPVYKGRLF-NGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVE------QGE 583 (834)
Q Consensus 513 ~~f~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~------~~~ 583 (834)
++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999854 68999999997542 3345678999999999999999999999964 368
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++||||+.++.+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 8999999987665443 235889999999999999999999998 9999999999999999999999999988
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCccc--c----ccchhhhhcc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSFN--L----LGHAWDLWKH 737 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~~--~----~~~~~~~~~~ 737 (834)
...... ......+|+.|+|||++.+..++.++||||+||+++||++|+.||......... . .......+..
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 754332 233457899999999999999999999999999999999999998643211100 0 0000000000
Q ss_pred ----------cc-------cccccccccccCC--CCHHHHhHHHHHHHhccccCCCCCCCHHHHHH
Q 003274 738 ----------ER-------VHELMDPVILQDE--IPLPMLMRYVNVALLCVQENAADRPTMSDVVS 784 (834)
Q Consensus 738 ----------~~-------~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~ 784 (834)
.. ............. .......++.+|+.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000000000001 11234568899999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=346.81 Aligned_cols=266 Identities=24% Similarity=0.295 Sum_probs=196.5
Q ss_pred hcCcccccccccCCcEeEEEEEe-cCccEEEEEEcccCC--cccHHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Ce
Q 003274 512 TENFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQS--GQGLKEFKNEMMLIAELQHRNLVRILGCCVEQ-----GE 583 (834)
Q Consensus 512 ~~~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~H~niv~l~~~~~~~-----~~ 583 (834)
.++|++.++||+|+||+||+|+. .+|+.||||+++... ....+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999985 569999999997543 23456788999999999999999999998643 34
Q ss_pred EEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeecccccce
Q 003274 584 KILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKISDFGLAR 663 (834)
Q Consensus 584 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 663 (834)
.++++||+.+|+|.+++. .+.+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 577788899999999883 346999999999999999999999998 9999999999999999999999999997
Q ss_pred ecCCCCccCCceeeeccCcccCceeecCC-CCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-cccc-----chhhhhc
Q 003274 664 MFGGDELQGNTKRIVGTYGYMSPEYALDG-LFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-NLLG-----HAWDLWK 736 (834)
Q Consensus 664 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~~~~-----~~~~~~~ 736 (834)
..... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ ..+. .......
T Consensus 170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 64322 2335789999999987765 468999999999999999999999864332110 0000 0000000
Q ss_pred cc---ccccccccccccCCCC-----HHHHhHHHHHHHhccccCCCCCCCHHHHHH--HHhcc
Q 003274 737 HE---RVHELMDPVILQDEIP-----LPMLMRYVNVALLCVQENAADRPTMSDVVS--MISNE 789 (834)
Q Consensus 737 ~~---~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~ 789 (834)
.. ................ .....++.+|+.+||+.||++|||+.|+++ .+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 00 0000000000000111 113457889999999999999999999987 45443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7e-35 Score=320.09 Aligned_cols=262 Identities=18% Similarity=0.228 Sum_probs=192.1
Q ss_pred CcccccccccCCcEeEEEEEe-cCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-----------CCceeeEEEEEEeC
Q 003274 514 NFSMQCKLGEGGFGPVYKGRL-FNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-----------HRNLVRILGCCVEQ 581 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------H~niv~l~~~~~~~ 581 (834)
+|++.++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 489999999999999999985 568999999997543 23467788999998885 57899999888643
Q ss_pred --CeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEeccCCC-----
Q 003274 582 --GEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMN----- 653 (834)
Q Consensus 582 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl~~~~~----- 653 (834)
...+++++++..+..............+++..+..++.||++||+|||+ .+ |+||||||+||||+.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 4667778877666554444334455678899999999999999999998 55 999999999999987654
Q ss_pred -eeecccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHHHHHhcCCCCCCCCCCCcc-c----c
Q 003274 654 -PKISDFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILMLETLSSRKNTGVYNTDSF-N----L 727 (834)
Q Consensus 654 -~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll~elltG~~p~~~~~~~~~-~----~ 727 (834)
+|++|||.+...... .....||+.|+|||++.+..++.++||||+||+++||++|+.||........ . +
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 999999999865322 2335799999999999999999999999999999999999999864332110 0 0
Q ss_pred ccchh-------hhh----------ccccccccccc---------ccccCCCCHHHHhHHHHHHHhccccCCCCCCCHHH
Q 003274 728 LGHAW-------DLW----------KHERVHELMDP---------VILQDEIPLPMLMRYVNVALLCVQENAADRPTMSD 781 (834)
Q Consensus 728 ~~~~~-------~~~----------~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e 781 (834)
..... ... ........+.. .............++.+|+.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 00000 000 00000000000 00112334556788999999999999999999999
Q ss_pred HHH
Q 003274 782 VVS 784 (834)
Q Consensus 782 vl~ 784 (834)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.86 E-value=6.7e-22 Score=174.55 Aligned_cols=107 Identities=25% Similarity=0.426 Sum_probs=95.0
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||.|.+|++|. +|.|.|.|+.+|| +.||. ..++||.||++.| +..+.|.|+.||+|||++++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~~Gnlvl~~~~ 68 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD---VDKPIWATNTGGL--SRSCFLSMQTDGNLVVYNPS 68 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe---CCceeeEeCCCCC--CCccEEEEeccceEEEECCC
Confidence 47899999999999995 5999999999998 77764 3588999999887 56789999999999999999
Q ss_pred CCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCC
Q 003274 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~ 151 (834)
|.+||+|++.+.....+|+|+||||||||+. .+||||+|
T Consensus 69 g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~--------~~W~S~t~ 107 (108)
T d1jpca_ 69 NKPIWASNTGGQNGNYVCILQKDRNVVIYGT--------DRWATGTH 107 (108)
T ss_dssp CCEEEECCCCCSCSCEEEEECTTSCEEEEEC--------CCCCCCCC
T ss_pred ccceEEccccCCCCcEEEEEcCCCCEEEeCC--------CcccCCCC
Confidence 9999999987776777899999999999975 38999988
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.86 E-value=1.3e-21 Score=174.47 Aligned_cols=112 Identities=24% Similarity=0.448 Sum_probs=97.0
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
+|+|.+||.|.+|++|+| |.|.|+|+.+|| +.++. ..++||.||++.| +..+.|.|+.||+|||+++
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~---~~~~vW~s~~~~~--~~~~~l~l~~dGnLvl~~~- 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD---NNRAVWASGTNGK--ASGCVLKMQNDGNLVIYSG- 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCTTS--CSSEEEEECTTSCEEEEET-
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc---CCcEEEEccCccC--CCCcEEEEeccccEEEEec-
Confidence 489999999999999975 999999999998 66654 4589999999887 4567899999999999996
Q ss_pred CCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCch
Q 003274 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSD 154 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtD 154 (834)
+.++|++++.+......|+|+|+||||||+.++ .++|||+.+|+|
T Consensus 68 ~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~~-----~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 SRAIWASNTNRQNGNYYLILQRDRNVVIYDNSN-----NAIWATHTNVGN 112 (112)
T ss_dssp TEEEEECCCCCSCCCCEEEECTTSCEEEECTTS-----CEEEECCCCCCC
T ss_pred CCeEEEEeeccCCCceEEEEcCCCCEEEECCCC-----cEEecCCCccCC
Confidence 678899887776677889999999999998643 689999999985
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.85 E-value=2.9e-21 Score=170.40 Aligned_cols=108 Identities=19% Similarity=0.352 Sum_probs=94.1
Q ss_pred ccccCCceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCC
Q 003274 25 ADTMTTASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQT 104 (834)
Q Consensus 25 ~~~l~~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~ 104 (834)
.|+|.+||.|.+|++|.+ |.|.|+|+.+|+ +.++. ..++||+||++.|. ...+.|.|+.||+|||+|++
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~---~~~~vW~ant~~~~-~~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD---HSTSVWASNTGILG-KKGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE---TTEEEEECCCCCTT-CCCCEEEECTTSCEEEECSS
T ss_pred CCCccCCCEEeCCCEEEe--CCEEEEecCCCe-----EEEEe---CCEEEEEeCCCCCC-ceeEEEEEcCCceEEEEeCC
Confidence 378999999999999975 889999999987 55543 45899999999997 45788999999999999999
Q ss_pred CCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCC
Q 003274 105 NGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDH 151 (834)
Q Consensus 105 ~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~ 151 (834)
|.+||+|+++...+.+.|+|+||||||||++ .+|||+-|
T Consensus 70 g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~--------~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSVRGNGNYVLVLQEDGNVVIYGS--------DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCCCCSSCCEEEECTTSCEEEECC--------EEEECCCC
T ss_pred CcEEEEEeeECCCCCEEEEEeCCCcEEEECC--------CEecCCCc
Confidence 9999999987666778899999999999964 39999865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.84 E-value=7.4e-22 Score=194.94 Aligned_cols=169 Identities=18% Similarity=0.181 Sum_probs=120.7
Q ss_pred ccccccccCCcEeEEEEEecCccEEEEEEcccCCc------------------ccHHHHHHHHHHHhhcCCCceeeEEEE
Q 003274 516 SMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSG------------------QGLKEFKNEMMLIAELQHRNLVRILGC 577 (834)
Q Consensus 516 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~H~niv~l~~~ 577 (834)
.+.++||+|+||+||+|+..+|+.||||+++.... .....+..|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988899999998753210 012334568889999999999988765
Q ss_pred EEeCCeEEEEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCEEeccCCCeeec
Q 003274 578 CVEQGEKILILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYSRLRIIHRDLKASNVLLDKDMNPKIS 657 (834)
Q Consensus 578 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 657 (834)
. ..+++|||+++..+.. ++.....+++.|++++|+|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 2379999998866533 233445679999999999999988 9999999999999865 48999
Q ss_pred ccccceecCCCCccCCceeeeccCcccCceeecCCCCCccccchhhHHHH
Q 003274 658 DFGLARMFGGDELQGNTKRIVGTYGYMSPEYALDGLFSIKSDVFSFGILM 707 (834)
Q Consensus 658 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGvll 707 (834)
|||+|.....+....... ..... -.|. ....|+.++|+||..--+
T Consensus 145 DFG~a~~~~~~~~~~~l~---rd~~~-~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 145 DFPQSVEVGEEGWREILE---RDVRN-IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCTTCEETTSTTHHHHHH---HHHHH-HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHHH---HHHHH-HHHH-HcCCCCCcccHHHHHHHH
Confidence 999998754322110000 00000 0011 235678899999975444
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.67 E-value=1.7e-16 Score=141.38 Aligned_cols=101 Identities=21% Similarity=0.412 Sum_probs=83.7
Q ss_pred eeccCCCeE--EeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCCCCeEE
Q 003274 32 SFIRDGEKL--TSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIW 109 (834)
Q Consensus 32 ~~l~~~~~l--~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w 109 (834)
|.|.++|.| .+..|.|.|.|+.+|| |.+ |+ ..++||.||+..+ +..+.|.|+.||+|||+|++|.+||
T Consensus 15 ~~l~~~q~l~~~~~~~~y~l~mQ~DGN-----LVL-y~--~~~~vWssnt~~~--~~~~~l~l~~dGnLvL~d~~g~~vW 84 (119)
T d1b2pa_ 15 QILHATESLEILFGTHVYRFIMQTDCN-----LVL-YD--NNNPIWATNTGGL--GNGCRAVLQPDGVLVVITNENVTVW 84 (119)
T ss_dssp CEEETTCEEEEEETTEEEEEEECTTSC-----EEE-EE--TTEEEEECCCTTS--CSSCEEEECTTSCEEEECTTCCEEE
T ss_pred CEEeCCCeEEEecCCceEEEEECCCCc-----EEE-EE--CCeEEEEecCCCC--CcceEEEEEeCCCEEEECCCCcEEE
Confidence 455555554 5679999999999998 555 33 4688999999876 4568999999999999999999999
Q ss_pred EEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccC
Q 003274 110 STNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFD 150 (834)
Q Consensus 110 ~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd 150 (834)
++++.+.....+++|+||||||||++ ++|||-.
T Consensus 85 sS~t~~~~~~~~l~Lq~DGNlvlYg~--------~~W~S~T 117 (119)
T d1b2pa_ 85 QSPVAGKAGHYVLVLQPDRNVVIYGD--------ALWATQT 117 (119)
T ss_dssp ECSCCCCSSCEEEEECTTSCEEEEES--------EEEECCC
T ss_pred ECCCcCCCCceEEEEcCCCCEEEECC--------CEeccCC
Confidence 99988776777899999999999964 4999964
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.60 E-value=5.8e-16 Score=138.30 Aligned_cols=102 Identities=22% Similarity=0.332 Sum_probs=85.6
Q ss_pred EEEEeec-CCeeEEeeCCCCCCCCCCceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCcc
Q 003274 63 GIWFRRV-PDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTA 141 (834)
Q Consensus 63 ~iw~~~~-~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~ 141 (834)
.|||..+ .++.+|++|++.|+....-+|.|+.||||||+++ +.++|++++.+.+....|+|+++|||||++.++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~~---- 85 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQN---- 85 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETTT----
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcCCC----
Confidence 5788876 5789999999999977777999999999999985 788999998877777889999999999998753
Q ss_pred ccceeeccCCCchhhhccccccccccCCCceEEEEcCCCCCCCCCceeecccccCCceEE
Q 003274 142 ESYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMC 201 (834)
Q Consensus 142 ~~~~WqSFd~PtDTlLpg~klg~~~~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~ 201 (834)
+++||||. +.++|.|.+.++++|...++
T Consensus 86 -~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 86 -IAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp -EEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred -CEEEEeCC-------------------------------CCCCCcEEEEECCCCcEEEe
Confidence 78999972 34567888999999887654
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.51 E-value=9.1e-15 Score=128.97 Aligned_cols=98 Identities=23% Similarity=0.376 Sum_probs=80.9
Q ss_pred ceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCCCCeEEE
Q 003274 31 ASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWS 110 (834)
Q Consensus 31 ~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~ 110 (834)
.|.|.++|.| .+|.|.|.|+.+|| |.++. ...+||.+|... ...+.+.|+.||||||+|.++.+||+
T Consensus 14 ~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~---~~~~vW~s~t~~---~~~~~l~l~~dGNLvl~d~~~~~vWs 80 (115)
T d1dlpa1 14 PQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD---SDVRVWASNTAG---ATGCRAVLQSDGLLVILTAQNTIRWS 80 (115)
T ss_dssp CSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE---SSSEEECCCCCS---CSCCBCCBCSSSCBCCBCTTTCCSCC
T ss_pred cceecCCCcE--EcCCEEEEECCCCe-----EEEEc---CCeeEEEcccCC---CCceEEEEeccCCEEEEccCCCEEEE
Confidence 3556666666 46889999999998 76653 357899998653 33678999999999999999999999
Q ss_pred EcccCCCCCceEEEccCCCEEEecCCCCCccccceeecc
Q 003274 111 TNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSF 149 (834)
Q Consensus 111 ~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSF 149 (834)
+++....+.++++|++|||||||+. .+|+|-
T Consensus 81 S~t~~~~g~y~l~Lq~DGNlvlY~~--------~~Wssg 111 (115)
T d1dlpa1 81 SGTKGSIGNYVLVLQPDRTVTIYGP--------GLWDSG 111 (115)
T ss_dssp CCCCCCSSCCEEEECSSSCEEEECS--------EEEECS
T ss_pred cCCCCCCCCEEEEECCCCcEEEeCC--------CeecCC
Confidence 9988777888899999999999964 499985
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.46 E-value=1.8e-14 Score=127.08 Aligned_cols=109 Identities=22% Similarity=0.276 Sum_probs=86.4
Q ss_pred EEEeec-CCeeEEeeCCCCCCCCCCceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccc
Q 003274 64 IWFRRV-PDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAE 142 (834)
Q Consensus 64 iw~~~~-~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~ 142 (834)
|||.-. ..+..|..+.+.++.....+|.|+.||||||++ .+.++|++++.+. ....+.|+++|||||++.++
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~-~~~~l~l~~dGNLvl~d~~~----- 75 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGA-TGCRAVLQSDGLLVILTAQN----- 75 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSC-SCCBCCBCSSSCBCCBCTTT-----
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCC-CceEEEEeccCCEEEEccCC-----
Confidence 555433 457778899999997777899999999999998 5789999998653 46778999999999998753
Q ss_pred cceeeccCCCchhhhccccccccccCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeecc
Q 003274 143 SYLWQSFDHPSDTLLQDMKLGWDFKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (834)
Q Consensus 143 ~~~WqSFd~PtDTlLpg~klg~~~~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
.+||||+- +.+.|.|.+.|+++|...++ ...+|.+|.
T Consensus 76 ~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGT 112 (115)
T ss_dssp CCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSC
T ss_pred CEEEEcCC-------------------------------CCCCCCEEEEECCCCcEEEe----CCCeecCCC
Confidence 68999862 34689999999999986543 236887763
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.35 E-value=1.2e-12 Score=116.46 Aligned_cols=99 Identities=22% Similarity=0.380 Sum_probs=79.8
Q ss_pred CceeccCCCeEEeCCCeEEEEEeCCCCCCCeEEEEEEeecCCeeEEeeCCCCCCCCCCceEEEecCCceEEecCCCCeEE
Q 003274 30 TASFIRDGEKLTSSSQRFELGFFSPGKSKSRYLGIWFRRVPDTVVWVANRDRPISGRNAVLTISNNGNLVLLSQTNGTIW 109 (834)
Q Consensus 30 ~~~~l~~~~~l~s~~g~f~lgf~~~~~~~~~~~~iw~~~~~~~~vW~anr~~p~~~~~~~l~~~~~g~l~l~~~~~~~~w 109 (834)
+.+.|.+++.| ..|.|.|.|..+|+ |.++. ...+||.++... .+..+.+.|+.+|||||+|.++.+||
T Consensus 22 ~~~~l~~~q~l--~~g~y~L~~q~DGN-----LvL~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~~~~lW 89 (120)
T d1dlpa2 22 HPQTLHATQSL--QLSPYRLSMETDCN-----LVLFD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQNIAVW 89 (120)
T ss_dssp CCCEECSSCCC--BCSSCEEEEETTTE-----EEEEB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETTTEEEE
T ss_pred cccEEcCCCee--EcCCEEEEEcCCCc-----EEEec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCCCCEEE
Confidence 34566677777 35789999999987 66642 357899887543 35678899999999999999999999
Q ss_pred EEcccCCCCCceEEEccCCCEEEecCCCCCccccceeec
Q 003274 110 STNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQS 148 (834)
Q Consensus 110 ~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqS 148 (834)
+|++.+..+.+.++|++|||||||+. .+|.|
T Consensus 90 ~S~t~~~~~~~~l~Lq~DGnlvlY~~--------~~W~t 120 (120)
T d1dlpa2 90 TSGNSRSAGRYVFVLQPDRNLAIYGG--------ALWTT 120 (120)
T ss_dssp ECCCCCSSSCCEEEECSSSCEEEECC--------CCCBC
T ss_pred EeCCCCCCCcEEEEECCCCcEEEeCC--------CcccC
Confidence 99987777778899999999999964 38986
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.91 E-value=2.3e-09 Score=94.54 Aligned_cols=84 Identities=26% Similarity=0.326 Sum_probs=65.4
Q ss_pred eEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccccC
Q 003274 89 VLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDFKS 168 (834)
Q Consensus 89 ~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~~~ 168 (834)
+|.|+.||||||+++ +.++|++++.+......+.|+++|||||++..+ .++|+|.
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~g-----~~vWsS~------------------- 87 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNEN-----VTVWQSP------------------- 87 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEECS-------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCCCCcceEEEEEeCCCEEEECCCC-----cEEEECC-------------------
Confidence 688999999999975 678999998877667889999999999998753 6799862
Q ss_pred CCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeec
Q 003274 169 GLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSG 213 (834)
Q Consensus 169 g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
+.-+.|.|.+.|+.+|...++ ..+.|.++
T Consensus 88 ------------t~~~~~~~~l~Lq~DGNlvlY----g~~~W~S~ 116 (119)
T d1b2pa_ 88 ------------VAGKAGHYVLVLQPDRNVVIY----GDALWATQ 116 (119)
T ss_dssp ------------CCCCSSCEEEEECTTSCEEEE----ESEEEECC
T ss_pred ------------CcCCCCceEEEEcCCCCEEEE----CCCEeccC
Confidence 111346788889998887654 23577765
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.87 E-value=2.7e-09 Score=92.65 Aligned_cols=78 Identities=26% Similarity=0.417 Sum_probs=61.2
Q ss_pred CceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccc
Q 003274 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~ 166 (834)
.-+|.|+.||||||++ .+.+||++++.+.+....++|+++|||||++.++ +++|+|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~g-----~~vWsS------------------ 75 (108)
T d1jpca_ 20 SFVFIMQEDCNLVLYD-VDKPIWATNTGGLSRSCFLSMQTDGNLVVYNPSN-----KPIWAS------------------ 75 (108)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECTTC-----CEEEEC------------------
T ss_pred CEEEEECCCCeEEEEe-CCceeeEeCCCCCCCccEEEEeccceEEEECCCc-----cceEEc------------------
Confidence 3468899999999997 5689999998877667789999999999998753 689986
Q ss_pred cCCCceEEEEcCCCCCCCCCceeecccccCCceEE
Q 003274 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMC 201 (834)
Q Consensus 167 ~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~ 201 (834)
.+..+.+.|.+.|+.+|...++
T Consensus 76 -------------~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 -------------NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp -------------CCCCSCSCEEEEECTTSCEEEE
T ss_pred -------------cccCCCCcEEEEEcCCCCEEEe
Confidence 1112456778888888877654
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.69 E-value=3.8e-08 Score=85.25 Aligned_cols=87 Identities=24% Similarity=0.344 Sum_probs=63.3
Q ss_pred CceEEEecCCceEEecCCCCeEEEEcccCCC-CCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhcccccccc
Q 003274 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDV-KNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWD 165 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~-~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~ 165 (834)
.-.|.|+.||||||+. .+.+||++++.... ....+.|+++|||||++.++ .++|+|
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~g-----~~vW~s----------------- 76 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAEG-----RSLWAS----------------- 76 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSSS-----CEEEEC-----------------
T ss_pred CEEEEecCCCeEEEEe-CCEEEEEeCCCCCCceeEEEEEcCCceEEEEeCCC-----cEEEEE-----------------
Confidence 3568899999999997 56899999986433 35678999999999998753 689987
Q ss_pred ccCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeecc
Q 003274 166 FKSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSGQ 214 (834)
Q Consensus 166 ~~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g~ 214 (834)
.+....|.|.+.|+.+|...++ + ...|.++.
T Consensus 77 --------------~t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t 107 (109)
T d1kj1a_ 77 --------------HSVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGT 107 (109)
T ss_dssp --------------CCCCCSSCCEEEECTTSCEEEE--C--CEEEECCC
T ss_pred --------------eeECCCCCEEEEEeCCCcEEEE--C--CCEecCCC
Confidence 1111346678888888877643 3 24676653
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.53 E-value=1.9e-07 Score=81.35 Aligned_cols=88 Identities=25% Similarity=0.414 Sum_probs=64.9
Q ss_pred CceEEEecCCceEEecCCCCeEEEEcccCCCCCceEEEccCCCEEEecCCCCCccccceeeccCCCchhhhccccccccc
Q 003274 87 NAVLTISNNGNLVLLSQTNGTIWSTNVSSDVKNPVAQLRDDGNLVIRDNSSDSTAESYLWQSFDHPSDTLLQDMKLGWDF 166 (834)
Q Consensus 87 ~~~l~~~~~g~l~l~~~~~~~~w~~~~~~~~~~~~~~l~d~gnlvl~~~~~~~~~~~~~WqSFd~PtDTlLpg~klg~~~ 166 (834)
.-.|.|+.||||||++ .+.+||++++.+......++|+.+|||||++.. +.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~~------~~~w~s------------------ 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSGS------RAIWAS------------------ 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEETT------EEEEEC------------------
T ss_pred CEEEEEcCCCCEEEEc-CCcEEEEccCccCCCCcEEEEeccccEEEEecC------CeEEEE------------------
Confidence 4578899999999997 578999999876666778899999999999853 356654
Q ss_pred cCCCceEEEEcCCCCCCCCCceeecccccCCceEEEecCCeeeEeec
Q 003274 167 KSGLERLLSSWQSAEDPSPGRYTYGLDIHVLPKMCTFNGSVKFTCSG 213 (834)
Q Consensus 167 ~~g~~~~l~sw~s~~dps~G~~~~~~~~~~~~~~~~~~~~~~~~~~g 213 (834)
.+.-..|.|.+.|+.+|...++- ......|.++
T Consensus 75 -------------~t~~~~~~~~l~L~ddGNlvly~-~~~~~~W~S~ 107 (112)
T d1xd5a_ 75 -------------NTNRQNGNYYLILQRDRNVVIYD-NSNNAIWATH 107 (112)
T ss_dssp -------------CCCCSCCCCEEEECTTSCEEEEC-TTSCEEEECC
T ss_pred -------------eeccCCCceEEEEcCCCCEEEEC-CCCcEEecCC
Confidence 11223466788898888876542 2244678775
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.40 E-value=7.9e-07 Score=89.93 Aligned_cols=149 Identities=16% Similarity=0.124 Sum_probs=104.3
Q ss_pred HHHHHhcCcccccccccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC-CCceeeEEEEEEeCCeEE
Q 003274 507 SVAAATENFSMQCKLGEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ-HRNLVRILGCCVEQGEKI 585 (834)
Q Consensus 507 ~~~~~~~~f~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-H~niv~l~~~~~~~~~~~ 585 (834)
++...-+.|...+..+.++...||+.. .+++.++||+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 344455677776655555567899986 456678889886655445556788999888774 444677888888888999
Q ss_pred EEEEecCCCCcchhcccccccCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------
Q 003274 586 LILEYMPNKSLDVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQYS--------------------------------- 632 (834)
Q Consensus 586 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~~~--------------------------------- 632 (834)
+|||++++..+....... .....++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998875543211 112334555666666666321
Q ss_pred -----------------------CCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 633 -----------------------RLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 633 -----------------------~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12379999999999999877677999998754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=2e-05 Score=78.76 Aligned_cols=131 Identities=20% Similarity=0.193 Sum_probs=88.1
Q ss_pred ccccCC-cEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcC--CCceeeEEEEEEeCCeEEEEEEecCCCCc
Q 003274 520 KLGEGG-FGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQ--HRNLVRILGCCVEQGEKILILEYMPNKSL 596 (834)
Q Consensus 520 ~lG~G~-fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--H~niv~l~~~~~~~~~~~lV~Ey~~~gsL 596 (834)
.+..|. -+.||+....++..+++|...... ...+..|+..++.+. .-.+.+++.+..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344454 367999988788889999865443 234677888888774 33466778888888899999999988776
Q ss_pred chhcccccccCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 003274 597 DVYLFDPIKKRLLDWEARIRIIQGIAQGLLYLHQ---------------------------------------------- 630 (834)
Q Consensus 597 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gl~~LH~---------------------------------------------- 630 (834)
.... ... ...+.++++.|+-||+
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 4321 111 1112233333333332
Q ss_pred -----c----CCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 631 -----Y----SRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 631 -----~----~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
. .+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 122389999999999999877778999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.43 E-value=0.00021 Score=76.14 Aligned_cols=76 Identities=11% Similarity=0.176 Sum_probs=49.5
Q ss_pred cccccCCcEeEEEEEecC-ccEEEEEEcccC-------CcccHHHHHHHHHHHhhc-CC--CceeeEEEEEEeCCeEEEE
Q 003274 519 CKLGEGGFGPVYKGRLFN-GQEVAVKRLSSQ-------SGQGLKEFKNEMMLIAEL-QH--RNLVRILGCCVEQGEKILI 587 (834)
Q Consensus 519 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~-------~~~~~~~~~~E~~~l~~l-~H--~niv~l~~~~~~~~~~~lV 587 (834)
+.||.|....||+....+ ++.++||.-... -+...++...|.+.|..+ .+ ..+.+++.+ +....++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 478999999999998644 678999964321 122344566788888777 33 335555544 44566899
Q ss_pred EEecCCCCc
Q 003274 588 LEYMPNKSL 596 (834)
Q Consensus 588 ~Ey~~~gsL 596 (834)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.47 E-value=0.0047 Score=63.42 Aligned_cols=135 Identities=13% Similarity=0.137 Sum_probs=79.4
Q ss_pred EeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce--eeEE-----EEEEeCCeEEEEEEecCCCCcchh
Q 003274 527 GPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL--VRIL-----GCCVEQGEKILILEYMPNKSLDVY 599 (834)
Q Consensus 527 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~-----~~~~~~~~~~lV~Ey~~~gsL~~~ 599 (834)
-.||+++.++|+.+++|+.+... ...+++..|...+..|....+ +..+ ......+..+.+++++++..+...
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 47999999999999999986542 245678889988888842222 1111 122345677899999987654311
Q ss_pred c--------------cc------ccccCCCCH-------------------HHHHHHHHHHHHHHHHHH----hcCCCCe
Q 003274 600 L--------------FD------PIKKRLLDW-------------------EARIRIIQGIAQGLLYLH----QYSRLRI 636 (834)
Q Consensus 600 l--------------~~------~~~~~~l~~-------------------~~~~~i~~~ia~gl~~LH----~~~~~~i 636 (834)
- +. ......+++ ..+..+...+.+.++.+. +..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 00 000111111 111112222233333332 2234568
Q ss_pred EecCCCCCCEEeccCCCeeeccccccee
Q 003274 637 IHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 637 vH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
+|+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999743 45899998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.31 E-value=0.0048 Score=65.21 Aligned_cols=77 Identities=17% Similarity=0.280 Sum_probs=50.7
Q ss_pred CcccccccccCCcEeEEEEEecCc--------cEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce-eeEEEEEEeCCeE
Q 003274 514 NFSMQCKLGEGGFGPVYKGRLFNG--------QEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL-VRILGCCVEQGEK 584 (834)
Q Consensus 514 ~f~~~~~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni-v~l~~~~~~~~~~ 584 (834)
++++ +.|+.|---.+|++...++ +.|.+++.. ... ......+|..+++.+.-.++ .++++++..
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~---- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence 3444 5788888889999986543 456666654 222 23345689999998843344 467776643
Q ss_pred EEEEEecCCCCcc
Q 003274 585 ILILEYMPNKSLD 597 (834)
Q Consensus 585 ~lV~Ey~~~gsL~ 597 (834)
.+|+||+++..+.
T Consensus 117 g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 117 GRLEEYIPSRPLS 129 (395)
T ss_dssp EEEECCCCEEECC
T ss_pred ceEEEEeccccCC
Confidence 6899999876553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.88 E-value=0.12 Score=51.84 Aligned_cols=158 Identities=13% Similarity=0.035 Sum_probs=82.9
Q ss_pred cHHHHHHHhcCccccccc-----ccCCcEeEEEEEecCccEEEEEEcccCCcccHHHHHHHHHHHhhcCCCce--eeEE-
Q 003274 504 SLASVAAATENFSMQCKL-----GEGGFGPVYKGRLFNGQEVAVKRLSSQSGQGLKEFKNEMMLIAELQHRNL--VRIL- 575 (834)
Q Consensus 504 ~~~~~~~~~~~f~~~~~l-----G~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~H~ni--v~l~- 575 (834)
+.+++..-..+|.+.+.. ..|---+.|+.+..+| .+++|+..... ..++...|++++..|.+.++ ...+
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence 445566666777664443 3565678899987665 58899886532 23455567777777743221 1111
Q ss_pred -----EEEEeCCeEEEEEEecCCCCcchhcc--------------------cccccCCCC------------------HH
Q 003274 576 -----GCCVEQGEKILILEYMPNKSLDVYLF--------------------DPIKKRLLD------------------WE 612 (834)
Q Consensus 576 -----~~~~~~~~~~lV~Ey~~~gsL~~~l~--------------------~~~~~~~l~------------------~~ 612 (834)
.+.........++.++.+........ ......... ..
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 11223445667777776654421110 000000000 00
Q ss_pred HHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCEEeccCCCeeeccccccee
Q 003274 613 ARIRIIQGIAQGLLYLHQ-YSRLRIIHRDLKASNVLLDKDMNPKISDFGLARM 664 (834)
Q Consensus 613 ~~~~i~~~ia~gl~~LH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 664 (834)
.....+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 111122222222222221 2234599999999999999888778999999854
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.98 E-value=0.094 Score=32.94 Aligned_cols=32 Identities=31% Similarity=0.576 Sum_probs=25.7
Q ss_pred CCCCCCCCCCCCCccCCC-CCCCccccccceecc
Q 003274 286 QYCGKYGYCGANTICSLD-QTPMCECLEGFKLKS 318 (834)
Q Consensus 286 ~~Cd~~~~CG~~g~C~~~-~~~~C~C~~Gf~~~~ 318 (834)
|.|.+-..|| +|.|+.- ..-.|.|-+||+|..
T Consensus 2 dECsignpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSVGNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGTTCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred CccccCCccC-CceeeecccceEEeecCCcCCCc
Confidence 6799999999 7899743 334699999999954
|